<SEC-DOCUMENT>0000883237-24-000050.txt : 20240508
<SEC-HEADER>0000883237-24-000050.hdr.sgml : 20240508
<ACCEPTANCE-DATETIME>20240508082515
ACCESSION NUMBER:		0000883237-24-000050
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		81
CONFORMED PERIOD OF REPORT:	20240331
FILED AS OF DATE:		20240508
DATE AS OF CHANGE:		20240508

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			VIRTUS INVESTMENT PARTNERS, INC.
		CENTRAL INDEX KEY:			0000883237
		STANDARD INDUSTRIAL CLASSIFICATION:	INVESTMENT ADVICE [6282]
		ORGANIZATION NAME:           	02 Finance
		IRS NUMBER:				263962811
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-10994
		FILM NUMBER:		24924373

	BUSINESS ADDRESS:	
		STREET 1:		ONE FINANCIAL PLAZA
		STREET 2:		26TH FLOOR
		CITY:			HARTFORD
		STATE:			CT
		ZIP:			06103
		BUSINESS PHONE:		860-263-4707

	MAIL ADDRESS:	
		STREET 1:		ONE FINANCIAL PLAZA
		STREET 2:		26TH FLOOR
		CITY:			HARTFORD
		STATE:			CT
		ZIP:			06103

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PHOENIX INVESTMENT PARTNERS LTD/CT
		DATE OF NAME CHANGE:	19990312

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PHOENIX DUFF & PHELPS CORP
		DATE OF NAME CHANGE:	19951117

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DUFF & PHELPS CORP
		DATE OF NAME CHANGE:	19930328
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>vrts-20240331.htm
<DESCRIPTION>10-Q VRTS 03.31.2024
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:571d5707-32d3-4d02-bf11-c9dc53da4569,g:f6b55787-7777-46c4-a428-e04c6c3401d1,d:b5b8a7200088450192ffaafa34312190-->
<html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:vrts="http://www.virtus.com/20240331" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:ecd="http://xbrl.sec.gov/ecd/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>vrts-20240331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-25">false</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-26">2024</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-27">Q1</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-28">0000883237</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" id="f-29">--12-31</ix:nonNumeric><ix:nonNumeric contextRef="c-135" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="f-529">P1Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="vrts-20240331.xsd"/></ix:references><ix:resources><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="collateralized_loan_obligation"><xbrli:measure>vrts:collateralized_loan_obligation</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-05-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vrts:InvestmentManagementFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vrts:InvestmentManagementFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vrts:DistributionAndServiceFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vrts:DistributionAndServiceFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vrts:AdministrationAndShareholderServiceFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vrts:AdministrationAndShareholderServiceFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vrts:OtherIncomeAndfeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vrts:OtherIncomeAndfeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vrts:OpenEndFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vrts:OpenEndFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vrts:ClosedEndFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vrts:ClosedEndFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vrts:RetailSeparateAccountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vrts:RetailSeparateAccountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vrts:InstitutionalAccountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vrts:InstitutionalAccountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vrts:AlphaSimplexGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vrts:AlphaSimplexGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">vrts:SponsoredFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">vrts:SponsoredFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">vrts:SponsoredFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">vrts:SponsoredFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">vrts:SponsoredFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">vrts:NonqualifiedRetirementPlanAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">vrts:NonqualifiedRetirementPlanAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">vrts:NonqualifiedRetirementPlanAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">vrts:NonqualifiedRetirementPlanAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vrts:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vrts:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vrts:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vrts:ContingentConsiderationLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">vrts:SponsoredFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">vrts:SponsoredFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">vrts:SponsoredFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">vrts:NonqualifiedRetirementPlanAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">vrts:NonqualifiedRetirementPlanAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">vrts:NonqualifiedRetirementPlanAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">vrts:NonqualifiedRetirementPlanAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vrts:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vrts:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vrts:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vrts:ContingentConsiderationLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vrts:WestchesterCapitalManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vrts:WestchesterCapitalManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vrts:WestchesterCapitalManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vrts:WestchesterCapitalManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputComparabilityAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vrts:NFJInvestmentGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vrts:NFJInvestmentGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vrts:NFJInvestmentGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputComparabilityAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vrts:NFJInvestmentGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vrts:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vrts:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vrts:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vrts:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-21</xbrli:startDate><xbrli:endDate>2024-02-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">vrts:RestrictedStockUnitsRSUsPerformanceBasedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">vrts:RestrictedStockUnitsRSUsPerformanceBasedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">vrts:PerformanceStockUnitsIncentiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">vrts:RestrictedStockUnitsandPerformanceSharesUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">vrts:RestrictedStockUnitsandPerformanceSharesUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">vrts:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vrts:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">vrts:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vrts:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-28</xbrli:startDate><xbrli:endDate>2021-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vrts:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vrts:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-28</xbrli:startDate><xbrli:endDate>2021-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">vrts:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">vrts:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">vrts:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vrts:CreditFacility2017Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VotingInterestEntityVOEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryGlobalAndPrivateFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VotingInterestEntityVOEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryGlobalAndPrivateFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vrts:SubordinatedNotesNewfleetCLO20161Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vrts:SeniorSecuredFloatingRateNotesNewfleetCLO20161Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vrts:SubordinatedNotesNewfleetCLO20161Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SubordinatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883237</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ib5b8a7200088450192ffaafa34312190_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:251.25pt"><tr><td style="width:1.0pt"/><td style="width:48.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:48.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:48.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:48.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:48.25pt"/><td style="width:1.0pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-Q</ix:nonNumeric> </span></div><div style="margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:251.25pt"><tr><td style="width:1.0pt"/><td style="width:48.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:48.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:48.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:48.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:48.25pt"/><td style="width:1.0pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:4.756%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:93.044%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="f-2">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3">March&#160;31, 2024</ix:nonNumeric> </span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:4.756%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:93.044%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-4">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> to </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-10994</ix:nonNumeric> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:251.25pt"><tr><td style="width:1.0pt"/><td style="width:48.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:48.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:48.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:48.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:48.25pt"/><td style="width:1.0pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><img src="vrts-20240331_g1.jpg" alt="vrtslogo2019a02.jpg" style="height:61px;margin-bottom:5pt;vertical-align:text-bottom;width:288px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:20pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-6">VIRTUS INVESTMENT PARTNERS, INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:251.25pt"><tr><td style="width:1.0pt"/><td style="width:48.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:48.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:48.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:48.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:48.25pt"/><td style="width:1.0pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:48.533%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.486%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-7">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-8">26-3962811</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-9">One Financial Plaza</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-10">Hartford</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-11">CT</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-12">06103</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive offices, including Zip Code)</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-13">800</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-14">248-7971</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:251.25pt"><tr><td style="width:1.0pt"/><td style="width:48.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:48.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:48.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:48.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:48.25pt"/><td style="width:1.0pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.233%"><tr><td style="width:1.0%"/><td style="width:40.752%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.657%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.713%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.657%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.521%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-15">Common Stock, $0.01 par value</ix:nonNumeric> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-16">VRTS</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-17">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-18">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746; No&#160;&#160;&#9744;</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-19">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;&#160;&#160;No&#160;&#160;&#9744;</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.</span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:24.825%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.122%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.825%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.608%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-20">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="f-21">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-22">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  &#160;&#9744;&#160;</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-23">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;No&#160;&#160;&#9746;</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares outstanding of the registrant&#8217;s common stock was <ix:nonFraction unitRef="shares" contextRef="c-2" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-24">7,127,881</ix:nonFraction> as of May&#160;1, 2024.</span></div><div style="margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ib5b8a7200088450192ffaafa34312190_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_7">Table of Contents</a></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIRTUS INVESTMENT PARTNERS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX </span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:8.270%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:84.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.025%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_10">Part&#160;I. FINANCIAL INFORMATION</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_13">Financial Statements</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_16">Condensed Consolidated Balance Sheets (Unaudited) as of </a><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_16">March</a><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_16"> 3</a><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_16">1</a><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_16">, 202</a><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_16">4</a><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_16"> and December 31, 202</a><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_16">3</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_16">1</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_19">Condensed Consolidated Statements of Operations (Unaudited) for the Three Months Ended March 31, 2024 and 2023</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_19">2</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_22">Condensed Consolidated Statements of Comprehensive Income (Unaudited) for the Three Months Ended March 31, 2024 and 2023</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_22">3</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_22">Condensed Consolidated Statements of Cash Flows (Unaudited) for the Three Months Ended March 31, 2024 and 2023</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_25">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_28">Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) for the Three Months Ended March 31, 2024 and 2023</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_28">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_31">Notes to Condensed Consolidated Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_34">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_94">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_94">18</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_100">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_100">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_103">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_103">28</a></span></div></td></tr><tr style="height:15pt"><td colspan="9" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_106">Part&#160;II. OTHER INFORMATION</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_109">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_109">29</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_112">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_112">29</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_115">Unregistered Sales of Equity Securities</a><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_115"> and </a><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_115">Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_115">29</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_118">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_118">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_121">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_121">30</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_124">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_124">31</a></span></div></td></tr></table></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"We," "us," "our," the "Company," and "Virtus" as used in this Quarterly Report on Form 10-Q (the "10-Q") refer to Virtus Investment Partners, Inc., a Delaware corporation, and its subsidiaries.</span></div><div style="margin-bottom:17pt;margin-top:17pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ib5b8a7200088450192ffaafa34312190_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_7">Table of Contents</a></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I &#8211; FINANCIAL INFORMATION</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div id="ib5b8a7200088450192ffaafa34312190_13"></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1.&#160;&#160;&#160;&#160;Financial Statements</span></div><div id="ib5b8a7200088450192ffaafa34312190_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Virtus Investment Partners, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.783%"><tr><td style="width:1.0%"/><td style="width:74.428%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.531%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.555%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.986%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in thousands, except share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-30">123,880</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-31">239,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="3" id="f-32">127,448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="3" id="f-33">132,696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccountsReceivableNet" format="ixt:num-dot-decimal" scale="3" id="f-34">116,387</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AccountsReceivableNet" format="ixt:num-dot-decimal" scale="3" id="f-35">109,076</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets of consolidated investment products ("CIP")</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents of CIP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-36">123,030</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-37">100,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash pledged or on deposit of CIP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" scale="3" id="f-38">767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" scale="3" id="f-39">680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments of CIP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="3" id="f-40">2,081,225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="3" id="f-41">2,082,713</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets of CIP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-42">31,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:OtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-43">43,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Furniture, equipment and leasehold improvements, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-44">26,088</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-45">26,216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-46">416,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-47">432,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-48">397,098</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-49">397,098</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred taxes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-50">23,974</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-51">25,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-52">79,596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-53">89,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-54">3,548,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-55">3,678,629</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities and Equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-56">95,591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-57">200,837</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-58">44,282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-59">38,756</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DividendsPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-60">16,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DividendsPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-61">17,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="f-62">66,704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="f-63">90,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-64">253,008</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-65">253,412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-66">67,460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-67">91,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities of CIP</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Notes payable of CIP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="3" id="f-68">1,922,051</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="3" id="f-69">1,922,243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Securities purchased payable and other liabilities of CIP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="vrts:SecuritiesPurchasedPayableAndOtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-70">91,288</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="vrts:SecuritiesPurchasedPayableAndOtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-71">90,523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-72">2,556,937</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-73">2,705,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commitments and Contingencies (Note 14)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-5" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-74"/></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-6" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-75"/></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-76">115,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-77">104,869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Equity attributable to Virtus Investment Partners, Inc.:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-78"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-79">0.01</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-80"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-81">1,000,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-82">12,224,489</ix:nonFraction> shares issued and <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-83">7,127,881</ix:nonFraction> shares outstanding at March&#160;31, 2024; and <ix:nonFraction unitRef="shares" contextRef="c-6" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-84">12,163,228</ix:nonFraction> shares issued and <ix:nonFraction unitRef="shares" contextRef="c-6" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-85">7,087,728</ix:nonFraction> shares outstanding at December&#160;31, 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-86">122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-87">122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-88">1,298,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-89">1,300,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained earnings (accumulated deficit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-90">223,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-91">207,356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-92">187</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-93">87</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury stock, at cost, <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-94">5,096,608</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-6" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-95">5,075,500</ix:nonFraction> shares at March&#160;31, 2024 and December&#160;31, 2023, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="3" id="f-96">649,463</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="3" id="f-97">644,464</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total equity attributable to Virtus Investment Partners, Inc.</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-98">871,652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-99">863,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="f-100">4,351</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="f-101">4,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total equity </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-102">876,003</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-103">868,289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities and equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-104">3,548,125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-105">3,678,629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="ib5b8a7200088450192ffaafa34312190_19"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_7">Table of Contents</a></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Virtus Investment Partners, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Operations</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.163%"><tr><td style="width:1.0%"/><td style="width:74.166%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.821%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.689%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.824%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in thousands, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment management fees</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-106">188,360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-107">164,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distribution and service fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-108">14,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-109">14,153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Administration and shareholder service fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-110">18,678</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-111">18,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income and fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-112">974</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-113">884</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-114">222,042</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-115">197,874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Expenses</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employment expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:LaborAndRelatedExpense" format="ixt:num-dot-decimal" scale="3" id="f-116">115,163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:LaborAndRelatedExpense" format="ixt:num-dot-decimal" scale="3" id="f-117">98,614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distribution and other asset-based expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" format="ixt:num-dot-decimal" scale="3" id="f-118">24,348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" format="ixt:num-dot-decimal" scale="3" id="f-119">23,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:OtherCostAndExpenseOperating" format="ixt:num-dot-decimal" scale="3" id="f-120">31,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" name="us-gaap:OtherCostAndExpenseOperating" format="ixt:num-dot-decimal" scale="3" id="f-121">30,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other operating expenses of consolidated investment products ("CIP")</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:OtherCostAndExpenseOperating" scale="3" id="f-122">690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:OtherCostAndExpenseOperating" scale="3" id="f-123">700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="f-124">797</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="3" id="f-125">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="f-126">2,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="f-127">1,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="vrts:AmortizationOfIntangibleAssetsAndContingentAmortization" format="ixt:num-dot-decimal" scale="3" id="f-128">15,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="vrts:AmortizationOfIntangibleAssetsAndContingentAmortization" format="ixt:num-dot-decimal" scale="3" id="f-129">14,391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-130">189,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-131">169,295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Income (Loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-132">32,306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-133">28,579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Income (Expense)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Realized and unrealized gain (loss) on investments, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:GainLossOnInvestments" format="ixt:num-dot-decimal" scale="3" id="f-134">3,416</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" name="us-gaap:GainLossOnInvestments" format="ixt:num-dot-decimal" scale="3" id="f-135">2,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Realized and unrealized gain (loss) of CIP, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:GainLossOnInvestments" format="ixt:num-dot-decimal" scale="3" id="f-136">1,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:GainLossOnInvestments" format="ixt:num-dot-decimal" scale="3" id="f-137">2,596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-138">550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-139">343</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-140">5,501</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-141">4,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest Income (Expense)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-142">5,681</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-143">5,005</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest and dividend income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:InvestmentIncomeInterestAndDividend" format="ixt:num-dot-decimal" scale="3" id="f-144">3,469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" name="us-gaap:InvestmentIncomeInterestAndDividend" format="ixt:num-dot-decimal" scale="3" id="f-145">3,238</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest and dividend income of investments of CIP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:InvestmentIncomeInterestAndDividend" format="ixt:num-dot-decimal" scale="3" id="f-146">51,115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:InvestmentIncomeInterestAndDividend" format="ixt:num-dot-decimal" scale="3" id="f-147">46,814</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense of CIP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-148">40,012</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-149">35,203</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total interest income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="f-150">8,891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="f-151">9,844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income (Loss) Before Income Taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-152">46,698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-153">43,346</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-154">8,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-155">8,703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Income (Loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-156">37,867</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-157">34,643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-158">8,009</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-159">3,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net Income (Loss) Attributable to Virtus Investment Partners, Inc.</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="f-160">29,858</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="f-161">38,624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earnings (Loss) per Share&#8212;Basic</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-162">4.19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-17" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-163">5.33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earnings (Loss) per Share&#8212;Diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-164">4.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-17" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-165">5.21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Shares Outstanding&#8212;Basic</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-166">7,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-17" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-167">7,245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Shares Outstanding&#8212;Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-168">7,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-17" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-169">7,410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="ib5b8a7200088450192ffaafa34312190_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_7">Table of Contents</a></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Virtus Investment Partners, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Comprehensive Income</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.070%"><tr><td style="width:1.0%"/><td style="width:72.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.446%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.736%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.448%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net Income (Loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-170">37,867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-171">34,643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other comprehensive income (loss), net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment, net of tax of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="3" id="f-172">36</ix:nonFraction> and $(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="3" id="f-173">35</ix:nonFraction>) for the three months ended March 31, 2024 and 2023, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="f-174">100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="f-175">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-176">100</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-177">99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-178">37,767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-179">34,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive (income) loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-180">8,009</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-181">3,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive Income (Loss) Attributable to Virtus Investment Partners, Inc.</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-182">29,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-183">38,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="ib5b8a7200088450192ffaafa34312190_25"></div><hr style="page-break-after:always"/><div style="min-height:31.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_7">Table of Contents</a></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Virtus Investment Partners, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.783%"><tr><td style="width:1.0%"/><td style="width:75.486%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.229%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.857%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.928%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash Flows from Operating Activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-184">37,867</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-185">34,643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by (used in) operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation expense, intangible asset and other amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-186">18,164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-187">16,410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-188">6,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-189">5,749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity in earnings of equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-190">498</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-191">554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Realized and unrealized (gains) losses on investments, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:DebtAndEquitySecuritiesGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-192">3,393</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" name="us-gaap:DebtAndEquitySecuritiesGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-193">2,670</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-194">1,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-195">1,441</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales (purchases) of investments, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromPaymentsForTradingSecurities" format="ixt:num-dot-decimal" scale="3" id="f-196">5,987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:ProceedsFromPaymentsForTradingSecurities" format="ixt:num-dot-decimal" scale="3" id="f-197">5,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable, net and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInOperatingAssets" scale="3" id="f-198">341</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="f-199">8,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued compensation and benefits, accounts payable, accrued liabilities and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-200">120,631</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-201">115,514</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating activities of consolidated investment products ("CIP"):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Realized and unrealized (gains) losses on investments of CIP, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:DebtAndEquitySecuritiesGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-202">3,732</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:DebtAndEquitySecuritiesGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-203">3,844</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of investments by CIP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:PaymentsForPurchaseOfSecuritiesOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-204">304,516</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:PaymentsForPurchaseOfSecuritiesOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-205">320,808</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales of investments by CIP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:ProceedsFromSaleOfSecuritiesOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-206">323,720</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:ProceedsFromSaleOfSecuritiesOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-207">323,380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net proceeds (purchases) of short-term investments and securities sold short by CIP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="vrts:ProceedsFromPaymentsForOtherInvestmentsOperatingActivities" scale="3" id="f-208">206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" sign="-" name="vrts:ProceedsFromPaymentsForOtherInvestmentsOperatingActivities" scale="3" id="f-209">218</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in other assets and liabilities of CIP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="f-210">4,722</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="f-211">3,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 49.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by (used in) operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-212">34,528</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-213">42,959</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash Flows from Investing Activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-214">1,923</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-215">1,448</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in cash and cash equivalents of CIP due to consolidation (deconsolidation), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" sign="-" name="vrts:IncreaseDecreaseInCashAndCashEquivalentsOfSubsidiariesDueToConsolidation" scale="3" id="f-216">537</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" sign="-" name="vrts:IncreaseDecreaseInCashAndCashEquivalentsOfSubsidiariesDueToConsolidation" scale="3" id="f-217">52</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of equity method investment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="f-218">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-219">11,645</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 49.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-220">2,460</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-221">13,145</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash Flows from Financing Activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayments on credit agreement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" scale="3" id="f-222">688</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" scale="3" id="f-223">688</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock dividends paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-224">14,929</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-225">14,083</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of common shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-226">5,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="3" id="f-227">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payment of contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-228">24,234</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-229">27,179</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes paid related to net share settlement of restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-230">9,854</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-231">12,209</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Affiliate equity sales (purchases)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="vrts:DisposalOfPaymentsForAffiliateEquity" scale="3" id="f-232">419</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="vrts:DisposalOfPaymentsForAffiliateEquity" format="ixt:fixed-zero" scale="3" id="f-233">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net contributions from (distributions to) noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromPaymentsToMinorityShareholders" format="ixt:num-dot-decimal" scale="3" id="f-234">16,772</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:ProceedsFromPaymentsToMinorityShareholders" scale="3" id="f-235">294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing activities of CIP:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments on borrowings by CIP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:RepaymentsOfOtherDebt" format="ixt:num-dot-decimal" scale="3" id="f-236">17,794</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:RepaymentsOfOtherDebt" format="ixt:num-dot-decimal" scale="3" id="f-237">61,213</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-238">56,146</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-239">115,078</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="f-240">203</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="f-241">180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-242">93,337</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-243">171,002</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash, beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-244">341,014</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-245">589,179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash, end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-246">247,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-247">418,177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-Cash Financing Activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase (decrease) to noncontrolling interests due to consolidation (deconsolidation) of CIP, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:MinorityInterestChangeInRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="f-248">13,624</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" sign="-" name="us-gaap:MinorityInterestChangeInRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="f-249">3,447</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock dividends payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="vrts:CommonStockDividendsAccruedButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="f-250">13,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="vrts:CommonStockDividendsAccruedButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="f-251">11,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;text-align:center"><span><br/></span></div><div style="margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:75.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.962%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reconciliation of cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-252">123,880</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-253">239,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash of CIP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-254">123,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-255">100,732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash pledged or on deposit of CIP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" scale="3" id="f-256">767</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" scale="3" id="f-257">680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-258">247,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-259">341,014</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-align:center"><span><br/></span></div><div style="margin-top:6pt;text-align:center"><span><br/></span></div><div style="margin-top:6pt;text-align:center"><span><br/></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="ib5b8a7200088450192ffaafa34312190_28"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_7">Table of Contents</a></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Virtus Investment Partners, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Changes in Stockholders' Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.285%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.852%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.341%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:4.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.501%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.692%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.852%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.934%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.943%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="57" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Permanent Equity</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Temporary Equity</span></td></tr><tr style="height:27pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Retained Earnings (Accumulated<br/>Deficit)</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Total<br/>Attributed To<br/>Virtus Investment Partners, Inc.</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>Interests</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Total<br/>Equity</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Redeemable<br/>Non-<br/>controlling<br/>Interests</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:100%">(in thousands, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Par&#160;Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balances at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-24" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-260">7,181,554</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-261">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-262">1,286,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-263">130,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-264">358</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-28" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-265">4,851,693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-266">599,248</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-267">817,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-268">5,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-269">822,936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-270">113,718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-271">38,624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-272">38,624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="3" id="f-273">765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-274">39,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" sign="-" name="us-gaap:TemporaryEquityNetIncome" format="ixt:num-dot-decimal" scale="3" id="f-275">4,746</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="f-276">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="f-277">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="f-278">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net subscriptions (redemptions) and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="3" id="f-279">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="3" id="f-280">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" sign="-" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="3" id="f-281">300</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" sign="-" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="3" id="f-282">300</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" sign="-" name="vrts:NoncontrollingInterestSubscriptionsRedemptions" format="ixt:num-dot-decimal" scale="3" id="f-283">2,342</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="c-17" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-284">1.65</ix:nonFraction> per common share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="f-285">13,093</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="f-286">13,093</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="f-287">13,093</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Issuance of common shares related to employee stock transactions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-36" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-288">106,840</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-289">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-290">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:fixed-zero" scale="3" id="f-291">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:fixed-zero" scale="3" id="f-292">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Taxes paid on stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-293">12,209</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-294">12,209</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-295">12,209</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-296">7,475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-297">7,475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-298">7,475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balances at March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-37" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-299">7,288,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-300">121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-301">1,281,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-302">155,792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-303">259</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-41" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-304">4,851,693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-305">599,248</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-306">837,915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-307">6,382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-308">844,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-309">106,630</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balances at December 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-44" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-310">7,087,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-311">122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-312">1,300,999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-313">207,356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-314">87</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-48" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-315">5,075,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-316">644,464</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-317">863,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-318">4,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-319">868,289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-320">104,869</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-321">29,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-322">29,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="3" id="f-323">391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-324">30,249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:TemporaryEquityNetIncome" format="ixt:num-dot-decimal" scale="3" id="f-325">7,618</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="f-326">100</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="f-327">100</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="f-328">100</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net subscriptions (redemptions) and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-3" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="3" id="f-329">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="3" id="f-330">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-3" sign="-" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="3" id="f-331">403</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="3" id="f-332">403</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="vrts:NoncontrollingInterestSubscriptionsRedemptions" format="ixt:num-dot-decimal" scale="3" id="f-333">2,698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-334">1.90</ix:nonFraction> per common share)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="f-335">14,191</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="f-336">14,191</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="f-337">14,191</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Repurchases of common shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-56" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="0" id="f-338">21,108</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-57" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="0" id="f-339">21,108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="f-340">4,999</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="f-341">4,999</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="f-342">4,999</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Issuance of common shares related to employee stock transactions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-56" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-343">61,261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:fixed-zero" scale="3" id="f-344">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:fixed-zero" scale="3" id="f-345">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Taxes paid on stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-346">9,852</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-347">9,852</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-348">9,852</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-349">7,010</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-350">7,010</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-351">7,010</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balances at March 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-58" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-352">7,127,881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-353">122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-354">1,298,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-355">223,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-356">187</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-62" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-357">5,096,608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-358">649,463</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-359">871,652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-360">4,351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-361">876,003</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-362">115,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.567%"><tr><td style="width:1.0%"/><td style="width:24.008%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.313%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.878%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:4.660%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.530%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.726%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.117%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.878%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.965%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.660%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.660%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.975%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="ib5b8a7200088450192ffaafa34312190_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_7">Table of Contents</a></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Virtus Investment Partners, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div id="ib5b8a7200088450192ffaafa34312190_34"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="c-1" name="us-gaap:NatureOfOperations" id="f-363" continuedAt="f-363-1" escape="true">Organization and Business</ix:nonNumeric></span></div><ix:continuation id="f-363-1"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Virtus Investment Partners, Inc. (the "Company," "we," "us," "our" or "Virtus"), a Delaware corporation, operates in the investment management industry through its subsidiaries.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides investment management and related services to institutions and individuals.  The Company's investment strategies are offered to institutional clients through institutional separate and commingled accounts, including structured products.  The Company&#8217;s retail investment management services are provided to individuals through products consisting of: mutual funds registered pursuant to the Investment Company Act of 1940, as amended ("U.S. retail funds"); Undertaking for Collective Investment in Transferable Securities and Qualifying Investor Funds (collectively, "global funds") and collectively with U.S. retail funds, variable insurance funds, and exchange-traded funds ("ETFs"), (the "open-end funds"); closed-end funds (collectively, with open-end funds, the "funds"); and retail separate accounts that include intermediary-sold and private client accounts.  The Company also provides subadvisory services to other investment advisers.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div id="ib5b8a7200088450192ffaafa34312190_37"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="f-364" continuedAt="f-364-1" escape="true">Basis of Presentation and Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="f-364-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="f-365" escape="true"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") for interim financial information.  Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements.  In the opinion of management, these financial statements contain all adjustments, consisting only of normal recurring adjustments, necessary for a fair statement of the Company&#8217;s financial condition and results of operations.  Operating results for the three months ended March&#160;31, 2024 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2024.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2023 (the "2023 Annual Report on Form 10-K") filed with the Securities and Exchange Commission (the "SEC").  The Company&#8217;s significant accounting policies, which have been consistently applied, are summarized in its 2023 Annual Report on Form 10-K.</span></div></ix:nonNumeric><div style="text-indent:18pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-366" escape="true"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Standards Not Yet Implemented</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the Financial Accounting Standards Board (the "FASB") issued Accounting Standards Update ("ASU") 2023-07, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting (Topic 280)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  This standard updates reportable segment disclosure requirements, clarifies circumstances in which an entity can disclose multiple segment measures of profit or loss and provides new segment disclosure requirements for entities with a single reportable segment.  This standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024.  Early adoption is permitted, with the amendments to be applied retrospectively to all prior periods presented in the financial statements.  The Company is in the process of evaluating the impact of adopting this standard and, at this time, does not anticipate it will have a material impact on its consolidated financial statements.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740).</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  This standard updates income tax disclosure requirements by requiring disaggregated information about a reporting entity's effective tax rate reconciliation as well as information on income taxes paid.  This standard is effective for fiscal years beginning after December 15, 2024.  Early adoption is permitted.  The Company is in the process of evaluating the impact of adopting this standard and, at this time, does not anticipate it will have a material impact on its consolidated financial statements.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2024, the FASB issued ASU 2024-01, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Stock Compensation (Topic 718), Scope Application of Profits Interest and Similar Awards.  </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This standard provides clarity regarding whether profits interest and similar awards are within the scope of Topic 718 of the Accounting Standards Codification.  This standard is effective for fiscal years beginning after December 15, 2024.  Early adoption is permitted.  The Company is in the process of evaluating the impact of adopting this standard and, at this time, does not anticipate it will have a material impact on its consolidated financial statements.</span></div></ix:nonNumeric></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="ib5b8a7200088450192ffaafa34312190_40"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_7">Table of Contents</a></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="f-367" continuedAt="f-367-1" escape="true">Revenues</ix:nonNumeric></span></div><ix:continuation id="f-367-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="f-368" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's revenues are recognized when a performance obligation is satisfied, which occurs when control of the services is transferred to customers.  Investment management fees, distribution and service fees, and administration and shareholder service fees are generally calculated as a percentage of average net assets of the investment portfolios managed.  The net asset values from which these fees are calculated are variable in nature and subject to factors outside of the Company's control, such as additional investments, withdrawals and market performance.  Because of this, these fees are considered constrained until the end of the contractual measurement period (monthly or quarterly), which is when asset values are generally determinable.</span></div></ix:nonNumeric><div><span><br/></span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investment Management Fees by Source&#160;&#160;&#160;&#160;</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="f-369" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes investment management fees by source:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.444%"><tr><td style="width:1.0%"/><td style="width:61.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.215%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.852%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.218%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investment management fees</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Open-end funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-370">78,680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-371">71,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Closed-end funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-372">14,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-373">14,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retail separate accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-374">48,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-375">40,079</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Institutional accounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-376">46,305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-377">38,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total investment management fees</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-378">188,360</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-379">164,478</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric></ix:continuation><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div id="ib5b8a7200088450192ffaafa34312190_43"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="c-1" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="f-380" continuedAt="f-380-1" escape="true">Acquisitions</ix:nonNumeric></span></div><ix:continuation id="f-380-1"><div style="margin-bottom:3pt;padding-left:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">AlphaSimplex Group, LLC</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2023, the Company completed the acquisition of AlphaSimplex Group, LLC ("AlphaSimplex"), which was accounted for in accordance with Accounting Standards Codification ("ASC") 805, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">("ASC 805"). </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price paid of $<ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="f-381">113.4</ix:nonFraction>&#160;million was allocated to the assets acquired and liabilities assumed based upon their estimated fair values at the date of the acquisition.  Goodwill of $<ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-382">48.3</ix:nonFraction>&#160;million and intangible assets of $<ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="f-383">55.4</ix:nonFraction>&#160;million were recorded for the acquisition.</span></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:36pt"><span><br/></span></div><div id="ib5b8a7200088450192ffaafa34312190_49"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="c-1" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="f-384" continuedAt="f-384-1" escape="true">Intangible Assets, Net</ix:nonNumeric></span></div><ix:continuation id="f-384-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="f-385" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of intangible assets, net:</span></div><div style="margin-bottom:3pt;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.473%"><tr><td style="width:1.0%"/><td style="width:30.272%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.971%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.616%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.971%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.616%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.971%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.616%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.971%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.616%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.980%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Definite-Lived</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Indefinite-Lived</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Book Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Book Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Book Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Book Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances at December 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-386">806,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-387">416,834</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-388">389,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-389">42,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-390">432,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="f-391">15,335</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="f-392">15,335</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="f-393">15,335</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances at March 31, 2024</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-394">806,655</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-395">432,169</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-396">374,486</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-397">42,298</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-398">416,784</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="f-399" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Definite-lived intangible asset amortization for the remainder of fiscal year 2024 and succeeding fiscal years is estimated as follows: </span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.912%"><tr><td style="width:1.0%"/><td style="width:53.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.631%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:42.857%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount<br/></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="f-400">40,964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-401">51,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-402">50,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="f-403">47,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="f-404">41,787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 and thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="vrts:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="f-405">142,201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-406">374,486</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_7">Table of Contents</a></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span><br/></span></div><div id="ib5b8a7200088450192ffaafa34312190_52"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="c-1" name="us-gaap:InvestmentTextBlock" id="f-407" continuedAt="f-407-1" escape="true">Investments</ix:nonNumeric></span></div><ix:continuation id="f-407-1"><div style="margin-bottom:5pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments consist primarily of investments in the Company's sponsored products.  <ix:nonNumeric contextRef="c-1" name="us-gaap:InvestmentTableTextBlock" id="f-408" continuedAt="f-408-1" escape="true">The Company's investments, excluding the assets of consolidated investment products ("CIP") discussed in Note 16, at March&#160;31, 2024 and December&#160;31, 2023 were as follows:</ix:nonNumeric></span></div><ix:continuation id="f-408-1"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.602%"><tr><td style="width:1.0%"/><td style="width:62.616%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.599%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.684%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment securities - fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="f-409">90,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="f-410">97,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-411">23,208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-412">22,710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonqualified retirement plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-3" name="vrts:InvestmentsInNonqualifiedRetirementPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-413">13,743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-3" name="vrts:InvestmentsInNonqualifiedRetirementPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-414">12,682</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-3" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="3" id="f-415">127,448</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-3" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="3" id="f-416">132,696</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:63pt;padding-right:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The Company's equity method investments are valued on a three-month lag based upon the availability of financial information.</span></div></ix:continuation><div style="margin-bottom:3pt;text-indent:11.25pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investment Securities - fair value</span></div><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment securities - fair value consist of investments in the Company's sponsored funds and separately managed accounts.  <ix:nonNumeric contextRef="c-1" name="us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock" id="f-417" continuedAt="f-417-1" escape="true">The composition of the Company&#8217;s investment securities - fair value was as follows:</ix:nonNumeric></span></div><ix:continuation id="f-417-1"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.304%"><tr><td style="width:1.0%"/><td style="width:39.794%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.627%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.972%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.627%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.972%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.627%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.978%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investment Securities - fair value</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sponsored funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-3" name="us-gaap:EquitySecuritiesFvNiCost" format="ixt:num-dot-decimal" scale="3" id="f-418">69,067</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="f-419">69,514</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-3" name="us-gaap:EquitySecuritiesFvNiCost" format="ixt:num-dot-decimal" scale="3" id="f-420">80,794</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="f-421">77,433</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-3" name="us-gaap:EquitySecuritiesFvNiCost" format="ixt:num-dot-decimal" scale="3" id="f-422">16,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="f-423">20,983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:EquitySecuritiesFvNiCost" format="ixt:num-dot-decimal" scale="3" id="f-424">16,353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="f-425">19,871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total investment securities - fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:EquitySecuritiesFvNiCost" format="ixt:num-dot-decimal" scale="3" id="f-426">85,942</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="f-427">90,497</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:EquitySecuritiesFvNiCost" format="ixt:num-dot-decimal" scale="3" id="f-428">97,147</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="f-429">97,304</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2024 and 2023, the Company recognized net realized losses of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:DebtAndEquitySecuritiesRealizedGainLoss" format="ixt:num-dot-decimal" scale="6" id="f-430">0.4</ix:nonFraction>&#160;million and net realized gains $<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-5" name="us-gaap:DebtAndEquitySecuritiesRealizedGainLoss" format="ixt:num-dot-decimal" scale="6" id="f-431">1.3</ix:nonFraction>&#160;million, respectively, related to its investment securities - fair value.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:11.25pt"><span><br/></span></div><div id="ib5b8a7200088450192ffaafa34312190_55"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueDisclosuresTextBlock" id="f-432" continuedAt="f-432-1" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="f-433" continuedAt="f-433-1" escape="true"><ix:continuation id="f-432-1" continuedAt="f-432-2"><div style="margin-bottom:5pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s assets and liabilities measured at fair value on a recurring basis, excluding the assets and liabilities of CIP discussed in Note 16, as of March&#160;31, 2024 and December&#160;31, 2023 by fair value hierarchy level were as follows:</span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">March&#160;31, 2024 &#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-434">92,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-435">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-436">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-437">92,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investment securities - fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sponsored funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="f-438">69,514</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="3" id="f-439">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="3" id="f-440">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="f-441">69,514</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="f-442">20,983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="3" id="f-443">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="3" id="f-444">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="f-445">20,983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonqualified retirement plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-3" name="vrts:InvestmentsInNonqualifiedRetirementPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-446">13,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-3" name="vrts:InvestmentsInNonqualifiedRetirementPlanAssets" format="ixt:fixed-zero" scale="3" id="f-447">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-3" name="vrts:InvestmentsInNonqualifiedRetirementPlanAssets" format="ixt:fixed-zero" scale="3" id="f-448">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-3" name="vrts:InvestmentsInNonqualifiedRetirementPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-449">13,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-450">196,698</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-451">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-452">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-453">196,698</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-454">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-455">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-456">41,708</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-457">41,708</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-458">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-459">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-460">41,708</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-461">41,708</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_7">Table of Contents</a></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-432-2" continuedAt="f-432-3"><ix:continuation id="f-433-1" continuedAt="f-433-2"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December&#160;31, 2023 </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-462">197,240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-463">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-464">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-465">197,240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investment securities - fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sponsored funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="f-466">77,433</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="3" id="f-467">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="3" id="f-468">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="f-469">77,433</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="f-470">19,871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="3" id="f-471">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="3" id="f-472">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="f-473">19,871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonqualified retirement plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" name="vrts:InvestmentsInNonqualifiedRetirementPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-474">12,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-3" name="vrts:InvestmentsInNonqualifiedRetirementPlanAssets" format="ixt:fixed-zero" scale="3" id="f-475">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-3" name="vrts:InvestmentsInNonqualifiedRetirementPlanAssets" format="ixt:fixed-zero" scale="3" id="f-476">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-3" name="vrts:InvestmentsInNonqualifiedRetirementPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-477">12,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-478">307,226</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-479">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-480">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-481">307,226</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-482">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-483">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-484">56,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-485">56,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-486">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-487">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-488">56,200</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-489">56,200</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="f-490" continuedAt="f-490-1" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a discussion of the valuation methodologies used for the Company&#8217;s assets measured at fair value:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash equivalents </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">represent investments in money market funds.  Cash investments in money market funds are valued using published net asset values and are classified as Level 1.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sponsored funds </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">represent investments in open-end funds, closed-end funds and ETFs for which the Company acts as the investment manager.  The fair value of open-end funds is determined based on their published net asset values and are categorized as Level 1.  The fair value of closed-end funds and ETFs is determined based on the official closing price on the exchange on which they are traded and are categorized as Level 1.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity securities</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> represent securities traded on active markets, are valued at the official closing price (typically the last sale or bid) on the exchange on which the securities are primarily traded and are categorized as Level 1.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nonqualified retirement plan assets </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">represent mutual funds within the Company's nonqualified retirement plan whose fair value is determined based on their published net asset value and are categorized as Level 1.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent consideration </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">represents</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">liabilities associated with the Company's Westchester Capital Management ("WCM") and NFJ Investment Group ("NFJ")  transactions .  The continent consideration related to the WCM transaction as of March&#160;31, 2024 was $<ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-491">11.1</ix:nonFraction>&#160;million and represents the fair value of future potential earn-out payments based on pre-established performance metrics related to revenue growth rates.  The estimated fair value of the WCM liability is measured using an options pricing model valuation technique utilizing unobservable market data inputs prepared with the assistance of an independent valuation firm.  The most significant unobservable inputs used relate to the aforementioned revenue growth rates, discount rate (range of <ix:nonFraction unitRef="number" contextRef="c-116" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="f-492">6</ix:nonFraction>%-<ix:nonFraction unitRef="number" contextRef="c-117" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="f-493">7</ix:nonFraction>%) and the market price of risk adjustment (<ix:nonFraction unitRef="number" contextRef="c-118" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="f-494">9</ix:nonFraction>%).  The NFJ contingent consideration liability as of March&#160;31, 2024 was $<ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-495">30.6</ix:nonFraction>&#160;million and represents the fair value of the projected future revenue participation payments.  The NFJ revenue participation payments consist of variable payments based on a percentage of the investment management fees earned on certain NFJ managed assets.  The estimated fair value of the NFJ liability is measured using an options pricing model valuation technique utilizing unobservable market data inputs prepared with the assistance of an independent valuation firm.  The most significant unobservable inputs used relate to the revenue growth rates, discount rates (range of <ix:nonFraction unitRef="number" contextRef="c-120" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="f-496">6</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-121" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="f-497">7</ix:nonFraction>%) and the market price of risk adjustment (<ix:nonFraction unitRef="number" contextRef="c-122" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="f-498">7</ix:nonFraction>%).  These liabilities are categorized as Level 3. </span></div></ix:nonNumeric></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_7">Table of Contents</a></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-432-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="f-499" escape="true"><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of beginning and ending balances of the Company's contingent consideration liabilities:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.801%"><tr><td style="width:1.0%"/><td style="width:75.337%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.031%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.098%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.034%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="f-500">56,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="f-501">78,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reduction for payments made</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-3" name="vrts:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReductionOfLiability" format="ixt:num-dot-decimal" scale="3" id="f-502">14,492</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" name="vrts:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReductionOfLiability" format="ixt:num-dot-decimal" scale="3" id="f-503">16,390</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent consideration, end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="f-504">41,708</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="f-505">61,710</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, accounts receivable, accounts payable and accrued liabilities equal or approximate fair value based on the short-term nature of these instruments.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div id="ib5b8a7200088450192ffaafa34312190_61"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="f-506" continuedAt="f-506-1" escape="true">Equity Transactions </ix:nonNumeric></span></div><ix:continuation id="f-506-1"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends Declared</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 21, 2024, the Company declared a quarterly cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-127" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-507">1.90</ix:nonFraction> per common share to be paid on May 15, 2024 to shareholders of record at the close of business on April 30, 2024. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock Repurchases</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2024, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="f-508">21,108</ix:nonFraction> common shares at a weighted average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="f-509">236.84</ix:nonFraction> per share for a total cost, including fees and expenses, of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="f-510">5.0</ix:nonFraction> million under its share repurchase program.  As of March&#160;31, 2024, <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" format="ixt:num-dot-decimal" scale="0" id="f-511">583,437</ix:nonFraction> shares remained available for repurchase.  Under the terms of the program, the Company may repurchase shares of its common stock from time to time at its discretion through open market repurchases, privately negotiated transactions and/or other mechanisms, depending on price and prevailing market and business conditions.  The program, which has no specified term, may be suspended or terminated at any time.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div id="ib5b8a7200088450192ffaafa34312190_64"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9. <ix:nonNumeric contextRef="c-1" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="f-512" continuedAt="f-512-1" escape="true">Accumulated Other Comprehensive Income (Loss)</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="f-513" escape="true"><ix:continuation id="f-512-1"><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in accumulated other comprehensive income (loss) were as follows: </span></div><div style="margin-bottom:3pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.842%"><tr><td style="width:1.0%"/><td style="width:74.994%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.641%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.978%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-514">87</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-515">358</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss) (1)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-516">100</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-517">99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at end of period</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-518">187</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-519">259</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:54pt;padding-right:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;Consists of foreign currency translation adjustments, net of tax of $<ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="3" id="f-520">36</ix:nonFraction> and $(<ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="3" id="f-521">35</ix:nonFraction>) for the </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> months ended March&#160;31, 2024 and 2023, respectively.</span></div></ix:continuation></ix:nonNumeric><div style="padding-left:49.5pt;text-indent:-13.5pt"><span><br/></span></div><div style="padding-left:49.5pt;text-indent:-13.5pt"><span><br/></span></div><div id="ib5b8a7200088450192ffaafa34312190_67"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-522" continuedAt="f-522-1" escape="true">Stock-Based Compensation</ix:nonNumeric></span></div><ix:continuation id="f-522-1" continuedAt="f-522-2"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity-based awards, including restricted stock units ("RSUs"), performance stock units ("PSUs"), stock options and unrestricted shares of common stock, may be granted to officers, employees and directors of the Company pursuant to the Company's Omnibus Incentive and Equity Plan (the "Omnibus Plan").  At March&#160;31, 2024, <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-523">375,169</ix:nonFraction> shares of common stock remained available for issuance of the <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-524">3,370,000</ix:nonFraction> shares that are authorized for issuance under the Omnibus Plan. </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><ix:nonNumeric contextRef="c-1" name="vrts:StockBasedCompensationExpenseTableTextBlock" id="f-525" escape="true"><div style="margin-bottom:5pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense is summarized as follows:</span></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:58.771%"><tr><td style="width:1.0%"/><td style="width:61.337%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.059%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.043%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.061%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-526">6,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-527">5,749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="margin-bottom:3pt;text-indent:18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_7">Table of Contents</a></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-522-2"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each RSU entitles the holder to <ix:nonFraction unitRef="number" contextRef="c-134" decimals="INF" name="vrts:ConversionOfStockConversionRatio" format="ixt-sec:numwordsen" scale="0" id="f-528">one</ix:nonFraction> share of common stock when the restriction expires.  RSUs may be time-vested or performance-contingent PSUs that convert into RSUs after performance measurement is complete and generally vest in <span style="-sec-ix-hidden:f-529">one</span> to <ix:nonNumeric contextRef="c-136" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-530">three years</ix:nonNumeric>.  Shares that are issued upon vesting are newly issued shares from the Omnibus Plan and are not issued from treasury stock.</span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" id="f-531" escape="true"><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSU activity, inclusive of PSUs, for the three months ended March&#160;31, 2024 is summarized as follows:&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:76.169%"><tr><td style="width:1.0%"/><td style="width:58.017%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.861%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.863%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number<br/>of&#160;Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant&#160;Date<br/>Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-137" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-532">344,717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-137" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-533">204.48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-138" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-534">108,658</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-138" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-535">235.14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-138" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-536">8,333</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-138" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-537">261.65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-138" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-538">103,849</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-138" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-539">229.92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at March 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-139" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-540">341,193</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-139" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-541">205.10</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2024 and 2023, a total of <ix:nonFraction unitRef="shares" contextRef="c-138" decimals="INF" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-542">42,588</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-140" decimals="INF" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-543">70,716</ix:nonFraction> RSUs, respectively, were withheld by the Company as a result of net share settlements to settle minimum employee tax withholding obligations and for which the Company paid $<ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-5" name="vrts:PaymentOfWithholdingTaxesRelatedToRestrictedStock" format="ixt:num-dot-decimal" scale="6" id="f-544">9.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-5" name="vrts:PaymentOfWithholdingTaxesRelatedToRestrictedStock" format="ixt:num-dot-decimal" scale="6" id="f-545">12.2</ix:nonFraction> million respectively, in minimum employee tax withholding obligations.  These net share settlements had the effect of share repurchases by the Company as they reduced the number of shares that would have otherwise been issued as a result of the vesting.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2024 and 2023, the Company granted <ix:nonFraction unitRef="shares" contextRef="c-141" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-546">26,733</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-142" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-547">44,291</ix:nonFraction> PSUs, respectively, that contain performance-based metrics in addition to a service condition.  Compensation expense for PSUs is generally recognized over a <ix:nonNumeric contextRef="c-143" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:durwordsen" id="f-548">three-year</ix:nonNumeric> service period based upon the value determined using a combination of (i) the intrinsic value method for awards that contain a performance metric that represents a "performance condition" in accordance with ASC 718, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Compensation </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">("ASC 718") and (ii) the Monte Carlo simulation valuation model for awards that contain a "market condition" performance metric under ASC 718.  Compensation expense for PSU awards that contain a market condition is fixed at the date of grant and will not be adjusted in future periods based upon the achievement of the market condition.  Compensation expense for PSU awards with a performance condition is recorded each period based upon a probability assessment of the expected outcome of the performance metric with a final adjustment upon measurement at the end of the performance period.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2024, unamortized stock-based compensation expense for unvested RSUs and PSUs was $<ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="f-549">45.5</ix:nonFraction> million with a weighted-average remaining contractual life of <ix:nonNumeric contextRef="c-145" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-550">1.6</ix:nonNumeric> years.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="ib5b8a7200088450192ffaafa34312190_73"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-551" continuedAt="f-551-1" escape="true">Earnings (Loss) Per Share</ix:nonNumeric></span></div><ix:continuation id="f-551-1" continuedAt="f-551-2"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings (loss) per share ("EPS") is calculated in accordance with ASC 260, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings per Share</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Basic EPS is computed by dividing net income (loss) attributable to Virtus Investment Partners, Inc. by the weighted-average number of common shares outstanding for the period, excluding dilution for potential common stock issuances.  Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock, including shares issuable upon the vesting of RSUs and stock option exercises using the treasury stock method, as determined under the if-converted method.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_7">Table of Contents</a></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-551-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-552" escape="true"><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The computation of basic and diluted EPS is as follows:&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.748%"><tr><td style="width:1.0%"/><td style="width:77.168%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.325%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Income (Loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-553">37,867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-554">34,643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-555">8,009</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-556">3,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Income (Loss) Attributable to Virtus Investment Partners, Inc.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="f-557">29,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="f-558">38,624</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic: Weighted-average number of shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-559">7,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-17" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-560">7,245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: Incremental shares from assumed conversion of dilutive instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="f-561">168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-17" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="f-562">165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted: Weighted-average number of shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-563">7,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-17" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-564">7,410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (Loss) per Share&#8212;Basic</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-565">4.19</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-17" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-566">5.33</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (Loss) per Share&#8212;Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-567">4.10</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-17" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-568">5.21</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="f-569" escape="true"><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table details the securities that have been excluded from the above computation of weighted-average number of shares for diluted EPS, because the effect would be anti-dilutive.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.871%"><tr><td style="width:1.0%"/><td style="width:76.935%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.435%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.438%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-146" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="f-570">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-147" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="f-571">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total anti-dilutive securities</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="f-572">1</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-17" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="f-573">40</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div id="ib5b8a7200088450192ffaafa34312190_76"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12. <ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-574" continuedAt="f-574-1" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="f-574-1"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In calculating the provision for income taxes, the Company uses an estimate of the annual effective tax rate based upon the facts and circumstances at each interim period.  On a quarterly basis, the estimated annual effective tax rate is adjusted, as appropriate, based upon changes in facts and circumstances, if any, compared to those forecasted at the beginning of the fiscal year and at each interim period thereafter.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes reflected U.S. federal, state and local taxes at an estimated effective tax rate of <ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-575">18.9</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-17" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-576">20.1</ix:nonFraction>% for the three months ended March&#160;31, 2024 and 2023, respectively.  The lower estimated effective tax rate for the three months ended March 31, 2024 was primarily due to excess tax benefits associated with stock-based compensation and the change in valuation allowances in the current year related to the tax effects of unrealized gains on certain Company investments.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div id="ib5b8a7200088450192ffaafa34312190_79"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13. <ix:nonNumeric contextRef="c-1" name="us-gaap:DebtDisclosureTextBlock" id="f-577" continuedAt="f-577-1" escape="true">Debt</ix:nonNumeric></span></div><ix:continuation id="f-577-1" continuedAt="f-577-2"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Agreement </span></div></ix:continuation><div style="text-indent:36pt"><ix:continuation id="f-577-2" continuedAt="f-577-3"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's credit agreement, as amended (the "Credit Agreement"), comprises (i) a $<ix:nonFraction unitRef="usd" contextRef="c-148" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-578">275.0</ix:nonFraction> million term loan with a <ix:nonNumeric contextRef="c-149" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="f-579">seven-year</ix:nonNumeric> term (the "Term Loan") expiring in September 2028, and (ii) a $<ix:nonFraction unitRef="usd" contextRef="c-150" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-580">175.0</ix:nonFraction> million revolving credit facility with a <ix:nonNumeric contextRef="c-151" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="f-581">five-year</ix:nonNumeric> term expiring in September 2026.  The Company repaid $<ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-5" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="6" id="f-582">0.7</ix:nonFraction>&#160;million outstanding under the Term Loan during the three months ended March&#160;31, 2024 and had $<ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="f-583">258.1</ix:nonFraction> million outstanding under the Term Loan at March&#160;31, 2024.  In accordance with ASC 835, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest</span></ix:continuation><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-577-3">, the amounts outstanding under the Company's Term Loan are presented on the Condensed Consolidated Balance Sheet net of related debt issuance costs, which were $<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="us-gaap:DeferredFinanceCostsGross" format="ixt:num-dot-decimal" scale="6" id="f-584">5.1</ix:nonFraction> million as of March&#160;31, 2024.</ix:continuation>  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div id="ib5b8a7200088450192ffaafa34312190_82"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14. <ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-585" continuedAt="f-585-1" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="f-585-1" continuedAt="f-585-2"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Matters</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved from time to time in litigation and arbitration, as well as examinations, inquiries and investigations by various regulatory bodies, involving its compliance with, among other things, securities laws, client investment guidelines, laws governing the activities of broker-dealers and other laws and regulations affecting its products and other activities.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_7">Table of Contents</a></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-585-2"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records a liability when it is both probable that a liability has been incurred and the amount of the liability can be reasonably estimated.  Significant judgment is required in both the determination of probability and the determination as to whether a loss is reasonably estimable.  Based on information currently available, available insurance coverage, indemnities and established reserves, the Company believes that the outcomes of its legal and regulatory proceedings are not likely, either individually or in the aggregate, to have a material adverse effect on the Company's results of operations, cash flows or its consolidated financial condition.  However, in the event of unexpected subsequent developments, and given the inherent unpredictability of these legal and regulatory matters, the Company can provide no assurance that its assessment of any legal matter will reflect the ultimate outcome, and an adverse outcome in certain matters could have a material adverse effect on the Company's results of operations or cash flows in particular quarterly or annual periods.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="ib5b8a7200088450192ffaafa34312190_85"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15. <ix:nonNumeric contextRef="c-1" name="us-gaap:MinorityInterestDisclosureTextBlock" id="f-586" continuedAt="f-586-1" escape="true">Redeemable Noncontrolling Interests</ix:nonNumeric></span></div><ix:continuation id="f-586-1"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="vrts:NoncontrollingInterestPolicyTextBlock" id="f-587" escape="true">Redeemable noncontrolling interests represent third-party investments in the Company's CIP and minority interests held in a consolidated affiliate.  Minority interests held in the affiliate are subject to holder put rights and Company call rights at established multiples of earnings before interest, taxes, depreciation and amortization and, as such, are considered redeemable at other than fair value.  The rights are exercisable at pre-established intervals or upon certain conditions, such as retirement.  The put and call rights are not legally detachable or separately exercisable and are deemed to be embedded in the related noncontrolling interests.  The Company, in purchasing affiliate equity, has the option to settle in cash or shares of the Company's common stock and is entitled to the cash flow associated with any purchased equity.  These minority interests in the affiliate are recorded at estimated redemption value within redeemable noncontrolling interests on the Company's Condensed Consolidated Balance Sheets, and any changes in the estimated redemption value are recorded on the Condensed Consolidated Statements of Operations within noncontrolling interests.</ix:nonNumeric>  </span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:RedeemableNoncontrollingInterestTableTextBlock" id="f-588" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redeemable noncontrolling interests for the three months ended March&#160;31, 2024 included the following amounts:</span></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.906%"><tr><td style="width:1.0%"/><td style="width:50.881%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.143%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.143%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.147%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CIP</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Affiliate Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances at December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:RedeemableNoncontrollingInterestEquityRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="f-589">30,643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:RedeemableNoncontrollingInterestEquityRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="f-590">74,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RedeemableNoncontrollingInterestEquityRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="f-591">104,869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to noncontrolling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-592">1,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-593">1,829</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-594">3,258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in redemption value (1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" name="us-gaap:MinorityInterestChangeInRedemptionValue" format="ixt:fixed-zero" scale="3" id="f-595">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-3" name="us-gaap:MinorityInterestChangeInRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="f-596">4,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-3" name="us-gaap:MinorityInterestChangeInRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="f-597">4,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net income (loss) attributable to noncontrolling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:TemporaryEquityNetIncome" format="ixt:num-dot-decimal" scale="3" id="f-598">1,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:TemporaryEquityNetIncome" format="ixt:num-dot-decimal" scale="3" id="f-599">6,189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:TemporaryEquityNetIncome" format="ixt:num-dot-decimal" scale="3" id="f-600">7,618</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Affiliate equity sales (purchases)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates" format="ixt:fixed-zero" scale="3" id="f-601">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates" scale="3" id="f-602">419</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates" scale="3" id="f-603">419</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net subscriptions (redemptions) and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" sign="-" name="vrts:NoncontrollingInterestSubscriptionsRedemptionsAndOther" format="ixt:num-dot-decimal" scale="3" id="f-604">3,117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="vrts:NoncontrollingInterestSubscriptionsRedemptionsAndOther" format="ixt:fixed-zero" scale="3" id="f-605">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="vrts:NoncontrollingInterestSubscriptionsRedemptionsAndOther" format="ixt:num-dot-decimal" scale="3" id="f-606">3,117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances at March 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:RedeemableNoncontrollingInterestEquityRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="f-607">35,189</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" name="us-gaap:RedeemableNoncontrollingInterestEquityRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="f-608">79,996</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RedeemableNoncontrollingInterestEquityRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="f-609">115,185</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;Relates to noncontrolling interests redeemable at other than fair value.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">        </span></div><div id="ib5b8a7200088450192ffaafa34312190_88"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16. <ix:nonNumeric contextRef="c-1" name="srt:CondensedFinancialStatementsTextBlock" id="f-610" continuedAt="f-610-1" escape="true">Consolidation</ix:nonNumeric></span></div><ix:continuation id="f-610-1" continuedAt="f-610-2"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include the accounts of the Company, its subsidiaries and investment products that are consolidated.  A voting interest entity ("VOE") is consolidated when the Company is considered to have a controlling financial interest, which is typically present when the Company owns a majority of the voting interest in an entity or otherwise has the power to govern the financial and operating policies of the entity.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates any variable interest entity ("VIE") in which the Company has a variable interest for consolidation.  A VIE is an entity in which either (i) the equity investment at risk is not sufficient to permit the entity to finance its own activities without additional financial support, or (ii) where as a group, the holders of the equity investment at risk do not possess any one of the following: (a) the power through voting or similar rights to direct the activities that most significantly impact the entity's economic performance, (b) the obligation to absorb expected losses or the right to receive expected residual returns of the entity, or (c) proportionate voting and economic interests and where substantially all of the entity's activities either involve or are conducted on behalf of an investor with disproportionately fewer voting rights.  If an entity has any of these characteristics, it is considered a VIE and is required to be consolidated by its primary beneficiary.  The primary beneficiary is the entity that has both the power to direct the activities that most significantly impact the VIE's economic performance and has the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_7">Table of Contents</a></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="text-indent:36pt"><span><br/></span></div><ix:continuation id="f-610-2" continuedAt="f-610-3"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of its business, the Company sponsors various investment products, some of which are consolidated by the Company.  CIP includes both VOEs, made up primarily of U.S. retail funds and ETFs in which the Company holds a controlling financial interest, and VIEs, which consist of collateralized loan obligations ("CLO") and certain global and private funds ("GF") of which the Company is considered the primary beneficiary.  The consolidation and deconsolidation of these investment products have no impact on the Company's net income (loss).  The Company's risk with respect to these investment products is limited to its beneficial interests in these products.  The Company has no right to the benefits from, and does not bear the risks associated with, these investment products beyond the Company's investments in, and fees generated from, these products.</span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="srt:ScheduleOfCondensedBalanceSheetTableTextBlock" id="f-611" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the balances of CIP that, after intercompany eliminations, were reflected on the Condensed Consolidated Balance Sheets as of March&#160;31, 2024 and December&#160;31, 2023:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.321%"><tr><td style="width:1.0%"/><td style="width:30.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.102%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.873%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.096%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.873%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.096%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.873%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.102%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.026%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.096%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.026%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.103%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">VOEs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">VIEs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">VOEs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">VIEs</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CLOs </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GFs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CLOs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GFs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-612">1,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-613">119,914</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-614">2,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-615">1,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-616">98,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-617">2,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="3" id="f-618">40,591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="3" id="f-619">1,962,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="3" id="f-620">77,937</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="3" id="f-621">30,985</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-3" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="3" id="f-622">1,972,342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="3" id="f-623">79,386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" name="us-gaap:OtherAssets" scale="3" id="f-624">616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="us-gaap:OtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-625">30,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" name="us-gaap:OtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-626">1,168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" name="us-gaap:OtherAssets" scale="3" id="f-627">174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-3" name="us-gaap:OtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-628">41,985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="us-gaap:OtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-629">1,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" name="us-gaap:NotesPayable" format="ixt:fixed-zero" scale="3" id="f-630">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="us-gaap:NotesPayable" format="ixt:num-dot-decimal" scale="3" id="f-631">1,922,051</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" name="us-gaap:NotesPayable" format="ixt:fixed-zero" scale="3" id="f-632">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" name="us-gaap:NotesPayable" format="ixt:fixed-zero" scale="3" id="f-633">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-3" name="us-gaap:NotesPayable" format="ixt:num-dot-decimal" scale="3" id="f-634">1,922,243</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="us-gaap:NotesPayable" format="ixt:fixed-zero" scale="3" id="f-635">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securities purchased payable and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" name="vrts:SecuritiesPurchasedPayable" format="ixt:num-dot-decimal" scale="3" id="f-636">1,019</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="vrts:SecuritiesPurchasedPayable" format="ixt:num-dot-decimal" scale="3" id="f-637">88,270</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" name="vrts:SecuritiesPurchasedPayable" format="ixt:num-dot-decimal" scale="3" id="f-638">1,999</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" name="vrts:SecuritiesPurchasedPayable" scale="3" id="f-639">740</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-3" name="vrts:SecuritiesPurchasedPayable" format="ixt:num-dot-decimal" scale="3" id="f-640">89,167</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="vrts:SecuritiesPurchasedPayable" scale="3" id="f-641">616</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-642">12,311</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-643">4,351</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-644">22,878</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-645">7,316</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-646">4,363</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-647">23,327</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net interests in CIP</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" name="vrts:NetInterestInInvestmentProducts" format="ixt:num-dot-decimal" scale="3" id="f-648">29,148</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="vrts:NetInterestInInvestmentProducts" format="ixt:num-dot-decimal" scale="3" id="f-649">98,003</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" name="vrts:NetInterestInInvestmentProducts" format="ixt:num-dot-decimal" scale="3" id="f-650">56,840</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" name="vrts:NetInterestInInvestmentProducts" format="ixt:num-dot-decimal" scale="3" id="f-651">24,326</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-3" name="vrts:NetInterestInInvestmentProducts" format="ixt:num-dot-decimal" scale="3" id="f-652">96,655</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="vrts:NetInterestInInvestmentProducts" format="ixt:num-dot-decimal" scale="3" id="f-653">58,607</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consolidated CLOs</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the Company's CIP that are VIEs are CLOs.  The financial information of certain CLOs is included on the Company's condensed consolidated financial statements on a one-month lag based upon the availability of their financial information.  A majority-owned consolidated private fund, whose primary purpose is to invest in CLOs for which the Company serves as the collateral manager, is also included.  At March&#160;31, 2024, the Company consolidated <ix:nonFraction unitRef="collateralized_loan_obligation" contextRef="c-162" decimals="INF" name="vrts:NumberofCollateralizedLoanObligationsConsolidated" format="ixt-sec:numwordsen" scale="0" id="f-654">seven</ix:nonFraction> CLOs.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments of CLOs</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CLOs held investments of $<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-8" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="9" id="f-655">2.0</ix:nonFraction> billion at March&#160;31, 2024, consisting of bank loan investments that comprise the majority of the CLOs' portfolio asset collateral and are senior secured corporate loans across a variety of industries.  These bank loan investments mature at various dates between 2024 and 2032 and generally pay interest at SOFR plus a spread.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Notes Payable of CLOs</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CLOs held notes payable with a total value, at par, of $<ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-8" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="f-656">2.1</ix:nonFraction> billion at March&#160;31, 2024, consisting of senior secured floating rate notes payable with a par value of $<ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-8" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="f-657">1.9</ix:nonFraction> billion and subordinated notes with a par value of $<ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-658">215.1</ix:nonFraction> million.  These note obligations bear interest at variable rates based on SOFR plus a pre-defined spread. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's beneficial interests and maximum exposure to loss related to these consolidated CLOs is limited to (i) ownership in the subordinated notes and (ii) accrued management fees.  The secured notes of the consolidated CLOs have contractual recourse only to the related assets of the CLO and are classified as financial liabilities.  <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfVariableInterestEntitiesTextBlock" id="f-659" continuedAt="f-659-1" escape="true">Although these beneficial interests are eliminated upon consolidation, the application of the measurement alternative prescribed by ASU 2014-13, </ix:nonNumeric></span><ix:continuation id="f-659-1" continuedAt="f-659-2"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidation (Topic 810)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASU 2014-13"), results in the net assets of the consolidated CLOs shown above to be equivalent to the beneficial interests retained by the Company at March&#160;31, 2024, as shown in the table below:</span></ix:continuation></div><ix:continuation id="f-659-2" continuedAt="f-659-3"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.818%"><tr><td style="width:1.0%"/><td style="width:70.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.747%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subordinated notes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="vrts:VariableInterestEntityReportingEntityInvolvementBeneficialInterestsSubordinatedDebtAmount" format="ixt:num-dot-decimal" scale="3" id="f-660">96,416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued investment management fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="vrts:VariableInterestEntityReportingEntityInvolvementBeneficialInterestsDeferredRevenueAmount" format="ixt:num-dot-decimal" scale="3" id="f-661">1,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Beneficial Interests</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="vrts:VariableInterestEntityReportingEntityInvolvementBeneficialInterestsAmount" format="ixt:num-dot-decimal" scale="3" id="f-662">98,003</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_7">Table of Contents</a></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-610-3" continuedAt="f-610-4"><ix:continuation id="f-659-3"><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents income and expenses of the consolidated CLOs included on the Company&#8217;s Condensed Consolidated Statements of Operations for the period indicated:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.719%"><tr><td style="width:1.0%"/><td style="width:67.897%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.903%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized gain (loss), net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-3" name="us-gaap:GainLossOnInvestments" scale="3" id="f-663">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-3" name="us-gaap:InvestmentIncomeInterestAndDividend" format="ixt:num-dot-decimal" scale="3" id="f-664">49,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-665">49,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-3" name="us-gaap:OtherCostAndExpenseOperating" scale="3" id="f-666">499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-667">40,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-3" name="vrts:OperatingandNonoperatingExpense" format="ixt:num-dot-decimal" scale="3" id="f-668">40,510</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="f-669">391</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Income (Loss) Attributable to CLOs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="f-670">8,380</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the Company&#8217;s own economic interests in the consolidated CLOs, which are eliminated upon consolidation:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.719%"><tr><td style="width:1.0%"/><td style="width:67.897%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.903%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions received and unrealized gains (losses) on the subordinated notes held by the Company</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-3" name="vrts:VariableInterestEntityMeasureofActivityDistributionsReceivedandUnrealizedGainsLossesOnInvestment" format="ixt:num-dot-decimal" scale="3" id="f-671">6,083</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment management fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-3" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues" format="ixt:num-dot-decimal" scale="3" id="f-672">2,297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Economic Interests</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-3" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="f-673">8,380</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation><div style="padding-left:36pt;text-indent:11.25pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements of CIP</span></div><ix:continuation id="f-433-2" continuedAt="f-433-3"><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assets and liabilities of CIP measured at fair value on a recurring basis as of March&#160;31, 2024 and December&#160;31, 2023 by fair value hierarchy level were as follows:</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As of March&#160;31, 2024 </span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.812%"><tr><td style="width:1.0%"/><td style="width:45.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.479%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.798%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.479%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.800%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-674">119,914</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-675">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-676">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-677">119,914</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-678">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-679">2,003,579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-680">47,551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-681">2,051,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-682">29,469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="f-683">384</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="f-684">242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-685">30,095</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-686">149,383</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-687">2,003,963</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-688">47,793</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-689">2,201,139</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-3" name="us-gaap:NotesPayableFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-690">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-3" name="us-gaap:NotesPayableFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-691">1,922,051</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-3" name="us-gaap:NotesPayableFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-692">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-3" name="us-gaap:NotesPayableFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-693">1,922,051</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-3" name="us-gaap:FinancialInstrumentsSoldNotYetPurchasedAtFairValue" scale="3" id="f-694">485</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-3" name="us-gaap:FinancialInstrumentsSoldNotYetPurchasedAtFairValue" format="ixt:fixed-zero" scale="3" id="f-695">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-3" name="us-gaap:FinancialInstrumentsSoldNotYetPurchasedAtFairValue" format="ixt:fixed-zero" scale="3" id="f-696">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-3" name="us-gaap:FinancialInstrumentsSoldNotYetPurchasedAtFairValue" scale="3" id="f-697">485</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="f-698">485</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-699">1,922,051</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-700">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-701">1,922,536</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_7">Table of Contents</a></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-610-4" continuedAt="f-610-5"><ix:continuation id="f-433-3"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As of December&#160;31, 2023 </span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.812%"><tr><td style="width:1.0%"/><td style="width:45.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.479%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.798%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.479%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.800%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-702">98,101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-703">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-704">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-705">98,101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="f-706">241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-707">2,012,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-708">36,616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-709">2,049,617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-710">32,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="f-711">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="f-712">446</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-713">33,096</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-714">130,984</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-715">2,012,768</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-716">37,062</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-717">2,180,814</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-3" name="us-gaap:NotesPayableFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-718">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-3" name="us-gaap:NotesPayableFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-719">1,922,243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-3" name="us-gaap:NotesPayableFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-720">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" name="us-gaap:NotesPayableFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-721">1,922,243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-3" name="us-gaap:FinancialInstrumentsSoldNotYetPurchasedAtFairValue" scale="3" id="f-722">518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-3" name="us-gaap:FinancialInstrumentsSoldNotYetPurchasedAtFairValue" format="ixt:fixed-zero" scale="3" id="f-723">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-3" name="us-gaap:FinancialInstrumentsSoldNotYetPurchasedAtFairValue" format="ixt:fixed-zero" scale="3" id="f-724">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" name="us-gaap:FinancialInstrumentsSoldNotYetPurchasedAtFairValue" scale="3" id="f-725">518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="f-726">518</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-727">1,922,243</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-728">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-729">1,922,761</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><ix:continuation id="f-490-1"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a discussion of the valuation methodologies used for the assets and liabilities of the Company&#8217;s CIP measured at fair value:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 assets represent cash investments in money market funds and debt and equity investments that are valued using published net asset values or the official closing price on the exchange on which the securities are traded.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 assets represent most debt securities (including bank loans) and certain equity securities (including non-U.S. securities), for which closing prices are not readily available or are deemed to not reflect readily available market prices, and are valued using an independent pricing service.  Debt investments, other than bank loans, are valued based on quotations received from independent pricing services or from dealers who make markets in such securities.  Bank loan investments, which are included as debt investments, are generally priced at the average mid-point of bid and ask quotations obtained from a third-party pricing service.  Fair value may also be based upon valuations obtained from independent third-party brokers or dealers utilizing matrix pricing models that consider information regarding securities with similar characteristics.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 assets include debt and equity securities that are not widely traded, are illiquid or are priced by dealers based on pricing models used by market makers in the security.  These securities are valued using unadjusted prices from an independent pricing service.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 liabilities consist of short sales transactions in which a security is sold that is not owned or is owned but there is no intention to deliver, in anticipation that the price of the security will decline.  Short sales are recorded on the Condensed Consolidated Balance Sheets within other liabilities of CIP and are classified as Level 1 based on the underlying equity security.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 liabilities consist of notes payable issued by CLOs and are measured using the measurement alternative in ASU 2014-13.  Accordingly, the fair value of CLO liabilities was measured as the fair value of CLO assets less the sum of (i) the fair value of the beneficial interests held by the Company, and (ii) the carrying value of any beneficial interests that represent compensation for services.  The fair value of the beneficial interests held by the Company is based on third-party pricing information without adjustment.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The securities purchased payable at March&#160;31, 2024 and December&#160;31, 2023 approximated fair value due to the short-term nature of the instruments. </span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_7">Table of Contents</a></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-610-5" continuedAt="f-610-6"><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="f-730" escape="true"><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a reconciliation of assets of CIP for Level 3 investments for which significant unobservable inputs were used to determine fair value:</span></div><div style="margin-bottom:3pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.912%"><tr><td style="width:1.0%"/><td style="width:64.890%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.341%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.926%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.343%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="3" id="f-731">37,062</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-196" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="3" id="f-732">43,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized gains (losses), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-3" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="3" id="f-733">324</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="3" id="f-734">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" format="ixt:fixed-zero" scale="3" id="f-735">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="3" id="f-736">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" format="ixt:num-dot-decimal" scale="3" id="f-737">14,625</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" format="ixt:num-dot-decimal" scale="3" id="f-738">7,195</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers to Level 2</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" format="ixt:num-dot-decimal" scale="3" id="f-739">13,468</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" format="ixt:num-dot-decimal" scale="3" id="f-740">35,747</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers from Level 2</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:num-dot-decimal" scale="3" id="f-741">39,148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:num-dot-decimal" scale="3" id="f-742">9,904</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at end of period (1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="3" id="f-743">47,793</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="3" id="f-744">10,658</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:108pt;padding-right:90pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8pt">The investments that are categorized as Level 3 were valued utilizing third-party pricing information without adjustment.  Transfers in and/or out of levels are reflected when significant inputs, including market inputs or performance attributes, used for the fair value measurement become observable/unobservable at period end.</span></div></ix:nonNumeric><div style="text-indent:11.25pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationVariableInterestEntityPolicy" id="f-745" continuedAt="f-745-1" escape="true"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nonconsolidated VIEs</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company serves as the collateral manager for other CLOs that are not consolidated.  The assets and liabilities of these CLOs reside in bankruptcy remote, special purpose entities in which the Company has no ownership of, nor holds any notes issued by, the CLOs, and provides neither recourse nor guarantees.  The Company has determined that the investment management fees it receives for serving as collateral manager for these CLOs did not represent a variable interest as (i) the fees the Company earns are compensation for services provided and are commensurate with the level of effort required to provide the investment management services, (ii) the Company does not hold other interests in the CLOs that individually, or in the aggregate, would absorb more than an insignificant amount of the CLOs' expected losses or receive more than an insignificant amount of the CLOs' expected residual return, and (iii) the investment management arrangement only includes terms, conditions and amounts that are customarily present in arrangements for similar services negotiated at arm's length. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:nonNumeric></ix:continuation><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-610-6"><ix:continuation id="f-745-1">The Company has interests in certain other VIEs that the Company does not consolidate as it is not the primary beneficiary since its interest in these entities does not provide the Company with the power to direct the activities that most significantly impact the entities' economic performance.</ix:continuation>  At March&#160;31, 2024, the carrying value and maximum risk of loss related to the Company's interest in these VIEs was $<ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-5" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" format="ixt:num-dot-decimal" scale="6" id="f-746">29.1</ix:nonFraction> million.</ix:continuation>  </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><div id="ib5b8a7200088450192ffaafa34312190_94"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_7">Table of Contents</a></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2.&#160;&#160;&#160;&#160;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cautionary Statement Regarding Forward Looking Statements</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q contains statements that are, or may be considered to be, forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, as amended, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act").  All statements that are not historical facts, including statements about our beliefs or expectations, are "forward-looking statements."  These statements may be identified by such forward-looking terminology as "expect," "estimate," "intent," "plan," "intend," "believe," "anticipate," "may," "will," "should," "could," "continue," "project," "opportunity," "predict," "would," "potential," "future," "forecast," "guarantee," "assume," "likely," "target" or similar statements or variations of such terms.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our forward-looking statements are based on a series of expectations, assumptions and projections about the Company and the markets in which we operate, are not guarantees of future results or performance, and involve substantial risks and uncertainty, including assumptions and projections concerning our assets under management, net asset inflows and outflows, operating cash flows, business plans and ability to borrow, for all future periods.  All forward-looking statements contained in this Quarterly Report on Form 10-Q are as of the date of this Quarterly Report on Form 10-Q only.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We can give no assurance that such expectations or forward-looking statements will prove to be correct.  Actual results may differ materially.  We do not undertake or plan to update or revise any such forward-looking statements to reflect actual results, changes in plans, assumptions, estimates or projections, or other circumstances occurring after the date of this Quarterly Report on Form 10-Q, even if such results, changes or circumstances make it clear that any forward-looking information will not be realized.  If there are any future public statements or disclosures by us that modify or impact any of the forward-looking statements contained in or accompanying this Quarterly Report on Form 10-Q, such statements or disclosures will be deemed to modify or supersede such statements in this Quarterly Report on Form 10-Q.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business and our forward-looking statements involve substantial known and unknown risks and uncertainties, including those discussed under "Risk Factors" and "Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations" in our 2023 Annual Report on Form 10-K and this Quarterly Report on Form 10-Q, resulting from: (i) any reduction in our assets under management; (ii) inability to achieve the expected benefits of strategic transactions; (iii) withdrawal, renegotiation or termination of investment advisory agreements; (iv) damage to our reputation; (v) inability to satisfy financial debt covenants and required payments; (vi) inability to attract and retain key personnel; (vii) challenges from competition; (viii) adverse developments related to unaffiliated subadvisers; (ix) negative changes in key distribution relationships; (x) interruptions, breaches, or failures of technology systems; (xi) loss on our investments; (xii) lack of sufficient capital on satisfactory terms; (xiii) adverse regulatory and legal developments; (xiv) failure to comply with investment guidelines or other contractual requirements; (xv) adverse civil litigation, government investigations, or proceedings; (xvi) unfavorable changes in tax laws or limitations; (xvii) inability to make common stock dividend payments; (xviii) impediments from certain corporate governance provisions; (xix) losses or costs not covered by insurance; (xx) impairment of goodwill or other intangible assets; and other risks and uncertainties.  Any occurrence of, or any material adverse change in, one or more risk factors or risks and uncertainties referred to above, in our 2023 Annual Report on Form 10-K, this Quarterly Report on Form 10-Q and our other periodic reports filed with the Securities and Exchange Commission (the "SEC") could materially and adversely affect our operations, financial results, cash flows, prospects and liquidity.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain other factors that may impact our continuing operations, prospects, financial results and liquidity, or that may cause actual results to differ from such forward-looking statements, are discussed or included in the Company&#8217;s periodic reports filed with the SEC and are available on our website at www.virtus.com under "Investor Relations."  You are urged to carefully consider all such factors.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Our Business</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide investment management and related services to institutions and individuals.  We use a multi-manager, multi-style approach, offering investment strategies from affiliated managers, each having its own distinct investment style, autonomous investment process and individual brand, as well as from select unaffiliated managers for certain of our retail funds.  By offering a broad array of products, we believe we can appeal to a greater number of investors and have offerings across market cycles and through changes in investor preferences.  Our earnings are primarily from asset-based fees charged for services relating to these various products, including investment management, fund administration, distribution, and shareholder services.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_7">Table of Contents</a></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer investment strategies for institutional and individual investors in different investment products and through multiple distribution channels.  Our investment strategies are available in a diverse range of styles and disciplines, managed by differentiated investment managers.  We have offerings in various asset classes (equity, fixed income, multi-asset and alternatives), geographies (domestic, global, international and emerging), market capitalizations (large, mid and small), styles (growth, core and value) and investment approaches (fundamental and quantitative).  Our institutional products are offered through institutional separate accounts and commingled accounts, including structured products to a variety of institutional clients.  Our products include open-end funds, closed-end funds and retail separate accounts.  We also provide subadvisory services to other investment advisers.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our institutional distribution resources include affiliate-specific sales teams primarily focused on the U.S. market, supported by shared consultant relations and U.S. and non-U.S. institutional sales distribution.  Our institutional products are marketed through relationships with consultants as well as directly to clients.  We target key market segments, including foundations and endowments, corporations, public and private pension plans, sovereign wealth funds and subadvisory relationships.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our retail distribution resources in the U.S. consist of regional sales professionals, a national account relationship group and specialized teams for retirement and ETFs.  Our U.S. retail funds and retail separate accounts are distributed through financial intermediaries.  We have broad distribution access in the U.S. retail market, with distribution partners that include national and regional broker-dealers, independent broker-dealers and registered investment advisers, banks and insurance companies.  In many of these firms, we have a number of products that are on preferred "recommended" lists and on fee-based advisory programs.  Our private client business is marketed directly to individual clients by financial advisory teams at our affiliated investment managers.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Highlights</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.08pt">Net income per diluted share was $4.10 in the first quarter of 2024, a decrease of $1.11, or 21.3%, compared to net income per diluted share of $5.21 in the first quarter of 2023.</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.08pt">Total sales were $7.6 billion in the first quarter of 2024, an increase of $1.3 billion, or 21.6%, from $6.2 billion in the first quarter of 2023.  Net flows were $(1.2) billion in the first quarter of 2024 compared to net flows of $(1.9) billion in the first quarter of 2023.</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.08pt">Assets under management were $179.3 billion at March&#160;31, 2024, an increase of $24.5 billion, or 15.8%, from March&#160;31, 2023.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Under Management </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2024, total assets under management were $179.3 billion, representing an increase of $24.5 billion, or 15.8%, from March&#160;31, 2023, and an increase of $7.1 billion, or 4.1%, from December&#160;31, 2023.  The increase in total assets under management from March&#160;31, 2023 included $25.7 billion from positive market performance and $7.8 billion from the acquisition of AlphaSimplex Group LLC on April 1, 2023 ("AlphaSimplex"), partially offset by $6.6 billion of net outflows.  The increase in total assets under management from December&#160;31, 2023 included $8.7 billion from positive market performance partially offset by $1.2 billion of net outflows.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_7">Table of Contents</a></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Under Management by Product</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our assets under management by product:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"><tr><td style="width:1.0%"/><td style="width:45.597%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.649%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.649%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.649%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.652%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Open-End Funds (1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,818&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,865&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,953&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Closed-End Funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(294)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retail Separate Accounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,816&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Institutional Accounts (2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,384&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">179,311</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">154,849</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24,462</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15.8</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average Assets Under Management (3)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">173,358</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">152,361</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,997</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13.8</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;padding-right:4.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8pt">Represents assets under management of U.S. retail funds, global funds, ETFs and variable insurance funds. </span></div><div style="padding-left:18pt;padding-right:4.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8pt">Represents assets under management of institutional separate and commingled accounts including structured products. </span></div><div style="padding-left:18pt;padding-right:4.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8pt">Averages are calculated as follows:</span></div><div style="padding-left:36pt;padding-right:4.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.52pt">Funds - average daily or weekly balances</span></div><div style="padding-left:36pt;padding-right:4.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.52pt">Retail Separate Accounts - prior-quarter ending balances</span></div><div style="padding-left:36pt;padding-right:4.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.52pt">Institutional Accounts - average of month-end balances</span></div><div style="padding-left:18pt;padding-right:4.5pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-right:4.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Asset Flows by Product&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:5pt;padding-right:18pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes asset flows by product:</span></div><div style="margin-bottom:3pt;padding-left:9pt;padding-right:9pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.824%"><tr><td style="width:1.0%"/><td style="width:67.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.101%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.715%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.103%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Open-End Funds (1)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,062&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inflows</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outflows</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,104)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,792)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net flows</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(628)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,781)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market performance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,771&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(176)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">57,818</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">53,865</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Closed-End Funds</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,361&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inflows</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outflows</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net flows</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market performance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(201)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(212)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,064</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,358</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Retail Separate Accounts</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inflows</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outflows</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,695)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,288)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net flows</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market performance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">46,816</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">37,397</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_7">Table of Contents</a></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-bottom:3pt;padding-left:9pt;padding-right:9pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.824%"><tr><td style="width:1.0%"/><td style="width:67.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.101%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.715%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.103%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Institutional Accounts (3)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,969&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,663&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inflows</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,734&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outflows</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,022)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,047)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net flows</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,288)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(195)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market performance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,001&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,906&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">64,613</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">53,229</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inflows</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outflows</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,821)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,127)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net flows</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,238)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,893)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market performance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(446)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(482)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">179,311</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">154,849</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:67.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8pt">Represents assets under management of U.S. retail funds, global funds, ETFs and variable insurance funds.  </span></div><div style="padding-left:67.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8pt">Represents open-end and closed-end fund distributions net of reinvestments, the net change in assets from cash management strategies, and the impact of non-sales related activities such as asset acquisitions/(dispositions), seed capital investments/(withdrawals), current income or capital returned by structured products and the use of leverage.</span></div><div style="padding-left:67.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8pt">Represents assets under management of institutional separate and commingled accounts including structured products.</span></div><div style="padding-right:54pt"><span><br/></span></div><div style="padding-right:54pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-right:54pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Under Management by Asset Class</span></div><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes assets under management by asset class:</span></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.011%"><tr><td style="width:1.0%"/><td style="width:25.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.026%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.630%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.026%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.630%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.029%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.630%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.029%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.630%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.029%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.630%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.035%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% of Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Class</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,990&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,037&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Multi-asset (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alternatives (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">179,311</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">154,849</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24,462</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15.8</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr></table><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:49.5pt;padding-right:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Consists of strategies and client accounts with substantial holdings in at least two of the following asset classes: equity, fixed income and alternatives.</span></div><div style="padding-left:49.5pt;padding-right:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Consists of managed futures, event-driven, real estate securities, infrastructure, long/short and other strategies.</span></div><div style="padding-left:108pt;padding-right:54pt;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-right:54pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_7">Table of Contents</a></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-bottom:3pt;padding-right:54pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Average Assets Under Management and Average Fees Earned</span></div><div style="margin-bottom:3pt;padding-right:54pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the average management fees earned in basis points and average assets under management:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.152%"><tr><td style="width:1.0%"/><td style="width:45.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.167%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.322%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.102%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average&#160;Fee&#160;Earned</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(expressed in basis points)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average&#160;Assets&#160;Under</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Management</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> (3)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Products</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Open-End Funds (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Closed-End Funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,424&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retail Separate Accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Institutional Accounts (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,466&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,444&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">All Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">173,358</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">152,361</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;padding-right:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8pt">Represents assets under management of U.S. retail funds, global funds, ETFs and variable insurance funds.</span></div><div style="padding-left:18pt;padding-right:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8pt">Represents assets under management of institutional separate and commingled accounts including structured products.</span></div><div style="padding-left:18pt;padding-right:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8pt">Averages are calculated as follows:</span></div><div style="padding-left:36pt;padding-right:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.52pt">Funds - average daily or weekly balances</span></div><div style="padding-left:36pt;padding-right:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.52pt">Retail Separate Accounts - prior-quarter ending balances</span></div><div style="padding-left:36pt;padding-right:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.52pt">Institutional Accounts - average of month-end balances</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Average fees earned represent investment management fees, net of revenue-related adjustments, divided by average net assets, excluding the impact of consolidated investment products ("CIP").</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Revenue-related adjustments are based on specific agreements and reflect the portion of investment management fees passed-through to third-party client intermediaries for services to investors in sponsored investment products.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fund fees are calculated based on average daily or weekly net assets.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Retail separate account fees are calculated based on the end of the preceding or current quarter&#8217;s asset values or on an average of month-end balances.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Institutional account fees are calculated based on an average of month-end balances, an average of current quarter&#8217;s asset values or on a combination of the underlying cash flows and the principal value of the product.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Average fees earned will vary based on several factors, including the asset mix and expense reimbursements to the funds.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The average fee rate earned on all products for the three months ended March&#160;31, 2024 decreased by 0.1 basis points compared to the same period in the prior year primarily due to a shift in asset mix to lower fee assets partially offset by the addition of alternative strategies with higher fee rates from the AlphaSimplex acquisition. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_7">Table of Contents</a></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Results of Operations </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Summary Financial Data</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.485%"><tr><td style="width:1.0%"/><td style="width:45.503%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.541%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.743%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.541%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.743%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.541%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.743%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.545%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment management fees</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,360&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,478&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,882&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222,042&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,874&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,168&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,736&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,295&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,441&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,306&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,579&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,727&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,923&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,891&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,844&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(953)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,698&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,346&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,352&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,831&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,867&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,643&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,224&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,009)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,981&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,990)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(301.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Income (Loss) Attributable to Virtus Investment Partners, Inc.</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,858&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,624&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,766)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per share-diluted</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.10&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.21&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.11)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.3)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2024, total revenues increased 12.2% to $222.0 million from $197.9 million in the first quarter of 2023, primarily as a result of increased average assets under management during the current year period compared to the prior year period.  Operating income increased $3.7 million to $32.3 million in the first quarter of 2024 compared to $28.6 million in the first quarter of 2023, due primarily to the aforementioned increased revenue, partially offset by increased operating expenses due to the addition of AlphaSimplex.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues</span></div><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues by source were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.409%"><tr><td style="width:1.0%"/><td style="width:47.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.085%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investment management fees</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Open-end funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Closed-end funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(284)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retail separate accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,079&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Institutional accounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,305&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investment management fees</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,360&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,478&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,882&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Distribution and service fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Administration and shareholder service fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,678&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income and fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">884&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">222,042</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">197,874</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24,168</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12.2</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:54pt;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment Management Fees</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment management fees are earned based on a percentage of assets under management and are paid pursuant to the terms of the respective investment management agreements, which generally require monthly or quarterly payments.  Investment management fees increased by $23.9 million, or 14.5%, for the three months ended March&#160;31, 2024, compared to the same period in the prior year primarily due to  the increase in average assets under management.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distribution and Service Fees</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Distribution and service fees are sales- and asset-based fees earned from open-end funds for marketing and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_7">Table of Contents</a></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">distribution services.  Distribution and service fees remained consistent during the three months ended March&#160;31, 2024, compared to the same period in the prior year.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Administration and Shareholder Service Fees</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Administration and shareholder service fees represent fees earned for fund administration and shareholder services from our U.S. retail funds, ETFs and certain closed-end funds.  Fund administration and shareholder service fees increased by $0.3 million, or 1.7%, for the three months ended March&#160;31, 2024, compared to the same period in the prior year primarily due to the addition of AlphaSimplex.</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income and Fees</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income and fees primarily represent fees related to other fee-earning assets and contingent sales charges earned from investor redemptions of certain shares sold without a front-end sales charge.  Other income and fees remained consistent during the three months ended March&#160;31, 2024, compared to the same period in the prior year.</span></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses by category were as follows:</span></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.485%"><tr><td style="width:1.0%"/><td style="width:45.503%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.541%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.743%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.541%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.743%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.541%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.743%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.545%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employment expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,549&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution and other asset-based expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,348&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,715&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,730&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses of CIP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">797&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">797&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/M</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,028&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">944&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total operating expenses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">189,736</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">169,295</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,441</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12.1</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:58.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">N/M - Not meaningful</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employment Expenses</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employment expenses consist of fixed and variable compensation and related employee benefit costs.  Employment expenses of $115.2 million increased by $16.5 million, or 16.8%, compared to the same period in the prior year primarily due to the addition of AlphaSimplex and an increase in profit- and sales-based compensation in the current year.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distribution and Other Asset-Based Expenses</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Distribution and other asset-based expenses consist primarily of payments to third-party client intermediaries for providing services to investors in sponsored investment products.  These payments are primarily based on assets under management.  Distribution and other asset-based expenses also include the amortization of deferred sales commissions related to up-front commissions on shares sold without a front-end sales charge to shareholders.  The deferred sales commissions are amortized on a straight-line basis over the period commissions are recovered from distribution fee revenues and contingent sales charges received upon redemption of shares.  During the three months ended March&#160;31, 2024, distribution and other asset-based expenses increased $0.6 million, or 2.7%, compared to the same period in the prior year primarily due to an increase in assets under management in share classes that have asset-based distribution and other asset-based expenses.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Operating Expenses</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating expenses primarily consist of investment research and technology costs, professional fees, travel and distribution-related costs, rent and occupancy expenses, and other business costs.  Other operating expenses increased $0.6 million, or 2.1%, for the three months ended March&#160;31, 2024, compared to the same period in the prior year.  The increase was primarily attributable to the addition of AlphaSimplex partially offset by lower professional fees in the current year period. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_7">Table of Contents</a></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Operating Expenses of CIP</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating expenses of CIP remained consistent during the three months ended March&#160;31, 2024 compared to the same period in the prior year.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Depreciation Expense</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense consists primarily of the straight-line depreciation of furniture, equipment and leasehold improvements.  Depreciation expense increased $0.9 million, or 77.1%, for the three months ended March&#160;31, 2024,  compared to the respective period in the prior year.  The increase was primarily due to the addition of AlphaSimplex and software and equipment purchases in the prior year and depreciation expense for new office space.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization Expense</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense consists of the amortization of definite-lived intangible assets over their estimated useful lives.  Amortization expense increased $0.9 million, or 6.6%, for the three months ended March&#160;31, 2024, compared to the same period in the prior year, primarily due to the addition of AlphaSimplex.</span></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income (Expense)</span></div><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other Income (Expense), net by category were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.052%"><tr><td style="width:1.0%"/><td style="width:49.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.422%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.828%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.422%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.828%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.422%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.828%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Income (Expense)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized gain (loss) on investments, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,416&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized gain (loss) of CIP, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,061)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(343)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(260.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Other Income (Expense), net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,501</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,923</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">578</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.7</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Realized and unrealized gain (loss) on investments, net</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized and unrealized gain (loss) on investments, net changed during the three months ended March&#160;31, 2024 by $0.7 million, compared to the same period in the prior year.  The realized and unrealized gains and losses reflect changes in overall market conditions for the respective periods.  </span></div><div><span><br/></span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Realized and unrealized gain (loss) of CIP, net</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized and unrealized gain (loss) of CIP, net changed by $(1.1) million during the three months ended March&#160;31, 2024, compared to the same period in the prior year.  The change for the three months ended March&#160;31, 2024 consisted primarily of unrealized losses of $17.9 million due to changes in market values of leveraged loans, partially offset by changes in unrealized gains of $16.8 million related to the value of the notes payable.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other income (expense), net</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net changed by $0.9 million during the three months ended March&#160;31, 2024, compared to the same period in the prior year primarily due to changes in the gains and losses on our equity method investments.  </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_7">Table of Contents</a></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Income (Expense)</span></div><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest Income (Expense), net by category were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.614%"><tr><td style="width:1.0%"/><td style="width:50.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.875%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest Income (Expense)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,681)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,005)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(676)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and dividend income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and dividend income of investments of CIP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,814&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense of CIP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,012)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,203)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,809)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Interest Income (Expense), net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,891</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,844</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(953)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense increased $0.7 million, or 13.5%, during the three months ended March&#160;31, 2024, compared to the same period in the prior year due primarily to higher average interest rates during the current year period.</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest and Dividend Income</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and dividend income increased $0.2 million, or 7.1%, during the three months ended March&#160;31, 2024,  compared to the same period in the prior year.  The increase was primarily attributable to both higher interest earned on cash balances and a higher average investment balance in the current year period compared to the prior year period. </span></div><div><span><br/></span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest and Dividend Income of Investments of CIP</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and dividend income of investments of CIP increased $4.3 million, or 9.2%, for the three months ended March&#160;31, 2024, compared to the same period in the prior year.  The increase was primarily due to higher average interest rates during the current year period and the addition of a CLO in the third quarter of 2023.</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense of CIP</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense of CIP represents interest expense on the notes payable of CIP.  Interest expense of CIP increased by $4.8 million, or 13.7%, for the three months ended March&#160;31, 2024, compared to the same period in the prior year primarily due to higher average interest rates and the addition of a CLO in the third quarter of 2023.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax Expense (Benefit)</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes reflected U.S. federal, state and local taxes at an estimated effective tax rate of 18.9% and 20.1% for the three months ended March&#160;31, 2024 and 2023, respectively.  The lower estimated effective tax rate for the three months ended March&#160;31, 2024 was primarily due to excess tax benefits associated with stock-based compensation and the change in valuation allowances in the current year related to the tax effects of unrealized gains on certain of our investments. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="ib5b8a7200088450192ffaafa34312190_97"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_7">Table of Contents</a></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain Financial Data</span></div><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes certain financial data relating to our liquidity and capital resources:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.783%"><tr><td style="width:1.0%"/><td style="width:42.253%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.555%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.555%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.984%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.555%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.988%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,<br/>2024</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Data</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,880&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(115,722)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,448&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,248)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,234)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(404)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876,003&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">868,289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160; </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.783%"><tr><td style="width:1.0%"/><td style="width:42.253%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.555%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.555%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.984%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.555%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.988%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flow Data</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Provided by (Used in):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,528)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,959)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,431&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,460)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,145)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,685&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56,146)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(115,078)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2024, we had $123.9 million of cash and cash equivalents and $127.4 million of investments, which included $90.5 million of investment securities, compared to $239.6 million of cash and cash equivalents and $132.7 million of investments, which included $97.3 million of investment securities, at December&#160;31, 2023.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Uses of Capital </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating expenses consist of employee compensation and related benefit costs and other operating expenses, which primarily consist of investment research, technology costs, professional fees, distribution and occupancy costs, as well as interest on our indebtedness and income taxes.  Annual incentive compensation, our largest annual operating cash expenditure, is paid in the first quarter of the year.  In 2024 and 2023, we paid $146.1 million and $142.1 million, respectively, in incentive compensation earned during the years ended December&#160;31, 2023 and 2022, respectively.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to operating activities, other uses of cash could include: (i) investments in organic growth, including seeding or launching new products and expanding distribution; (ii) debt principal payments through scheduled amortization or additional paydowns; (iii) dividend payments to common stockholders; (iv) repurchases of our common stock, or withholding obligations for the net settlement of employee share transactions; (v) investments in our technology infrastructure; (vi) investments in inorganic growth opportunities that may require upfront and/or future payments; (vii) integration costs, including restructuring and severance, related to acquisitions, if any; and (viii) purchases of affiliate equity interests.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capital and Reserve Requirements</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our subsidiaries are registered with the SEC, Central Bank of Ireland (CBI) or other regulators that subject them to certain rules regarding minimum net capital.  Failure to meet these requirements could result in adverse consequences to us, including additional reporting requirements, or interruption of our business.  At March&#160;31, 2024, these subsidiaries were in compliance with all minimum net capital requirements.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Balance Sheet</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents consist of cash in banks and money market fund investments. Investments consist primarily of investments in our sponsored funds.  CIP represent investment products for which we provide investment </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_7">Table of Contents</a></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">management services and where we have either a controlling financial interest or are considered the primary beneficiary of an investment product that is considered a variable interest entity.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Cash Flow</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities of $34.5 million for the three months ended March&#160;31, 2024 decreased by $8.4 million from net cash used in operating activities of $43.0 million for the same period in the prior year primarily due to an increase in cash from higher net income and an increase of $17.1 million in net sales of investments by CIP in the current year period partially offset by an increase in payments in incentive compensation in the current year.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Cash Flow</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows from investing activities consist primarily of capital expenditures and other investing activities related to our business operations.  Net cash used in investing activities of $2.5 million for the three months ended March&#160;31, 2024 decreased by $10.7 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> from net cash used in investing activities </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of $13.1 million for the same period in the prior year primarily due to cash paid for an equity method investment in the prior year period that did not reoccur in the current year period.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Cash Flow</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows from financing activities consist primarily of transactions related to our common shares, issuance and repayment of debt by us and CIP, payments of contingent consideration and purchases and sales of noncontrolling interests.  Net cash used in financing activities of $56.1 million for the three months ended March&#160;31, 2024 decreased by $58.9 million from net cash used in investing activities of $115.1 million for the same period in the prior year primarily due to a $43.4 million decrease in the repayment on borrowings of CIP and a $16.5 million increase in net contributions from noncontrolling interests.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Agreement</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's credit agreement, as amended (the "Credit Agreement"), comprises (i) a $275.0 million term loan with a seven-year term (the "Term Loan") expiring in September 2028, and (ii) a $175.0 million revolving credit facility with a five-year term expiring in September 2026. The Company repaid $0.7&#160;million outstanding under the Term Loan during the three months ended March&#160;31, 2024 and had $258.1 million outstanding under the Term Loan at March&#160;31, 2024.  In accordance with ASC 835, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the amounts outstanding under the Company's Term Loan are presented on the Condensed Consolidated Balance Sheet net of related debt issuance costs, which were $5.1 million as of March&#160;31, 2024.  </span></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial statements and the accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America, which require the use of estimates.  Actual results will vary from these estimates.  A discussion of our critical accounting policies and estimates is included in Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations in our 2023 Annual Report on Form 10-K.  A complete description of our significant accounting policies is included in our 2023 Annual Report on Form 10-K.  There were no material changes in our critical accounting policies and estimates in the three months ended March&#160;31, 2024. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of accounting standards, see Note 2 in our condensed consolidated financial statements.&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div id="ib5b8a7200088450192ffaafa34312190_100"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is primarily exposed to market risk associated with unfavorable movements in interest rates and securities prices.  During the three months ended March&#160;31, 2024, there were no material changes to the information contained in Part II, Item 7A of the Company's 2023 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span><br/></span></div><div id="ib5b8a7200088450192ffaafa34312190_103"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4.&#160;&#160;&#160;&#160;Controls and Procedures</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain disclosure controls and procedures designed to ensure that information required to be disclosed in reports filed or submitted under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms and that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_7">Table of Contents</a></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">appropriate, to allow timely decisions regarding required disclosure.  Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) as of the end of the period covered by this Quarterly Report on Form 10-Q.  Based on their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that the Company&#8217;s disclosure controls and procedures were effective at the reasonable assurance level as of March&#160;31, 2024, the end of the period covered by this Quarterly Report on Form 10-Q.</span></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) or 15d-15(f) under the Exchange Act) that occurred during the period covered by this Quarterly Report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div id="ib5b8a7200088450192ffaafa34312190_106"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II &#8211; OTHER INFORMATION</span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div id="ib5b8a7200088450192ffaafa34312190_109"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1.&#160;&#160;&#160;&#160;Legal Proceedings </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information set forth in response to Item 103 of Regulation S-K under "Legal Proceedings" is incorporated by reference from Part I, Financial Information Item 1. "Financial Statements" Note 14 "Commitments and Contingencies" of this Quarterly Report on Form 10-Q.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div id="ib5b8a7200088450192ffaafa34312190_112"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1A.&#160;&#160;&#160;&#160;Risk Factors</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to the Company&#8217;s risk factors from those previously reported in our 2023 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div id="ib5b8a7200088450192ffaafa34312190_115"></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2.&#160;&#160;&#160;&#160;Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An aggregate of 5,680,045 shares of our common stock have been authorized to be repurchased under a share repurchase program since it was initially approved in 2010 by our Board of Directors.  As of March&#160;31, 2024, 583,437 shares remained available for repurchase.  Under the terms of the program, we may repurchase shares of our common stock from time to time at our discretion through open market repurchases, privately negotiated transactions and/or other mechanisms, depending on price, prevailing market and business conditions, tax and other financial considerations.  The program, which has no specified term, may be suspended or terminated at any time.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information regarding our share repurchases in each month during the quarter ended March&#160;31, 2024.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"/><td style="width:26.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.623%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.623%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.586%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.767%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.771%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total number of shares purchased</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Average price paid per share (1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total number of shares purchased as part of publicly announced plans or programs (2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maximum number of shares that may yet be purchased under the plans or programs (2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1-31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604,545&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 1-29, 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232.77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594,911&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 1-31, 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,474&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,474&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583,437&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,108&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,108&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="padding-left:36pt;padding-right:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8pt">Average price paid per share is calculated on a settlement basis and excludes commissions and taxes.</span></div><div style="padding-left:36pt;padding-right:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8pt">The share repurchases above were completed pursuant to a program announced in the fourth quarter of 2010 and most recently expanded in May 2022.  This repurchase program is not subject to an expiration date.</span></div><div><span><br/></span></div><div style="padding-right:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_7">Table of Contents</a></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="padding-right:36pt"><span><br/></span></div><div><span><br/></span></div><div id="ib5b8a7200088450192ffaafa34312190_118"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;5.&#160;&#160;&#160;&#160;Other Information</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2024, none of the Company's directors or officers (as defined in Rule 16a-1(f) of the Securities Exchange Act of 1934, as amended), <ix:nonNumeric contextRef="c-1" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-747"><ix:nonNumeric contextRef="c-1" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-748">adopted</ix:nonNumeric></ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-749"><ix:nonNumeric contextRef="c-1" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-750">terminated</ix:nonNumeric></ix:nonNumeric> or modified a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K of the Securities Act of 1933, as amended).</span></div><div><span><br/></span></div><div id="ib5b8a7200088450192ffaafa34312190_121"></div><div style="-sec-extract:summary;margin-bottom:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;6.&#160;&#160;&#160;&#160;Exhibits</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:89.399%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exhibit</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Number</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="vrts03312024ex-311.htm">31.1</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of the Registrant&#8217;s Chief Executive Officer pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="vrts03312024ex-312.htm">31.2</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of the Registrant&#8217;s Chief Financial Officer pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="vrts03312024ex-321.htm">32.1</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of the Registrant&#8217;s Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101)</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="ib5b8a7200088450192ffaafa34312190_124"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib5b8a7200088450192ffaafa34312190_7">Table of Contents</a></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated: May&#160;8, 2024 </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:27.450%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:65.665%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">VIRTUS INVESTMENT PARTNERS, INC.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Michael A. Angerthal</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Michael A. Angerthal</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Executive Vice President and Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>vrts03312024ex-311.htm
<DESCRIPTION>EX-31.1 CERTIFICATION OF CEO
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="ia726635cfce846b78c5cbb3265f664dc_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION UNDER SECTION 302</font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, George R. Aylward, certify that&#58;</font></div><div style="margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this Quarterly Report on Form 10-Q of Virtus Investment Partners, Inc.&#59;</font></div><div style="margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May&#160;8, 2024 </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.409%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47; &#160;&#160;&#160;&#160;G</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EORGE</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> R. A</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">YLWARD</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">George R. Aylward</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">President, Chief Executive Officer and Director</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>vrts03312024ex-312.htm
<DESCRIPTION>EX-31.2 CERTIFICATION OF CFO
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="ic6643af6d7a3428db0c89de5eb9794fb_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION UNDER SECTION 302</font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Michael A. Angerthal, certify that&#58;</font></div><div style="margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this Quarterly Report on Form 10-Q of Virtus Investment Partners, Inc.&#59;</font></div><div style="margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:5pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May&#160;8, 2024 </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.192%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47; &#160;&#160;&#160;&#160;M</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ICHAEL</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> A. A</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NGERTHAL</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Michael A. Angerthal</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Executive&#160;Vice&#160;President,&#160;Chief&#160;Financial&#160;Officer<br>(Principal&#160;Financial&#160;Officer&#160;and&#160;Principal&#160;Accounting&#160;Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>vrts03312024ex-321.htm
<DESCRIPTION>EX-32.1 CERTIFICATION OF CEO AND CFO
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i3c849d33f3514ed4a634439c4c0c26f9_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with this Quarterly Report on Form 10-Q of Virtus Investment Partners, Inc. (the &#8220;Company&#8221;) for the period ended March&#160;31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), each of the undersigned officers of the Company hereby certifies, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge&#58;</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:31.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.88pt">the Report fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:31.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.88pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; May&#160;8, 2024 </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.233%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;&#160;&#160;&#160;&#160;G</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EORGE</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> R. A</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">YLWARD</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">George R. Aylward</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">President, Chief Executive Officer and Director</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.526%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;&#160;&#160;&#160;&#160;M</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ICHAEL</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> A. A</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NGERTHAL</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Michael A. Angerthal</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Executive&#160;Vice&#160;President,&#160;Chief&#160;Financial&#160;Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Principal Financial Officer and<br>Principal Accounting Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>vrts-20240331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:571d5707-32d3-4d02-bf11-c9dc53da4569,g:f6b55787-7777-46c4-a428-e04c6c3401d1-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:vrts="http://www.virtus.com/20240331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.virtus.com/20240331">
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2023" schemaLocation="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vrts-20240331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vrts-20240331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vrts-20240331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vrts-20240331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.virtus.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.virtus.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>0000002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.virtus.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>0000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperations" roleURI="http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations">
        <link:definition>0000004 - Statement - Condensed Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncome" roleURI="http://www.virtus.com/role/CondensedConsolidatedStatementsofComprehensiveIncome">
        <link:definition>0000005 - Statement - Condensed Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncomeParenthetical" roleURI="http://www.virtus.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeParenthetical">
        <link:definition>0000006 - Statement - Condensed Consolidated Statements of Comprehensive Income (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>0000007 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofChangesinStockholdersEquity" roleURI="http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity">
        <link:definition>0000008 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofChangesinStockholdersEquityParenthetical" roleURI="http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityParenthetical">
        <link:definition>0000009 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandBusiness" roleURI="http://www.virtus.com/role/OrganizationandBusiness">
        <link:definition>0000010 - Disclosure - Organization and Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSignificantAccountingPolicies" roleURI="http://www.virtus.com/role/BasisofPresentationandSignificantAccountingPolicies">
        <link:definition>0000011 - Disclosure - Basis of Presentation and Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenues" roleURI="http://www.virtus.com/role/Revenues">
        <link:definition>0000012 - Disclosure - Revenues</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Acquisitions" roleURI="http://www.virtus.com/role/Acquisitions">
        <link:definition>0000013 - Disclosure - Acquisitions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsNet" roleURI="http://www.virtus.com/role/IntangibleAssetsNet">
        <link:definition>0000014 - Disclosure - Intangible Assets, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Investments" roleURI="http://www.virtus.com/role/Investments">
        <link:definition>0000015 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.virtus.com/role/FairValueMeasurements">
        <link:definition>0000016 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityTransactions" roleURI="http://www.virtus.com/role/EquityTransactions">
        <link:definition>0000017 - Disclosure - Equity Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeLoss" roleURI="http://www.virtus.com/role/AccumulatedOtherComprehensiveIncomeLoss">
        <link:definition>0000018 - Disclosure - Accumulated Other Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation" roleURI="http://www.virtus.com/role/StockBasedCompensation">
        <link:definition>0000019 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossPerShare" roleURI="http://www.virtus.com/role/EarningsLossPerShare">
        <link:definition>0000020 - Disclosure - Earnings (Loss) Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.virtus.com/role/IncomeTaxes">
        <link:definition>0000021 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://www.virtus.com/role/Debt">
        <link:definition>0000022 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.virtus.com/role/CommitmentsandContingencies">
        <link:definition>0000023 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterests" roleURI="http://www.virtus.com/role/RedeemableNoncontrollingInterests">
        <link:definition>0000024 - Disclosure - Redeemable Noncontrolling Interests</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Consolidation" roleURI="http://www.virtus.com/role/Consolidation">
        <link:definition>0000025 - Disclosure - Consolidation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSignificantAccountingPoliciesPolicies" roleURI="http://www.virtus.com/role/BasisofPresentationandSignificantAccountingPoliciesPolicies">
        <link:definition>9954471 - Disclosure - Basis of Presentation and Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesTables" roleURI="http://www.virtus.com/role/RevenuesTables">
        <link:definition>9954472 - Disclosure - Revenues (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsNetTables" roleURI="http://www.virtus.com/role/IntangibleAssetsNetTables">
        <link:definition>9954473 - Disclosure - Intangible Assets, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsTables" roleURI="http://www.virtus.com/role/InvestmentsTables">
        <link:definition>9954474 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.virtus.com/role/FairValueMeasurementsTables">
        <link:definition>9954475 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeLossTables" roleURI="http://www.virtus.com/role/AccumulatedOtherComprehensiveIncomeLossTables">
        <link:definition>9954476 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationTables" roleURI="http://www.virtus.com/role/StockBasedCompensationTables">
        <link:definition>9954477 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossPerShareTables" roleURI="http://www.virtus.com/role/EarningsLossPerShareTables">
        <link:definition>9954478 - Disclosure - Earnings (Loss) Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsTables" roleURI="http://www.virtus.com/role/RedeemableNoncontrollingInterestsTables">
        <link:definition>9954479 - Disclosure - Redeemable Noncontrolling Interests (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidationTables" roleURI="http://www.virtus.com/role/ConsolidationTables">
        <link:definition>9954480 - Disclosure - Consolidation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesDetails" roleURI="http://www.virtus.com/role/RevenuesDetails">
        <link:definition>9954481 - Disclosure - Revenues (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsDetails" roleURI="http://www.virtus.com/role/AcquisitionsDetails">
        <link:definition>9954482 - Disclosure - Acquisitions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsNetGoodwillandIntangibleAssetsNetDetails" roleURI="http://www.virtus.com/role/IntangibleAssetsNetGoodwillandIntangibleAssetsNetDetails">
        <link:definition>9954483 - Disclosure - Intangible Assets, Net - Goodwill and Intangible Assets, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsNetEstimatedAmortizationExpenseofIntangibleAssetsSucceedingYearsDetails" roleURI="http://www.virtus.com/role/IntangibleAssetsNetEstimatedAmortizationExpenseofIntangibleAssetsSucceedingYearsDetails">
        <link:definition>9954484 - Disclosure - Intangible Assets, Net - Estimated Amortization Expense of Intangible Assets Succeeding Years (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsInvestmentsDetails" roleURI="http://www.virtus.com/role/InvestmentsInvestmentsDetails">
        <link:definition>9954485 - Disclosure - Investments - Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsMarketableSecuritiesDetails" roleURI="http://www.virtus.com/role/InvestmentsMarketableSecuritiesDetails">
        <link:definition>9954486 - Disclosure - Investments - Marketable Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsNarrativeDetails" roleURI="http://www.virtus.com/role/InvestmentsNarrativeDetails">
        <link:definition>9954487 - Disclosure - Investments - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsChangesinAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" roleURI="http://www.virtus.com/role/FairValueMeasurementsChangesinAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails">
        <link:definition>9954488 - Disclosure - Fair Value Measurements - Changes in Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://www.virtus.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>9954489 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsRollforwardoftheContingentConsiderationLiabilitiesValuedUsingLevel3InputsDetails" roleURI="http://www.virtus.com/role/FairValueMeasurementsRollforwardoftheContingentConsiderationLiabilitiesValuedUsingLevel3InputsDetails">
        <link:definition>9954490 - Disclosure - Fair Value Measurements - Rollforward of the Contingent Consideration Liabilities Valued Using Level 3 Inputs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityTransactionsDetails" roleURI="http://www.virtus.com/role/EquityTransactionsDetails">
        <link:definition>9954491 - Disclosure - Equity Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeLossDetails" roleURI="http://www.virtus.com/role/AccumulatedOtherComprehensiveIncomeLossDetails">
        <link:definition>9954492 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationAdditionalInformationDetails" roleURI="http://www.virtus.com/role/StockBasedCompensationAdditionalInformationDetails">
        <link:definition>9954493 - Disclosure - Stock-Based Compensation - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationStockBasedCompensationExpenseDetails" roleURI="http://www.virtus.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails">
        <link:definition>9954494 - Disclosure - Stock-Based Compensation - Stock Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationRestrictedStockUnitsActivityDetails" roleURI="http://www.virtus.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails">
        <link:definition>9954495 - Disclosure - Stock-Based Compensation - Restricted Stock Units Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossPerShareScheduleofComputationofBasicandDilutedEarningsPerShareDetails" roleURI="http://www.virtus.com/role/EarningsLossPerShareScheduleofComputationofBasicandDilutedEarningsPerShareDetails">
        <link:definition>9954496 - Disclosure - Earnings (Loss) Per Share - Schedule of Computation of Basic and Diluted Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" roleURI="http://www.virtus.com/role/EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails">
        <link:definition>9954497 - Disclosure - Earnings (Loss) Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.virtus.com/role/IncomeTaxesDetails">
        <link:definition>9954498 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtDetails" roleURI="http://www.virtus.com/role/DebtDetails">
        <link:definition>9954499 - Disclosure - Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsScheduleofRedeemableNoncontrollingInterestDetails" roleURI="http://www.virtus.com/role/RedeemableNoncontrollingInterestsScheduleofRedeemableNoncontrollingInterestDetails">
        <link:definition>9954500 - Disclosure - Redeemable Noncontrolling Interests - Schedule of Redeemable Noncontrolling Interest (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidationCondensedConsolidatedBalanceSheetsDetails" roleURI="http://www.virtus.com/role/ConsolidationCondensedConsolidatedBalanceSheetsDetails">
        <link:definition>9954501 - Disclosure - Consolidation - Condensed Consolidated Balance Sheets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidationAdditionalInformationDetails" roleURI="http://www.virtus.com/role/ConsolidationAdditionalInformationDetails">
        <link:definition>9954502 - Disclosure - Consolidation - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidationBeneficialInterestsofConsolidatedInvestmentProductDetails" roleURI="http://www.virtus.com/role/ConsolidationBeneficialInterestsofConsolidatedInvestmentProductDetails">
        <link:definition>9954503 - Disclosure - Consolidation - Beneficial Interests of Consolidated Investment Product (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidationRevenueandExpensesofConsolidatedInvestmentProductDetails" roleURI="http://www.virtus.com/role/ConsolidationRevenueandExpensesofConsolidatedInvestmentProductDetails">
        <link:definition>9954504 - Disclosure - Consolidation - Revenue and Expenses of Consolidated Investment Product (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidationEconomicInterestsofConsolidatedInvestmentProductDetails" roleURI="http://www.virtus.com/role/ConsolidationEconomicInterestsofConsolidatedInvestmentProductDetails">
        <link:definition>9954505 - Disclosure - Consolidation - Economic Interests of Consolidated Investment Product (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" roleURI="http://www.virtus.com/role/ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails">
        <link:definition>9954506 - Disclosure - Consolidation - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidationAssetsRelatedtoConsolidatedSponsoredInvestmentProductsUnobservableInputReconciliationDetails" roleURI="http://www.virtus.com/role/ConsolidationAssetsRelatedtoConsolidatedSponsoredInvestmentProductsUnobservableInputReconciliationDetails">
        <link:definition>9954507 - Disclosure - Consolidation - Assets Related to Consolidated Sponsored Investment Products, Unobservable Input Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="vrts_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" abstract="false" name="FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrts_AmortizationOfIntangibleAssetsAndContingentAmortization" abstract="false" name="AmortizationOfIntangibleAssetsAndContingentAmortization" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrts_NFJInvestmentGroupMember" abstract="true" name="NFJInvestmentGroupMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrts_NetInterestInInvestmentProducts" abstract="false" name="NetInterestInInvestmentProducts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrts_CreditFacility2017Member" abstract="true" name="CreditFacility2017Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vrts_AdministrationAndShareholderServiceFeesMember" abstract="true" name="AdministrationAndShareholderServiceFeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember" abstract="true" name="VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vrts_ExpensesAbstract" abstract="true" name="ExpensesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="vrts_VotingInterestEntityVOEMember" abstract="true" name="VotingInterestEntityVOEMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vrts_NoncontrollingInterestSubscriptionsRedemptions" abstract="false" name="NoncontrollingInterestSubscriptionsRedemptions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember" abstract="true" name="VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vrts_WestchesterCapitalManagementMember" abstract="true" name="WestchesterCapitalManagementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vrts_TermLoanMember" abstract="true" name="TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vrts_SecuritiesPurchasedPayableAndOtherLiabilities" abstract="false" name="SecuritiesPurchasedPayableAndOtherLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrts_OtherIncomeAndfeesMember" abstract="true" name="OtherIncomeAndfeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vrts_StockBasedCompensationExpenseTableTextBlock" abstract="false" name="StockBasedCompensationExpenseTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="vrts_ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember" abstract="true" name="ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vrts_DisposalOfPaymentsForAffiliateEquity" abstract="false" name="DisposalOfPaymentsForAffiliateEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrts_IntangibleAssetsNetExcludingGoodwillRollForward" abstract="true" name="IntangibleAssetsNetExcludingGoodwillRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="vrts_NoncashFinancingItemsAbstract" abstract="true" name="NoncashFinancingItemsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="vrts_ConversionOfStockConversionRatio" abstract="false" name="ConversionOfStockConversionRatio" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="vrts_NoncontrollingInterestPolicyTextBlock" abstract="false" name="NoncontrollingInterestPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="vrts_SubordinatedNotesNewfleetCLO20161Member" abstract="true" name="SubordinatedNotesNewfleetCLO20161Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vrts_ContingentConsiderationLiabilityMember" abstract="true" name="ContingentConsiderationLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsAmount" abstract="false" name="VariableInterestEntityReportingEntityInvolvementBeneficialInterestsAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrts_SponsoredFundsMember" abstract="true" name="SponsoredFundsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vrts_DistributionAndServiceFeesMember" abstract="true" name="DistributionAndServiceFeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vrts_RetailSeparateAccountsMember" abstract="true" name="RetailSeparateAccountsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vrts_VariableInterestEntityMeasureofActivityDistributionsReceivedandUnrealizedGainsLossesOnInvestment" abstract="false" name="VariableInterestEntityMeasureofActivityDistributionsReceivedandUnrealizedGainsLossesOnInvestment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrts_PerformanceStockUnitsIncentiveMember" abstract="true" name="PerformanceStockUnitsIncentiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vrts_IncreaseDecreaseInCashAndCashEquivalentsOfSubsidiariesDueToConsolidation" abstract="false" name="IncreaseDecreaseInCashAndCashEquivalentsOfSubsidiariesDueToConsolidation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrts_AlphaSimplexGroupLLCMember" abstract="true" name="AlphaSimplexGroupLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsSubordinatedDebtAmount" abstract="false" name="VariableInterestEntityReportingEntityInvolvementBeneficialInterestsSubordinatedDebtAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrts_ClosedEndFundsMember" abstract="true" name="ClosedEndFundsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vrts_ProceedsFromPaymentsForOtherInvestmentsOperatingActivities" abstract="false" name="ProceedsFromPaymentsForOtherInvestmentsOperatingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrts_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReductionOfLiability" abstract="false" name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReductionOfLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrts_InvestmentsInNonqualifiedRetirementPlanAssets" abstract="false" name="InvestmentsInNonqualifiedRetirementPlanAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrts_OperatingandNonoperatingExpense" abstract="false" name="OperatingandNonoperatingExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrts_CommonStockDividendsAccruedButNotYetPaid" abstract="false" name="CommonStockDividendsAccruedButNotYetPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrts_NoncontrollingInterestSubscriptionsRedemptionsAndOther" abstract="false" name="NoncontrollingInterestSubscriptionsRedemptionsAndOther" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrts_PaymentOfWithholdingTaxesRelatedToRestrictedStock" abstract="false" name="PaymentOfWithholdingTaxesRelatedToRestrictedStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrts_CreditAgreementMember" abstract="true" name="CreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vrts_InvestmentManagementFeesMember" abstract="true" name="InvestmentManagementFeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vrts_VariableInterestEntityPrimaryBeneficiaryGlobalAndPrivateFundsMember" abstract="true" name="VariableInterestEntityPrimaryBeneficiaryGlobalAndPrivateFundsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vrts_RestrictedStockUnitsandPerformanceSharesUnitsMember" abstract="true" name="RestrictedStockUnitsandPerformanceSharesUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vrts_RestrictedStockUnitsRSUsPerformanceBasedMember" abstract="true" name="RestrictedStockUnitsRSUsPerformanceBasedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vrts_NumberofCollateralizedLoanObligationsConsolidated" abstract="false" name="NumberofCollateralizedLoanObligationsConsolidated" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vrts_NonqualifiedRetirementPlanAssetsMember" abstract="true" name="NonqualifiedRetirementPlanAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vrts_InstitutionalAccountsMember" abstract="true" name="InstitutionalAccountsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vrts_SeniorSecuredFloatingRateNotesNewfleetCLO20161Member" abstract="true" name="SeniorSecuredFloatingRateNotesNewfleetCLO20161Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vrts_OpenEndFundsMember" abstract="true" name="OpenEndFundsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="vrts_SecuritiesPurchasedPayable" abstract="false" name="SecuritiesPurchasedPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsDeferredRevenueAmount" abstract="false" name="VariableInterestEntityReportingEntityInvolvementBeneficialInterestsDeferredRevenueAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>vrts-20240331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:571d5707-32d3-4d02-bf11-c9dc53da4569,g:f6b55787-7777-46c4-a428-e04c6c3401d1-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.virtus.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="vrts-20240331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.virtus.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_fe351000-057e-4bd8-a912-bbcacafe71ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_292e16cb-36b0-49a6-a31b-fa75f0956ba3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_fe351000-057e-4bd8-a912-bbcacafe71ae" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_292e16cb-36b0-49a6-a31b-fa75f0956ba3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_d4447ab3-7930-4728-8fb7-4b9eb223509c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_fe351000-057e-4bd8-a912-bbcacafe71ae" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_d4447ab3-7930-4728-8fb7-4b9eb223509c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_76514d0f-a016-429a-913a-7e1dcc07ea1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_fe351000-057e-4bd8-a912-bbcacafe71ae" xlink:to="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_76514d0f-a016-429a-913a-7e1dcc07ea1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_24345b53-1afe-4070-a4e8-bbeb340c22f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_fe351000-057e-4bd8-a912-bbcacafe71ae" xlink:to="loc_us-gaap_LongTermDebt_24345b53-1afe-4070-a4e8-bbeb340c22f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities_666101e0-26e6-4d78-9926-8a9a49e17480" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_fe351000-057e-4bd8-a912-bbcacafe71ae" xlink:to="loc_us-gaap_OtherLiabilities_666101e0-26e6-4d78-9926-8a9a49e17480" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_32e875bb-6c35-4fdd-9b52-0714bc700e2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotes"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_fe351000-057e-4bd8-a912-bbcacafe71ae" xlink:to="loc_us-gaap_SeniorNotes_32e875bb-6c35-4fdd-9b52-0714bc700e2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_SecuritiesPurchasedPayableAndOtherLiabilities_f011504d-64cf-4c1e-a3cd-2403545624ba" xlink:href="vrts-20240331.xsd#vrts_SecuritiesPurchasedPayableAndOtherLiabilities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_fe351000-057e-4bd8-a912-bbcacafe71ae" xlink:to="loc_vrts_SecuritiesPurchasedPayableAndOtherLiabilities_f011504d-64cf-4c1e-a3cd-2403545624ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_10e7f082-6495-4b5c-8602-889cd5a443b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_fe351000-057e-4bd8-a912-bbcacafe71ae" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_10e7f082-6495-4b5c-8602-889cd5a443b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2f0aa1ce-f7ef-4a27-ba6c-c3f6998d6fed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b3fc891e-7534-4bbb-93da-8346a792f7cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2f0aa1ce-f7ef-4a27-ba6c-c3f6998d6fed" xlink:to="loc_us-gaap_StockholdersEquity_b3fc891e-7534-4bbb-93da-8346a792f7cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_d1e2f413-9f31-4d61-9c68-e87c91e5f949" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2f0aa1ce-f7ef-4a27-ba6c-c3f6998d6fed" xlink:to="loc_us-gaap_MinorityInterest_d1e2f413-9f31-4d61-9c68-e87c91e5f949" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_856c4681-a90c-429b-b1f9-ba301e943d34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_78860820-aaa1-4859-b599-a60dda7ab90f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_856c4681-a90c-429b-b1f9-ba301e943d34" xlink:to="loc_us-gaap_CommonStockValue_78860820-aaa1-4859-b599-a60dda7ab90f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_41e3953c-9731-4aae-b299-e6c0f993292f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_856c4681-a90c-429b-b1f9-ba301e943d34" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_41e3953c-9731-4aae-b299-e6c0f993292f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d300a58d-8134-4b12-9b5c-4039e679d9d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_856c4681-a90c-429b-b1f9-ba301e943d34" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d300a58d-8134-4b12-9b5c-4039e679d9d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_26cde5d1-4a5e-44e8-8ab6-7d926f26b968" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_856c4681-a90c-429b-b1f9-ba301e943d34" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_26cde5d1-4a5e-44e8-8ab6-7d926f26b968" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_905d02a4-b364-4e8d-b557-99198682e500" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_856c4681-a90c-429b-b1f9-ba301e943d34" xlink:to="loc_us-gaap_TreasuryStockCommonValue_905d02a4-b364-4e8d-b557-99198682e500" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_845be76b-0f19-4d53-9f58-71c39d4f53cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_4ac37ca2-f735-486c-9534-062e9b754408" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_845be76b-0f19-4d53-9f58-71c39d4f53cf" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_4ac37ca2-f735-486c-9534-062e9b754408" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a9e9a478-a00a-461e-a5a5-44ddfc092a52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_845be76b-0f19-4d53-9f58-71c39d4f53cf" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a9e9a478-a00a-461e-a5a5-44ddfc092a52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7a28663a-c49b-4a8c-9b41-c282bebb2c42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_845be76b-0f19-4d53-9f58-71c39d4f53cf" xlink:to="loc_us-gaap_Goodwill_7a28663a-c49b-4a8c-9b41-c282bebb2c42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_c61f7eae-6f3c-44ea-9d98-8780de8a0960" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_845be76b-0f19-4d53-9f58-71c39d4f53cf" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_c61f7eae-6f3c-44ea-9d98-8780de8a0960" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet_d7668d2d-c925-467e-a4f7-8865b3e9fe66" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_845be76b-0f19-4d53-9f58-71c39d4f53cf" xlink:to="loc_us-gaap_AccountsReceivableNet_d7668d2d-c925-467e-a4f7-8865b3e9fe66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_4f91d7c3-e929-4b4e-8cee-5b4846b4c01f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Investments"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_845be76b-0f19-4d53-9f58-71c39d4f53cf" xlink:to="loc_us-gaap_Investments_4f91d7c3-e929-4b4e-8cee-5b4846b4c01f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets_fcf78509-e5bf-4f6c-9c7a-35a6d9149816" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssets"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_845be76b-0f19-4d53-9f58-71c39d4f53cf" xlink:to="loc_us-gaap_OtherAssets_fcf78509-e5bf-4f6c-9c7a-35a6d9149816" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_e9c9ff70-0606-4a13-afa1-f70774569bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_845be76b-0f19-4d53-9f58-71c39d4f53cf" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_e9c9ff70-0606-4a13-afa1-f70774569bcc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_70cbf312-a0f8-494a-88c3-4ef3155845af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_845be76b-0f19-4d53-9f58-71c39d4f53cf" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_70cbf312-a0f8-494a-88c3-4ef3155845af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_54d7f5c7-6053-4275-92a9-665c4a0c3459" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_f3b4578e-95c2-4314-956f-91dceef33770" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_54d7f5c7-6053-4275-92a9-665c4a0c3459" xlink:to="loc_us-gaap_Liabilities_f3b4578e-95c2-4314-956f-91dceef33770" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_4c760afc-e686-422f-b357-da29f35f5c2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_54d7f5c7-6053-4275-92a9-665c4a0c3459" xlink:to="loc_us-gaap_CommitmentsAndContingencies_4c760afc-e686-422f-b357-da29f35f5c2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_a894873d-c5c1-4588-b679-1368297260e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_54d7f5c7-6053-4275-92a9-665c4a0c3459" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_a894873d-c5c1-4588-b679-1368297260e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1c830749-f8ad-4e89-9327-05bda0fff88c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_54d7f5c7-6053-4275-92a9-665c4a0c3459" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1c830749-f8ad-4e89-9327-05bda0fff88c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="vrts-20240331.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_437a8344-cab4-4c1d-bc6d-b9ebd29db34e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_06c9d277-b37a-4122-b8c8-f02f93bf141a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_437a8344-cab4-4c1d-bc6d-b9ebd29db34e" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_06c9d277-b37a-4122-b8c8-f02f93bf141a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_64ff4055-b9de-4957-82b8-ceb88e565b10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_437a8344-cab4-4c1d-bc6d-b9ebd29db34e" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_64ff4055-b9de-4957-82b8-ceb88e565b10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_1b19a82f-df7b-47e3-850a-ed85b40676eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_437a8344-cab4-4c1d-bc6d-b9ebd29db34e" xlink:to="loc_us-gaap_OperatingIncomeLoss_1b19a82f-df7b-47e3-850a-ed85b40676eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e3792be6-00d5-4352-ac8f-9fa2dab8665b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2e7fc2f7-fe90-4cb3-92aa-9d0af507b8f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_e3792be6-00d5-4352-ac8f-9fa2dab8665b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2e7fc2f7-fe90-4cb3-92aa-9d0af507b8f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_45c7aeb2-f987-4567-b47b-46ffd35e4e66" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_e3792be6-00d5-4352-ac8f-9fa2dab8665b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_45c7aeb2-f987-4567-b47b-46ffd35e4e66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_7a703773-2b3c-4cec-bd56-9b31b68f14b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating_09a238f9-771c-4167-8467-f7e119691aff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_7a703773-2b3c-4cec-bd56-9b31b68f14b7" xlink:to="loc_us-gaap_OtherCostAndExpenseOperating_09a238f9-771c-4167-8467-f7e119691aff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense_2bddd5b5-154b-46f7-a0aa-f2ac0ad5f0b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_7a703773-2b3c-4cec-bd56-9b31b68f14b7" xlink:to="loc_us-gaap_LaborAndRelatedExpense_2bddd5b5-154b-46f7-a0aa-f2ac0ad5f0b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_287209b9-3168-4e02-af70-885087ec1ac0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_7a703773-2b3c-4cec-bd56-9b31b68f14b7" xlink:to="loc_us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_287209b9-3168-4e02-af70-885087ec1ac0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_AmortizationOfIntangibleAssetsAndContingentAmortization_5d1f9378-8ba2-46ec-b5f5-320dbf69edca" xlink:href="vrts-20240331.xsd#vrts_AmortizationOfIntangibleAssetsAndContingentAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_7a703773-2b3c-4cec-bd56-9b31b68f14b7" xlink:to="loc_vrts_AmortizationOfIntangibleAssetsAndContingentAmortization_5d1f9378-8ba2-46ec-b5f5-320dbf69edca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_ae9f2832-1720-42bd-abf6-9df3bd04bb25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_7a703773-2b3c-4cec-bd56-9b31b68f14b7" xlink:to="loc_us-gaap_Depreciation_ae9f2832-1720-42bd-abf6-9df3bd04bb25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_c1ebd77b-2e0d-4c45-a535-e40f91134936" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_7a703773-2b3c-4cec-bd56-9b31b68f14b7" xlink:to="loc_us-gaap_RestructuringCharges_c1ebd77b-2e0d-4c45-a535-e40f91134936" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_c41cfa84-59f1-49de-9ccd-892e8c40e9ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3d352796-60e7-4fbe-a132-9bb953691c71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_c41cfa84-59f1-49de-9ccd-892e8c40e9ea" xlink:to="loc_us-gaap_ProfitLoss_3d352796-60e7-4fbe-a132-9bb953691c71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_a56a2ccf-f339-46b4-a765-783cee31da71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_c41cfa84-59f1-49de-9ccd-892e8c40e9ea" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_a56a2ccf-f339-46b4-a765-783cee31da71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_caa739d6-60e8-42e3-91e6-e5557ce7f10f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_43b8e0f1-6fc0-4017-95ee-d6515464906a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_caa739d6-60e8-42e3-91e6-e5557ce7f10f" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_43b8e0f1-6fc0-4017-95ee-d6515464906a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_a0053e35-b52f-431a-b682-ed2b8d2bd43c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_caa739d6-60e8-42e3-91e6-e5557ce7f10f" xlink:to="loc_us-gaap_GainLossOnInvestments_a0053e35-b52f-431a-b682-ed2b8d2bd43c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_66e6f7a1-3a34-4a53-b65f-d0a0a7cd5689" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_3a3839f1-4640-4f55-bf9c-662c143a222f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_66e6f7a1-3a34-4a53-b65f-d0a0a7cd5689" xlink:to="loc_us-gaap_InterestExpense_3a3839f1-4640-4f55-bf9c-662c143a222f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_989aaeb2-a26c-4841-9822-7daa7678c7b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_66e6f7a1-3a34-4a53-b65f-d0a0a7cd5689" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_989aaeb2-a26c-4841-9822-7daa7678c7b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_1a35bf91-f970-42a3-8d54-c898bc69f488" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_e7d5ce29-a241-4011-aab1-4a6c23df4c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_1a35bf91-f970-42a3-8d54-c898bc69f488" xlink:to="loc_us-gaap_OperatingExpenses_e7d5ce29-a241-4011-aab1-4a6c23df4c4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_32dc06cf-e3cf-460f-9842-91ac4fab9825" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_1a35bf91-f970-42a3-8d54-c898bc69f488" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_32dc06cf-e3cf-460f-9842-91ac4fab9825" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="vrts-20240331.xsd#CondensedConsolidatedStatementsofComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.virtus.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_8ed37d38-3ad4-4fa1-9eb5-b86736e6890f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_cd476351-1f36-4cdc-868c-38783b6bf814" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_8ed37d38-3ad4-4fa1-9eb5-b86736e6890f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_cd476351-1f36-4cdc-868c-38783b6bf814" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_4af66f5f-1ec7-4142-8ac4-7f53972a85a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ebe87783-1017-496d-82be-ce389b8521a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_4af66f5f-1ec7-4142-8ac4-7f53972a85a7" xlink:to="loc_us-gaap_ProfitLoss_ebe87783-1017-496d-82be-ce389b8521a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e770d500-f247-4d21-9a11-c3400282963b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_4af66f5f-1ec7-4142-8ac4-7f53972a85a7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e770d500-f247-4d21-9a11-c3400282963b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_ecbd24e0-2122-4b2f-b22e-42afca11f1ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_8af8605a-206e-4b5e-83b4-cbbd9b5884a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_ecbd24e0-2122-4b2f-b22e-42afca11f1ac" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_8af8605a-206e-4b5e-83b4-cbbd9b5884a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1e41747b-b069-40b9-ac70-18278d9230ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_ecbd24e0-2122-4b2f-b22e-42afca11f1ac" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1e41747b-b069-40b9-ac70-18278d9230ee" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="vrts-20240331.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5438efbb-e40b-4f0b-800c-b4884bdbb3f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_05a89d4e-0017-4f51-97ae-30c2074d149f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5438efbb-e40b-4f0b-800c-b4884bdbb3f2" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_05a89d4e-0017-4f51-97ae-30c2074d149f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_IncreaseDecreaseInCashAndCashEquivalentsOfSubsidiariesDueToConsolidation_88356ec0-eec0-4994-ab0c-d2b94404182b" xlink:href="vrts-20240331.xsd#vrts_IncreaseDecreaseInCashAndCashEquivalentsOfSubsidiariesDueToConsolidation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5438efbb-e40b-4f0b-800c-b4884bdbb3f2" xlink:to="loc_vrts_IncreaseDecreaseInCashAndCashEquivalentsOfSubsidiariesDueToConsolidation_88356ec0-eec0-4994-ab0c-d2b94404182b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_8cd5edfe-f441-40c6-b6d1-b4310316befc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5438efbb-e40b-4f0b-800c-b4884bdbb3f2" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_8cd5edfe-f441-40c6-b6d1-b4310316befc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1e7c8f34-e5fa-44ba-98d4-6720922d9843" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_f4c55db1-9a21-4765-880c-4de7a2839607" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1e7c8f34-e5fa-44ba-98d4-6720922d9843" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_f4c55db1-9a21-4765-880c-4de7a2839607" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsToMinorityShareholders_b1d9bd36-9b83-4a1f-9d31-8c53f09f181a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsToMinorityShareholders"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1e7c8f34-e5fa-44ba-98d4-6720922d9843" xlink:to="loc_us-gaap_ProceedsFromPaymentsToMinorityShareholders_b1d9bd36-9b83-4a1f-9d31-8c53f09f181a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_e349866e-6cb6-4db9-8016-2864c3d785a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1e7c8f34-e5fa-44ba-98d4-6720922d9843" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_e349866e-6cb6-4db9-8016-2864c3d785a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_0cfeada3-3761-4bed-b161-174f2f3d19f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1e7c8f34-e5fa-44ba-98d4-6720922d9843" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_0cfeada3-3761-4bed-b161-174f2f3d19f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_b24fcaa3-10be-4c39-a4f7-6ad8c0b5566e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1e7c8f34-e5fa-44ba-98d4-6720922d9843" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_b24fcaa3-10be-4c39-a4f7-6ad8c0b5566e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_DisposalOfPaymentsForAffiliateEquity_255ea5fc-63ff-4df0-b6b0-70ce3f386c2a" xlink:href="vrts-20240331.xsd#vrts_DisposalOfPaymentsForAffiliateEquity"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1e7c8f34-e5fa-44ba-98d4-6720922d9843" xlink:to="loc_vrts_DisposalOfPaymentsForAffiliateEquity_255ea5fc-63ff-4df0-b6b0-70ce3f386c2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherDebt_60c03401-f1f1-418d-8a09-d3d181aa8d18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfOtherDebt"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1e7c8f34-e5fa-44ba-98d4-6720922d9843" xlink:to="loc_us-gaap_RepaymentsOfOtherDebt_60c03401-f1f1-418d-8a09-d3d181aa8d18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_675fbe41-83bb-4dda-94a3-16136b7f24f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1e7c8f34-e5fa-44ba-98d4-6720922d9843" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_675fbe41-83bb-4dda-94a3-16136b7f24f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_aa6de56b-6b62-46cc-bf76-b32185eef282" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d46b5ef4-b1ff-4375-a032-f5d4e89c9c03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_aa6de56b-6b62-46cc-bf76-b32185eef282" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d46b5ef4-b1ff-4375-a032-f5d4e89c9c03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_97b9ec01-4634-4a8c-b339-798e336dc984" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_aa6de56b-6b62-46cc-bf76-b32185eef282" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_97b9ec01-4634-4a8c-b339-798e336dc984" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_de9b2b29-3c30-4783-83e8-ab0d160fab26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ae525d3a-6382-4d79-889e-4e9b182d3a26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_de9b2b29-3c30-4783-83e8-ab0d160fab26" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ae525d3a-6382-4d79-889e-4e9b182d3a26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f973b080-f6c3-4679-9f42-379eaa82128f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_de9b2b29-3c30-4783-83e8-ab0d160fab26" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f973b080-f6c3-4679-9f42-379eaa82128f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7773da8b-d98c-4a37-b84f-03aec1cfda83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_de9b2b29-3c30-4783-83e8-ab0d160fab26" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7773da8b-d98c-4a37-b84f-03aec1cfda83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_68138486-55ba-4f0c-aa84-6be76f056b52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_de9b2b29-3c30-4783-83e8-ab0d160fab26" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_68138486-55ba-4f0c-aa84-6be76f056b52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1342bad4-de58-4b53-9e4e-41925049aac4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_72afeac3-5a68-40ec-9d86-f61846b83995" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtAndEquitySecuritiesGainLoss"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1342bad4-de58-4b53-9e4e-41925049aac4" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_72afeac3-5a68-40ec-9d86-f61846b83995" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities_8b1ae030-ae8a-4fc3-9eb0-adce4cfe38f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1342bad4-de58-4b53-9e4e-41925049aac4" xlink:to="loc_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities_8b1ae030-ae8a-4fc3-9eb0-adce4cfe38f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_938092b8-e332-4ebe-80c7-af9745e4cce4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1342bad4-de58-4b53-9e4e-41925049aac4" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_938092b8-e332-4ebe-80c7-af9745e4cce4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4b2eb85f-33a0-4b80-afb1-b6ef19d0688d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1342bad4-de58-4b53-9e4e-41925049aac4" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4b2eb85f-33a0-4b80-afb1-b6ef19d0688d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLiabilities_b58cac83-a635-42b5-85e1-e8a549338a17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1342bad4-de58-4b53-9e4e-41925049aac4" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLiabilities_b58cac83-a635-42b5-85e1-e8a549338a17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_3bea33b7-ec2a-49fe-a56c-e559460649a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1342bad4-de58-4b53-9e4e-41925049aac4" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_3bea33b7-ec2a-49fe-a56c-e559460649a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_066a4c94-84b2-49fa-bda0-2c5974a5fe0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1342bad4-de58-4b53-9e4e-41925049aac4" xlink:to="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_066a4c94-84b2-49fa-bda0-2c5974a5fe0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_797cacca-8f0e-43fb-a036-ac334d5957b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1342bad4-de58-4b53-9e4e-41925049aac4" xlink:to="loc_us-gaap_ProfitLoss_797cacca-8f0e-43fb-a036-ac334d5957b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_2a036488-0100-4b2c-900c-9eea61acee4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1342bad4-de58-4b53-9e4e-41925049aac4" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_2a036488-0100-4b2c-900c-9eea61acee4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForTradingSecurities_75b76c1f-5503-4f1e-ae1f-b69289b7f169" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsForTradingSecurities"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1342bad4-de58-4b53-9e4e-41925049aac4" xlink:to="loc_us-gaap_ProceedsFromPaymentsForTradingSecurities_75b76c1f-5503-4f1e-ae1f-b69289b7f169" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingAssets_475876f1-0078-4549-a77b-0acf5cd9b350" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingAssets"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1342bad4-de58-4b53-9e4e-41925049aac4" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingAssets_475876f1-0078-4549-a77b-0acf5cd9b350" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_cb7bb33f-8639-4952-a557-b0491ca2cd7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1342bad4-de58-4b53-9e4e-41925049aac4" xlink:to="loc_us-gaap_ShareBasedCompensation_cb7bb33f-8639-4952-a557-b0491ca2cd7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_ProceedsFromPaymentsForOtherInvestmentsOperatingActivities_8a507446-6d3f-41ff-9601-cc2c8434844a" xlink:href="vrts-20240331.xsd#vrts_ProceedsFromPaymentsForOtherInvestmentsOperatingActivities"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1342bad4-de58-4b53-9e4e-41925049aac4" xlink:to="loc_vrts_ProceedsFromPaymentsForOtherInvestmentsOperatingActivities_8a507446-6d3f-41ff-9601-cc2c8434844a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/IntangibleAssetsNetGoodwillandIntangibleAssetsNetDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#IntangibleAssetsNetGoodwillandIntangibleAssetsNetDetails"/>
  <link:calculationLink xlink:role="http://www.virtus.com/role/IntangibleAssetsNetGoodwillandIntangibleAssetsNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b0163ecf-530a-4a81-8902-de33195039e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_f110648f-1068-4385-a099-6687fbed4db2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b0163ecf-530a-4a81-8902-de33195039e0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_f110648f-1068-4385-a099-6687fbed4db2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_5c3ddc79-c368-48a3-a42e-20b8e94ca243" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b0163ecf-530a-4a81-8902-de33195039e0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_5c3ddc79-c368-48a3-a42e-20b8e94ca243" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_deb6afd5-9e45-4794-9922-96b9efd52194" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_4c83dda7-a678-4d90-9b58-76f6c96ec4fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_deb6afd5-9e45-4794-9922-96b9efd52194" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_4c83dda7-a678-4d90-9b58-76f6c96ec4fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_42fdd469-e8ad-4c04-a0f9-a6007f1d229d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_deb6afd5-9e45-4794-9922-96b9efd52194" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_42fdd469-e8ad-4c04-a0f9-a6007f1d229d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/IntangibleAssetsNetEstimatedAmortizationExpenseofIntangibleAssetsSucceedingYearsDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#IntangibleAssetsNetEstimatedAmortizationExpenseofIntangibleAssetsSucceedingYearsDetails"/>
  <link:calculationLink xlink:role="http://www.virtus.com/role/IntangibleAssetsNetEstimatedAmortizationExpenseofIntangibleAssetsSucceedingYearsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_fd7d7a7e-9d05-46f8-9ccd-666e0a77d6fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_40d7c389-616d-4426-92ae-8f2e64397e56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_fd7d7a7e-9d05-46f8-9ccd-666e0a77d6fb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_40d7c389-616d-4426-92ae-8f2e64397e56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_715d12e8-a9a8-4794-9625-f1722cce7ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_fd7d7a7e-9d05-46f8-9ccd-666e0a77d6fb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_715d12e8-a9a8-4794-9625-f1722cce7ce8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_211e9720-dcb4-422b-a1eb-ea90be607c28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_fd7d7a7e-9d05-46f8-9ccd-666e0a77d6fb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_211e9720-dcb4-422b-a1eb-ea90be607c28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_fa341c4f-773a-439e-b97d-be4267af0d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_fd7d7a7e-9d05-46f8-9ccd-666e0a77d6fb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_fa341c4f-773a-439e-b97d-be4267af0d8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_410b3008-1f75-4c3e-a4ca-5f1c56b6d53b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_fd7d7a7e-9d05-46f8-9ccd-666e0a77d6fb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_410b3008-1f75-4c3e-a4ca-5f1c56b6d53b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_ce2ac1a5-748d-4b34-9987-3f052f34cab8" xlink:href="vrts-20240331.xsd#vrts_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_fd7d7a7e-9d05-46f8-9ccd-666e0a77d6fb" xlink:to="loc_vrts_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_ce2ac1a5-748d-4b34-9987-3f052f34cab8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/InvestmentsInvestmentsDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#InvestmentsInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.virtus.com/role/InvestmentsInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_a779c83e-e172-4ba2-bafe-6ad14c926811" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Investments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_874fd742-95a5-402c-b4bc-eaebde34309d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Investments_a779c83e-e172-4ba2-bafe-6ad14c926811" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_874fd742-95a5-402c-b4bc-eaebde34309d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_df157866-5b8c-425e-b576-343624c8a3ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Investments_a779c83e-e172-4ba2-bafe-6ad14c926811" xlink:to="loc_us-gaap_EquityMethodInvestments_df157866-5b8c-425e-b576-343624c8a3ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_InvestmentsInNonqualifiedRetirementPlanAssets_a2873b08-3256-499b-a354-ace6fd523911" xlink:href="vrts-20240331.xsd#vrts_InvestmentsInNonqualifiedRetirementPlanAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Investments_a779c83e-e172-4ba2-bafe-6ad14c926811" xlink:to="loc_vrts_InvestmentsInNonqualifiedRetirementPlanAssets_a2873b08-3256-499b-a354-ace6fd523911" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/FairValueMeasurementsChangesinAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#FairValueMeasurementsChangesinAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.virtus.com/role/FairValueMeasurementsChangesinAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_2b2696f0-141a-40f0-ac0d-151acdd6802a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_3d7a400f-fd97-471a-9eb0-35c79dc5136a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_2b2696f0-141a-40f0-ac0d-151acdd6802a" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_3d7a400f-fd97-471a-9eb0-35c79dc5136a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_e376f944-a230-45db-94c9-35fa282e950f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_2b2696f0-141a-40f0-ac0d-151acdd6802a" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_e376f944-a230-45db-94c9-35fa282e950f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_InvestmentsInNonqualifiedRetirementPlanAssets_0877318e-cd72-4dbc-9ae3-dde798bd9fb6" xlink:href="vrts-20240331.xsd#vrts_InvestmentsInNonqualifiedRetirementPlanAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_2b2696f0-141a-40f0-ac0d-151acdd6802a" xlink:to="loc_vrts_InvestmentsInNonqualifiedRetirementPlanAssets_0877318e-cd72-4dbc-9ae3-dde798bd9fb6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/ConsolidationCondensedConsolidatedBalanceSheetsDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#ConsolidationCondensedConsolidatedBalanceSheetsDetails"/>
  <link:calculationLink xlink:role="http://www.virtus.com/role/ConsolidationCondensedConsolidatedBalanceSheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_vrts_NetInterestInInvestmentProducts_7d52ee7b-7640-4184-9c90-1ca8537ccf3a" xlink:href="vrts-20240331.xsd#vrts_NetInterestInInvestmentProducts"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_2b6ea389-bb56-40a6-b5db-e2b63e2df7af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Investments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vrts_NetInterestInInvestmentProducts_7d52ee7b-7640-4184-9c90-1ca8537ccf3a" xlink:to="loc_us-gaap_Investments_2b6ea389-bb56-40a6-b5db-e2b63e2df7af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets_1174f0f9-d231-4e3d-a35e-acc15802d552" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vrts_NetInterestInInvestmentProducts_7d52ee7b-7640-4184-9c90-1ca8537ccf3a" xlink:to="loc_us-gaap_OtherAssets_1174f0f9-d231-4e3d-a35e-acc15802d552" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_SecuritiesPurchasedPayable_10140e44-3f50-44ca-aed1-f631655cb298" xlink:href="vrts-20240331.xsd#vrts_SecuritiesPurchasedPayable"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vrts_NetInterestInInvestmentProducts_7d52ee7b-7640-4184-9c90-1ca8537ccf3a" xlink:to="loc_vrts_SecuritiesPurchasedPayable_10140e44-3f50-44ca-aed1-f631655cb298" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0e7475a2-f766-41cf-b18e-19b931e0bfd2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vrts_NetInterestInInvestmentProducts_7d52ee7b-7640-4184-9c90-1ca8537ccf3a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0e7475a2-f766-41cf-b18e-19b931e0bfd2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_fac30fc9-66d0-4770-b41e-9d79525ec058" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vrts_NetInterestInInvestmentProducts_7d52ee7b-7640-4184-9c90-1ca8537ccf3a" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_fac30fc9-66d0-4770-b41e-9d79525ec058" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayable_7deac94f-0aa3-4384-b765-d6538c7bf6a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayable"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vrts_NetInterestInInvestmentProducts_7d52ee7b-7640-4184-9c90-1ca8537ccf3a" xlink:to="loc_us-gaap_NotesPayable_7deac94f-0aa3-4384-b765-d6538c7bf6a2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/ConsolidationBeneficialInterestsofConsolidatedInvestmentProductDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#ConsolidationBeneficialInterestsofConsolidatedInvestmentProductDetails"/>
  <link:calculationLink xlink:role="http://www.virtus.com/role/ConsolidationBeneficialInterestsofConsolidatedInvestmentProductDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsAmount_b390d2a3-add5-4370-a199-4be60431ec26" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsSubordinatedDebtAmount_7073ef57-3341-46fa-99ec-d12d6025a444" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsSubordinatedDebtAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsAmount_b390d2a3-add5-4370-a199-4be60431ec26" xlink:to="loc_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsSubordinatedDebtAmount_7073ef57-3341-46fa-99ec-d12d6025a444" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsDeferredRevenueAmount_d4e2ae50-f2d8-47cc-8e3a-f92f342c2bc7" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsDeferredRevenueAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsAmount_b390d2a3-add5-4370-a199-4be60431ec26" xlink:to="loc_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsDeferredRevenueAmount_d4e2ae50-f2d8-47cc-8e3a-f92f342c2bc7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/ConsolidationRevenueandExpensesofConsolidatedInvestmentProductDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#ConsolidationRevenueandExpensesofConsolidatedInvestmentProductDetails"/>
  <link:calculationLink xlink:role="http://www.virtus.com/role/ConsolidationRevenueandExpensesofConsolidatedInvestmentProductDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_0e666dcc-28a6-4e4e-bb22-d3b0bde7e359" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_7d46c065-1522-455b-af0b-485a74d7c362" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_0e666dcc-28a6-4e4e-bb22-d3b0bde7e359" xlink:to="loc_us-gaap_Revenues_7d46c065-1522-455b-af0b-485a74d7c362" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_OperatingandNonoperatingExpense_5748055c-4534-45b9-994c-be4708debafe" xlink:href="vrts-20240331.xsd#vrts_OperatingandNonoperatingExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_0e666dcc-28a6-4e4e-bb22-d3b0bde7e359" xlink:to="loc_vrts_OperatingandNonoperatingExpense_5748055c-4534-45b9-994c-be4708debafe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_83b09529-3ded-4154-aae0-23166a7722b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_0e666dcc-28a6-4e4e-bb22-d3b0bde7e359" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_83b09529-3ded-4154-aae0-23166a7722b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_OperatingandNonoperatingExpense_dd705da4-dcdf-40c0-bfa6-2c2304eb318c" xlink:href="vrts-20240331.xsd#vrts_OperatingandNonoperatingExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating_ea0aca54-3fea-4501-91b0-76f5feedfe62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vrts_OperatingandNonoperatingExpense_dd705da4-dcdf-40c0-bfa6-2c2304eb318c" xlink:to="loc_us-gaap_OtherCostAndExpenseOperating_ea0aca54-3fea-4501-91b0-76f5feedfe62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_bb8d1697-4d8b-4456-be4a-bf5299ab4bcf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vrts_OperatingandNonoperatingExpense_dd705da4-dcdf-40c0-bfa6-2c2304eb318c" xlink:to="loc_us-gaap_InterestExpense_bb8d1697-4d8b-4456-be4a-bf5299ab4bcf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_92a940bb-27cd-4c74-bdcb-1f0ae39a47fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_4cdcebc1-4faa-4d9b-a9f8-d1b7a37313ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_92a940bb-27cd-4c74-bdcb-1f0ae39a47fd" xlink:to="loc_us-gaap_GainLossOnInvestments_4cdcebc1-4faa-4d9b-a9f8-d1b7a37313ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_bb4c7615-8f7e-4296-9ecd-0b67f0c0dc7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_92a940bb-27cd-4c74-bdcb-1f0ae39a47fd" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_bb4c7615-8f7e-4296-9ecd-0b67f0c0dc7d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/ConsolidationEconomicInterestsofConsolidatedInvestmentProductDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#ConsolidationEconomicInterestsofConsolidatedInvestmentProductDetails"/>
  <link:calculationLink xlink:role="http://www.virtus.com/role/ConsolidationEconomicInterestsofConsolidatedInvestmentProductDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_e082dc1f-7596-418c-ba9a-5711c675d2c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityMeasureofActivityDistributionsReceivedandUnrealizedGainsLossesOnInvestment_7274611a-1e92-478a-9c4e-d5bf272e6046" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityMeasureofActivityDistributionsReceivedandUnrealizedGainsLossesOnInvestment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_e082dc1f-7596-418c-ba9a-5711c675d2c9" xlink:to="loc_vrts_VariableInterestEntityMeasureofActivityDistributionsReceivedandUnrealizedGainsLossesOnInvestment_7274611a-1e92-478a-9c4e-d5bf272e6046" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_933d4229-4a3f-4610-b6bb-e480597097c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_e082dc1f-7596-418c-ba9a-5711c675d2c9" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_933d4229-4a3f-4610-b6bb-e480597097c9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.virtus.com/role/ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_42e51872-f523-4f4a-8376-bf37c8c91974" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsSoldNotYetPurchasedAtFairValue_fa703501-855f-433a-9f4e-5eabe81096ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsSoldNotYetPurchasedAtFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_42e51872-f523-4f4a-8376-bf37c8c91974" xlink:to="loc_us-gaap_FinancialInstrumentsSoldNotYetPurchasedAtFairValue_fa703501-855f-433a-9f4e-5eabe81096ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableFairValueDisclosure_a97cc2c6-7ff4-499f-9008-9505d730a98c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_42e51872-f523-4f4a-8376-bf37c8c91974" xlink:to="loc_us-gaap_NotesPayableFairValueDisclosure_a97cc2c6-7ff4-499f-9008-9505d730a98c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_93894a69-0782-43d2-951c-c5f104efa1b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_37838574-0d05-4c33-9d10-4e11dd5517cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_93894a69-0782-43d2-951c-c5f104efa1b5" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_37838574-0d05-4c33-9d10-4e11dd5517cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_a9ca7204-9687-49ca-9f23-2b755c3a9bc4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_93894a69-0782-43d2-951c-c5f104efa1b5" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_a9ca7204-9687-49ca-9f23-2b755c3a9bc4" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>vrts-20240331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:571d5707-32d3-4d02-bf11-c9dc53da4569,g:f6b55787-7777-46c4-a428-e04c6c3401d1-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.virtus.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="vrts-20240331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:definitionLink xlink:role="http://www.virtus.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_13d730f2-a683-44c4-a879-9bd0d4396407" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_538f3dfa-7d89-4a1f-9b28-d83912e0044d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_13d730f2-a683-44c4-a879-9bd0d4396407" xlink:to="loc_us-gaap_StatementTable_538f3dfa-7d89-4a1f-9b28-d83912e0044d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_ac6f5499-5b57-4e1d-ab7a-98d4051ac5f7" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_538f3dfa-7d89-4a1f-9b28-d83912e0044d" xlink:to="loc_srt_ConsolidatedEntitiesAxis_ac6f5499-5b57-4e1d-ab7a-98d4051ac5f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_ac6f5499-5b57-4e1d-ab7a-98d4051ac5f7_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_ac6f5499-5b57-4e1d-ab7a-98d4051ac5f7" xlink:to="loc_srt_ConsolidatedEntitiesDomain_ac6f5499-5b57-4e1d-ab7a-98d4051ac5f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_389304d3-63d3-49ce-9213-b53992e2c95b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_ac6f5499-5b57-4e1d-ab7a-98d4051ac5f7" xlink:to="loc_srt_ConsolidatedEntitiesDomain_389304d3-63d3-49ce-9213-b53992e2c95b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember_56a88478-1d58-49c5-a3ed-9dfe95a8a5ec" xlink:href="vrts-20240331.xsd#vrts_ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_389304d3-63d3-49ce-9213-b53992e2c95b" xlink:to="loc_vrts_ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember_56a88478-1d58-49c5-a3ed-9dfe95a8a5ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember_2f22fa11-f4f3-4bcf-8688-6b4c785ceee8" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_389304d3-63d3-49ce-9213-b53992e2c95b" xlink:to="loc_vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember_2f22fa11-f4f3-4bcf-8688-6b4c785ceee8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_b11812c6-0bf1-4160-89cc-988e78b338fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_13d730f2-a683-44c4-a879-9bd0d4396407" xlink:to="loc_us-gaap_AssetsAbstract_b11812c6-0bf1-4160-89cc-988e78b338fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7dcf4f08-4192-4afb-bd20-b4737f035787" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_b11812c6-0bf1-4160-89cc-988e78b338fe" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7dcf4f08-4192-4afb-bd20-b4737f035787" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_bdd1b9a9-2936-4b4e-9432-c472e18a9aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Investments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_b11812c6-0bf1-4160-89cc-988e78b338fe" xlink:to="loc_us-gaap_Investments_bdd1b9a9-2936-4b4e-9432-c472e18a9aa1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet_1ed18468-939f-4647-8ff7-f76d5b2e904d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_b11812c6-0bf1-4160-89cc-988e78b338fe" xlink:to="loc_us-gaap_AccountsReceivableNet_1ed18468-939f-4647-8ff7-f76d5b2e904d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_1faab610-965a-47d7-b8a9-7d65167ca409" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_b11812c6-0bf1-4160-89cc-988e78b338fe" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_1faab610-965a-47d7-b8a9-7d65167ca409" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f9af9f65-778c-4005-b68e-352fe9d5a558" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_b11812c6-0bf1-4160-89cc-988e78b338fe" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f9af9f65-778c-4005-b68e-352fe9d5a558" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_4e5c8474-55fe-4865-838f-e231b101146d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_b11812c6-0bf1-4160-89cc-988e78b338fe" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_4e5c8474-55fe-4865-838f-e231b101146d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2de4382f-fbf2-48ab-8122-14d33e868414" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_b11812c6-0bf1-4160-89cc-988e78b338fe" xlink:to="loc_us-gaap_Goodwill_2de4382f-fbf2-48ab-8122-14d33e868414" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_5e0e1437-fc1b-4a60-b761-13bbb330f841" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_b11812c6-0bf1-4160-89cc-988e78b338fe" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_5e0e1437-fc1b-4a60-b761-13bbb330f841" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets_f6119ab3-31ce-4cd8-8449-a62291bee073" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_b11812c6-0bf1-4160-89cc-988e78b338fe" xlink:to="loc_us-gaap_OtherAssets_f6119ab3-31ce-4cd8-8449-a62291bee073" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_669c0a8d-bd7d-47b8-b59e-78c2f908ce1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_b11812c6-0bf1-4160-89cc-988e78b338fe" xlink:to="loc_us-gaap_Assets_669c0a8d-bd7d-47b8-b59e-78c2f908ce1d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d5904c2e-7cc9-4cd8-bbf0-cf22cfccc0c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_13d730f2-a683-44c4-a879-9bd0d4396407" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d5904c2e-7cc9-4cd8-bbf0-cf22cfccc0c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_bd3a7d0e-3fe1-4ddf-a64c-4e3ba6469c08" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d5904c2e-7cc9-4cd8-bbf0-cf22cfccc0c2" xlink:to="loc_us-gaap_LiabilitiesAbstract_bd3a7d0e-3fe1-4ddf-a64c-4e3ba6469c08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_a1a3c28b-b5fd-4d41-b277-b0ef311f5c76" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_bd3a7d0e-3fe1-4ddf-a64c-4e3ba6469c08" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_a1a3c28b-b5fd-4d41-b277-b0ef311f5c76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_4a774a20-4b72-40a7-ada8-644c71cf6800" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_bd3a7d0e-3fe1-4ddf-a64c-4e3ba6469c08" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_4a774a20-4b72-40a7-ada8-644c71cf6800" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_c68b16a3-2ef7-4831-bf2e-8b8d2388e933" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_bd3a7d0e-3fe1-4ddf-a64c-4e3ba6469c08" xlink:to="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_c68b16a3-2ef7-4831-bf2e-8b8d2388e933" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3d5e9998-777c-49ff-919a-52aefa1802ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_bd3a7d0e-3fe1-4ddf-a64c-4e3ba6469c08" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3d5e9998-777c-49ff-919a-52aefa1802ed" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_e8fb0fd4-a67a-46d6-805d-b187300a57fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_bd3a7d0e-3fe1-4ddf-a64c-4e3ba6469c08" xlink:to="loc_us-gaap_LongTermDebt_e8fb0fd4-a67a-46d6-805d-b187300a57fa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities_db3a0a11-188c-4fca-9b65-360b23569372" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_bd3a7d0e-3fe1-4ddf-a64c-4e3ba6469c08" xlink:to="loc_us-gaap_OtherLiabilities_db3a0a11-188c-4fca-9b65-360b23569372" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_48e6236e-9019-4a9f-9996-cd41fc4db5f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_bd3a7d0e-3fe1-4ddf-a64c-4e3ba6469c08" xlink:to="loc_us-gaap_SeniorNotes_48e6236e-9019-4a9f-9996-cd41fc4db5f8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_SecuritiesPurchasedPayableAndOtherLiabilities_05db7a40-8b94-4b2a-b449-517a5a29fa17" xlink:href="vrts-20240331.xsd#vrts_SecuritiesPurchasedPayableAndOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_bd3a7d0e-3fe1-4ddf-a64c-4e3ba6469c08" xlink:to="loc_vrts_SecuritiesPurchasedPayableAndOtherLiabilities_05db7a40-8b94-4b2a-b449-517a5a29fa17" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_f649727b-8e8a-4287-a867-9a3372c8a4e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_bd3a7d0e-3fe1-4ddf-a64c-4e3ba6469c08" xlink:to="loc_us-gaap_Liabilities_f649727b-8e8a-4287-a867-9a3372c8a4e7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_487491a4-3b73-4ee5-bb26-e9b849a0a1d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d5904c2e-7cc9-4cd8-bbf0-cf22cfccc0c2" xlink:to="loc_us-gaap_CommitmentsAndContingencies_487491a4-3b73-4ee5-bb26-e9b849a0a1d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_c4142f7f-e84a-483a-aa17-4ee00a9386d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d5904c2e-7cc9-4cd8-bbf0-cf22cfccc0c2" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_c4142f7f-e84a-483a-aa17-4ee00a9386d0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_f1383f29-9ef0-4335-8dc5-13d1107efbc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d5904c2e-7cc9-4cd8-bbf0-cf22cfccc0c2" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_f1383f29-9ef0-4335-8dc5-13d1107efbc7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_87df4938-9c56-4312-8da9-05f6949081bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_f1383f29-9ef0-4335-8dc5-13d1107efbc7" xlink:to="loc_us-gaap_StockholdersEquityAbstract_87df4938-9c56-4312-8da9-05f6949081bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_f7bf8f57-7d29-426d-9bcd-9f0701d8d79d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_87df4938-9c56-4312-8da9-05f6949081bc" xlink:to="loc_us-gaap_CommonStockValue_f7bf8f57-7d29-426d-9bcd-9f0701d8d79d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_1eef4173-ef25-403b-b1b6-23c976160940" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_87df4938-9c56-4312-8da9-05f6949081bc" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_1eef4173-ef25-403b-b1b6-23c976160940" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b060ccaa-ef8c-442a-9147-0700d5004362" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_87df4938-9c56-4312-8da9-05f6949081bc" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b060ccaa-ef8c-442a-9147-0700d5004362" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_46cc4cd3-7af8-4b30-8f25-b45c7dfce24c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_87df4938-9c56-4312-8da9-05f6949081bc" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_46cc4cd3-7af8-4b30-8f25-b45c7dfce24c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_7c50a9fd-9c21-4809-8620-8b64f85f52af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_87df4938-9c56-4312-8da9-05f6949081bc" xlink:to="loc_us-gaap_TreasuryStockCommonValue_7c50a9fd-9c21-4809-8620-8b64f85f52af" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1b5c9c71-7af5-4c3f-87d3-415a5767ed26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_87df4938-9c56-4312-8da9-05f6949081bc" xlink:to="loc_us-gaap_StockholdersEquity_1b5c9c71-7af5-4c3f-87d3-415a5767ed26" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_7e131153-eadb-4448-a2e1-3a84892514a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_f1383f29-9ef0-4335-8dc5-13d1107efbc7" xlink:to="loc_us-gaap_MinorityInterest_7e131153-eadb-4448-a2e1-3a84892514a2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6a6ef87e-39ce-4464-87a9-9d6f3d97bcc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_f1383f29-9ef0-4335-8dc5-13d1107efbc7" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6a6ef87e-39ce-4464-87a9-9d6f3d97bcc5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_e7da2b31-b15c-4239-9e40-d3c53c97ca0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d5904c2e-7cc9-4cd8-bbf0-cf22cfccc0c2" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_e7da2b31-b15c-4239-9e40-d3c53c97ca0c" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="vrts-20240331.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:definitionLink xlink:role="http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_75508091-6d84-4d41-98cd-fcd8706b3e45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2f17ae5d-3101-4146-92f3-4ea6938a5b51" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_75508091-6d84-4d41-98cd-fcd8706b3e45" xlink:to="loc_us-gaap_StatementTable_2f17ae5d-3101-4146-92f3-4ea6938a5b51" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d752db1d-4e99-41bc-8be1-28a79033dfc7" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2f17ae5d-3101-4146-92f3-4ea6938a5b51" xlink:to="loc_srt_ProductOrServiceAxis_d752db1d-4e99-41bc-8be1-28a79033dfc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d752db1d-4e99-41bc-8be1-28a79033dfc7_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_d752db1d-4e99-41bc-8be1-28a79033dfc7" xlink:to="loc_srt_ProductsAndServicesDomain_d752db1d-4e99-41bc-8be1-28a79033dfc7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_510bae5f-b618-4b3e-b05f-70fc76201808" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_d752db1d-4e99-41bc-8be1-28a79033dfc7" xlink:to="loc_srt_ProductsAndServicesDomain_510bae5f-b618-4b3e-b05f-70fc76201808" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_InvestmentManagementFeesMember_d82a957a-db9f-4138-8d93-4ff320db5eff" xlink:href="vrts-20240331.xsd#vrts_InvestmentManagementFeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_510bae5f-b618-4b3e-b05f-70fc76201808" xlink:to="loc_vrts_InvestmentManagementFeesMember_d82a957a-db9f-4138-8d93-4ff320db5eff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_DistributionAndServiceFeesMember_92b6150b-ff11-4604-934f-6d65a9a51904" xlink:href="vrts-20240331.xsd#vrts_DistributionAndServiceFeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_510bae5f-b618-4b3e-b05f-70fc76201808" xlink:to="loc_vrts_DistributionAndServiceFeesMember_92b6150b-ff11-4604-934f-6d65a9a51904" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_AdministrationAndShareholderServiceFeesMember_26c244c2-632f-4a65-9f86-39c0b4ae873e" xlink:href="vrts-20240331.xsd#vrts_AdministrationAndShareholderServiceFeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_510bae5f-b618-4b3e-b05f-70fc76201808" xlink:to="loc_vrts_AdministrationAndShareholderServiceFeesMember_26c244c2-632f-4a65-9f86-39c0b4ae873e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_OtherIncomeAndfeesMember_dac9f636-757d-4dbd-a581-a69393f0a66c" xlink:href="vrts-20240331.xsd#vrts_OtherIncomeAndfeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_510bae5f-b618-4b3e-b05f-70fc76201808" xlink:to="loc_vrts_OtherIncomeAndfeesMember_dac9f636-757d-4dbd-a581-a69393f0a66c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_5849bb5f-cd91-47f5-a8d7-18ca7d02f036" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2f17ae5d-3101-4146-92f3-4ea6938a5b51" xlink:to="loc_srt_ConsolidatedEntitiesAxis_5849bb5f-cd91-47f5-a8d7-18ca7d02f036" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_5849bb5f-cd91-47f5-a8d7-18ca7d02f036_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_5849bb5f-cd91-47f5-a8d7-18ca7d02f036" xlink:to="loc_srt_ConsolidatedEntitiesDomain_5849bb5f-cd91-47f5-a8d7-18ca7d02f036_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_128e3458-4987-4f0f-8950-22308ea8997a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_5849bb5f-cd91-47f5-a8d7-18ca7d02f036" xlink:to="loc_srt_ConsolidatedEntitiesDomain_128e3458-4987-4f0f-8950-22308ea8997a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember_ce82e346-abe7-4209-b901-6ebf67c0b66b" xlink:href="vrts-20240331.xsd#vrts_ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_128e3458-4987-4f0f-8950-22308ea8997a" xlink:to="loc_vrts_ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember_ce82e346-abe7-4209-b901-6ebf67c0b66b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember_81d05d8e-27aa-43ae-a426-31292da5d0fe" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_128e3458-4987-4f0f-8950-22308ea8997a" xlink:to="loc_vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember_81d05d8e-27aa-43ae-a426-31292da5d0fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_0bf3963a-791f-470a-bc53-9f9e998f8ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_75508091-6d84-4d41-98cd-fcd8706b3e45" xlink:to="loc_us-gaap_RevenuesAbstract_0bf3963a-791f-470a-bc53-9f9e998f8ef3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_190f8b03-b0c2-4083-a9cd-e77117b52d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_0bf3963a-791f-470a-bc53-9f9e998f8ef3" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_190f8b03-b0c2-4083-a9cd-e77117b52d5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_5261ff8d-d8e5-48d7-af6a-e438539ccbfe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_75508091-6d84-4d41-98cd-fcd8706b3e45" xlink:to="loc_us-gaap_OperatingExpensesAbstract_5261ff8d-d8e5-48d7-af6a-e438539ccbfe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense_550051e1-6442-40f7-8665-7a2eb613a548" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5261ff8d-d8e5-48d7-af6a-e438539ccbfe" xlink:to="loc_us-gaap_LaborAndRelatedExpense_550051e1-6442-40f7-8665-7a2eb613a548" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_ef332de5-ba5e-44fa-93de-d47dce90433f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5261ff8d-d8e5-48d7-af6a-e438539ccbfe" xlink:to="loc_us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_ef332de5-ba5e-44fa-93de-d47dce90433f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating_f343a4b7-ff33-46a3-bed5-c5e3d122dc3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5261ff8d-d8e5-48d7-af6a-e438539ccbfe" xlink:to="loc_us-gaap_OtherCostAndExpenseOperating_f343a4b7-ff33-46a3-bed5-c5e3d122dc3a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_da78c6bb-c09d-4d2c-90f8-4667e224a01b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5261ff8d-d8e5-48d7-af6a-e438539ccbfe" xlink:to="loc_us-gaap_RestructuringCharges_da78c6bb-c09d-4d2c-90f8-4667e224a01b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_414e1e9a-1608-43f9-8834-1b892d4c66d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5261ff8d-d8e5-48d7-af6a-e438539ccbfe" xlink:to="loc_us-gaap_Depreciation_414e1e9a-1608-43f9-8834-1b892d4c66d2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_AmortizationOfIntangibleAssetsAndContingentAmortization_11f62d78-dcd1-440c-92e0-f7eb6b97433d" xlink:href="vrts-20240331.xsd#vrts_AmortizationOfIntangibleAssetsAndContingentAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5261ff8d-d8e5-48d7-af6a-e438539ccbfe" xlink:to="loc_vrts_AmortizationOfIntangibleAssetsAndContingentAmortization_11f62d78-dcd1-440c-92e0-f7eb6b97433d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_704a0f92-fb87-4d16-bdd4-bf544f01a769" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5261ff8d-d8e5-48d7-af6a-e438539ccbfe" xlink:to="loc_us-gaap_OperatingExpenses_704a0f92-fb87-4d16-bdd4-bf544f01a769" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_aedd9289-b3df-4383-aa89-2ff5639c51b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_75508091-6d84-4d41-98cd-fcd8706b3e45" xlink:to="loc_us-gaap_OperatingIncomeLoss_aedd9289-b3df-4383-aa89-2ff5639c51b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_ad0c2066-ed12-417e-bc9e-46b1041d106f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_75508091-6d84-4d41-98cd-fcd8706b3e45" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_ad0c2066-ed12-417e-bc9e-46b1041d106f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_0fcdec9c-b2ae-4b07-8e86-97affec88e37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_ad0c2066-ed12-417e-bc9e-46b1041d106f" xlink:to="loc_us-gaap_GainLossOnInvestments_0fcdec9c-b2ae-4b07-8e86-97affec88e37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_0add14c1-d056-4b4a-bf0f-6c6c0fe09f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_ad0c2066-ed12-417e-bc9e-46b1041d106f" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_0add14c1-d056-4b4a-bf0f-6c6c0fe09f5a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_9ff8df25-c05e-4218-8d76-be7bef14f3c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_ad0c2066-ed12-417e-bc9e-46b1041d106f" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_9ff8df25-c05e-4218-8d76-be7bef14f3c9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNetAbstract_464285bc-f289-49a9-9924-03695613612a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_75508091-6d84-4d41-98cd-fcd8706b3e45" xlink:to="loc_us-gaap_InterestIncomeExpenseNetAbstract_464285bc-f289-49a9-9924-03695613612a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_0e1133c5-1e29-4b6f-aceb-b836c20e2dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestIncomeExpenseNetAbstract_464285bc-f289-49a9-9924-03695613612a" xlink:to="loc_us-gaap_InterestExpense_0e1133c5-1e29-4b6f-aceb-b836c20e2dc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_5bb2fc57-7d87-4458-86f4-cbea00bb60fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestIncomeExpenseNetAbstract_464285bc-f289-49a9-9924-03695613612a" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_5bb2fc57-7d87-4458-86f4-cbea00bb60fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_3842e92a-bac1-4655-860b-62665bac93de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestIncomeExpenseNetAbstract_464285bc-f289-49a9-9924-03695613612a" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_3842e92a-bac1-4655-860b-62665bac93de" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4dc931b6-f0b6-4d88-a1b4-94ab99ddad07" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_75508091-6d84-4d41-98cd-fcd8706b3e45" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4dc931b6-f0b6-4d88-a1b4-94ab99ddad07" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_086ad443-eac3-416b-b65a-8a4e3bb1512b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_75508091-6d84-4d41-98cd-fcd8706b3e45" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_086ad443-eac3-416b-b65a-8a4e3bb1512b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8d974a67-c92f-492f-8156-4b5f1eb3338b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_75508091-6d84-4d41-98cd-fcd8706b3e45" xlink:to="loc_us-gaap_ProfitLoss_8d974a67-c92f-492f-8156-4b5f1eb3338b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_545f6cf0-262f-447c-9b1c-2ac5dd775b75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_75508091-6d84-4d41-98cd-fcd8706b3e45" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_545f6cf0-262f-447c-9b1c-2ac5dd775b75" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_3e3f4efd-74ca-4af8-9f73-781ea553a6b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_75508091-6d84-4d41-98cd-fcd8706b3e45" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_3e3f4efd-74ca-4af8-9f73-781ea553a6b9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_8df25018-d82e-4e98-81d1-e39ae5cffc75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_75508091-6d84-4d41-98cd-fcd8706b3e45" xlink:to="loc_us-gaap_EarningsPerShareBasic_8df25018-d82e-4e98-81d1-e39ae5cffc75" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_9fbb3e5b-77df-43a6-b383-979a6f94d759" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_75508091-6d84-4d41-98cd-fcd8706b3e45" xlink:to="loc_us-gaap_EarningsPerShareDiluted_9fbb3e5b-77df-43a6-b383-979a6f94d759" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b6769c1c-e722-4e43-9f31-6e17aec2687b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_75508091-6d84-4d41-98cd-fcd8706b3e45" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b6769c1c-e722-4e43-9f31-6e17aec2687b" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ccfabd54-4d99-4489-a248-ccd749a79677" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_75508091-6d84-4d41-98cd-fcd8706b3e45" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ccfabd54-4d99-4489-a248-ccd749a79677" xlink:type="arc" order="13"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="vrts-20240331.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:definitionLink xlink:role="http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c8975a37-5457-4fa9-9b18-16cc65500d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_5483fa30-fd0e-40ba-be73-2da753d5a1fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_c8975a37-5457-4fa9-9b18-16cc65500d6e" xlink:to="loc_us-gaap_StatementTable_5483fa30-fd0e-40ba-be73-2da753d5a1fb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_61ea9333-48bf-48ed-a420-174f84d0ed73" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_5483fa30-fd0e-40ba-be73-2da753d5a1fb" xlink:to="loc_srt_ConsolidatedEntitiesAxis_61ea9333-48bf-48ed-a420-174f84d0ed73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_61ea9333-48bf-48ed-a420-174f84d0ed73_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_61ea9333-48bf-48ed-a420-174f84d0ed73" xlink:to="loc_srt_ConsolidatedEntitiesDomain_61ea9333-48bf-48ed-a420-174f84d0ed73_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_c62ad258-846c-4368-ae7e-bc83b701dace" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_61ea9333-48bf-48ed-a420-174f84d0ed73" xlink:to="loc_srt_ConsolidatedEntitiesDomain_c62ad258-846c-4368-ae7e-bc83b701dace" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember_6ae0e5a9-46b5-471c-94bc-5ca3a5820683" xlink:href="vrts-20240331.xsd#vrts_ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_c62ad258-846c-4368-ae7e-bc83b701dace" xlink:to="loc_vrts_ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember_6ae0e5a9-46b5-471c-94bc-5ca3a5820683" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember_e84d13c7-6998-4aea-b535-4f78bacb27a4" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_c62ad258-846c-4368-ae7e-bc83b701dace" xlink:to="loc_vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember_e84d13c7-6998-4aea-b535-4f78bacb27a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_06217459-c0c2-410c-9590-0dc371c4337a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c8975a37-5457-4fa9-9b18-16cc65500d6e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_06217459-c0c2-410c-9590-0dc371c4337a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ed3f288b-5337-407c-a37a-c214c67e860c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_06217459-c0c2-410c-9590-0dc371c4337a" xlink:to="loc_us-gaap_ProfitLoss_ed3f288b-5337-407c-a37a-c214c67e860c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e512ea3a-07d5-413c-b36a-9cf69afa0cab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_06217459-c0c2-410c-9590-0dc371c4337a" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e512ea3a-07d5-413c-b36a-9cf69afa0cab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_6494ba58-2b09-4ec8-8de9-329dd65972ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e512ea3a-07d5-413c-b36a-9cf69afa0cab" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_6494ba58-2b09-4ec8-8de9-329dd65972ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_e840b403-743e-4a20-8d04-446715ebbb57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e512ea3a-07d5-413c-b36a-9cf69afa0cab" xlink:to="loc_us-gaap_ShareBasedCompensation_e840b403-743e-4a20-8d04-446715ebbb57" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_e06bd199-5978-4486-85d5-e30619c0e5a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e512ea3a-07d5-413c-b36a-9cf69afa0cab" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_e06bd199-5978-4486-85d5-e30619c0e5a1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_f24a2df0-4587-4d49-ad3f-aa5f3d7c8f41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtAndEquitySecuritiesGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e512ea3a-07d5-413c-b36a-9cf69afa0cab" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_f24a2df0-4587-4d49-ad3f-aa5f3d7c8f41" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_212d506c-3f35-437c-b935-82da2602fdb4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e512ea3a-07d5-413c-b36a-9cf69afa0cab" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_212d506c-3f35-437c-b935-82da2602fdb4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39b0a765-b9fe-4f70-b373-06a846f7bf59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e512ea3a-07d5-413c-b36a-9cf69afa0cab" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39b0a765-b9fe-4f70-b373-06a846f7bf59" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForTradingSecurities_a77faeb3-d985-47c5-89d4-980316ce9d53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsForTradingSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39b0a765-b9fe-4f70-b373-06a846f7bf59" xlink:to="loc_us-gaap_ProceedsFromPaymentsForTradingSecurities_a77faeb3-d985-47c5-89d4-980316ce9d53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingAssets_1ad247c2-c26e-40cd-b9d0-191dc7cb2661" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39b0a765-b9fe-4f70-b373-06a846f7bf59" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingAssets_1ad247c2-c26e-40cd-b9d0-191dc7cb2661" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLiabilities_3d040a4a-e16a-4e59-aabe-4b3f38c56af9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39b0a765-b9fe-4f70-b373-06a846f7bf59" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLiabilities_3d040a4a-e16a-4e59-aabe-4b3f38c56af9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8ba85728-5cac-44ff-8238-0367243916d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e512ea3a-07d5-413c-b36a-9cf69afa0cab" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8ba85728-5cac-44ff-8238-0367243916d2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_ca58b6ba-8700-4ad1-a6e7-4d77418ccd7e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtAndEquitySecuritiesGainLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities_5a694543-bd1f-408e-bbca-8ebc2943d37f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8ba85728-5cac-44ff-8238-0367243916d2" xlink:to="loc_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities_5a694543-bd1f-408e-bbca-8ebc2943d37f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_e20f3196-251e-4af3-8d40-2c8b884039ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8ba85728-5cac-44ff-8238-0367243916d2" xlink:to="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_e20f3196-251e-4af3-8d40-2c8b884039ae" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_ProceedsFromPaymentsForOtherInvestmentsOperatingActivities_164ade4a-cd9e-4800-ae1a-ebd317b1b64a" xlink:href="vrts-20240331.xsd#vrts_ProceedsFromPaymentsForOtherInvestmentsOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8ba85728-5cac-44ff-8238-0367243916d2" xlink:to="loc_vrts_ProceedsFromPaymentsForOtherInvestmentsOperatingActivities_164ade4a-cd9e-4800-ae1a-ebd317b1b64a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_08f62dc3-36b2-40a1-9399-65fc2c2e2f89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8ba85728-5cac-44ff-8238-0367243916d2" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_08f62dc3-36b2-40a1-9399-65fc2c2e2f89" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d41a0940-6f36-4c3f-9bc1-7c59e353d58d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_06217459-c0c2-410c-9590-0dc371c4337a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d41a0940-6f36-4c3f-9bc1-7c59e353d58d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_7ed5fae5-acda-4188-b3b0-2613bd21c39c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c8975a37-5457-4fa9-9b18-16cc65500d6e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_7ed5fae5-acda-4188-b3b0-2613bd21c39c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e9342049-ec54-406c-bd24-1bf7b299eccb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_7ed5fae5-acda-4188-b3b0-2613bd21c39c" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e9342049-ec54-406c-bd24-1bf7b299eccb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_IncreaseDecreaseInCashAndCashEquivalentsOfSubsidiariesDueToConsolidation_c0746736-203b-42a4-bb12-699ef717c213" xlink:href="vrts-20240331.xsd#vrts_IncreaseDecreaseInCashAndCashEquivalentsOfSubsidiariesDueToConsolidation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_7ed5fae5-acda-4188-b3b0-2613bd21c39c" xlink:to="loc_vrts_IncreaseDecreaseInCashAndCashEquivalentsOfSubsidiariesDueToConsolidation_c0746736-203b-42a4-bb12-699ef717c213" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_093647ef-e0ba-4a0c-a5ba-7513db2e6abb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_7ed5fae5-acda-4188-b3b0-2613bd21c39c" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_093647ef-e0ba-4a0c-a5ba-7513db2e6abb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7d8c87cb-fbc4-4ac4-aaac-3c3577819c2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_7ed5fae5-acda-4188-b3b0-2613bd21c39c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7d8c87cb-fbc4-4ac4-aaac-3c3577819c2a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1c50cd35-8dd3-499f-be65-62f1da31335d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c8975a37-5457-4fa9-9b18-16cc65500d6e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1c50cd35-8dd3-499f-be65-62f1da31335d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_71e4072d-2f4c-41cb-bbc8-d0b74b928da4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1c50cd35-8dd3-499f-be65-62f1da31335d" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_71e4072d-2f4c-41cb-bbc8-d0b74b928da4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_09dab1fc-9330-44c7-9a0f-d4e1facd4d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1c50cd35-8dd3-499f-be65-62f1da31335d" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_09dab1fc-9330-44c7-9a0f-d4e1facd4d5b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_57998bb3-51a2-401b-80da-98334bec632f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1c50cd35-8dd3-499f-be65-62f1da31335d" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_57998bb3-51a2-401b-80da-98334bec632f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_ac73536d-0b52-4d90-8906-28ad25334cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1c50cd35-8dd3-499f-be65-62f1da31335d" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_ac73536d-0b52-4d90-8906-28ad25334cdf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_da66ba99-1154-43b4-9803-cd8dae9d9d75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1c50cd35-8dd3-499f-be65-62f1da31335d" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_da66ba99-1154-43b4-9803-cd8dae9d9d75" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_DisposalOfPaymentsForAffiliateEquity_238f94e4-a451-4ffb-aefb-7b8e4ba5bb55" xlink:href="vrts-20240331.xsd#vrts_DisposalOfPaymentsForAffiliateEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1c50cd35-8dd3-499f-be65-62f1da31335d" xlink:to="loc_vrts_DisposalOfPaymentsForAffiliateEquity_238f94e4-a451-4ffb-aefb-7b8e4ba5bb55" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsToMinorityShareholders_ecb7239e-7c0e-4900-8e1d-1d4cf3e8c3e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsToMinorityShareholders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1c50cd35-8dd3-499f-be65-62f1da31335d" xlink:to="loc_us-gaap_ProceedsFromPaymentsToMinorityShareholders_ecb7239e-7c0e-4900-8e1d-1d4cf3e8c3e7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherDebt_1491c0ed-202e-4d07-b94a-0612f9d84b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfOtherDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1c50cd35-8dd3-499f-be65-62f1da31335d" xlink:to="loc_us-gaap_RepaymentsOfOtherDebt_1491c0ed-202e-4d07-b94a-0612f9d84b3f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a23c6860-84ae-48ff-8118-ed8e118918a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1c50cd35-8dd3-499f-be65-62f1da31335d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a23c6860-84ae-48ff-8118-ed8e118918a3" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e6d82414-03df-4bf9-9552-ccdfcc52d0aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c8975a37-5457-4fa9-9b18-16cc65500d6e" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e6d82414-03df-4bf9-9552-ccdfcc52d0aa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_28f242f3-df6e-41d1-a06f-43840f7a4ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c8975a37-5457-4fa9-9b18-16cc65500d6e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_28f242f3-df6e-41d1-a06f-43840f7a4ddc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c142ed84-5ad5-408b-937a-ff308f7153f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c8975a37-5457-4fa9-9b18-16cc65500d6e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c142ed84-5ad5-408b-937a-ff308f7153f0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_97875378-236e-49a0-a76a-4de638d92b25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_NoncashFinancingItemsAbstract_a59a9ec3-2fa3-4e9f-be3e-053de061d86f" xlink:href="vrts-20240331.xsd#vrts_NoncashFinancingItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c8975a37-5457-4fa9-9b18-16cc65500d6e" xlink:to="loc_vrts_NoncashFinancingItemsAbstract_a59a9ec3-2fa3-4e9f-be3e-053de061d86f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue_955b27ce-fc3e-41fd-83cd-bb4ca2e7cc30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestChangeInRedemptionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vrts_NoncashFinancingItemsAbstract_a59a9ec3-2fa3-4e9f-be3e-053de061d86f" xlink:to="loc_us-gaap_MinorityInterestChangeInRedemptionValue_955b27ce-fc3e-41fd-83cd-bb4ca2e7cc30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_CommonStockDividendsAccruedButNotYetPaid_349a62fa-c9c2-48f2-a924-08db12d8c220" xlink:href="vrts-20240331.xsd#vrts_CommonStockDividendsAccruedButNotYetPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vrts_NoncashFinancingItemsAbstract_a59a9ec3-2fa3-4e9f-be3e-053de061d86f" xlink:to="loc_vrts_CommonStockDividendsAccruedButNotYetPaid_349a62fa-c9c2-48f2-a924-08db12d8c220" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_3cab8d92-49d8-4913-9e85-b56081faa187" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c8975a37-5457-4fa9-9b18-16cc65500d6e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_3cab8d92-49d8-4913-9e85-b56081faa187" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f57aae63-0efd-49a7-bef1-3feb4a91cff9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_3cab8d92-49d8-4913-9e85-b56081faa187" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f57aae63-0efd-49a7-bef1-3feb4a91cff9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_5cc5cdfc-2ed6-4959-987c-51285bf325d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_3cab8d92-49d8-4913-9e85-b56081faa187" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_5cc5cdfc-2ed6-4959-987c-51285bf325d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4ea7bfa3-b4c7-4f70-a38a-acf6ca9cd7b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity" xlink:type="simple" xlink:href="vrts-20240331.xsd#CondensedConsolidatedStatementsofChangesinStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_513499f3-cced-4976-a5a8-73caf2aa8fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_86471629-05db-4470-88d4-df7dee0b3c57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_513499f3-cced-4976-a5a8-73caf2aa8fb9" xlink:to="loc_us-gaap_StatementTable_86471629-05db-4470-88d4-df7dee0b3c57" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_820ce415-ce3c-466e-b591-3fb550df96b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_86471629-05db-4470-88d4-df7dee0b3c57" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_820ce415-ce3c-466e-b591-3fb550df96b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_820ce415-ce3c-466e-b591-3fb550df96b6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_820ce415-ce3c-466e-b591-3fb550df96b6" xlink:to="loc_us-gaap_EquityComponentDomain_820ce415-ce3c-466e-b591-3fb550df96b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8a7458b4-9a97-41f4-ae77-d0411f95b6de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_820ce415-ce3c-466e-b591-3fb550df96b6" xlink:to="loc_us-gaap_EquityComponentDomain_8a7458b4-9a97-41f4-ae77-d0411f95b6de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_caaeec2a-738c-4b17-a60a-3021d31a34f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8a7458b4-9a97-41f4-ae77-d0411f95b6de" xlink:to="loc_us-gaap_ParentMember_caaeec2a-738c-4b17-a60a-3021d31a34f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_a7f2313e-cc94-4225-9bca-1ff3f811b818" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_caaeec2a-738c-4b17-a60a-3021d31a34f0" xlink:to="loc_us-gaap_CommonStockMember_a7f2313e-cc94-4225-9bca-1ff3f811b818" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_6fceacb2-4f4b-4701-9963-590172bc0e8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_caaeec2a-738c-4b17-a60a-3021d31a34f0" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_6fceacb2-4f4b-4701-9963-590172bc0e8e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_717f2e01-5d2b-48dd-bb41-343e86eb4aff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_caaeec2a-738c-4b17-a60a-3021d31a34f0" xlink:to="loc_us-gaap_RetainedEarningsMember_717f2e01-5d2b-48dd-bb41-343e86eb4aff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_8e8789b2-421b-4e98-b6b7-0989efe2df94" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_caaeec2a-738c-4b17-a60a-3021d31a34f0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_8e8789b2-421b-4e98-b6b7-0989efe2df94" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_cc57e66f-8d61-47b1-bbc1-dafd67d5b0d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_caaeec2a-738c-4b17-a60a-3021d31a34f0" xlink:to="loc_us-gaap_TreasuryStockCommonMember_cc57e66f-8d61-47b1-bbc1-dafd67d5b0d2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_acdc9c4b-dc07-4974-87c1-3523f3cf094a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8a7458b4-9a97-41f4-ae77-d0411f95b6de" xlink:to="loc_us-gaap_NoncontrollingInterestMember_acdc9c4b-dc07-4974-87c1-3523f3cf094a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6bdd6b58-f173-4a91-b2de-f99560bbce32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_513499f3-cced-4976-a5a8-73caf2aa8fb9" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6bdd6b58-f173-4a91-b2de-f99560bbce32" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_6f3eb580-fa69-4ee2-a779-87e6d505dc6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6bdd6b58-f173-4a91-b2de-f99560bbce32" xlink:to="loc_us-gaap_CommonStockSharesIssued_6f3eb580-fa69-4ee2-a779-87e6d505dc6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5182000c-d89d-4b86-b425-13dc6087dd7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6bdd6b58-f173-4a91-b2de-f99560bbce32" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5182000c-d89d-4b86-b425-13dc6087dd7b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_52e07ab0-4313-47d2-8f51-0828ee617ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6bdd6b58-f173-4a91-b2de-f99560bbce32" xlink:to="loc_us-gaap_TreasuryStockCommonShares_52e07ab0-4313-47d2-8f51-0828ee617ea4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_688c820b-2f62-4497-b7f0-27de8e41c1c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6bdd6b58-f173-4a91-b2de-f99560bbce32" xlink:to="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_688c820b-2f62-4497-b7f0-27de8e41c1c2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2d1bebd2-4f54-457a-8ef0-47de27e76b5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6bdd6b58-f173-4a91-b2de-f99560bbce32" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2d1bebd2-4f54-457a-8ef0-47de27e76b5f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_41767653-5c46-417c-87e4-c6ae14f4b891" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6bdd6b58-f173-4a91-b2de-f99560bbce32" xlink:to="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_41767653-5c46-417c-87e4-c6ae14f4b891" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_665005c7-7db6-46bc-86b0-de4b9ee13c00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6bdd6b58-f173-4a91-b2de-f99560bbce32" xlink:to="loc_us-gaap_DividendsCommonStockCash_665005c7-7db6-46bc-86b0-de4b9ee13c00" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_24512699-23aa-44c3-b5b4-a876cefcfb12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6bdd6b58-f173-4a91-b2de-f99560bbce32" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_24512699-23aa-44c3-b5b4-a876cefcfb12" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_87290a64-1d83-4788-b3ba-fe56478dfc2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6bdd6b58-f173-4a91-b2de-f99560bbce32" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_87290a64-1d83-4788-b3ba-fe56478dfc2a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_8ce3c047-be57-4719-a844-9392633ad8f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6bdd6b58-f173-4a91-b2de-f99560bbce32" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_8ce3c047-be57-4719-a844-9392633ad8f0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_705450af-4284-4abb-946d-36ab2bf15afa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6bdd6b58-f173-4a91-b2de-f99560bbce32" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_705450af-4284-4abb-946d-36ab2bf15afa" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_656f5bcd-091f-43d6-a7dc-8f4b740b81a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6bdd6b58-f173-4a91-b2de-f99560bbce32" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_656f5bcd-091f-43d6-a7dc-8f4b740b81a7" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_009c54ad-cb5a-4db2-8d46-3eae9acf4850" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6bdd6b58-f173-4a91-b2de-f99560bbce32" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_009c54ad-cb5a-4db2-8d46-3eae9acf4850" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_5c51f66a-004d-4205-b4c9-185b390bc3c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9f125951-3f76-4998-b6f2-b9a86ff8c79a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_83a95de6-c0c4-4e69-873a-d32574a7cb81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_44c657a4-61fd-4de8-93d3-2f647c51f257" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_513499f3-cced-4976-a5a8-73caf2aa8fb9" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_44c657a4-61fd-4de8-93d3-2f647c51f257" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_19573209-d1fa-4ad9-a7be-a28a0431a4fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_44c657a4-61fd-4de8-93d3-2f647c51f257" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_19573209-d1fa-4ad9-a7be-a28a0431a4fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_4b6b1130-ea90-485d-94e7-5c052ca19f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_44c657a4-61fd-4de8-93d3-2f647c51f257" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_4b6b1130-ea90-485d-94e7-5c052ca19f1e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_NoncontrollingInterestSubscriptionsRedemptions_1a1d6286-4951-455b-972b-eec66b42c223" xlink:href="vrts-20240331.xsd#vrts_NoncontrollingInterestSubscriptionsRedemptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_44c657a4-61fd-4de8-93d3-2f647c51f257" xlink:to="loc_vrts_NoncontrollingInterestSubscriptionsRedemptions_1a1d6286-4951-455b-972b-eec66b42c223" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_f322bcf4-2154-43e7-a690-c63a6005a371" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.virtus.com/role/RevenuesDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#RevenuesDetails"/>
  <link:definitionLink xlink:role="http://www.virtus.com/role/RevenuesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_6549c47e-c442-4e64-9cef-01e978b59d41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_333b94a3-0a62-4fc6-9628-f102287f1ed3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_6549c47e-c442-4e64-9cef-01e978b59d41" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_333b94a3-0a62-4fc6-9628-f102287f1ed3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_176276c5-9179-435d-8224-9fb9e1f743a2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_333b94a3-0a62-4fc6-9628-f102287f1ed3" xlink:to="loc_srt_ProductOrServiceAxis_176276c5-9179-435d-8224-9fb9e1f743a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_176276c5-9179-435d-8224-9fb9e1f743a2_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_176276c5-9179-435d-8224-9fb9e1f743a2" xlink:to="loc_srt_ProductsAndServicesDomain_176276c5-9179-435d-8224-9fb9e1f743a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9cd1b05e-a78b-4d50-9c14-625f4c9ff8f3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_176276c5-9179-435d-8224-9fb9e1f743a2" xlink:to="loc_srt_ProductsAndServicesDomain_9cd1b05e-a78b-4d50-9c14-625f4c9ff8f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_InvestmentManagementFeesMember_239b7753-0330-4528-8175-a3c7bcf5052d" xlink:href="vrts-20240331.xsd#vrts_InvestmentManagementFeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9cd1b05e-a78b-4d50-9c14-625f4c9ff8f3" xlink:to="loc_vrts_InvestmentManagementFeesMember_239b7753-0330-4528-8175-a3c7bcf5052d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_OpenEndFundsMember_c90257a8-e465-4d1c-9b9a-7981bf302ae3" xlink:href="vrts-20240331.xsd#vrts_OpenEndFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vrts_InvestmentManagementFeesMember_239b7753-0330-4528-8175-a3c7bcf5052d" xlink:to="loc_vrts_OpenEndFundsMember_c90257a8-e465-4d1c-9b9a-7981bf302ae3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_ClosedEndFundsMember_5cacc36a-82af-4577-a7fd-7cd65405eccd" xlink:href="vrts-20240331.xsd#vrts_ClosedEndFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vrts_InvestmentManagementFeesMember_239b7753-0330-4528-8175-a3c7bcf5052d" xlink:to="loc_vrts_ClosedEndFundsMember_5cacc36a-82af-4577-a7fd-7cd65405eccd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_RetailSeparateAccountsMember_64c1a488-a3ae-412b-b3ef-469771d3d152" xlink:href="vrts-20240331.xsd#vrts_RetailSeparateAccountsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vrts_InvestmentManagementFeesMember_239b7753-0330-4528-8175-a3c7bcf5052d" xlink:to="loc_vrts_RetailSeparateAccountsMember_64c1a488-a3ae-412b-b3ef-469771d3d152" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_InstitutionalAccountsMember_0c455a68-4fea-449d-98c1-d9e6493c2fe5" xlink:href="vrts-20240331.xsd#vrts_InstitutionalAccountsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vrts_InvestmentManagementFeesMember_239b7753-0330-4528-8175-a3c7bcf5052d" xlink:to="loc_vrts_InstitutionalAccountsMember_0c455a68-4fea-449d-98c1-d9e6493c2fe5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_59f4e25f-aba6-4924-9357-93058fb78dca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_6549c47e-c442-4e64-9cef-01e978b59d41" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_59f4e25f-aba6-4924-9357-93058fb78dca" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.virtus.com/role/AcquisitionsDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#AcquisitionsDetails"/>
  <link:definitionLink xlink:role="http://www.virtus.com/role/AcquisitionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_5cf0346e-1b59-4c8b-a6a6-18597df318d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_56ae01c2-208a-49e0-adc2-039ecea26394" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5cf0346e-1b59-4c8b-a6a6-18597df318d1" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_56ae01c2-208a-49e0-adc2-039ecea26394" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b28acb08-183d-4763-8919-ffb0ff40938c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_56ae01c2-208a-49e0-adc2-039ecea26394" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b28acb08-183d-4763-8919-ffb0ff40938c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b28acb08-183d-4763-8919-ffb0ff40938c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b28acb08-183d-4763-8919-ffb0ff40938c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b28acb08-183d-4763-8919-ffb0ff40938c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_904490db-ad26-45ae-b5bc-867408a4b3c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b28acb08-183d-4763-8919-ffb0ff40938c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_904490db-ad26-45ae-b5bc-867408a4b3c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_AlphaSimplexGroupLLCMember_21d09ae3-39c8-4196-9c33-2eb12dde0c98" xlink:href="vrts-20240331.xsd#vrts_AlphaSimplexGroupLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_904490db-ad26-45ae-b5bc-867408a4b3c3" xlink:to="loc_vrts_AlphaSimplexGroupLLCMember_21d09ae3-39c8-4196-9c33-2eb12dde0c98" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_b85a4775-033a-4438-af7a-f93798330359" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5cf0346e-1b59-4c8b-a6a6-18597df318d1" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_b85a4775-033a-4438-af7a-f93798330359" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_26177ec0-78e6-43fa-9f56-30b6a54da565" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5cf0346e-1b59-4c8b-a6a6-18597df318d1" xlink:to="loc_us-gaap_Goodwill_26177ec0-78e6-43fa-9f56-30b6a54da565" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_6d18a114-1e81-4c70-b6b4-b6348da8b101" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5cf0346e-1b59-4c8b-a6a6-18597df318d1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_6d18a114-1e81-4c70-b6b4-b6348da8b101" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.virtus.com/role/InvestmentsInvestmentsDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#InvestmentsInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.virtus.com/role/InvestmentsInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_fd784726-9af9-4095-91a9-3b8e5d59600e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_cd421430-cf5c-4e05-9e95-39452d67dd49" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_fd784726-9af9-4095-91a9-3b8e5d59600e" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_cd421430-cf5c-4e05-9e95-39452d67dd49" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_38a4a25d-9b75-41c7-ad55-a2e8659c3ff2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_cd421430-cf5c-4e05-9e95-39452d67dd49" xlink:to="loc_srt_ConsolidatedEntitiesAxis_38a4a25d-9b75-41c7-ad55-a2e8659c3ff2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_38a4a25d-9b75-41c7-ad55-a2e8659c3ff2_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_38a4a25d-9b75-41c7-ad55-a2e8659c3ff2" xlink:to="loc_srt_ConsolidatedEntitiesDomain_38a4a25d-9b75-41c7-ad55-a2e8659c3ff2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_2e888235-cdd1-457c-86af-b5851404a2a3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_38a4a25d-9b75-41c7-ad55-a2e8659c3ff2" xlink:to="loc_srt_ConsolidatedEntitiesDomain_2e888235-cdd1-457c-86af-b5851404a2a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_d0bdaeb4-784a-45d4-b137-2f12c619fff5" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_2e888235-cdd1-457c-86af-b5851404a2a3" xlink:to="loc_srt_ParentCompanyMember_d0bdaeb4-784a-45d4-b137-2f12c619fff5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_5e3ea560-96a0-43d3-afcf-2498c12b55af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_fd784726-9af9-4095-91a9-3b8e5d59600e" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_5e3ea560-96a0-43d3-afcf-2498c12b55af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_93cead96-7fa5-483d-b6f2-570747d1f26c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_fd784726-9af9-4095-91a9-3b8e5d59600e" xlink:to="loc_us-gaap_EquityMethodInvestments_93cead96-7fa5-483d-b6f2-570747d1f26c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_InvestmentsInNonqualifiedRetirementPlanAssets_774b9cd3-cec7-47c2-b64d-cfc9a5f8153b" xlink:href="vrts-20240331.xsd#vrts_InvestmentsInNonqualifiedRetirementPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_fd784726-9af9-4095-91a9-3b8e5d59600e" xlink:to="loc_vrts_InvestmentsInNonqualifiedRetirementPlanAssets_774b9cd3-cec7-47c2-b64d-cfc9a5f8153b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_e7afa705-5c0c-4f6b-bbae-37614ba08a96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Investments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_fd784726-9af9-4095-91a9-3b8e5d59600e" xlink:to="loc_us-gaap_Investments_e7afa705-5c0c-4f6b-bbae-37614ba08a96" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.virtus.com/role/InvestmentsMarketableSecuritiesDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#InvestmentsMarketableSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.virtus.com/role/InvestmentsMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9c8f82da-0657-4e36-b2ff-323d25fd1a94" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a53ce75f-8cc1-4353-8ca4-97479b771a22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9c8f82da-0657-4e36-b2ff-323d25fd1a94" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a53ce75f-8cc1-4353-8ca4-97479b771a22" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_ad6a52a4-3afb-4b10-ab92-0de5ae0d5b38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a53ce75f-8cc1-4353-8ca4-97479b771a22" xlink:to="loc_us-gaap_FinancialInstrumentAxis_ad6a52a4-3afb-4b10-ab92-0de5ae0d5b38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ad6a52a4-3afb-4b10-ab92-0de5ae0d5b38_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ad6a52a4-3afb-4b10-ab92-0de5ae0d5b38" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ad6a52a4-3afb-4b10-ab92-0de5ae0d5b38_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7cf21784-2858-4d35-af72-afebdbf16e75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ad6a52a4-3afb-4b10-ab92-0de5ae0d5b38" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7cf21784-2858-4d35-af72-afebdbf16e75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_SponsoredFundsMember_a1bc0991-e83b-4e2c-b1dd-f2aaa3e3a288" xlink:href="vrts-20240331.xsd#vrts_SponsoredFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7cf21784-2858-4d35-af72-afebdbf16e75" xlink:to="loc_vrts_SponsoredFundsMember_a1bc0991-e83b-4e2c-b1dd-f2aaa3e3a288" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_124ff274-37df-4aa9-90a9-ae3f5aaa9986" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7cf21784-2858-4d35-af72-afebdbf16e75" xlink:to="loc_us-gaap_EquitySecuritiesMember_124ff274-37df-4aa9-90a9-ae3f5aaa9986" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesAbstract_363e8c88-1625-4266-808d-7e263dd26827" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9c8f82da-0657-4e36-b2ff-323d25fd1a94" xlink:to="loc_us-gaap_MarketableSecuritiesAbstract_363e8c88-1625-4266-808d-7e263dd26827" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCost_86431a51-5bc5-4774-b905-40cea2ec03ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesAbstract_363e8c88-1625-4266-808d-7e263dd26827" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCost_86431a51-5bc5-4774-b905-40cea2ec03ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_f82e9c5b-b29a-4a15-af0a-08328bfaffff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesAbstract_363e8c88-1625-4266-808d-7e263dd26827" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_f82e9c5b-b29a-4a15-af0a-08328bfaffff" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.virtus.com/role/FairValueMeasurementsChangesinAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#FairValueMeasurementsChangesinAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.virtus.com/role/FairValueMeasurementsChangesinAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_d0d1dab2-dee5-41c3-a6e3-8b25f15d1e28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_828f169b-bc29-43ce-9ad7-1d11bb4c9ebd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_d0d1dab2-dee5-41c3-a6e3-8b25f15d1e28" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_828f169b-bc29-43ce-9ad7-1d11bb4c9ebd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f66175c4-6b06-4763-b046-f4f250107b47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_828f169b-bc29-43ce-9ad7-1d11bb4c9ebd" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f66175c4-6b06-4763-b046-f4f250107b47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f66175c4-6b06-4763-b046-f4f250107b47_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f66175c4-6b06-4763-b046-f4f250107b47" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f66175c4-6b06-4763-b046-f4f250107b47_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7b4da85d-65cb-4f73-a5f7-3b2bc553e1f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f66175c4-6b06-4763-b046-f4f250107b47" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7b4da85d-65cb-4f73-a5f7-3b2bc553e1f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_1847ea84-3f24-4fec-a84e-6da9266d6b61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7b4da85d-65cb-4f73-a5f7-3b2bc553e1f7" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_1847ea84-3f24-4fec-a84e-6da9266d6b61" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_8711715d-2a9d-488b-ae14-e0e10df35314" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7b4da85d-65cb-4f73-a5f7-3b2bc553e1f7" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_8711715d-2a9d-488b-ae14-e0e10df35314" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_a0d5fb05-40c9-4093-b35f-f11804d5e29d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7b4da85d-65cb-4f73-a5f7-3b2bc553e1f7" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_a0d5fb05-40c9-4093-b35f-f11804d5e29d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_289e5958-8310-48c6-8f18-4e206c0d3dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_828f169b-bc29-43ce-9ad7-1d11bb4c9ebd" xlink:to="loc_us-gaap_FinancialInstrumentAxis_289e5958-8310-48c6-8f18-4e206c0d3dc3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_289e5958-8310-48c6-8f18-4e206c0d3dc3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_289e5958-8310-48c6-8f18-4e206c0d3dc3" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_289e5958-8310-48c6-8f18-4e206c0d3dc3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7d1f9fbe-d0fd-4047-8dbe-b17f8abff1b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_289e5958-8310-48c6-8f18-4e206c0d3dc3" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7d1f9fbe-d0fd-4047-8dbe-b17f8abff1b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_SponsoredFundsMember_fd33cef4-f95f-46bd-ad29-0fec03def4c6" xlink:href="vrts-20240331.xsd#vrts_SponsoredFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7d1f9fbe-d0fd-4047-8dbe-b17f8abff1b3" xlink:to="loc_vrts_SponsoredFundsMember_fd33cef4-f95f-46bd-ad29-0fec03def4c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_f9fa4b52-537c-43ab-b146-daade29c41d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7d1f9fbe-d0fd-4047-8dbe-b17f8abff1b3" xlink:to="loc_us-gaap_EquitySecuritiesMember_f9fa4b52-537c-43ab-b146-daade29c41d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_NonqualifiedRetirementPlanAssetsMember_b74caa7f-edc2-4a94-9afa-0ef4478b44a9" xlink:href="vrts-20240331.xsd#vrts_NonqualifiedRetirementPlanAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7d1f9fbe-d0fd-4047-8dbe-b17f8abff1b3" xlink:to="loc_vrts_NonqualifiedRetirementPlanAssetsMember_b74caa7f-edc2-4a94-9afa-0ef4478b44a9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_ade7fd35-c673-443c-ad33-82d647a5a133" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_828f169b-bc29-43ce-9ad7-1d11bb4c9ebd" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_ade7fd35-c673-443c-ad33-82d647a5a133" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ade7fd35-c673-443c-ad33-82d647a5a133_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_ade7fd35-c673-443c-ad33-82d647a5a133" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ade7fd35-c673-443c-ad33-82d647a5a133_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_0b6d3102-4069-4857-81b8-f4e80024208b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_ade7fd35-c673-443c-ad33-82d647a5a133" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_0b6d3102-4069-4857-81b8-f4e80024208b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_ContingentConsiderationLiabilityMember_570d6b09-7a17-4e1c-ae5a-6cea8309e542" xlink:href="vrts-20240331.xsd#vrts_ContingentConsiderationLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_0b6d3102-4069-4857-81b8-f4e80024208b" xlink:to="loc_vrts_ContingentConsiderationLiabilityMember_570d6b09-7a17-4e1c-ae5a-6cea8309e542" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_69bf2fba-bbae-4621-b9d6-737f25206e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_d0d1dab2-dee5-41c3-a6e3-8b25f15d1e28" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_69bf2fba-bbae-4621-b9d6-737f25206e5f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_f86928fb-30e4-498b-8261-791669f3c287" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_69bf2fba-bbae-4621-b9d6-737f25206e5f" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_f86928fb-30e4-498b-8261-791669f3c287" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesAbstract_df4d8032-11c6-48bd-8890-af9211759919" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_69bf2fba-bbae-4621-b9d6-737f25206e5f" xlink:to="loc_us-gaap_MarketableSecuritiesAbstract_df4d8032-11c6-48bd-8890-af9211759919" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_9f7d4a9f-98d3-4bd7-a027-e4fd76bedaf1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesAbstract_df4d8032-11c6-48bd-8890-af9211759919" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_9f7d4a9f-98d3-4bd7-a027-e4fd76bedaf1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_InvestmentsInNonqualifiedRetirementPlanAssets_4e61088d-5817-427d-9295-d147c96ea356" xlink:href="vrts-20240331.xsd#vrts_InvestmentsInNonqualifiedRetirementPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_69bf2fba-bbae-4621-b9d6-737f25206e5f" xlink:to="loc_vrts_InvestmentsInNonqualifiedRetirementPlanAssets_4e61088d-5817-427d-9295-d147c96ea356" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_2fef1226-00f2-4361-b717-248496cdd4ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_69bf2fba-bbae-4621-b9d6-737f25206e5f" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_2fef1226-00f2-4361-b717-248496cdd4ac" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_8912e276-66cd-4001-86e6-3f342a91cfa2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_d0d1dab2-dee5-41c3-a6e3-8b25f15d1e28" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_8912e276-66cd-4001-86e6-3f342a91cfa2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_6d54ef7a-9ff6-4537-8771-4b7a68290f5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_8912e276-66cd-4001-86e6-3f342a91cfa2" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_6d54ef7a-9ff6-4537-8771-4b7a68290f5b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.virtus.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.virtus.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_cd29294b-7613-41aa-8507-eea4f955f4ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_444db690-e960-4cc1-bf32-f8a8193dfed0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_cd29294b-7613-41aa-8507-eea4f955f4ec" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_444db690-e960-4cc1-bf32-f8a8193dfed0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f7e1a96e-130b-4934-8bf6-cf9892260345" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_444db690-e960-4cc1-bf32-f8a8193dfed0" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f7e1a96e-130b-4934-8bf6-cf9892260345" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f7e1a96e-130b-4934-8bf6-cf9892260345_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f7e1a96e-130b-4934-8bf6-cf9892260345" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f7e1a96e-130b-4934-8bf6-cf9892260345_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0d0ee1ad-681b-4c27-a9b4-943976244442" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f7e1a96e-130b-4934-8bf6-cf9892260345" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0d0ee1ad-681b-4c27-a9b4-943976244442" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_WestchesterCapitalManagementMember_05c32b66-c387-4b82-8076-ea89e1fada43" xlink:href="vrts-20240331.xsd#vrts_WestchesterCapitalManagementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0d0ee1ad-681b-4c27-a9b4-943976244442" xlink:to="loc_vrts_WestchesterCapitalManagementMember_05c32b66-c387-4b82-8076-ea89e1fada43" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_NFJInvestmentGroupMember_cb198131-6ece-49f3-a97a-32c4b9a008ee" xlink:href="vrts-20240331.xsd#vrts_NFJInvestmentGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0d0ee1ad-681b-4c27-a9b4-943976244442" xlink:to="loc_vrts_NFJInvestmentGroupMember_cb198131-6ece-49f3-a97a-32c4b9a008ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_be7c2979-e37d-41c9-bc46-350a0c6d931a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_444db690-e960-4cc1-bf32-f8a8193dfed0" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_be7c2979-e37d-41c9-bc46-350a0c6d931a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_be7c2979-e37d-41c9-bc46-350a0c6d931a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_be7c2979-e37d-41c9-bc46-350a0c6d931a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_be7c2979-e37d-41c9-bc46-350a0c6d931a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ffec4edb-5849-4fd3-99dd-f68502275fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_be7c2979-e37d-41c9-bc46-350a0c6d931a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ffec4edb-5849-4fd3-99dd-f68502275fd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_5aef6f4d-a33c-4eac-96ef-415c03f8d83a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ffec4edb-5849-4fd3-99dd-f68502275fd4" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_5aef6f4d-a33c-4eac-96ef-415c03f8d83a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e564e0e7-f689-4271-abc0-54a69fce82fa" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_444db690-e960-4cc1-bf32-f8a8193dfed0" xlink:to="loc_srt_RangeAxis_e564e0e7-f689-4271-abc0-54a69fce82fa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e564e0e7-f689-4271-abc0-54a69fce82fa_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e564e0e7-f689-4271-abc0-54a69fce82fa" xlink:to="loc_srt_RangeMember_e564e0e7-f689-4271-abc0-54a69fce82fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_29f54b2a-daa5-4aca-ac87-4bac12aa25fd" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e564e0e7-f689-4271-abc0-54a69fce82fa" xlink:to="loc_srt_RangeMember_29f54b2a-daa5-4aca-ac87-4bac12aa25fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d32596de-72f4-412d-9107-3796864c29d5" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_29f54b2a-daa5-4aca-ac87-4bac12aa25fd" xlink:to="loc_srt_MinimumMember_d32596de-72f4-412d-9107-3796864c29d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f50f7f6d-7579-414d-a45c-48894af5fb00" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_29f54b2a-daa5-4aca-ac87-4bac12aa25fd" xlink:to="loc_srt_MaximumMember_f50f7f6d-7579-414d-a45c-48894af5fb00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_0ff1ba30-ba42-4aef-ba1d-f6855d7fe5e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_444db690-e960-4cc1-bf32-f8a8193dfed0" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_0ff1ba30-ba42-4aef-ba1d-f6855d7fe5e5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_0ff1ba30-ba42-4aef-ba1d-f6855d7fe5e5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_0ff1ba30-ba42-4aef-ba1d-f6855d7fe5e5" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_0ff1ba30-ba42-4aef-ba1d-f6855d7fe5e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_9c75869a-9548-40ef-8c2b-1438ed43d056" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_0ff1ba30-ba42-4aef-ba1d-f6855d7fe5e5" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_9c75869a-9548-40ef-8c2b-1438ed43d056" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_bd12a854-d492-460c-bfc3-da204637a66b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_9c75869a-9548-40ef-8c2b-1438ed43d056" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_bd12a854-d492-460c-bfc3-da204637a66b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputComparabilityAdjustmentMember_adeb998e-ceb7-403b-b9e9-659f7b7d2674" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputComparabilityAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_9c75869a-9548-40ef-8c2b-1438ed43d056" xlink:to="loc_us-gaap_MeasurementInputComparabilityAdjustmentMember_adeb998e-ceb7-403b-b9e9-659f7b7d2674" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_648d0232-8ade-4ec4-821c-4232d6aa9ece" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_cd29294b-7613-41aa-8507-eea4f955f4ec" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_648d0232-8ade-4ec4-821c-4232d6aa9ece" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_8c5b0f82-2bb7-477a-be8e-3d523d51e37b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_cd29294b-7613-41aa-8507-eea4f955f4ec" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_8c5b0f82-2bb7-477a-be8e-3d523d51e37b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.virtus.com/role/FairValueMeasurementsRollforwardoftheContingentConsiderationLiabilitiesValuedUsingLevel3InputsDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#FairValueMeasurementsRollforwardoftheContingentConsiderationLiabilitiesValuedUsingLevel3InputsDetails"/>
  <link:definitionLink xlink:role="http://www.virtus.com/role/FairValueMeasurementsRollforwardoftheContingentConsiderationLiabilitiesValuedUsingLevel3InputsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_92dae755-5bf1-4689-a73f-38ae5ba4b8bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_cd55b0f6-f812-4530-85b0-43937e43bdc2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_92dae755-5bf1-4689-a73f-38ae5ba4b8bb" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_cd55b0f6-f812-4530-85b0-43937e43bdc2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9e9e8653-78ac-4e97-a8b4-688d66108695" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_cd55b0f6-f812-4530-85b0-43937e43bdc2" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9e9e8653-78ac-4e97-a8b4-688d66108695" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9e9e8653-78ac-4e97-a8b4-688d66108695_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9e9e8653-78ac-4e97-a8b4-688d66108695" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9e9e8653-78ac-4e97-a8b4-688d66108695_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2297b250-8186-4ab5-8be5-984d8d2a03cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9e9e8653-78ac-4e97-a8b4-688d66108695" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2297b250-8186-4ab5-8be5-984d8d2a03cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_07417032-9bd1-4b85-9714-d0a831805623" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2297b250-8186-4ab5-8be5-984d8d2a03cf" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_07417032-9bd1-4b85-9714-d0a831805623" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_c941a53b-706b-44bf-b1dc-63b7ea34e9d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_cd55b0f6-f812-4530-85b0-43937e43bdc2" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_c941a53b-706b-44bf-b1dc-63b7ea34e9d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c941a53b-706b-44bf-b1dc-63b7ea34e9d7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_c941a53b-706b-44bf-b1dc-63b7ea34e9d7" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c941a53b-706b-44bf-b1dc-63b7ea34e9d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_99f70f66-7ab2-40ad-9001-fcbc02aaf49b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_c941a53b-706b-44bf-b1dc-63b7ea34e9d7" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_99f70f66-7ab2-40ad-9001-fcbc02aaf49b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_ContingentConsiderationLiabilityMember_16e465e1-f722-4a05-964a-976f362bd67c" xlink:href="vrts-20240331.xsd#vrts_ContingentConsiderationLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_99f70f66-7ab2-40ad-9001-fcbc02aaf49b" xlink:to="loc_vrts_ContingentConsiderationLiabilityMember_16e465e1-f722-4a05-964a-976f362bd67c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_a886d240-b7b5-4284-aa1c-39a700c54ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_92dae755-5bf1-4689-a73f-38ae5ba4b8bb" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_a886d240-b7b5-4284-aa1c-39a700c54ab1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_d506d810-f7fc-4e08-8d1f-8e038864a5e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_a886d240-b7b5-4284-aa1c-39a700c54ab1" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_d506d810-f7fc-4e08-8d1f-8e038864a5e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReductionOfLiability_6c80ab17-e631-44b9-afb4-9ce7531a09b3" xlink:href="vrts-20240331.xsd#vrts_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReductionOfLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_a886d240-b7b5-4284-aa1c-39a700c54ab1" xlink:to="loc_vrts_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReductionOfLiability_6c80ab17-e631-44b9-afb4-9ce7531a09b3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_040672ac-0527-4ed2-aefb-d1e88bfaef99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.virtus.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#AccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:definitionLink xlink:role="http://www.virtus.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_94cc5642-3bf0-4c72-87e3-b083f093fbeb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_becc8043-19f1-48de-abc8-1e8547910019" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_94cc5642-3bf0-4c72-87e3-b083f093fbeb" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_becc8043-19f1-48de-abc8-1e8547910019" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_52ce26e1-8786-4d7e-a621-2fe073af4d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_becc8043-19f1-48de-abc8-1e8547910019" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_52ce26e1-8786-4d7e-a621-2fe073af4d8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_52ce26e1-8786-4d7e-a621-2fe073af4d8a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_52ce26e1-8786-4d7e-a621-2fe073af4d8a" xlink:to="loc_us-gaap_EquityComponentDomain_52ce26e1-8786-4d7e-a621-2fe073af4d8a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_04f9c468-3524-4c19-b367-4915f5c19729" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_52ce26e1-8786-4d7e-a621-2fe073af4d8a" xlink:to="loc_us-gaap_EquityComponentDomain_04f9c468-3524-4c19-b367-4915f5c19729" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_c4843ae5-629c-45d1-ba1b-a0ea90313c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_04f9c468-3524-4c19-b367-4915f5c19729" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_c4843ae5-629c-45d1-ba1b-a0ea90313c9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_e7d058b9-f2ce-4804-9855-e4f9f52eeeff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_94cc5642-3bf0-4c72-87e3-b083f093fbeb" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_e7d058b9-f2ce-4804-9855-e4f9f52eeeff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ee6844c7-573b-4068-9006-9325b84058d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_e7d058b9-f2ce-4804-9855-e4f9f52eeeff" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ee6844c7-573b-4068-9006-9325b84058d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5374071b-5637-48a5-92ce-74f470723b14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_e7d058b9-f2ce-4804-9855-e4f9f52eeeff" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5374071b-5637-48a5-92ce-74f470723b14" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b48d0be5-4542-4747-835d-bfdaa60cae87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_d06a6f81-e382-4ee1-af57-d181961e01d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_94cc5642-3bf0-4c72-87e3-b083f093fbeb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_d06a6f81-e382-4ee1-af57-d181961e01d7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.virtus.com/role/StockBasedCompensationAdditionalInformationDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#StockBasedCompensationAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.virtus.com/role/StockBasedCompensationAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_086c0f5c-872e-498a-80db-ce17f90ad988" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b7e6004d-337f-4b9d-b6bb-f93020079ce6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_086c0f5c-872e-498a-80db-ce17f90ad988" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b7e6004d-337f-4b9d-b6bb-f93020079ce6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_326f47a9-67fb-41d7-a633-ec69e3a76846" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b7e6004d-337f-4b9d-b6bb-f93020079ce6" xlink:to="loc_us-gaap_StatementClassOfStockAxis_326f47a9-67fb-41d7-a633-ec69e3a76846" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_326f47a9-67fb-41d7-a633-ec69e3a76846_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_326f47a9-67fb-41d7-a633-ec69e3a76846" xlink:to="loc_us-gaap_ClassOfStockDomain_326f47a9-67fb-41d7-a633-ec69e3a76846_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_082d4d15-5dee-4348-8a16-672970db3f11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_326f47a9-67fb-41d7-a633-ec69e3a76846" xlink:to="loc_us-gaap_ClassOfStockDomain_082d4d15-5dee-4348-8a16-672970db3f11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_ac64c8cb-eff5-44b7-9778-43da72c6ec16" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_082d4d15-5dee-4348-8a16-672970db3f11" xlink:to="loc_us-gaap_CommonStockMember_ac64c8cb-eff5-44b7-9778-43da72c6ec16" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_151e0f8a-caa2-46f0-a184-b5fecf01a91f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b7e6004d-337f-4b9d-b6bb-f93020079ce6" xlink:to="loc_srt_RangeAxis_151e0f8a-caa2-46f0-a184-b5fecf01a91f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_151e0f8a-caa2-46f0-a184-b5fecf01a91f_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_151e0f8a-caa2-46f0-a184-b5fecf01a91f" xlink:to="loc_srt_RangeMember_151e0f8a-caa2-46f0-a184-b5fecf01a91f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a6f613e0-c1c1-42f0-8110-1fff404cfb41" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_151e0f8a-caa2-46f0-a184-b5fecf01a91f" xlink:to="loc_srt_RangeMember_a6f613e0-c1c1-42f0-8110-1fff404cfb41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_685dea1f-221f-4633-9e0b-8e7a0305195a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a6f613e0-c1c1-42f0-8110-1fff404cfb41" xlink:to="loc_srt_MinimumMember_685dea1f-221f-4633-9e0b-8e7a0305195a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_842db12f-4f0f-49b0-99d9-23daa26e7d2b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a6f613e0-c1c1-42f0-8110-1fff404cfb41" xlink:to="loc_srt_MaximumMember_842db12f-4f0f-49b0-99d9-23daa26e7d2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_2e9a78ce-ed84-436f-b60e-b89c280f9888" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b7e6004d-337f-4b9d-b6bb-f93020079ce6" xlink:to="loc_us-gaap_AwardTypeAxis_2e9a78ce-ed84-436f-b60e-b89c280f9888" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2e9a78ce-ed84-436f-b60e-b89c280f9888_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_2e9a78ce-ed84-436f-b60e-b89c280f9888" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2e9a78ce-ed84-436f-b60e-b89c280f9888_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c58b6a47-ac31-4234-88aa-6b6e16de5b26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_2e9a78ce-ed84-436f-b60e-b89c280f9888" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c58b6a47-ac31-4234-88aa-6b6e16de5b26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_RestrictedStockUnitsandPerformanceSharesUnitsMember_ef31cb0a-2aa8-4121-b519-f39817f7e371" xlink:href="vrts-20240331.xsd#vrts_RestrictedStockUnitsandPerformanceSharesUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c58b6a47-ac31-4234-88aa-6b6e16de5b26" xlink:to="loc_vrts_RestrictedStockUnitsandPerformanceSharesUnitsMember_ef31cb0a-2aa8-4121-b519-f39817f7e371" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_deb831a0-2de4-4406-baaa-3da1cb8d85c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vrts_RestrictedStockUnitsandPerformanceSharesUnitsMember_ef31cb0a-2aa8-4121-b519-f39817f7e371" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_deb831a0-2de4-4406-baaa-3da1cb8d85c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_RestrictedStockUnitsRSUsPerformanceBasedMember_d904ae2e-aac5-45ac-a534-56ed6e0c7c86" xlink:href="vrts-20240331.xsd#vrts_RestrictedStockUnitsRSUsPerformanceBasedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vrts_RestrictedStockUnitsandPerformanceSharesUnitsMember_ef31cb0a-2aa8-4121-b519-f39817f7e371" xlink:to="loc_vrts_RestrictedStockUnitsRSUsPerformanceBasedMember_d904ae2e-aac5-45ac-a534-56ed6e0c7c86" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_PerformanceStockUnitsIncentiveMember_3db76557-cbec-48dd-8adc-c38f5e70296b" xlink:href="vrts-20240331.xsd#vrts_PerformanceStockUnitsIncentiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vrts_RestrictedStockUnitsandPerformanceSharesUnitsMember_ef31cb0a-2aa8-4121-b519-f39817f7e371" xlink:to="loc_vrts_PerformanceStockUnitsIncentiveMember_3db76557-cbec-48dd-8adc-c38f5e70296b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_43ac5ae9-3368-4af8-afa8-e100388f7ba4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_086c0f5c-872e-498a-80db-ce17f90ad988" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_43ac5ae9-3368-4af8-afa8-e100388f7ba4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_957fbc71-dbc1-4431-9d47-bc3e56c7c17b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_086c0f5c-872e-498a-80db-ce17f90ad988" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_957fbc71-dbc1-4431-9d47-bc3e56c7c17b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_ConversionOfStockConversionRatio_c7ae1f59-d2fc-4ceb-816b-32550661a955" xlink:href="vrts-20240331.xsd#vrts_ConversionOfStockConversionRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_086c0f5c-872e-498a-80db-ce17f90ad988" xlink:to="loc_vrts_ConversionOfStockConversionRatio_c7ae1f59-d2fc-4ceb-816b-32550661a955" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d852832d-5a20-47c0-9448-a1d15eba1c00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_086c0f5c-872e-498a-80db-ce17f90ad988" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d852832d-5a20-47c0-9448-a1d15eba1c00" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_cb186501-a508-4a48-a1a5-12c2170ff5a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_086c0f5c-872e-498a-80db-ce17f90ad988" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_cb186501-a508-4a48-a1a5-12c2170ff5a8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_PaymentOfWithholdingTaxesRelatedToRestrictedStock_297ab09b-b6ab-4f59-86e2-2114a1ba7881" xlink:href="vrts-20240331.xsd#vrts_PaymentOfWithholdingTaxesRelatedToRestrictedStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_086c0f5c-872e-498a-80db-ce17f90ad988" xlink:to="loc_vrts_PaymentOfWithholdingTaxesRelatedToRestrictedStock_297ab09b-b6ab-4f59-86e2-2114a1ba7881" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_3b21e342-fcb1-4245-86b2-b8498640c41b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_086c0f5c-872e-498a-80db-ce17f90ad988" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_3b21e342-fcb1-4245-86b2-b8498640c41b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_75a3d144-134d-4c3a-8013-69521836fe2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_086c0f5c-872e-498a-80db-ce17f90ad988" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_75a3d144-134d-4c3a-8013-69521836fe2a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_3051921a-f929-4da5-87e4-3d06333cc64e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_086c0f5c-872e-498a-80db-ce17f90ad988" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_3051921a-f929-4da5-87e4-3d06333cc64e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_55ad92b9-0689-4251-b6d6-34b40b6df830" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_086c0f5c-872e-498a-80db-ce17f90ad988" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_55ad92b9-0689-4251-b6d6-34b40b6df830" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.virtus.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#StockBasedCompensationRestrictedStockUnitsActivityDetails"/>
  <link:definitionLink xlink:role="http://www.virtus.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e0942307-395a-4e23-bed8-575779cce62d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_50749154-1479-4d09-a5ad-252b4ce256cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e0942307-395a-4e23-bed8-575779cce62d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_50749154-1479-4d09-a5ad-252b4ce256cc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c6218e55-2da9-47eb-b1a1-c2a8fb3526aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_50749154-1479-4d09-a5ad-252b4ce256cc" xlink:to="loc_us-gaap_AwardTypeAxis_c6218e55-2da9-47eb-b1a1-c2a8fb3526aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c6218e55-2da9-47eb-b1a1-c2a8fb3526aa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_c6218e55-2da9-47eb-b1a1-c2a8fb3526aa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c6218e55-2da9-47eb-b1a1-c2a8fb3526aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_abed6562-316b-420a-808f-a3c4c36c6391" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_c6218e55-2da9-47eb-b1a1-c2a8fb3526aa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_abed6562-316b-420a-808f-a3c4c36c6391" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_5976143e-5fe9-4f52-a67a-d4fce2500dcb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_abed6562-316b-420a-808f-a3c4c36c6391" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_5976143e-5fe9-4f52-a67a-d4fce2500dcb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_43fffee8-12c9-44a8-a4c0-0f258ffe43cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e0942307-395a-4e23-bed8-575779cce62d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_43fffee8-12c9-44a8-a4c0-0f258ffe43cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1ecc2a19-2922-45cd-9b2a-ca0d3e23e93c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_43fffee8-12c9-44a8-a4c0-0f258ffe43cc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1ecc2a19-2922-45cd-9b2a-ca0d3e23e93c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0da8550d-e3b2-45f4-b7c4-770bb1dd6b64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_43fffee8-12c9-44a8-a4c0-0f258ffe43cc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0da8550d-e3b2-45f4-b7c4-770bb1dd6b64" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_90118e9a-c784-45b9-9390-bb25b3a2797e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_43fffee8-12c9-44a8-a4c0-0f258ffe43cc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_90118e9a-c784-45b9-9390-bb25b3a2797e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_141543b2-0f89-4631-8f6c-4eba441bf6dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_43fffee8-12c9-44a8-a4c0-0f258ffe43cc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_141543b2-0f89-4631-8f6c-4eba441bf6dd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c364df26-bf5e-4f52-9171-b4fba3ae23c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_25171e6a-9e11-438d-b59a-6c10c5f2096c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e0942307-395a-4e23-bed8-575779cce62d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_25171e6a-9e11-438d-b59a-6c10c5f2096c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e32dd9c8-b31f-4a80-ae7b-8f7a2665f743" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_25171e6a-9e11-438d-b59a-6c10c5f2096c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e32dd9c8-b31f-4a80-ae7b-8f7a2665f743" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ab6a3cda-85c3-4102-bd8f-093fb08eba8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_25171e6a-9e11-438d-b59a-6c10c5f2096c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ab6a3cda-85c3-4102-bd8f-093fb08eba8f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_96638d8a-0f8e-4127-94f6-c0760515be14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_25171e6a-9e11-438d-b59a-6c10c5f2096c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_96638d8a-0f8e-4127-94f6-c0760515be14" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_87840cf4-2af0-4919-8bf8-145da53a7ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_25171e6a-9e11-438d-b59a-6c10c5f2096c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_87840cf4-2af0-4919-8bf8-145da53a7ce0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_09b3684d-fad0-4800-8228-72e0e26ffac7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.virtus.com/role/EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.virtus.com/role/EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_ad05eb56-03c1-49d4-b5c0-9adf8757678c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6ab0af81-eb49-4d45-89c7-522912777bec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_ad05eb56-03c1-49d4-b5c0-9adf8757678c" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6ab0af81-eb49-4d45-89c7-522912777bec" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_4778001c-7da7-415c-b7bc-be928fd5c932" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6ab0af81-eb49-4d45-89c7-522912777bec" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_4778001c-7da7-415c-b7bc-be928fd5c932" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4778001c-7da7-415c-b7bc-be928fd5c932_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_4778001c-7da7-415c-b7bc-be928fd5c932" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4778001c-7da7-415c-b7bc-be928fd5c932_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_aa65487e-cdea-49df-8328-f738618748ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_4778001c-7da7-415c-b7bc-be928fd5c932" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_aa65487e-cdea-49df-8328-f738618748ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_d1da2cfc-7065-4c2e-be26-86ea6b787929" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_aa65487e-cdea-49df-8328-f738618748ee" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_d1da2cfc-7065-4c2e-be26-86ea6b787929" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_74a5ac14-a748-4ca8-a844-d75caf40d21e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_ad05eb56-03c1-49d4-b5c0-9adf8757678c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_74a5ac14-a748-4ca8-a844-d75caf40d21e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.virtus.com/role/DebtDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#DebtDetails"/>
  <link:definitionLink xlink:role="http://www.virtus.com/role/DebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_821eb040-e7c1-4264-b13d-c6b78d04c588" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_5e882453-dd91-4aac-b01f-8da2da9b12fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_821eb040-e7c1-4264-b13d-c6b78d04c588" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_5e882453-dd91-4aac-b01f-8da2da9b12fd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_7c885ab5-d9a5-456d-b4e6-73c95c9eb146" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_5e882453-dd91-4aac-b01f-8da2da9b12fd" xlink:to="loc_us-gaap_CreditFacilityAxis_7c885ab5-d9a5-456d-b4e6-73c95c9eb146" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_7c885ab5-d9a5-456d-b4e6-73c95c9eb146_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_7c885ab5-d9a5-456d-b4e6-73c95c9eb146" xlink:to="loc_us-gaap_CreditFacilityDomain_7c885ab5-d9a5-456d-b4e6-73c95c9eb146_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_6ace0e8f-fcd8-4b82-981c-70b7ecf4d1ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_7c885ab5-d9a5-456d-b4e6-73c95c9eb146" xlink:to="loc_us-gaap_CreditFacilityDomain_6ace0e8f-fcd8-4b82-981c-70b7ecf4d1ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_TermLoanMember_8bbaddee-d3c8-4845-9ffa-182cec98d2a1" xlink:href="vrts-20240331.xsd#vrts_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_6ace0e8f-fcd8-4b82-981c-70b7ecf4d1ef" xlink:to="loc_vrts_TermLoanMember_8bbaddee-d3c8-4845-9ffa-182cec98d2a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_e58b6077-1541-495d-b4a7-db48ab0e5258" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_6ace0e8f-fcd8-4b82-981c-70b7ecf4d1ef" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_e58b6077-1541-495d-b4a7-db48ab0e5258" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_632e905e-a6b8-4730-acc4-ab165dad9f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_5e882453-dd91-4aac-b01f-8da2da9b12fd" xlink:to="loc_us-gaap_DebtInstrumentAxis_632e905e-a6b8-4730-acc4-ab165dad9f7f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_632e905e-a6b8-4730-acc4-ab165dad9f7f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_632e905e-a6b8-4730-acc4-ab165dad9f7f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_632e905e-a6b8-4730-acc4-ab165dad9f7f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9032349a-8ec3-4b8b-a5e5-2a5374b2e296" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_632e905e-a6b8-4730-acc4-ab165dad9f7f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9032349a-8ec3-4b8b-a5e5-2a5374b2e296" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_CreditAgreementMember_552ee7c2-88e6-43b7-8b64-67e3e972be9e" xlink:href="vrts-20240331.xsd#vrts_CreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9032349a-8ec3-4b8b-a5e5-2a5374b2e296" xlink:to="loc_vrts_CreditAgreementMember_552ee7c2-88e6-43b7-8b64-67e3e972be9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_CreditFacility2017Member_07b577af-5c20-49b6-9216-df1c3db7fcd8" xlink:href="vrts-20240331.xsd#vrts_CreditFacility2017Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9032349a-8ec3-4b8b-a5e5-2a5374b2e296" xlink:to="loc_vrts_CreditFacility2017Member_07b577af-5c20-49b6-9216-df1c3db7fcd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_6450710c-848c-4fcd-b076-aefdcb843f23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_5e882453-dd91-4aac-b01f-8da2da9b12fd" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_6450710c-848c-4fcd-b076-aefdcb843f23" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6450710c-848c-4fcd-b076-aefdcb843f23_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6450710c-848c-4fcd-b076-aefdcb843f23" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6450710c-848c-4fcd-b076-aefdcb843f23_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_808105f1-6cad-4025-a268-1aa3e6570846" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6450710c-848c-4fcd-b076-aefdcb843f23" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_808105f1-6cad-4025-a268-1aa3e6570846" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_f0365c2a-643f-46b7-ba7a-a01d9f22eb3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_808105f1-6cad-4025-a268-1aa3e6570846" xlink:to="loc_us-gaap_SecuredDebtMember_f0365c2a-643f-46b7-ba7a-a01d9f22eb3c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c0a0eb6d-b6ca-436a-9e8c-f0cdfe450012" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_821eb040-e7c1-4264-b13d-c6b78d04c588" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c0a0eb6d-b6ca-436a-9e8c-f0cdfe450012" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_2840740a-1345-4ed2-a101-e968ae5ddd74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_821eb040-e7c1-4264-b13d-c6b78d04c588" xlink:to="loc_us-gaap_DebtInstrumentTerm_2840740a-1345-4ed2-a101-e968ae5ddd74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_8a8f9149-030e-42f8-8aec-312506b935fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_821eb040-e7c1-4264-b13d-c6b78d04c588" xlink:to="loc_us-gaap_RepaymentsOfDebt_8a8f9149-030e-42f8-8aec-312506b935fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_5185ad0a-99f3-45d6-9758-cc1e10e168ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_821eb040-e7c1-4264-b13d-c6b78d04c588" xlink:to="loc_us-gaap_LineOfCredit_5185ad0a-99f3-45d6-9758-cc1e10e168ce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_4487d16c-3861-41d0-9f8d-11d3b91b1676" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_821eb040-e7c1-4264-b13d-c6b78d04c588" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_4487d16c-3861-41d0-9f8d-11d3b91b1676" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.virtus.com/role/RedeemableNoncontrollingInterestsScheduleofRedeemableNoncontrollingInterestDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#RedeemableNoncontrollingInterestsScheduleofRedeemableNoncontrollingInterestDetails"/>
  <link:definitionLink xlink:role="http://www.virtus.com/role/RedeemableNoncontrollingInterestsScheduleofRedeemableNoncontrollingInterestDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_9a8951fa-6fad-4e1a-8682-5814996037bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_27093485-032f-4859-8b74-c8640d9b677f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MinorityInterestLineItems_9a8951fa-6fad-4e1a-8682-5814996037bd" xlink:to="loc_us-gaap_MinorityInterestTable_27093485-032f-4859-8b74-c8640d9b677f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_66982e35-9233-4953-89d4-156d8bfa06f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_27093485-032f-4859-8b74-c8640d9b677f" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_66982e35-9233-4953-89d4-156d8bfa06f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_66982e35-9233-4953-89d4-156d8bfa06f6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_66982e35-9233-4953-89d4-156d8bfa06f6" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_66982e35-9233-4953-89d4-156d8bfa06f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_2bb0301f-d019-463b-a46d-27d4cf5d94d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_66982e35-9233-4953-89d4-156d8bfa06f6" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_2bb0301f-d019-463b-a46d-27d4cf5d94d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_d633916a-e3ac-4cc2-a147-c0baafb87110" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_2bb0301f-d019-463b-a46d-27d4cf5d94d3" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_d633916a-e3ac-4cc2-a147-c0baafb87110" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_4e2b01de-50d7-43a2-bf8a-62fe93b80a92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_d633916a-e3ac-4cc2-a147-c0baafb87110" xlink:to="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_4e2b01de-50d7-43a2-bf8a-62fe93b80a92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_d3546dbc-49df-42c8-bdff-128514804bf8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_27093485-032f-4859-8b74-c8640d9b677f" xlink:to="loc_srt_ConsolidatedEntitiesAxis_d3546dbc-49df-42c8-bdff-128514804bf8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_d3546dbc-49df-42c8-bdff-128514804bf8_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_d3546dbc-49df-42c8-bdff-128514804bf8" xlink:to="loc_srt_ConsolidatedEntitiesDomain_d3546dbc-49df-42c8-bdff-128514804bf8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_eda8aa1b-4099-4029-a15e-fe41d6d5058f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_d3546dbc-49df-42c8-bdff-128514804bf8" xlink:to="loc_srt_ConsolidatedEntitiesDomain_eda8aa1b-4099-4029-a15e-fe41d6d5058f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember_28602150-0e56-471d-9a88-8b725a6c2f93" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_eda8aa1b-4099-4029-a15e-fe41d6d5058f" xlink:to="loc_vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember_28602150-0e56-471d-9a88-8b725a6c2f93" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_ab0900a7-bf90-4bb7-b371-f2c523392157" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AffiliatedEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_eda8aa1b-4099-4029-a15e-fe41d6d5058f" xlink:to="loc_srt_AffiliatedEntityMember_ab0900a7-bf90-4bb7-b371-f2c523392157" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_30fd3af4-2cf0-4205-8bb6-188d98fb6f27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_9a8951fa-6fad-4e1a-8682-5814996037bd" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_30fd3af4-2cf0-4205-8bb6-188d98fb6f27" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue_b7578777-3ddb-48bf-9860-61e1a1c214cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_30fd3af4-2cf0-4205-8bb6-188d98fb6f27" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue_b7578777-3ddb-48bf-9860-61e1a1c214cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_fa221128-be2b-45fe-8ce5-e0b2aedaec8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_30fd3af4-2cf0-4205-8bb6-188d98fb6f27" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_fa221128-be2b-45fe-8ce5-e0b2aedaec8f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue_4f43228f-561f-4495-a10d-5e90ceb90fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestChangeInRedemptionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_30fd3af4-2cf0-4205-8bb6-188d98fb6f27" xlink:to="loc_us-gaap_MinorityInterestChangeInRedemptionValue_4f43228f-561f-4495-a10d-5e90ceb90fdb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_30de04f2-def9-4daa-b409-7b6e5f31a81b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_30fd3af4-2cf0-4205-8bb6-188d98fb6f27" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_30de04f2-def9-4daa-b409-7b6e5f31a81b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_c061ebd3-32cc-46f2-af71-43a8990729f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_30fd3af4-2cf0-4205-8bb6-188d98fb6f27" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_c061ebd3-32cc-46f2-af71-43a8990729f5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_NoncontrollingInterestSubscriptionsRedemptionsAndOther_acbc6975-ddd2-4f14-b74e-f6a3360e9773" xlink:href="vrts-20240331.xsd#vrts_NoncontrollingInterestSubscriptionsRedemptionsAndOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_30fd3af4-2cf0-4205-8bb6-188d98fb6f27" xlink:to="loc_vrts_NoncontrollingInterestSubscriptionsRedemptionsAndOther_acbc6975-ddd2-4f14-b74e-f6a3360e9773" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue_8da86360-d710-4c6d-9d7e-8616e962871f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.virtus.com/role/ConsolidationCondensedConsolidatedBalanceSheetsDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#ConsolidationCondensedConsolidatedBalanceSheetsDetails"/>
  <link:definitionLink xlink:role="http://www.virtus.com/role/ConsolidationCondensedConsolidatedBalanceSheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_6bff1813-d2f1-432a-99bc-59b5fb35aaa4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_10280f7e-f551-4523-bcbd-de1a25823b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_6bff1813-d2f1-432a-99bc-59b5fb35aaa4" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_10280f7e-f551-4523-bcbd-de1a25823b9d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_b843559b-43d7-423c-9ee4-6f3bd43b1a7b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_10280f7e-f551-4523-bcbd-de1a25823b9d" xlink:to="loc_srt_ConsolidatedEntitiesAxis_b843559b-43d7-423c-9ee4-6f3bd43b1a7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_b843559b-43d7-423c-9ee4-6f3bd43b1a7b_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_b843559b-43d7-423c-9ee4-6f3bd43b1a7b" xlink:to="loc_srt_ConsolidatedEntitiesDomain_b843559b-43d7-423c-9ee4-6f3bd43b1a7b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_7bc71751-9b34-493f-9e00-3d0f3f97adb0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_b843559b-43d7-423c-9ee4-6f3bd43b1a7b" xlink:to="loc_srt_ConsolidatedEntitiesDomain_7bc71751-9b34-493f-9e00-3d0f3f97adb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VotingInterestEntityVOEMember_8fd0d425-e047-4a75-837c-19fd425d18b0" xlink:href="vrts-20240331.xsd#vrts_VotingInterestEntityVOEMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_7bc71751-9b34-493f-9e00-3d0f3f97adb0" xlink:to="loc_vrts_VotingInterestEntityVOEMember_8fd0d425-e047-4a75-837c-19fd425d18b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember_eb003950-5bc7-4956-a2ee-ab0c54b112fa" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_7bc71751-9b34-493f-9e00-3d0f3f97adb0" xlink:to="loc_vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember_eb003950-5bc7-4956-a2ee-ab0c54b112fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityPrimaryBeneficiaryGlobalAndPrivateFundsMember_f79ce885-962c-46b8-89d4-f240224e038f" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityPrimaryBeneficiaryGlobalAndPrivateFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_7bc71751-9b34-493f-9e00-3d0f3f97adb0" xlink:to="loc_vrts_VariableInterestEntityPrimaryBeneficiaryGlobalAndPrivateFundsMember_f79ce885-962c-46b8-89d4-f240224e038f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_29abf073-4a0a-4a54-babf-5bedcccc9cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_6bff1813-d2f1-432a-99bc-59b5fb35aaa4" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_29abf073-4a0a-4a54-babf-5bedcccc9cdc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_130aa508-a064-4383-b5ab-47e26b3753cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Investments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_6bff1813-d2f1-432a-99bc-59b5fb35aaa4" xlink:to="loc_us-gaap_Investments_130aa508-a064-4383-b5ab-47e26b3753cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets_58f6b6b3-3abe-492c-858b-4c5bddc13839" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_6bff1813-d2f1-432a-99bc-59b5fb35aaa4" xlink:to="loc_us-gaap_OtherAssets_58f6b6b3-3abe-492c-858b-4c5bddc13839" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayable_c161ca0f-77eb-46d5-a710-949cddf682d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_6bff1813-d2f1-432a-99bc-59b5fb35aaa4" xlink:to="loc_us-gaap_NotesPayable_c161ca0f-77eb-46d5-a710-949cddf682d7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_SecuritiesPurchasedPayable_e8e6e57b-735a-4d09-8b42-002a4c1f1b6c" xlink:href="vrts-20240331.xsd#vrts_SecuritiesPurchasedPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_6bff1813-d2f1-432a-99bc-59b5fb35aaa4" xlink:to="loc_vrts_SecuritiesPurchasedPayable_e8e6e57b-735a-4d09-8b42-002a4c1f1b6c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_7fa46cc7-7bec-480a-bdba-af3d3ac51c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_6bff1813-d2f1-432a-99bc-59b5fb35aaa4" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_7fa46cc7-7bec-480a-bdba-af3d3ac51c2b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_NetInterestInInvestmentProducts_5e6f782e-047e-40e7-96c8-6eb5e151152b" xlink:href="vrts-20240331.xsd#vrts_NetInterestInInvestmentProducts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_6bff1813-d2f1-432a-99bc-59b5fb35aaa4" xlink:to="loc_vrts_NetInterestInInvestmentProducts_5e6f782e-047e-40e7-96c8-6eb5e151152b" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.virtus.com/role/ConsolidationAdditionalInformationDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#ConsolidationAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.virtus.com/role/ConsolidationAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_ac19caee-cdff-4675-9f42-dfac0d0aafcb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fa2c5b9d-c873-461c-9fac-8ff4ad7eee29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_ac19caee-cdff-4675-9f42-dfac0d0aafcb" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fa2c5b9d-c873-461c-9fac-8ff4ad7eee29" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_9ba9508c-797b-4fb9-8a83-6ceeee47afc5" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fa2c5b9d-c873-461c-9fac-8ff4ad7eee29" xlink:to="loc_srt_ConsolidatedEntitiesAxis_9ba9508c-797b-4fb9-8a83-6ceeee47afc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_9ba9508c-797b-4fb9-8a83-6ceeee47afc5_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_9ba9508c-797b-4fb9-8a83-6ceeee47afc5" xlink:to="loc_srt_ConsolidatedEntitiesDomain_9ba9508c-797b-4fb9-8a83-6ceeee47afc5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_d94ec4cd-1cec-4cd8-ba10-8be50cb73ba4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_9ba9508c-797b-4fb9-8a83-6ceeee47afc5" xlink:to="loc_srt_ConsolidatedEntitiesDomain_d94ec4cd-1cec-4cd8-ba10-8be50cb73ba4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember_92b94ac2-f646-45fc-8cf0-595ff6e1685e" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_d94ec4cd-1cec-4cd8-ba10-8be50cb73ba4" xlink:to="loc_vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember_92b94ac2-f646-45fc-8cf0-595ff6e1685e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_48d38332-11f8-4e7d-917b-355c62d51f1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_d94ec4cd-1cec-4cd8-ba10-8be50cb73ba4" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_48d38332-11f8-4e7d-917b-355c62d51f1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_787957c4-364d-4627-9fa6-9d1dbb411081" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fa2c5b9d-c873-461c-9fac-8ff4ad7eee29" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_787957c4-364d-4627-9fa6-9d1dbb411081" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_787957c4-364d-4627-9fa6-9d1dbb411081_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_787957c4-364d-4627-9fa6-9d1dbb411081" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_787957c4-364d-4627-9fa6-9d1dbb411081_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d4120f9b-53d4-48ac-9d29-af47e27b7bf4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_787957c4-364d-4627-9fa6-9d1dbb411081" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d4120f9b-53d4-48ac-9d29-af47e27b7bf4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_9eed2313-843c-4f58-8d3f-4b823616c517" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d4120f9b-53d4-48ac-9d29-af47e27b7bf4" xlink:to="loc_us-gaap_SeniorNotesMember_9eed2313-843c-4f58-8d3f-4b823616c517" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubordinatedDebtMember_2aaab144-7654-4ced-b5f8-7fc7fd423dea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubordinatedDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d4120f9b-53d4-48ac-9d29-af47e27b7bf4" xlink:to="loc_us-gaap_SubordinatedDebtMember_2aaab144-7654-4ced-b5f8-7fc7fd423dea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_edff61c5-bcb9-4599-919f-f59edba48887" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fa2c5b9d-c873-461c-9fac-8ff4ad7eee29" xlink:to="loc_us-gaap_DebtInstrumentAxis_edff61c5-bcb9-4599-919f-f59edba48887" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_edff61c5-bcb9-4599-919f-f59edba48887_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_edff61c5-bcb9-4599-919f-f59edba48887" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_edff61c5-bcb9-4599-919f-f59edba48887_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ea816c64-843e-484c-a974-e66b7c9b0aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_edff61c5-bcb9-4599-919f-f59edba48887" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ea816c64-843e-484c-a974-e66b7c9b0aa9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_SubordinatedNotesNewfleetCLO20161Member_60efaa6f-6d02-451e-a430-225c92773580" xlink:href="vrts-20240331.xsd#vrts_SubordinatedNotesNewfleetCLO20161Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ea816c64-843e-484c-a974-e66b7c9b0aa9" xlink:to="loc_vrts_SubordinatedNotesNewfleetCLO20161Member_60efaa6f-6d02-451e-a430-225c92773580" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_SeniorSecuredFloatingRateNotesNewfleetCLO20161Member_4816b4a2-89f2-4523-979b-4e28f1398ea9" xlink:href="vrts-20240331.xsd#vrts_SeniorSecuredFloatingRateNotesNewfleetCLO20161Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ea816c64-843e-484c-a974-e66b7c9b0aa9" xlink:to="loc_vrts_SeniorSecuredFloatingRateNotesNewfleetCLO20161Member_4816b4a2-89f2-4523-979b-4e28f1398ea9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fbecb3f2-44bd-4dc4-acca-07fe816ece99" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fa2c5b9d-c873-461c-9fac-8ff4ad7eee29" xlink:to="loc_srt_RangeAxis_fbecb3f2-44bd-4dc4-acca-07fe816ece99" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fbecb3f2-44bd-4dc4-acca-07fe816ece99_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_fbecb3f2-44bd-4dc4-acca-07fe816ece99" xlink:to="loc_srt_RangeMember_fbecb3f2-44bd-4dc4-acca-07fe816ece99_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4584029d-9003-4e44-97a7-f65261b4509a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_fbecb3f2-44bd-4dc4-acca-07fe816ece99" xlink:to="loc_srt_RangeMember_4584029d-9003-4e44-97a7-f65261b4509a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_770d6c10-dbf3-417a-baaa-beb1a4ef6cd4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4584029d-9003-4e44-97a7-f65261b4509a" xlink:to="loc_srt_MinimumMember_770d6c10-dbf3-417a-baaa-beb1a4ef6cd4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_802de47f-7aeb-4757-b1b0-e8e0730e0bfd" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4584029d-9003-4e44-97a7-f65261b4509a" xlink:to="loc_srt_MaximumMember_802de47f-7aeb-4757-b1b0-e8e0730e0bfd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_NumberofCollateralizedLoanObligationsConsolidated_09d09266-071c-4a97-91f2-fbc59a594c53" xlink:href="vrts-20240331.xsd#vrts_NumberofCollateralizedLoanObligationsConsolidated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_ac19caee-cdff-4675-9f42-dfac0d0aafcb" xlink:to="loc_vrts_NumberofCollateralizedLoanObligationsConsolidated_09d09266-071c-4a97-91f2-fbc59a594c53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_61b3d0b2-9380-4c2b-8c68-9af26e55a8f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Investments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_ac19caee-cdff-4675-9f42-dfac0d0aafcb" xlink:to="loc_us-gaap_Investments_61b3d0b2-9380-4c2b-8c68-9af26e55a8f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_7b42b7ec-48c5-4aa7-aa95-a96c07682a24" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_ac19caee-cdff-4675-9f42-dfac0d0aafcb" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_7b42b7ec-48c5-4aa7-aa95-a96c07682a24" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_b28efbc6-2491-4162-9be2-bb2a9c73e63d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_ac19caee-cdff-4675-9f42-dfac0d0aafcb" xlink:to="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_b28efbc6-2491-4162-9be2-bb2a9c73e63d" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.virtus.com/role/ConsolidationBeneficialInterestsofConsolidatedInvestmentProductDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#ConsolidationBeneficialInterestsofConsolidatedInvestmentProductDetails"/>
  <link:definitionLink xlink:role="http://www.virtus.com/role/ConsolidationBeneficialInterestsofConsolidatedInvestmentProductDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_eed02d72-5476-4947-b1fc-b405c09ff793" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_a87a6b10-b270-44b0-93ad-4bc0feb654ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_eed02d72-5476-4947-b1fc-b405c09ff793" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_a87a6b10-b270-44b0-93ad-4bc0feb654ac" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_5f7d6953-0904-429b-b76c-e2f202c91ae5" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_a87a6b10-b270-44b0-93ad-4bc0feb654ac" xlink:to="loc_srt_ConsolidatedEntitiesAxis_5f7d6953-0904-429b-b76c-e2f202c91ae5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_5f7d6953-0904-429b-b76c-e2f202c91ae5_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_5f7d6953-0904-429b-b76c-e2f202c91ae5" xlink:to="loc_srt_ConsolidatedEntitiesDomain_5f7d6953-0904-429b-b76c-e2f202c91ae5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_7fa66ada-e49f-421b-8ae5-921d3a439b7a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_5f7d6953-0904-429b-b76c-e2f202c91ae5" xlink:to="loc_srt_ConsolidatedEntitiesDomain_7fa66ada-e49f-421b-8ae5-921d3a439b7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember_0d8d56df-7be5-42d7-bc10-97821a4e8b6b" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_7fa66ada-e49f-421b-8ae5-921d3a439b7a" xlink:to="loc_vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember_0d8d56df-7be5-42d7-bc10-97821a4e8b6b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsSubordinatedDebtAmount_77bcc746-2807-4dbd-b29e-78964b1153ac" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsSubordinatedDebtAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_eed02d72-5476-4947-b1fc-b405c09ff793" xlink:to="loc_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsSubordinatedDebtAmount_77bcc746-2807-4dbd-b29e-78964b1153ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsDeferredRevenueAmount_776344b2-9330-4fd5-adb4-3d8282aee881" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsDeferredRevenueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_eed02d72-5476-4947-b1fc-b405c09ff793" xlink:to="loc_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsDeferredRevenueAmount_776344b2-9330-4fd5-adb4-3d8282aee881" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsAmount_14b2c4bc-479b-4989-810f-4bf0904a672a" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_eed02d72-5476-4947-b1fc-b405c09ff793" xlink:to="loc_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsAmount_14b2c4bc-479b-4989-810f-4bf0904a672a" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.virtus.com/role/ConsolidationRevenueandExpensesofConsolidatedInvestmentProductDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#ConsolidationRevenueandExpensesofConsolidatedInvestmentProductDetails"/>
  <link:definitionLink xlink:role="http://www.virtus.com/role/ConsolidationRevenueandExpensesofConsolidatedInvestmentProductDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_ecccdbe2-e6bf-49cb-b198-4f640176c960" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_76c9f21e-34ca-4ea8-9344-f41751357a2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_ecccdbe2-e6bf-49cb-b198-4f640176c960" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_76c9f21e-34ca-4ea8-9344-f41751357a2e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_98b70693-daae-421a-bfb8-e89e3e600db2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_76c9f21e-34ca-4ea8-9344-f41751357a2e" xlink:to="loc_srt_ConsolidatedEntitiesAxis_98b70693-daae-421a-bfb8-e89e3e600db2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_98b70693-daae-421a-bfb8-e89e3e600db2_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_98b70693-daae-421a-bfb8-e89e3e600db2" xlink:to="loc_srt_ConsolidatedEntitiesDomain_98b70693-daae-421a-bfb8-e89e3e600db2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_6c6d4513-4411-4a8c-b152-fb6aa647719b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_98b70693-daae-421a-bfb8-e89e3e600db2" xlink:to="loc_srt_ConsolidatedEntitiesDomain_6c6d4513-4411-4a8c-b152-fb6aa647719b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember_cffd591b-829a-48f3-bc27-1e60714eb9eb" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_6c6d4513-4411-4a8c-b152-fb6aa647719b" xlink:to="loc_vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember_cffd591b-829a-48f3-bc27-1e60714eb9eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_d90de450-6b91-4a35-aa53-de8efe16979e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_ecccdbe2-e6bf-49cb-b198-4f640176c960" xlink:to="loc_us-gaap_RevenuesAbstract_d90de450-6b91-4a35-aa53-de8efe16979e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_fc07a455-344c-4e32-ab74-d7ecb995cd29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_d90de450-6b91-4a35-aa53-de8efe16979e" xlink:to="loc_us-gaap_GainLossOnInvestments_fc07a455-344c-4e32-ab74-d7ecb995cd29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_c4c8a813-cf3e-4d06-97c8-0aa63b862d84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_d90de450-6b91-4a35-aa53-de8efe16979e" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_c4c8a813-cf3e-4d06-97c8-0aa63b862d84" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_133334ce-1d5e-47ef-9a2f-66d757620287" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_d90de450-6b91-4a35-aa53-de8efe16979e" xlink:to="loc_us-gaap_Revenues_133334ce-1d5e-47ef-9a2f-66d757620287" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_ExpensesAbstract_dabf9b6c-f8ab-41ff-be69-a40ff46c0481" xlink:href="vrts-20240331.xsd#vrts_ExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_ecccdbe2-e6bf-49cb-b198-4f640176c960" xlink:to="loc_vrts_ExpensesAbstract_dabf9b6c-f8ab-41ff-be69-a40ff46c0481" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating_073f13d0-ffda-40e3-aaf1-647f15407d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vrts_ExpensesAbstract_dabf9b6c-f8ab-41ff-be69-a40ff46c0481" xlink:to="loc_us-gaap_OtherCostAndExpenseOperating_073f13d0-ffda-40e3-aaf1-647f15407d0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_dfa31d21-3d8e-406c-8812-c083ce98b40b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vrts_ExpensesAbstract_dabf9b6c-f8ab-41ff-be69-a40ff46c0481" xlink:to="loc_us-gaap_InterestExpense_dfa31d21-3d8e-406c-8812-c083ce98b40b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_OperatingandNonoperatingExpense_27e5ad09-4e7b-4603-b1b1-ce6853aca5e7" xlink:href="vrts-20240331.xsd#vrts_OperatingandNonoperatingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vrts_ExpensesAbstract_dabf9b6c-f8ab-41ff-be69-a40ff46c0481" xlink:to="loc_vrts_OperatingandNonoperatingExpense_27e5ad09-4e7b-4603-b1b1-ce6853aca5e7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_41a05605-cda7-4aa6-be82-5b6f3a1101b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_ecccdbe2-e6bf-49cb-b198-4f640176c960" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_41a05605-cda7-4aa6-be82-5b6f3a1101b4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_0fa9d7da-e87d-47df-b934-4c18d5d119f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_ecccdbe2-e6bf-49cb-b198-4f640176c960" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_0fa9d7da-e87d-47df-b934-4c18d5d119f6" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.virtus.com/role/ConsolidationEconomicInterestsofConsolidatedInvestmentProductDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#ConsolidationEconomicInterestsofConsolidatedInvestmentProductDetails"/>
  <link:definitionLink xlink:role="http://www.virtus.com/role/ConsolidationEconomicInterestsofConsolidatedInvestmentProductDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_fab03f65-6ac6-41e6-9ed1-16081a6ba5a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_3547549c-891b-4c88-a47a-2528b9a4072a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_fab03f65-6ac6-41e6-9ed1-16081a6ba5a2" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_3547549c-891b-4c88-a47a-2528b9a4072a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_3a0f9e9d-1d72-4998-9056-3433a212f93c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_3547549c-891b-4c88-a47a-2528b9a4072a" xlink:to="loc_srt_ConsolidatedEntitiesAxis_3a0f9e9d-1d72-4998-9056-3433a212f93c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_3a0f9e9d-1d72-4998-9056-3433a212f93c_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_3a0f9e9d-1d72-4998-9056-3433a212f93c" xlink:to="loc_srt_ConsolidatedEntitiesDomain_3a0f9e9d-1d72-4998-9056-3433a212f93c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_3e544693-8d4d-4026-87d8-a6735c8c89fe" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_3a0f9e9d-1d72-4998-9056-3433a212f93c" xlink:to="loc_srt_ConsolidatedEntitiesDomain_3e544693-8d4d-4026-87d8-a6735c8c89fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember_b7046915-2384-454d-9e55-84732a9fccbe" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_3e544693-8d4d-4026-87d8-a6735c8c89fe" xlink:to="loc_vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember_b7046915-2384-454d-9e55-84732a9fccbe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityMeasureofActivityDistributionsReceivedandUnrealizedGainsLossesOnInvestment_957e09fe-fd56-4004-b074-3e7fe3a3476b" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityMeasureofActivityDistributionsReceivedandUnrealizedGainsLossesOnInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_fab03f65-6ac6-41e6-9ed1-16081a6ba5a2" xlink:to="loc_vrts_VariableInterestEntityMeasureofActivityDistributionsReceivedandUnrealizedGainsLossesOnInvestment_957e09fe-fd56-4004-b074-3e7fe3a3476b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_bc8ee9ce-c03b-436a-a680-a0ed4ec4e5bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_fab03f65-6ac6-41e6-9ed1-16081a6ba5a2" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_bc8ee9ce-c03b-436a-a680-a0ed4ec4e5bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_0755743a-b513-4fca-8860-bd8682186635" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_fab03f65-6ac6-41e6-9ed1-16081a6ba5a2" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_0755743a-b513-4fca-8860-bd8682186635" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.virtus.com/role/ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.virtus.com/role/ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3dda0b0c-1f15-4858-b33f-190da4512e95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_875cefc4-56af-463e-9787-c39da692f6ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3dda0b0c-1f15-4858-b33f-190da4512e95" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_875cefc4-56af-463e-9787-c39da692f6ad" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_afd12146-1d8a-4f3a-bad0-a34bb892e8e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_875cefc4-56af-463e-9787-c39da692f6ad" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_afd12146-1d8a-4f3a-bad0-a34bb892e8e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_afd12146-1d8a-4f3a-bad0-a34bb892e8e1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_afd12146-1d8a-4f3a-bad0-a34bb892e8e1" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_afd12146-1d8a-4f3a-bad0-a34bb892e8e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_c66d0033-f1a7-4d90-ac85-7b45ce2a621d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_afd12146-1d8a-4f3a-bad0-a34bb892e8e1" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_c66d0033-f1a7-4d90-ac85-7b45ce2a621d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_22ce05e4-7adc-4af8-8742-4698215358d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_c66d0033-f1a7-4d90-ac85-7b45ce2a621d" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_22ce05e4-7adc-4af8-8742-4698215358d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_42aab79c-4c77-4bb3-a350-344817ad9537" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_875cefc4-56af-463e-9787-c39da692f6ad" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_42aab79c-4c77-4bb3-a350-344817ad9537" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_42aab79c-4c77-4bb3-a350-344817ad9537_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_42aab79c-4c77-4bb3-a350-344817ad9537" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_42aab79c-4c77-4bb3-a350-344817ad9537_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e7b8bdea-2230-4b12-b2a2-56e43bce06ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_42aab79c-4c77-4bb3-a350-344817ad9537" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e7b8bdea-2230-4b12-b2a2-56e43bce06ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_d0903300-1cba-4146-812e-b0bd49e938c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e7b8bdea-2230-4b12-b2a2-56e43bce06ff" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_d0903300-1cba-4146-812e-b0bd49e938c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_03ca7bb3-d421-4bae-b92a-42cd198e9111" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e7b8bdea-2230-4b12-b2a2-56e43bce06ff" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_03ca7bb3-d421-4bae-b92a-42cd198e9111" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_c6ac0b21-ea51-4767-b9b3-d34dd1993f62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e7b8bdea-2230-4b12-b2a2-56e43bce06ff" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_c6ac0b21-ea51-4767-b9b3-d34dd1993f62" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_30067ec6-0189-4962-b2de-5fefcd5cc878" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_875cefc4-56af-463e-9787-c39da692f6ad" xlink:to="loc_us-gaap_FinancialInstrumentAxis_30067ec6-0189-4962-b2de-5fefcd5cc878" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_30067ec6-0189-4962-b2de-5fefcd5cc878_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_30067ec6-0189-4962-b2de-5fefcd5cc878" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_30067ec6-0189-4962-b2de-5fefcd5cc878_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_00a4d401-4c1e-451b-8a91-06a719170152" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_30067ec6-0189-4962-b2de-5fefcd5cc878" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_00a4d401-4c1e-451b-8a91-06a719170152" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_de6fb117-64df-430d-9af5-200ab6bc4f45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_00a4d401-4c1e-451b-8a91-06a719170152" xlink:to="loc_us-gaap_DebtSecuritiesMember_de6fb117-64df-430d-9af5-200ab6bc4f45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_36d93fa9-0e83-4b8c-b0d2-4250f3776e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_00a4d401-4c1e-451b-8a91-06a719170152" xlink:to="loc_us-gaap_EquitySecuritiesMember_36d93fa9-0e83-4b8c-b0d2-4250f3776e5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_26c7ffef-2a19-453a-ae55-b8af14a3924d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_875cefc4-56af-463e-9787-c39da692f6ad" xlink:to="loc_srt_ConsolidatedEntitiesAxis_26c7ffef-2a19-453a-ae55-b8af14a3924d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_26c7ffef-2a19-453a-ae55-b8af14a3924d_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_26c7ffef-2a19-453a-ae55-b8af14a3924d" xlink:to="loc_srt_ConsolidatedEntitiesDomain_26c7ffef-2a19-453a-ae55-b8af14a3924d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_5eacf2bb-0231-4a39-90b2-b216d7f93b91" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_26c7ffef-2a19-453a-ae55-b8af14a3924d" xlink:to="loc_srt_ConsolidatedEntitiesDomain_5eacf2bb-0231-4a39-90b2-b216d7f93b91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember_ff14afbb-633d-431b-acca-2fdac69fb10a" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_5eacf2bb-0231-4a39-90b2-b216d7f93b91" xlink:to="loc_vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember_ff14afbb-633d-431b-acca-2fdac69fb10a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_1a4ed2e2-bfb8-47c5-9911-c53e2d100089" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3dda0b0c-1f15-4858-b33f-190da4512e95" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_1a4ed2e2-bfb8-47c5-9911-c53e2d100089" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_a5f88951-4553-41b0-9ce7-a7f389836142" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_1a4ed2e2-bfb8-47c5-9911-c53e2d100089" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_a5f88951-4553-41b0-9ce7-a7f389836142" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_6489bf69-f6a0-4966-8601-229c771982d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_1a4ed2e2-bfb8-47c5-9911-c53e2d100089" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_6489bf69-f6a0-4966-8601-229c771982d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_03d322e3-ef92-4e39-adcc-7b1a4d178828" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_1a4ed2e2-bfb8-47c5-9911-c53e2d100089" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_03d322e3-ef92-4e39-adcc-7b1a4d178828" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_9d625d1d-d6b4-4ca5-838f-b0f303f28116" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3dda0b0c-1f15-4858-b33f-190da4512e95" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_9d625d1d-d6b4-4ca5-838f-b0f303f28116" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableFairValueDisclosure_ef372912-c219-4911-a950-585b2dca34e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_9d625d1d-d6b4-4ca5-838f-b0f303f28116" xlink:to="loc_us-gaap_NotesPayableFairValueDisclosure_ef372912-c219-4911-a950-585b2dca34e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsSoldNotYetPurchasedAtFairValue_4b5fdec7-deea-42ad-9022-770f79ab672a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsSoldNotYetPurchasedAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_9d625d1d-d6b4-4ca5-838f-b0f303f28116" xlink:to="loc_us-gaap_FinancialInstrumentsSoldNotYetPurchasedAtFairValue_4b5fdec7-deea-42ad-9022-770f79ab672a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_b8f4d55b-f0fd-4b35-80b3-c3a0376bf213" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_9d625d1d-d6b4-4ca5-838f-b0f303f28116" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_b8f4d55b-f0fd-4b35-80b3-c3a0376bf213" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.virtus.com/role/ConsolidationAssetsRelatedtoConsolidatedSponsoredInvestmentProductsUnobservableInputReconciliationDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#ConsolidationAssetsRelatedtoConsolidatedSponsoredInvestmentProductsUnobservableInputReconciliationDetails"/>
  <link:definitionLink xlink:role="http://www.virtus.com/role/ConsolidationAssetsRelatedtoConsolidatedSponsoredInvestmentProductsUnobservableInputReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_b8b91211-7dbb-4620-87aa-a64ca6ef552f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_83bee653-48e7-4f80-af3b-c9bf0a1e2a19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_b8b91211-7dbb-4620-87aa-a64ca6ef552f" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_83bee653-48e7-4f80-af3b-c9bf0a1e2a19" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_6b235187-016d-4e8b-a32f-2394eb1d12cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_83bee653-48e7-4f80-af3b-c9bf0a1e2a19" xlink:to="loc_us-gaap_FinancialInstrumentAxis_6b235187-016d-4e8b-a32f-2394eb1d12cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6b235187-016d-4e8b-a32f-2394eb1d12cf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6b235187-016d-4e8b-a32f-2394eb1d12cf" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6b235187-016d-4e8b-a32f-2394eb1d12cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0e99a071-9a04-4235-9e1f-6b1e8c747b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6b235187-016d-4e8b-a32f-2394eb1d12cf" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0e99a071-9a04-4235-9e1f-6b1e8c747b6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_4d531cbb-ee72-48ba-a757-6d6e59cdd08e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0e99a071-9a04-4235-9e1f-6b1e8c747b6e" xlink:to="loc_us-gaap_DebtSecuritiesMember_4d531cbb-ee72-48ba-a757-6d6e59cdd08e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_95af5daa-aca5-4f01-8977-a5ea09e9f27e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_83bee653-48e7-4f80-af3b-c9bf0a1e2a19" xlink:to="loc_srt_ConsolidatedEntitiesAxis_95af5daa-aca5-4f01-8977-a5ea09e9f27e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_95af5daa-aca5-4f01-8977-a5ea09e9f27e_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_95af5daa-aca5-4f01-8977-a5ea09e9f27e" xlink:to="loc_srt_ConsolidatedEntitiesDomain_95af5daa-aca5-4f01-8977-a5ea09e9f27e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_9fc5ee3d-1779-4435-b1e3-2f0d7f35cf3e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_95af5daa-aca5-4f01-8977-a5ea09e9f27e" xlink:to="loc_srt_ConsolidatedEntitiesDomain_9fc5ee3d-1779-4435-b1e3-2f0d7f35cf3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember_1cce9c5b-ed88-4691-9b99-5626c6d9b1e6" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_9fc5ee3d-1779-4435-b1e3-2f0d7f35cf3e" xlink:to="loc_vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember_1cce9c5b-ed88-4691-9b99-5626c6d9b1e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1caa43d9-8d1e-4dae-82cf-2c71878a3517" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_b8b91211-7dbb-4620-87aa-a64ca6ef552f" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1caa43d9-8d1e-4dae-82cf-2c71878a3517" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_07e34b82-6555-4f68-bbf7-bcd4ac36b839" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1caa43d9-8d1e-4dae-82cf-2c71878a3517" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_07e34b82-6555-4f68-bbf7-bcd4ac36b839" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_f3315c14-4661-4655-92d6-4a6f880e3ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1caa43d9-8d1e-4dae-82cf-2c71878a3517" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_f3315c14-4661-4655-92d6-4a6f880e3ba8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_47f1aebe-3413-418e-8bcd-45bf5d5e665f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1caa43d9-8d1e-4dae-82cf-2c71878a3517" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_47f1aebe-3413-418e-8bcd-45bf5d5e665f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_210d4b83-9db1-4ecb-a75a-9c21d433ae3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1caa43d9-8d1e-4dae-82cf-2c71878a3517" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_210d4b83-9db1-4ecb-a75a-9c21d433ae3d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_1625163e-111f-4f5e-918e-d8fb272709aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1caa43d9-8d1e-4dae-82cf-2c71878a3517" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_1625163e-111f-4f5e-918e-d8fb272709aa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_1d5af86c-2bb9-4ef1-8cce-594b6a0ddb05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1caa43d9-8d1e-4dae-82cf-2c71878a3517" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_1d5af86c-2bb9-4ef1-8cce-594b6a0ddb05" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_465b2e78-e750-4f73-8e48-a093e8ba5115" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardTypeOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_RestrictedStockUnitsRSUsPerformanceBasedMember_be55b034-b26e-4ee0-9f5f-e67e5811fa50" xlink:href="vrts-20240331.xsd#vrts_RestrictedStockUnitsRSUsPerformanceBasedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_vrts_RestrictedStockUnitsRSUsPerformanceBasedMember_be55b034-b26e-4ee0-9f5f-e67e5811fa50" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_PerformanceStockUnitsIncentiveMember_26059de2-fd83-456b-b9b5-0372b8bafc96" xlink:href="vrts-20240331.xsd#vrts_PerformanceStockUnitsIncentiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_vrts_PerformanceStockUnitsIncentiveMember_26059de2-fd83-456b-b9b5-0372b8bafc96" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_RestrictedStockUnitsandPerformanceSharesUnitsMember_f451bd53-8f8c-46b2-b314-1263e06f4f1c" xlink:href="vrts-20240331.xsd#vrts_RestrictedStockUnitsandPerformanceSharesUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_vrts_RestrictedStockUnitsandPerformanceSharesUnitsMember_f451bd53-8f8c-46b2-b314-1263e06f4f1c" xlink:type="arc" order="7"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>vrts-20240331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:571d5707-32d3-4d02-bf11-c9dc53da4569,g:f6b55787-7777-46c4-a428-e04c6c3401d1-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_RepaymentsOfOtherDebt_47be905d-a958-4cf6-b3ba-b624307f115e_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfOtherDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Payments on borrowings by CIP</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfOtherDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfOtherDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Other Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfOtherDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfOtherDebt" xlink:to="lab_us-gaap_RepaymentsOfOtherDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_81d19cb3-a802-40c1-acab-70f404e7f599_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_743c8cd7-3081-4813-af82-110a83e09a35_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2e2e6660-e82c-4460-ad88-895107db8617_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_cd091f9b-750a-4c61-a449-232662430440_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_087261de-ab38-4bf8-b82c-e748fd5e225f_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7335fc34-5f70-451f-9e76-4f606fd4627f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue_b6165f08-ac10-495a-a428-f5c744c4796c_periodStartLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue_de3a266b-d7b7-4733-a37e-620848fab97a_periodEndLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Redemption Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_d4d76e10-68b1-41a0-bc2e-234e0a153082_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Sales</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06b3f0b2-5554-4588-9278-b27265437372_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0d46a65e-876f-4a82-aa66-e863bfe7fb86_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Number of shares, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_723f6830-5b29-4753-a3e8-0fc0b3b0eb04_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Number of shares, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_RetailSeparateAccountsMember_bdb33e1a-5e18-4b81-8741-2f0bae655844_terseLabel_en-US" xlink:label="lab_vrts_RetailSeparateAccountsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retail separate accounts</link:label>
    <link:label id="lab_vrts_RetailSeparateAccountsMember_label_en-US" xlink:label="lab_vrts_RetailSeparateAccountsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retail Separate Accounts [Member]</link:label>
    <link:label id="lab_vrts_RetailSeparateAccountsMember_documentation_en-US" xlink:label="lab_vrts_RetailSeparateAccountsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Retail Separate Accounts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_RetailSeparateAccountsMember" xlink:href="vrts-20240331.xsd#vrts_RetailSeparateAccountsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_RetailSeparateAccountsMember" xlink:to="lab_vrts_RetailSeparateAccountsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_3cc86086-06e5-4339-a243-a07a0f9f17d9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_NetInterestInInvestmentProducts_23b19386-4dc8-4751-8201-4c0339685616_totalLabel_en-US" xlink:label="lab_vrts_NetInterestInInvestmentProducts" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net interests in CIP</link:label>
    <link:label id="lab_vrts_NetInterestInInvestmentProducts_label_en-US" xlink:label="lab_vrts_NetInterestInInvestmentProducts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Interest In Investment Products</link:label>
    <link:label id="lab_vrts_NetInterestInInvestmentProducts_documentation_en-US" xlink:label="lab_vrts_NetInterestInInvestmentProducts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Net Interest in Investment Products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_NetInterestInInvestmentProducts" xlink:href="vrts-20240331.xsd#vrts_NetInterestInInvestmentProducts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_NetInterestInInvestmentProducts" xlink:to="lab_vrts_NetInterestInInvestmentProducts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_690322f3-a86e-4725-ab64-4a53df35cfcf_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_5512f29c-fd10-454d-9858-f3c07ac0e25f_terseLabel_en-US" xlink:label="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Marketable Securities</link:label>
    <link:label id="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_label_en-US" xlink:label="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:to="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_da22b825-70d7-42c6-8b24-7426e7507bdb_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revolving credit facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d94a4df4-4a9e-450a-892c-2f77dad12f97_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of exchange rate changes on cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_bc4e4ebd-9824-4961-ab6c-a8fcb617241d_negatedLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Transfers to Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_70e62bfe-1f68-4881-b311-0175a11ad7c9_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation adjustment, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_76122e6b-98d7-4bdf-ad66-71caeb8d13be_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sales of investments by CIP</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale of Securities, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities" xlink:to="lab_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_8d9e2475-c20c-4c3c-84a6-416e3ace20b6_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_81a1d400-5ef8-405e-b0cf-528a3d6a1328_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_d618b5f3-577c-4f25-8b60-838f36f89d5d_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other income (expense), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_0c67c3ef-298c-499a-920b-c9a8009cbed3_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies (Note 14)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_2e729dad-6bf1-4335-b6c3-c6b66f2da4e1_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_e5e1e779-c894-4276-90cd-4142a283f9ea_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Transactions</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_954501cf-b9b0-413a-a9c9-837b7b7879ca_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_6e19428c-77fe-40d9-820f-b4e4f6f17127_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubordinatedDebtMember_442510e1-2e6d-4c02-b5ca-6d77ab4fe59f_terseLabel_en-US" xlink:label="lab_us-gaap_SubordinatedDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subordinated Debt</link:label>
    <link:label id="lab_us-gaap_SubordinatedDebtMember_label_en-US" xlink:label="lab_us-gaap_SubordinatedDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subordinated Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubordinatedDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubordinatedDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubordinatedDebtMember" xlink:to="lab_us-gaap_SubordinatedDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_eff35778-748d-49ce-85bf-fcdc339d416c_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityLineItems" xlink:to="lab_us-gaap_VariableInterestEntityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestAbstract_4489eaca-028b-4302-95ee-0a1759a9d83d_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract" xlink:to="lab_us-gaap_NoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestTable_859075aa-8e77-4817-ab7c-648467608898_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestTable_label_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestTable" xlink:to="lab_us-gaap_MinorityInterestTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_03d0580d-202c-464d-b5a7-175869b98430_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_99f29377-0590-4bda-8b47-e057659093b5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Grant&#160;Date Fair&#160;Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_383208e9-4f39-4f4e-bd55-b2b05567cc56_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_f1f009ec-9b64-4e1d-86ca-e47b2f325a1c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payment of contingent consideration</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_597e48cf-af25-4ad7-aa0f-c34a4a3ae0bd_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Common stock dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_a710c5ff-cef5-421f-921f-67508c2cd5d2_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings (Loss) per Share&#8212;Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsTable_20c88a15-cb95-48ef-95e3-e1d7f47261eb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember_c25bad79-67fb-4eb9-9184-0b175deee119_terseLabel_en-US" xlink:label="lab_vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CLOs</link:label>
    <link:label id="lab_vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember_label_en-US" xlink:label="lab_vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary, Collateralized Loan Obligation [Member]</link:label>
    <link:label id="lab_vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember_documentation_en-US" xlink:label="lab_vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary, Collateralized Loan Obligation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember" xlink:to="lab_vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_1b8aa601-11fd-421e-ad44-5a05eb9f858a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level&#160;3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_34d7f73f-9076-4f4b-957b-7742f90ca25e_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_6a9639ec-c59c-4cf9-a47f-3b0e46a5b131_periodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period, treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_80a07825-0933-42cf-804a-adb777d503d3_periodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period, treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_a5a10795-71f5-4d25-ab8d-a7e55bccd97a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Income (Expense)</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_0ca216b1-237b-4de9-8318-77784717fb65_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_3ea92db7-10a5-4b02-9386-0a7707758a36_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchase of equity method investment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterestAndDividend_e2597693-dca5-4fba-9646-8c9d77dfc175_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest and dividend income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterestAndDividend_82e4f075-696a-4b8e-a8a8-4ce4a3b7d275_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterestAndDividend_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment Income, Interest and Dividend</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterestAndDividend" xlink:to="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_d2e6416f-b02d-48db-a3d8-6e93e5e2df06_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Income (Loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_0c664ee5-8f87-421c-ae91-3b679d059366_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt investments</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesMember" xlink:to="lab_us-gaap_DebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsAmount_a2c2973a-8a17-482f-8836-f6aa7a76fc4e_totalLabel_en-US" xlink:label="lab_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Beneficial Interests</link:label>
    <link:label id="lab_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsAmount_label_en-US" xlink:label="lab_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Interest Entity, Reporting Entity Involvement, Beneficial Interests, Amount</link:label>
    <link:label id="lab_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsAmount_documentation_en-US" xlink:label="lab_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Variable Interest Entity, Reporting Entity Involvement, Beneficial Interests, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsAmount" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsAmount" xlink:to="lab_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_4476214e-3606-4429-a20b-1afa010d5c5e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_95814ff3-0a6b-457a-a64d-a9dfc9a30d90_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_9ea3c3a5-d1bb-4c50-a56b-0b471dca570f_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock repurchased during period, value</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_fe86c58e-c443-4075-bc5f-bc36873baf5f_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity attributable to Virtus Investment Partners, Inc.:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_0d2e10d9-33a8-451a-a1c5-d0e963baa4ab_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Computation of Basic and Diluted Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_88fe3c28-f595-4b27-bf13-2be56738c4ee_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_NFJInvestmentGroupMember_2ea124c0-b1f8-4ab8-bfbd-181695a7158d_terseLabel_en-US" xlink:label="lab_vrts_NFJInvestmentGroupMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">NFJ Investment Group</link:label>
    <link:label id="lab_vrts_NFJInvestmentGroupMember_label_en-US" xlink:label="lab_vrts_NFJInvestmentGroupMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">NFJ Investment Group [Member]</link:label>
    <link:label id="lab_vrts_NFJInvestmentGroupMember_documentation_en-US" xlink:label="lab_vrts_NFJInvestmentGroupMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">NFJ Investment Group</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_NFJInvestmentGroupMember" xlink:href="vrts-20240331.xsd#vrts_NFJInvestmentGroupMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_NFJInvestmentGroupMember" xlink:to="lab_vrts_NFJInvestmentGroupMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_eedd30aa-070e-4524-915a-dea4f894cd1c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Realized (losses) gains on trading securities</link:label>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt and Equity Securities, Realized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtAndEquitySecuritiesRealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss" xlink:to="lab_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_479b274d-d05a-4d49-b39e-8ea9e83fa9fe_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Reconciliation of Assets of Consolidated Sponsored Investment Products For Level 3 Investments, Unobservable Inputs Used to Determine Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_11f38306-ceae-4897-84ba-141978df59a9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of&#160;Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_OtherIncomeAndfeesMember_32ff57c7-0f24-4f36-a23f-b7fbe30e5c0f_terseLabel_en-US" xlink:label="lab_vrts_OtherIncomeAndfeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other income and fees</link:label>
    <link:label id="lab_vrts_OtherIncomeAndfeesMember_label_en-US" xlink:label="lab_vrts_OtherIncomeAndfeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Income And fees [Member]</link:label>
    <link:label id="lab_vrts_OtherIncomeAndfeesMember_documentation_en-US" xlink:label="lab_vrts_OtherIncomeAndfeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Income And fees [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_OtherIncomeAndfeesMember" xlink:href="vrts-20240331.xsd#vrts_OtherIncomeAndfeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_OtherIncomeAndfeesMember" xlink:to="lab_vrts_OtherIncomeAndfeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_caa17cd4-0ee1-478d-8847-6c9d69138046_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level&#160;1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_77615283-10e5-46f9-9f24-c2559fd6757c_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_900b4428-452c-422e-995a-2ea37c684923_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2483d3af-a5e8-47c0-9b81-21d8d9dd6f8a_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_8427e3c8-1733-494c-9875-b99310e14389_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares of common stock available for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_e91d14b5-45f0-4f83-bbf9-da3adf8f148d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_38727b28-7417-449b-8d76-fad0b9d9c407_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_51e45bc5-bf3f-4000-98f1-4349d72206df_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_c1f2abe2-2273-4a6c-9342-15cf358ce901_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee-related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_5a6d4bb4-6fda-4cff-9dc6-460f1d18c7f3_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_6ac55f52-36db-4f35-afe5-5fd335ee3bfc_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_0026fff4-3160-4924-8251-98d4063109d4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_a808dd75-2226-4ba1-9c90-f5e1b75dc0f9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash dividends declared per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_7ebd72e6-1a5a-4cae-81bd-c8381602217e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_AdministrationAndShareholderServiceFeesMember_a570c321-fb49-4098-98d8-696292d4e5a5_terseLabel_en-US" xlink:label="lab_vrts_AdministrationAndShareholderServiceFeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Administration and shareholder service fees</link:label>
    <link:label id="lab_vrts_AdministrationAndShareholderServiceFeesMember_label_en-US" xlink:label="lab_vrts_AdministrationAndShareholderServiceFeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Administration And Shareholder Service Fees [Member]</link:label>
    <link:label id="lab_vrts_AdministrationAndShareholderServiceFeesMember_documentation_en-US" xlink:label="lab_vrts_AdministrationAndShareholderServiceFeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Administration And Shareholder Service Fees [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_AdministrationAndShareholderServiceFeesMember" xlink:href="vrts-20240331.xsd#vrts_AdministrationAndShareholderServiceFeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_AdministrationAndShareholderServiceFeesMember" xlink:to="lab_vrts_AdministrationAndShareholderServiceFeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_f823549a-7e09-4834-acfd-127d1061102c_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_cb47ab17-8be1-43b7-9a6c-b0763782ae25_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_2edf06cf-67a7-4eb6-a065-866278f113e2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Restricted Stock Units Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_f8ffa66a-54c9-44c1-90d9-af66955ecd1d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Term of debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_CreditAgreementMember_6eff88cd-c5bf-4466-ab4b-7efe8faf3e03_terseLabel_en-US" xlink:label="lab_vrts_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Agreement</link:label>
    <link:label id="lab_vrts_CreditAgreementMember_label_en-US" xlink:label="lab_vrts_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:label id="lab_vrts_CreditAgreementMember_documentation_en-US" xlink:label="lab_vrts_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_CreditAgreementMember" xlink:href="vrts-20240331.xsd#vrts_CreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_CreditAgreementMember" xlink:to="lab_vrts_CreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_0c05600b-e90e-4b80-8e0e-f8934ba50a24_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_9fc30cc2-fec8-4eb2-962e-0f28090d4e48_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_82accd5f-0d44-44b6-b867-3915e380c859_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1b7447e5-0574-4e71-8a0d-1af04da2160f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_d43b7eca-e996-49b5-9ee1-6096e91611b8_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_bdf581ef-2857-4bcd-ae0a-149aa050335c_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease_c3e3efe8-e448-4300-be1c-b4e0d46b9cc0_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net subscriptions (redemptions) and other</link:label>
    <link:label id="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:to="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_56a8c2a5-2e59-48d5-8005-7be26731ba6b_negatedLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Taxes paid on stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_StockBasedCompensationExpenseTableTextBlock_743b2867-3b17-4611-b376-b15924218c2c_terseLabel_en-US" xlink:label="lab_vrts_StockBasedCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock Based Compensation Expense</link:label>
    <link:label id="lab_vrts_StockBasedCompensationExpenseTableTextBlock_label_en-US" xlink:label="lab_vrts_StockBasedCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Based Compensation Expense [Table Text Block]</link:label>
    <link:label id="lab_vrts_StockBasedCompensationExpenseTableTextBlock_documentation_en-US" xlink:label="lab_vrts_StockBasedCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Based Compensation Expense Table [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_StockBasedCompensationExpenseTableTextBlock" xlink:href="vrts-20240331.xsd#vrts_StockBasedCompensationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_StockBasedCompensationExpenseTableTextBlock" xlink:to="lab_vrts_StockBasedCompensationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_3926ab6b-99a0-47c9-95c0-4d03f90f50fa_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Income</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_0ad59b66-6646-4f0c-aff8-1e91c225b9c7_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nonconsolidated VIEs</link:label>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation, Variable Interest Entity, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:to="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_SponsoredFundsMember_4eca21b7-a008-4989-b13a-28e6b953b514_terseLabel_en-US" xlink:label="lab_vrts_SponsoredFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sponsored funds</link:label>
    <link:label id="lab_vrts_SponsoredFundsMember_9c356aa8-2510-4652-ad3e-6611eb98c7c4_verboseLabel_en-US" xlink:label="lab_vrts_SponsoredFundsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Sponsored funds</link:label>
    <link:label id="lab_vrts_SponsoredFundsMember_label_en-US" xlink:label="lab_vrts_SponsoredFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sponsored Funds [Member]</link:label>
    <link:label id="lab_vrts_SponsoredFundsMember_documentation_en-US" xlink:label="lab_vrts_SponsoredFundsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sponsored Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_SponsoredFundsMember" xlink:href="vrts-20240331.xsd#vrts_SponsoredFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_SponsoredFundsMember" xlink:to="lab_vrts_SponsoredFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_0d8c2185-30d6-4c04-a3da-0415622bf995_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_43098082-ba8d-43f3-a011-92f78bb8509e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_c1aee19a-6acb-4a9d-8c4c-727b839c4104_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableFairValueDisclosure_4dcd2aaf-abba-4d4d-bdba-b2b3d3acc826_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes payable</link:label>
    <link:label id="lab_us-gaap_NotesPayableFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_NotesPayableFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Payable, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableFairValueDisclosure" xlink:to="lab_us-gaap_NotesPayableFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e16e223f-3f57-48e3-9e6d-f80868e64ae4_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total anti-dilutive securities (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_9b9fd80d-1725-45b1-8671-1c9406eeaf40_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e244c1ad-e631-4332-a6e7-facfc7858701_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares, granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_3e67a4d3-c69c-4410-9064-50db3c0420dc_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_85ca6cda-77b9-461d-8aa9-533489918edc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_5976cdb3-97de-49ce-8e30-431ef5547a49_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_acdb60b2-a0b1-4873-bf1e-747c0df6c567_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_edefbc94-be93-4e0d-894d-f3980fb252d8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares of common stock reserved for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_eb6698d7-864e-4040-9f14-d4fc66151498_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remainder of 2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_da689f2b-04ef-41a4-97e2-57b5d40c0d43_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business combination, contingent consideration, liability, measurement input</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_AlphaSimplexGroupLLCMember_a1d88622-2d91-450f-9729-361f0e100814_terseLabel_en-US" xlink:label="lab_vrts_AlphaSimplexGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AlphaSimplex Group, LLC</link:label>
    <link:label id="lab_vrts_AlphaSimplexGroupLLCMember_label_en-US" xlink:label="lab_vrts_AlphaSimplexGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AlphaSimplex Group, LLC [Member]</link:label>
    <link:label id="lab_vrts_AlphaSimplexGroupLLCMember_documentation_en-US" xlink:label="lab_vrts_AlphaSimplexGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">AlphaSimplex Group, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_AlphaSimplexGroupLLCMember" xlink:href="vrts-20240331.xsd#vrts_AlphaSimplexGroupLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_AlphaSimplexGroupLLCMember" xlink:to="lab_vrts_AlphaSimplexGroupLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_ce672e21-e451-411e-8f36-9d49fdd68591_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_e5e02c4a-31da-444c-b6ea-610735e342da_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_234ee452-d41f-4de5-ac27-dfbec6964d95_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_b6624c25-1d38-4e1a-b595-750a7cd04b20_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input, Discount Rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLiabilities_6f18f48b-d223-40ee-8ef6-640594c7c82c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued compensation and benefits, accounts payable, accrued liabilities and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_dad4ca9d-d3ce-42c2-b72a-456abb93d297_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Intangible amortization</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_ffb62786-3bf4-4456-b233-e226e2f20e1f_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_0dbb590c-d8d9-4fa5-88a9-c6aaa1b81865_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_ac42f86b-c6b3-401f-bacc-37bb4b1a3e84_periodStartLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Definite-Lived net book value, beginning of period</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_ebb73c4e-de79-446b-a8db-36cccc0894f3_periodEndLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Definite-Lived net book value, end of period</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_ed092923-8045-499b-8c09-405a81b1553d_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_36beeeb0-06e2-4b64-b5b6-e46dbdb01038_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New Accounting Standards Not Yet Implemented</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_c2f205b1-da36-49ae-8228-1e237d0c111c_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_1aa407fc-968c-4968-b92b-5e988723f2a4_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment management fees</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Interest Entity, Measure of Activity, Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues" xlink:to="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6ea17569-463c-4872-a86a-cddb3dad9a46_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents and restricted cash, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_14dafa1b-b33c-42d7-9643-2428af930a29_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents and restricted cash, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e6f01755-3f45-48e9-9a71-76522ffb63b2_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_cb7f1f39-764f-437c-92df-73570d45b151_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xml:lang="en-US">Accumulated amortization, beginning of period</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_5466e86b-bb40-44e9-933a-c93dc00005e4_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xml:lang="en-US">Accumulated amortization, end of period</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_6edd7f8a-93f9-4dd3-96c7-eeb4ccb72e15_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRollForward_36ccba64-b845-486e-80f1-52543ae6ef29_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Definite-Lived</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_c778b761-be35-4cb8-a567-5843f34a1065_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_15b30390-e01e-47fd-b20a-efeff665184e_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period, common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_55b647b7-4623-43ce-bb00-e03a7009570c_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period, common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_5e65301b-10ae-4b9a-91c1-3f96caac1bc5_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Number of shares, settled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_c8205b5c-ec35-4814-bca9-69310efb965a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_e74ce170-48a9-4f9b-8fa7-981d2f91fd27_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, at cost, 5,096,608 and 5,075,500 shares at March&#160;31, 2024 and December&#160;31, 2023, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonValue" xlink:to="lab_us-gaap_TreasuryStockCommonValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_486486a4-4a55-4660-b39e-68ca9becbc24_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsDeferredRevenueAmount_73ae152b-000e-4a4c-9f28-6c49a2011567_terseLabel_en-US" xlink:label="lab_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsDeferredRevenueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued investment management fees</link:label>
    <link:label id="lab_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsDeferredRevenueAmount_label_en-US" xlink:label="lab_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsDeferredRevenueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Interest Entity, Reporting Entity Involvement, Beneficial Interests, Deferred Revenue, Amount</link:label>
    <link:label id="lab_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsDeferredRevenueAmount_documentation_en-US" xlink:label="lab_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsDeferredRevenueAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Variable Interest Entity, Reporting Entity Involvement, Beneficial Interests, Deferred Revenue, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsDeferredRevenueAmount" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsDeferredRevenueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsDeferredRevenueAmount" xlink:to="lab_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsDeferredRevenueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_f6f411c7-732b-4215-ad0a-6c9b87b0dd58_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets measured at fair value</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_d45a4cc7-f1e2-4798-a382-087cb5cf97e7_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b54e513c-2a7f-4d74-9a37-cf00a9f1c2a3_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_31146688-8e64-4cc5-bc28-a6fd1fa0e070_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_ConversionOfStockConversionRatio_bcca3ef9-5d23-453e-809f-b5872444300a_terseLabel_en-US" xlink:label="lab_vrts_ConversionOfStockConversionRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion ratio</link:label>
    <link:label id="lab_vrts_ConversionOfStockConversionRatio_label_en-US" xlink:label="lab_vrts_ConversionOfStockConversionRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conversion Of Stock, Conversion Ratio</link:label>
    <link:label id="lab_vrts_ConversionOfStockConversionRatio_documentation_en-US" xlink:label="lab_vrts_ConversionOfStockConversionRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Conversion Of Stock, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_ConversionOfStockConversionRatio" xlink:href="vrts-20240331.xsd#vrts_ConversionOfStockConversionRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_ConversionOfStockConversionRatio" xlink:to="lab_vrts_ConversionOfStockConversionRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_f86c6d19-8e0d-427e-996e-1521f9ff7dcc_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Period for recognition of compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDisclosureTextBlock_d65effce-4157-4cbc-984a-1f5146058850_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Redeemable Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDisclosureTextBlock" xlink:to="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_SubordinatedNotesNewfleetCLO20161Member_ef2cac8e-9477-4c43-a78d-ebe0e1d8fc68_terseLabel_en-US" xlink:label="lab_vrts_SubordinatedNotesNewfleetCLO20161Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CLO subordinated notes</link:label>
    <link:label id="lab_vrts_SubordinatedNotesNewfleetCLO20161Member_label_en-US" xlink:label="lab_vrts_SubordinatedNotesNewfleetCLO20161Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subordinated Notes - Newfleet CLO 2016-1 [Member]</link:label>
    <link:label id="lab_vrts_SubordinatedNotesNewfleetCLO20161Member_documentation_en-US" xlink:label="lab_vrts_SubordinatedNotesNewfleetCLO20161Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Subordinated Notes - Newfleet CLO 2016-1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_SubordinatedNotesNewfleetCLO20161Member" xlink:href="vrts-20240331.xsd#vrts_SubordinatedNotesNewfleetCLO20161Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_SubordinatedNotesNewfleetCLO20161Member" xlink:to="lab_vrts_SubordinatedNotesNewfleetCLO20161Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_09b6f9b8-4c2c-4265-8b59-10d109da049e_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_7b8eee78-e6e5-4910-b2e9-5278ec3aa4d3_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss) Attributable to Virtus Investment Partners, Inc.</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_3e7d9a0e-c412-4d2c-a29c-e9d10ccab681_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unamortized stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_05629e73-3966-4531-b11e-2523e01c3918_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_NoncontrollingInterestSubscriptionsRedemptions_6b83821b-b92a-4cbd-a13f-0f184ecd1a78_terseLabel_en-US" xlink:label="lab_vrts_NoncontrollingInterestSubscriptionsRedemptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net subscriptions (redemptions) and other</link:label>
    <link:label id="lab_vrts_NoncontrollingInterestSubscriptionsRedemptions_label_en-US" xlink:label="lab_vrts_NoncontrollingInterestSubscriptionsRedemptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest, Subscriptions (Redemptions)</link:label>
    <link:label id="lab_vrts_NoncontrollingInterestSubscriptionsRedemptions_documentation_en-US" xlink:label="lab_vrts_NoncontrollingInterestSubscriptionsRedemptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest, Subscriptions (Redemptions)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_NoncontrollingInterestSubscriptionsRedemptions" xlink:href="vrts-20240331.xsd#vrts_NoncontrollingInterestSubscriptionsRedemptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_NoncontrollingInterestSubscriptionsRedemptions" xlink:to="lab_vrts_NoncontrollingInterestSubscriptionsRedemptions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_c30b8cd5-3d70-4424-b448-b7aa3a44cfbe_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_3401ec7c-251e-4ed1-8c92-41eda2ba4f54_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Repurchases of common shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_9aa20998-90af-4015-9cf1-f67bdadeee7d_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Carrying value and maximum risk of loss</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:to="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_b7d84c51-4730-4827-934c-eabea01a1b60_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesGainLoss_dbe8b736-4dbd-48d8-8ab8-c4dc63d251ab_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Realized and unrealized (gains) losses on investments, net</link:label>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesGainLoss_5deeafce-2d11-403e-ae53-fd9aa0ecb5b7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Realized and unrealized (gains) losses on investments of CIP, net</link:label>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesGainLoss_label_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt and Equity Securities, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtAndEquitySecuritiesGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndEquitySecuritiesGainLoss" xlink:to="lab_us-gaap_DebtAndEquitySecuritiesGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_5c4f69af-5bfe-47fa-80e7-4c85b2bd4214_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_b82e6bbd-1943-49d0-9130-7c9f5b0838ed_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_a081d834-2063-434d-81f6-039074aeaf07_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Portion at Other than Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Portion at Other than Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_f5398cb6-3c9b-4080-8407-f826a0ff9a9c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_ProceedsFromPaymentsForOtherInvestmentsOperatingActivities_8dcf0e01-4d04-4352-9bb8-8b8793757e48_terseLabel_en-US" xlink:label="lab_vrts_ProceedsFromPaymentsForOtherInvestmentsOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net proceeds (purchases) of short-term investments and securities sold short by CIP</link:label>
    <link:label id="lab_vrts_ProceedsFromPaymentsForOtherInvestmentsOperatingActivities_label_en-US" xlink:label="lab_vrts_ProceedsFromPaymentsForOtherInvestmentsOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds From (Payments For) Other Investments, Operating Activities</link:label>
    <link:label id="lab_vrts_ProceedsFromPaymentsForOtherInvestmentsOperatingActivities_documentation_en-US" xlink:label="lab_vrts_ProceedsFromPaymentsForOtherInvestmentsOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Proceeds From (Payments For) Other Investments, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_ProceedsFromPaymentsForOtherInvestmentsOperatingActivities" xlink:href="vrts-20240331.xsd#vrts_ProceedsFromPaymentsForOtherInvestmentsOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_ProceedsFromPaymentsForOtherInvestmentsOperatingActivities" xlink:to="lab_vrts_ProceedsFromPaymentsForOtherInvestmentsOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_06caa4d1-3db1-417d-a992-4847d74793b8_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income (loss) attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_InstitutionalAccountsMember_7f760528-5ca0-45ad-8877-10386c12f96c_terseLabel_en-US" xlink:label="lab_vrts_InstitutionalAccountsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Institutional accounts</link:label>
    <link:label id="lab_vrts_InstitutionalAccountsMember_label_en-US" xlink:label="lab_vrts_InstitutionalAccountsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Institutional Accounts [Member]</link:label>
    <link:label id="lab_vrts_InstitutionalAccountsMember_documentation_en-US" xlink:label="lab_vrts_InstitutionalAccountsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Institutional Accounts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_InstitutionalAccountsMember" xlink:href="vrts-20240331.xsd#vrts_InstitutionalAccountsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_InstitutionalAccountsMember" xlink:to="lab_vrts_InstitutionalAccountsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_cb416c75-8fc5-4452-98b5-bdb2e443d2d5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsLineItems_09fb56fa-7faa-415e-a529-24d2c20d8858_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_686af78e-be04-4513-88b5-83bada8581ce_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_863e72ca-efd6-4c9d-9215-cb863ee2fc64_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_cb8241cb-e506-44c9-b82a-9d13639429b7_netLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_20db200c-e5f9-4e8c-8915-77165b3fd58c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss), before reclassifications, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss) before Reclassifications, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_b7efeb9c-ddd0-45aa-b902-f89434f7f1e1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_OperatingandNonoperatingExpense_c28610ed-e4c3-4f08-95db-b266a6250644_totalLabel_en-US" xlink:label="lab_vrts_OperatingandNonoperatingExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Expense</link:label>
    <link:label id="lab_vrts_OperatingandNonoperatingExpense_label_en-US" xlink:label="lab_vrts_OperatingandNonoperatingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating and Nonoperating Expense</link:label>
    <link:label id="lab_vrts_OperatingandNonoperatingExpense_documentation_en-US" xlink:label="lab_vrts_OperatingandNonoperatingExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Operating and Nonoperating Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_OperatingandNonoperatingExpense" xlink:href="vrts-20240331.xsd#vrts_OperatingandNonoperatingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_OperatingandNonoperatingExpense" xlink:to="lab_vrts_OperatingandNonoperatingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_c6c6862a-99f6-41f3-9c2c-e4484257e407_periodStartLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Net book value, beginning of period</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_8d5c81d9-c4ae-41bb-a045-3d7fff2c6396_periodEndLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Net book value, end of period</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8e346c50-fa4f-405c-b70c-5dfae1cacd2f_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Weighted average grant date fair value, outstanding (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_78b048e4-e3d2-40a6-b9dd-be896d80221f_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Weighted average grant date fair value, outstanding (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_74bb504d-d71d-4730-9e96-cc4638e61a47_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common shares related to employee stock transactions</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_10d746dc-1797-4ee2-999c-7b654d5d01e2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f5019b19-342b-4828-9b4b-ada584609bca_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_83e638c3-7345-4ef1-8d7d-e9a4ae8c1425_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_13a3a26e-49b8-463a-8a75-fc34cbea6a88_verboseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Equity method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_SeniorSecuredFloatingRateNotesNewfleetCLO20161Member_d48c571c-4ef6-4477-970d-ad8044098ff9_terseLabel_en-US" xlink:label="lab_vrts_SeniorSecuredFloatingRateNotesNewfleetCLO20161Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CLO senior secured floating rate notes</link:label>
    <link:label id="lab_vrts_SeniorSecuredFloatingRateNotesNewfleetCLO20161Member_label_en-US" xlink:label="lab_vrts_SeniorSecuredFloatingRateNotesNewfleetCLO20161Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Secured Floating Rate Notes - Newfleet CLO 2016-1 [Member]</link:label>
    <link:label id="lab_vrts_SeniorSecuredFloatingRateNotesNewfleetCLO20161Member_documentation_en-US" xlink:label="lab_vrts_SeniorSecuredFloatingRateNotesNewfleetCLO20161Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Secured Floating Rate Notes - Newfleet CLO 2016-1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_SeniorSecuredFloatingRateNotesNewfleetCLO20161Member" xlink:href="vrts-20240331.xsd#vrts_SeniorSecuredFloatingRateNotesNewfleetCLO20161Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_SeniorSecuredFloatingRateNotesNewfleetCLO20161Member" xlink:to="lab_vrts_SeniorSecuredFloatingRateNotesNewfleetCLO20161Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_81656be8-61bd-4f60-85b2-63ad34c66510_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsToMinorityShareholders_1c771e72-fb68-400b-ac2e-0cf04350a41f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net contributions from (distributions to) noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsToMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from (Payments to) Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsToMinorityShareholders" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsToMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsToMinorityShareholders" xlink:to="lab_us-gaap_ProceedsFromPaymentsToMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_4630d334-213b-47cc-841c-e9a4a81bbafd_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_2ebc6cf6-5a24-4ad6-9967-f8932cf19402_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_05fc882c-769b-4936-9051-cea21f77c4cc_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_22c2a816-9e50-426b-b31d-bdc73ba59a00_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_ExpensesAbstract_f22a1525-1273-4cb0-a7d2-faafa080bc99_terseLabel_en-US" xlink:label="lab_vrts_ExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expenses:</link:label>
    <link:label id="lab_vrts_ExpensesAbstract_label_en-US" xlink:label="lab_vrts_ExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expenses [Abstract]</link:label>
    <link:label id="lab_vrts_ExpensesAbstract_documentation_en-US" xlink:label="lab_vrts_ExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_ExpensesAbstract" xlink:href="vrts-20240331.xsd#vrts_ExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_ExpensesAbstract" xlink:to="lab_vrts_ExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_d9e9d88d-ad5b-4210-afac-15897f017aed_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_26fe3676-6a2a-42d3-9bb1-70f1e5fca46d_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Repurchase of common shares</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_fcf4a1de-d3c8-4226-8bef-94ea31869998_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsSoldNotYetPurchasedAtFairValue_aa991d75-1ce9-4d75-915f-652d082bf553_verboseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsSoldNotYetPurchasedAtFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Short sales</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsSoldNotYetPurchasedAtFairValue_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsSoldNotYetPurchasedAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instruments Sold, Not yet Purchased, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsSoldNotYetPurchasedAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsSoldNotYetPurchasedAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsSoldNotYetPurchasedAtFairValue" xlink:to="lab_us-gaap_FinancialInstrumentsSoldNotYetPurchasedAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_29ec27a8-0a61-4d93-a3e9-c83ace5f6331_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-Lived</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-Lived Intangible Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_2fa382c5-8ef7-4507-8a41-898ddb271fb4_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Condensed Consolidated Balance Sheets</link:label>
    <link:label id="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Condensed Balance Sheet [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfCondensedBalanceSheetTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:to="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_afb76c42-2c2a-4e82-b9b9-2c1cbd10e776_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Attributed To Virtus Investment Partners, Inc.</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_03c6cbea-c86d-4e1f-967f-e313cb23db73_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nonconsolidated VIEs</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e50241c5-a3b4-4201-8bd5-c054ba00badb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_037712c5-7240-4e80-a476-84405e50af0d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_abc0fc8d-efb4-43c1-97bc-ce7138361b69_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retained earnings (accumulated deficit)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3aac2fcb-0c16-49b7-b284-91d142f799cd_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_162e7ea4-9e4f-496c-a672-89e817493518_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForTradingSecurities_ce6f1f91-a354-47ef-b3b4-f70fc0b88bd2_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForTradingSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sales (purchases) of investments, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForTradingSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForTradingSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from (Payments for) Trading Securities, Short-Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForTradingSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsForTradingSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForTradingSecurities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForTradingSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_7546831a-ecc2-486a-bced-98351e9e9f4e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Transfers from Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_c9700a54-db0d-4a1b-8848-6e540e9807fd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt par value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_2ab3e8a2-8c24-4e41-a4c3-2e5fa80b1361_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_bd70c3cc-12bd-4616-ab03-ca1860246bc7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_070f14d7-3ce7-4103-89ad-9ca6dcda2dab_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating activities of consolidated investment products ("CIP"):</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_359b3c03-d05f-439d-9872-9c6f3bbffd3a_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_d66e941f-bea3-483e-ac96-d18e8a5dc5aa_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_a839e4aa-6aff-44ca-a2b0-a148230fc38d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestChangeInRedemptionValue_36832134-6b04-4703-87d8-ae6259a6d209_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (decrease) to noncontrolling interests due to consolidation (deconsolidation) of CIP, net</link:label>
    <link:label id="lab_us-gaap_MinorityInterestChangeInRedemptionValue_380529ff-70f6-4d36-b502-3108783f0fa1_verboseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Changes in redemption value</link:label>
    <link:label id="lab_us-gaap_MinorityInterestChangeInRedemptionValue_label_en-US" xlink:label="lab_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest, Change in Redemption Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestChangeInRedemptionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:to="lab_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCostAndExpenseOperating_d60eed5e-ff4e-4e5f-8285-6781f782541c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCostAndExpenseOperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other operating expenses</link:label>
    <link:label id="lab_us-gaap_OtherCostAndExpenseOperating_d78f5a04-8296-45e8-abd3-8ef752faa646_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherCostAndExpenseOperating" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other operating expenses</link:label>
    <link:label id="lab_us-gaap_OtherCostAndExpenseOperating_label_en-US" xlink:label="lab_us-gaap_OtherCostAndExpenseOperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Cost and Expense, Operating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCostAndExpenseOperating" xlink:to="lab_us-gaap_OtherCostAndExpenseOperating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayable_42a16ab0-f8c1-4db9-a33c-c3d30852f9ad_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NotesPayable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Notes payable</link:label>
    <link:label id="lab_us-gaap_NotesPayable_label_en-US" xlink:label="lab_us-gaap_NotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayable" xlink:to="lab_us-gaap_NotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_7b8df26f-3e16-4045-8590-a486a2639744_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3b5e1669-88c5-4aa3-95f1-a8f1063c68c4_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_5f7aa1a6-5ba7-4b9e-9ec1-8bfdd019c3d0_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Redeemable Non-controlling Interests [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_a4ca0362-c239-4093-9e48-c8b1d1d47e00_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_7157d4bf-7aeb-4a10-a69e-a412b46d2a7a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_7ef2e021-613c-4a78-876d-44357fc3c845_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_a56441f4-7b6c-42da-8507-652452b7cf56_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_d58eb312-d7f5-4de5-9886-02454e4b3e5a_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment securities - fair value</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_02b4885d-83cb-4b0d-858d-c609e408145b_verboseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2bd75258-f90b-41fb-a9e5-1a9db5c0df05_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Virtus Investment Partners, Inc.</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_454638d3-f6ab-4bf5-9d7d-de38400a546d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_318daba6-45f4-486e-bb7c-a9edb1130312_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt repayments</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6845a8f4-2570-4c30-86b3-eb963c67b5e8_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated effective income tax rate (as percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_f33773ef-3e36-478c-b93d-fe3d01f164c2_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_d7e9e324-5362-48b7-a0e8-080e1f40b088_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_495c5e1d-8f85-4664-8926-ab69d1e7cb9a_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_43016850-54dc-4d74-9558-c9c7a6d89b15_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_bbd0a089-a52d-41d6-a46a-bfd726d9a288_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ec989656-59e3-438b-9b55-cd47a588d379_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_9d9158ec-f5fa-4809-8b6f-1cdb67100790_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_a2a99e2e-6bcf-4d6d-b33a-de725f2d27cf_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_bdfec955-f2d7-42d8-9bc5-3fb6338362f6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of VIE Consolidated Investment Product</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Variable Interest Entities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AffiliatedEntityMember_83c73c3c-94e6-4a76-8c95-0ea404ae266a_terseLabel_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Affiliate Noncontrolling Interests</link:label>
    <link:label id="lab_srt_AffiliatedEntityMember_label_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Affiliated Entity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AffiliatedEntityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AffiliatedEntityMember" xlink:to="lab_srt_AffiliatedEntityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_5500217e-e917-4360-a875-98c8fba1547b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, $0.01 par value, 1,000,000,000 shares authorized; 12,224,489 shares issued and 7,127,881 shares outstanding at March&#160;31, 2024; and 12,163,228 shares issued and 7,087,728 shares outstanding at December&#160;31, 2023</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cefc1045-0ec4-4c66-932b-9ceb70da2297_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_ace939e5-24ad-4da6-8d51-6bb0dc4a4892_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CondensedFinancialStatementsTextBlock_6c69dbf3-f7be-4d2f-9dc4-e43635fa9915_terseLabel_en-US" xlink:label="lab_srt_CondensedFinancialStatementsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidation</link:label>
    <link:label id="lab_srt_CondensedFinancialStatementsTextBlock_label_en-US" xlink:label="lab_srt_CondensedFinancialStatementsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Condensed Financial Statements [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsTextBlock" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedFinancialStatementsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedFinancialStatementsTextBlock" xlink:to="lab_srt_CondensedFinancialStatementsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_541fdecc-4a34-4b1e-96e3-66b4076e98d9_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_1edcb37f-0290-4d50-bbda-5e26834553a3_verboseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Equity investments</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_0d646534-5ecc-4ee4-8a2f-3b0b6092a39f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_64c7a6e5-5465-4a22-b920-e7778c4d2eb4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNet_e8f9efa2-a907-42d1-9584-af0ebd09af38_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNet_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNet" xlink:to="lab_us-gaap_AccountsReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_649ada5f-88f7-400f-b472-5bb46ea6d495_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_dfcffc05-16c1-468d-bf04-bc5331ef3218_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_23894186-3694-4e15-817c-b3046af07af1_verboseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Redeemable noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_7084cf10-3f8a-4d45-8c08-262513550fd0_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_16312b4c-f16e-475e-a1bb-40a5a761eebd_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_b4fa15a0-98bb-4bd0-b1af-b8935bb6b207_negatedLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilities_5e1ec56d-77e7-48ff-8d41-221f49382804_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilities_label_en-US" xlink:label="lab_us-gaap_OtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilities" xlink:to="lab_us-gaap_OtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_18b70f7c-8bdf-45d4-b4dd-ae1450c12db6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_b5d2a0e8-fc9c-4800-a841-8c3e909ec6b3_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_PerformanceStockUnitsIncentiveMember_4a198154-beca-44bf-b0a0-e90e52ee22d1_terseLabel_en-US" xlink:label="lab_vrts_PerformanceStockUnitsIncentiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Performance Stock Units, Incentive</link:label>
    <link:label id="lab_vrts_PerformanceStockUnitsIncentiveMember_label_en-US" xlink:label="lab_vrts_PerformanceStockUnitsIncentiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Performance Stock Units, Incentive [Member]</link:label>
    <link:label id="lab_vrts_PerformanceStockUnitsIncentiveMember_documentation_en-US" xlink:label="lab_vrts_PerformanceStockUnitsIncentiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Performance Stock Units, Incentive [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_PerformanceStockUnitsIncentiveMember" xlink:href="vrts-20240331.xsd#vrts_PerformanceStockUnitsIncentiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_PerformanceStockUnitsIncentiveMember" xlink:to="lab_vrts_PerformanceStockUnitsIncentiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_814c7c67-d15d-4b80-b515-ea415d59d7b7_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock repurchased during period, shares</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_26af4a20-a2bb-4695-a8c4-cdd0ae210ac7_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration, beginning of period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_681adca8-9b82-4bc9-a5cd-0b88fdeb993f_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration, end of period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_f1d563f8-8f9b-432e-98dc-3f7f1ba673ab_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Changes in Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Investments_36345eec-6f80-4946-889b-bf8afc4c5caa_terseLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_Investments_9e2b806f-d390-492e-9d02-5ea29ddbf3b9_totalLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total investments</link:label>
    <link:label id="lab_us-gaap_Investments_fcd244c8-c0b8-4a93-9837-88000057acef_netLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_Investments_label_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Investments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Investments" xlink:to="lab_us-gaap_Investments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b846f764-1d96-408e-ab70-e90dcf826e21_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average grant-date fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_9168b7d5-d15b-433a-aba4-7e327c6cd2a8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_CommonStockDividendsAccruedButNotYetPaid_332a9038-0d63-4a3c-ae33-1dbe7c6fce76_terseLabel_en-US" xlink:label="lab_vrts_CommonStockDividendsAccruedButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock dividends payable</link:label>
    <link:label id="lab_vrts_CommonStockDividendsAccruedButNotYetPaid_label_en-US" xlink:label="lab_vrts_CommonStockDividendsAccruedButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock Dividends Accrued But Not Yet Paid</link:label>
    <link:label id="lab_vrts_CommonStockDividendsAccruedButNotYetPaid_documentation_en-US" xlink:label="lab_vrts_CommonStockDividendsAccruedButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Common Stock Dividends Accrued But Not Yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_CommonStockDividendsAccruedButNotYetPaid" xlink:href="vrts-20240331.xsd#vrts_CommonStockDividendsAccruedButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_CommonStockDividendsAccruedButNotYetPaid" xlink:to="lab_vrts_CommonStockDividendsAccruedButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_VariableInterestEntityMeasureofActivityDistributionsReceivedandUnrealizedGainsLossesOnInvestment_cdfef079-dbe8-49ed-aeda-9a3b2191cd3b_terseLabel_en-US" xlink:label="lab_vrts_VariableInterestEntityMeasureofActivityDistributionsReceivedandUnrealizedGainsLossesOnInvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Distributions received and unrealized gains (losses) on the subordinated notes held by the Company</link:label>
    <link:label id="lab_vrts_VariableInterestEntityMeasureofActivityDistributionsReceivedandUnrealizedGainsLossesOnInvestment_label_en-US" xlink:label="lab_vrts_VariableInterestEntityMeasureofActivityDistributionsReceivedandUnrealizedGainsLossesOnInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Interest Entity, Measure of Activity, Distributions Received and Unrealized Gains (Losses) On Investment</link:label>
    <link:label id="lab_vrts_VariableInterestEntityMeasureofActivityDistributionsReceivedandUnrealizedGainsLossesOnInvestment_documentation_en-US" xlink:label="lab_vrts_VariableInterestEntityMeasureofActivityDistributionsReceivedandUnrealizedGainsLossesOnInvestment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Variable Interest Entity, Measure of Activity, Distributions Received and Unrealized Gains (Losses) On Investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityMeasureofActivityDistributionsReceivedandUnrealizedGainsLossesOnInvestment" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityMeasureofActivityDistributionsReceivedandUnrealizedGainsLossesOnInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_VariableInterestEntityMeasureofActivityDistributionsReceivedandUnrealizedGainsLossesOnInvestment" xlink:to="lab_vrts_VariableInterestEntityMeasureofActivityDistributionsReceivedandUnrealizedGainsLossesOnInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTableTextBlock_729860d4-7ae5-4b66-9725-87b2feadc77c_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTableTextBlock" xlink:to="lab_us-gaap_InvestmentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc7f36f4-99e3-426e-b5b1-fd912f968d57_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by (used in) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_d8052b1c-9911-49d2-b289-af7f1450f565_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Estimated Amortization Expense of Intangible Assets Succeeding Years</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_8d0fa27f-c7d3-4baf-b387-e249c405344a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_530996c8-b6d9-4091-bafe-a332310af67b_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Organization and Business</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_09d66ed3-80b5-412d-94a4-e7a38daef064_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation expense, intangible asset and other amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember_c125072c-6684-49b7-9896-074e9266496d_terseLabel_en-US" xlink:label="lab_vrts_ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidated Entity excluding Consolidated Investment Products</link:label>
    <link:label id="lab_vrts_ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember_label_en-US" xlink:label="lab_vrts_ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidated Entity Excluding Variable Interest Entities (VIE) and Voting Interest Entities (VOE) [Member]</link:label>
    <link:label id="lab_vrts_ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember_documentation_en-US" xlink:label="lab_vrts_ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Consolidated Entity Excluding Variable Interest Entities (VIE) and Voting Interest Entities (VOE) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember" xlink:href="vrts-20240331.xsd#vrts_ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember" xlink:to="lab_vrts_ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_3484bebb-6685-4da7-a1f3-ddf804bc999b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_aac7b6b0-cfac-49be-8860-41798163f72e_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total equity attributable to Virtus Investment Partners, Inc.</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_ClosedEndFundsMember_e1a1e914-e3fc-4f65-afc4-85b5612d2025_terseLabel_en-US" xlink:label="lab_vrts_ClosedEndFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Closed-end funds</link:label>
    <link:label id="lab_vrts_ClosedEndFundsMember_label_en-US" xlink:label="lab_vrts_ClosedEndFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Closed End Funds [Member]</link:label>
    <link:label id="lab_vrts_ClosedEndFundsMember_documentation_en-US" xlink:label="lab_vrts_ClosedEndFundsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Closed End Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_ClosedEndFundsMember" xlink:href="vrts-20240331.xsd#vrts_ClosedEndFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_ClosedEndFundsMember" xlink:to="lab_vrts_ClosedEndFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_04529cc8-addd-4947-bdfe-21b7d78f3337_verboseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_a19ad3d9-5df7-4f30-aa30-9669533ca362_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total net income (loss) attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity, Net Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityNetIncome" xlink:to="lab_us-gaap_TemporaryEquityNetIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_36c90793-e6e8-44ee-a929-14602ab21084_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Realized and unrealized gain (loss) on investments, net</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_WestchesterCapitalManagementMember_b178584f-f2a5-4418-945b-2b04fc505eac_terseLabel_en-US" xlink:label="lab_vrts_WestchesterCapitalManagementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Westchester</link:label>
    <link:label id="lab_vrts_WestchesterCapitalManagementMember_label_en-US" xlink:label="lab_vrts_WestchesterCapitalManagementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Westchester Capital Management [Member]</link:label>
    <link:label id="lab_vrts_WestchesterCapitalManagementMember_documentation_en-US" xlink:label="lab_vrts_WestchesterCapitalManagementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Westchester Capital Management</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_WestchesterCapitalManagementMember" xlink:href="vrts-20240331.xsd#vrts_WestchesterCapitalManagementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_WestchesterCapitalManagementMember" xlink:to="lab_vrts_WestchesterCapitalManagementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_DistributionAndServiceFeesMember_d5df87f7-6963-40d2-9bb6-ac3c1d1e09d3_terseLabel_en-US" xlink:label="lab_vrts_DistributionAndServiceFeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Distribution and service fees</link:label>
    <link:label id="lab_vrts_DistributionAndServiceFeesMember_label_en-US" xlink:label="lab_vrts_DistributionAndServiceFeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Distribution And Service Fees [Member]</link:label>
    <link:label id="lab_vrts_DistributionAndServiceFeesMember_documentation_en-US" xlink:label="lab_vrts_DistributionAndServiceFeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Distribution And Service Fees [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_DistributionAndServiceFeesMember" xlink:href="vrts-20240331.xsd#vrts_DistributionAndServiceFeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_DistributionAndServiceFeesMember" xlink:to="lab_vrts_DistributionAndServiceFeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e62422a3-3937-47ae-9ff1-c803b07cf63f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_ade597c3-6ce6-4375-ad87-4f017800a5e8_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash pledged or on deposit of CIP</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_20bb4966-6bb2-426e-8d13-df86d151ee25_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash pledged or on deposit of CIP</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_e155bd68-df55-4694-9938-11458532199a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation adjustment, net of tax of $36 and $(35) for the three months ended March 31, 2024 and 2023, respectively</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_593d8925-975c-4b48-b8ee-69f03f93877f_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_195f198e-80cf-41e1-a7a3-24dc513ea34a_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Income (Loss) Before Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e5ea5de6-4f1a-4698-ae02-da88df395992_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_NonqualifiedRetirementPlanAssetsMember_2c1b9096-a4df-453e-9922-b440a1de6956_terseLabel_en-US" xlink:label="lab_vrts_NonqualifiedRetirementPlanAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nonqualified retirement plan assets</link:label>
    <link:label id="lab_vrts_NonqualifiedRetirementPlanAssetsMember_label_en-US" xlink:label="lab_vrts_NonqualifiedRetirementPlanAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonqualified Retirement Plan Assets [Member]</link:label>
    <link:label id="lab_vrts_NonqualifiedRetirementPlanAssetsMember_documentation_en-US" xlink:label="lab_vrts_NonqualifiedRetirementPlanAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Nonqualified Retirement Plan Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_NonqualifiedRetirementPlanAssetsMember" xlink:href="vrts-20240331.xsd#vrts_NonqualifiedRetirementPlanAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_NonqualifiedRetirementPlanAssetsMember" xlink:to="lab_vrts_NonqualifiedRetirementPlanAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_69919e40-a64c-4b25-9e32-28a9a929f271_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_3fd69301-7c54-4474-99e2-85b70bf4a918_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level&#160;2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_dc2b29c1-8385-4138-8d47-a33555e66557_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_5796520c-0958-43d1-b015-1b7ac7e88caa_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_de491b71-828e-41b7-b080-d127fffb2c3d_periodStartLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Net book value, beginning of period</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_1e4a9946-2abd-4000-a95a-b710012383ec_periodEndLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Net book value, end of period</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_463becfb-7fc6-44ab-9095-f5b5c736fbff_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ParentCompanyMember_b74728a2-0aed-4f08-9816-713dbb453957_terseLabel_en-US" xlink:label="lab_srt_ParentCompanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Parent</link:label>
    <link:label id="lab_srt_ParentCompanyMember_label_en-US" xlink:label="lab_srt_ParentCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Parent Company [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ParentCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ParentCompanyMember" xlink:to="lab_srt_ParentCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_50ba39ed-69c5-4764-9c89-0741f0f1f661_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Definite-lived intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_fe822172-dd73-417b-855e-5ef57eab69f4_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_05393b43-c5d1-47a7-9785-b8b689cd2af9_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_31182d98-6693-4fdf-85a6-e23e8c3464ff_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_04fd2b49-c396-4a6f-bd0e-fca8dec3e295_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_532ef859-88b3-4cbd-bf4f-9098274048d3_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_NumberofCollateralizedLoanObligationsConsolidated_24bed9ad-31dc-4814-8116-81bae686104b_terseLabel_en-US" xlink:label="lab_vrts_NumberofCollateralizedLoanObligationsConsolidated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of consolidated CLOs</link:label>
    <link:label id="lab_vrts_NumberofCollateralizedLoanObligationsConsolidated_label_en-US" xlink:label="lab_vrts_NumberofCollateralizedLoanObligationsConsolidated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Collateralized Loan Obligations Consolidated</link:label>
    <link:label id="lab_vrts_NumberofCollateralizedLoanObligationsConsolidated_documentation_en-US" xlink:label="lab_vrts_NumberofCollateralizedLoanObligationsConsolidated" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of Collateralized Loan Obligations Consolidated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_NumberofCollateralizedLoanObligationsConsolidated" xlink:href="vrts-20240331.xsd#vrts_NumberofCollateralizedLoanObligationsConsolidated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_NumberofCollateralizedLoanObligationsConsolidated" xlink:to="lab_vrts_NumberofCollateralizedLoanObligationsConsolidated" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_637b7f70-e7af-4abc-9b63-1050572b216c_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_59a16da5-84b9-4dd5-93f4-38703a9fd9d0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_306a8163-123f-4dbe-a2b0-9e935834f363_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings (Loss) Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_ccf894da-7cf8-40a2-aaea-a3c16a223eb0_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_TermLoanMember_8319add7-980c-4005-ad28-179fa9c4ca22_terseLabel_en-US" xlink:label="lab_vrts_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Term loan</link:label>
    <link:label id="lab_vrts_TermLoanMember_label_en-US" xlink:label="lab_vrts_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:label id="lab_vrts_TermLoanMember_documentation_en-US" xlink:label="lab_vrts_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_TermLoanMember" xlink:href="vrts-20240331.xsd#vrts_TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_TermLoanMember" xlink:to="lab_vrts_TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_90b4e6df-4b2d-42b2-b88a-79c2f3f89076_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Liabilities of Consolidated Sponsored Investment Products For Level 3 Investments, Unobservable Inputs Used to Determine Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_cc34a66e-0793-4167-92de-f606cbcc3d97_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b5f772d5-9d07-4e9d-ba46-937c19e16cc1_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c471d61e-f3ef-43e0-8c65-f18299b27800_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2ef30a31-54a4-4d28-92ee-e73c5f333d73_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsSubordinatedDebtAmount_2bd73b43-8db5-4c69-baee-40f79e1d7262_terseLabel_en-US" xlink:label="lab_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsSubordinatedDebtAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subordinated notes</link:label>
    <link:label id="lab_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsSubordinatedDebtAmount_label_en-US" xlink:label="lab_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsSubordinatedDebtAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Interest Entity, Reporting Entity Involvement, Beneficial Interests, Subordinated Debt, Amount</link:label>
    <link:label id="lab_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsSubordinatedDebtAmount_documentation_en-US" xlink:label="lab_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsSubordinatedDebtAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Variable Interest Entity, Reporting Entity Involvement, Beneficial Interests, Subordinated Debt, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsSubordinatedDebtAmount" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsSubordinatedDebtAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsSubordinatedDebtAmount" xlink:to="lab_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsSubordinatedDebtAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_b53c44ef-d0fc-45c8-ab99-4a8da580957b_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_IntangibleAssetsNetExcludingGoodwillRollForward_57ba9fba-25e6-4cf7-8df3-b3d5fa9b5887_terseLabel_en-US" xlink:label="lab_vrts_IntangibleAssetsNetExcludingGoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_vrts_IntangibleAssetsNetExcludingGoodwillRollForward_label_en-US" xlink:label="lab_vrts_IntangibleAssetsNetExcludingGoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill) [Roll Forward]</link:label>
    <link:label id="lab_vrts_IntangibleAssetsNetExcludingGoodwillRollForward_documentation_en-US" xlink:label="lab_vrts_IntangibleAssetsNetExcludingGoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill) [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_IntangibleAssetsNetExcludingGoodwillRollForward" xlink:href="vrts-20240331.xsd#vrts_IntangibleAssetsNetExcludingGoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_IntangibleAssetsNetExcludingGoodwillRollForward" xlink:to="lab_vrts_IntangibleAssetsNetExcludingGoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d8b9dc5e-8329-4601-98a5-2d1f7c58072e_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_4758dd3f-fe81-49b9-b061-37ecaaaaef49_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Furniture, equipment and leasehold improvements, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_NoncontrollingInterestSubscriptionsRedemptionsAndOther_1083b715-98b0-4d8e-b656-cd49bc6f0b9f_negatedTerseLabel_en-US" xlink:label="lab_vrts_NoncontrollingInterestSubscriptionsRedemptionsAndOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Net subscriptions (redemptions) and other</link:label>
    <link:label id="lab_vrts_NoncontrollingInterestSubscriptionsRedemptionsAndOther_label_en-US" xlink:label="lab_vrts_NoncontrollingInterestSubscriptionsRedemptionsAndOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest, Subscriptions (Redemptions) And Other</link:label>
    <link:label id="lab_vrts_NoncontrollingInterestSubscriptionsRedemptionsAndOther_documentation_en-US" xlink:label="lab_vrts_NoncontrollingInterestSubscriptionsRedemptionsAndOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest, Subscriptions (Redemptions) And Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_NoncontrollingInterestSubscriptionsRedemptionsAndOther" xlink:href="vrts-20240331.xsd#vrts_NoncontrollingInterestSubscriptionsRedemptionsAndOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_NoncontrollingInterestSubscriptionsRedemptionsAndOther" xlink:to="lab_vrts_NoncontrollingInterestSubscriptionsRedemptionsAndOther" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0ab6e7e0-bc63-43f0-abe0-62aeedfb2344_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_afccd2e2-3c9f-41f4-ac76-38d254a655b1_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net current-period other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_NoncontrollingInterestPolicyTextBlock_73910735-0b7b-4651-9bac-e4b208c151bf_terseLabel_en-US" xlink:label="lab_vrts_NoncontrollingInterestPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest</link:label>
    <link:label id="lab_vrts_NoncontrollingInterestPolicyTextBlock_label_en-US" xlink:label="lab_vrts_NoncontrollingInterestPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest [Policy Text Block]</link:label>
    <link:label id="lab_vrts_NoncontrollingInterestPolicyTextBlock_documentation_en-US" xlink:label="lab_vrts_NoncontrollingInterestPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest Policy [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_NoncontrollingInterestPolicyTextBlock" xlink:href="vrts-20240331.xsd#vrts_NoncontrollingInterestPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_NoncontrollingInterestPolicyTextBlock" xlink:to="lab_vrts_NoncontrollingInterestPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_ec097842-9faf-4e95-b218-a03e3a657d5a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_144bc57d-8f16-47e0-bf4f-1c5d85491278_negatedLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Cash dividends declared, common</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_2ad7c913-43f8-407a-b0ee-2618525e2a6d_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2cb78996-84e9-4192-b426-6c96412b036d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_b817698e-b1c6-4f58-ba32-d6bd8a051a9b_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total liabilities measured at fair value</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_4998e515-c6ed-4031-a0a6-8f21e57c9925_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities measured at fair value</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_093b658f-097e-4a27-b586-b1ffcff3c4c2_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Taxes paid related to net share settlement of restricted stock units</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_c2fd61d1-d1a5-4555-bb8b-c0b8adfbedf7_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash Flows from Financing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_bed35c4a-1cef-4f0c-858b-cf93b150c358_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_f61ea5d0-3d5c-4b8a-9c05-fa60a5a9ace2_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsGross" xlink:to="lab_us-gaap_DeferredFinanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_5054fe1d-5a03-4526-87cd-8835c7a04e37_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_c614c64c-df24-4232-b2a0-f9ae9c1453ae_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_6e2a9a60-1ce1-42b5-be94-de41269ae9b1_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_VariableInterestEntityPrimaryBeneficiaryGlobalAndPrivateFundsMember_ade780f4-5915-4320-9a58-2618b014e121_verboseLabel_en-US" xlink:label="lab_vrts_VariableInterestEntityPrimaryBeneficiaryGlobalAndPrivateFundsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">GFs</link:label>
    <link:label id="lab_vrts_VariableInterestEntityPrimaryBeneficiaryGlobalAndPrivateFundsMember_label_en-US" xlink:label="lab_vrts_VariableInterestEntityPrimaryBeneficiaryGlobalAndPrivateFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary, Global and Private Funds [Member]</link:label>
    <link:label id="lab_vrts_VariableInterestEntityPrimaryBeneficiaryGlobalAndPrivateFundsMember_documentation_en-US" xlink:label="lab_vrts_VariableInterestEntityPrimaryBeneficiaryGlobalAndPrivateFundsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary, Global and Private Funds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityPrimaryBeneficiaryGlobalAndPrivateFundsMember" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityPrimaryBeneficiaryGlobalAndPrivateFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_VariableInterestEntityPrimaryBeneficiaryGlobalAndPrivateFundsMember" xlink:to="lab_vrts_VariableInterestEntityPrimaryBeneficiaryGlobalAndPrivateFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_2e1b1753-c8ae-4d9e-bd47-d4b6d9ada512_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_bda6578c-654c-4e9d-97a9-ddbf6cd68ec3_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred taxes, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_6dbd7b9f-4a90-4348-ba5b-4a1ff889d371_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_2caa8d03-122e-4416-bf7b-adcb21c64f92_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Affiliate equity sales (purchases)</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Interest in Subsidiaries and Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:to="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_8c1ef782-73d1-410e-9903-45a74c39a4b6_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNetAbstract_1d4bbede-ddba-455f-a0e0-bd7f7c5a66b2_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest Income (Expense)</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNetAbstract_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Income (Expense), Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNetAbstract" xlink:to="lab_us-gaap_InterestIncomeExpenseNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_SecuritiesPurchasedPayableAndOtherLiabilities_bb64a01f-95e5-4f21-a0b6-06df90f6ea2c_terseLabel_en-US" xlink:label="lab_vrts_SecuritiesPurchasedPayableAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Securities purchased payable and other liabilities of CIP</link:label>
    <link:label id="lab_vrts_SecuritiesPurchasedPayableAndOtherLiabilities_label_en-US" xlink:label="lab_vrts_SecuritiesPurchasedPayableAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Securities Purchased Payable And Other Liabilities</link:label>
    <link:label id="lab_vrts_SecuritiesPurchasedPayableAndOtherLiabilities_documentation_en-US" xlink:label="lab_vrts_SecuritiesPurchasedPayableAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Securities Purchased Payable And Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_SecuritiesPurchasedPayableAndOtherLiabilities" xlink:href="vrts-20240331.xsd#vrts_SecuritiesPurchasedPayableAndOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_SecuritiesPurchasedPayableAndOtherLiabilities" xlink:to="lab_vrts_SecuritiesPurchasedPayableAndOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_InvestmentsInNonqualifiedRetirementPlanAssets_1fbec08a-1669-4143-bc65-d4d249ac8fad_terseLabel_en-US" xlink:label="lab_vrts_InvestmentsInNonqualifiedRetirementPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nonqualified retirement plan assets</link:label>
    <link:label id="lab_vrts_InvestmentsInNonqualifiedRetirementPlanAssets_76710cdb-c1d0-4f3a-a774-6faf2cdaa24c_verboseLabel_en-US" xlink:label="lab_vrts_InvestmentsInNonqualifiedRetirementPlanAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Nonqualified retirement plan assets</link:label>
    <link:label id="lab_vrts_InvestmentsInNonqualifiedRetirementPlanAssets_label_en-US" xlink:label="lab_vrts_InvestmentsInNonqualifiedRetirementPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments In Nonqualified Retirement Plan Assets</link:label>
    <link:label id="lab_vrts_InvestmentsInNonqualifiedRetirementPlanAssets_documentation_en-US" xlink:label="lab_vrts_InvestmentsInNonqualifiedRetirementPlanAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Investments In Nonqualified Retirement Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_InvestmentsInNonqualifiedRetirementPlanAssets" xlink:href="vrts-20240331.xsd#vrts_InvestmentsInNonqualifiedRetirementPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_InvestmentsInNonqualifiedRetirementPlanAssets" xlink:to="lab_vrts_InvestmentsInNonqualifiedRetirementPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_44780090-fb17-4c12-bba1-b816a6e34ef9_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_f9c2e59a-9988-4ec8-ab2d-56ba8ae93084_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Earnings (Loss) per Share&#8212;Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_b779d6a5-5d25-4729-9c1e-52a5a82f9322_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_5334bdd1-8138-444e-9abf-e7731cd47545_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_f5e8311d-03e9-4dc3-b698-b1a937cae447_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash Flows from Investing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_a0ad5f31-4a60-4a8e-842b-ef25c889ebab_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring expense</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_a9083653-c87f-4ff7-9404-eac6a349da67_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2eb401ad-afd3-4e2e-813c-28424cc11ffb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_90116e24-c721-4e20-af97-2577795535d8_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsAbstract_80700211-62ae-42b5-9804-1204f50a1f2a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Investments [Abstract]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsAbstract" xlink:to="lab_us-gaap_ScheduleOfInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_3daded2e-7d45-4691-b88b-f3b0e7c5f62e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Repayments on credit agreement</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_PaymentOfWithholdingTaxesRelatedToRestrictedStock_3795e99c-cfcf-42c4-ad7f-0e780dcf2539_terseLabel_en-US" xlink:label="lab_vrts_PaymentOfWithholdingTaxesRelatedToRestrictedStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash used for employee withholding tax payments</link:label>
    <link:label id="lab_vrts_PaymentOfWithholdingTaxesRelatedToRestrictedStock_label_en-US" xlink:label="lab_vrts_PaymentOfWithholdingTaxesRelatedToRestrictedStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment Of Withholding Taxes Related To Restricted Stock</link:label>
    <link:label id="lab_vrts_PaymentOfWithholdingTaxesRelatedToRestrictedStock_documentation_en-US" xlink:label="lab_vrts_PaymentOfWithholdingTaxesRelatedToRestrictedStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payment Of Withholding Taxes Related To Restricted Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_PaymentOfWithholdingTaxesRelatedToRestrictedStock" xlink:href="vrts-20240331.xsd#vrts_PaymentOfWithholdingTaxesRelatedToRestrictedStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_PaymentOfWithholdingTaxesRelatedToRestrictedStock" xlink:to="lab_vrts_PaymentOfWithholdingTaxesRelatedToRestrictedStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_afeb7b0e-2a67-4bb5-b82f-90a4d005b431_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_AmortizationOfIntangibleAssetsAndContingentAmortization_171d48b2-4870-4b92-ab70-f60879dcd713_terseLabel_en-US" xlink:label="lab_vrts_AmortizationOfIntangibleAssetsAndContingentAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_vrts_AmortizationOfIntangibleAssetsAndContingentAmortization_label_en-US" xlink:label="lab_vrts_AmortizationOfIntangibleAssetsAndContingentAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Intangible Assets and Contingent Amortization</link:label>
    <link:label id="lab_vrts_AmortizationOfIntangibleAssetsAndContingentAmortization_documentation_en-US" xlink:label="lab_vrts_AmortizationOfIntangibleAssetsAndContingentAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amortization of Intangible Assets and Contingent Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_AmortizationOfIntangibleAssetsAndContingentAmortization" xlink:href="vrts-20240331.xsd#vrts_AmortizationOfIntangibleAssetsAndContingentAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_AmortizationOfIntangibleAssetsAndContingentAmortization" xlink:to="lab_vrts_AmortizationOfIntangibleAssetsAndContingentAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_7dd1c1ef-cd63-40a9-a28d-016209081e82_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_label_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestLineItems" xlink:to="lab_us-gaap_MinorityInterestLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18a27fff-2bc7-4d3c-b0e4-34da398e168a_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by (used in) operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_c3a6df33-6a98-4893-ad6c-46d6cbd2b24a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_2aa0aca9-7253-49bb-a9e0-ec69db63456f_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTextBlock_3fdc8cb5-0da8-4457-9ee8-fee174897c43_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTextBlock" xlink:to="lab_us-gaap_InvestmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_3ae857a0-6b48-455e-a709-7ee1ea6619ef_totalLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Economic Interests</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Interest Entity, Measure of Activity, Income or Loss before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" xlink:to="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableCurrentAndNoncurrent_79586536-55c8-424f-86ad-c84675626953_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends payable</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_96c97fa9-4538-4c4b-815f-65005b0aabd5_negatedLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Comprehensive (income) loss attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestments_924b749e-9a5f-418e-ab4f-8790248bda1d_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Realized and unrealized gain (loss) on investments, net</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestments_7ef54f69-5ac5-45da-a3ee-5ab72327cef9_verboseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Realized and unrealized gain (loss), net</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestments" xlink:to="lab_us-gaap_GainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_CreditFacility2017Member_04fd38f0-ad03-4fb2-a124-a43fcc428ca2_terseLabel_en-US" xlink:label="lab_vrts_CreditFacility2017Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility 2017</link:label>
    <link:label id="lab_vrts_CreditFacility2017Member_label_en-US" xlink:label="lab_vrts_CreditFacility2017Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility 2017 [Member]</link:label>
    <link:label id="lab_vrts_CreditFacility2017Member_documentation_en-US" xlink:label="lab_vrts_CreditFacility2017Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Credit Facility 2017 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_CreditFacility2017Member" xlink:href="vrts-20240331.xsd#vrts_CreditFacility2017Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_CreditFacility2017Member" xlink:to="lab_vrts_CreditFacility2017Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_14aafba6-7191-439f-8530-be5d38c6e8ce_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_ce4661c2-375c-4d8c-9267-83bc8cc058a9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average grant date fair value, forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_419d23ab-81ee-47fa-bc6a-9482925ef78f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred taxes, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5b56e640-330f-46e3-a1fc-45f3822104e9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_6e21f631-697b-4bb7-b23a-4cb0a1985f25_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_fa9c6261-4fa9-4a50-affe-8cce403eb3c3_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Number of shares, forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_7f3cec75-5b08-45cd-b5fa-d5964fcf7673_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares available for repurchase (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_d4a14a86-0e39-43bd-a189-d21dc95f88a2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill and Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssets_e2e294d0-ae14-475d-b20f-8f2ed4e0afc8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssets_25f916d9-65d2-4b26-88b5-a67f24d24e28_netLabel_en-US" xlink:label="lab_us-gaap_OtherAssets" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssets_label_en-US" xlink:label="lab_us-gaap_OtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssets" xlink:to="lab_us-gaap_OtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_a29dd619-033a-44e0-b0a1-0ec9dccc2649_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common shares related to employee stock transactions (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_510f39a2-7197-4b72-8828-ec707fa4eaef_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_RestrictedStockUnitsandPerformanceSharesUnitsMember_fa6c074e-33d0-48dc-99a0-879a7611430d_terseLabel_en-US" xlink:label="lab_vrts_RestrictedStockUnitsandPerformanceSharesUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">RSUs and PSUs</link:label>
    <link:label id="lab_vrts_RestrictedStockUnitsandPerformanceSharesUnitsMember_label_en-US" xlink:label="lab_vrts_RestrictedStockUnitsandPerformanceSharesUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock Units and Performance Shares Units [Member]</link:label>
    <link:label id="lab_vrts_RestrictedStockUnitsandPerformanceSharesUnitsMember_documentation_en-US" xlink:label="lab_vrts_RestrictedStockUnitsandPerformanceSharesUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Restricted Stock Units and Performance Shares Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_RestrictedStockUnitsandPerformanceSharesUnitsMember" xlink:href="vrts-20240331.xsd#vrts_RestrictedStockUnitsandPerformanceSharesUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_RestrictedStockUnitsandPerformanceSharesUnitsMember" xlink:to="lab_vrts_RestrictedStockUnitsandPerformanceSharesUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_e724096a-4977-4867-b9ee-227159d4eebc_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plus: Incremental shares from assumed conversion of dilutive instruments (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_c4d549ff-ca7c-4339-b418-662fa2f5eded_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Change in other assets and liabilities of CIP</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_1a4a5d1c-77f4-488d-8bdc-fe7aad35b9c8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_NoncashFinancingItemsAbstract_3189f922-123b-4009-be41-eb74742aebc6_terseLabel_en-US" xlink:label="lab_vrts_NoncashFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Cash Financing Activities:</link:label>
    <link:label id="lab_vrts_NoncashFinancingItemsAbstract_label_en-US" xlink:label="lab_vrts_NoncashFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncash Financing Items [Abstract]</link:label>
    <link:label id="lab_vrts_NoncashFinancingItemsAbstract_documentation_en-US" xlink:label="lab_vrts_NoncashFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Noncash Financing Items</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_NoncashFinancingItemsAbstract" xlink:href="vrts-20240331.xsd#vrts_NoncashFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_NoncashFinancingItemsAbstract" xlink:to="lab_vrts_NoncashFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_c703edc0-fd15-4325-bc5d-dc29fb27c594_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities_f0e26f74-4868-4031-bb03-0153d49d1cf0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchases of investments by CIP</link:label>
    <link:label id="lab_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Purchase of Securities, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities" xlink:to="lab_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_a20ed56d-5d2a-467c-86e1-cc3a39582732_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_b1996c0b-8115-48d4-9d85-f67b6cf36d88_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_e7fdb43d-9db5-4371-9ac3-ef861e8a98a9_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_7105cd9e-63dd-4a16-b997-d9353b1f0ec0_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_90826ea2-4283-430d-921d-777120282afc_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_9ade99a6-dd95-417d-957f-20ef3c3c935b_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_f3704b1e-49b4-44ed-b521-f5e8b1a34645_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_3fe71aeb-15bf-45d7-8d5c-dc8faca88e83_periodStartLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Gross book value, beginning of period</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_30cee964-fc03-4c4c-a7dc-e743ffb05987_periodEndLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Gross book value balance, end of period</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_e89f8b58-62d7-4c9d-b624-a43a145efed2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_d994245d-7bb2-4089-a22e-feb30eb8c5d3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_IncreaseDecreaseInCashAndCashEquivalentsOfSubsidiariesDueToConsolidation_283d01dd-f1a3-4e52-b626-2797ac5e68cd_terseLabel_en-US" xlink:label="lab_vrts_IncreaseDecreaseInCashAndCashEquivalentsOfSubsidiariesDueToConsolidation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in cash and cash equivalents of CIP due to consolidation (deconsolidation), net</link:label>
    <link:label id="lab_vrts_IncreaseDecreaseInCashAndCashEquivalentsOfSubsidiariesDueToConsolidation_label_en-US" xlink:label="lab_vrts_IncreaseDecreaseInCashAndCashEquivalentsOfSubsidiariesDueToConsolidation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Cash And Cash Equivalents Of Subsidiaries Due To Consolidation</link:label>
    <link:label id="lab_vrts_IncreaseDecreaseInCashAndCashEquivalentsOfSubsidiariesDueToConsolidation_documentation_en-US" xlink:label="lab_vrts_IncreaseDecreaseInCashAndCashEquivalentsOfSubsidiariesDueToConsolidation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Cash And Cash Equivalents Of Subsidiaries Due To Consolidation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_IncreaseDecreaseInCashAndCashEquivalentsOfSubsidiariesDueToConsolidation" xlink:href="vrts-20240331.xsd#vrts_IncreaseDecreaseInCashAndCashEquivalentsOfSubsidiariesDueToConsolidation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_IncreaseDecreaseInCashAndCashEquivalentsOfSubsidiariesDueToConsolidation" xlink:to="lab_vrts_IncreaseDecreaseInCashAndCashEquivalentsOfSubsidiariesDueToConsolidation" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_5529a98c-ce0a-4d0e-b83b-cd74b121290e_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_32d73340-cd85-4517-8212-db0c2db0a48d_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_cb1ca1a9-7c80-4b0f-a052-3fa9e0270b6b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_64511d11-be09-4972-b800-f42803a5b142_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_66dd2c90-7e44-409a-9339-f612196d504e_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_da49675f-6a66-4fc2-bde7-b6e2df1fb23a_verboseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_ea55d3b8-803c-4bd4-a0ad-31579c85dbee_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Redeemable Noncontrolling Interest [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RedeemableNoncontrollingInterestTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_b8cc25d3-1faf-482f-bc97-827815f6457b_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_SecuritiesPurchasedPayable_7b06fa03-b24d-49da-8bc0-adc743d46882_negatedTerseLabel_en-US" xlink:label="lab_vrts_SecuritiesPurchasedPayable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Securities purchased payable and other liabilities</link:label>
    <link:label id="lab_vrts_SecuritiesPurchasedPayable_label_en-US" xlink:label="lab_vrts_SecuritiesPurchasedPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Securities Purchased Payable</link:label>
    <link:label id="lab_vrts_SecuritiesPurchasedPayable_documentation_en-US" xlink:label="lab_vrts_SecuritiesPurchasedPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Securities Purchased Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_SecuritiesPurchasedPayable" xlink:href="vrts-20240331.xsd#vrts_SecuritiesPurchasedPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_SecuritiesPurchasedPayable" xlink:to="lab_vrts_SecuritiesPurchasedPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_5b99acef-d363-41a9-a903-651a62e24ab2_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_4eb27e9c-b6f1-4e7f-ae44-7d7ab836243d_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_46c57225-9e39-41f1-80a0-36cf986867f5_netLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_f13a14cc-9c6c-448e-bc02-da5e8f7fc4ae_terseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share settlement under RSUs (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotes_6719e2ec-8970-4b0b-a981-99aa866bfc4c_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes payable of CIP</link:label>
    <link:label id="lab_us-gaap_SeniorNotes_label_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotes" xlink:to="lab_us-gaap_SeniorNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_VotingInterestEntityVOEMember_5aa6ad1c-629c-4bf6-b45b-46d7e235ca9f_terseLabel_en-US" xlink:label="lab_vrts_VotingInterestEntityVOEMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">VOEs</link:label>
    <link:label id="lab_vrts_VotingInterestEntityVOEMember_label_en-US" xlink:label="lab_vrts_VotingInterestEntityVOEMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Voting Interest Entity (VOE) [Member]</link:label>
    <link:label id="lab_vrts_VotingInterestEntityVOEMember_documentation_en-US" xlink:label="lab_vrts_VotingInterestEntityVOEMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Voting Interest Entity (VOE) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VotingInterestEntityVOEMember" xlink:href="vrts-20240331.xsd#vrts_VotingInterestEntityVOEMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_VotingInterestEntityVOEMember" xlink:to="lab_vrts_VotingInterestEntityVOEMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_7b17eb88-8e09-4cc7-88e1-593e71508f03_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_f28e48c9-2476-40fa-84a7-681ca9c8705f_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_8a9375bf-f8c7-40dd-bc19-412ae5cbe9e8_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_1e690220-0578-48a1-960a-923e1620c21b_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesAbstract_c0740949-38c5-4a52-b4cc-b4a3210ce186_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment Securities - fair value</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesAbstract_5a897e2e-cbce-4b32-8834-dfe101de03ee_verboseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Investment securities - fair value</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesAbstract" xlink:to="lab_us-gaap_MarketableSecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_286f74d1-3db5-4edc-b0d8-d1ac9f69d686_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repurchases of common shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a6398c8f-9fe1-47f3-aa5f-4e4cc0597b5a_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Shares Outstanding&#8212;Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f4df3770-435d-4b3c-8495-e40f41449cf7_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted: Weighted-average number of shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingAssets_47533f1f-aeef-456f-a8d4-dce068a506c0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, net and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_3f4396c7-554e-4429-bff2-585d70006eb5_terseLabel_en-US" xlink:label="lab_vrts_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2029 and thereafter</link:label>
    <link:label id="lab_vrts_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_label_en-US" xlink:label="lab_vrts_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, After Year Four</link:label>
    <link:label id="lab_vrts_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_documentation_en-US" xlink:label="lab_vrts_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:href="vrts-20240331.xsd#vrts_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:to="lab_vrts_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_ContingentConsiderationLiabilityMember_8c296de9-9ada-46d1-985e-2d33f8cc9cfc_terseLabel_en-US" xlink:label="lab_vrts_ContingentConsiderationLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_vrts_ContingentConsiderationLiabilityMember_label_en-US" xlink:label="lab_vrts_ContingentConsiderationLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Consideration Liability [Member]</link:label>
    <link:label id="lab_vrts_ContingentConsiderationLiabilityMember_documentation_en-US" xlink:label="lab_vrts_ContingentConsiderationLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contingent Consideration Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_ContingentConsiderationLiabilityMember" xlink:href="vrts-20240331.xsd#vrts_ContingentConsiderationLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_ContingentConsiderationLiabilityMember" xlink:to="lab_vrts_ContingentConsiderationLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_54427687-201e-44dd-b5de-059b3fb80ed4_totalLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total interest income (expense), net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Income (Expense), Nonoperating, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_272a4c40-27ab-49fe-8d36-60e30bd80c88_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_42821ccd-8c47-4a0f-b455-0d3ab5add0ee_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_InvestmentManagementFeesMember_2f300f99-6dd6-42ef-a944-d692a6d900cb_terseLabel_en-US" xlink:label="lab_vrts_InvestmentManagementFeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment management fees</link:label>
    <link:label id="lab_vrts_InvestmentManagementFeesMember_6c546cde-64da-4cd1-b421-a0e8fd8d9b26_verboseLabel_en-US" xlink:label="lab_vrts_InvestmentManagementFeesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Investment management fees</link:label>
    <link:label id="lab_vrts_InvestmentManagementFeesMember_label_en-US" xlink:label="lab_vrts_InvestmentManagementFeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment Management Fees [Member]</link:label>
    <link:label id="lab_vrts_InvestmentManagementFeesMember_documentation_en-US" xlink:label="lab_vrts_InvestmentManagementFeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Investment Management Fees [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_InvestmentManagementFeesMember" xlink:href="vrts-20240331.xsd#vrts_InvestmentManagementFeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_InvestmentManagementFeesMember" xlink:to="lab_vrts_InvestmentManagementFeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4df1c136-4ce0-4bb5-ab4b-73573926fc79_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_0fe6a27e-a6fd-4fe0-ba82-5997e5a7fe0c_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_8a4af92b-86ce-4909-8ed1-abee8c2bb893_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_72a2505a-24d7-4424-8830-5ce0f1ba52a1_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average remaining amortization period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_5e198021-b520-499c-9698-c494b0f3f9d6_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember_e691be0e-ba33-47c5-8739-4c82cb2edcd3_terseLabel_en-US" xlink:label="lab_vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidated Investment Products</link:label>
    <link:label id="lab_vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember_ca3b2608-a139-49d6-89cf-98cc66a3a100_verboseLabel_en-US" xlink:label="lab_vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">CIP</link:label>
    <link:label id="lab_vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember_label_en-US" xlink:label="lab_vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary, and Voting Interest Entity [Member]</link:label>
    <link:label id="lab_vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember_documentation_en-US" xlink:label="lab_vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Variable Interest Entity (VIE), Primary Beneficiary, and Voting Interest Entity (VOE) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember" xlink:to="lab_vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_a4c8a7a0-bead-4d17-983f-832db826117a_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Equity in earnings of equity method investments</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_dac658ca-b3fd-4bd0-ba5e-9536d20cded5_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f7f2a679-18d7-49fc-bf11-99f75ff0d6b8_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_66ba2ec5-f9e6-456c-aed9-2de7dafbf929_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Measurements, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LaborAndRelatedExpense_71021e00-7151-4b08-9821-e834ddb3887b_terseLabel_en-US" xlink:label="lab_us-gaap_LaborAndRelatedExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employment expenses</link:label>
    <link:label id="lab_us-gaap_LaborAndRelatedExpense_label_en-US" xlink:label="lab_us-gaap_LaborAndRelatedExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Labor and Related Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LaborAndRelatedExpense" xlink:to="lab_us-gaap_LaborAndRelatedExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_700be99f-bddf-4e19-a275-c8b5b2061a43_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReductionOfLiability_30f50885-7baf-495a-a53a-8178c762db44_negatedTerseLabel_en-US" xlink:label="lab_vrts_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReductionOfLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Reduction for payments made</link:label>
    <link:label id="lab_vrts_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReductionOfLiability_label_en-US" xlink:label="lab_vrts_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReductionOfLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Reduction Of Liability</link:label>
    <link:label id="lab_vrts_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReductionOfLiability_documentation_en-US" xlink:label="lab_vrts_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReductionOfLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Reduction Of Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReductionOfLiability" xlink:href="vrts-20240331.xsd#vrts_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReductionOfLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReductionOfLiability" xlink:to="lab_vrts_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReductionOfLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_542459d8-32e6-48b2-b637-12404fd5b9f4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average grant date fair value, settled (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_1e4e973f-7a91-4ea8-91ba-99cd0a32db1d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchases</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_45c39dec-d4c4-47e6-8b61-231de304c4f3_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_cc091511-44b6-488e-8bbf-e1ae90f2c20d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3052174c-cfb7-4cd6-905e-bad9de19c3e5_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net increase (decrease) in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_cfc73770-ae13-4e11-8297-4446e5c4ac57_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Secured Debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_87069c9e-10e0-46ba-b363-1d864bcec968_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_5ddc16e8-af0b-441c-ae94-bf7deb8cbf35_terseLabel_en-US" xlink:label="lab_us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Distribution and other asset-based expenses</link:label>
    <link:label id="lab_us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_label_en-US" xlink:label="lab_us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expense Related to Distribution or Servicing and Underwriting Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" xlink:to="lab_us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiCost_eb365a58-9bcd-45b7-a703-3bc3f0fa503e_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiCost_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Securities, FV-NI, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiCost" xlink:to="lab_us-gaap_EquitySecuritiesFvNiCost" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_OpenEndFundsMember_d309bd14-763f-4f82-bd39-998bcc0e26f7_terseLabel_en-US" xlink:label="lab_vrts_OpenEndFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Open-end funds</link:label>
    <link:label id="lab_vrts_OpenEndFundsMember_label_en-US" xlink:label="lab_vrts_OpenEndFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Open End Funds [Member]</link:label>
    <link:label id="lab_vrts_OpenEndFundsMember_documentation_en-US" xlink:label="lab_vrts_OpenEndFundsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Open End Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_OpenEndFundsMember" xlink:href="vrts-20240331.xsd#vrts_OpenEndFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_OpenEndFundsMember" xlink:to="lab_vrts_OpenEndFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_814ed124-8150-4927-ba1e-c56e677294d9_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Shares Outstanding&#8212;Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_dfe2c92e-7b64-4fbe-8abb-670d9ad42e40_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic: Weighted-average number of shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_0f0debc3-1464-4df2-a5ee-f625f961eff7_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_e079ebbb-ab54-42d4-819f-e4aeaa86c551_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_606a97c8-9c8f-46e1-b29e-23d47ea8d200_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_a7bef133-c2ad-4c13-a346-a13b5b88410f_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Income:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_6a22a73b-afec-4370-98b7-65fe1a9caf86_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_RestrictedStockUnitsRSUsPerformanceBasedMember_9a37a67d-3d89-4fc3-973f-8e2af25e21c6_terseLabel_en-US" xlink:label="lab_vrts_RestrictedStockUnitsRSUsPerformanceBasedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted stock units (RSUs), performance-based</link:label>
    <link:label id="lab_vrts_RestrictedStockUnitsRSUsPerformanceBasedMember_label_en-US" xlink:label="lab_vrts_RestrictedStockUnitsRSUsPerformanceBasedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs), Performance-Based [Member]</link:label>
    <link:label id="lab_vrts_RestrictedStockUnitsRSUsPerformanceBasedMember_documentation_en-US" xlink:label="lab_vrts_RestrictedStockUnitsRSUsPerformanceBasedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs), Performance-Based [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_RestrictedStockUnitsRSUsPerformanceBasedMember" xlink:href="vrts-20240331.xsd#vrts_RestrictedStockUnitsRSUsPerformanceBasedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_RestrictedStockUnitsRSUsPerformanceBasedMember" xlink:to="lab_vrts_RestrictedStockUnitsRSUsPerformanceBasedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vrts_DisposalOfPaymentsForAffiliateEquity_8fbed41d-6b73-41f9-b4d9-8ca0aa846f5d_negatedLabel_en-US" xlink:label="lab_vrts_DisposalOfPaymentsForAffiliateEquity" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Affiliate equity sales (purchases)</link:label>
    <link:label id="lab_vrts_DisposalOfPaymentsForAffiliateEquity_label_en-US" xlink:label="lab_vrts_DisposalOfPaymentsForAffiliateEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Of (Payments For) Affiliate Equity</link:label>
    <link:label id="lab_vrts_DisposalOfPaymentsForAffiliateEquity_documentation_en-US" xlink:label="lab_vrts_DisposalOfPaymentsForAffiliateEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal Of (Payments For) Affiliate Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_DisposalOfPaymentsForAffiliateEquity" xlink:href="vrts-20240331.xsd#vrts_DisposalOfPaymentsForAffiliateEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vrts_DisposalOfPaymentsForAffiliateEquity" xlink:to="lab_vrts_DisposalOfPaymentsForAffiliateEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputComparabilityAdjustmentMember_64de7503-1e22-4e23-819c-f64b3d09f94a_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputComparabilityAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input, Comparability Adjustment</link:label>
    <link:label id="lab_us-gaap_MeasurementInputComparabilityAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputComparabilityAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Comparability Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputComparabilityAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputComparabilityAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputComparabilityAdjustmentMember" xlink:to="lab_us-gaap_MeasurementInputComparabilityAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_7ae9c2c7-9f9b-467f-a07a-9fb8daa4b052_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash Flows from Operating Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_be8c052f-e171-4cca-aa4e-ca0f86760472_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_6c60eaa0-7472-4fac-979f-f4a238884ec2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss), net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_453f9f16-7e2f-4566-ab51-f2a73ed37a19_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding borrowings</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_822937b1-a728-4b38-962e-535b5af6f6d8_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_3d42210b-2510-4c79-96d1-1cf7418f2d08_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non- controlling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>vrts-20240331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:571d5707-32d3-4d02-bf11-c9dc53da4569,g:f6b55787-7777-46c4-a428-e04c6c3401d1-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.virtus.com/role/Cover" xlink:type="simple" xlink:href="vrts-20240331.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_f70f96d1-7b90-403b-bbae-6f209e3259ad" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_1a377873-1f31-4716-b8a5-fac53ef95b1f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f70f96d1-7b90-403b-bbae-6f209e3259ad" xlink:to="loc_dei_DocumentType_1a377873-1f31-4716-b8a5-fac53ef95b1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_78a9e832-3748-4bad-b292-84fbc19f6c15" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f70f96d1-7b90-403b-bbae-6f209e3259ad" xlink:to="loc_dei_DocumentQuarterlyReport_78a9e832-3748-4bad-b292-84fbc19f6c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_6e332623-5a69-41e6-ae91-5e5ec2e6d27a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f70f96d1-7b90-403b-bbae-6f209e3259ad" xlink:to="loc_dei_DocumentPeriodEndDate_6e332623-5a69-41e6-ae91-5e5ec2e6d27a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_d55e7613-0237-4434-b383-0ba594ba1654" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f70f96d1-7b90-403b-bbae-6f209e3259ad" xlink:to="loc_dei_DocumentTransitionReport_d55e7613-0237-4434-b383-0ba594ba1654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_7506da44-53a4-4635-8969-ae68ee35bb08" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f70f96d1-7b90-403b-bbae-6f209e3259ad" xlink:to="loc_dei_EntityFileNumber_7506da44-53a4-4635-8969-ae68ee35bb08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_6d64aaea-be34-4ac0-a043-c28c95b988c6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f70f96d1-7b90-403b-bbae-6f209e3259ad" xlink:to="loc_dei_EntityRegistrantName_6d64aaea-be34-4ac0-a043-c28c95b988c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_61b5a160-05e2-4416-9d9c-964937e8b690" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f70f96d1-7b90-403b-bbae-6f209e3259ad" xlink:to="loc_dei_EntityIncorporationStateCountryCode_61b5a160-05e2-4416-9d9c-964937e8b690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_fb4555d2-85b9-40fb-a3b2-5f7b7c2669c6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f70f96d1-7b90-403b-bbae-6f209e3259ad" xlink:to="loc_dei_EntityTaxIdentificationNumber_fb4555d2-85b9-40fb-a3b2-5f7b7c2669c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_3fcf6de1-1cfa-436d-a76d-b079fa363f87" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f70f96d1-7b90-403b-bbae-6f209e3259ad" xlink:to="loc_dei_EntityAddressAddressLine1_3fcf6de1-1cfa-436d-a76d-b079fa363f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_015b97ae-ae41-41f2-b148-ea02cd6491b2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f70f96d1-7b90-403b-bbae-6f209e3259ad" xlink:to="loc_dei_EntityAddressCityOrTown_015b97ae-ae41-41f2-b148-ea02cd6491b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_04c3563e-717f-45fa-9859-498acb7232b2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f70f96d1-7b90-403b-bbae-6f209e3259ad" xlink:to="loc_dei_EntityAddressStateOrProvince_04c3563e-717f-45fa-9859-498acb7232b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_9953db0d-8a3f-4bad-8e3e-64467604deff" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f70f96d1-7b90-403b-bbae-6f209e3259ad" xlink:to="loc_dei_EntityAddressPostalZipCode_9953db0d-8a3f-4bad-8e3e-64467604deff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_f82d8c5a-3bd7-479a-a0fa-1fa0f76e9134" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f70f96d1-7b90-403b-bbae-6f209e3259ad" xlink:to="loc_dei_CityAreaCode_f82d8c5a-3bd7-479a-a0fa-1fa0f76e9134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_cc783dd7-7149-4634-8d0d-cc42842af877" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f70f96d1-7b90-403b-bbae-6f209e3259ad" xlink:to="loc_dei_LocalPhoneNumber_cc783dd7-7149-4634-8d0d-cc42842af877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_d3f315ba-7d37-4a0a-8f2f-aac381e08d4c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f70f96d1-7b90-403b-bbae-6f209e3259ad" xlink:to="loc_dei_Security12bTitle_d3f315ba-7d37-4a0a-8f2f-aac381e08d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_1d4877cf-7183-4430-a624-902935851ac8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f70f96d1-7b90-403b-bbae-6f209e3259ad" xlink:to="loc_dei_TradingSymbol_1d4877cf-7183-4430-a624-902935851ac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_2d44a425-ed66-4b16-95f3-614aafe3d51f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f70f96d1-7b90-403b-bbae-6f209e3259ad" xlink:to="loc_dei_SecurityExchangeName_2d44a425-ed66-4b16-95f3-614aafe3d51f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_ecdd4ae2-81d7-46b9-bcfd-fd7019729f48" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f70f96d1-7b90-403b-bbae-6f209e3259ad" xlink:to="loc_dei_EntityCurrentReportingStatus_ecdd4ae2-81d7-46b9-bcfd-fd7019729f48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_b3fa20a6-b2d7-414d-b578-c396304a38c7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f70f96d1-7b90-403b-bbae-6f209e3259ad" xlink:to="loc_dei_EntityInteractiveDataCurrent_b3fa20a6-b2d7-414d-b578-c396304a38c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_91e8e17a-eaaa-498d-a8a0-d79e0b45a760" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f70f96d1-7b90-403b-bbae-6f209e3259ad" xlink:to="loc_dei_EntityFilerCategory_91e8e17a-eaaa-498d-a8a0-d79e0b45a760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_8661c037-a311-4f4e-aef4-3596bb9b1dcd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f70f96d1-7b90-403b-bbae-6f209e3259ad" xlink:to="loc_dei_EntitySmallBusiness_8661c037-a311-4f4e-aef4-3596bb9b1dcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_a1aec15b-5bbd-4767-9320-bab311e9be4a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f70f96d1-7b90-403b-bbae-6f209e3259ad" xlink:to="loc_dei_EntityEmergingGrowthCompany_a1aec15b-5bbd-4767-9320-bab311e9be4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_a22a9679-4033-400e-ae2d-40411de46f6b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f70f96d1-7b90-403b-bbae-6f209e3259ad" xlink:to="loc_dei_EntityShellCompany_a22a9679-4033-400e-ae2d-40411de46f6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_b2f588b7-20a1-49af-8b7c-51080aaa8d61" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f70f96d1-7b90-403b-bbae-6f209e3259ad" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_b2f588b7-20a1-49af-8b7c-51080aaa8d61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_60de518a-8dac-4e5c-a8f7-9bad6cbccf61" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f70f96d1-7b90-403b-bbae-6f209e3259ad" xlink:to="loc_dei_AmendmentFlag_60de518a-8dac-4e5c-a8f7-9bad6cbccf61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_39d8ad6d-70d6-4fea-905b-3815039f5790" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f70f96d1-7b90-403b-bbae-6f209e3259ad" xlink:to="loc_dei_DocumentFiscalYearFocus_39d8ad6d-70d6-4fea-905b-3815039f5790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_036f4d6c-a39f-4251-98da-01ca800bacef" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f70f96d1-7b90-403b-bbae-6f209e3259ad" xlink:to="loc_dei_DocumentFiscalPeriodFocus_036f4d6c-a39f-4251-98da-01ca800bacef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_efed8d48-b11e-4f89-ad10-0915c37e490d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f70f96d1-7b90-403b-bbae-6f209e3259ad" xlink:to="loc_dei_EntityCentralIndexKey_efed8d48-b11e-4f89-ad10-0915c37e490d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_d3ce5d9f-af16-4b60-8c41-367175bd300e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f70f96d1-7b90-403b-bbae-6f209e3259ad" xlink:to="loc_dei_CurrentFiscalYearEndDate_d3ce5d9f-af16-4b60-8c41-367175bd300e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="vrts-20240331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_b34f8ce5-18c6-415e-b6c4-b37f70f1e27b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_538f3dfa-7d89-4a1f-9b28-d83912e0044d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b34f8ce5-18c6-415e-b6c4-b37f70f1e27b" xlink:to="loc_us-gaap_StatementTable_538f3dfa-7d89-4a1f-9b28-d83912e0044d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_ac6f5499-5b57-4e1d-ab7a-98d4051ac5f7" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_538f3dfa-7d89-4a1f-9b28-d83912e0044d" xlink:to="loc_srt_ConsolidatedEntitiesAxis_ac6f5499-5b57-4e1d-ab7a-98d4051ac5f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_389304d3-63d3-49ce-9213-b53992e2c95b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_ac6f5499-5b57-4e1d-ab7a-98d4051ac5f7" xlink:to="loc_srt_ConsolidatedEntitiesDomain_389304d3-63d3-49ce-9213-b53992e2c95b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember_56a88478-1d58-49c5-a3ed-9dfe95a8a5ec" xlink:href="vrts-20240331.xsd#vrts_ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_389304d3-63d3-49ce-9213-b53992e2c95b" xlink:to="loc_vrts_ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember_56a88478-1d58-49c5-a3ed-9dfe95a8a5ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember_2f22fa11-f4f3-4bcf-8688-6b4c785ceee8" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_389304d3-63d3-49ce-9213-b53992e2c95b" xlink:to="loc_vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember_2f22fa11-f4f3-4bcf-8688-6b4c785ceee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_13d730f2-a683-44c4-a879-9bd0d4396407" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_538f3dfa-7d89-4a1f-9b28-d83912e0044d" xlink:to="loc_us-gaap_StatementLineItems_13d730f2-a683-44c4-a879-9bd0d4396407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_b11812c6-0bf1-4160-89cc-988e78b338fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_13d730f2-a683-44c4-a879-9bd0d4396407" xlink:to="loc_us-gaap_AssetsAbstract_b11812c6-0bf1-4160-89cc-988e78b338fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7dcf4f08-4192-4afb-bd20-b4737f035787" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b11812c6-0bf1-4160-89cc-988e78b338fe" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7dcf4f08-4192-4afb-bd20-b4737f035787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_bdd1b9a9-2936-4b4e-9432-c472e18a9aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Investments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b11812c6-0bf1-4160-89cc-988e78b338fe" xlink:to="loc_us-gaap_Investments_bdd1b9a9-2936-4b4e-9432-c472e18a9aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet_1ed18468-939f-4647-8ff7-f76d5b2e904d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b11812c6-0bf1-4160-89cc-988e78b338fe" xlink:to="loc_us-gaap_AccountsReceivableNet_1ed18468-939f-4647-8ff7-f76d5b2e904d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_1faab610-965a-47d7-b8a9-7d65167ca409" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b11812c6-0bf1-4160-89cc-988e78b338fe" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_1faab610-965a-47d7-b8a9-7d65167ca409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f9af9f65-778c-4005-b68e-352fe9d5a558" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b11812c6-0bf1-4160-89cc-988e78b338fe" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f9af9f65-778c-4005-b68e-352fe9d5a558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_4e5c8474-55fe-4865-838f-e231b101146d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b11812c6-0bf1-4160-89cc-988e78b338fe" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_4e5c8474-55fe-4865-838f-e231b101146d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2de4382f-fbf2-48ab-8122-14d33e868414" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b11812c6-0bf1-4160-89cc-988e78b338fe" xlink:to="loc_us-gaap_Goodwill_2de4382f-fbf2-48ab-8122-14d33e868414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_5e0e1437-fc1b-4a60-b761-13bbb330f841" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b11812c6-0bf1-4160-89cc-988e78b338fe" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_5e0e1437-fc1b-4a60-b761-13bbb330f841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets_f6119ab3-31ce-4cd8-8449-a62291bee073" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b11812c6-0bf1-4160-89cc-988e78b338fe" xlink:to="loc_us-gaap_OtherAssets_f6119ab3-31ce-4cd8-8449-a62291bee073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_669c0a8d-bd7d-47b8-b59e-78c2f908ce1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b11812c6-0bf1-4160-89cc-988e78b338fe" xlink:to="loc_us-gaap_Assets_669c0a8d-bd7d-47b8-b59e-78c2f908ce1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d5904c2e-7cc9-4cd8-bbf0-cf22cfccc0c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_13d730f2-a683-44c4-a879-9bd0d4396407" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d5904c2e-7cc9-4cd8-bbf0-cf22cfccc0c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_bd3a7d0e-3fe1-4ddf-a64c-4e3ba6469c08" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d5904c2e-7cc9-4cd8-bbf0-cf22cfccc0c2" xlink:to="loc_us-gaap_LiabilitiesAbstract_bd3a7d0e-3fe1-4ddf-a64c-4e3ba6469c08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_a1a3c28b-b5fd-4d41-b277-b0ef311f5c76" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_bd3a7d0e-3fe1-4ddf-a64c-4e3ba6469c08" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_a1a3c28b-b5fd-4d41-b277-b0ef311f5c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_4a774a20-4b72-40a7-ada8-644c71cf6800" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_bd3a7d0e-3fe1-4ddf-a64c-4e3ba6469c08" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_4a774a20-4b72-40a7-ada8-644c71cf6800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_c68b16a3-2ef7-4831-bf2e-8b8d2388e933" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_bd3a7d0e-3fe1-4ddf-a64c-4e3ba6469c08" xlink:to="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_c68b16a3-2ef7-4831-bf2e-8b8d2388e933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3d5e9998-777c-49ff-919a-52aefa1802ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_bd3a7d0e-3fe1-4ddf-a64c-4e3ba6469c08" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3d5e9998-777c-49ff-919a-52aefa1802ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_e8fb0fd4-a67a-46d6-805d-b187300a57fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_bd3a7d0e-3fe1-4ddf-a64c-4e3ba6469c08" xlink:to="loc_us-gaap_LongTermDebt_e8fb0fd4-a67a-46d6-805d-b187300a57fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities_db3a0a11-188c-4fca-9b65-360b23569372" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_bd3a7d0e-3fe1-4ddf-a64c-4e3ba6469c08" xlink:to="loc_us-gaap_OtherLiabilities_db3a0a11-188c-4fca-9b65-360b23569372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_48e6236e-9019-4a9f-9996-cd41fc4db5f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotes"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_bd3a7d0e-3fe1-4ddf-a64c-4e3ba6469c08" xlink:to="loc_us-gaap_SeniorNotes_48e6236e-9019-4a9f-9996-cd41fc4db5f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_SecuritiesPurchasedPayableAndOtherLiabilities_05db7a40-8b94-4b2a-b449-517a5a29fa17" xlink:href="vrts-20240331.xsd#vrts_SecuritiesPurchasedPayableAndOtherLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_bd3a7d0e-3fe1-4ddf-a64c-4e3ba6469c08" xlink:to="loc_vrts_SecuritiesPurchasedPayableAndOtherLiabilities_05db7a40-8b94-4b2a-b449-517a5a29fa17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_f649727b-8e8a-4287-a867-9a3372c8a4e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_bd3a7d0e-3fe1-4ddf-a64c-4e3ba6469c08" xlink:to="loc_us-gaap_Liabilities_f649727b-8e8a-4287-a867-9a3372c8a4e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_487491a4-3b73-4ee5-bb26-e9b849a0a1d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d5904c2e-7cc9-4cd8-bbf0-cf22cfccc0c2" xlink:to="loc_us-gaap_CommitmentsAndContingencies_487491a4-3b73-4ee5-bb26-e9b849a0a1d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_c4142f7f-e84a-483a-aa17-4ee00a9386d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d5904c2e-7cc9-4cd8-bbf0-cf22cfccc0c2" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_c4142f7f-e84a-483a-aa17-4ee00a9386d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_f1383f29-9ef0-4335-8dc5-13d1107efbc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d5904c2e-7cc9-4cd8-bbf0-cf22cfccc0c2" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_f1383f29-9ef0-4335-8dc5-13d1107efbc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_87df4938-9c56-4312-8da9-05f6949081bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_f1383f29-9ef0-4335-8dc5-13d1107efbc7" xlink:to="loc_us-gaap_StockholdersEquityAbstract_87df4938-9c56-4312-8da9-05f6949081bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_f7bf8f57-7d29-426d-9bcd-9f0701d8d79d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_87df4938-9c56-4312-8da9-05f6949081bc" xlink:to="loc_us-gaap_CommonStockValue_f7bf8f57-7d29-426d-9bcd-9f0701d8d79d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_1eef4173-ef25-403b-b1b6-23c976160940" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_87df4938-9c56-4312-8da9-05f6949081bc" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_1eef4173-ef25-403b-b1b6-23c976160940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b060ccaa-ef8c-442a-9147-0700d5004362" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_87df4938-9c56-4312-8da9-05f6949081bc" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b060ccaa-ef8c-442a-9147-0700d5004362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_46cc4cd3-7af8-4b30-8f25-b45c7dfce24c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_87df4938-9c56-4312-8da9-05f6949081bc" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_46cc4cd3-7af8-4b30-8f25-b45c7dfce24c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_7c50a9fd-9c21-4809-8620-8b64f85f52af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_87df4938-9c56-4312-8da9-05f6949081bc" xlink:to="loc_us-gaap_TreasuryStockCommonValue_7c50a9fd-9c21-4809-8620-8b64f85f52af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1b5c9c71-7af5-4c3f-87d3-415a5767ed26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_87df4938-9c56-4312-8da9-05f6949081bc" xlink:to="loc_us-gaap_StockholdersEquity_1b5c9c71-7af5-4c3f-87d3-415a5767ed26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_7e131153-eadb-4448-a2e1-3a84892514a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_f1383f29-9ef0-4335-8dc5-13d1107efbc7" xlink:to="loc_us-gaap_MinorityInterest_7e131153-eadb-4448-a2e1-3a84892514a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6a6ef87e-39ce-4464-87a9-9d6f3d97bcc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_f1383f29-9ef0-4335-8dc5-13d1107efbc7" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6a6ef87e-39ce-4464-87a9-9d6f3d97bcc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_e7da2b31-b15c-4239-9e40-d3c53c97ca0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d5904c2e-7cc9-4cd8-bbf0-cf22cfccc0c2" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_e7da2b31-b15c-4239-9e40-d3c53c97ca0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="vrts-20240331.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_065d7df9-32eb-455b-8d05-c81cccafc4eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_602d52c7-cd11-407f-8183-5dc8f0c4b72a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_065d7df9-32eb-455b-8d05-c81cccafc4eb" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_602d52c7-cd11-407f-8183-5dc8f0c4b72a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_96e2327b-e3b5-4a26-8a2b-882dcdabf420" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_065d7df9-32eb-455b-8d05-c81cccafc4eb" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_96e2327b-e3b5-4a26-8a2b-882dcdabf420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_e2775eb6-f079-4427-b114-9f16ae86b0fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_065d7df9-32eb-455b-8d05-c81cccafc4eb" xlink:to="loc_us-gaap_CommonStockSharesIssued_e2775eb6-f079-4427-b114-9f16ae86b0fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d2c5599f-bcd1-4b11-b808-fcb2196be0a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_065d7df9-32eb-455b-8d05-c81cccafc4eb" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_d2c5599f-bcd1-4b11-b808-fcb2196be0a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_bed9c916-1bb7-4733-9b0e-3eca040353aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_065d7df9-32eb-455b-8d05-c81cccafc4eb" xlink:to="loc_us-gaap_TreasuryStockCommonShares_bed9c916-1bb7-4733-9b0e-3eca040353aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="vrts-20240331.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_d73b8fba-4596-4b4a-8236-af8eb68c74b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2f17ae5d-3101-4146-92f3-4ea6938a5b51" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d73b8fba-4596-4b4a-8236-af8eb68c74b0" xlink:to="loc_us-gaap_StatementTable_2f17ae5d-3101-4146-92f3-4ea6938a5b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d752db1d-4e99-41bc-8be1-28a79033dfc7" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2f17ae5d-3101-4146-92f3-4ea6938a5b51" xlink:to="loc_srt_ProductOrServiceAxis_d752db1d-4e99-41bc-8be1-28a79033dfc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_510bae5f-b618-4b3e-b05f-70fc76201808" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_d752db1d-4e99-41bc-8be1-28a79033dfc7" xlink:to="loc_srt_ProductsAndServicesDomain_510bae5f-b618-4b3e-b05f-70fc76201808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_InvestmentManagementFeesMember_d82a957a-db9f-4138-8d93-4ff320db5eff" xlink:href="vrts-20240331.xsd#vrts_InvestmentManagementFeesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_510bae5f-b618-4b3e-b05f-70fc76201808" xlink:to="loc_vrts_InvestmentManagementFeesMember_d82a957a-db9f-4138-8d93-4ff320db5eff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_DistributionAndServiceFeesMember_92b6150b-ff11-4604-934f-6d65a9a51904" xlink:href="vrts-20240331.xsd#vrts_DistributionAndServiceFeesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_510bae5f-b618-4b3e-b05f-70fc76201808" xlink:to="loc_vrts_DistributionAndServiceFeesMember_92b6150b-ff11-4604-934f-6d65a9a51904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_AdministrationAndShareholderServiceFeesMember_26c244c2-632f-4a65-9f86-39c0b4ae873e" xlink:href="vrts-20240331.xsd#vrts_AdministrationAndShareholderServiceFeesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_510bae5f-b618-4b3e-b05f-70fc76201808" xlink:to="loc_vrts_AdministrationAndShareholderServiceFeesMember_26c244c2-632f-4a65-9f86-39c0b4ae873e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_OtherIncomeAndfeesMember_dac9f636-757d-4dbd-a581-a69393f0a66c" xlink:href="vrts-20240331.xsd#vrts_OtherIncomeAndfeesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_510bae5f-b618-4b3e-b05f-70fc76201808" xlink:to="loc_vrts_OtherIncomeAndfeesMember_dac9f636-757d-4dbd-a581-a69393f0a66c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_5849bb5f-cd91-47f5-a8d7-18ca7d02f036" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2f17ae5d-3101-4146-92f3-4ea6938a5b51" xlink:to="loc_srt_ConsolidatedEntitiesAxis_5849bb5f-cd91-47f5-a8d7-18ca7d02f036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_128e3458-4987-4f0f-8950-22308ea8997a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_5849bb5f-cd91-47f5-a8d7-18ca7d02f036" xlink:to="loc_srt_ConsolidatedEntitiesDomain_128e3458-4987-4f0f-8950-22308ea8997a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember_ce82e346-abe7-4209-b901-6ebf67c0b66b" xlink:href="vrts-20240331.xsd#vrts_ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_128e3458-4987-4f0f-8950-22308ea8997a" xlink:to="loc_vrts_ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember_ce82e346-abe7-4209-b901-6ebf67c0b66b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember_81d05d8e-27aa-43ae-a426-31292da5d0fe" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_128e3458-4987-4f0f-8950-22308ea8997a" xlink:to="loc_vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember_81d05d8e-27aa-43ae-a426-31292da5d0fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_75508091-6d84-4d41-98cd-fcd8706b3e45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2f17ae5d-3101-4146-92f3-4ea6938a5b51" xlink:to="loc_us-gaap_StatementLineItems_75508091-6d84-4d41-98cd-fcd8706b3e45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_0bf3963a-791f-470a-bc53-9f9e998f8ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_75508091-6d84-4d41-98cd-fcd8706b3e45" xlink:to="loc_us-gaap_RevenuesAbstract_0bf3963a-791f-470a-bc53-9f9e998f8ef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_190f8b03-b0c2-4083-a9cd-e77117b52d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_0bf3963a-791f-470a-bc53-9f9e998f8ef3" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_190f8b03-b0c2-4083-a9cd-e77117b52d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_5261ff8d-d8e5-48d7-af6a-e438539ccbfe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_75508091-6d84-4d41-98cd-fcd8706b3e45" xlink:to="loc_us-gaap_OperatingExpensesAbstract_5261ff8d-d8e5-48d7-af6a-e438539ccbfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense_550051e1-6442-40f7-8665-7a2eb613a548" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5261ff8d-d8e5-48d7-af6a-e438539ccbfe" xlink:to="loc_us-gaap_LaborAndRelatedExpense_550051e1-6442-40f7-8665-7a2eb613a548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_ef332de5-ba5e-44fa-93de-d47dce90433f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5261ff8d-d8e5-48d7-af6a-e438539ccbfe" xlink:to="loc_us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_ef332de5-ba5e-44fa-93de-d47dce90433f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating_f343a4b7-ff33-46a3-bed5-c5e3d122dc3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5261ff8d-d8e5-48d7-af6a-e438539ccbfe" xlink:to="loc_us-gaap_OtherCostAndExpenseOperating_f343a4b7-ff33-46a3-bed5-c5e3d122dc3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_da78c6bb-c09d-4d2c-90f8-4667e224a01b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5261ff8d-d8e5-48d7-af6a-e438539ccbfe" xlink:to="loc_us-gaap_RestructuringCharges_da78c6bb-c09d-4d2c-90f8-4667e224a01b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_414e1e9a-1608-43f9-8834-1b892d4c66d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5261ff8d-d8e5-48d7-af6a-e438539ccbfe" xlink:to="loc_us-gaap_Depreciation_414e1e9a-1608-43f9-8834-1b892d4c66d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_AmortizationOfIntangibleAssetsAndContingentAmortization_11f62d78-dcd1-440c-92e0-f7eb6b97433d" xlink:href="vrts-20240331.xsd#vrts_AmortizationOfIntangibleAssetsAndContingentAmortization"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5261ff8d-d8e5-48d7-af6a-e438539ccbfe" xlink:to="loc_vrts_AmortizationOfIntangibleAssetsAndContingentAmortization_11f62d78-dcd1-440c-92e0-f7eb6b97433d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_704a0f92-fb87-4d16-bdd4-bf544f01a769" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5261ff8d-d8e5-48d7-af6a-e438539ccbfe" xlink:to="loc_us-gaap_OperatingExpenses_704a0f92-fb87-4d16-bdd4-bf544f01a769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_aedd9289-b3df-4383-aa89-2ff5639c51b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_75508091-6d84-4d41-98cd-fcd8706b3e45" xlink:to="loc_us-gaap_OperatingIncomeLoss_aedd9289-b3df-4383-aa89-2ff5639c51b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_ad0c2066-ed12-417e-bc9e-46b1041d106f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_75508091-6d84-4d41-98cd-fcd8706b3e45" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_ad0c2066-ed12-417e-bc9e-46b1041d106f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_0fcdec9c-b2ae-4b07-8e86-97affec88e37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_ad0c2066-ed12-417e-bc9e-46b1041d106f" xlink:to="loc_us-gaap_GainLossOnInvestments_0fcdec9c-b2ae-4b07-8e86-97affec88e37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_0add14c1-d056-4b4a-bf0f-6c6c0fe09f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_ad0c2066-ed12-417e-bc9e-46b1041d106f" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_0add14c1-d056-4b4a-bf0f-6c6c0fe09f5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_9ff8df25-c05e-4218-8d76-be7bef14f3c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_ad0c2066-ed12-417e-bc9e-46b1041d106f" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_9ff8df25-c05e-4218-8d76-be7bef14f3c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNetAbstract_464285bc-f289-49a9-9924-03695613612a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNetAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_75508091-6d84-4d41-98cd-fcd8706b3e45" xlink:to="loc_us-gaap_InterestIncomeExpenseNetAbstract_464285bc-f289-49a9-9924-03695613612a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_0e1133c5-1e29-4b6f-aceb-b836c20e2dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestIncomeExpenseNetAbstract_464285bc-f289-49a9-9924-03695613612a" xlink:to="loc_us-gaap_InterestExpense_0e1133c5-1e29-4b6f-aceb-b836c20e2dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_5bb2fc57-7d87-4458-86f4-cbea00bb60fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestIncomeExpenseNetAbstract_464285bc-f289-49a9-9924-03695613612a" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_5bb2fc57-7d87-4458-86f4-cbea00bb60fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_3842e92a-bac1-4655-860b-62665bac93de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestIncomeExpenseNetAbstract_464285bc-f289-49a9-9924-03695613612a" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_3842e92a-bac1-4655-860b-62665bac93de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4dc931b6-f0b6-4d88-a1b4-94ab99ddad07" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_75508091-6d84-4d41-98cd-fcd8706b3e45" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4dc931b6-f0b6-4d88-a1b4-94ab99ddad07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_086ad443-eac3-416b-b65a-8a4e3bb1512b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_75508091-6d84-4d41-98cd-fcd8706b3e45" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_086ad443-eac3-416b-b65a-8a4e3bb1512b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8d974a67-c92f-492f-8156-4b5f1eb3338b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_75508091-6d84-4d41-98cd-fcd8706b3e45" xlink:to="loc_us-gaap_ProfitLoss_8d974a67-c92f-492f-8156-4b5f1eb3338b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_545f6cf0-262f-447c-9b1c-2ac5dd775b75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_75508091-6d84-4d41-98cd-fcd8706b3e45" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_545f6cf0-262f-447c-9b1c-2ac5dd775b75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_3e3f4efd-74ca-4af8-9f73-781ea553a6b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_75508091-6d84-4d41-98cd-fcd8706b3e45" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_3e3f4efd-74ca-4af8-9f73-781ea553a6b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_8df25018-d82e-4e98-81d1-e39ae5cffc75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_75508091-6d84-4d41-98cd-fcd8706b3e45" xlink:to="loc_us-gaap_EarningsPerShareBasic_8df25018-d82e-4e98-81d1-e39ae5cffc75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_9fbb3e5b-77df-43a6-b383-979a6f94d759" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_75508091-6d84-4d41-98cd-fcd8706b3e45" xlink:to="loc_us-gaap_EarningsPerShareDiluted_9fbb3e5b-77df-43a6-b383-979a6f94d759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b6769c1c-e722-4e43-9f31-6e17aec2687b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_75508091-6d84-4d41-98cd-fcd8706b3e45" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b6769c1c-e722-4e43-9f31-6e17aec2687b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ccfabd54-4d99-4489-a248-ccd749a79677" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_75508091-6d84-4d41-98cd-fcd8706b3e45" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ccfabd54-4d99-4489-a248-ccd749a79677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="vrts-20240331.xsd#CondensedConsolidatedStatementsofComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4cde54f7-f6aa-4f33-b82f-80a7192d1fed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f7a923be-b511-45bc-9963-268065bcfef7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4cde54f7-f6aa-4f33-b82f-80a7192d1fed" xlink:to="loc_us-gaap_ProfitLoss_f7a923be-b511-45bc-9963-268065bcfef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_3f7c1a5c-9ef1-4163-8136-762ef84e6de7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4cde54f7-f6aa-4f33-b82f-80a7192d1fed" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_3f7c1a5c-9ef1-4163-8136-762ef84e6de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_a49e06ee-f369-466a-aa08-1c8fe33dd2c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_3f7c1a5c-9ef1-4163-8136-762ef84e6de7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_a49e06ee-f369-466a-aa08-1c8fe33dd2c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5cc14b8f-cb62-4019-8e72-5bf3cace0652" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_3f7c1a5c-9ef1-4163-8136-762ef84e6de7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5cc14b8f-cb62-4019-8e72-5bf3cace0652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_842bec36-718f-408d-82a3-98b769cee517" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4cde54f7-f6aa-4f33-b82f-80a7192d1fed" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_842bec36-718f-408d-82a3-98b769cee517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_8b8b0492-c79f-468b-9797-81a048cd32fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4cde54f7-f6aa-4f33-b82f-80a7192d1fed" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_8b8b0492-c79f-468b-9797-81a048cd32fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_45cdce97-2978-4230-9343-3e3799ed63c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4cde54f7-f6aa-4f33-b82f-80a7192d1fed" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_45cdce97-2978-4230-9343-3e3799ed63c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeParenthetical" xlink:type="simple" xlink:href="vrts-20240331.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeParenthetical"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b834ed8f-1ab5-4e55-bd94-2937278e9a06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_91b63a66-f934-4e77-8af5-a6e064661292" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b834ed8f-1ab5-4e55-bd94-2937278e9a06" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_91b63a66-f934-4e77-8af5-a6e064661292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="vrts-20240331.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_b7bf64f6-be46-4cd2-a260-45470a22b8f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_5483fa30-fd0e-40ba-be73-2da753d5a1fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b7bf64f6-be46-4cd2-a260-45470a22b8f8" xlink:to="loc_us-gaap_StatementTable_5483fa30-fd0e-40ba-be73-2da753d5a1fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_61ea9333-48bf-48ed-a420-174f84d0ed73" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5483fa30-fd0e-40ba-be73-2da753d5a1fb" xlink:to="loc_srt_ConsolidatedEntitiesAxis_61ea9333-48bf-48ed-a420-174f84d0ed73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_c62ad258-846c-4368-ae7e-bc83b701dace" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_61ea9333-48bf-48ed-a420-174f84d0ed73" xlink:to="loc_srt_ConsolidatedEntitiesDomain_c62ad258-846c-4368-ae7e-bc83b701dace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember_6ae0e5a9-46b5-471c-94bc-5ca3a5820683" xlink:href="vrts-20240331.xsd#vrts_ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_c62ad258-846c-4368-ae7e-bc83b701dace" xlink:to="loc_vrts_ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember_6ae0e5a9-46b5-471c-94bc-5ca3a5820683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember_e84d13c7-6998-4aea-b535-4f78bacb27a4" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_c62ad258-846c-4368-ae7e-bc83b701dace" xlink:to="loc_vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember_e84d13c7-6998-4aea-b535-4f78bacb27a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c8975a37-5457-4fa9-9b18-16cc65500d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5483fa30-fd0e-40ba-be73-2da753d5a1fb" xlink:to="loc_us-gaap_StatementLineItems_c8975a37-5457-4fa9-9b18-16cc65500d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_06217459-c0c2-410c-9590-0dc371c4337a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c8975a37-5457-4fa9-9b18-16cc65500d6e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_06217459-c0c2-410c-9590-0dc371c4337a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ed3f288b-5337-407c-a37a-c214c67e860c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_06217459-c0c2-410c-9590-0dc371c4337a" xlink:to="loc_us-gaap_ProfitLoss_ed3f288b-5337-407c-a37a-c214c67e860c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e512ea3a-07d5-413c-b36a-9cf69afa0cab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_06217459-c0c2-410c-9590-0dc371c4337a" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e512ea3a-07d5-413c-b36a-9cf69afa0cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_6494ba58-2b09-4ec8-8de9-329dd65972ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e512ea3a-07d5-413c-b36a-9cf69afa0cab" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_6494ba58-2b09-4ec8-8de9-329dd65972ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_e840b403-743e-4a20-8d04-446715ebbb57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e512ea3a-07d5-413c-b36a-9cf69afa0cab" xlink:to="loc_us-gaap_ShareBasedCompensation_e840b403-743e-4a20-8d04-446715ebbb57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_e06bd199-5978-4486-85d5-e30619c0e5a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e512ea3a-07d5-413c-b36a-9cf69afa0cab" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_e06bd199-5978-4486-85d5-e30619c0e5a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_f24a2df0-4587-4d49-ad3f-aa5f3d7c8f41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtAndEquitySecuritiesGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e512ea3a-07d5-413c-b36a-9cf69afa0cab" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_f24a2df0-4587-4d49-ad3f-aa5f3d7c8f41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_212d506c-3f35-437c-b935-82da2602fdb4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e512ea3a-07d5-413c-b36a-9cf69afa0cab" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_212d506c-3f35-437c-b935-82da2602fdb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39b0a765-b9fe-4f70-b373-06a846f7bf59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e512ea3a-07d5-413c-b36a-9cf69afa0cab" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39b0a765-b9fe-4f70-b373-06a846f7bf59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForTradingSecurities_a77faeb3-d985-47c5-89d4-980316ce9d53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsForTradingSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39b0a765-b9fe-4f70-b373-06a846f7bf59" xlink:to="loc_us-gaap_ProceedsFromPaymentsForTradingSecurities_a77faeb3-d985-47c5-89d4-980316ce9d53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingAssets_1ad247c2-c26e-40cd-b9d0-191dc7cb2661" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39b0a765-b9fe-4f70-b373-06a846f7bf59" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingAssets_1ad247c2-c26e-40cd-b9d0-191dc7cb2661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLiabilities_3d040a4a-e16a-4e59-aabe-4b3f38c56af9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39b0a765-b9fe-4f70-b373-06a846f7bf59" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLiabilities_3d040a4a-e16a-4e59-aabe-4b3f38c56af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8ba85728-5cac-44ff-8238-0367243916d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e512ea3a-07d5-413c-b36a-9cf69afa0cab" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8ba85728-5cac-44ff-8238-0367243916d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_ca58b6ba-8700-4ad1-a6e7-4d77418ccd7e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtAndEquitySecuritiesGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8ba85728-5cac-44ff-8238-0367243916d2" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_ca58b6ba-8700-4ad1-a6e7-4d77418ccd7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities_5a694543-bd1f-408e-bbca-8ebc2943d37f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8ba85728-5cac-44ff-8238-0367243916d2" xlink:to="loc_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities_5a694543-bd1f-408e-bbca-8ebc2943d37f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_e20f3196-251e-4af3-8d40-2c8b884039ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8ba85728-5cac-44ff-8238-0367243916d2" xlink:to="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_e20f3196-251e-4af3-8d40-2c8b884039ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_ProceedsFromPaymentsForOtherInvestmentsOperatingActivities_164ade4a-cd9e-4800-ae1a-ebd317b1b64a" xlink:href="vrts-20240331.xsd#vrts_ProceedsFromPaymentsForOtherInvestmentsOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8ba85728-5cac-44ff-8238-0367243916d2" xlink:to="loc_vrts_ProceedsFromPaymentsForOtherInvestmentsOperatingActivities_164ade4a-cd9e-4800-ae1a-ebd317b1b64a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_08f62dc3-36b2-40a1-9399-65fc2c2e2f89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8ba85728-5cac-44ff-8238-0367243916d2" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_08f62dc3-36b2-40a1-9399-65fc2c2e2f89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d41a0940-6f36-4c3f-9bc1-7c59e353d58d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_06217459-c0c2-410c-9590-0dc371c4337a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d41a0940-6f36-4c3f-9bc1-7c59e353d58d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_7ed5fae5-acda-4188-b3b0-2613bd21c39c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c8975a37-5457-4fa9-9b18-16cc65500d6e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_7ed5fae5-acda-4188-b3b0-2613bd21c39c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e9342049-ec54-406c-bd24-1bf7b299eccb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_7ed5fae5-acda-4188-b3b0-2613bd21c39c" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e9342049-ec54-406c-bd24-1bf7b299eccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_IncreaseDecreaseInCashAndCashEquivalentsOfSubsidiariesDueToConsolidation_c0746736-203b-42a4-bb12-699ef717c213" xlink:href="vrts-20240331.xsd#vrts_IncreaseDecreaseInCashAndCashEquivalentsOfSubsidiariesDueToConsolidation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_7ed5fae5-acda-4188-b3b0-2613bd21c39c" xlink:to="loc_vrts_IncreaseDecreaseInCashAndCashEquivalentsOfSubsidiariesDueToConsolidation_c0746736-203b-42a4-bb12-699ef717c213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_093647ef-e0ba-4a0c-a5ba-7513db2e6abb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_7ed5fae5-acda-4188-b3b0-2613bd21c39c" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_093647ef-e0ba-4a0c-a5ba-7513db2e6abb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7d8c87cb-fbc4-4ac4-aaac-3c3577819c2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_7ed5fae5-acda-4188-b3b0-2613bd21c39c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7d8c87cb-fbc4-4ac4-aaac-3c3577819c2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1c50cd35-8dd3-499f-be65-62f1da31335d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c8975a37-5457-4fa9-9b18-16cc65500d6e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1c50cd35-8dd3-499f-be65-62f1da31335d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_71e4072d-2f4c-41cb-bbc8-d0b74b928da4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1c50cd35-8dd3-499f-be65-62f1da31335d" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_71e4072d-2f4c-41cb-bbc8-d0b74b928da4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_09dab1fc-9330-44c7-9a0f-d4e1facd4d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1c50cd35-8dd3-499f-be65-62f1da31335d" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_09dab1fc-9330-44c7-9a0f-d4e1facd4d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_57998bb3-51a2-401b-80da-98334bec632f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1c50cd35-8dd3-499f-be65-62f1da31335d" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_57998bb3-51a2-401b-80da-98334bec632f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_ac73536d-0b52-4d90-8906-28ad25334cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1c50cd35-8dd3-499f-be65-62f1da31335d" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_ac73536d-0b52-4d90-8906-28ad25334cdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_da66ba99-1154-43b4-9803-cd8dae9d9d75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1c50cd35-8dd3-499f-be65-62f1da31335d" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_da66ba99-1154-43b4-9803-cd8dae9d9d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_DisposalOfPaymentsForAffiliateEquity_238f94e4-a451-4ffb-aefb-7b8e4ba5bb55" xlink:href="vrts-20240331.xsd#vrts_DisposalOfPaymentsForAffiliateEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1c50cd35-8dd3-499f-be65-62f1da31335d" xlink:to="loc_vrts_DisposalOfPaymentsForAffiliateEquity_238f94e4-a451-4ffb-aefb-7b8e4ba5bb55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsToMinorityShareholders_ecb7239e-7c0e-4900-8e1d-1d4cf3e8c3e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsToMinorityShareholders"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1c50cd35-8dd3-499f-be65-62f1da31335d" xlink:to="loc_us-gaap_ProceedsFromPaymentsToMinorityShareholders_ecb7239e-7c0e-4900-8e1d-1d4cf3e8c3e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherDebt_1491c0ed-202e-4d07-b94a-0612f9d84b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfOtherDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1c50cd35-8dd3-499f-be65-62f1da31335d" xlink:to="loc_us-gaap_RepaymentsOfOtherDebt_1491c0ed-202e-4d07-b94a-0612f9d84b3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a23c6860-84ae-48ff-8118-ed8e118918a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1c50cd35-8dd3-499f-be65-62f1da31335d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a23c6860-84ae-48ff-8118-ed8e118918a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e6d82414-03df-4bf9-9552-ccdfcc52d0aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c8975a37-5457-4fa9-9b18-16cc65500d6e" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e6d82414-03df-4bf9-9552-ccdfcc52d0aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_28f242f3-df6e-41d1-a06f-43840f7a4ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c8975a37-5457-4fa9-9b18-16cc65500d6e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_28f242f3-df6e-41d1-a06f-43840f7a4ddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c142ed84-5ad5-408b-937a-ff308f7153f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c8975a37-5457-4fa9-9b18-16cc65500d6e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c142ed84-5ad5-408b-937a-ff308f7153f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_97875378-236e-49a0-a76a-4de638d92b25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c8975a37-5457-4fa9-9b18-16cc65500d6e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_97875378-236e-49a0-a76a-4de638d92b25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_NoncashFinancingItemsAbstract_a59a9ec3-2fa3-4e9f-be3e-053de061d86f" xlink:href="vrts-20240331.xsd#vrts_NoncashFinancingItemsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c8975a37-5457-4fa9-9b18-16cc65500d6e" xlink:to="loc_vrts_NoncashFinancingItemsAbstract_a59a9ec3-2fa3-4e9f-be3e-053de061d86f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue_955b27ce-fc3e-41fd-83cd-bb4ca2e7cc30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestChangeInRedemptionValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vrts_NoncashFinancingItemsAbstract_a59a9ec3-2fa3-4e9f-be3e-053de061d86f" xlink:to="loc_us-gaap_MinorityInterestChangeInRedemptionValue_955b27ce-fc3e-41fd-83cd-bb4ca2e7cc30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_CommonStockDividendsAccruedButNotYetPaid_349a62fa-c9c2-48f2-a924-08db12d8c220" xlink:href="vrts-20240331.xsd#vrts_CommonStockDividendsAccruedButNotYetPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vrts_NoncashFinancingItemsAbstract_a59a9ec3-2fa3-4e9f-be3e-053de061d86f" xlink:to="loc_vrts_CommonStockDividendsAccruedButNotYetPaid_349a62fa-c9c2-48f2-a924-08db12d8c220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_3cab8d92-49d8-4913-9e85-b56081faa187" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c8975a37-5457-4fa9-9b18-16cc65500d6e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_3cab8d92-49d8-4913-9e85-b56081faa187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f57aae63-0efd-49a7-bef1-3feb4a91cff9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_3cab8d92-49d8-4913-9e85-b56081faa187" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f57aae63-0efd-49a7-bef1-3feb4a91cff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_5cc5cdfc-2ed6-4959-987c-51285bf325d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_3cab8d92-49d8-4913-9e85-b56081faa187" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_5cc5cdfc-2ed6-4959-987c-51285bf325d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4ea7bfa3-b4c7-4f70-a38a-acf6ca9cd7b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_3cab8d92-49d8-4913-9e85-b56081faa187" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4ea7bfa3-b4c7-4f70-a38a-acf6ca9cd7b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity" xlink:type="simple" xlink:href="vrts-20240331.xsd#CondensedConsolidatedStatementsofChangesinStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_b22a7fcc-10cf-4a71-a5f5-fc4818e4391f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_86471629-05db-4470-88d4-df7dee0b3c57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_b22a7fcc-10cf-4a71-a5f5-fc4818e4391f" xlink:to="loc_us-gaap_StatementTable_86471629-05db-4470-88d4-df7dee0b3c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_820ce415-ce3c-466e-b591-3fb550df96b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_86471629-05db-4470-88d4-df7dee0b3c57" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_820ce415-ce3c-466e-b591-3fb550df96b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8a7458b4-9a97-41f4-ae77-d0411f95b6de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_820ce415-ce3c-466e-b591-3fb550df96b6" xlink:to="loc_us-gaap_EquityComponentDomain_8a7458b4-9a97-41f4-ae77-d0411f95b6de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_caaeec2a-738c-4b17-a60a-3021d31a34f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8a7458b4-9a97-41f4-ae77-d0411f95b6de" xlink:to="loc_us-gaap_ParentMember_caaeec2a-738c-4b17-a60a-3021d31a34f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_a7f2313e-cc94-4225-9bca-1ff3f811b818" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_caaeec2a-738c-4b17-a60a-3021d31a34f0" xlink:to="loc_us-gaap_CommonStockMember_a7f2313e-cc94-4225-9bca-1ff3f811b818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_6fceacb2-4f4b-4701-9963-590172bc0e8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_caaeec2a-738c-4b17-a60a-3021d31a34f0" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_6fceacb2-4f4b-4701-9963-590172bc0e8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_717f2e01-5d2b-48dd-bb41-343e86eb4aff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_caaeec2a-738c-4b17-a60a-3021d31a34f0" xlink:to="loc_us-gaap_RetainedEarningsMember_717f2e01-5d2b-48dd-bb41-343e86eb4aff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_8e8789b2-421b-4e98-b6b7-0989efe2df94" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_caaeec2a-738c-4b17-a60a-3021d31a34f0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_8e8789b2-421b-4e98-b6b7-0989efe2df94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_cc57e66f-8d61-47b1-bbc1-dafd67d5b0d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_caaeec2a-738c-4b17-a60a-3021d31a34f0" xlink:to="loc_us-gaap_TreasuryStockCommonMember_cc57e66f-8d61-47b1-bbc1-dafd67d5b0d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_acdc9c4b-dc07-4974-87c1-3523f3cf094a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8a7458b4-9a97-41f4-ae77-d0411f95b6de" xlink:to="loc_us-gaap_NoncontrollingInterestMember_acdc9c4b-dc07-4974-87c1-3523f3cf094a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_513499f3-cced-4976-a5a8-73caf2aa8fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_86471629-05db-4470-88d4-df7dee0b3c57" xlink:to="loc_us-gaap_StatementLineItems_513499f3-cced-4976-a5a8-73caf2aa8fb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6bdd6b58-f173-4a91-b2de-f99560bbce32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_513499f3-cced-4976-a5a8-73caf2aa8fb9" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6bdd6b58-f173-4a91-b2de-f99560bbce32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_6f3eb580-fa69-4ee2-a779-87e6d505dc6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6bdd6b58-f173-4a91-b2de-f99560bbce32" xlink:to="loc_us-gaap_CommonStockSharesIssued_6f3eb580-fa69-4ee2-a779-87e6d505dc6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5182000c-d89d-4b86-b425-13dc6087dd7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6bdd6b58-f173-4a91-b2de-f99560bbce32" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5182000c-d89d-4b86-b425-13dc6087dd7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_52e07ab0-4313-47d2-8f51-0828ee617ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6bdd6b58-f173-4a91-b2de-f99560bbce32" xlink:to="loc_us-gaap_TreasuryStockCommonShares_52e07ab0-4313-47d2-8f51-0828ee617ea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_688c820b-2f62-4497-b7f0-27de8e41c1c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6bdd6b58-f173-4a91-b2de-f99560bbce32" xlink:to="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_688c820b-2f62-4497-b7f0-27de8e41c1c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2d1bebd2-4f54-457a-8ef0-47de27e76b5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6bdd6b58-f173-4a91-b2de-f99560bbce32" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2d1bebd2-4f54-457a-8ef0-47de27e76b5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_41767653-5c46-417c-87e4-c6ae14f4b891" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6bdd6b58-f173-4a91-b2de-f99560bbce32" xlink:to="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_41767653-5c46-417c-87e4-c6ae14f4b891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_665005c7-7db6-46bc-86b0-de4b9ee13c00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6bdd6b58-f173-4a91-b2de-f99560bbce32" xlink:to="loc_us-gaap_DividendsCommonStockCash_665005c7-7db6-46bc-86b0-de4b9ee13c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_24512699-23aa-44c3-b5b4-a876cefcfb12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6bdd6b58-f173-4a91-b2de-f99560bbce32" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_24512699-23aa-44c3-b5b4-a876cefcfb12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_87290a64-1d83-4788-b3ba-fe56478dfc2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6bdd6b58-f173-4a91-b2de-f99560bbce32" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_87290a64-1d83-4788-b3ba-fe56478dfc2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_8ce3c047-be57-4719-a844-9392633ad8f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6bdd6b58-f173-4a91-b2de-f99560bbce32" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_8ce3c047-be57-4719-a844-9392633ad8f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_705450af-4284-4abb-946d-36ab2bf15afa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6bdd6b58-f173-4a91-b2de-f99560bbce32" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_705450af-4284-4abb-946d-36ab2bf15afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_656f5bcd-091f-43d6-a7dc-8f4b740b81a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6bdd6b58-f173-4a91-b2de-f99560bbce32" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_656f5bcd-091f-43d6-a7dc-8f4b740b81a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_009c54ad-cb5a-4db2-8d46-3eae9acf4850" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6bdd6b58-f173-4a91-b2de-f99560bbce32" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_009c54ad-cb5a-4db2-8d46-3eae9acf4850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_5c51f66a-004d-4205-b4c9-185b390bc3c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6bdd6b58-f173-4a91-b2de-f99560bbce32" xlink:to="loc_us-gaap_CommonStockSharesIssued_5c51f66a-004d-4205-b4c9-185b390bc3c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9f125951-3f76-4998-b6f2-b9a86ff8c79a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6bdd6b58-f173-4a91-b2de-f99560bbce32" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9f125951-3f76-4998-b6f2-b9a86ff8c79a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_83a95de6-c0c4-4e69-873a-d32574a7cb81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6bdd6b58-f173-4a91-b2de-f99560bbce32" xlink:to="loc_us-gaap_TreasuryStockCommonShares_83a95de6-c0c4-4e69-873a-d32574a7cb81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_44c657a4-61fd-4de8-93d3-2f647c51f257" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_513499f3-cced-4976-a5a8-73caf2aa8fb9" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_44c657a4-61fd-4de8-93d3-2f647c51f257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_19573209-d1fa-4ad9-a7be-a28a0431a4fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_44c657a4-61fd-4de8-93d3-2f647c51f257" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_19573209-d1fa-4ad9-a7be-a28a0431a4fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_4b6b1130-ea90-485d-94e7-5c052ca19f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_44c657a4-61fd-4de8-93d3-2f647c51f257" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_4b6b1130-ea90-485d-94e7-5c052ca19f1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_NoncontrollingInterestSubscriptionsRedemptions_1a1d6286-4951-455b-972b-eec66b42c223" xlink:href="vrts-20240331.xsd#vrts_NoncontrollingInterestSubscriptionsRedemptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_44c657a4-61fd-4de8-93d3-2f647c51f257" xlink:to="loc_vrts_NoncontrollingInterestSubscriptionsRedemptions_1a1d6286-4951-455b-972b-eec66b42c223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_f322bcf4-2154-43e7-a690-c63a6005a371" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_44c657a4-61fd-4de8-93d3-2f647c51f257" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_f322bcf4-2154-43e7-a690-c63a6005a371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityParenthetical" xlink:type="simple" xlink:href="vrts-20240331.xsd#CondensedConsolidatedStatementsofChangesinStockholdersEquityParenthetical"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_e5085976-b42b-44a1-b27e-6d532ebbbddf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_141346b0-9388-4c3b-a407-dc8dca310392" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_e5085976-b42b-44a1-b27e-6d532ebbbddf" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_141346b0-9388-4c3b-a407-dc8dca310392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/OrganizationandBusiness" xlink:type="simple" xlink:href="vrts-20240331.xsd#OrganizationandBusiness"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/OrganizationandBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a734bc45-26cb-44d2-b7cb-9befa0158a59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_f2865163-5e96-4673-9ab3-04009b0b83a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a734bc45-26cb-44d2-b7cb-9befa0158a59" xlink:to="loc_us-gaap_NatureOfOperations_f2865163-5e96-4673-9ab3-04009b0b83a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/BasisofPresentationandSignificantAccountingPolicies" xlink:type="simple" xlink:href="vrts-20240331.xsd#BasisofPresentationandSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/BasisofPresentationandSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_57368160-5d70-484d-a9fe-bd19195e0d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_3babdebb-4e27-4efb-88c1-11a3b468ccb2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_57368160-5d70-484d-a9fe-bd19195e0d2a" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_3babdebb-4e27-4efb-88c1-11a3b468ccb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/Revenues" xlink:type="simple" xlink:href="vrts-20240331.xsd#Revenues"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/Revenues" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5c35e926-1e1b-4115-aacc-66b98515a6f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_524c1724-25e4-4ba1-907c-2012d4185fac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5c35e926-1e1b-4115-aacc-66b98515a6f4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_524c1724-25e4-4ba1-907c-2012d4185fac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/Acquisitions" xlink:type="simple" xlink:href="vrts-20240331.xsd#Acquisitions"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/Acquisitions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_7796594c-ffba-4561-bff6-c3c8e869fac5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_eb79c43e-c4a4-438e-8ea9-4223f69cf290" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_7796594c-ffba-4561-bff6-c3c8e869fac5" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_eb79c43e-c4a4-438e-8ea9-4223f69cf290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/IntangibleAssetsNet" xlink:type="simple" xlink:href="vrts-20240331.xsd#IntangibleAssetsNet"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/IntangibleAssetsNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_484511a5-0dc2-48be-8183-dc7d0a78f38f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_a14d45d6-0f6c-4fd6-ae08-f6a9ba922b07" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_484511a5-0dc2-48be-8183-dc7d0a78f38f" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_a14d45d6-0f6c-4fd6-ae08-f6a9ba922b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/Investments" xlink:type="simple" xlink:href="vrts-20240331.xsd#Investments"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/Investments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsAbstract_3a91e1bf-0096-4561-87e5-542463d1c013" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTextBlock_4cfc06da-ce1d-42b3-9f84-70996d455d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsAbstract_3a91e1bf-0096-4561-87e5-542463d1c013" xlink:to="loc_us-gaap_InvestmentTextBlock_4cfc06da-ce1d-42b3-9f84-70996d455d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="vrts-20240331.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_91b1823e-72ca-455f-883b-a95cfa54d006" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_c5af80ce-3ba2-46f5-a9dd-2464ec6efebb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_91b1823e-72ca-455f-883b-a95cfa54d006" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_c5af80ce-3ba2-46f5-a9dd-2464ec6efebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/EquityTransactions" xlink:type="simple" xlink:href="vrts-20240331.xsd#EquityTransactions"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/EquityTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_016ca269-e3e7-41c3-a12a-bd7d5857a3a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_4ac55b5d-2d19-4b62-9a46-ac2a5c305a03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_016ca269-e3e7-41c3-a12a-bd7d5857a3a9" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_4ac55b5d-2d19-4b62-9a46-ac2a5c305a03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/AccumulatedOtherComprehensiveIncomeLoss" xlink:type="simple" xlink:href="vrts-20240331.xsd#AccumulatedOtherComprehensiveIncomeLoss"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/AccumulatedOtherComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_0a48025e-b399-47b5-a7ce-c91e2587a2eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_c8dc17ee-968e-4b5d-b845-dc4cc51b4829" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0a48025e-b399-47b5-a7ce-c91e2587a2eb" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_c8dc17ee-968e-4b5d-b845-dc4cc51b4829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="vrts-20240331.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fefabe18-f819-4109-a7b4-12c094ef31f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_5ed151ea-1200-4651-8e49-866697f1bf7e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fefabe18-f819-4109-a7b4-12c094ef31f7" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_5ed151ea-1200-4651-8e49-866697f1bf7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/EarningsLossPerShare" xlink:type="simple" xlink:href="vrts-20240331.xsd#EarningsLossPerShare"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/EarningsLossPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_4508eadd-30fb-455d-8a6d-a9e470645dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_b95f6fe9-a65f-46ab-be67-9263bc38058e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4508eadd-30fb-455d-8a6d-a9e470645dfc" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_b95f6fe9-a65f-46ab-be67-9263bc38058e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/IncomeTaxes" xlink:type="simple" xlink:href="vrts-20240331.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_c7a2350b-984c-4673-8a07-6dd502f6a17c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_88618681-5ea6-4f23-b43c-ab4ea3b93d72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c7a2350b-984c-4673-8a07-6dd502f6a17c" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_88618681-5ea6-4f23-b43c-ab4ea3b93d72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/Debt" xlink:type="simple" xlink:href="vrts-20240331.xsd#Debt"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_0605e6c1-0a67-4b9b-b6aa-8b8903959e21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_8c91c018-8386-45cd-bf76-227470efcbca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0605e6c1-0a67-4b9b-b6aa-8b8903959e21" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_8c91c018-8386-45cd-bf76-227470efcbca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="vrts-20240331.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9139a8aa-bbbc-4d67-a09a-426551b1f239" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_b46b6bf8-fab4-4b4e-b5a8-6fa93d5d5a26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9139a8aa-bbbc-4d67-a09a-426551b1f239" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_b46b6bf8-fab4-4b4e-b5a8-6fa93d5d5a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/RedeemableNoncontrollingInterests" xlink:type="simple" xlink:href="vrts-20240331.xsd#RedeemableNoncontrollingInterests"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/RedeemableNoncontrollingInterests" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_1bdb034e-f919-4398-82ca-3e414b9aac23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDisclosureTextBlock_f83e0963-d383-4452-be13-5d2298e0a310" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_1bdb034e-f919-4398-82ca-3e414b9aac23" xlink:to="loc_us-gaap_MinorityInterestDisclosureTextBlock_f83e0963-d383-4452-be13-5d2298e0a310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/Consolidation" xlink:type="simple" xlink:href="vrts-20240331.xsd#Consolidation"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/Consolidation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_443ead6f-aca9-4b4b-8991-c47c1e451b10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsTextBlock_382c8cb9-2a90-44d6-8af1-bbc70d2005e6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedFinancialStatementsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_443ead6f-aca9-4b4b-8991-c47c1e451b10" xlink:to="loc_srt_CondensedFinancialStatementsTextBlock_382c8cb9-2a90-44d6-8af1-bbc70d2005e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/BasisofPresentationandSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="vrts-20240331.xsd#BasisofPresentationandSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/BasisofPresentationandSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d14db311-e7bc-4c8e-9b63-a6b21f5d1904" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_f62f7d2a-635f-4c6f-8699-4bf461018205" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d14db311-e7bc-4c8e-9b63-a6b21f5d1904" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_f62f7d2a-635f-4c6f-8699-4bf461018205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_d451bc24-b4b3-4be9-92a3-e38c156fc7b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d14db311-e7bc-4c8e-9b63-a6b21f5d1904" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_d451bc24-b4b3-4be9-92a3-e38c156fc7b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_d651dd9a-1472-4707-81b7-c7aad34439d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d14db311-e7bc-4c8e-9b63-a6b21f5d1904" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_d651dd9a-1472-4707-81b7-c7aad34439d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_5fce1913-2d4b-4e40-8ef7-2258557ff40c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d14db311-e7bc-4c8e-9b63-a6b21f5d1904" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_5fce1913-2d4b-4e40-8ef7-2258557ff40c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_NoncontrollingInterestPolicyTextBlock_92ce86b7-5acd-449a-90aa-f0daa5725d66" xlink:href="vrts-20240331.xsd#vrts_NoncontrollingInterestPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d14db311-e7bc-4c8e-9b63-a6b21f5d1904" xlink:to="loc_vrts_NoncontrollingInterestPolicyTextBlock_92ce86b7-5acd-449a-90aa-f0daa5725d66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_95516f9b-5087-495b-b4c3-8c7c395c230e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d14db311-e7bc-4c8e-9b63-a6b21f5d1904" xlink:to="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_95516f9b-5087-495b-b4c3-8c7c395c230e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/RevenuesTables" xlink:type="simple" xlink:href="vrts-20240331.xsd#RevenuesTables"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/RevenuesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_28c1372d-b1c4-46c8-956d-b26432864b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_3a04fd12-68dd-4d4c-811d-73f52c2ba0f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_28c1372d-b1c4-46c8-956d-b26432864b3b" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_3a04fd12-68dd-4d4c-811d-73f52c2ba0f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/IntangibleAssetsNetTables" xlink:type="simple" xlink:href="vrts-20240331.xsd#IntangibleAssetsNetTables"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/IntangibleAssetsNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5ecb51ad-368b-4425-8532-b55a81e803d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_e069ee49-41dc-4dbc-a432-b1d63c6ecb2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5ecb51ad-368b-4425-8532-b55a81e803d7" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_e069ee49-41dc-4dbc-a432-b1d63c6ecb2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_a8939f55-cf71-468a-94a8-4379c9a81d92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5ecb51ad-368b-4425-8532-b55a81e803d7" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_a8939f55-cf71-468a-94a8-4379c9a81d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/InvestmentsTables" xlink:type="simple" xlink:href="vrts-20240331.xsd#InvestmentsTables"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/InvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsAbstract_33e5c804-7207-4c85-95b9-a635fb127e8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTableTextBlock_2bd1efec-c37a-4534-b5b3-381d033c0be8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsAbstract_33e5c804-7207-4c85-95b9-a635fb127e8d" xlink:to="loc_us-gaap_InvestmentTableTextBlock_2bd1efec-c37a-4534-b5b3-381d033c0be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_aa9433d8-8ae6-4367-9af6-9ef3a0bd5347" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsAbstract_33e5c804-7207-4c85-95b9-a635fb127e8d" xlink:to="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_aa9433d8-8ae6-4367-9af6-9ef3a0bd5347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="vrts-20240331.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_e229c1de-ce28-44b5-8083-73da3591c5d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_c23ffef0-9e3c-40ca-9c21-1953007a5cbe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e229c1de-ce28-44b5-8083-73da3591c5d1" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_c23ffef0-9e3c-40ca-9c21-1953007a5cbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_5f811336-9dfb-422c-9498-de03c1f89bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e229c1de-ce28-44b5-8083-73da3591c5d1" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_5f811336-9dfb-422c-9498-de03c1f89bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/AccumulatedOtherComprehensiveIncomeLossTables" xlink:type="simple" xlink:href="vrts-20240331.xsd#AccumulatedOtherComprehensiveIncomeLossTables"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/AccumulatedOtherComprehensiveIncomeLossTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_076637aa-a4b2-4b9f-91e0-99fc966956c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_aa177e24-5576-4da1-9a49-ff11af190646" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_076637aa-a4b2-4b9f-91e0-99fc966956c4" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_aa177e24-5576-4da1-9a49-ff11af190646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="vrts-20240331.xsd#StockBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bdf4ced8-490d-40bf-bcb1-a7e2651171c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_StockBasedCompensationExpenseTableTextBlock_f4cca759-2195-40c0-b172-fe83a71e3d4b" xlink:href="vrts-20240331.xsd#vrts_StockBasedCompensationExpenseTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bdf4ced8-490d-40bf-bcb1-a7e2651171c8" xlink:to="loc_vrts_StockBasedCompensationExpenseTableTextBlock_f4cca759-2195-40c0-b172-fe83a71e3d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_248cc041-8e46-4ff0-bd5b-92f0baeb0987" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bdf4ced8-490d-40bf-bcb1-a7e2651171c8" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_248cc041-8e46-4ff0-bd5b-92f0baeb0987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/EarningsLossPerShareTables" xlink:type="simple" xlink:href="vrts-20240331.xsd#EarningsLossPerShareTables"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/EarningsLossPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_6f428eaf-4ea5-4c89-9509-b7b95cd20b00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_85003db5-2f35-4335-8e0e-ef8e2c7e027c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6f428eaf-4ea5-4c89-9509-b7b95cd20b00" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_85003db5-2f35-4335-8e0e-ef8e2c7e027c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_17572be5-2555-4097-8943-b9776651899f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6f428eaf-4ea5-4c89-9509-b7b95cd20b00" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_17572be5-2555-4097-8943-b9776651899f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/RedeemableNoncontrollingInterestsTables" xlink:type="simple" xlink:href="vrts-20240331.xsd#RedeemableNoncontrollingInterestsTables"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/RedeemableNoncontrollingInterestsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_6281da6d-8bdd-4895-bd3b-4f342dd897ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_bece792e-7db1-47d9-b963-690b22e0f82d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RedeemableNoncontrollingInterestTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_6281da6d-8bdd-4895-bd3b-4f342dd897ce" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_bece792e-7db1-47d9-b963-690b22e0f82d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/ConsolidationTables" xlink:type="simple" xlink:href="vrts-20240331.xsd#ConsolidationTables"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/ConsolidationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b5e7d041-02c5-4166-8bfa-d66b54fa5303" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_8c649b2b-b3ff-43a8-aaed-6cf65227dcef" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfCondensedBalanceSheetTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b5e7d041-02c5-4166-8bfa-d66b54fa5303" xlink:to="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_8c649b2b-b3ff-43a8-aaed-6cf65227dcef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_d5a241f0-60e9-407e-8cb3-60e82b31f1c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b5e7d041-02c5-4166-8bfa-d66b54fa5303" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_d5a241f0-60e9-407e-8cb3-60e82b31f1c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_29cac79f-382c-4e88-b47c-138b368fb647" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b5e7d041-02c5-4166-8bfa-d66b54fa5303" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_29cac79f-382c-4e88-b47c-138b368fb647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_372721d9-6e5c-4db4-8170-4eaf36f17b91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b5e7d041-02c5-4166-8bfa-d66b54fa5303" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_372721d9-6e5c-4db4-8170-4eaf36f17b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/RevenuesDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#RevenuesDetails"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/RevenuesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7fcd55c4-e3f0-48ec-9972-17fe5545527c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_333b94a3-0a62-4fc6-9628-f102287f1ed3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7fcd55c4-e3f0-48ec-9972-17fe5545527c" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_333b94a3-0a62-4fc6-9628-f102287f1ed3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_176276c5-9179-435d-8224-9fb9e1f743a2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_333b94a3-0a62-4fc6-9628-f102287f1ed3" xlink:to="loc_srt_ProductOrServiceAxis_176276c5-9179-435d-8224-9fb9e1f743a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9cd1b05e-a78b-4d50-9c14-625f4c9ff8f3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_176276c5-9179-435d-8224-9fb9e1f743a2" xlink:to="loc_srt_ProductsAndServicesDomain_9cd1b05e-a78b-4d50-9c14-625f4c9ff8f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_InvestmentManagementFeesMember_239b7753-0330-4528-8175-a3c7bcf5052d" xlink:href="vrts-20240331.xsd#vrts_InvestmentManagementFeesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9cd1b05e-a78b-4d50-9c14-625f4c9ff8f3" xlink:to="loc_vrts_InvestmentManagementFeesMember_239b7753-0330-4528-8175-a3c7bcf5052d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_OpenEndFundsMember_c90257a8-e465-4d1c-9b9a-7981bf302ae3" xlink:href="vrts-20240331.xsd#vrts_OpenEndFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vrts_InvestmentManagementFeesMember_239b7753-0330-4528-8175-a3c7bcf5052d" xlink:to="loc_vrts_OpenEndFundsMember_c90257a8-e465-4d1c-9b9a-7981bf302ae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_ClosedEndFundsMember_5cacc36a-82af-4577-a7fd-7cd65405eccd" xlink:href="vrts-20240331.xsd#vrts_ClosedEndFundsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vrts_InvestmentManagementFeesMember_239b7753-0330-4528-8175-a3c7bcf5052d" xlink:to="loc_vrts_ClosedEndFundsMember_5cacc36a-82af-4577-a7fd-7cd65405eccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_RetailSeparateAccountsMember_64c1a488-a3ae-412b-b3ef-469771d3d152" xlink:href="vrts-20240331.xsd#vrts_RetailSeparateAccountsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vrts_InvestmentManagementFeesMember_239b7753-0330-4528-8175-a3c7bcf5052d" xlink:to="loc_vrts_RetailSeparateAccountsMember_64c1a488-a3ae-412b-b3ef-469771d3d152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_InstitutionalAccountsMember_0c455a68-4fea-449d-98c1-d9e6493c2fe5" xlink:href="vrts-20240331.xsd#vrts_InstitutionalAccountsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vrts_InvestmentManagementFeesMember_239b7753-0330-4528-8175-a3c7bcf5052d" xlink:to="loc_vrts_InstitutionalAccountsMember_0c455a68-4fea-449d-98c1-d9e6493c2fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_6549c47e-c442-4e64-9cef-01e978b59d41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_333b94a3-0a62-4fc6-9628-f102287f1ed3" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_6549c47e-c442-4e64-9cef-01e978b59d41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_59f4e25f-aba6-4924-9357-93058fb78dca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_6549c47e-c442-4e64-9cef-01e978b59d41" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_59f4e25f-aba6-4924-9357-93058fb78dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/AcquisitionsDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#AcquisitionsDetails"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/AcquisitionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_cec6d822-3bdc-41f6-af44-919aa529d697" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_56ae01c2-208a-49e0-adc2-039ecea26394" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_cec6d822-3bdc-41f6-af44-919aa529d697" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_56ae01c2-208a-49e0-adc2-039ecea26394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b28acb08-183d-4763-8919-ffb0ff40938c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_56ae01c2-208a-49e0-adc2-039ecea26394" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b28acb08-183d-4763-8919-ffb0ff40938c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_904490db-ad26-45ae-b5bc-867408a4b3c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b28acb08-183d-4763-8919-ffb0ff40938c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_904490db-ad26-45ae-b5bc-867408a4b3c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_AlphaSimplexGroupLLCMember_21d09ae3-39c8-4196-9c33-2eb12dde0c98" xlink:href="vrts-20240331.xsd#vrts_AlphaSimplexGroupLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_904490db-ad26-45ae-b5bc-867408a4b3c3" xlink:to="loc_vrts_AlphaSimplexGroupLLCMember_21d09ae3-39c8-4196-9c33-2eb12dde0c98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_5cf0346e-1b59-4c8b-a6a6-18597df318d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_56ae01c2-208a-49e0-adc2-039ecea26394" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_5cf0346e-1b59-4c8b-a6a6-18597df318d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_b85a4775-033a-4438-af7a-f93798330359" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5cf0346e-1b59-4c8b-a6a6-18597df318d1" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_b85a4775-033a-4438-af7a-f93798330359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_26177ec0-78e6-43fa-9f56-30b6a54da565" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5cf0346e-1b59-4c8b-a6a6-18597df318d1" xlink:to="loc_us-gaap_Goodwill_26177ec0-78e6-43fa-9f56-30b6a54da565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_6d18a114-1e81-4c70-b6b4-b6348da8b101" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5cf0346e-1b59-4c8b-a6a6-18597df318d1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_6d18a114-1e81-4c70-b6b4-b6348da8b101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/IntangibleAssetsNetGoodwillandIntangibleAssetsNetDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#IntangibleAssetsNetGoodwillandIntangibleAssetsNetDetails"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/IntangibleAssetsNetGoodwillandIntangibleAssetsNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_41cf3606-6633-4274-9e16-e6d16ada7db1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_92c475bf-397e-4854-8896-3b3d442ff11c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_41cf3606-6633-4274-9e16-e6d16ada7db1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_92c475bf-397e-4854-8896-3b3d442ff11c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_8958dcd1-ca0d-4720-a3b4-2d4f2d55a44f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_92c475bf-397e-4854-8896-3b3d442ff11c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_8958dcd1-ca0d-4720-a3b4-2d4f2d55a44f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_64ce4273-8bae-4b8b-b6e2-8a5ad2615517" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_92c475bf-397e-4854-8896-3b3d442ff11c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_64ce4273-8bae-4b8b-b6e2-8a5ad2615517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_adb5307e-27a3-499f-bed6-b309935186fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_92c475bf-397e-4854-8896-3b3d442ff11c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_adb5307e-27a3-499f-bed6-b309935186fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_687e1848-ffe8-440a-b177-027ad778ac37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_92c475bf-397e-4854-8896-3b3d442ff11c" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_687e1848-ffe8-440a-b177-027ad778ac37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_edde2a5e-5c54-469c-986a-245983623a5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_92c475bf-397e-4854-8896-3b3d442ff11c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_edde2a5e-5c54-469c-986a-245983623a5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e542c1a5-d0aa-4e53-8c73-ac2b60699660" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_92c475bf-397e-4854-8896-3b3d442ff11c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e542c1a5-d0aa-4e53-8c73-ac2b60699660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1da03eb3-7442-447e-9e9a-bf346d1c0e4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_92c475bf-397e-4854-8896-3b3d442ff11c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1da03eb3-7442-447e-9e9a-bf346d1c0e4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_a7f2384c-f07a-4e82-9da2-1de3d18ee282" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_41cf3606-6633-4274-9e16-e6d16ada7db1" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_a7f2384c-f07a-4e82-9da2-1de3d18ee282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_98591b44-8fe2-4d6a-b2d9-1f1a3b85e0f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_a7f2384c-f07a-4e82-9da2-1de3d18ee282" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_98591b44-8fe2-4d6a-b2d9-1f1a3b85e0f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_cfd376ca-4ba9-4b43-9c6a-5f1724c037a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_a7f2384c-f07a-4e82-9da2-1de3d18ee282" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_cfd376ca-4ba9-4b43-9c6a-5f1724c037a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_IntangibleAssetsNetExcludingGoodwillRollForward_2c135230-b056-40a1-a511-ebd0f1dd3382" xlink:href="vrts-20240331.xsd#vrts_IntangibleAssetsNetExcludingGoodwillRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_41cf3606-6633-4274-9e16-e6d16ada7db1" xlink:to="loc_vrts_IntangibleAssetsNetExcludingGoodwillRollForward_2c135230-b056-40a1-a511-ebd0f1dd3382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0b8885d7-153b-48c8-aeb9-7b3b336ccd42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vrts_IntangibleAssetsNetExcludingGoodwillRollForward_2c135230-b056-40a1-a511-ebd0f1dd3382" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0b8885d7-153b-48c8-aeb9-7b3b336ccd42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_fe9f03b5-ddbf-4127-b100-f62b8332f24d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vrts_IntangibleAssetsNetExcludingGoodwillRollForward_2c135230-b056-40a1-a511-ebd0f1dd3382" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_fe9f03b5-ddbf-4127-b100-f62b8332f24d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f78f9e0e-9260-4dbd-b019-940602d79014" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vrts_IntangibleAssetsNetExcludingGoodwillRollForward_2c135230-b056-40a1-a511-ebd0f1dd3382" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f78f9e0e-9260-4dbd-b019-940602d79014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/IntangibleAssetsNetEstimatedAmortizationExpenseofIntangibleAssetsSucceedingYearsDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#IntangibleAssetsNetEstimatedAmortizationExpenseofIntangibleAssetsSucceedingYearsDetails"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/IntangibleAssetsNetEstimatedAmortizationExpenseofIntangibleAssetsSucceedingYearsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_39a3b291-f3c2-4352-8dff-5f53159922f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_4d275df1-c6a5-47ad-90c3-7c4000dd0ec1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_39a3b291-f3c2-4352-8dff-5f53159922f0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_4d275df1-c6a5-47ad-90c3-7c4000dd0ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_788c97a1-84bb-4fff-a715-3b0286d7c43a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_39a3b291-f3c2-4352-8dff-5f53159922f0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_788c97a1-84bb-4fff-a715-3b0286d7c43a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_a6377f99-3469-49ab-ae5c-0558a176ad72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_39a3b291-f3c2-4352-8dff-5f53159922f0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_a6377f99-3469-49ab-ae5c-0558a176ad72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_13a0ba39-1610-4487-9371-04666976d2c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_39a3b291-f3c2-4352-8dff-5f53159922f0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_13a0ba39-1610-4487-9371-04666976d2c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_f26b6aa5-ad32-4c61-89c0-f2c8da3b4c36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_39a3b291-f3c2-4352-8dff-5f53159922f0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_f26b6aa5-ad32-4c61-89c0-f2c8da3b4c36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_04ccfcc4-fdf9-45f3-8a2a-ba9adeef1407" xlink:href="vrts-20240331.xsd#vrts_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_39a3b291-f3c2-4352-8dff-5f53159922f0" xlink:to="loc_vrts_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_04ccfcc4-fdf9-45f3-8a2a-ba9adeef1407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_fb271749-b6c9-42ea-9f5c-7553ffb8a889" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_39a3b291-f3c2-4352-8dff-5f53159922f0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_fb271749-b6c9-42ea-9f5c-7553ffb8a889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/InvestmentsInvestmentsDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#InvestmentsInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/InvestmentsInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsAbstract_2f637658-cf8f-408e-91b4-45ca678bd96a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_cd421430-cf5c-4e05-9e95-39452d67dd49" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsAbstract_2f637658-cf8f-408e-91b4-45ca678bd96a" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_cd421430-cf5c-4e05-9e95-39452d67dd49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_38a4a25d-9b75-41c7-ad55-a2e8659c3ff2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_cd421430-cf5c-4e05-9e95-39452d67dd49" xlink:to="loc_srt_ConsolidatedEntitiesAxis_38a4a25d-9b75-41c7-ad55-a2e8659c3ff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_2e888235-cdd1-457c-86af-b5851404a2a3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_38a4a25d-9b75-41c7-ad55-a2e8659c3ff2" xlink:to="loc_srt_ConsolidatedEntitiesDomain_2e888235-cdd1-457c-86af-b5851404a2a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_d0bdaeb4-784a-45d4-b137-2f12c619fff5" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_2e888235-cdd1-457c-86af-b5851404a2a3" xlink:to="loc_srt_ParentCompanyMember_d0bdaeb4-784a-45d4-b137-2f12c619fff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_fd784726-9af9-4095-91a9-3b8e5d59600e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_cd421430-cf5c-4e05-9e95-39452d67dd49" xlink:to="loc_us-gaap_ScheduleOfInvestmentsLineItems_fd784726-9af9-4095-91a9-3b8e5d59600e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_5e3ea560-96a0-43d3-afcf-2498c12b55af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_fd784726-9af9-4095-91a9-3b8e5d59600e" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_5e3ea560-96a0-43d3-afcf-2498c12b55af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_93cead96-7fa5-483d-b6f2-570747d1f26c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_fd784726-9af9-4095-91a9-3b8e5d59600e" xlink:to="loc_us-gaap_EquityMethodInvestments_93cead96-7fa5-483d-b6f2-570747d1f26c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_InvestmentsInNonqualifiedRetirementPlanAssets_774b9cd3-cec7-47c2-b64d-cfc9a5f8153b" xlink:href="vrts-20240331.xsd#vrts_InvestmentsInNonqualifiedRetirementPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_fd784726-9af9-4095-91a9-3b8e5d59600e" xlink:to="loc_vrts_InvestmentsInNonqualifiedRetirementPlanAssets_774b9cd3-cec7-47c2-b64d-cfc9a5f8153b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_e7afa705-5c0c-4f6b-bbae-37614ba08a96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Investments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_fd784726-9af9-4095-91a9-3b8e5d59600e" xlink:to="loc_us-gaap_Investments_e7afa705-5c0c-4f6b-bbae-37614ba08a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/InvestmentsMarketableSecuritiesDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#InvestmentsMarketableSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/InvestmentsMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsAbstract_036589fb-43e2-4cb8-b9d7-88a775dbbf0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a53ce75f-8cc1-4353-8ca4-97479b771a22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsAbstract_036589fb-43e2-4cb8-b9d7-88a775dbbf0a" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a53ce75f-8cc1-4353-8ca4-97479b771a22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_ad6a52a4-3afb-4b10-ab92-0de5ae0d5b38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a53ce75f-8cc1-4353-8ca4-97479b771a22" xlink:to="loc_us-gaap_FinancialInstrumentAxis_ad6a52a4-3afb-4b10-ab92-0de5ae0d5b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7cf21784-2858-4d35-af72-afebdbf16e75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ad6a52a4-3afb-4b10-ab92-0de5ae0d5b38" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7cf21784-2858-4d35-af72-afebdbf16e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_SponsoredFundsMember_a1bc0991-e83b-4e2c-b1dd-f2aaa3e3a288" xlink:href="vrts-20240331.xsd#vrts_SponsoredFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7cf21784-2858-4d35-af72-afebdbf16e75" xlink:to="loc_vrts_SponsoredFundsMember_a1bc0991-e83b-4e2c-b1dd-f2aaa3e3a288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_124ff274-37df-4aa9-90a9-ae3f5aaa9986" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7cf21784-2858-4d35-af72-afebdbf16e75" xlink:to="loc_us-gaap_EquitySecuritiesMember_124ff274-37df-4aa9-90a9-ae3f5aaa9986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9c8f82da-0657-4e36-b2ff-323d25fd1a94" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a53ce75f-8cc1-4353-8ca4-97479b771a22" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9c8f82da-0657-4e36-b2ff-323d25fd1a94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesAbstract_363e8c88-1625-4266-808d-7e263dd26827" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9c8f82da-0657-4e36-b2ff-323d25fd1a94" xlink:to="loc_us-gaap_MarketableSecuritiesAbstract_363e8c88-1625-4266-808d-7e263dd26827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCost_86431a51-5bc5-4774-b905-40cea2ec03ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesAbstract_363e8c88-1625-4266-808d-7e263dd26827" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCost_86431a51-5bc5-4774-b905-40cea2ec03ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_f82e9c5b-b29a-4a15-af0a-08328bfaffff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesAbstract_363e8c88-1625-4266-808d-7e263dd26827" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_f82e9c5b-b29a-4a15-af0a-08328bfaffff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/InvestmentsNarrativeDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#InvestmentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/InvestmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsAbstract_2397c3e4-6445-474f-8815-d9e02e58b932" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_e2e815d1-fffb-489c-bf64-c7990bcc3759" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtAndEquitySecuritiesRealizedGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsAbstract_2397c3e4-6445-474f-8815-d9e02e58b932" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_e2e815d1-fffb-489c-bf64-c7990bcc3759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/FairValueMeasurementsChangesinAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#FairValueMeasurementsChangesinAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/FairValueMeasurementsChangesinAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0a395f0c-95f9-49ce-86ec-a92c55b4d1f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_828f169b-bc29-43ce-9ad7-1d11bb4c9ebd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0a395f0c-95f9-49ce-86ec-a92c55b4d1f5" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_828f169b-bc29-43ce-9ad7-1d11bb4c9ebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f66175c4-6b06-4763-b046-f4f250107b47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_828f169b-bc29-43ce-9ad7-1d11bb4c9ebd" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f66175c4-6b06-4763-b046-f4f250107b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7b4da85d-65cb-4f73-a5f7-3b2bc553e1f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f66175c4-6b06-4763-b046-f4f250107b47" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7b4da85d-65cb-4f73-a5f7-3b2bc553e1f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_1847ea84-3f24-4fec-a84e-6da9266d6b61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7b4da85d-65cb-4f73-a5f7-3b2bc553e1f7" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_1847ea84-3f24-4fec-a84e-6da9266d6b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_8711715d-2a9d-488b-ae14-e0e10df35314" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7b4da85d-65cb-4f73-a5f7-3b2bc553e1f7" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_8711715d-2a9d-488b-ae14-e0e10df35314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_a0d5fb05-40c9-4093-b35f-f11804d5e29d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7b4da85d-65cb-4f73-a5f7-3b2bc553e1f7" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_a0d5fb05-40c9-4093-b35f-f11804d5e29d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_289e5958-8310-48c6-8f18-4e206c0d3dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_828f169b-bc29-43ce-9ad7-1d11bb4c9ebd" xlink:to="loc_us-gaap_FinancialInstrumentAxis_289e5958-8310-48c6-8f18-4e206c0d3dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7d1f9fbe-d0fd-4047-8dbe-b17f8abff1b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_289e5958-8310-48c6-8f18-4e206c0d3dc3" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7d1f9fbe-d0fd-4047-8dbe-b17f8abff1b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_SponsoredFundsMember_fd33cef4-f95f-46bd-ad29-0fec03def4c6" xlink:href="vrts-20240331.xsd#vrts_SponsoredFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7d1f9fbe-d0fd-4047-8dbe-b17f8abff1b3" xlink:to="loc_vrts_SponsoredFundsMember_fd33cef4-f95f-46bd-ad29-0fec03def4c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_f9fa4b52-537c-43ab-b146-daade29c41d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7d1f9fbe-d0fd-4047-8dbe-b17f8abff1b3" xlink:to="loc_us-gaap_EquitySecuritiesMember_f9fa4b52-537c-43ab-b146-daade29c41d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_NonqualifiedRetirementPlanAssetsMember_b74caa7f-edc2-4a94-9afa-0ef4478b44a9" xlink:href="vrts-20240331.xsd#vrts_NonqualifiedRetirementPlanAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7d1f9fbe-d0fd-4047-8dbe-b17f8abff1b3" xlink:to="loc_vrts_NonqualifiedRetirementPlanAssetsMember_b74caa7f-edc2-4a94-9afa-0ef4478b44a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_ade7fd35-c673-443c-ad33-82d647a5a133" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_828f169b-bc29-43ce-9ad7-1d11bb4c9ebd" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_ade7fd35-c673-443c-ad33-82d647a5a133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_0b6d3102-4069-4857-81b8-f4e80024208b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_ade7fd35-c673-443c-ad33-82d647a5a133" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_0b6d3102-4069-4857-81b8-f4e80024208b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_ContingentConsiderationLiabilityMember_570d6b09-7a17-4e1c-ae5a-6cea8309e542" xlink:href="vrts-20240331.xsd#vrts_ContingentConsiderationLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_0b6d3102-4069-4857-81b8-f4e80024208b" xlink:to="loc_vrts_ContingentConsiderationLiabilityMember_570d6b09-7a17-4e1c-ae5a-6cea8309e542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_d0d1dab2-dee5-41c3-a6e3-8b25f15d1e28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_828f169b-bc29-43ce-9ad7-1d11bb4c9ebd" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_d0d1dab2-dee5-41c3-a6e3-8b25f15d1e28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_69bf2fba-bbae-4621-b9d6-737f25206e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_d0d1dab2-dee5-41c3-a6e3-8b25f15d1e28" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_69bf2fba-bbae-4621-b9d6-737f25206e5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_f86928fb-30e4-498b-8261-791669f3c287" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_69bf2fba-bbae-4621-b9d6-737f25206e5f" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_f86928fb-30e4-498b-8261-791669f3c287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesAbstract_df4d8032-11c6-48bd-8890-af9211759919" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_69bf2fba-bbae-4621-b9d6-737f25206e5f" xlink:to="loc_us-gaap_MarketableSecuritiesAbstract_df4d8032-11c6-48bd-8890-af9211759919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_9f7d4a9f-98d3-4bd7-a027-e4fd76bedaf1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesAbstract_df4d8032-11c6-48bd-8890-af9211759919" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_9f7d4a9f-98d3-4bd7-a027-e4fd76bedaf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_InvestmentsInNonqualifiedRetirementPlanAssets_4e61088d-5817-427d-9295-d147c96ea356" xlink:href="vrts-20240331.xsd#vrts_InvestmentsInNonqualifiedRetirementPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_69bf2fba-bbae-4621-b9d6-737f25206e5f" xlink:to="loc_vrts_InvestmentsInNonqualifiedRetirementPlanAssets_4e61088d-5817-427d-9295-d147c96ea356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_2fef1226-00f2-4361-b717-248496cdd4ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_69bf2fba-bbae-4621-b9d6-737f25206e5f" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_2fef1226-00f2-4361-b717-248496cdd4ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_8912e276-66cd-4001-86e6-3f342a91cfa2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_d0d1dab2-dee5-41c3-a6e3-8b25f15d1e28" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_8912e276-66cd-4001-86e6-3f342a91cfa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_6d54ef7a-9ff6-4537-8771-4b7a68290f5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_8912e276-66cd-4001-86e6-3f342a91cfa2" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_6d54ef7a-9ff6-4537-8771-4b7a68290f5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b59bdfb5-98ca-4a7d-9b33-033b428700cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_444db690-e960-4cc1-bf32-f8a8193dfed0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b59bdfb5-98ca-4a7d-9b33-033b428700cb" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_444db690-e960-4cc1-bf32-f8a8193dfed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f7e1a96e-130b-4934-8bf6-cf9892260345" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_444db690-e960-4cc1-bf32-f8a8193dfed0" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f7e1a96e-130b-4934-8bf6-cf9892260345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0d0ee1ad-681b-4c27-a9b4-943976244442" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f7e1a96e-130b-4934-8bf6-cf9892260345" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0d0ee1ad-681b-4c27-a9b4-943976244442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_WestchesterCapitalManagementMember_05c32b66-c387-4b82-8076-ea89e1fada43" xlink:href="vrts-20240331.xsd#vrts_WestchesterCapitalManagementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0d0ee1ad-681b-4c27-a9b4-943976244442" xlink:to="loc_vrts_WestchesterCapitalManagementMember_05c32b66-c387-4b82-8076-ea89e1fada43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_NFJInvestmentGroupMember_cb198131-6ece-49f3-a97a-32c4b9a008ee" xlink:href="vrts-20240331.xsd#vrts_NFJInvestmentGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0d0ee1ad-681b-4c27-a9b4-943976244442" xlink:to="loc_vrts_NFJInvestmentGroupMember_cb198131-6ece-49f3-a97a-32c4b9a008ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_be7c2979-e37d-41c9-bc46-350a0c6d931a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_444db690-e960-4cc1-bf32-f8a8193dfed0" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_be7c2979-e37d-41c9-bc46-350a0c6d931a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ffec4edb-5849-4fd3-99dd-f68502275fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_be7c2979-e37d-41c9-bc46-350a0c6d931a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ffec4edb-5849-4fd3-99dd-f68502275fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_5aef6f4d-a33c-4eac-96ef-415c03f8d83a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ffec4edb-5849-4fd3-99dd-f68502275fd4" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_5aef6f4d-a33c-4eac-96ef-415c03f8d83a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e564e0e7-f689-4271-abc0-54a69fce82fa" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_444db690-e960-4cc1-bf32-f8a8193dfed0" xlink:to="loc_srt_RangeAxis_e564e0e7-f689-4271-abc0-54a69fce82fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_29f54b2a-daa5-4aca-ac87-4bac12aa25fd" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e564e0e7-f689-4271-abc0-54a69fce82fa" xlink:to="loc_srt_RangeMember_29f54b2a-daa5-4aca-ac87-4bac12aa25fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d32596de-72f4-412d-9107-3796864c29d5" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_29f54b2a-daa5-4aca-ac87-4bac12aa25fd" xlink:to="loc_srt_MinimumMember_d32596de-72f4-412d-9107-3796864c29d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f50f7f6d-7579-414d-a45c-48894af5fb00" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_29f54b2a-daa5-4aca-ac87-4bac12aa25fd" xlink:to="loc_srt_MaximumMember_f50f7f6d-7579-414d-a45c-48894af5fb00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_0ff1ba30-ba42-4aef-ba1d-f6855d7fe5e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_444db690-e960-4cc1-bf32-f8a8193dfed0" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_0ff1ba30-ba42-4aef-ba1d-f6855d7fe5e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_9c75869a-9548-40ef-8c2b-1438ed43d056" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_0ff1ba30-ba42-4aef-ba1d-f6855d7fe5e5" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_9c75869a-9548-40ef-8c2b-1438ed43d056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_bd12a854-d492-460c-bfc3-da204637a66b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_9c75869a-9548-40ef-8c2b-1438ed43d056" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_bd12a854-d492-460c-bfc3-da204637a66b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputComparabilityAdjustmentMember_adeb998e-ceb7-403b-b9e9-659f7b7d2674" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputComparabilityAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_9c75869a-9548-40ef-8c2b-1438ed43d056" xlink:to="loc_us-gaap_MeasurementInputComparabilityAdjustmentMember_adeb998e-ceb7-403b-b9e9-659f7b7d2674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_cd29294b-7613-41aa-8507-eea4f955f4ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_444db690-e960-4cc1-bf32-f8a8193dfed0" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_cd29294b-7613-41aa-8507-eea4f955f4ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_648d0232-8ade-4ec4-821c-4232d6aa9ece" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_cd29294b-7613-41aa-8507-eea4f955f4ec" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_648d0232-8ade-4ec4-821c-4232d6aa9ece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_8c5b0f82-2bb7-477a-be8e-3d523d51e37b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_cd29294b-7613-41aa-8507-eea4f955f4ec" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_8c5b0f82-2bb7-477a-be8e-3d523d51e37b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/FairValueMeasurementsRollforwardoftheContingentConsiderationLiabilitiesValuedUsingLevel3InputsDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#FairValueMeasurementsRollforwardoftheContingentConsiderationLiabilitiesValuedUsingLevel3InputsDetails"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/FairValueMeasurementsRollforwardoftheContingentConsiderationLiabilitiesValuedUsingLevel3InputsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_dbf1645a-9df1-4b7d-a230-95862e07c44b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_cd55b0f6-f812-4530-85b0-43937e43bdc2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_dbf1645a-9df1-4b7d-a230-95862e07c44b" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_cd55b0f6-f812-4530-85b0-43937e43bdc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9e9e8653-78ac-4e97-a8b4-688d66108695" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_cd55b0f6-f812-4530-85b0-43937e43bdc2" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9e9e8653-78ac-4e97-a8b4-688d66108695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2297b250-8186-4ab5-8be5-984d8d2a03cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9e9e8653-78ac-4e97-a8b4-688d66108695" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2297b250-8186-4ab5-8be5-984d8d2a03cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_07417032-9bd1-4b85-9714-d0a831805623" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2297b250-8186-4ab5-8be5-984d8d2a03cf" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_07417032-9bd1-4b85-9714-d0a831805623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_c941a53b-706b-44bf-b1dc-63b7ea34e9d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_cd55b0f6-f812-4530-85b0-43937e43bdc2" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_c941a53b-706b-44bf-b1dc-63b7ea34e9d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_99f70f66-7ab2-40ad-9001-fcbc02aaf49b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_c941a53b-706b-44bf-b1dc-63b7ea34e9d7" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_99f70f66-7ab2-40ad-9001-fcbc02aaf49b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_ContingentConsiderationLiabilityMember_16e465e1-f722-4a05-964a-976f362bd67c" xlink:href="vrts-20240331.xsd#vrts_ContingentConsiderationLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_99f70f66-7ab2-40ad-9001-fcbc02aaf49b" xlink:to="loc_vrts_ContingentConsiderationLiabilityMember_16e465e1-f722-4a05-964a-976f362bd67c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_92dae755-5bf1-4689-a73f-38ae5ba4b8bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_cd55b0f6-f812-4530-85b0-43937e43bdc2" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_92dae755-5bf1-4689-a73f-38ae5ba4b8bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_a886d240-b7b5-4284-aa1c-39a700c54ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_92dae755-5bf1-4689-a73f-38ae5ba4b8bb" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_a886d240-b7b5-4284-aa1c-39a700c54ab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_d506d810-f7fc-4e08-8d1f-8e038864a5e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_a886d240-b7b5-4284-aa1c-39a700c54ab1" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_d506d810-f7fc-4e08-8d1f-8e038864a5e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReductionOfLiability_6c80ab17-e631-44b9-afb4-9ce7531a09b3" xlink:href="vrts-20240331.xsd#vrts_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReductionOfLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_a886d240-b7b5-4284-aa1c-39a700c54ab1" xlink:to="loc_vrts_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReductionOfLiability_6c80ab17-e631-44b9-afb4-9ce7531a09b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_040672ac-0527-4ed2-aefb-d1e88bfaef99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_a886d240-b7b5-4284-aa1c-39a700c54ab1" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_040672ac-0527-4ed2-aefb-d1e88bfaef99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/EquityTransactionsDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#EquityTransactionsDetails"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/EquityTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_4194798f-85bc-47b1-8996-5501d4b968ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_21e7960f-05c3-48cc-962a-e3f6081ab359" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4194798f-85bc-47b1-8996-5501d4b968ff" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_21e7960f-05c3-48cc-962a-e3f6081ab359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_f526166e-950c-44d7-8b45-a97b8df386a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4194798f-85bc-47b1-8996-5501d4b968ff" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_f526166e-950c-44d7-8b45-a97b8df386a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_7005a729-26a2-42b9-b03b-d1d30fad7427" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4194798f-85bc-47b1-8996-5501d4b968ff" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_7005a729-26a2-42b9-b03b-d1d30fad7427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_4fe74462-950d-4f78-a923-9aa16dd29ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4194798f-85bc-47b1-8996-5501d4b968ff" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_4fe74462-950d-4f78-a923-9aa16dd29ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_8dffa94e-5c8d-46bc-8895-d0d8ed7c4135" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4194798f-85bc-47b1-8996-5501d4b968ff" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_8dffa94e-5c8d-46bc-8895-d0d8ed7c4135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#AccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_0548d263-971a-41cd-a4fe-2d145961f606" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_becc8043-19f1-48de-abc8-1e8547910019" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0548d263-971a-41cd-a4fe-2d145961f606" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_becc8043-19f1-48de-abc8-1e8547910019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_52ce26e1-8786-4d7e-a621-2fe073af4d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_becc8043-19f1-48de-abc8-1e8547910019" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_52ce26e1-8786-4d7e-a621-2fe073af4d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_04f9c468-3524-4c19-b367-4915f5c19729" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_52ce26e1-8786-4d7e-a621-2fe073af4d8a" xlink:to="loc_us-gaap_EquityComponentDomain_04f9c468-3524-4c19-b367-4915f5c19729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_c4843ae5-629c-45d1-ba1b-a0ea90313c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_04f9c468-3524-4c19-b367-4915f5c19729" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_c4843ae5-629c-45d1-ba1b-a0ea90313c9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_94cc5642-3bf0-4c72-87e3-b083f093fbeb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_becc8043-19f1-48de-abc8-1e8547910019" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_94cc5642-3bf0-4c72-87e3-b083f093fbeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_e7d058b9-f2ce-4804-9855-e4f9f52eeeff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_94cc5642-3bf0-4c72-87e3-b083f093fbeb" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_e7d058b9-f2ce-4804-9855-e4f9f52eeeff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ee6844c7-573b-4068-9006-9325b84058d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_e7d058b9-f2ce-4804-9855-e4f9f52eeeff" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ee6844c7-573b-4068-9006-9325b84058d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5374071b-5637-48a5-92ce-74f470723b14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_e7d058b9-f2ce-4804-9855-e4f9f52eeeff" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5374071b-5637-48a5-92ce-74f470723b14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b48d0be5-4542-4747-835d-bfdaa60cae87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_e7d058b9-f2ce-4804-9855-e4f9f52eeeff" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b48d0be5-4542-4747-835d-bfdaa60cae87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_d06a6f81-e382-4ee1-af57-d181961e01d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_94cc5642-3bf0-4c72-87e3-b083f093fbeb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_d06a6f81-e382-4ee1-af57-d181961e01d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/StockBasedCompensationAdditionalInformationDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#StockBasedCompensationAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/StockBasedCompensationAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6cdd06cb-e61a-408d-b452-c9eb571f3923" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b7e6004d-337f-4b9d-b6bb-f93020079ce6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6cdd06cb-e61a-408d-b452-c9eb571f3923" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b7e6004d-337f-4b9d-b6bb-f93020079ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_326f47a9-67fb-41d7-a633-ec69e3a76846" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b7e6004d-337f-4b9d-b6bb-f93020079ce6" xlink:to="loc_us-gaap_StatementClassOfStockAxis_326f47a9-67fb-41d7-a633-ec69e3a76846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_082d4d15-5dee-4348-8a16-672970db3f11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_326f47a9-67fb-41d7-a633-ec69e3a76846" xlink:to="loc_us-gaap_ClassOfStockDomain_082d4d15-5dee-4348-8a16-672970db3f11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_ac64c8cb-eff5-44b7-9778-43da72c6ec16" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_082d4d15-5dee-4348-8a16-672970db3f11" xlink:to="loc_us-gaap_CommonStockMember_ac64c8cb-eff5-44b7-9778-43da72c6ec16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_151e0f8a-caa2-46f0-a184-b5fecf01a91f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b7e6004d-337f-4b9d-b6bb-f93020079ce6" xlink:to="loc_srt_RangeAxis_151e0f8a-caa2-46f0-a184-b5fecf01a91f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a6f613e0-c1c1-42f0-8110-1fff404cfb41" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_151e0f8a-caa2-46f0-a184-b5fecf01a91f" xlink:to="loc_srt_RangeMember_a6f613e0-c1c1-42f0-8110-1fff404cfb41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_685dea1f-221f-4633-9e0b-8e7a0305195a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a6f613e0-c1c1-42f0-8110-1fff404cfb41" xlink:to="loc_srt_MinimumMember_685dea1f-221f-4633-9e0b-8e7a0305195a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_842db12f-4f0f-49b0-99d9-23daa26e7d2b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a6f613e0-c1c1-42f0-8110-1fff404cfb41" xlink:to="loc_srt_MaximumMember_842db12f-4f0f-49b0-99d9-23daa26e7d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_2e9a78ce-ed84-436f-b60e-b89c280f9888" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b7e6004d-337f-4b9d-b6bb-f93020079ce6" xlink:to="loc_us-gaap_AwardTypeAxis_2e9a78ce-ed84-436f-b60e-b89c280f9888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c58b6a47-ac31-4234-88aa-6b6e16de5b26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_2e9a78ce-ed84-436f-b60e-b89c280f9888" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c58b6a47-ac31-4234-88aa-6b6e16de5b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_RestrictedStockUnitsandPerformanceSharesUnitsMember_ef31cb0a-2aa8-4121-b519-f39817f7e371" xlink:href="vrts-20240331.xsd#vrts_RestrictedStockUnitsandPerformanceSharesUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c58b6a47-ac31-4234-88aa-6b6e16de5b26" xlink:to="loc_vrts_RestrictedStockUnitsandPerformanceSharesUnitsMember_ef31cb0a-2aa8-4121-b519-f39817f7e371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_deb831a0-2de4-4406-baaa-3da1cb8d85c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vrts_RestrictedStockUnitsandPerformanceSharesUnitsMember_ef31cb0a-2aa8-4121-b519-f39817f7e371" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_deb831a0-2de4-4406-baaa-3da1cb8d85c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_RestrictedStockUnitsRSUsPerformanceBasedMember_d904ae2e-aac5-45ac-a534-56ed6e0c7c86" xlink:href="vrts-20240331.xsd#vrts_RestrictedStockUnitsRSUsPerformanceBasedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vrts_RestrictedStockUnitsandPerformanceSharesUnitsMember_ef31cb0a-2aa8-4121-b519-f39817f7e371" xlink:to="loc_vrts_RestrictedStockUnitsRSUsPerformanceBasedMember_d904ae2e-aac5-45ac-a534-56ed6e0c7c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_PerformanceStockUnitsIncentiveMember_3db76557-cbec-48dd-8adc-c38f5e70296b" xlink:href="vrts-20240331.xsd#vrts_PerformanceStockUnitsIncentiveMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vrts_RestrictedStockUnitsandPerformanceSharesUnitsMember_ef31cb0a-2aa8-4121-b519-f39817f7e371" xlink:to="loc_vrts_PerformanceStockUnitsIncentiveMember_3db76557-cbec-48dd-8adc-c38f5e70296b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_086c0f5c-872e-498a-80db-ce17f90ad988" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b7e6004d-337f-4b9d-b6bb-f93020079ce6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_086c0f5c-872e-498a-80db-ce17f90ad988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_43ac5ae9-3368-4af8-afa8-e100388f7ba4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_086c0f5c-872e-498a-80db-ce17f90ad988" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_43ac5ae9-3368-4af8-afa8-e100388f7ba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_957fbc71-dbc1-4431-9d47-bc3e56c7c17b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_086c0f5c-872e-498a-80db-ce17f90ad988" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_957fbc71-dbc1-4431-9d47-bc3e56c7c17b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_ConversionOfStockConversionRatio_c7ae1f59-d2fc-4ceb-816b-32550661a955" xlink:href="vrts-20240331.xsd#vrts_ConversionOfStockConversionRatio"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_086c0f5c-872e-498a-80db-ce17f90ad988" xlink:to="loc_vrts_ConversionOfStockConversionRatio_c7ae1f59-d2fc-4ceb-816b-32550661a955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d852832d-5a20-47c0-9448-a1d15eba1c00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_086c0f5c-872e-498a-80db-ce17f90ad988" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d852832d-5a20-47c0-9448-a1d15eba1c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_cb186501-a508-4a48-a1a5-12c2170ff5a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_086c0f5c-872e-498a-80db-ce17f90ad988" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_cb186501-a508-4a48-a1a5-12c2170ff5a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_PaymentOfWithholdingTaxesRelatedToRestrictedStock_297ab09b-b6ab-4f59-86e2-2114a1ba7881" xlink:href="vrts-20240331.xsd#vrts_PaymentOfWithholdingTaxesRelatedToRestrictedStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_086c0f5c-872e-498a-80db-ce17f90ad988" xlink:to="loc_vrts_PaymentOfWithholdingTaxesRelatedToRestrictedStock_297ab09b-b6ab-4f59-86e2-2114a1ba7881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_3b21e342-fcb1-4245-86b2-b8498640c41b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_086c0f5c-872e-498a-80db-ce17f90ad988" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_3b21e342-fcb1-4245-86b2-b8498640c41b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_75a3d144-134d-4c3a-8013-69521836fe2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_086c0f5c-872e-498a-80db-ce17f90ad988" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_75a3d144-134d-4c3a-8013-69521836fe2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_3051921a-f929-4da5-87e4-3d06333cc64e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_086c0f5c-872e-498a-80db-ce17f90ad988" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_3051921a-f929-4da5-87e4-3d06333cc64e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_55ad92b9-0689-4251-b6d6-34b40b6df830" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_086c0f5c-872e-498a-80db-ce17f90ad988" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_55ad92b9-0689-4251-b6d6-34b40b6df830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#StockBasedCompensationStockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_694a7225-a97d-40b9-9b2d-6cc98b258939" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_0b3781f8-9291-4f28-bd33-325a2b6b79a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_694a7225-a97d-40b9-9b2d-6cc98b258939" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_0b3781f8-9291-4f28-bd33-325a2b6b79a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#StockBasedCompensationRestrictedStockUnitsActivityDetails"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_93db3d24-a2a2-4cc9-95d0-04ef0550aef9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_50749154-1479-4d09-a5ad-252b4ce256cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_93db3d24-a2a2-4cc9-95d0-04ef0550aef9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_50749154-1479-4d09-a5ad-252b4ce256cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c6218e55-2da9-47eb-b1a1-c2a8fb3526aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_50749154-1479-4d09-a5ad-252b4ce256cc" xlink:to="loc_us-gaap_AwardTypeAxis_c6218e55-2da9-47eb-b1a1-c2a8fb3526aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_abed6562-316b-420a-808f-a3c4c36c6391" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_c6218e55-2da9-47eb-b1a1-c2a8fb3526aa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_abed6562-316b-420a-808f-a3c4c36c6391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_5976143e-5fe9-4f52-a67a-d4fce2500dcb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_abed6562-316b-420a-808f-a3c4c36c6391" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_5976143e-5fe9-4f52-a67a-d4fce2500dcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e0942307-395a-4e23-bed8-575779cce62d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_50749154-1479-4d09-a5ad-252b4ce256cc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e0942307-395a-4e23-bed8-575779cce62d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_43fffee8-12c9-44a8-a4c0-0f258ffe43cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e0942307-395a-4e23-bed8-575779cce62d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_43fffee8-12c9-44a8-a4c0-0f258ffe43cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1ecc2a19-2922-45cd-9b2a-ca0d3e23e93c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_43fffee8-12c9-44a8-a4c0-0f258ffe43cc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1ecc2a19-2922-45cd-9b2a-ca0d3e23e93c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0da8550d-e3b2-45f4-b7c4-770bb1dd6b64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_43fffee8-12c9-44a8-a4c0-0f258ffe43cc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0da8550d-e3b2-45f4-b7c4-770bb1dd6b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_90118e9a-c784-45b9-9390-bb25b3a2797e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_43fffee8-12c9-44a8-a4c0-0f258ffe43cc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_90118e9a-c784-45b9-9390-bb25b3a2797e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_141543b2-0f89-4631-8f6c-4eba441bf6dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_43fffee8-12c9-44a8-a4c0-0f258ffe43cc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_141543b2-0f89-4631-8f6c-4eba441bf6dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c364df26-bf5e-4f52-9171-b4fba3ae23c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_43fffee8-12c9-44a8-a4c0-0f258ffe43cc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c364df26-bf5e-4f52-9171-b4fba3ae23c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_25171e6a-9e11-438d-b59a-6c10c5f2096c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e0942307-395a-4e23-bed8-575779cce62d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_25171e6a-9e11-438d-b59a-6c10c5f2096c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e32dd9c8-b31f-4a80-ae7b-8f7a2665f743" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_25171e6a-9e11-438d-b59a-6c10c5f2096c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e32dd9c8-b31f-4a80-ae7b-8f7a2665f743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ab6a3cda-85c3-4102-bd8f-093fb08eba8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_25171e6a-9e11-438d-b59a-6c10c5f2096c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ab6a3cda-85c3-4102-bd8f-093fb08eba8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_96638d8a-0f8e-4127-94f6-c0760515be14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_25171e6a-9e11-438d-b59a-6c10c5f2096c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_96638d8a-0f8e-4127-94f6-c0760515be14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_87840cf4-2af0-4919-8bf8-145da53a7ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_25171e6a-9e11-438d-b59a-6c10c5f2096c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_87840cf4-2af0-4919-8bf8-145da53a7ce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_09b3684d-fad0-4800-8228-72e0e26ffac7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_25171e6a-9e11-438d-b59a-6c10c5f2096c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_09b3684d-fad0-4800-8228-72e0e26ffac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/EarningsLossPerShareScheduleofComputationofBasicandDilutedEarningsPerShareDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#EarningsLossPerShareScheduleofComputationofBasicandDilutedEarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/EarningsLossPerShareScheduleofComputationofBasicandDilutedEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_89dfd1a0-1890-4b06-9952-415c3517dfda" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_649afb61-20bd-419f-b011-ab6e9fff394b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_89dfd1a0-1890-4b06-9952-415c3517dfda" xlink:to="loc_us-gaap_ProfitLoss_649afb61-20bd-419f-b011-ab6e9fff394b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_92ba4d23-98b9-4197-81ba-55f6b42c5036" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_89dfd1a0-1890-4b06-9952-415c3517dfda" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_92ba4d23-98b9-4197-81ba-55f6b42c5036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_260be30d-ef85-4987-b46d-ee2a97d6e84e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_89dfd1a0-1890-4b06-9952-415c3517dfda" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_260be30d-ef85-4987-b46d-ee2a97d6e84e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d39ecda8-2b37-48d4-8242-195cdd50e629" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_89dfd1a0-1890-4b06-9952-415c3517dfda" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d39ecda8-2b37-48d4-8242-195cdd50e629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_19f2f19f-b523-40ee-a336-6580609391dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d39ecda8-2b37-48d4-8242-195cdd50e629" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_19f2f19f-b523-40ee-a336-6580609391dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_a1955e8b-e5ff-4764-bbda-546d57d6c012" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d39ecda8-2b37-48d4-8242-195cdd50e629" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_a1955e8b-e5ff-4764-bbda-546d57d6c012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1c9d78fe-ca70-4750-adcf-2ccad93c1c38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d39ecda8-2b37-48d4-8242-195cdd50e629" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1c9d78fe-ca70-4750-adcf-2ccad93c1c38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_9a4721ca-358b-4ace-8b3c-7bb3fdfa8afd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_89dfd1a0-1890-4b06-9952-415c3517dfda" xlink:to="loc_us-gaap_EarningsPerShareBasic_9a4721ca-358b-4ace-8b3c-7bb3fdfa8afd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_03482f46-b4b3-46fe-a087-171b9c363be9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_89dfd1a0-1890-4b06-9952-415c3517dfda" xlink:to="loc_us-gaap_EarningsPerShareDiluted_03482f46-b4b3-46fe-a087-171b9c363be9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_f3f7f8d0-90aa-4ff3-88c9-82cec8b85da9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6ab0af81-eb49-4d45-89c7-522912777bec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f3f7f8d0-90aa-4ff3-88c9-82cec8b85da9" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6ab0af81-eb49-4d45-89c7-522912777bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_4778001c-7da7-415c-b7bc-be928fd5c932" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6ab0af81-eb49-4d45-89c7-522912777bec" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_4778001c-7da7-415c-b7bc-be928fd5c932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_aa65487e-cdea-49df-8328-f738618748ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_4778001c-7da7-415c-b7bc-be928fd5c932" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_aa65487e-cdea-49df-8328-f738618748ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_d1da2cfc-7065-4c2e-be26-86ea6b787929" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_aa65487e-cdea-49df-8328-f738618748ee" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_d1da2cfc-7065-4c2e-be26-86ea6b787929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_ad05eb56-03c1-49d4-b5c0-9adf8757678c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6ab0af81-eb49-4d45-89c7-522912777bec" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_ad05eb56-03c1-49d4-b5c0-9adf8757678c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_74a5ac14-a748-4ca8-a844-d75caf40d21e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_ad05eb56-03c1-49d4-b5c0-9adf8757678c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_74a5ac14-a748-4ca8-a844-d75caf40d21e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_a821f00f-ed5a-4a2b-b3bc-7e338d733e1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ec0b746c-d6b0-4d9c-bb77-b9aa95cfbfd1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a821f00f-ed5a-4a2b-b3bc-7e338d733e1a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ec0b746c-d6b0-4d9c-bb77-b9aa95cfbfd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/DebtDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#DebtDetails"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/DebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1805350f-372c-45e8-b027-a61c7e1c3627" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_5e882453-dd91-4aac-b01f-8da2da9b12fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1805350f-372c-45e8-b027-a61c7e1c3627" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_5e882453-dd91-4aac-b01f-8da2da9b12fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_7c885ab5-d9a5-456d-b4e6-73c95c9eb146" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_5e882453-dd91-4aac-b01f-8da2da9b12fd" xlink:to="loc_us-gaap_CreditFacilityAxis_7c885ab5-d9a5-456d-b4e6-73c95c9eb146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_6ace0e8f-fcd8-4b82-981c-70b7ecf4d1ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_7c885ab5-d9a5-456d-b4e6-73c95c9eb146" xlink:to="loc_us-gaap_CreditFacilityDomain_6ace0e8f-fcd8-4b82-981c-70b7ecf4d1ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_TermLoanMember_8bbaddee-d3c8-4845-9ffa-182cec98d2a1" xlink:href="vrts-20240331.xsd#vrts_TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_6ace0e8f-fcd8-4b82-981c-70b7ecf4d1ef" xlink:to="loc_vrts_TermLoanMember_8bbaddee-d3c8-4845-9ffa-182cec98d2a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_e58b6077-1541-495d-b4a7-db48ab0e5258" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_6ace0e8f-fcd8-4b82-981c-70b7ecf4d1ef" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_e58b6077-1541-495d-b4a7-db48ab0e5258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_632e905e-a6b8-4730-acc4-ab165dad9f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_5e882453-dd91-4aac-b01f-8da2da9b12fd" xlink:to="loc_us-gaap_DebtInstrumentAxis_632e905e-a6b8-4730-acc4-ab165dad9f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9032349a-8ec3-4b8b-a5e5-2a5374b2e296" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_632e905e-a6b8-4730-acc4-ab165dad9f7f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9032349a-8ec3-4b8b-a5e5-2a5374b2e296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_CreditAgreementMember_552ee7c2-88e6-43b7-8b64-67e3e972be9e" xlink:href="vrts-20240331.xsd#vrts_CreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9032349a-8ec3-4b8b-a5e5-2a5374b2e296" xlink:to="loc_vrts_CreditAgreementMember_552ee7c2-88e6-43b7-8b64-67e3e972be9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_CreditFacility2017Member_07b577af-5c20-49b6-9216-df1c3db7fcd8" xlink:href="vrts-20240331.xsd#vrts_CreditFacility2017Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9032349a-8ec3-4b8b-a5e5-2a5374b2e296" xlink:to="loc_vrts_CreditFacility2017Member_07b577af-5c20-49b6-9216-df1c3db7fcd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_6450710c-848c-4fcd-b076-aefdcb843f23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_5e882453-dd91-4aac-b01f-8da2da9b12fd" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_6450710c-848c-4fcd-b076-aefdcb843f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_808105f1-6cad-4025-a268-1aa3e6570846" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6450710c-848c-4fcd-b076-aefdcb843f23" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_808105f1-6cad-4025-a268-1aa3e6570846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_f0365c2a-643f-46b7-ba7a-a01d9f22eb3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_808105f1-6cad-4025-a268-1aa3e6570846" xlink:to="loc_us-gaap_SecuredDebtMember_f0365c2a-643f-46b7-ba7a-a01d9f22eb3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_821eb040-e7c1-4264-b13d-c6b78d04c588" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_5e882453-dd91-4aac-b01f-8da2da9b12fd" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_821eb040-e7c1-4264-b13d-c6b78d04c588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c0a0eb6d-b6ca-436a-9e8c-f0cdfe450012" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_821eb040-e7c1-4264-b13d-c6b78d04c588" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c0a0eb6d-b6ca-436a-9e8c-f0cdfe450012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_2840740a-1345-4ed2-a101-e968ae5ddd74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_821eb040-e7c1-4264-b13d-c6b78d04c588" xlink:to="loc_us-gaap_DebtInstrumentTerm_2840740a-1345-4ed2-a101-e968ae5ddd74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_8a8f9149-030e-42f8-8aec-312506b935fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_821eb040-e7c1-4264-b13d-c6b78d04c588" xlink:to="loc_us-gaap_RepaymentsOfDebt_8a8f9149-030e-42f8-8aec-312506b935fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_5185ad0a-99f3-45d6-9758-cc1e10e168ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_821eb040-e7c1-4264-b13d-c6b78d04c588" xlink:to="loc_us-gaap_LineOfCredit_5185ad0a-99f3-45d6-9758-cc1e10e168ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_4487d16c-3861-41d0-9f8d-11d3b91b1676" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_821eb040-e7c1-4264-b13d-c6b78d04c588" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_4487d16c-3861-41d0-9f8d-11d3b91b1676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/RedeemableNoncontrollingInterestsScheduleofRedeemableNoncontrollingInterestDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#RedeemableNoncontrollingInterestsScheduleofRedeemableNoncontrollingInterestDetails"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/RedeemableNoncontrollingInterestsScheduleofRedeemableNoncontrollingInterestDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_df76acc6-5083-4b0b-827c-5ed956eb96ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_27093485-032f-4859-8b74-c8640d9b677f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_df76acc6-5083-4b0b-827c-5ed956eb96ee" xlink:to="loc_us-gaap_MinorityInterestTable_27093485-032f-4859-8b74-c8640d9b677f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_66982e35-9233-4953-89d4-156d8bfa06f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_27093485-032f-4859-8b74-c8640d9b677f" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_66982e35-9233-4953-89d4-156d8bfa06f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_2bb0301f-d019-463b-a46d-27d4cf5d94d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_66982e35-9233-4953-89d4-156d8bfa06f6" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_2bb0301f-d019-463b-a46d-27d4cf5d94d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_d633916a-e3ac-4cc2-a147-c0baafb87110" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_2bb0301f-d019-463b-a46d-27d4cf5d94d3" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_d633916a-e3ac-4cc2-a147-c0baafb87110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_4e2b01de-50d7-43a2-bf8a-62fe93b80a92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_d633916a-e3ac-4cc2-a147-c0baafb87110" xlink:to="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_4e2b01de-50d7-43a2-bf8a-62fe93b80a92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_d3546dbc-49df-42c8-bdff-128514804bf8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_27093485-032f-4859-8b74-c8640d9b677f" xlink:to="loc_srt_ConsolidatedEntitiesAxis_d3546dbc-49df-42c8-bdff-128514804bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_eda8aa1b-4099-4029-a15e-fe41d6d5058f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_d3546dbc-49df-42c8-bdff-128514804bf8" xlink:to="loc_srt_ConsolidatedEntitiesDomain_eda8aa1b-4099-4029-a15e-fe41d6d5058f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember_28602150-0e56-471d-9a88-8b725a6c2f93" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_eda8aa1b-4099-4029-a15e-fe41d6d5058f" xlink:to="loc_vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember_28602150-0e56-471d-9a88-8b725a6c2f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_ab0900a7-bf90-4bb7-b371-f2c523392157" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_eda8aa1b-4099-4029-a15e-fe41d6d5058f" xlink:to="loc_srt_AffiliatedEntityMember_ab0900a7-bf90-4bb7-b371-f2c523392157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_9a8951fa-6fad-4e1a-8682-5814996037bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_27093485-032f-4859-8b74-c8640d9b677f" xlink:to="loc_us-gaap_MinorityInterestLineItems_9a8951fa-6fad-4e1a-8682-5814996037bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_30fd3af4-2cf0-4205-8bb6-188d98fb6f27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_9a8951fa-6fad-4e1a-8682-5814996037bd" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_30fd3af4-2cf0-4205-8bb6-188d98fb6f27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue_b7578777-3ddb-48bf-9860-61e1a1c214cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_30fd3af4-2cf0-4205-8bb6-188d98fb6f27" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue_b7578777-3ddb-48bf-9860-61e1a1c214cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_fa221128-be2b-45fe-8ce5-e0b2aedaec8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_30fd3af4-2cf0-4205-8bb6-188d98fb6f27" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_fa221128-be2b-45fe-8ce5-e0b2aedaec8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue_4f43228f-561f-4495-a10d-5e90ceb90fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestChangeInRedemptionValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_30fd3af4-2cf0-4205-8bb6-188d98fb6f27" xlink:to="loc_us-gaap_MinorityInterestChangeInRedemptionValue_4f43228f-561f-4495-a10d-5e90ceb90fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_30de04f2-def9-4daa-b409-7b6e5f31a81b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_30fd3af4-2cf0-4205-8bb6-188d98fb6f27" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_30de04f2-def9-4daa-b409-7b6e5f31a81b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_c061ebd3-32cc-46f2-af71-43a8990729f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_30fd3af4-2cf0-4205-8bb6-188d98fb6f27" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_c061ebd3-32cc-46f2-af71-43a8990729f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_NoncontrollingInterestSubscriptionsRedemptionsAndOther_acbc6975-ddd2-4f14-b74e-f6a3360e9773" xlink:href="vrts-20240331.xsd#vrts_NoncontrollingInterestSubscriptionsRedemptionsAndOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_30fd3af4-2cf0-4205-8bb6-188d98fb6f27" xlink:to="loc_vrts_NoncontrollingInterestSubscriptionsRedemptionsAndOther_acbc6975-ddd2-4f14-b74e-f6a3360e9773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue_8da86360-d710-4c6d-9d7e-8616e962871f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_30fd3af4-2cf0-4205-8bb6-188d98fb6f27" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue_8da86360-d710-4c6d-9d7e-8616e962871f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/ConsolidationCondensedConsolidatedBalanceSheetsDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#ConsolidationCondensedConsolidatedBalanceSheetsDetails"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/ConsolidationCondensedConsolidatedBalanceSheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d2b8b145-71d8-4b21-b630-61fdfbbdaebc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_10280f7e-f551-4523-bcbd-de1a25823b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d2b8b145-71d8-4b21-b630-61fdfbbdaebc" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_10280f7e-f551-4523-bcbd-de1a25823b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_b843559b-43d7-423c-9ee4-6f3bd43b1a7b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_10280f7e-f551-4523-bcbd-de1a25823b9d" xlink:to="loc_srt_ConsolidatedEntitiesAxis_b843559b-43d7-423c-9ee4-6f3bd43b1a7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_7bc71751-9b34-493f-9e00-3d0f3f97adb0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_b843559b-43d7-423c-9ee4-6f3bd43b1a7b" xlink:to="loc_srt_ConsolidatedEntitiesDomain_7bc71751-9b34-493f-9e00-3d0f3f97adb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VotingInterestEntityVOEMember_8fd0d425-e047-4a75-837c-19fd425d18b0" xlink:href="vrts-20240331.xsd#vrts_VotingInterestEntityVOEMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_7bc71751-9b34-493f-9e00-3d0f3f97adb0" xlink:to="loc_vrts_VotingInterestEntityVOEMember_8fd0d425-e047-4a75-837c-19fd425d18b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember_eb003950-5bc7-4956-a2ee-ab0c54b112fa" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_7bc71751-9b34-493f-9e00-3d0f3f97adb0" xlink:to="loc_vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember_eb003950-5bc7-4956-a2ee-ab0c54b112fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityPrimaryBeneficiaryGlobalAndPrivateFundsMember_f79ce885-962c-46b8-89d4-f240224e038f" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityPrimaryBeneficiaryGlobalAndPrivateFundsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_7bc71751-9b34-493f-9e00-3d0f3f97adb0" xlink:to="loc_vrts_VariableInterestEntityPrimaryBeneficiaryGlobalAndPrivateFundsMember_f79ce885-962c-46b8-89d4-f240224e038f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_6bff1813-d2f1-432a-99bc-59b5fb35aaa4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_10280f7e-f551-4523-bcbd-de1a25823b9d" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_6bff1813-d2f1-432a-99bc-59b5fb35aaa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_29abf073-4a0a-4a54-babf-5bedcccc9cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_6bff1813-d2f1-432a-99bc-59b5fb35aaa4" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_29abf073-4a0a-4a54-babf-5bedcccc9cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_130aa508-a064-4383-b5ab-47e26b3753cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Investments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_6bff1813-d2f1-432a-99bc-59b5fb35aaa4" xlink:to="loc_us-gaap_Investments_130aa508-a064-4383-b5ab-47e26b3753cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets_58f6b6b3-3abe-492c-858b-4c5bddc13839" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_6bff1813-d2f1-432a-99bc-59b5fb35aaa4" xlink:to="loc_us-gaap_OtherAssets_58f6b6b3-3abe-492c-858b-4c5bddc13839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayable_c161ca0f-77eb-46d5-a710-949cddf682d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_6bff1813-d2f1-432a-99bc-59b5fb35aaa4" xlink:to="loc_us-gaap_NotesPayable_c161ca0f-77eb-46d5-a710-949cddf682d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_SecuritiesPurchasedPayable_e8e6e57b-735a-4d09-8b42-002a4c1f1b6c" xlink:href="vrts-20240331.xsd#vrts_SecuritiesPurchasedPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_6bff1813-d2f1-432a-99bc-59b5fb35aaa4" xlink:to="loc_vrts_SecuritiesPurchasedPayable_e8e6e57b-735a-4d09-8b42-002a4c1f1b6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_7fa46cc7-7bec-480a-bdba-af3d3ac51c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_6bff1813-d2f1-432a-99bc-59b5fb35aaa4" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_7fa46cc7-7bec-480a-bdba-af3d3ac51c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_NetInterestInInvestmentProducts_5e6f782e-047e-40e7-96c8-6eb5e151152b" xlink:href="vrts-20240331.xsd#vrts_NetInterestInInvestmentProducts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_6bff1813-d2f1-432a-99bc-59b5fb35aaa4" xlink:to="loc_vrts_NetInterestInInvestmentProducts_5e6f782e-047e-40e7-96c8-6eb5e151152b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/ConsolidationAdditionalInformationDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#ConsolidationAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/ConsolidationAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_66903492-eccf-4344-9e40-b8edc1424ee2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fa2c5b9d-c873-461c-9fac-8ff4ad7eee29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_66903492-eccf-4344-9e40-b8edc1424ee2" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fa2c5b9d-c873-461c-9fac-8ff4ad7eee29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_9ba9508c-797b-4fb9-8a83-6ceeee47afc5" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fa2c5b9d-c873-461c-9fac-8ff4ad7eee29" xlink:to="loc_srt_ConsolidatedEntitiesAxis_9ba9508c-797b-4fb9-8a83-6ceeee47afc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_d94ec4cd-1cec-4cd8-ba10-8be50cb73ba4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_9ba9508c-797b-4fb9-8a83-6ceeee47afc5" xlink:to="loc_srt_ConsolidatedEntitiesDomain_d94ec4cd-1cec-4cd8-ba10-8be50cb73ba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember_92b94ac2-f646-45fc-8cf0-595ff6e1685e" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_d94ec4cd-1cec-4cd8-ba10-8be50cb73ba4" xlink:to="loc_vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember_92b94ac2-f646-45fc-8cf0-595ff6e1685e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_48d38332-11f8-4e7d-917b-355c62d51f1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_d94ec4cd-1cec-4cd8-ba10-8be50cb73ba4" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_48d38332-11f8-4e7d-917b-355c62d51f1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_787957c4-364d-4627-9fa6-9d1dbb411081" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fa2c5b9d-c873-461c-9fac-8ff4ad7eee29" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_787957c4-364d-4627-9fa6-9d1dbb411081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d4120f9b-53d4-48ac-9d29-af47e27b7bf4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_787957c4-364d-4627-9fa6-9d1dbb411081" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d4120f9b-53d4-48ac-9d29-af47e27b7bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_9eed2313-843c-4f58-8d3f-4b823616c517" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d4120f9b-53d4-48ac-9d29-af47e27b7bf4" xlink:to="loc_us-gaap_SeniorNotesMember_9eed2313-843c-4f58-8d3f-4b823616c517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubordinatedDebtMember_2aaab144-7654-4ced-b5f8-7fc7fd423dea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubordinatedDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d4120f9b-53d4-48ac-9d29-af47e27b7bf4" xlink:to="loc_us-gaap_SubordinatedDebtMember_2aaab144-7654-4ced-b5f8-7fc7fd423dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_edff61c5-bcb9-4599-919f-f59edba48887" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fa2c5b9d-c873-461c-9fac-8ff4ad7eee29" xlink:to="loc_us-gaap_DebtInstrumentAxis_edff61c5-bcb9-4599-919f-f59edba48887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ea816c64-843e-484c-a974-e66b7c9b0aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_edff61c5-bcb9-4599-919f-f59edba48887" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ea816c64-843e-484c-a974-e66b7c9b0aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_SubordinatedNotesNewfleetCLO20161Member_60efaa6f-6d02-451e-a430-225c92773580" xlink:href="vrts-20240331.xsd#vrts_SubordinatedNotesNewfleetCLO20161Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ea816c64-843e-484c-a974-e66b7c9b0aa9" xlink:to="loc_vrts_SubordinatedNotesNewfleetCLO20161Member_60efaa6f-6d02-451e-a430-225c92773580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_SeniorSecuredFloatingRateNotesNewfleetCLO20161Member_4816b4a2-89f2-4523-979b-4e28f1398ea9" xlink:href="vrts-20240331.xsd#vrts_SeniorSecuredFloatingRateNotesNewfleetCLO20161Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ea816c64-843e-484c-a974-e66b7c9b0aa9" xlink:to="loc_vrts_SeniorSecuredFloatingRateNotesNewfleetCLO20161Member_4816b4a2-89f2-4523-979b-4e28f1398ea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fbecb3f2-44bd-4dc4-acca-07fe816ece99" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fa2c5b9d-c873-461c-9fac-8ff4ad7eee29" xlink:to="loc_srt_RangeAxis_fbecb3f2-44bd-4dc4-acca-07fe816ece99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4584029d-9003-4e44-97a7-f65261b4509a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_fbecb3f2-44bd-4dc4-acca-07fe816ece99" xlink:to="loc_srt_RangeMember_4584029d-9003-4e44-97a7-f65261b4509a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_770d6c10-dbf3-417a-baaa-beb1a4ef6cd4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4584029d-9003-4e44-97a7-f65261b4509a" xlink:to="loc_srt_MinimumMember_770d6c10-dbf3-417a-baaa-beb1a4ef6cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_802de47f-7aeb-4757-b1b0-e8e0730e0bfd" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4584029d-9003-4e44-97a7-f65261b4509a" xlink:to="loc_srt_MaximumMember_802de47f-7aeb-4757-b1b0-e8e0730e0bfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_ac19caee-cdff-4675-9f42-dfac0d0aafcb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fa2c5b9d-c873-461c-9fac-8ff4ad7eee29" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_ac19caee-cdff-4675-9f42-dfac0d0aafcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_NumberofCollateralizedLoanObligationsConsolidated_09d09266-071c-4a97-91f2-fbc59a594c53" xlink:href="vrts-20240331.xsd#vrts_NumberofCollateralizedLoanObligationsConsolidated"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_ac19caee-cdff-4675-9f42-dfac0d0aafcb" xlink:to="loc_vrts_NumberofCollateralizedLoanObligationsConsolidated_09d09266-071c-4a97-91f2-fbc59a594c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_61b3d0b2-9380-4c2b-8c68-9af26e55a8f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Investments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_ac19caee-cdff-4675-9f42-dfac0d0aafcb" xlink:to="loc_us-gaap_Investments_61b3d0b2-9380-4c2b-8c68-9af26e55a8f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_7b42b7ec-48c5-4aa7-aa95-a96c07682a24" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_ac19caee-cdff-4675-9f42-dfac0d0aafcb" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_7b42b7ec-48c5-4aa7-aa95-a96c07682a24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_b28efbc6-2491-4162-9be2-bb2a9c73e63d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_ac19caee-cdff-4675-9f42-dfac0d0aafcb" xlink:to="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_b28efbc6-2491-4162-9be2-bb2a9c73e63d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/ConsolidationBeneficialInterestsofConsolidatedInvestmentProductDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#ConsolidationBeneficialInterestsofConsolidatedInvestmentProductDetails"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/ConsolidationBeneficialInterestsofConsolidatedInvestmentProductDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dcf2f593-520b-4523-9704-f51c3a4db557" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_a87a6b10-b270-44b0-93ad-4bc0feb654ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dcf2f593-520b-4523-9704-f51c3a4db557" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_a87a6b10-b270-44b0-93ad-4bc0feb654ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_5f7d6953-0904-429b-b76c-e2f202c91ae5" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_a87a6b10-b270-44b0-93ad-4bc0feb654ac" xlink:to="loc_srt_ConsolidatedEntitiesAxis_5f7d6953-0904-429b-b76c-e2f202c91ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_7fa66ada-e49f-421b-8ae5-921d3a439b7a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_5f7d6953-0904-429b-b76c-e2f202c91ae5" xlink:to="loc_srt_ConsolidatedEntitiesDomain_7fa66ada-e49f-421b-8ae5-921d3a439b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember_0d8d56df-7be5-42d7-bc10-97821a4e8b6b" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_7fa66ada-e49f-421b-8ae5-921d3a439b7a" xlink:to="loc_vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember_0d8d56df-7be5-42d7-bc10-97821a4e8b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_eed02d72-5476-4947-b1fc-b405c09ff793" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_a87a6b10-b270-44b0-93ad-4bc0feb654ac" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_eed02d72-5476-4947-b1fc-b405c09ff793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsSubordinatedDebtAmount_77bcc746-2807-4dbd-b29e-78964b1153ac" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsSubordinatedDebtAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_eed02d72-5476-4947-b1fc-b405c09ff793" xlink:to="loc_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsSubordinatedDebtAmount_77bcc746-2807-4dbd-b29e-78964b1153ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsDeferredRevenueAmount_776344b2-9330-4fd5-adb4-3d8282aee881" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsDeferredRevenueAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_eed02d72-5476-4947-b1fc-b405c09ff793" xlink:to="loc_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsDeferredRevenueAmount_776344b2-9330-4fd5-adb4-3d8282aee881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsAmount_14b2c4bc-479b-4989-810f-4bf0904a672a" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_eed02d72-5476-4947-b1fc-b405c09ff793" xlink:to="loc_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsAmount_14b2c4bc-479b-4989-810f-4bf0904a672a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/ConsolidationRevenueandExpensesofConsolidatedInvestmentProductDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#ConsolidationRevenueandExpensesofConsolidatedInvestmentProductDetails"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/ConsolidationRevenueandExpensesofConsolidatedInvestmentProductDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0cacdad3-a1aa-4321-b0f1-b9005343c8b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_76c9f21e-34ca-4ea8-9344-f41751357a2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0cacdad3-a1aa-4321-b0f1-b9005343c8b2" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_76c9f21e-34ca-4ea8-9344-f41751357a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_98b70693-daae-421a-bfb8-e89e3e600db2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_76c9f21e-34ca-4ea8-9344-f41751357a2e" xlink:to="loc_srt_ConsolidatedEntitiesAxis_98b70693-daae-421a-bfb8-e89e3e600db2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_6c6d4513-4411-4a8c-b152-fb6aa647719b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_98b70693-daae-421a-bfb8-e89e3e600db2" xlink:to="loc_srt_ConsolidatedEntitiesDomain_6c6d4513-4411-4a8c-b152-fb6aa647719b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember_cffd591b-829a-48f3-bc27-1e60714eb9eb" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_6c6d4513-4411-4a8c-b152-fb6aa647719b" xlink:to="loc_vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember_cffd591b-829a-48f3-bc27-1e60714eb9eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_ecccdbe2-e6bf-49cb-b198-4f640176c960" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_76c9f21e-34ca-4ea8-9344-f41751357a2e" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_ecccdbe2-e6bf-49cb-b198-4f640176c960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_d90de450-6b91-4a35-aa53-de8efe16979e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_ecccdbe2-e6bf-49cb-b198-4f640176c960" xlink:to="loc_us-gaap_RevenuesAbstract_d90de450-6b91-4a35-aa53-de8efe16979e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_fc07a455-344c-4e32-ab74-d7ecb995cd29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_d90de450-6b91-4a35-aa53-de8efe16979e" xlink:to="loc_us-gaap_GainLossOnInvestments_fc07a455-344c-4e32-ab74-d7ecb995cd29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_c4c8a813-cf3e-4d06-97c8-0aa63b862d84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_d90de450-6b91-4a35-aa53-de8efe16979e" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_c4c8a813-cf3e-4d06-97c8-0aa63b862d84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_133334ce-1d5e-47ef-9a2f-66d757620287" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_d90de450-6b91-4a35-aa53-de8efe16979e" xlink:to="loc_us-gaap_Revenues_133334ce-1d5e-47ef-9a2f-66d757620287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_ExpensesAbstract_dabf9b6c-f8ab-41ff-be69-a40ff46c0481" xlink:href="vrts-20240331.xsd#vrts_ExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_ecccdbe2-e6bf-49cb-b198-4f640176c960" xlink:to="loc_vrts_ExpensesAbstract_dabf9b6c-f8ab-41ff-be69-a40ff46c0481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating_073f13d0-ffda-40e3-aaf1-647f15407d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vrts_ExpensesAbstract_dabf9b6c-f8ab-41ff-be69-a40ff46c0481" xlink:to="loc_us-gaap_OtherCostAndExpenseOperating_073f13d0-ffda-40e3-aaf1-647f15407d0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_dfa31d21-3d8e-406c-8812-c083ce98b40b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vrts_ExpensesAbstract_dabf9b6c-f8ab-41ff-be69-a40ff46c0481" xlink:to="loc_us-gaap_InterestExpense_dfa31d21-3d8e-406c-8812-c083ce98b40b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_OperatingandNonoperatingExpense_27e5ad09-4e7b-4603-b1b1-ce6853aca5e7" xlink:href="vrts-20240331.xsd#vrts_OperatingandNonoperatingExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vrts_ExpensesAbstract_dabf9b6c-f8ab-41ff-be69-a40ff46c0481" xlink:to="loc_vrts_OperatingandNonoperatingExpense_27e5ad09-4e7b-4603-b1b1-ce6853aca5e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_41a05605-cda7-4aa6-be82-5b6f3a1101b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_ecccdbe2-e6bf-49cb-b198-4f640176c960" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_41a05605-cda7-4aa6-be82-5b6f3a1101b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_0fa9d7da-e87d-47df-b934-4c18d5d119f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_ecccdbe2-e6bf-49cb-b198-4f640176c960" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_0fa9d7da-e87d-47df-b934-4c18d5d119f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/ConsolidationEconomicInterestsofConsolidatedInvestmentProductDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#ConsolidationEconomicInterestsofConsolidatedInvestmentProductDetails"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/ConsolidationEconomicInterestsofConsolidatedInvestmentProductDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_95e738b3-a32c-4e30-bb77-3dbc341cc745" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_3547549c-891b-4c88-a47a-2528b9a4072a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_95e738b3-a32c-4e30-bb77-3dbc341cc745" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_3547549c-891b-4c88-a47a-2528b9a4072a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_3a0f9e9d-1d72-4998-9056-3433a212f93c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_3547549c-891b-4c88-a47a-2528b9a4072a" xlink:to="loc_srt_ConsolidatedEntitiesAxis_3a0f9e9d-1d72-4998-9056-3433a212f93c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_3e544693-8d4d-4026-87d8-a6735c8c89fe" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_3a0f9e9d-1d72-4998-9056-3433a212f93c" xlink:to="loc_srt_ConsolidatedEntitiesDomain_3e544693-8d4d-4026-87d8-a6735c8c89fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember_b7046915-2384-454d-9e55-84732a9fccbe" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_3e544693-8d4d-4026-87d8-a6735c8c89fe" xlink:to="loc_vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember_b7046915-2384-454d-9e55-84732a9fccbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_fab03f65-6ac6-41e6-9ed1-16081a6ba5a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_3547549c-891b-4c88-a47a-2528b9a4072a" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_fab03f65-6ac6-41e6-9ed1-16081a6ba5a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityMeasureofActivityDistributionsReceivedandUnrealizedGainsLossesOnInvestment_957e09fe-fd56-4004-b074-3e7fe3a3476b" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityMeasureofActivityDistributionsReceivedandUnrealizedGainsLossesOnInvestment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_fab03f65-6ac6-41e6-9ed1-16081a6ba5a2" xlink:to="loc_vrts_VariableInterestEntityMeasureofActivityDistributionsReceivedandUnrealizedGainsLossesOnInvestment_957e09fe-fd56-4004-b074-3e7fe3a3476b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_bc8ee9ce-c03b-436a-a680-a0ed4ec4e5bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_fab03f65-6ac6-41e6-9ed1-16081a6ba5a2" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_bc8ee9ce-c03b-436a-a680-a0ed4ec4e5bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_0755743a-b513-4fca-8860-bd8682186635" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_fab03f65-6ac6-41e6-9ed1-16081a6ba5a2" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_0755743a-b513-4fca-8860-bd8682186635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f1e07df0-f6da-43d5-9041-ed8f7d19ac54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_875cefc4-56af-463e-9787-c39da692f6ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f1e07df0-f6da-43d5-9041-ed8f7d19ac54" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_875cefc4-56af-463e-9787-c39da692f6ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_afd12146-1d8a-4f3a-bad0-a34bb892e8e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_875cefc4-56af-463e-9787-c39da692f6ad" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_afd12146-1d8a-4f3a-bad0-a34bb892e8e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_c66d0033-f1a7-4d90-ac85-7b45ce2a621d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_afd12146-1d8a-4f3a-bad0-a34bb892e8e1" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_c66d0033-f1a7-4d90-ac85-7b45ce2a621d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_22ce05e4-7adc-4af8-8742-4698215358d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_c66d0033-f1a7-4d90-ac85-7b45ce2a621d" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_22ce05e4-7adc-4af8-8742-4698215358d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_42aab79c-4c77-4bb3-a350-344817ad9537" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_875cefc4-56af-463e-9787-c39da692f6ad" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_42aab79c-4c77-4bb3-a350-344817ad9537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e7b8bdea-2230-4b12-b2a2-56e43bce06ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_42aab79c-4c77-4bb3-a350-344817ad9537" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e7b8bdea-2230-4b12-b2a2-56e43bce06ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_d0903300-1cba-4146-812e-b0bd49e938c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e7b8bdea-2230-4b12-b2a2-56e43bce06ff" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_d0903300-1cba-4146-812e-b0bd49e938c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_03ca7bb3-d421-4bae-b92a-42cd198e9111" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e7b8bdea-2230-4b12-b2a2-56e43bce06ff" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_03ca7bb3-d421-4bae-b92a-42cd198e9111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_c6ac0b21-ea51-4767-b9b3-d34dd1993f62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e7b8bdea-2230-4b12-b2a2-56e43bce06ff" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_c6ac0b21-ea51-4767-b9b3-d34dd1993f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_30067ec6-0189-4962-b2de-5fefcd5cc878" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_875cefc4-56af-463e-9787-c39da692f6ad" xlink:to="loc_us-gaap_FinancialInstrumentAxis_30067ec6-0189-4962-b2de-5fefcd5cc878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_00a4d401-4c1e-451b-8a91-06a719170152" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_30067ec6-0189-4962-b2de-5fefcd5cc878" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_00a4d401-4c1e-451b-8a91-06a719170152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_de6fb117-64df-430d-9af5-200ab6bc4f45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_00a4d401-4c1e-451b-8a91-06a719170152" xlink:to="loc_us-gaap_DebtSecuritiesMember_de6fb117-64df-430d-9af5-200ab6bc4f45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_36d93fa9-0e83-4b8c-b0d2-4250f3776e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_00a4d401-4c1e-451b-8a91-06a719170152" xlink:to="loc_us-gaap_EquitySecuritiesMember_36d93fa9-0e83-4b8c-b0d2-4250f3776e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_26c7ffef-2a19-453a-ae55-b8af14a3924d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_875cefc4-56af-463e-9787-c39da692f6ad" xlink:to="loc_srt_ConsolidatedEntitiesAxis_26c7ffef-2a19-453a-ae55-b8af14a3924d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_5eacf2bb-0231-4a39-90b2-b216d7f93b91" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_26c7ffef-2a19-453a-ae55-b8af14a3924d" xlink:to="loc_srt_ConsolidatedEntitiesDomain_5eacf2bb-0231-4a39-90b2-b216d7f93b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember_ff14afbb-633d-431b-acca-2fdac69fb10a" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_5eacf2bb-0231-4a39-90b2-b216d7f93b91" xlink:to="loc_vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember_ff14afbb-633d-431b-acca-2fdac69fb10a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3dda0b0c-1f15-4858-b33f-190da4512e95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_875cefc4-56af-463e-9787-c39da692f6ad" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3dda0b0c-1f15-4858-b33f-190da4512e95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_1a4ed2e2-bfb8-47c5-9911-c53e2d100089" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3dda0b0c-1f15-4858-b33f-190da4512e95" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_1a4ed2e2-bfb8-47c5-9911-c53e2d100089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_a5f88951-4553-41b0-9ce7-a7f389836142" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_1a4ed2e2-bfb8-47c5-9911-c53e2d100089" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_a5f88951-4553-41b0-9ce7-a7f389836142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_6489bf69-f6a0-4966-8601-229c771982d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_1a4ed2e2-bfb8-47c5-9911-c53e2d100089" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_6489bf69-f6a0-4966-8601-229c771982d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_03d322e3-ef92-4e39-adcc-7b1a4d178828" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_1a4ed2e2-bfb8-47c5-9911-c53e2d100089" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_03d322e3-ef92-4e39-adcc-7b1a4d178828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_9d625d1d-d6b4-4ca5-838f-b0f303f28116" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3dda0b0c-1f15-4858-b33f-190da4512e95" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_9d625d1d-d6b4-4ca5-838f-b0f303f28116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableFairValueDisclosure_ef372912-c219-4911-a950-585b2dca34e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_9d625d1d-d6b4-4ca5-838f-b0f303f28116" xlink:to="loc_us-gaap_NotesPayableFairValueDisclosure_ef372912-c219-4911-a950-585b2dca34e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsSoldNotYetPurchasedAtFairValue_4b5fdec7-deea-42ad-9022-770f79ab672a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsSoldNotYetPurchasedAtFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_9d625d1d-d6b4-4ca5-838f-b0f303f28116" xlink:to="loc_us-gaap_FinancialInstrumentsSoldNotYetPurchasedAtFairValue_4b5fdec7-deea-42ad-9022-770f79ab672a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_b8f4d55b-f0fd-4b35-80b3-c3a0376bf213" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_9d625d1d-d6b4-4ca5-838f-b0f303f28116" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_b8f4d55b-f0fd-4b35-80b3-c3a0376bf213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.virtus.com/role/ConsolidationAssetsRelatedtoConsolidatedSponsoredInvestmentProductsUnobservableInputReconciliationDetails" xlink:type="simple" xlink:href="vrts-20240331.xsd#ConsolidationAssetsRelatedtoConsolidatedSponsoredInvestmentProductsUnobservableInputReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.virtus.com/role/ConsolidationAssetsRelatedtoConsolidatedSponsoredInvestmentProductsUnobservableInputReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f01f42c3-5051-4e71-91c0-15d61d8573ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_83bee653-48e7-4f80-af3b-c9bf0a1e2a19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f01f42c3-5051-4e71-91c0-15d61d8573ca" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_83bee653-48e7-4f80-af3b-c9bf0a1e2a19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_6b235187-016d-4e8b-a32f-2394eb1d12cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_83bee653-48e7-4f80-af3b-c9bf0a1e2a19" xlink:to="loc_us-gaap_FinancialInstrumentAxis_6b235187-016d-4e8b-a32f-2394eb1d12cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0e99a071-9a04-4235-9e1f-6b1e8c747b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6b235187-016d-4e8b-a32f-2394eb1d12cf" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0e99a071-9a04-4235-9e1f-6b1e8c747b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_4d531cbb-ee72-48ba-a757-6d6e59cdd08e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0e99a071-9a04-4235-9e1f-6b1e8c747b6e" xlink:to="loc_us-gaap_DebtSecuritiesMember_4d531cbb-ee72-48ba-a757-6d6e59cdd08e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_95af5daa-aca5-4f01-8977-a5ea09e9f27e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_83bee653-48e7-4f80-af3b-c9bf0a1e2a19" xlink:to="loc_srt_ConsolidatedEntitiesAxis_95af5daa-aca5-4f01-8977-a5ea09e9f27e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_9fc5ee3d-1779-4435-b1e3-2f0d7f35cf3e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_95af5daa-aca5-4f01-8977-a5ea09e9f27e" xlink:to="loc_srt_ConsolidatedEntitiesDomain_9fc5ee3d-1779-4435-b1e3-2f0d7f35cf3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember_1cce9c5b-ed88-4691-9b99-5626c6d9b1e6" xlink:href="vrts-20240331.xsd#vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_9fc5ee3d-1779-4435-b1e3-2f0d7f35cf3e" xlink:to="loc_vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember_1cce9c5b-ed88-4691-9b99-5626c6d9b1e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_b8b91211-7dbb-4620-87aa-a64ca6ef552f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_83bee653-48e7-4f80-af3b-c9bf0a1e2a19" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_b8b91211-7dbb-4620-87aa-a64ca6ef552f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1caa43d9-8d1e-4dae-82cf-2c71878a3517" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_b8b91211-7dbb-4620-87aa-a64ca6ef552f" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1caa43d9-8d1e-4dae-82cf-2c71878a3517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_07e34b82-6555-4f68-bbf7-bcd4ac36b839" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1caa43d9-8d1e-4dae-82cf-2c71878a3517" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_07e34b82-6555-4f68-bbf7-bcd4ac36b839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_f3315c14-4661-4655-92d6-4a6f880e3ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1caa43d9-8d1e-4dae-82cf-2c71878a3517" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_f3315c14-4661-4655-92d6-4a6f880e3ba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_47f1aebe-3413-418e-8bcd-45bf5d5e665f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1caa43d9-8d1e-4dae-82cf-2c71878a3517" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_47f1aebe-3413-418e-8bcd-45bf5d5e665f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_210d4b83-9db1-4ecb-a75a-9c21d433ae3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1caa43d9-8d1e-4dae-82cf-2c71878a3517" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_210d4b83-9db1-4ecb-a75a-9c21d433ae3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_1625163e-111f-4f5e-918e-d8fb272709aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1caa43d9-8d1e-4dae-82cf-2c71878a3517" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_1625163e-111f-4f5e-918e-d8fb272709aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_1d5af86c-2bb9-4ef1-8cce-594b6a0ddb05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1caa43d9-8d1e-4dae-82cf-2c71878a3517" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_1d5af86c-2bb9-4ef1-8cce-594b6a0ddb05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_465b2e78-e750-4f73-8e48-a093e8ba5115" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1caa43d9-8d1e-4dae-82cf-2c71878a3517" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_465b2e78-e750-4f73-8e48-a093e8ba5115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_RestrictedStockUnitsRSUsPerformanceBasedMember" xlink:href="vrts-20240331.xsd#vrts_RestrictedStockUnitsRSUsPerformanceBasedMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_vrts_RestrictedStockUnitsRSUsPerformanceBasedMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_PerformanceStockUnitsIncentiveMember" xlink:href="vrts-20240331.xsd#vrts_PerformanceStockUnitsIncentiveMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_vrts_PerformanceStockUnitsIncentiveMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrts_RestrictedStockUnitsandPerformanceSharesUnitsMember" xlink:href="vrts-20240331.xsd#vrts_RestrictedStockUnitsandPerformanceSharesUnitsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_vrts_RestrictedStockUnitsandPerformanceSharesUnitsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_us-gaap_NetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>vrts-20240331_g1.jpg
<DESCRIPTION>VIRTUS LOGO
<TEXT>
begin 644 vrts-20240331_g1.jpg
M_]C_X  02D9)1@ ! 0$"6 )8  #_X0!F17AI9@  34T *@    @ ! $:  4
M   !    /@$;  4    !    1@$H  ,    !  (   $Q  (    0    3@
M    "2>^   #Z  ))[X   /H<&%I;G0N;F5T(#0N,BXU /_; $,  0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_  !$( PP.
M$@,!(0 "$0$#$0'_Q  ?   !!0$! 0$! 0           0(#! 4&!P@)"@O_
MQ "U$  " 0,# @0#!04$!    7T! @, !!$%$B$Q008346$'(G$4,H&1H0@C
M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-45597
M6%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ
MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X
M^?K_Q  ? 0 # 0$! 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($
M! ,$!P4$!  ! G<  0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B
M<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G
M:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X
MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$
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M^R)_T5O_ ,L+XF__ #&4?\/ _P!D3_HK?_EA?$W_ .8RCDEV_+_,.:/?\_\
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M3+/&IZ;>6OV._O;6_/D>>+4V\L,LAY]O\[?J-)R=DKM_UU/DK_B(V_X(S_\
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M3_\ ..HYH]_S_P @]E4_E_%?YA_Q$;?\$9_^CQ__ #7K]JG_ .<=1_Q$;?\
M!&?_ */'_P#->OVJ?_G'4<T>_P"?^0>RJ?R_BO\ ,/\ B(V_X(S_ /1X_P#Y
MKU^U3_\ ..H_XB-O^",__1X__FO7[5/_ ,XZCFCW_/\ R#V53^7\5_F'_$1M
M_P $9_\ H\?_ ,UZ_:I_^<=1_P 1&W_!&?\ Z/'_ /->OVJ?_G'4<T>_Y_Y!
M[*I_+^*_S#_B(V_X(S_]'C_^:]?M4_\ SCJ/^(C;_@C/_P!'C_\ FO7[5/\
M\XZCFCW_ #_R#V53^7\5_F'_ !$;?\$9_P#H\?\ \UZ_:I_^<=1_Q$;?\$9_
M^CQ__->OVJ?_ )QU'-'O^?\ D'LJG\OXK_,/^(C;_@C/_P!'C_\ FO7[5/\
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M_P#->OVJ?_G'4<T>_P"?^0>RJ?R_BO\ ,/\ B(V_X(S_ /1X_P#YKU^U3_\
M..H_XB-O^",__1X__FO7[5/_ ,XZCFCW_/\ R#V53^7\5_F'_$1M_P $9_\
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M,_\ T>/_ .:]?M4__..HYH]_S_R#V53^7\5_F'_$1M_P1G_Z/'_\UZ_:I_\
MG'4?\1&W_!&?_H\?_P UZ_:I_P#G'4<T>_Y_Y![*I_+^*_S#_B(V_P"",_\
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M(V_X(S_]'C_^:]?M4_\ SCJ.:/?\_P#(/95/Y?Q7^8?\1&W_  1G_P"CQ_\
MS7K]JG_YQU'_ !$;?\$9_P#H\?\ \UZ_:I_^<=1S1[_G_D'LJG\OXK_,/^(C
M;_@C/_T>/_YKU^U3_P#..H_XB-O^",__ $>/_P":]?M4_P#SCJ.:/?\ /_(/
M95/Y?Q7^8?\ $1M_P1G_ .CQ_P#S7K]JG_YQU'_$1M_P1G_Z/'_\UZ_:I_\
MG'4<T>_Y_P"0>RJ?R_BO\P_XB-O^",__ $>/_P":]?M4_P#SCJ/^(C;_ ((S
M_P#1X_\ YKU^U3_\XZCFCW_/_(/95/Y?Q7^8?\1&W_!&?_H\?_S7K]JG_P"<
M=1_Q$;?\$9_^CQ__ #7K]JG_ .<=1S1[_G_D'LJG\OXK_,/^(C;_ ((S_P#1
MX_\ YKU^U3_\XZC_ (B-O^",_P#T>/\ ^:]?M4__ #CJ.:/?\_\ (/95/Y?Q
M7^8?\1&W_!&?_H\?_P UZ_:I_P#G'4?\1&W_  1G_P"CQ_\ S7K]JG_YQU'-
M'O\ G_D'LJG\OXK_ ##_ (B-O^",_P#T>/\ ^:]?M4__ #CJ/^(C;_@C/_T>
M/_YKU^U3_P#..HYH]_S_ ,@]E4_E_%?YEW3O^#B?_@C=JE[;Z?;?ME64<]U)
MY<<FH? S]IC2+)6P6S<:GJWP9LM.LX\ _O;NZ@B!PN_) /HNF?\ !=7_ ()*
MZO<_9+3]M[X60RB)IBVJ:=X\T2VVHRJ0+W6?"&GV;2DL-D G\]UW.L3*CE:5
MFKWC;SDEVZ-I]27":WC+Y1;_ "3/5?#O_!7'_@F%XG:S_LW]O7]EBV^W?:/)
M_P"$B^,G@WPAL^S>=YGVL^+-3T4:=O\ L[_9_MYM?M>Z#[+Y_P!JMO-^AO"G
M[8?[)'CY+9_ O[4O[.?C1+Q()+-_"?QN^&?B-;J.ZD\FVDMFT?Q/>+.ES+^Y
M@>,LLTI\M"S?+0M=M>NFOY7)=TKM-)[.2:O]Z1] 6&H6&JVD&H:7?6>HV%R&
M:VOM/N8;RSN$21HV:&YMWDAF"R)(C%'8*ZLI^935V@ HH ** "B@ HH ** "
MB@ HH ** "B@ HH ** /G7]J+]J_X _L7_">]^.'[2OC[_A6WPNTW6]$\.WO
MB?\ X1;QKXQ\G6/$-P]KH]G_ &+X!\.>*O$4GVR=&3[1%I$EK;XWW4\"$/7Y
MG_\ $1M_P1G_ .CQ_P#S7K]JG_YQU)M+?3[RHPE)-Q5[.SU2ULGU?9H/^(C;
M_@C/_P!'C_\ FO7[5/\ \XZC_B(V_P"",_\ T>/_ .:]?M4__..I<T>_Y_Y%
M>RJ?R_BO\P_XB-O^",__ $>/_P":]?M4_P#SCJ/^(C;_ ((S_P#1X_\ YKU^
MU3_\XZCFCW_/_(/95/Y?Q7^8?\1&W_!&?_H\?_S7K]JG_P"<=1_Q$;?\$9_^
MCQ__ #7K]JG_ .<=1S1[_G_D'LJG\OXK_,/^(C;_ ((S_P#1X_\ YKU^U3_\
MXZC_ (B-O^",_P#T>/\ ^:]?M4__ #CJ.:/?\_\ (/95/Y?Q7^8?\1&W_!&?
M_H\?_P UZ_:I_P#G'4?\1&W_  1G_P"CQ_\ S7K]JG_YQU'-'O\ G_D'LJG\
MOXK_ ##_ (B-O^",_P#T>/\ ^:]?M4__ #CJ/^(C;_@C/_T>/_YKU^U3_P#.
M.HYH]_S_ ,@]E4_E_%?YA_Q$;?\ !&?_ */'_P#->OVJ?_G'4?\ $1M_P1G_
M .CQ_P#S7K]JG_YQU'-'O^?^0>RJ?R_BO\P_XB-O^",__1X__FO7[5/_ ,XZ
MC_B(V_X(S_\ 1X__ )KU^U3_ /..HYH]_P _\@]E4_E_%?YA_P 1&W_!&?\
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M]JG_ .<=1_Q$;?\ !&?_ */'_P#->OVJ?_G'4<T>_P"?^0>RJ?R_BO\ ,/\
MB(V_X(S_ /1X_P#YKU^U3_\ ..H_XB-O^",__1X__FO7[5/_ ,XZCFCW_/\
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M_$1M_P $9_\ H\?_ ,UZ_:I_^<=1S1[_ )_Y![*I_+^*_P P_P"(C;_@C/\
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MU)M+1NW_  5?]2U3G)72NO5?YA_Q$;?\$9_^CQ__ #7K]JG_ .<=1_Q$;?\
M!&?_ */'_P#->OVJ?_G'4N:/?\_\A^RJ?R_BO\P_XB-O^",__1X__FO7[5/_
M ,XZC_B(V_X(S_\ 1X__ )KU^U3_ /..HYH]_P _\@]E4_E_%?YA_P 1&W_!
M&?\ Z/'_ /->OVJ?_G'4?\1&W_!&?_H\?_S7K]JG_P"<=1S1[_G_ )![*I_+
M^*_S#_B(V_X(S_\ 1X__ )KU^U3_ /..H_XB-O\ @C/_ -'C_P#FO7[5/_SC
MJ.:/?\_\@]E4_E_%?YA_Q$;?\$9_^CQ__->OVJ?_ )QU'_$1M_P1G_Z/'_\
M->OVJ?\ YQU'-'O^?^0>RJ?R_BO\P_XB-O\ @C/_ -'C_P#FO7[5/_SCJ/\
MB(V_X(S_ /1X_P#YKU^U3_\ ..HYH]_S_P @]E4_E_%?YA_Q$;?\$9_^CQ__
M #7K]JG_ .<=1_Q$;?\ !&?_ */'_P#->OVJ?_G'4<T>_P"?^0>RJ?R_BO\
M,/\ B(V_X(S_ /1X_P#YKU^U3_\ ..H_XB-O^",__1X__FO7[5/_ ,XZCFCW
M_/\ R#V53^7\5_F'_$1M_P $9_\ H\?_ ,UZ_:I_^<=1_P 1&W_!&?\ Z/'_
M /->OVJ?_G'4<T>_Y_Y![*I_+^*_S#_B(V_X(S_]'C_^:]?M4_\ SCJ/^(C;
M_@C/_P!'C_\ FO7[5/\ \XZCFCW_ #_R#V53^7\5_F'_ !$;?\$9_P#H\?\
M\UZ_:I_^<=1_Q$;?\$9_^CQ__->OVJ?_ )QU'-'O^?\ D'LJG\OXK_,/^(C;
M_@C/_P!'C_\ FO7[5/\ \XZC_B(V_P"",_\ T>/_ .:]?M4__..HYH]_S_R#
MV53^7\5_F'_$1M_P1G_Z/'_\UZ_:I_\ G'4?\1&W_!&?_H\?_P UZ_:I_P#G
M'4<T>_Y_Y![*I_+^*_S#_B(V_P"",_\ T>/_ .:]?M4__..H_P"(C;_@C/\
M]'C_ /FO7[5/_P XZCFCW_/_ "#V53^7\5_F?HI^R-^VI^S/^W9\-];^+G[*
MGQ+_ .%J?#SP[XWU+X<:SX@_X0WQ_P"!_L?C/2-!\-^)M0T;^ROB-X5\(:Y<
M?9]#\7^'+[^T;73+C2IO[1^SP7TMW:WUO:_4U40TUHPHH$%% !10 44 %% '
MYA_M-?\ !9/_ ()N?L<_%W6_@1^T?^T=_P *Y^*WAS3]"U76?"O_  J#X\>+
MOL>G^)=+MM;T6?\ MSP)\+O%'ANX^VZ9>6]QY5KK%Q-;>9Y%VEO<K)$O@/\
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M/^(C;_@C/_T>/_YKU^U3_P#..H_XB-O^",__ $>/_P":]?M4_P#SCJ.:/?\
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M*/2[=5>>:^2V0SU2E%];/M)>G5:?-\JZZ&3I36J7,O+1[7U3_).3/U&^#O\
MP4-_84^/_EQ_!W]KK]GKQUJ$DB1C0=,^*GA"V\5JTG^J,WA#4]4L/%$$<Y++
M;S3:1'%<2),D+R/#*J?9%5^7=:IVWLUH_D9^7731[ZZK3S044@"B@ HH **
M"B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH **
M/Q,_X*S))_PD_P %Y-CA#H/C*,2;3Y9==1T%F4-]TL%96*YR%85^15;0^%?U
MU,9_$_1=^R"BJ)"B@ HH ** "B@ HH ** "B@#],/^"5D<K?M ^-)51S#'\'
M=>B>4(QB227QKX :*-W'RAY%AE9%9MSK%*5QL;'[\5C/XG\OR1M#;YA14E!1
M0 44 %?"W_!1F*27]E;QCY4<DGEZ]X-E?8C/Y<:>(['?(Q4':BYR7?Y5R <4
MU\2]5^:_KR$]GZ/\C^<"BMS ** "B@ HH ** "B@#[V_X)L1R-^U%HC*KNL?
MA+Q@\I520B'34C#2$#"J9)$C#$A=[HGWF%?T95C/XOZ_$VA\/S_1?U\NFP45
M)044 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %?Y^'_!WM_R>7^S
M!_V;)-_ZM3QQ2E\,O1?^E1-*7\2/S_\ 26?R345@=@44 %% !10 44 %% !1
M0 44 %% !10 44 %% !10 44 ?Z2?_!J?_RB[U#_ +.;^+7_ *CWPYK^E6NC
MHO\ #'_TE'#/XY?XI?FPHH)"B@ HH ** "B@ HH _+G_ (+7?\HI?VY_^R%Z
MY_Z<M)K_ "7:SJ=/G^ATT-I>J_(**S-PHH ** "B@ HH ** "B@ HH ** "O
M[MO^#/#_ ))3^W+_ -E"^"/_ *C?Q$K2GO+_  _^W1,JWP?-']F5%:'(%% !
M7BW[27_)NWQ[_P"R+?%+_P!0;7::W7JOS _Q@**YCT HH ** "B@ HH ** "
MB@ HH ** "B@ HH ** "B@ HH *_1_\ X(__ /*43]@W_LYOX6_^I#;54/CC
M_BC^:)G\$O\ #+\F?ZY-%;'"%% !10!_GX?\'>W_ ">7^S!_V;)-_P"K4\<5
M_)-653XGZ1_])1V4OX<?G_Z4PHJ#0** "B@ HH ** "B@ HH ** "B@ HH *
M* "B@ HH ** "B@ HH ** "B@#JO"OCCQKX%O'U'P3XP\4^#M0=H6DOO"OB#
M5O#UXY@\WR"]UI%W:3,T/G3>46<F/S9-F/,>OLCX=_\ !47_ (*-_"K8/!'[
M<'[4.G6L2A8=*U+XS>./%&@0@*4S#X>\5ZQK>APN5.TO%IR,VV/+'R8]EJ4E
MLW9='K'I]EW6[[/T,Y0C*]XQNVE?9OX?M+WK]%KY;'Z!?##_ (.7O^"MGP[$
M,>M?&KP-\7;*WD=TLOB=\'O +[HW>*0P3ZGX TGP!KUS&I24+)<:O+<JES,B
MW'EPV8M/TW^#_P#P>"?&#3Y;6#X_?L;_  V\6PN(4O=5^#_Q#\4?#N2V8+B>
MYM= \9Z=\45O0T@#16,WB2P,<9*OJ$I&YZ4_YE\UZJ^FSLGLK&;H)_"VO)ZK
M9;.]UYMN7DN_ZU? [_@ZA_X)F_$P6EI\3D^-W[.^IRNL=Y/XY^';^,O#,,K)
M&2UIJ_PGU#QOKEQ:!V:(7%[X4TN4&)Y)+:&'8Y_:7X!_MT?L<_M2Q1-^SY^T
MS\&/BK?2!"WA_P +^/-!G\86PE4O%_:'@FZN[7Q=IIE1',2ZAHEJTGERJF6B
ME"6K2^%W\MG]W7Y7,90E'=:=UJNG7I>ZM>S?1'U=102%% !10 44 %% !10
M44 %% !10!_.Y_P=$_\ *)_QK_V6GX+_ /J07=?YG593W^7ZLZ:'PR_Q_P#M
ML HJ#<** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "
MB@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** /])/_ (-3_P#E%WJ'_9S?
MQ:_]1[X<U_2K71T7^&/_ *2CAG\<O\4OS844$A10!_"K_P 'B7_)1_V$/^Q)
M^/G_ *??A77\8-95/B?I'_TE'92_AQ^?_I3"BH- HH ** "B@ HH ** "B@
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M+/5+&156ZM+RXL9[:[F_1JK_ "[_ -=>ZW6SU,&FFTTTUNG_ %JO-73Z,**
M"B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH **
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M<?,C,M8E:&044 %% !10 5]N_LU_L,_$WX\O9>(]8CN/ /PSD*3'Q/JEF_\
M:.O0!@2OA32)3%)?I*#L&L71M]&C42/!/J-Q;M8.F[+\BHJ[MMU=^U]3]Y_@
MW\!_AC\!_#__  CWPZ\.PZ;YX1M6UR\V7WB37YD7B;6-8,<<]P$9F:"RA%OI
MEF7E&GV-J)90?9*PNV;=%VM]VB\W^>]_,** "B@ HH ** "B@ HH ** "B@
MHH ** "B@ HH ** "B@ K^+'_@ZF_8._:D^-?C;X0?M7_"+X8:K\2OA'\*/@
MS?>"/B5-X.(UGQ7X.N;?QCXC\4-X@U/PA;J=:N?"0TS5E:\U_1[?4K?1GM+R
M77UTFR6UO;DM=-;MVLN]I)V]7;3N73:C.+>BOOZJVOEWZ6WT/X9:*YSM"B@
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M"[K_ #.JRGO\OU9TT/AE_C_]M@%%0;A10 44 %% !10 44 %% !10 44 %%
M!10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %%
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MRZF/[(MUDN;R[\*:E<,^HM)IMNAEDT?5)M0N+VV29[34!=0P:??5&33\O/\
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M7XC3CPS\+(+^.-T:33?A;X9N56^LY/,8RZ?X\\4>.K)WCBF2V@9-M?T,^!_
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M/[1%\(?"$K7UAX!M5F5S%KKW.K^.9XY;FWF\4II=P-)@_;ZMMDDMOUZOU?\
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M#AUC=KJNO2]NZZ[-KK=)R.FG5YK1G:]U9[)[6OVEY;-]KV/AFBLC<** "B@
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M  '&!3JP-PHH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@
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MBQ7[#9S@YK\S*QE'E_X&UM/Z[G7"2DKKOJNJ=EH[==NK^X**DH** "B@ HH
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M %% !10 44 %% !10!_I)_\ !J?_ ,HN]0_[.;^+7_J/?#FOZ5:Z.B_PQ_\
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M_0-66UDEG@M]2M(KV*--2T:^>VG_ +-UK39+O2-3BB::PO;F "2O*:Q=UO\
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M#N2&RTJUMH+>WB^\ZORZ+9=%_7X]3F;;;;U;U;?7^ON2T6@44 %% !10 44
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M=YV2459?/SVO\KJ]O2^R..4Y3WV6R[:6OVO^5W;=W]=HH)"B@ HH ** "B@
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MZ,T5D:A10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10
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M>KT/U"_XA1O^"GW_ $,/[+'_ (=?QC_\ZNC_ (A1O^"GW_0P_LL?^'7\8_\
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M30^&7^/_ -M@%%0;A10 44 %% !10 44 %% !10 44 %% !10 44 %% !10
M44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10!_I)_\ !J?_
M ,HN]0_[.;^+7_J/?#FOZ5:Z.B_PQ_\ 24<,_CE_BE^;"B@D** "B@ HH **
M /S5_P""I'_!-_X2_P#!23]FCQ;\,/%NA:-9_%G0]%U?5O@/\4I+*$:_\/\
MQ]':-/IL0U-/*NY?!_B2\@MM)\9^'Y+AM/U'3)1?I#%KFE:+J6G_ .2OKNAZ
MMX9UO6?#>OZ?<:5KOA[5=0T36M+NUV76FZMI-W-8:C872 G;<6=Y;S6TR@E5
ME1P#WJ*G1_+TVM^OG96[&]%[QOU32WZI?+I]]S)HK(Z0HH ** "B@ HH **
M"B@ KZ>_8O\ V9O$G[9/[5/P*_9B\*71T_5?C%\0-)\,76L"$W'_  CWAM!-
MJ_C/Q/\ 9A_Q\KX7\'Z9KGB%[;*_:1IGD;D#EQ4=6EW:7WM;DR=DWV3?W?U_
MP4?ZY'[,/[+_ ,$_V//@QX.^ WP!\%:=X*\ >#--M[."&UM[7^U_$.II!%%J
M'BOQAJL%O;S>(_%VOSQ?;=<UV]7S[NZ=E1;>TBMK2#Z"K8X=>NOF^H44 %%
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M07-K<)%/!,C#;)%+&DBG[R U3J&FM[W\_E_5NAHMON_)>OX-^H44AA10 44
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MZXN %<O#8+J*ZD55&?S+-'0&1!7]3=93W3[_ *&L/A^;_)!14%A10 44 %%
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MW?DKK[TOR9E6^!^;7YW_ $/[5:*U.0** "B@ HH ** "B@ HH ** "B@ HH
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M4WNN_;5;J_RZKS[=,*BGIL]-/N^'NKZ='TM9IG T5!J%% !10 44 %% !10
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MUU;2;69=\,\<D;[68%DX..:BILO)O\;?Y&]#>7?W?N3U_P"#\EZ4J*R.D**
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MS9/@+_ZJOPI6M/:7K'\I'-B-X>D_S@?3=%68!10 44 %% !10 44 %% !10
M44 %% !10!^$O_!0S]J'6]4^*6E?#7X;^)]5T;3_ (3ZDU[JVL:!J=SI]U<?
M$-4>"18;RQEBG0^$[:233%:.9'CU:\UJWECW6T+U[;^Q!^W'X_\ BGXTT?X,
M_$[3[37]5O[#5YM(\>6BPZ=J#?V)ID^J/;>(=-@A2PO'EM;.>.+4[!;&99$M
MUO+.]DFGOTTY?<OU2O?OW_#_ #[DJ7[QVV;2LKZ/17W756W\]['ZVT5F4%%
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MB6T;P];2911L=+:^UJWV/*##K2_O-V8H_P!!:PD[MM&\=EZ+\D%%(844 %%
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M;2W\2>'+^.#6?#M_,D5W!+8W>EZEJ/P?6#5G;^M4FNK.V$N:*??\[:K[[_\
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M?^DLRK?PY>L/_2XG^@?16IR!10 44 %% !10 44 %% !10 44 %% !10 44
M%?XQ?[4/_)S'[1'_ &73XM_^I_X@J)[?/]&;4/C?^%_FCPNBLCJ"B@ HH **
M /[MO^#/#_DE/[<O_90O@C_ZC?Q$K^S*NCHO\,?_ $E'%4^.7J%%! 44 %%
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M>#=?\;W'Q;^&R_NOLC>!OBRH\:Z?8Z:(E1A8>%]4U36?!40FC$PE\,2J[W(
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MH ** "O]G_\ 9M_Y-V^ G_9%OA;_ .H-H5:4^OR_4YL1O#TG^<#VFBM# **
M"B@ HH ** "B@ HH ** "B@ K_(V_P""P'_*43]O+_LYOXI?^I#<U,_@_P"W
MH_E(UH_Q/^W)?^E0/S@HK$ZPHH ** "B@ HH ** "B@ K^S[_@SM_P"2C_MW
M_P#8D_ /_P!/OQ4JH?$OG^3,JW\.7K#_ -+B?W545L<@44 %% !10 44 %%
M!10!\E?MJ?L5_ ?]O?X#^)OV?_V@/#*ZSX9UE3?>'_$%B(+;Q;\//%MM!-%I
M'C;P3J\L,[:3X@TEIY%!:.;3]6T^:^T+7;'4=$U'4=.N?\K+_@H7^P+\9_\
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MV\W2_AAX?FNK:1D5XE\3^*!<:1I*.KY&4TA/$=Y$Z_/#=6MK*-C!&$R?NO\
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M0 44 %% !7^1M_P6 _Y2B?MY?]G-_%+_ -2&YJ9_!_V]'\I&M'^)_P!N2_\
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MR7JK^B=W^&OR(F[1EK;W7_E^;M\^I_K(45L<044 %% !10 44 %% !10 44
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MI>_VUO\ L=O O_JG/AS43V^?Z,UH_P 3_MR7_I4#\>Z*R.L** "B@ HH **
M"B@ HH *_K9_X-"?^3R_VG_^S9(?_5J>!ZNG\2])?^DLRK?PY>L/_2XG^@?1
M6IR!10 44 %% !10 44 %% !10 44 %% !10 44 %?XQ?[4/_)S'[1'_ &73
MXM_^I_X@J)[?/]&;4/C?^%_FCPNBLCJ"B@ HH ** /[MO^#/#_DE/[<O_90O
M@C_ZC?Q$K^S*NCHO\,?_ $E'%4^.7J%%! 44 %% !10 5SOB[Q9X<\!>%/$W
MCGQCK%EX=\(^#/#VM>+/%7B#4I##IVA>'/#NFW6L:YK%_,%8Q66F:99W5[=2
M!6*00.VTT ?Y&O\ P4V_;A\4?\%"_P!LGXJ_M(:W]OLO#.JWR>%/A-X8OYEE
M?P;\)/"\UU;^#=! 1$2*[NDN+WQ/KZQ@Q2>*O$6O7$;%)QCX#K&6[?\ 5K*W
MX?/OJ=T%:,5U25_6VOXA14E!10 44 %% !3XXWE=8XT:221ECCCC5F=W8A45
M$ )=G)VHB_,6_5K4/^ ?ZS__  1S_8@T[]@?]@CX,_""YTR&R^)?BC2H?BQ\
M;[ORE2\O?BKX]L-/OM8TZ\E$$#3+X*TJ+1/ %A(T2-)IWA6UGD!N+B>63]1J
MWVT[67W:' VY-M[O7[PHH$%% !10 44 %% !10 44 %% !10 5XG^TA\#/"7
M[3/P#^,?[/OCJ(2>%/C'\.?%?P^U:7RHYIM.3Q)H]UI]KK=B) 0FJ:!?36VM
MZ3/P]KJ>GVEU"4EA5Z%Y[ ?XW'Q(\ ^)/A3\0_'OPN\96L=CXO\ AMXT\4>
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M3Y7_ ,CEK;QONEY];7\NG0Z*BJ,0HH ** "B@ HH ** "B@ HH ** /YW/\
M@Z)_Y1/^-?\ LM/P7_\ 4@NZ_P SJLI[_+]6=-#X9?X__;8!14&X44 %% !1
M0 44 %% !10 5_L__LV_\F[? 3_LBWPM_P#4&T*M*?7Y?J<V(WAZ3_.![316
MA@%% !10 44 %% !10 44 %% !10 5_D;?\ !8#_ )2B?MY?]G-_%+_U(;FI
MG\'_ &]'\I&M'^)_VY+_ -*@?G!16)UA10 44 %% !10 44 %% !7]GW_!G;
M_P E'_;O_P"Q)^ ?_I]^*E5#XE\_R9E6_AR]8?\ I<3^ZJBMCD"B@ HH **
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MVW_!GA_R2G]N7_LH7P1_]1OXB5_9E71T7^&/_I*.*I\<O4**" HH ** "B@
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M[A2>"H#?7$KH_P E^7]7.?8** "B@ HH ** /U%_X)9?$/\ L/XK>,OAS=7
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M>S_E?6,MWZ_AI;^ON2.VFVX1]%Z;*_X_A;K<**DL** "B@ HH ** "B@ HH
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MK7^_>MX_"O3^MO\ A^^IQ5&W.7JEUZ)=_.__  =PHID!10 44 %% !10 44
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M'(%% !10 44 %% !10 44 %% 'QO_P % OV4=#_;<_8X^/O[,NM16?VKXD^
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M;_0_J HK0Y0HH ** "B@ HH ** "B@ HH _S>/\ @ZZ_Y2?>'O\ LUCX4?\
MJ8_%2OYGJQG\3^7Y([:?P1] HJ2PHH ** "B@ HH ** "B@#]_/^#97_ )2Z
M_!3_ +)[\<__ %5GB.O].RMH?"OG^;..K_$E\O\ TE!15&844 %% !10 44
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MB6*>998I8Y9[6,+)%--MN'Q?>_P=_P#/Y&=5VIR^7WN44OZ_(_T6Z*U.,**
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ML,%H=!@\0^8(OWD3W-J[NBLJ2_OG64_B^[\O\[FT+J/JV_R7Z!14%!10 44
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MPZZM(0-J_KK71MIVLONT^_N<#ES-R[N_WA10(** "B@ HH ** "B@ HH **
M"B@#^=S_ (.B?^43_C7_ ++3\%__ %(+NO\ ,ZK*>_R_5G30^&7^/_VV 45!
MN%% !10 44 %% !10 44 %?[/_[-O_)NWP$_[(M\+?\ U!M"K2GU^7ZG-B-X
M>D_S@>TT5H8!10 44 %% !10 44 %% !10 44 %?Y&W_  6 _P"4HG[>7_9S
M?Q2_]2&YJ9_!_P!O1_*1K1_B?]N2_P#2H'YP45B=844 %% !10 44 %% !10
M 5_9]_P9V_\ )1_V[_\ L2?@'_Z??BI50^)?/\F95OX<O6'_ *7$_NJHK8Y
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M44 %?[)O[%'_ "9I^R3_ -FR? 7_ -57X4K6GM+UC^4CFQ&\/2?YP/INBK,
MHH ** "B@ HH ** "B@ HH ** /Y[O\ @HO^T*/BA\3H_AGX;O3-X)^%]W=6
MEW)!([6VL^."&MM9O2 526+08PV@6#M&QCN1KEQ!/):ZA&!^=%;Q5HHQD[OO
MLNO;S"BF2%% !10!WWPO^)WC#X/^-]%\?^!]2;3M=T6?<JR!I;'4;.4!;W2=
M5M5DB^V:9J$&8KNWWH_*3VTT%W!!<1?TZ_L^?'OPA^T-\/['QKX8D%I?1%;+
MQ3X9FG6;4?#&MJFZ6QNB%B,]G< ?:=)U-84AU"R8,4@NXKRTM,YK:7W_ (6?
MYHT@^ENM]-.D5^:OYZ]['NM%9F@44 %% !10 44 %% 'YD?\%1/AM_PD?P:\
M/?$6SMM]]\-_$T4=_. !Y7AKQ>8=*O&<CE\>(+?PPL8Z1B>X?&9'S^!U:P?N
MF4_B]4OR_3L%%60%% !10 44 %?U(_L?_$0_$[]G/X7^(IY_/U.R\/Q>%M;8
MDF<ZMX2=_#\T]SDL/M&I06-OJTA4A&^W*Z)&KB-(GLGY_G_PQI3W?I]VJ_SM
M\SZ7HK(T"B@ HH ** "B@#Y4_;4^)O\ PJW]G'XA:O;W'V?6?$&GKX)T AC'
M*=2\5B33IY;:08*W.GZ*=7U:$K\P;3QP.H_F"K6&S]3*;V7E^?\ PP459 44
M ?TC?\$^/A;_ ,*X_9R\-:E=V[0ZW\2+B?Q[J)DB*2K8ZG'%:^&H5=SODMW\
M/6=AJD(V1HDNJ77EH0[33_<58-W;?]?U8W6B7HO/HNWW?U<**0PHH ** "B@
M HH S]4U/3]$TZ^UC5[VUTW2=,M+B_U&_O9DMK2QLK6%Y[J\NKB8K'#!!"CR
M2N[*JHKLQ)P*_G'_ &S_ -K?4_VAO%)\.^&;B[L?A)X8OG;0;!@\$GB?4HO-
M@/BS5H&6.56DBDDBT6PN5)TRQEDD9(KV^O46X*[O;1+3??3\?R(F[*W?Y6M;
M]++S]4?#]%:F044 %% !7T/^RW\=-0_9]^+_ (?\:*\TOARZ?^PO&VG1[W%]
MX6U":$7LD<*D>;?:5+';ZSIJ@J9+RQ2U9UM[B=735TT.+LT^S/ZDM.U"QU>P
ML=5TRZM[_3-3L[74--O[25)K6]L+R&.YM+RVGC)26WN()8YH9$9DDB='4X-7
MZP7I8W_K\%?J]_Z6P44 %% !10 44 %% !10 44 %% !10 44 ?!'_!4#]EE
M/VS?V"/VF_V?+?3X]0\3>+/AIJNL?#R(VWVB9?B?X&>#QO\ #M+9D_TBW:_\
M6^']*TB[GM<SG3-1OK?RKF&>:TN/\A&2-XG:.1&CDC9HY(Y%971U)5U=" 49
M"-KHWS!OTB:V?K^G^9T4'I)>=_OLOT_ 9161T!10 44 %% !10 44 %% !7]
M3O\ P:>?M+?\*R_;F^)/[.VJZFEKH'[3'PENYM&L9+E(A??$OX.37GBW0$A@
ME=%GE7P#J?Q2D<0![G$4;;3!',T=P^+UNO7_ (-]N^WD9U5>G+?IMY23?Y:^
M5S_1+HK4XPHH ** "B@ HH ** "B@ HH ** "B@ HH *_P M_P#X.(OVIQ^T
M_P#\%0/C1:Z3J0U#P3^SU;Z9^SGX0\JY:6V6X^'TM_/\0I0@/V<7!^*6M>-;
M(W$.YKBPT[3?-D80HD4RV]6E;776_P"G4UH_'Z)O;S2_7<_#>BL3K"B@ HH
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M9KJW^+?QN^&G@35E DV6_AW7O%NE6?BC49S"RSBTTGPX^IZI>M ?M"6EG,8
M9505_LF111P1QPPQI##"B10PQ(L<444:A(XXXT"I''&BJJ(JA44!5%;0^';K
MOZ*.GR_&YRUOBBNR_I_.W3M]TM%48A10 44 %% !10 44 %% !10!_F\?\'7
M7_*3[P]_V:Q\*/\ U,?BI7\SU8S^)_+\D=M/X(^@45)844 %% !10 44 %%
M!10!^_G_  ;*_P#*77X*?]D]^.?_ *JSQ'7^G96T/A7S_-G'5_B2^7_I*"BJ
M,PHH ** "B@ HH ** "B@ HH _R!?^"GOP17]G/_ (*$_MA_!^WMEL]*\,?'
MKQ[?>&;1(O(6V\&>,=5D\<>"(%C#N,1>$?$FB1AU*K*%\U40/L3X1K&6[]?Z
M_K\$=T'>$7TY8V].5?UT"BI*/])/_@U/_P"47>H?]G-_%K_U'OAS7]*M='1?
MX8_^DHX9_'+_ !2_-A102%% !10 44 %% !7^4W_ ,%]_P#E+W^VM_V.W@7_
M -4Y\.:B>WS_ $9K1_B?]N2_]*@?CW161UA10 44 %% !10 44 %% !7];/_
M  :$_P#)Y?[3_P#V;)#_ .K4\#U=/XEZ2_\ 2695OX<O6'_I<3_0/HK4Y HH
M ** "B@ HH ** "B@ HH ** "B@ HH ** "O\8O]J'_DYC]HC_LNGQ;_ /4_
M\05$]OG^C-J'QO\ PO\ -'A=%9'4%% !10 44 ?W;?\ !GA_R2G]N7_LH7P1
M_P#4;^(E?V95T=%_AC_Z2CBJ?'+U"B@@** "B@ HH _D%_X.[OC_ #>%OV;_
M -F+]FS3-0,-S\7?BIXF^)GB2U@*&6;PY\(=!L]*TZUON"T5G?\ B+XD6FHV
MH^3[1=^&6*/MLY4/\"-9U+W7I_P?R:9U45:%_P":3?X)?H%%9FP44 %% !10
M 44 %?U+_P#!I3X\M/#O_!0SXN>";WR4_P"%A_LL>+X]+D;/VB36_"OQ&^&.
MMQV<>Z5$\B70CXBNI\13S>986VSRXO/:JA?F5O/\4U^IG5UIR^3^Z2:/]%&B
MMCC"B@ HH ** "B@ HH ** "B@ HH ** "B@""YMK>]M[BSO+>"[L[N"6VNK
M6YBCGM[FWGC:*>WN()5>*:":)VCEBD5HY(V9'5E8BO\ '*_;E_9_N/V5_P!L
M/]I7]GJ:W>WM/A1\9/'/A?P_Y@D#77@Z+6[J[\#ZD%F8RA-7\'W>AZI&)&=O
M+O!^\D \QYGM\_\ A]/DO/1=+FU%VDUW7Y22[/O^)\IT5B=044 %?[)O[%'_
M "9I^R3_ -FR? 7_ -57X4K6GM+UC^4CFQ&\/2?YP/INBK, HH ** "B@ HH
M ** "B@ HH *^0OVTOV@5^ /P>U"^TJY2+QWXQ^U>&?!$2EO.M+N:WQJ7B)5
M7G;X=LIENH2P:'^UI])@GCDAGD!:U:7FA-V3;_IWT/YE7=Y'>65WDDD=I)))
M&,CR/(=SN[MEG9V))))9F/I25N8!10 44 %% !7N/[/GQZ\7_L\_$&Q\:^&)
M'N;&4PV7BKPY-,T=AXFT$S+)<V%PV)%M[R(!IM*U)8I)=-O L@BGM);NSNAJ
MZ:_K=;>8T[-/SU\UV/Z=/A=\3O"'QA\#Z+X_\$Z@NHZ'K5L)-K%4O=+OXE47
MVC:M;J[M::KILQ,%U#EHVPEQ;2W%G/;7,_H=<^QOT5K_ #7DNO7^NX44 %%
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M#UM_Z4G^-ONN?VN45J<H44 %% !10 44 %% !10 44 %% !10!_.Y_P=$_\
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M_P#U5GB.O].RMH?"OG^;..K_ !)?+_TE!15&844 %% !10 44 %% !10 44
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M4 %% !7^,7^U#_R<Q^T1_P!ET^+?_J?^(*B>WS_1FU#XW_A?YH\+HK(Z@HH
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MB@ HH ** /YW/^#HG_E$_P"-?^RT_!?_ -2"[K_,ZK*>_P OU9TT/AE_C_\
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MH ** "B@ K_*;_X+[_\ *7O]M;_L=O O_JG/AS43V^?Z,UH_Q/\ MR7_ *5
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MBD5DDC=5964HXS4-<[Z+M^J7]?Y;'>OZ^Y?UHVO,**0PHH ** "B@ HH **
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M4 %?UL_\&A/_ ">7^T__ -FR0_\ JU/ ]73^)>DO_2695OX<O6'_ *7$_P!
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M5%;Q^%?=^"?ZG'534V^]G^"OVZ_UT113,PHH ** "B@ HH ** "B@ HH **
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MMBM[:WC2""&-,G;'%$B(BCA57FLZG3Y_I_P36&S]4OZ^_7\-2U169844 %%
M!10 5\.?MG_M;Z9^SQX5;P]X;FM=0^+'B>RE&@V#&.YA\-:?(RPR^*-9@$JN
M@0&1-!LY%V:CJ,+R/'-8V-ZC.*NTK7$W9-]MOO7?_AS^<?4]3U+6M2O]7U>_
MN]4U75+NXO\ 4=2O[B2ZO;Z]NI&FN;NZN9F>:>XGF=I)99&9F9LFJ5;F 44
M%% !10 44 %% !5O3M2O](U&QU;2KNXL-3TN]M=1TV_M9&ANK&_LITN;2[MI
MDVO%<6UQ%'-#(AW1R(CKR* /ZD?V6OCI8_M _"'P_P"-%EMH_$MHBZ'XWTV
MJ#I_BC3XHEO)%A"J8K+5XGBUG3D4NL5K?I:F:2>VN-GT96#5FUV.C2RMV7Y+
M];A12 ** "B@ HH ** "B@ HH ** "B@ HH _P H3_@N/^RN/V2/^"FG[2?@
M;3--&F^"?B!XF'QS^'<<,#6]C_PBGQ<,WBBYL=,A( 33?#7C*;Q7X.M5C+1(
MGAS8A 7:/R2K&6DG_6Z3_KL=M-^Y'ORJ_JDE_7D%%26%% !10 44 %% !10
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M0 44 %% !7^1M_P6 _Y2B?MY?]G-_%+_ -2&YJ9_!_V]'\I&M'^)_P!N2_\
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M <$F6PT2PGM9L,JB/78SA_X/W2K&?Q/Y?D;05HK^OZTM_P /<**DH** "B@
MHH ^8_VH_P!I?PS^S;X$DUN\^S:KXRUE)[/P3X5>4J^J:@B?/J&H+$Z7$&@:
M47CFU.Y4HTS-!IMM+'>7<+I_,UXT\:>)_B)XIUKQGXQU>ZUOQ)K]XU]J>HW;
M9>61@$BAB1<1VUG:0)%:6-G L=O96D$-I;QI!$B#6FM&[?\ #:+\S.;V2]7\
MU_7ZZZ+F**LS"B@ HH ** "B@ HH ** /M;]A7]H4_ SXNVECKM\UM\/OB"]
MGX=\4"64K9Z9>&=DT#Q-(&81HNEW5Q)!>SDCRM(U#4)")7AA6OZ4JRFM;]_T
ML;0?N^C?^?ZA14%!10 44 %% !10 44 %% !10 44 %% '\;'_!W1^RA+XB^
M%G[.?[9WA[3?-O?AOX@U+X&?$F[A4O.?"?C;[1XH^'NH7?R8BTSP_P"*],\4
MZ29#)\VI>/M/A$3"0M'_  ?5G4W3[K\M/NT^^YUT7>%OY6U^4OU"BLS4** "
MB@ HH ** "B@ HH LVEY=:?=6M_875Q97]E<07EE>V<\MM=V=W;2K-;W-M<0
MLDUO<6\R)+#-$ZR12*DD;JZ@U_L5_L(?M$VW[6?[&W[-?[1<,HEO/BK\(?!_
MB'Q&J^7MM?&T6FQZ5X^TU3"L<3KI7C;3=>TU9$BB606F[R(=QA36'7MI][W.
M:O>\?^WO_;?^#]Y]:459@%% !10 44 %% !10 44 %% !10 5_)9_P ':G[4
M_P#PK_\ 91^#/[*.AZCY6N?M#?$27QKXPM8B7+?#;X/"QO[>RO4# 01ZQ\1-
M<\(ZEITD@83OX-U-(US"[*GLWY=K[Z;/U*@KSC_BB_N:?Z'^?516!W!10 44
M %=G\.O 7BCXJ_$'P)\+_!&GG5O&GQ)\9>&/ 7A#2E;8VI^*/&.MV/AW0-/5
M\%4-[JVHVML&*G:9>0<8IJ]]/+\U_6HG^2;^ZS]/ZT:/]D#]F+X$>%_V7_V>
M/@K^SQX,2,>'/@W\-O"7@"RN8X5MVU:?P_H]M9ZIX@NXU&/[2\2:LE]K^J2$
M[YM1U&YG?YI6KW6MS@"B@ HH ** "B@ HH ** "B@ HH ** "B@#^=S_ (.B
M?^43_C7_ ++3\%__ %(+NO\ ,ZK*>_R_5G30^&7^/_VV 45!N%% !10 44 %
M% !10 44 %?[/_[-O_)NWP$_[(M\+?\ U!M"K2GU^7ZG-B-X>D_S@>TT5H8!
M10 44 %% !10 44 %% !10 44 %?Y&W_  6 _P"4HG[>7_9S?Q2_]2&YJ9_!
M_P!O1_*1K1_B?]N2_P#2H'YP45B=844 %% !10 44 %% !10 5_9]_P9V_\
M)1_V[_\ L2?@'_Z??BI50^)?/\F95OX<O6'_ *7$_NJHK8Y HH ** "B@ HH
M ** "B@ HH *8[K&K2.RHB*SN[L%144%F9F8@*J@;F9N%&: /\1JBN<] **
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MZU2_7L?W8?\ !%K_ (./]#\<VGA;]EG_ (*'^+X-!\>0QV>A?#C]I_7I8H-
M\<,97@LO#_QFO\QP^'?%@1[2UTWQ[+$N@>(UBF;Q?>:-KJ+JGB;^R2">&ZAA
MN;::*YMKF*.>WN()%F@G@F42130RQEDEBE1E='1C')&596*FMD[J_P!_K97_
M *^70XI1<)6^[TLOQ5[-]=]+V)Z*9(44 %% !10 44 %% !10 44 %% !10
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MUKQK9&XAW-<6&G:;YLC"%$BF6WJTK:ZZW_3J:T?C]$WMYI?KN?AO16)UA10
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M<D=U^YO9]0@TT)<37D-O-4/B5^Z_-7_"Y,W:,O\ "_OZ;_U^O^L]16QPA10
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M (-"?^3R_P!I_P#[-DA_]6IX'JZ?Q+TE_P"DLRK?PY>L/_2XG^@?16IR!10
M44 %% !10 44 %% !10 44 %% !10 44 %?XQ?[4/_)S'[1'_9=/BW_ZG_B"
MHGM\_P!&;4/C?^%_FCPNBLCJ"B@ HH ** /[MO\ @SP_Y)3^W+_V4+X(_P#J
M-_$2O[,JZ.B_PQ_])1Q5/CEZA100%% !10 5YG\:-)AU_P"#OQ8T*YDEAM]:
M^&GCO29Y82OG1PZCX7U6SEDA$BM'YB1SLR>8C)O"[E9::W7JOS _Q8Z*YCT
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M)ZM<,TDK/'%')+HM_<MNU2QBDC=Y;VQO7;X?K>+ND_ZN825G;^OZZ!13$%%
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MJVD:E;%S;WNGZA ES9W,6]5=5F@D1PKHLB$E)$CD!6MBN<WO_5K:V044 %%
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MO_)NWP$_[(M\+?\ U!M"K2GU^7ZG-B-X>D_S@>TT5H8!10 44 %% !10 44
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M;VR 4S-?Z'X6\!MIT[>8D,5EXUV/#/+/%+9W#XO1-_A9?BT95O@??3_TI7_
M_OHHK4Y HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH _S>/^#KK_
M )2?>'O^S6/A1_ZF/Q4K^9ZL9_$_E^2.VG\$?0**DL** "B@ HH ** "B@ H
MH _?S_@V5_Y2Z_!3_LGOQS_]59XCK_3LK:'PKY_FSCJ_Q)?+_P!)0451F%%
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MB@ HH ** /YW/^#HG_E$_P"-?^RT_!?_ -2"[K_,ZK*>_P OU9TT/AE_C_\
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M'\W<WYY5C+=]=7_EW:Z?\$[:?P1?>,7_ .2H**DL** "B@ HH ** "B@ HH
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MRN0!)<.(P'GNIPB&>\N'ENKEU#SSRL YZFD'I^7DO^&]/6P44 %% !10 44
M%% !10 44 %% !10 5\8_P#!0S]E[3OVSOV*OVC_ -FR\MH)]1^)/PSUNW\&
MRW*J\6G?$C0!%XI^&FK,&D@^32_'FB>'KVX5;B#SK6&:V:>..>0T+71[/<:=
MFGV:?W.Y_CX7UC>Z7>WFFZE9W6GZAI]U<6.H:??6\MI>V-[:2O!=6=Y:SI'/
M;75M/')#<6\T<<T,T;QR(CIQ4K!Z:?UJEI\CN7?OK^"]>E@HI#"B@ HH **
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MDO\ TJ!^/=%9'6%% !10 44 %% !10 44 %?UL_\&A/_ ">7^T__ -FR0_\
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M0[RQU*T,D9:.40W*++$S1.'1F6OZA/V%O^#JK]J/X,?V7X*_;-\&67[4/@*
M6EFOC_0FTOP+\;M$M(@(I+FZFM[.+P5\0S%;QQ^5::MI_A37+ZZ:>ZU7QO=-
M($72,N71ZQ\MU>UVO3M=)^3U64Z:FKK22VVL]%H[:VTT>ZZ76C_L\_8K_P""
MF/[%_P"W_P"'TU3]FWXS:%XA\2060O-=^%GB$KX6^+7A=,'SCK'@759$U.>R
MMG4Q2:_H!USPO+(-MIKER>:^]:T_%/5-?U_P4]'9HY-5HTTUNGNOZ_%:K0**
M "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH **
M "B@ HH ** "B@#P#]HW]GSPE^T7X NO"/B)5LM8L_M%]X0\31QF2[\-ZV\6
MQ+@('C-WIUV%2#5]-=UCN[0 QM!>V]E>6W\QWQ)^&_B[X2^--:\!^-]+DTO7
M]#N3%+&<O:WELX+V>IZ=<[52[TV_@*7%G<HH+QOY<BQS1S0II3>Z?JO+:_\
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M_P"4O?[:W_8[>!?_ %3GPYJ)[?/]&:T?XG_;DO\ TJ!^/=%9'6%% !10 44
M%% !10 44 %?UL_\&A/_ ">7^T__ -FR0_\ JU/ ]73^)>DO_2695OX<O6'_
M *7$_P! ^BM3D"B@ HH ** "B@ HH ** "B@ HH ** "B@ HH *_QB_VH?\
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M6 _Y2B?MY?\ 9S?Q2_\ 4AN:F?P?]O1_*1K1_B?]N2_]*@?G!16)UA10 44
M%% !10 44 %% !7]GW_!G;_R4?\ ;O\ ^Q)^ ?\ Z??BI50^)?/\F95OX<O6
M'_I<3^ZJBMCD"B@ HH ** "B@ HH ** "B@#\#O^#C+]N%/V/_\ @GKXQ\&>
M&=7^P?%S]JR74/@9X)CMKD0ZGI_A#4],>7XN^+;=?EF%MI?@V?\ X11;VUDC
MN],\0>._#=[ RF-G3_,(K.H]EVN_O_X8Z:"]UON[?)+_ #;"BLS<** "B@ H
MH ** "OZ$?\ @WP_X)8W/[>O[35O\8/BGX?>X_97_9QUS2]=\:B]@SIOQ,^(
M]M]GU;PC\*(3)B.\T_=]E\4>/XT2XCC\+6]KH%VMK+XSTR]BJ&LEY._W=/GL
M9U)6B^_3[TK_ "W\S_341%C54151$541$4*BHH"JJJH 55 VJJ\*,<4^MCC"
MB@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH _S>/\ @ZZ_Y2?>
M'O\ LUCX4?\ J8_%2OYGJQG\3^7Y([:?P1] HJ2PHH ** "B@ HH ** "B@#
M]_/^#97_ )2Z_!3_ +)[\<__ %5GB.O].RMH?"OG^;..K_$E\O\ TE!15&84
M4 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 5_E-_\ !??_
M )2]_MK?]CMX%_\ 5.?#FHGM\_T9K1_B?]N2_P#2H'X]T5D=844 %% !10 4
M4 %% !10 5_6S_P:$_\ )Y?[3_\ V;)#_P"K4\#U=/XEZ2_])9E6_AR]8?\
MI<3_ $#Z*U.0** "B@ HH ** "B@ HH ** "B@ HH ** "B@ K_&+_:A_P"3
MF/VB/^RZ?%O_ -3_ ,05$]OG^C-J'QO_  O\T>%T5D=044 %% !10!_=M_P9
MX?\ )*?VY?\ LH7P1_\ 4;^(E?V95T=%_AC_ .DHXJGQR]0HH("B@ HH **
M/EG]MS]FW2?VOOV2/VA/V:M7^SQK\7OA?XE\,:->W7-OI'C 6O\ :?@3Q!*"
M&ROAWQKI^@ZZ$P0QT\*?O5_CL>)/#NM^$/$6O^$_$VF76C>)/"^M:IX=\0Z-
M>HL=[I.MZ)?3Z;JVF72*S*EU87]K<6LZJ6598F )%1/9>K_3_)]_34WH/5KT
M?7OY:=O^&N8E%9'2%% !10 44 %% !10 44 %% !10 44 %% !10!I:3J^K>
M']4T[7-!U34=%UK2;RWU#2M8TB]N=-U33+^SE6>TOM/U"SD@N[*\M9D26WN;
M:6*>"5$DB=&56K^D[]@?_@YU_;._9CCTCP-^TI:I^U[\*+)(;.*_\6:N=#^-
MV@V<:K&C6/Q*6SU"/Q>D*[YYH/'^DZWK6HR".W7Q=I=NO&D9<KY7K%V\GK;5
M-_\  OU\LITU-::2Z/[M&K[:>=MU?5/^U#]A+_@KS^PQ_P %"K"RLO@A\6;3
M1_BA-:"YU+X%?$P6G@SXMZ<\<,<]XECH%Q?7.G>-+.Q61#>:Q\/]8\5:1:!T
M2^O;6X+0+^G%:>:U7?\ KL<K33::LUNOZW"B@044 %% !10 44 %% !10 44
M %% !10 44 %% !7XO?MW_ME>-/"_P 5="^'WP:\7WOAU_AO<#4O%VJ:5+!)
M!J_BNY3]WX=U"VECN++5=)T&Q<#4-.ODGL[C6+^XMK^P%UHEM*M15WKM8F3L
MK['T?^QK^V]=_M#ZM/\ #WQAX2_LOQWI>@76O2:[X?+2>&=6T_3[FQL[B6>R
MN99+W0K]I-2M%$*S:E87<IE>.ZL&>WL:_1*E)6=OZVO^HT[I/[_P\]OZWO8H
MI#"B@ HH ** "B@ HH ** "B@#\^OVWOV/K3X[:#)X\\"V5O:_%OP[9$)%&L
M-NGCK2K90R:'J$SO%$FL6<2NV@ZE.>0W]D7LBV<MI<Z5_/#<VUS97-Q9WEO<
M6EW:7$MM=6MS%)!<VUS!(8I[>X@E"2PSPRH\<T,B*\3JZ.BLM;0=U;K^G0RF
MK-2[_P# W7^?F1451 44 %?JW^P)^V3_ ,(==Z9\#OBGJ^WPC?3BV\">)]1G
M(3PM?SLWE>'=4NIY,1>'=0G(CTNY?]WHU]-Y$^-(NO.TB9*Z\^A479^MOST_
MX/E='[FT5B;!10 44 ?S]?\ !3SX<?\ "+?'/2O'=K"\>G_$SPS;7,\OE;(F
M\1>%E@T/4XHV5 C$:/\ \(Y<RY)E,UU)))\I0M^;E;Q^%>B[F,M)/^MU<**9
M(44 %% !10!]M?\ !/CXB?\ " _M+^$[2YG\C2_']GJ7@/4,M\AN-52.^T%0
MF=K2S>)-+TBS1Q\R+=S% =S1R?TG5E/?U-8?#\W^2_KY!14%GR9^V[\3/^%7
M?LW?$#4K>X\C6/%%FG@/02.':^\5++9WSPN"#'<6?AY-<U*"0<K-91X ZU_,
M56L-GZ_HC*;U2[;_ /!\]/Z0459 44 ?U'?L??#,?"G]G?X;^')[=8-8U+1X
M_%OB$8=93K/BH_VQ)!<[L#[1I=E<6.BR! $V:8I!D)\R3Z:K!N^O<Z%LE^GD
MOZ_X<**0!10!^?W[;_[7MM\!O#S>!_!%Y%<?%OQ+8%[=TV3)X*T>Y\R(>(;R
M*2&6WEU.Y,<D>B:=/P&#:I=1FSA@@U'^=Z[N[N_O+F_OKF>\O;VXFNKR[N99
M+BYNKJXD::XN;B>5GDFGGE=Y)I9&:1Y'=GD9FK6"LMM[>>EE^OX_(RF]E\WO
MY6Z=O/3L0T59 44 %% !10 44 %?2'[,_P"S3XR_:2\:C1-%$FD^%=(>WG\9
M>,)H#)9:'83,VRWMT)07VNZ@L4J:7IJ.AD9)+FZD@L+:YN8QNR;&E=V_K^NG
MS/Z7OAQ\.?"/PG\':/X$\$:5%I/A_1+<0P0H$-S>3L ;K4]2N0J->ZI?R@SW
MMY(%>:4L55(ECCC[JN?S[ZF^VGI^2_K^KA10 44 %% !10 44 %% !10 44
M%% !10 44 %% !10 44 %% 'QO\ \%!_V8[+]LC]BO\ :2_9MN(+:?4?B;\+
MM?T_P@]Y#%/;V/Q$T5(_$_PVU:1)WC0KI7CW1/#FH.PFMY1';.(KJVD;SD_Q
M[M3TS4-%U+4-'U:SN=-U;2;Z[TS4].O89+>\T_4;">2UO;*[@E59(+FUN8I(
M)XG"O%+&Z,NY:F?V7MJ];:_9_P"#:_F=%!_$O1_Y]O+_ "Z.A16)T!10 44
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M+&K7<,EPW?DO/NE^O4RK/W'YM?FG^GZ]#^W6BM3D"B@ HH ** "B@ HH **
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MI6_"[ZZ-:[GTG15&(44 %% !10 44 %% !10 44 %% !10 44 %% !10 44
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M@$,*J^I0Z=*WD)^I]:>FJ[K;^N_8Y6FFTU9K=?UN%% @HH ** "B@ HH **
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M7I?\.W9:^;\S6FNN]]+>5U^;^>C/3J*S+"B@ HH ** "B@ HH ** "B@ HH
M** "B@ HH ** "B@ HH ** "O\KK_@O_ /LK_P##*O\ P4_^/FFZ7I@TWP1\
M;;NS_:+\")%:M:6CV'Q3FOKSQ?#:0@?9XK73?BAI_CS2K2&S;[/#865HB16F
M?LEO,MONO]YK1;Y_6+7XI_H?BY16)UA10 44 %% !10 44 %% !7]X'_  :&
M_M*/KGPG_:A_9+UC4)9+CP!XQ\._'#P19SMYF-!\>Z<GA'QK:V+%RT-CI.N>
M$O#%_):JD</V_P 77-W%OFNKMA=/XK=T_P -=?N,:WP>C3^]J/\ [=_77^RB
MBM3E"B@ HH ** "B@ HH ** /E;]N']I#3/V0_V1/VB/VD]4>W!^$?PL\3^)
MM#M[I0UOJ?C-K,Z7X"T*4,R+CQ!XWU'P_H8)( .H U_CIZSK&I^(=7U77];O
MKC4]9US4K[5]7U*\D,UWJ&IZE=2WNH7UU(>9+B[NYI;B>0\O+([$#=BHGLOG
M\]K?K_2-Z*^)^BZWWO\ U^.AF45D=(44 %% $T,,UU-%;V\,D]Q/)'#!!#&T
MLTTTK".*&&*,-)+)+(RI'&BLS,P1!FO]>?\ X)>_LFP_L2_L&_LW?L\3V2V7
MBKPM\/['7/B4HP\DGQ3\<S3>-/B+')<"25[N+3/%>N:EH>FS-(0-'TO3K>*.
M"WAAMX=8=7Z+\G_77O;KS5M%&/K^"C\^KTNU]UE]]T59@%% !10 44 %% !1
M0 44 %% !10 44 %% !10!_.Y_P=$_\ *)_QK_V6GX+_ /J07=?YG593W^7Z
MLZ:'PR_Q_P#ML HJ#<** "B@ HH ** "B@ HH *_V?\ ]FW_ )-V^ G_ &1;
MX6_^H-H5:4^OR_4YL1O#TG^<#VFBM# ** "B@ HH ** "B@ HH ** "B@ K_
M "-O^"P'_*43]O+_ +.;^*7_ *D-S4S^#_MZ/Y2-:/\ $_[<E_Z5 _."BL3K
M"B@ HH ** "B@ HH ** "O[/O^#.W_DH_P"W?_V)/P#_ /3[\5*J'Q+Y_DS*
MM_#EZP_]+B?W545L<@44 %% !10 44 %% !10 5_)5_P<S_\%7;;X$_"V]_8
M"^!WB<I\:OC)H,,GQTUG1YT-S\-_@[K, D7PA)<QR;K'Q7\5;.017%J5-S8_
M#R2^NIHK4^+?#U_0W9-]NV_;3[[E0CS2BO.[]%J_OV^9_GV45SG<%% !10 4
M4 %% !7T3^RQ^RQ\;OVSOC=X/_9^_9^\'W7C+XA>,KHB.,&2VT3PWHEO)%_;
M'C#QAK'E30^'_"/A^&9;G5M6N5<@O;6%A;7^L7^FZ;>M)MV7_#ZK_AWY*Y,F
MDKO9*[?HT_6[Z>?1G^IQ_P $O_\ @FC\&_\ @F5^SWIWPK\ 10>(OB1XF@TC
M6OCA\69[8Q:M\1_'%I9-'));)*7ET?P7H$MU?V7@GPPCLFDZ;/-=W\VH>(=4
MUS6-3_2>M_\ @+[CB;;=WNPHH$%% !10 44 %% !10 44 %% !10 44 %% !
M10 44 %% !10!_F\?\'77_*3[P]_V:Q\*/\ U,?BI7\SU8S^)_+\D=M/X(^@
M45)844 %% !10 44 %% !10!^_G_  ;*_P#*77X*?]D]^.?_ *JSQ'7^G96T
M/A7S_-G'5_B2^7_I*"BJ,PHH ** "B@ HH ** "B@ HH ** "B@ HH ** "B
M@ HH ** "B@ K_*;_P""^_\ RE[_ &UO^QV\"_\ JG/AS43V^?Z,UH_Q/^W)
M?^E0/Q[HK(ZPHH ** "B@ HH ** "B@ K^MG_@T)_P"3R_VG_P#LV2'_ -6I
MX'JZ?Q+TE_Z2S*M_#EZP_P#2XG^@?16IR!10 44 %% !10 44 %% !10 44
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MK=_+\O\ @(SG+9+U?X6\_-W_  .!HK0S"B@ HH ** "B@ KV'X&? _QK\?\
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MZ7K%^%>1D\J7_5;K:.D5YN_X+_)_\#8Y*SO*W9*_:^^GWA15&044 %% !10
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MYS>R^;^=K>G7[SHHJUY/KHO2ZO;R;LO5' T5F= 44 %% !10 44 ?;7["7[
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MZGO;N[SF]E]Z_(TA'JUHVDOP;_&VNRUW6I[C169H%% !10 44 %% !10 44
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M-O\ @L!_RE$_;R_[.;^*7_J0W-3/X/\ MZ/Y2-:/\3_MR7_I4#\X**Q.L**
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MYJ_W>2/S_HK$Z@HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH **
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M;R;D&0!G%V:]5^.@I:I^CMTV:?WZ:+KJ?@G16Y@%% !10 44 %>A_"+QU/\
M#/XH> ?'\!?_ (I/Q7HNL7*(&W3Z=:WL)U6S/EE69;S33=VDBJ1N6=E!'4'Z
MC3LT^SOYZ-;'];T$\-U##<6\T<]O/&DT$\+K+#/#*HDCEBDC+1R121LKQR(S
M*ZMD5^*O_!5GXCFZU_X:_"BSN T>DZ=?>.=<ACE5U-[JLTNBZ!'-&I(AN+.S
ML-;F"2?O6M]7BDPD<D;280UDNVZ^Y?/S-9-J+7_ UO&]EZ:;]3\B**W,0HH
M^A_V4/A>/B_\?OAUX0N8//T9=937_$B.NZ(^'_#:MK&HV\^0P$>IBTBT=&VM
MF?4(NN=R_P!4-9S>J7;]36'P_-_D@HK,LYSQ9XJ\/>!O#>M>+O%>J6VC>'?#
MUA/J>JZG>/LAM;6W )(49DGGFD9+>TM;=)+F\NI8+2UAFN)XHW_FE_:Q_:@\
M0_M(^.&NU^UZ3\/O#\UQ;>"O#$DC+L@9V237M8BCEE@D\0ZI&%,Y0O!I]H(M
M/M7E$=U>7UTU=M]%MY[?=^'Z$3LDEZ+[K7[=?D?*E%:F044 %% !10 44 %=
MY\,/AGXN^+OC71? 7@C3I-2US6[@1JS"066G6B%/MFKZK<Q1R&STK3HF\Z\N
MF1BB*L422W$D$$I>R?1=1I-M);L_IA_9M_9Q\'_LW^!U\-Z!G4M?U/[->>,/
M%<\7EWGB#5(HV5?+CW/]BTBP\R6+2]-C=UMX7>:XDN+^YN[J;Z+K!MMW-^B]
M%^"2_&WWW]644@"B@ HH ** "B@ HH ** "B@#GO$_BKPWX+T6]\2>+==TKP
MWH.FH9+W5]9O8+"Q@4@[5:>Y>-&FE8>7!!&7FN)2D4,<DKHE8/PU^)W@?XN^
M%H/&?P]UV'Q!X=N;[4=/CO8H+JTD6[TR[DM;B*XLK^&VOK.0A8[F&*\M[>66
MRN;.Z6-8;F%F-;7Z::V_K_@=0TZ6[_+2_77LG_D[=_10 44 %% !10 44 %%
M !10 44 %% '^61_P<$_LGQ_LH_\%._CA::+IC:=X#^/#6?[1G@9$MTAM5A^
M)ESJ$WCBSLUB5;:&VT[XI:7XYMK&QMUC6RTD:;"(HT:,O^)U935F_7]$U]US
MMI_!'T2^Y6^6VP45!844 %% !10 44 %% !10!_I$?\ !J_^TD?B_P#\$Z-1
M^"VJ7[7/B3]E[XK^)O!T%O-</<W2_#_X@R-\1_"-[*\A,D5N=?UCQ]H&GVWS
M1VUCX;@A@9(52&#^F"NA;+T7Y(X9*TFO/^EUV]0HH)"B@ HH ** "B@ KY6_
M;A_:0TS]D/\ 9$_:(_:3U1[<'X1_"SQ/XFT.WNE#6^I^,VLSI?@+0I0S(N/$
M'C?4?#^A@D@ Z@#0O/8%KIW/\=/6=8U/Q#J^JZ_K=]<:GK.N:E?:OJ^I7DAF
MN]0U/4KJ6]U"^NI#S)<7=W-+<3R'EY9'8@;L5F5@]^__  W]>FQWK16[677L
MOZT"BD,** "NK\#>"_$GQ(\;^#OAWX-TV;6O%_C[Q5X>\%^%='MD9KC5O$GB
MG5[30]#TR!$#NTU_JE_:VL2JC,9)5" G IK?[M_5?UI^0GWZ)-_=9[?+Y'^Q
MS^R?^S]X;_94_9I^!O[.7A,1-HWP<^&GA3P,+V%9%&M:KI.F0)XB\22I(=RW
M7B;Q"^J>(;P;8XQ=ZG/Y4,,6V)/H2MS@"B@ HH ** "B@ HH ** "B@ HH *
M* "B@ HH ** /YW/^#HG_E$_XU_[+3\%_P#U(+NO\SJLI[_+]6=-#X9?X_\
MVV 45!N%% !10 44 %% !10 44 %?[/_ .S;_P F[? 3_LBWPM_]0;0JTI]?
ME^IS8C>'I/\ .![316A@%% !10 44 %% !10 44 %% !10 5_D;?\%@/^4HG
M[>7_ &<W\4O_ %(;FIG\'_;T?RD:T?XG_;DO_2H'YP45B=844 %% !10 44
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M/_)S'[1'_9=/BW_ZG_B"HGM\_P!&;4/C?^%_FCPNBLCJ"B@ HH ** /[MO\
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M<C"1762-ERG&,DT_+I_E_D;1E=*WE?2[^SKZ/;YO8Z>BI*"B@ HH ** "B@
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M7<^/KQD.Z9P?\_RLJF_R_P"!^2_K6_50=X-=I-?@G^H45!L%% !10 44 %%
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M(M\+?_4&T*M*?7Y?J<V(WAZ3_.![316A@%% !10 44 %% !10 44 %% !10
M5_D;?\%@/^4HG[>7_9S?Q2_]2&YJ9_!_V]'\I&M'^)_VY+_TJ!^<%%8G6%%
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M\&A/_)Y?[3__ &;)#_ZM3P/5T_B7I+_TEF5;^'+UA_Z7$_T#Z*U.0** "B@
MHH ** "B@ HH ** "B@ HH ** "B@ K_ !B_VH?^3F/VB/\ LNGQ;_\ 4_\
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M8O%1EN=7,.W">1!XGAUVSA5 52.V6,X(('R%6\=EZ+\C!Z-_\.%%,044 %%
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M4 %?UL_\&A/_ ">7^T__ -FR0_\ JU/ ]73^)>DO_2695OX<O6'_ *7$_P!
M^BM3D"B@ HH ** "B@ HH ** "B@ HH ** "B@ HH *_QB_VH?\ DYC]HC_L
MNGQ;_P#4_P#$%1/;Y_HS:A\;_P +_-'A=%9'4%% !10 44 ?W;?\&>'_ "2G
M]N7_ +*%\$?_ %&_B)7]F5='1?X8_P#I*.*I\<O4**" HH ** "B@ HH **
M"OR0_P""K?\ P2)^ W_!4'X8?9O$,=G\/?VB/!VDSVWPC^.UAI[W&HZ,#,UZ
M?"/C.PMY[4^+? .I71E:73KF0ZCX<N[JXUGPQ=6=Q<ZM9:R;IKH]&--IIKHT
M_P#@?/9^1_F3_M=?L<?M!_L-_&36_@;^T?X#O_!7C+2A]KTR\"RWGA3QKX?D
MD>.R\6>!/$BPPV/B;PU?M')$E_9D3V5]#=Z/J]IINN:?J.F6?R]6#5M/ZV7X
M=M/^!VQ::36SLUWV6_FMGZ!12*"B@ HH ** "B@ HH ** "B@ HH ** "B@
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M "B@ HH ** "B@ K_9__ &;?^3=O@)_V1;X6_P#J#:%6E/K\OU.;$;P])_G
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M((?W?FZSJ]]+L9AO^9MWTS5&/X^;U;]7U"B@ HH ** "B@ HH ** "B@ HH
M** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH _P WC_@ZZ_Y2?>'O^S6/
MA1_ZF/Q4K^9ZL9_$_E^2.VG\$?0**DL** "B@ HH ** "B@ HH _?S_@V5_Y
M2Z_!3_LGOQS_ /56>(Z_T[*VA\*^?YLXZO\ $E\O_24%%49A10 44 %% !10
M 44 %% !10 44 %% !10 44 %% !10 44 %% !7^4W_P7W_Y2]_MK?\ 8[>!
M?_5.?#FHGM\_T9K1_B?]N2_]*@?CW161UA10 44 %% !10 44 %% !7];/\
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MTTKEGDDED8N[NS,[L7<5K36C?6_^6GZ_TC.H]E_6MOGTUZ=M!E%69A10 44
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MM!-;1W_^A56\=(K[_OZ_=;_ACCJN]27E9+[E]VM_SZA13,PHH ** "B@ HH
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MZJY@OK"[A@O],OH;G3]0MK:^MIX(N_K8X@HH ** "B@ HH ** "B@ HH **
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MF[? 3_LBWPM_]0;0JTI]?E^IS8C>'I/\X'M-%:& 44 %% !10 44 %% !10
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M%<17?EPQ^+M>U"W_ -!.MXNZ7HE]R7YJS.*I'ED^SU7W:_C?L%%,@** "B@
MHH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@#
M_-X_X.NO^4GWA[_LUCX4?^IC\5*_F>K&?Q/Y?DCMI_!'T"BI+"B@ HH ** "
MB@ HH ** /W\_P"#97_E+K\%/^R>_'/_ -59XCK_ $[*VA\*^?YLXZO\27R_
M])0451F%% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %?Y
M3?\ P7W_ .4O?[:W_8[>!?\ U3GPYJ)[?/\ 1FM'^)_VY+_TJ!^/=%9'6%%
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MW\RV\*>/[''B/P\WE+;VLTFM>&H;BYN_#5]-6L&[-=O>_)?C=?=]_/66B?\
M+[K^:36GEKUZ_=^J=%6<X44 %% !7YP?\%&?VA3\,OAHGPO\.WAA\9_%&TN;
M6]EB=UN-'\#B1K?5[I2K8CFU^19-!M2X(>R;6GB*7-K#(M15Y+UVUU\A-V3>
MMTM/O7]=^O<_GVHK8P"B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ]%\&?
M%_XJ?#HI_P (+\1/&7A6)&5C::+XBU.RTZ4J<J+G38[D:?<H#SY=Q:S)_L5]
M?^"?^"EW[2'A@Q0^(;CPE\0+1%6-CXAT"/3M2\M=NWRK[PO-H40G 4IY][97
M^Y6D:9'E(E$N*?3YK0M3:\[;)^O3_@Z;Z7/L3P3_ ,%6OA]J+0P?$#X9^*O#
M#L$22^\-:EIWBNS$N &FD@O4\,WEO;L<OY<2:A-$&\K_ $@H99/L/P/^V3^S
M1\0###HGQ9\-V%Y, !I_BI[KP=="5L?Z.C>)K?2[6ZN,G:$L;FZ$C<1.YS6;
M@T^_FM7M'=>;[;+>VI:DGUL]/^#;;T_X!])VE[::A;17FGW5M>VDZAX+JTFC
MN;:=#D!X;B!I(I%W#[R,X&#FK524%% !7Y,?MZ_L6R^+UU/XX?";2"_BF&.2
M]\?^%+!,/XBMK>+,OB31;.&+][XAAB3?K%G&=VMQ(;VW6365N!JU1=I+\?04
ME=>?3UT[_=TM<_#ZBMC ** "I;:ZN;*YM[RSN+BTN[2XBN;6ZMI9(+FVN8)!
M+!<6\\126&>&5$DAFC=7B=4='5A0!_0M^PW^V!;_ !PT&+X>^/+^"'XL>'+%
M0D\SQP#QSHUI'M_M>U624O-K]G$A?Q!9Q(HE3_B<6J?9WO8-.^:O^"K?PW\J
M_P#AG\6[*V?9=P7_ (!\07*QXB2>U:77O#"NZKAI[F&;Q.C-*^_R;&!(\I&0
MF27+.WW?/];Z??W-6[P\[+MNN6_7[OR5TC\>:*U,@HH ** "B@ HH ** /JS
M]BCX8)\5?VC/ .D7=L+G1/#EY)XX\0(ZN\7]F^%_+O;6*=5X:"^UQ]&TV979
M4,=\V[=_JW_>[]IG]HSPK^SAX!G\3ZP8M2\2ZD+BQ\%>%1,([G7M86(L'F5,
MS0:)INZ*?6-0V[+>)H;:(OJ%]8P393UDEZ:=KO?Y+4UAI!O5:W[;<NW?L?S*
M_$'Q_P"*_B?XPUOQUXUU:?6?$6O7;75[=3$B*)0 MO8V4&2EGI]C;K':V%G"
M!#:6D4<2 *NZN/K7LDK))+[E8RNV%% !10 44 %% !3H8IKB:*"".2:>:1(H
M88D:66665@D<44:!F>1W8*B*&9V;8G- '[U?L,_L4Q?"ZSL?BU\5])B?XDWT
M2W'ACP]>HLH\":?/$NV[O(&4HGBZ[1R)0?,?0;5A:HT.I2WR6WZ>5A)W;?W>
MG]:FZ5DE;U]0HI#"B@ HH ** "B@ HH ** "B@ HH *Y/Q+X[\#^"XUF\8^,
MO"OA*)D\U)?$WB'2-"C>,%D,B/JEY:*T>Y60./EW(1SBC^K=P_K[G<^6_%_[
M?W[+GA,2QK\07\47L+,#8^$="UG5O,VG&8M3EL[/07!/W675_F7YUR, _*/C
M[_@J[H,,%Q!\,/A=JVH7)RMOJGCK4K33+:!U)VRR:)H4VJS7J$A?W0UW3I,'
M=YBO\M:*'?3^EZ^:[KMT)<TM-WK;MKR]=NFFCZ['Y5?&#XU_$;XZ>*/^$L^(
MNN-JM]#"UKIMC;PK9Z-HEB7\PV.CZ;"?)M86;:TTK&6]O)$26]N;J55D7RJM
M%HK&3=_P_!6"B@1^MG_!,G]H9M&US4/@#XGOB-+\12W6N_#Z2XE7R['7XXC-
MKF@1-(,I%K=I"=4L8!(D$>I6-\L437NM,7_;RL9Z2?G9_P"?XFT7>*\M/NM_
M7](**DH** "B@ HH ** "B@ HH ** /\M_\ X.(?V5Q^S!_P5 ^--UI.FC3_
M  3^T+;Z9^T9X1\JV:*V:X^(,U_;_$*(.!]G-P/BEHOC6]-O#M:WT_4=-,L:
M"9'E_#>L9Z-KSO;7JD^IVTW[D?))>MDE^G].X45)844 %% !10 44 %% !3X
MY'B=9(V:.2-EDCDC9E='0AD9'!!1D(W(Z_,&_1H/^ ?["O\ P3M_:/\ ^&N/
MV'?V7OVB9KF.[UCXE?"+PQ>^+YH9/-C'Q!T.!_"OQ&@20(A9;7QYH7B*U&41
ME\DAP'!%?:%;GG[:=@HH ** "B@ KY'_ &\_VEK#]CW]C?\ :-_:4O984N?A
M3\+/$>M^&8[@0&WO_'E_ F@?#G2)Q<9@\K6_'NK^&](;>DP(OB$M[EREO*+^
MN@UJTN[/\=[4]3U#6M2U#6-6O+G4M6U:^N]3U/4;V:2XO-0U&_GDNKV]NYY6
M:2>YNKF62>>5RSRRR.[-N:J%8/\ I]]%?\?S.Y::=%HON7DOZ^Y%%(844 %?
M</\ P3;_ &5+G]M;]N+]F_\ 9N^SW,^@>/\ XBZ9-X^DM=ZRV?PR\*17'B_X
MDW:3I\MK<+X*T+6X-.FF9(VU6>PM\F2XC1ZBKR7JK^E]?^#Y$S=HM]E^/3?3
M?N?Z_MG:6FG6EK86%K;V5C96\%G965G!';VEG:6\:06]K:V\")#;VUO"B10P
MQ(D442*B*J+Q:K8X0HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH
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M>'_)*?VY?^RA?!'_ -1OXB5_9E71T7^&/_I*.*I\<O4**" HH ** "B@ HH
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MU<(=:>./19F[+S>WZEP5W?MK_E_G\C]8Z*Q-0HH ** "B@ HH ** "B@ HH
MYWQ%XO\ "GA&V6\\5^)_#WABT;.V[\0ZUINBVQQUQ/J5S;1'&#D[^*^8O%_[
M=W[+G@\SPS?$^R\07L)919^#]-U?Q()B"P;R-4T^R?06 9<*SZL@?.Z,LG--
M)MZ*_P!ZZKKHOU_$&[7O9;6OOOT^7E^:/ESQ?_P5;^'UF)4\"_"_Q?XAE 9(
M[CQ/JND>%;?S"I E$.FCQ9/)$K;66)S;/*GWS!)R/EGQ?_P5!_:!US=#X9TC
MP'X*M_F,<UGH]YKFJ+G'#W.N7]UID@3C;MT6+DR>9YB%42U#N_N_X/\ 7F9N
M?9=M]-?ZZW/EOQA^U-^T3X\\]?$OQA\;SV]T,7-AI6K2>&=+N$+;S'-I'AE-
M'TR2/> PB:T\M66,A!L3'@]Q<7%U-+<W4\US<3-OFGGEDFFE<X!9Y'9G=C@?
M,S,U6DELB&V]V1T4Q!10 44 :&C:QJ?A[5]+U[1;R?3M8T74+/5-+O[9MEQ9
M7]A.ES:7$+<XEAFBCD4G(.WYOEQ7]3O[-OQMTOX^_"7PYX_LC!!JTD1TKQ=I
M4+[O[&\5:>D2ZI:E?O+;W.^'5M-W;F;2]0LS*PD,BQQ/H^BW^9I3>MK-[-=]
MU?==3WNBLC0** "B@ HH ** "B@ HH ** /Y-/\ @[._917XC?LE_"/]K/0[
M)'U_]F_Q^?"/C&=$=2_PR^,D^F:/'=W4L:.)6T7XC:5X,L--BG\J.)/&&KRQ
M3K*ZP7/^?%653=>G_ _)(ZJ+O#TDUMY)Z=]_T"BH-@HH ** "B@ HH ** "B
M@#_00_X-)/VEHO''[)_QU_9>U74$EUWX#_%.U\=^&[65BDB_#_XPZ?(_V6TC
M8;9XM,\=>$?%E]?R1%FMI/%5@DZH)[5IOZV*Z$[I>B_!)?AL<,])R[WN_GK^
MH44$A10 44 %?R#_ /!V_P#M3CP;^SM\ OV1="U$)K'QJ\=WOQ3\<VT);ST\
M!?"V%+/P_87P+",6?B+QQXB@U6T*QR2&[^'\H+V\:E;M/9^G_ _4J"O.*_O)
M_<[_ *'\!]%8'<%% !10 5_:Y_P:*?LD?:]:_:/_ &W_ !'IC&#2+6S_ &=/
MA9>3(6BDU'4AI/CKXKWT"R,JQW.GV$/PWTJSOHHY&>#7/$5DDT"_:X9[I[OR
M7ZI?K_2,JS:AZM+:_5/\D]?U/[C**U.0** "B@ HH ** "B@ HH ** "B@ H
MH ** "B@ HH ** /YW/^#HG_ )1/^-?^RT_!?_U(+NO\SJLI[_+]6=-#X9?X
M_P#VV 45!N%% !10 44 %% !10 44 %?[/\ ^S;_ ,F[? 3_ +(M\+?_ %!M
M"K2GU^7ZG-B-X>D_S@>TT5H8!10 44 %% !10 44 %% !10 44 %?Y&W_!8#
M_E*)^WE_V<W\4O\ U(;FIG\'_;T?RD:T?XG_ &Y+_P!*@?G!16)UA10 44 %
M% !10 44 %% !7]GW_!G;_R4?]N__L2?@'_Z??BI50^)?/\ )F5;^'+UA_Z7
M$_NJHK8Y#_.\_P"#FW_@F"?V;?CQ#^VS\'_#8M?@A^T?X@N(_B98:39+%I_P
M^^/=VESJ>I7<L5M#'#9Z-\6+2&\\36<A\S_BL;#QFMW+;)J6@VT_\K5935I>
MNO\ G^-SLI.\%OI[K^27Z6WZA14&@44 %% !10 44 %% !7O?[,7[27Q7_9$
M^.WPX_:(^"NO-X?^(7PS\06VM:5,X>;3-6M,&WUCPSXALXY(AJ/AOQ-I4MYH
MNN:>9(WN=.O;@03V]VD%S"TVG?LU^?\ 7<4DFK/9Z?BOE?MUOL?ZSG[ 7[;_
M ,)O^"A'[,G@/]H_X37:16VNVYT?QUX/FN(Y]9^&_P 2-*M[4^*_ NNJA#BX
MTR>Z@O-(O9(K=->\-:CH?B.U@2SU>W1?M&M_RW7H]5^!P6:T:LUOZA10 44
M%% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44
M?YO'_!UU_P I/O#W_9K'PH_]3'XJ5_,]6,_B?R_)';3^"/H%%26%% !10 44
M %% !10 44 ?OY_P;*_\I=?@I_V3WXY_^JL\1U_IV5M#X5\_S9QU?XDOE_Z2
M@HJC,** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH *_P I
MO_@OO_RE[_;6_P"QV\"_^J<^'-1/;Y_HS6C_ !/^W)?^E0/Q[HK(ZPHH **
M"B@ HH ** "B@ K^MG_@T)_Y/+_:?_[-DA_]6IX'JZ?Q+TE_Z2S*M_#EZP_]
M+B?Z!]%:G(%% !10 44 %% !10 44 %% !10 44 %% !10 5_C%_M0_\G,?M
M$?\ 9=/BW_ZG_B"HGM\_T9M0^-_X7^:/"Z*R.H** "B@ HH _NV_X,\/^24_
MMR_]E"^"/_J-_$2O[,JZ.B_PQ_\ 24<53XY>H44$!10 44 %% !10 44 %%
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MAXDUS1_#]@H;=>ZUJ=EI-FNP N3<7\\$ "+\S9DRJX]: U['S7XQ_;=_9?\
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M?_U(+NO\SJLI[_+]6=-#X9?X_P#VV 45!N%% !10 44 %% !10 44 %?[/\
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MDH**HS"B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "O\
M*;_X+[_\I>_VUO\ L=O O_JG/AS43V^?Z,UH_P 3_MR7_I4#\>Z*R.L** "B
M@ HH ** "B@ HH *_K9_X-"?^3R_VG_^S9(?_5J>!ZNG\2])?^DLRK?PY>L/
M_2XG^@?16IR!10 44 %% !10 44 %% !10 44 %% !10 44 %?XQ?[4/_)S'
M[1'_ &73XM_^I_X@J)[?/]&;4/C?^%_FCPNBLCJ"B@ HH ** /[MO^#/#_DE
M/[<O_90O@C_ZC?Q$K^S*NCHO\,?_ $E'%4^.7J%%! 44 %% !10 44 %% !1
M0 44 %% !10 44 %% !7X[?MV_\ !#+]@#]O%-:\1^+/AA#\(?C+JTLUZWQL
M^"D&F^#?%NH:I*B@WGC+2$L9_"?CUIVA@6]N_$VB7/B%K:,P:=X@TMY&EHWW
MVNGVV[/H_,:;BTUHU^*[/NGU7SW29_%_^WA_P;8_MX_LDMKWC+X1:3#^UO\
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M5^S3]%%/;M?\.IQXJ/PR72\6_P 5YOKW/;:*W.,** "B@ HH _47]A7]B?\
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M\<>(H-5M"L<DAN_A_*"]O&I6[_@/K*>_R7XZK\SJH*T&^\F_P2_0**@V"B@
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M,U33;ZV>.YLK_3[V""[L[N"1)[>YABEC9'1&IKJ^UG^*!_U\S_4>_P""'?\
MP53T;_@I3^S+!!XWU#3K+]J7X*6FD^&?CAX?B\BT;Q/#)$]MX=^+V@V,96/^
MQO&T5G-_;UK:10P^'O&=KK&FI96FB77AB?4?VUK?HGW2?]>CT^1P-<K<=[.U
M_P"NZU"B@044 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10
M44 %% !10!_F\?\ !UU_RD^\/?\ 9K'PH_\ 4Q^*E?S/5C/XG\OR1VT_@CZ!
M14EA10 44 %% !10 44 %% '[^?\&RO_ "EU^"G_ &3WXY_^JL\1U_IV5M#X
M5\_S9QU?XDOE_P"DH**HS"B@ HH ** "B@ HH ** "B@ HH ** "B@ HH **
M "B@ HH ** "O\IO_@OO_P I>_VUO^QV\"_^J<^'-1/;Y_HS6C_$_P"W)?\
MI4#\>Z*R.L** "B@ HH ** "B@ HH *_K9_X-"?^3R_VG_\ LV2'_P!6IX'J
MZ?Q+TE_Z2S*M_#EZP_\ 2XG^@?16IR!10 44 %% !10 44 %% !10 44 %%
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MHEDC1"'/S9?Z=J&E74MAJEC>Z;>PG$UGJ%K/9W<1!*D26]Q'%+&<A@0RC!'
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M8I;6<\BZ4Y<LUYZ?>U_7_ N95H\U.2[*^SZ-.VFNMK?\,?TW45V'F!10 44
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M66L9):-6>G5)6^]/I_+]WT-15&(44 %% !10 44 %% !10 44 %% !10 44
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M'_U:G@>KI_$O27_I+,JW\.7K#_TN)_H'T5J<@44 %% !10 44 %% !10 44
M%% !10 44 %% !7^,7^U#_R<Q^T1_P!ET^+?_J?^(*B>WS_1FU#XW_A?YH\+
MHK(Z@HH ** "B@#^[;_@SP_Y)3^W+_V4+X(_^HW\1*_LRKHZ+_#'_P!)1Q5/
MCEZA100%% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !7YL_MU?\
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M9VA9TLK:VB(CJI2;27GKY[:]/S^6UU%16JZVMU[:=EWUZ:/N_6Z*D844 %%
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M.Y_P=$_\HG_&O_9:?@O_ .I!=U_F=5E/?Y?JSIH?#+_'_P"VP"BH-PHH **
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M'/;W$$BS03P3*)(IH98RR2Q2HRNCHQCDC*LK%34]:G$%% !10 44 %% !10
M44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 ?YO'_  ==?\I/O#W_
M &:Q\*/_ %,?BI7\SU8S^)_+\D=M/X(^@45)844 %% !10 44 %% !10!^_G
M_!LK_P I=?@I_P!D]^.?_JK/$=?Z=E;0^%?/\V<=7^)+Y?\ I*"BJ,PHH **
M "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ K_*;_X+[_\ *7O]
MM;_L=O O_JG/AS43V^?Z,UH_Q/\ MR7_ *5 _'NBLCK"B@ HH ** "B@ HH
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M736GDTFK^NK_ .">?B86E&7\R2WZQMZ:6MOY]"S16ISA10 44 %% !10 44
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MXB@U6T*QR2&[^'\H+V\:E;M/9^G_  /U*@KSBO[R?W._Z'\!]%8'<%% !10
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M^*7_ *D-S4S^#_MZ/Y2-:/\ $_[<E_Z5 _."BL3K"B@ HH ** "B@ HH **
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MZI;]797^]Z_,X9QY9-6LNGHU?N]MOD%%!(44 %% !10 44 %% !10 44 %%
M!10 44 %% !10 44 %% !10 44 %% '^;Q_P==?\I/O#W_9K'PH_]3'XJ5_,
M]6,_B?R_)';3^"/H%%26%% !10 44 %% !10 44 ?OY_P;*_\I=?@I_V3WXY
M_P#JK/$=?Z=E;0^%?/\ -G'5_B2^7_I*"BJ,PHH ** "B@ HH ** "B@ HH
M** "B@ HH ** "B@ HH ** "B@ K_*;_ ."^_P#RE[_;6_[';P+_ .J<^'-1
M/;Y_HS6C_$_[<E_Z5 _'NBLCK"B@ HH ** "B@ HH ** "OZV?\ @T)_Y/+_
M &G_ /LV2'_U:G@>KI_$O27_ *2S*M_#EZP_]+B?Z!]%:G(%% !10 44 %%
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M^!\SGQ,;T[]8M/Y-I/\ -/Y=KGZW45U'GA10 44 %% !10 44 %% !10 44
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M*FJ"OSN%% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %%
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M^([EIHX97\RZ_M3K=/1>B_+^O^#N<53XY>J?WI/]0HID!7^5U_P7_P#VJ/\
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M*W6B7HOQ29PS?OR]7^&@44R0HH ** "B@ HH ** "B@ HH ** "B@ HH **
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M\C#/:W<:L_V>_P!/N!+I^IV;$36-_;7-G/LFMY47MJ[CR;6;76^OY!10 44
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MS?Q2_P#4AN:F?P?]O1_*1K1_B?\ ;DO_ $J!^<%%8G6%% !10 44 %% !10
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M93!J-K;2[@0W 7^'M6BDGL_EU,W%KT[_ -:KYI'.T4R0HH ** "B@ K\P_\
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MW>Y-10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44
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M\2VNK6NQ))OM7@&3>]O'\EW_  &UE4WMV2_'7\FCJH*T'YR;_!+] HJ#8**
M"B@#_4H_X-Z?V25_92_X)D_!F75],-AX_P#VAFNOVC?'!FA$=XJ?$*STY?A_
MITC/&MW%'8_"_2O!LTVG7!'V'6[[7"D4;W-QO_<"NC9)=DE^!P2?,V^[N%%
M@HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** /YW/^#HG_ )1/
M^-?^RT_!?_U(+NO\SJLI[_+]6=-#X9?X_P#VV 45!N%% !10 44 %% !10 4
M4 %?[/\ ^S;_ ,F[? 3_ +(M\+?_ %!M"K2GU^7ZG-B-X>D_S@>TT5H8!10
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M6V+YMU_Q3V$<-+BR6TBW#R_*C4MG\OS6YK1^/Y,_G HK ZPHH ** "B@ HH
M** "B@ K^HC_ (-*-3L[#_@I3\5K6Y=DFUK]C+XF:9IZK&["2\A^,?[/^LNC
MLH*Q*+#2+V3S'PA>-(L^9*BM4=U_P?ZOZZ$5/@EZ?FT?Z,%%;'$%% !10 44
M %% !10 44 %% !10 44 %% !10!A^)=9/AWPYX@\0?9_MG]A:+JVL?9/.\C
M[5_9EC/>_9OM'E3^1YWD>5YWD2^5NW^5)MVM_B9U%3:+\W^%O\SHH?;_ .W?
MU"BLCH"B@ HH ** /];?_@C5X(?X??\ !++]A/071D-_^SMX%\;@,6)*?$RT
ME^)$;\RSD"2/Q6LBC>JJK*JQ0#]Q%^F-=!YX44 %% !10 44 %% !10 44 %
M% !10 44 %% !10 44 %% !10 44 %% !10!_%__ ,'-O_!(V#Q-H6L_\%(/
MV>?"\4?B;PW:P?\ #5'A/0[-(SKOABTA2ULOC9;6ENJ^9JWAJ*.VTWXA/'&[
MWGAW[%XKNC"OA_7KR\_A7K*IO?O^:T?^?S.NC*\+?RNWRLK?Y?(**@U"B@ H
MH ** "B@ HH ** /]A+_ ()JVUS9?\$Y_P!@.SO+>>TN[3]BG]E:VNK6YBD@
MN+:X@^!?@2*>WN()566&>&56CEBD59(Y%9'4,"**W6R]$<#>K]6?:U%,044
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M+2V\Q=_SGS ^7Q(<M@UUU1<ORT^7HOZ^^P44 %% !10 44 %% !10 44 %%
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M^MQH7BMI+JYUG6QI>E-[KOMZKI]S;^2,*ZNE+^6_W.WZV_X9:?TKT5H<P44
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MO[/#9I"QV2K&G\+?:S_\F7<TI7YUYW_*_P"A_)W16!V!10 44 %% !10 44
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MPKT2MV><M$EV044#"B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@
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MY_\ JK/$=?Z=E;0^%?/\V<=7^)+Y?^DH**HS"B@ HH ** "B@ HH ** "B@
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M%:V5C;06=G:P($AMK6VB6&W@A0<)%#$B1QJ.%10!P**V. LT4 %% !10 44
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M2&YJ9_!_V]'\I&M'^)_VY+_TJ!^<%%8G6%% !10 44 %% !10 44 %?V??\
M!G;_ ,E'_;O_ .Q)^ ?_ *??BI50^)?/\F95OX<O6'_I<3^ZJBMCD"B@ HH
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MHJC(** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH _S>/\
M@ZZ_Y2?>'O\ LUCX4?\ J8_%2OYGJQG\3^7Y([:?P1] HJ2PHH ** "B@ HH
M ** "B@#]_/^#97_ )2Z_!3_ +)[\<__ %5GB.O].RMH?"OG^;..K_$E\O\
MTE!15&844 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 5_+
M)_P=K?#B;Q+_ ,$^OA%\0[2$2W'PR_:>\++J$GE2M]G\.^-/ 'Q"T6[F$D<<
MBQEO$5MX4@Q<&&!Q-@3?:%MX+A/9^C_(J+]Z/^*/YH_SLJ*P.X** "B@ HH
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M-7_6,K:'P_-_DE]^CN<E9^\EV2OZ_CTL%%49!10 44 %% !10 44 %% !10
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M=T!9?B/\%=$M]"_:!TS3XTCG\5?!FU>9M+\>&"-/,OM;^&%]<_9]8E*M<3^
M-2N+V[NH]/\  =G;R?P$5E46M^Z_+3_)_,ZZ+O&W9V^5E;_+Y!14&H44 %%
M!10 44 %% !10 5_:1_P;&_\%;#X=U72O^";G[0/B67^P]?O;RX_96\5ZS=,
M\6DZ_>RS7^K?!2ZO+B4BVL=?G>[UKX>(VR./7Y-5\,12/-K?ARPCN#UMWT^=
MU;Y]/1LRK1O"_6.ORV?^?R/[H**U.0** "B@ HH ** "B@ HH ** "B@ HH
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M10 5_L__ +-O_)NWP$_[(M\+?_4&T*M*?7Y?J<V(WAZ3_.![316A@%% !10
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MKQO_ "Z_>TG]^GW,UHR:G;HU;YW5OPNOF?D+16)UA10 44 %% !10 44 %%
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MM?>-O$FA6(GVR01^'GLX8TLK:T)_I'KH6R]%]]E?\3AFK2DO-A102%% !10
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MP3#^.Y_:7_X)[_L?_&BXODU+6/%?P)\#6/BV^C<NEUX\\&::O@7X@RH?,E=
M?&_AGQ /(EEEF@QY$\CS1R,WW=71_6FWR//VT[::A10 44 %% !10 44 %%
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M)J_QA\)WEQ!G-MX8FN_&,S2CCR ?"MIK$23;OW3I/+$D+?Z^2 (Y3Y?\7?\
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ML[>)5C@M;2TAAMX(XPJQQ(JH-FXUKUW?EZ'DZ]=_Z_6_^7<HH ** "B@ HH
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M0 44 %% !10!_.Y_P=$_\HG_ !K_ -EI^"__ *D%W7^9U64]_E^K.FA\,O\
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M7EC*\L>FVI&U!7DWV7XO_@7.;%2M!+^9_@K-_C;TOL?HI174< 44 %% !10
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M0C-=^&]=TO7+55?[C&?2[J[B <<IEQD8KIJ@H** "B@ HH ** "B@ HH **
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M7^S_ /LV_P#)NWP$_P"R+?"W_P!0;0JTI]?E^IS8C>'I/\X'M-%:& 44 %%
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MB"[L[N"*YM;JVECGM[FWGC66"XMYXF>*:":)UDBEC9HY(V5T9E8&IZV.,**
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M_B*S\VX)E2V_M/K=*R7HG]ZOY]_^&V.*H[SD_.WHTDFOO044R HH ** "B@
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M2&YJ9_!_V]'\I&M'^)_VY+_TJ!^<%%8G6%% !10 44 %% !10 44 %?V??\
M!G;_ ,E'_;O_ .Q)^ ?_ *??BI50^)?/\F95OX<O6'_I<3^ZJBMCD"B@ HH
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M HH ** "B@ HH ** "B@ HH ** "B@ HH _S>/\ @ZZ_Y2?>'O\ LUCX4?\
MJ8_%2OYGJQG\3^7Y([:?P1] HJ2PHH ** "B@ HH ** "B@#]_/^#97_ )2Z
M_!3_ +)[\<__ %5GB.O].RMH?"OG^;..K_$E\O\ TE!15&844 %% !10 44
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M:5KGAFXN59H+75?%FB)<)*ET+>8;LF^PX_%%=Y17XH_S!Z*YSO"B@ HH **
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MK2F]&NM_T1E/H_)+:W:WY^?X,IT5H0%% !10 44 %% !10 44 %% !10 44
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M +(M\+?_ %!M"K2GU^7ZG-B-X>D_S@>TT5H8!10 44 %% !10 44 %% !10
M44 %?Y&W_!8#_E*)^WE_V<W\4O\ U(;FIG\'_;T?RD:T?XG_ &Y+_P!*@?G!
M16)UA10 44 %% !10 44 %% !7]GW_!G;_R4?]N__L2?@'_Z??BI50^)?/\
M)F5;^'+UA_Z7$_NJHK8Y HH ** "B@ HH ** "B@#_.(_P"#E?\ X)A+^R3^
MT?#^UC\(O#JV'[/G[3^O7MUKVGZ79Q6^C_#7X[R07&J>)?#\4%N@BLM%^(EI
M;7WCWPY&,(FKIXYTFUMK'2=&T>"7^8ZLIJS]==NZ5_QO_P -8[*3O!>7NO?H
MK?BK/YA14&@44 %% !10 44 %% !10 5^A'_  3,_P""@OQ)_P"";O[4WA'X
M]^"3>:QX4G">%OC#\/H;@16?Q#^&>HWEK-K6C%)72VBU[37MX=;\):G*5&G:
M_868FD.EW.IVUU479I_U:^OWJZ^9,X\R<>ZWZ+5/\TG\C_6+^!WQJ^&_[1GP
MB^'OQR^$'B.U\6_#7XG^&=/\5^$=>M08Q=:;?QG=;W=L_P"^T_5M+NX[G2M:
MTFZ"7ND:O8WVF7T<5Y:3Q+ZK6QPA10 44 %% !10 44 %% !10 44 %% !10
M 44 %% !10!_F\?\'77_ "D^\/?]FL?"C_U,?BI7\SU8S^)_+\D=M/X(^@45
M)844 %% !10 44 %% !10!^_G_!LK_REU^"G_9/?CG_ZJSQ'7^G96T/A7S_-
MG'5_B2^7_I*"BJ,PHH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH *
M* "B@ HH *_@_P#^#MC]BZ;PW\3_ (*?MU>$])(T3XD:7%\$?B[=6MK((K?Q
MUX4M+O5OASKFHW"1-&UUXE\&)K7AX23S1F.U^'VF01+)YI,::NFON^]?I<TI
M.TUYZ??I^9_&O16!V!10 44 %% !10 44 %% !10!_9?_P &Q'_!62W\!ZW:
M_P#!./X^^)!;^$O%VK7^J?LO^*M8NE2V\/>,=6N#>ZW\';FXE(2'3/&%])=^
M(/!)DD00^+9M8T)6N)?%&BVUE_=S6Z=TG\G\DOTM^1Q5%:;TM?5?/_@W7R^0
M44R HH ** "B@ HH ** "B@ HH *\X^+WQ:^'WP(^&'COXR?%?Q-IW@WX<_#
M;PSJGBWQ?XDU2=(;33M'TFW:>8H&(DN[^[<1V.DZ9:K)?ZOJMS9Z5I\%S?7E
MM!( ?Y.G_!4;_@H+XZ_X*2?M:>-/CYXDCO-$\$6B#P;\%_ 4]P)HO GPOT:[
MNY-%L)?+Q%+X@UVZNK[Q/XLO5WK/X@UB[MK61='L=)M;3\Z:QD[R;6JZ>EM/
MP_X9'=!<L4NJ2OVO;6WS"BI*"B@ HH [?X:_#GQI\7_B%X)^%7PX\/W_ (K\
M??$7Q3H7@OP;X;TQ ]]K?B3Q'J-OI6D:? '9(HVN;VZB1YYI([:VC\R>XEBM
MXY)4_P!=+_@G1^Q?X3_8!_8^^#O[,OAE[*_U#P?H(U+XB>*+.V:W_P"$U^*/
MB)EU7QWXJ?S'DNC:W>M336&@PWDMQ/IGA;3M!T;SV@TR$5K!:-]]/*VC?SO;
M^M^:LW[J]6UUV23?_DRN?;]%68!10 44 %% !10 5_!%_P '@G_)Q/[''_9%
MOB!_ZG-C2E\,O1?^E1-*7\2/S_\ 26?QZ45@=@44 %?Z*O\ P:B?M/1?%/\
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M0 44 %% !7^1M_P6 _Y2B?MY?]G-_%+_ -2&YJ9_!_V]'\I&M'^)_P!N2_\
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M[;/7O9V^>EOQZ&U&5FX][/YW2?S:?X'@%%8G4%% !10 44 %% !10 44 %%
M']2?_!MY_P %:S^R?\7(?V,OCOXC,'[.GQS\31'P%K^LWT@L/@_\8=7,%E:M
MYMP[0Z?X*^(TRVNE:]%F*ST?Q1_9/B/-G;7OBJZNO]%6MXN\5]S^7_ M_P #
M8XZBM-OI*S3[W6OXW[!13,PHH ** "B@ HH ** "B@ HH ** "B@ HH ** "
MB@#_ #>/^#KK_E)]X>_[-8^%'_J8_%2OYGJQG\3^7Y([:?P1] HJ2PHH **
M"B@ HH ** "B@#]_/^#97_E+K\%/^R>_'/\ ]59XCK_3LK:'PKY_FSCJ_P 2
M7R_])0451F%% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44
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M2-5VK6I6QPA10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %%
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M'Q;JEMI&AZ/80D+ON;RZ=%:>XF>&TL+* 37VI7\]MI^GVUS?7,$$H!_G=_\
M!:S_ (+]^,/V[#KW[-G[+TVO?#S]D:.[2W\2ZU=13:-XY^/4VG7DSQ3Z]"LJ
M7/A[X:2.MI?:;X)N%CU/5KBWM]3\7F.5;?P[H_\ ,U64W=Z;+;[E=]]?-+MO
M<[*4>6.OQ.S?D[+W?E^;;ZA14&@44 %% !7Z<?\ !)W_ ()P^.?^"E_[5GAK
MX/Z3]OT3X4^%S9^,OCU\0+:$M'X0^'5I=A9M/L9W4P?\)?XUN(F\->#[5EG>
M.^N;K7[FRN-$\/:RT%15W;^O.WG8F<N6+EV_-M)?UY]=C_5\^'/P]\%_"7P%
MX-^%_P .?#VG>$O 7P^\,Z+X0\'^&='@6WTW0_#OA^P@TS2M.M(EZ16UG;11
MEW+2S/NGG>2:5I&[2MCA"B@ HH ** "B@ HH *_@B_X/!/\ DXG]CC_LBWQ
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ME58237DCAAD/DYJ7)O\ R+44M$EKUW?3R^^WRW/4Z*D844 %% !10 44 %%
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M/_")T3_Y%HY(_P L?_ 5_D'M*G\\_P#P)_YA_P ,;?LI?]&]?"3_ ,(G1/\
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M7?!FOW_A[4S$'R6MWN]/EEMY 66:W>.5'='5SYM6#5M//^O\_F=\?A3[I/\
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MQ!^)%8R5F_O7SU]/+Y;+8[:;O!/=Z7WW22>_I_6X45)844 %% !10 44 %%
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MS_@V5_Y2Z_!3_LGOQS_]59XCK_3LK:'PKY_FSCJ_Q)?+_P!)0451F%% !10
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MQ_:H^!5]^S]\8-?\&[)I/#5XQU[P1?R"1EO?#.HRRM:P-,RCS;W1Y4GTB_(
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M:P\1:+J6B7JE<!@UKJ=M;3@KGYLH".XKGZNYF%% !10 44 %% !10 44 %%
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M=;67X)K]4O0Y*JM*Z^U^:23WU[-^;[W-:BF9!10 44 %% !10 44 %% !10
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MI+%/%*C1RQ2*LD<BNCH'!%5ZP?\ P-K;)':ME;;2WI8**0PHH ** "B@ HH
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MK@,D?PTTF]07OAG0;M#)X^U*TAU+4H1X%ACMO&W]]*(L:JB*J(BJB(BA45%
M5555 "JH&U57A1CBMTK)+T;^:6GRV.*I+FD[;+1>?G\W^%A]%,@** "B@ HH
M *^*OVYOV>S\=?@_=7.AV1N/B!\/_MGB/PEY2EKK4[80H=?\,QX)WG6K.VAG
MLX]OF/K&FZ9"LD4$MR7$[-/S\^Z_K_@-B:NFNZ].JW_KYG\UG()!!!!P0>""
M.H(]?\_4KH, K^L7X!_#K0/A7\(/ 7@WP_:06L%EX=TJZU&YB15DU;7=0L[>
MYUG6+J3:K37.H7TDD@:7)B@^SVD:);VT$*9U'MVO_EI\[_T[&E/J_3OW_%72
MO_E<]CHK,T"B@ HH ** "B@ HH ** "B@ HH ** "B@#\DOV[?VVSX8CU+X+
M?![6A_PDL@GL/'WC#39/F\.QD>5-X;T*]B< :_(-\>L:C#\VAI_H5K(FL/</
MHWXB<Y)))).23R23U)/K_GZ;05EZZF4W=VZ+]4K_ )6"BJ("B@ HH ** "B@
M KO_ (7?##QC\8O&VC> / VG?VCKVL2MM,CF&QTZQA >]U;5+K:WV73;"',E
MS-L>1B4M[:*XO)K>WF+VU?378:5W;^OZ6[\D?TT_LZ?L]^#_ -G3P);^$_#<
M0O-8OUM;SQAXGFC"WWB768H64SR<L;;2[(RSPZ+IB,8[*WDD:1I[ZZOKRZ_'
MW_@IW\3F\5_&[2OA[9W#2:5\,/#\$-S$K*T?_"3^*H[;6-4D#)P^S1E\-VI1
MRS07%O=H=A=Q64=9-OU_0UEI'Y+1_P#;OW[/RU>ZM;\V:*U,0HH ** "B@ H
MH ** /K7]ASXC?\ "MOVEOAY>W$S1:7XKO9/ &K@2^2CV_BSR[#33/(5*"WM
M?$0T2_G+X4):-F2/_6I_1'\8/A)X/^-O@/5_A_XVLOM.E:FOFV=Y$L8U+0M7
MABE2PUW1YY$D6VU*Q,TOEN5:.>VFN;&YCFL[NYMY<IZ237EW[KIZ6_JYK#6-
MG?=K[[:?.[MIOZG\Q'QU^"'C+X!>/]2\">+[8N8BUWH6N0Q2IIGB70Y79;/5
MM.DDS\K &&^M=[R6%_%<V<K,T(>3QZM4[I/N9M6=@HH$%% 'U]^R'^U7KO[-
M_C$0WS76K?#+Q)>6R>,/#\;/-)9,"L*^)M!A:1(HM:L8B!<0$I%K5C$+&ZDC
MFAT^^L/Z3?#?B30_&&@Z/XH\,ZG;ZSX?U[3[?4])U2S9FM[VRNHUDAFCW*DD
M9VG$L,R13P2K)#/#'/'(D>4U9WUU_2WYK^M36#NDNSO\KK[^R7X6N;M%06%%
M &7J^BZ/X@LI=,UW2=-UO39L&;3]7L;74K&4@%1YMI>1302<%OOQMU-?+OCC
M]AO]F+QV9IKSX8:;X>OYB6%_X+N+SPHT3L#N:/3=)G@T%F+'=^^TF9<]!C=E
MIM7MI^NVOZ?(&KVNKZKH]M.N^N[?SU/CSQM_P2@\-7)N+CX=?%?6])(!:VTO
MQEH=GKB2.Q'[N36=&FT)[:)1DK)_8M])@+&\9;][7QWXV_X)R_M-^$3/+IGA
M[0O'UC ID^U^#_$-JTIBP,;=*\1+X?U::<!@'ALK.\;>&$3S)^\-J:V=UYVT
M_K[S-PML]]+/Y==%J[]K'R+XM^'7Q \!7!M?&W@GQ9X1F#A OB/P]JNCB1CT
M\F2_M((YT<?-')"SQR+\\;NE<=6ES/5;JP44 %% !10 44 %% !10 44 %%
M!10 44 %% '[6?\ !,;]GL:=IFH?M!>)[ ?;=76\\/\ P[CN8CYEKI<<C6WB
M#Q)#O!57U2Y230["= DR6=IK*AFM=4BW_KY6,OB?R_)?C>YM'1+[_O"BI*"B
M@ HH ** "B@ HH ** "B@ HH ** "B@ HH _FN_X.C_V6/\ A>/_  3L3XTZ
M+IQN_&'[*/Q"T?Q[YT2^9=GX<>-Y;3P)\0+&"/:28([Z^\%^+-0D1D\C3_!]
MQ*V41Q7^;1653=>GZG50?NORE^%E^MPHJ#8** "B@ HH ** "B@ HH _4'_@
MC9^R3_PVA_P47_9Q^$>IZ7_:G@31O%L?Q5^*L4L=M+8_\*Z^%^SQ7J^FZI%<
M!A)8>+=3LM'\"2+'%-+YWBJW)2.$2W$'^M/6T/A^;_**_-,Y*SO+T2^]Z_E8
M**HR"B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH
M _CV_P"#O?XYZ3I/[.W[+'[-UOJ"GQ%XZ^,6M?&;4-.@<^=#X<^&?@W6/!ME
M-J(5@T=IJ>K_ !0F_L^.93'>W6@WDL8\W2]R_P $%93W^2_S_)K_ (>YU4?@
M_P"WG^2"BH-@HH ** "B@ HH ** "B@ K_5S_P""$OQNTGXZ?\$J/V0-8L-0
M:\U#X>_#F+X)>(K65Y9+G2-5^#E[=> [+3[@R/)L6;PQI'AW5["..1HH](U3
M3E5+?_CVATI[OTO\KV_5&%>]HOS?XV_R9^NM%:',%% !10 44 %% !10 44
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MR3F*\\^,G<Z[E^1Y(\.T5.GS_0NGJVKVV_/^K_GW]4HK,T"B@ HH ** "B@
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M8+EBDNEM>^BNW;2[>H45)044 %% !10 44 %% !10 5^Z/\ P14_X+,>*?\
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MN)H;>TLY[B:*)P/^&^\_AO\ ^"X/_!P]X0_:F^&OBO\ 8\_8D37#\(?%DO\
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M)-:WEM,A#0SV\KQ2(=ZNRUNG=77_  SMM_6YPRBXNS^3[K35?KV9I44""B@
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MJ_SW_#H<,XN#MTM=>:_X#T_'2Y/13)"B@ HH ** "B@ HH ** "B@ HH **
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MG_)Q/[''_9%OB!_ZG-C2E\,O1?\ I432E_$C\_\ TEG\>E%8'8%% !10 44
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M22A=EQX"^"OA;49K8JRL3"OQ0/Q(MV+@%&^T03@*S[ C['7\W/C+_P %2O\
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M6ET>&0Q-Z6[EP5V_+K\^ORN??]%9&H44 %% !10 44 %% !10 44 %% !10
M44 %% !10 5_FY?\'2W[+'_"D?\ @H;9?'#1=.%IX1_:O^'>E>-7GC79:_\
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M^BVTTZO5;]]5HK.W:^IU0IJ&KUE?XK:*]M(_E?=N^RT7F%%9FH44 %% !10
M44 %% !10 44 %% !7VQ^R?_ ,%%_P!M;]B/4[6\_9J_:&^('P]T:&Z-W=>
MFU,>)/A?J\CS--<MJWPT\3QZQX*N[BY\R='U-=%BUJW6YGEL-1M+B0SU46T[
MKROVM=;KJKVT_74F45)6:O\ +5>G;^KZ']3O['?_  =R+C2?"W[='[/K;FEM
MK2Y^+O[/4JE$1V6$W^N?"CQ?JH?9#E;S4[[P]XZDD:(7"Z3X1>9(+2;^I_\
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MS_\ 26?QZ45@=@44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %%
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M_P ZBX\-WD@W(&5I)#O==J1:3^%_+\T13^+7M^J/U.HK$U"B@ HH ** "B@
MHH ** "B@ HH *_/[]M?]L>R^ FC-X'\#W-EJ'Q;UVS9D!,5S;^!=,N(QY.M
MZI;$/%+JUTD@?0=)N%V$*-6U&-]/6SM=6<4W)?E_7W?,3=DW;I_E^'<_GCU/
M4]0UG4K_ %;5KVZU'5=4O+G4=2U*]FDN;R^OKV:2XN[R[N)F>2>YN9Y))9YI
M&:221WD<DG-5*W, HH ** "B@ HH ** +%A8WNI7MGINFV=S?ZA?W,-G86%G
M!+<W=Y=W,JP6]K:V\"O-<7%Q,Z1PPQHTDLC(B(SM7]#7[$?['5G\"=#B\>^.
M+2VO?BWXAL8]T<J0SQ^ M+N8B9=#TV93*C:S=I($\0:I"[+\ATG3W%FM[<ZK
M$W96[EP5W?M;\TOPO?[NY^@U%9&I_/5_P4O^)W_"9_'J'P597/FZ3\+]!MM(
M>-'9XO\ A(M<6'6M<F4YV"1;271--G55)CN-,FC=]^53\[*WCLO0QD[R?R_!
M6"BF2%?9?A7X6:?J'[#7Q1^*4FB:;-KFC_&?PQI]KKCV4#:Q8:';:?I6G7EM
M;:@;)KN#2[_4_&5DEQ;+?"SN;NSB>2!+BS@,Z?ZK\T5'K==&SXTHIDA10 44
M %% !7W1_P $[?B/_P ('^TEH.E7,OEZ7\1=*U+P/=^8V(TOKD1:KH,P3<JO
M/+K&E6NEPGJD>J3@??P5+5/^MM1Q?O+U1_2!16!N?F_^W5^QVGQET>X^)_P[
MT]%^*N@6 _M+3;>-5;Q[HUE !'9,$7,OB;3;:%(=$F+;[ZV1=&N&D"Z7)9_S
M\S136\TL$\<D,\,CQ30RHT4L4L3%)(I8W"LDB.I5T8*R,NQ^:V@[K7=6VUTL
MK?/?_@&4U9Z;/\[*_P#7KZC:*H@** "OVP_8!_;,.N1Z1\"/BKJQ.M0+!IWP
MX\4:A,,ZO!&L4%IX-U*=D^;5;>,;-"O;B4MJ<(_LEY#J4.GKJ,R5UYK^G_2U
M[%P>MN]OO337Y6]&?KQ16)J%% !10 44 %% !10 44 %>/>./@!\%?B2)CXV
M^%_@S7;B;_6:G-HEI:ZZ>OW-?TY+36XE;=EA#J$89E1F!:-"I=K9V_X<-]U=
M?\%?UKI\['Q[XY_X)@_ +Q"TUQX0U/QE\/KIVS#;V6JIXCT6('JK67B"*ZU>
M4#C9M\0Q;<?.),@I\>^.?^"5_P 7-',T_@7QQX-\:6L;'RK?4DU#PEK,RX)5
M4MG76M)W]F,VMP*,AQCG;:J=UY75O+I\^Z\D0Z:>UUZ[=.VJ6_>^W<^//&_[
M*O[17P]-R_B;X1>,H[2T#//JFC::?%&CPP@C$\^K>&7U?3[:)MR8:ZN(B&;8
MRJ_RUX Z/&[Q2H\<D;M')'(IC>-XSM='1L,C(P(((#*P]*T33VU_/[MS-IIZ
MKT?3IU^[02BF(** "B@ HH ^U/V%_P!GK_A>?Q?M+W7K!KGX>^ 'M/$/BLS1
M;[/5;M97;0/"\I8[)!J]W!)<WT)5TET73=3@8Q230/7]*E93>MNQK!6CYO\
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MBW$06R2K;6Z8CAC1%51YS63NW??;7Y+\OZL=45962LEM;;9;+H%%(844 %%
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M"DKI^6JWZ;_A?^M32E*TUY^[]^WXV_JZ?\HM%8'8%% !10 44 %% !10 44
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M[)IZKYKJMOPN[7^])NQR2C*#L^O5;;7MY/R;ONU=*Y['102%% !10 44 %%
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M>(-2O-9US6;R?4=5U749Y+J]O[VYD,L]S<W$I+RRRN<LQZ9"J%556M8*RO\
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M#&TFKVZ)F_MXWUBW!VZC':?I!6,ERNWI^.ING=+^M;*__#!14C"B@ HH **
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MKJQDRR3VD\,T<DD;HY\MK!Z.W;^N_P#PQW1?,K][/>^Z3_K[^H44B@HH **
M"B@ HH *_P!%[_@U2_9+;X-?L,^,/VD_$.E-9^+OVK?'\U[HT]S;F&Y'PF^%
M4NJ^$O"8V3+Y\2ZEXQNOB-K$<JB*#4](NM O8Q-;K:W$FE/=^GZK\?TN8UW[
MB7=K3TU_!V^=C^HJBM#E"B@ HH ** "B@ HH ** "B@ HH ** "B@ HH **
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MSOB^9)]TGZ72T_JP45(PHH ** "B@ HH ** "B@ HH ** "B@ K[=_X)F?\
M*2'_ ()]_P#9[O[*/_J^/ 5-;KU7YB>S]'^1_L%T5N< 44 %% !10 5_'_\
M\'@/_)L_[(/_ &73QI_Z@#4GL_1_D5#XX_XH_FC^!>BL#N"B@ HH ** "B@
MHH ** "B@ HH ** "B@ HH ** "B@ K^[;_@SP_Y)3^W+_V4+X(_^HW\1*TI
M[R_P_P#MT3*M\'S1_9E16AR!10 44 %% !10 44 %% !10 44 %% !10 44
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M"CIMCA@@C2.WM;6"..UM+6.&UM88K>*.-.?K?I8P\_,** "B@ HH ** "B@
MK]KOV"OV*SH:Z3\<OBWI+)K;!+_P!X-U6U0_V3$X5[3Q9K-M<*S+JTF1-H%A
M(D;Z4GEZG./[1DLUTV9NR[/^K_U\RX*\DWHDTV_GI^/^1^O5%8FH5^=__!2O
MXG?\(5\ E\'6=QY6K_%#7;70]BN4G'A[1GBUO7KB,C!:-IH-'TFY7HUOK#(_
M#TUNO5?F*3:3]/0_GGHK<P"B@#?\(>&M0\9>+/#'@_259M3\5>(-'\.Z<@7=
M_INM:A;Z=;9!9<JLUPK,-ZKM!RR??K^NO2O#FE:/X;TWPE:VRMH6EZ'9^'K:
MSF4/&=*LK"/38;:50%613:1K$Z[0K+T QBLZG3Y_H:T^KZWM^3_J^EOD?R6_
M$[P=<?#WXC>.O MP'#^$?%NO^'U=\YG@TK4[FTM;E2>62[M8HKB-C]^.5''7
MGAZT3ND^YF]&UV844""B@ HH ** /Z&/^":/Q'_X3']GT^$KJ82:E\,O$>HZ
M"$+%ICH>L2-X@T:YE)/"?:+_ %?2[=,?)!I 7.S8*_1"L9:2=OZT-ULO1?D@
MHJ1GX-?M[?L:M\.+^]^,OPNTDCX?ZG="3Q;X>T^ ^7X*U2Z?;_:-E;PQA8/"
MVI3L%,8Q#HNI3):Q^7I]U906GY>5M%WBN_4QDK/RZ?<K_C_2V"BJ)"B@#2T3
M7-9\-:SIGB#P_J5YHVN:->0:CI6JZ=/):WMA>VT@E@N;:XB(>*6)QE6'7!5@
MRLRU_2'^QS^UEI/[1GA/^S-:>TTSXJ^&;.(>*-'CQ#!K%H'$$?BG1(B3NLKE
MRBZE9Q$MI&H2K!(%L[K39KB*BT3[?K;\OR^XTIO5KI^>WZ>NQ]IT5D:!10 4
M4 %% !10 44 %% !10 44 %% !7RS^TA^RE\.?VA?#6HQWVCZ=HOQ BM)CX:
M\=V=JEMJEK?I&6M+?6Y[6,2ZSH<LBB*YL;Y;IK6":XFTL6E\5G+3LT_ZZ:?,
M35].^G735=/UZ'\Q>J:;>Z-J>HZ/J4#VNHZ5?7>FW]K)Q);WMA<26MU X_OP
MSQ/&W^TIJC6Y@%?JC_P30_9Z_P"$L\77OQT\363/H'@:Y;3/!D$\:F'4_&4D
M -WJH616$EOX9L+A&@<1J#K.H6=Q:W"W&CSQ%2=HO^NI4%>2\M?N:_KTOY'[
MKT5@;!10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 ?Y^?_!Q]
M_P $O/VD/$/[?\OQ]_9C_9J^-OQI\(_M ?#KPUXD\;7/P6^$OQ"^)5OX;^*'
M@^'_ (0?7;?7H_!?A_7+70FUWPUHW@[7K62ZDM'UK4;SQ!=+;O-;7=U<?@!_
MP[-_X*0_](^_VW?_ !%'X\?_ #!5G-/FT3Z;:]%^O^1UTYQY$G**MI:Z6BT6
M@?\ #LW_ (*0_P#2/O\ ;=_\11^/'_S!4?\ #LW_ (*0_P#2/O\ ;=_\11^/
M'_S!5%GV?W%\\?YH_>O\P_X=F_\ !2'_ *1]_MN_^(H_'C_Y@J/^'9O_  4A
M_P"D??[;O_B*/QX_^8*BS[/[@YX_S1^]?YA_P[-_X*0_](^_VW?_ !%'X\?_
M #!4?\.S?^"D/_2/O]MW_P 11^/'_P P5%GV?W!SQ_FC]Z_S#_AV;_P4A_Z1
M]_MN_P#B*/QX_P#F"H_X=F_\%(?^D??[;O\ XBC\>/\ Y@J+/L_N#GC_ #1^
M]?YA_P .S?\ @I#_ -(^_P!MW_Q%'X\?_,%1_P .S?\ @I#_ -(^_P!MW_Q%
M'X\?_,%19]G]P<\?YH_>O\SJ_ W_  2E_P""D'C?QMX.\%_\,,?M>^&/^$N\
M5>'?"_\ PDOB[]FGXS^'?"OA[^W]7M-)_MSQ-X@U?P98Z3H7A[2?M?V_6=8U
M2]M-/TS3;>XO+VZM[:"69/\ 6)^!?P?\)?L^?!?X4_ SP%:I:>#OA%\/?"/P
MZ\.HL$=N\VF>$=#LM%@OKM(?EDU'4OL9U'4[EFDFO-1NKJZN)I;B>65]()I.
MZ_"QSU97<;-.R>S36O+VVM9GJ]%68A10 44 %% !10 44 %% !10 44 %% !
M10 44 %% !10 44 %>1?'_3=2UKX$?&S1]'L+W5=6U7X2?$C3=+TO3;6>^U'
M4M1OO!NLVMEI^GV5K'+<WM[>W4L5O:6EO%+/<3R)%$C2NB4UNO5 ?Y*/_#LW
M_@I#_P!(^_VW?_$4?CQ_\P5'_#LW_@I#_P!(^_VW?_$4?CQ_\P5<]GV?W'=S
MQ_FC]Z_S#_AV;_P4A_Z1]_MN_P#B*/QX_P#F"H_X=F_\%(?^D??[;O\ XBC\
M>/\ Y@J+/L_N#GC_ #1^]?YA_P .S?\ @I#_ -(^_P!MW_Q%'X\?_,%1_P .
MS?\ @I#_ -(^_P!MW_Q%'X\?_,%19]G]P<\?YH_>O\P_X=F_\%(?^D??[;O_
M (BC\>/_ )@J/^'9O_!2'_I'W^V[_P"(H_'C_P"8*BS[/[@YX_S1^]?YA_P[
M-_X*0_\ 2/O]MW_Q%'X\?_,%1_P[-_X*0_\ 2/O]MW_Q%'X\?_,%19]G]P<\
M?YH_>O\ ,/\ AV;_ ,%(?^D??[;O_B*/QX_^8*C_ (=F_P#!2'_I'W^V[_XB
MC\>/_F"HL^S^X.>/\T?O7^8?\.S?^"D/_2/O]MW_ ,11^/'_ ,P5'_#LW_@I
M#_TC[_;=_P#$4?CQ_P#,%19]G]P<\?YH_>O\P_X=F_\ !2'_ *1]_MN_^(H_
M'C_Y@J/^'9O_  4A_P"D??[;O_B*/QX_^8*BS[/[@YX_S1^]?YA_P[-_X*0_
M](^_VW?_ !%'X\?_ #!4?\.S?^"D/_2/O]MW_P 11^/'_P P5%GV?W!SQ_FC
M]Z_S#_AV;_P4A_Z1]_MN_P#B*/QX_P#F"H_X=F_\%(?^D??[;O\ XBC\>/\
MY@J+/L_N#GC_ #1^]?YA_P .S?\ @I#_ -(^_P!MW_Q%'X\?_,%1_P .S?\
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MS^X.>/\ -'[U_F'_  [-_P""D/\ TC[_ &W?_$4?CQ_\P5'_  [-_P""D/\
MTC[_ &W?_$4?CQ_\P5%GV?W!SQ_FC]Z_S#_AV;_P4A_Z1]_MN_\ B*/QX_\
MF"H_X=F_\%(?^D??[;O_ (BC\>/_ )@J+/L_N#GC_-'[U_F'_#LW_@I#_P!(
M^_VW?_$4?CQ_\P5?V?\ _!JE^SC^T-^SQ\-/VR;#X_\ P'^,WP,OO%'CKX/W
MGAFR^,/PO\<?#*Z\0VFEZ!X\AU*YT.W\:Z'HDVKV^GS7EI#?36"W$=I)=6Z3
MM&\T8;2FFG*Z:]WJO[T3.K*+AI)/5:)IG]9E%6<H44 %% !10 44 %% !10
M44 %% !10 44 %% !10 44 %% !10 44 %% !10!Y3\8_@;\&_VA?!>H?#CX
MY_##P+\6? VI FZ\,>/O#.E>)M*$Q0I'>6D&J6UP=/U*W#;K/5-/>VU&SEQ+
M:7,,J*Z_S"?MC_\ !IW^R_\ $Z75?%7['GQ3\4?LX>);@O<P?#[QBM]\3_A-
M)*UP\OV33KZ^OH/B+X7C=)60W5SK_C>"%(((K?1X0TDI'9[_ "?;5/YKROZ6
M>I49R@[KYKH]K^CLDK_GL?RW?M7?\$(/^"FW[(YO=2\4?L]ZO\6?!5C&TLOQ
M#_9Z>\^+7AQ84DE2:YO-&TG3;7XA:'9P1QI<7%]XD\$:-81P3QL;G<LZ0?D%
M=VEUI]U=6%_:W%E?V5Q/9WME>02VUW9W=M*T-Q;7-O,J36]Q;S(\4T,J+)%(
MKQR(KJ164HN*UVZ-:INT;]%K;H]?S?7":FM'KI=.UUM?Y>>U[I-=*U%06%%
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MKG>\UXG@^RM-3^%-Y?O._P!I:]U;X>:E<R3J?-EDCEFCD_GL_:2_X-"OB?I
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M[TZ&+E*3O)M^O3T6R^2UZG<T4""B@ HH ** "B@ HH ** "B@ HH ** "B@
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M44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10
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MEE;_ ):.6Z:E<044 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %%
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MSK&R;%?Y]FX55_17LG9)7MM>UKV\S-MO=MVU5VW;TO>WR/1**0!10 44 %%
M!10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %%
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M6[9:"XB<;[74+&?8JW>G:A;M'<V-X@"S6TB,0D@=%XNM[W2:_K3U.?5:!10
M44 ?9'['?[5VL?LY>,?L6KO>:G\+?$U["OBO1(F\Q],N'$=LGBO1X2CM_:-A
M"BK>V<1B36K&);65A<6^G3VG])&@Z[I'B?1M*\1>']0MM6T36[&VU/2M3LI1
M-:7^GWL*W%K<P2+C<DL3JXW %=Q5@&! RFK._?\ X'_ ^9K!MI^32TOM>.]O
MN[=]=MBBH+"B@ HH ** "B@ HH ** "B@ K\S/\ @J7XC&F_ CPKX>21EN/$
MWQ'TUW3Y KZ;HFB:W=W.X%Q)N74)])(VQE>6WNF(TE:^)>OZH4OA?H?@5R2
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M-G:736\NG3YV^[[NKZ7M$WI9:7M?3HK;VW;:^5EN>&T5J9!10 44 %% !10
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MQ#% +S5=0D027-PT:JJK%;6\<-G;6]O!Z/7/=O?5FZV5O+\E_P -?K;U2**
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MTR:=,XTJ>V;2?V\K&2L_)[?K^)M%WBN^W3LNJ_JX45)044 %% !10 44 %%
M!10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %%
M!10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %%
M!10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %%
M!10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %%
M!10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %%
M!10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %%
M!10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %%
M!10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %%
M!10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %%
M!10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %%
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MT6GPZ@-4 Y_?V,4B[G3%?U15G4W3\OZ_,UAL_7]$%%9EA10 44 %?@Y^WO\
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M)#),UVZ!56.'Q38P27H*F0MK%CK,]R\;7UJC_E[6\7=+RLON1C-6D_/7_/\
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M;G3;Y8I+K2-05!'=VXDBD6"]M+VTMOH*L&FG8W6RMMI;KT7_  S\[A12 **
M"B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH **
M"B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH **
M"B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH **
M"B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH **
M"B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH **
M"B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH **
M"B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH **
M"B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH **
M"B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH **
M"B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH **
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M486>.*"0Z1I\HM5OKK58F[*W?_@&E-7=WTM:_=M?DKL_1&BLC0** "B@ HH
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MGRZKI$VIW"[G;_B9QR;]LJJMP^+Y/]"9ZQZZ-/\ X?\ KR/A*BM3$** "B@
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MMO$O_P LZ++LON#F?=_>'_"X/BU_T5'XB_\ A;>)?_EG1_PN#XM?]%1^(O\
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M5=_^&$VTG;3SUTU6WRO^FMC\,_\ A<'Q:_Z*C\1?_"V\2_\ RSH_X7!\6O\
MHJ/Q%_\ "V\2_P#RSK:R[+[C'F?=_>'_  N#XM?]%1^(O_A;>)?_ )9T?\+@
M^+7_ $5'XB_^%MXE_P#EG19=E]P<S[O[P_X7!\6O^BH_$7_PMO$O_P LZ/\
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M.JO'(C*Z,N].3FCKKM\^Z_K]1K?T:?XH_E3_ .%P?%K_ **C\1?_  MO$O\
M\LZ/^%P?%K_HJ/Q%_P#"V\2__+.M[+LON.?F?=_>'_"X/BU_T5'XB_\ A;>)
M?_EG7[F?\$R?$GB+Q1\!_%NH>)=>UOQ%?0_%[7[.*]UW5+[5KN*TC\'> 9TM
M8[F_GN)DMDFN+B9(5=8EEFE<+OD<M,TN5V6MUMIU5_P_JY<&^;5O;S:W7K^7
M?S/T7HK(T"OY^O\ @H9\0O'_ (=_:5US2_#_ (X\8Z%IL?A?PE*FGZ/XFUG3
M+)))=,WRR):V5]#;J\K'>[B,&1B2_)S50U>JOH_S73^OQ)DVD[77IZKY_P!>
MA\0_\+@^+7_14?B+_P"%MXE_^6='_"X/BU_T5'XB_P#A;>)?_EG6MEV7W&7,
M^[^\/^%P?%K_ **C\1?_  MO$O\ \LZ/^%P?%K_HJ/Q%_P#"V\2__+.BR[+[
M@YGW?WA_PN#XM?\ 14?B+_X6WB7_ .6='_"X/BU_T5'XB_\ A;>)?_EG19=E
M]P<S[O[P_P"%P?%K_HJ/Q%_\+;Q+_P#+.C_A<'Q:_P"BH_$7_P +;Q+_ /+.
MBR[+[@YGW?WA_P +@^+7_14?B+_X6WB7_P"6='_"X/BU_P!%1^(O_A;>)?\
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MV\2__+.C_A<'Q:_Z*C\1?_"V\2__ "SK:R[+[CGYGW?WA_PN#XM?]%1^(O\
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M4Z?UV_X)K3?36R=].SLGO_7SL=]169844 %?@-_P52_Y.$\'?]D:\/?^IO\
M$.KAO\OU1,_A?R_-'YH45J8GTA^R!_R<W\%/^QZTO_T&:OZF*RGO\OU9K#;Y
M_H@HJ"SY"_;G^')^)/[-7C^TM[=[C5?"4$'C[1EB57<7'A<R7.I[8\%Y'E\-
M3:Y;1QQE93+-&4\W'D2_S*5K3V?K^B,I[KKT\]$M_O\ N2]$459!]H_\$_\
MX@?\('^TWX*BGFD@TWQS#J7@+4=C\2/KD*SZ'&4+JKK)XFT_1(S\P9(Y&DC#
MR*(V_I7K*:UOW_0VA\/HW^2M?_/?N%%04%% !10!_/1_P4Q^(P\6_M!)X/M)
MQ+IWPT\-:=HSQQLLD/\ ;VN(OB'5YD=1CS!9WFBZ=<Q;F,-SI4T<A259(X_S
MNK>.D5Z+\=?Z_'4QE\3"BF2?TN?L$_#0_#;]FKP6MU (=7\<FY^(6J@J Q_X
M2-(/[$W9 ?(\,6>A^8C\I.TZX')/V96#=VV="5DO1?/1?UZ6"BD!_(Y\8/\
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MI?\ )O?@[_LLOA[_ -0CXATUNO5?F3/X7\OS1^ U%;F(44 %% !10 44 %%
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M]I?X=7L\ICTOQ3?2> M6&\1(]OXL5=/TUI96!18;7Q%_8FH3EEV^3:-\T?\
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M9"$DFDU/3HK&U,7]J7)?^<6M8/3T?]?J93W3[K\O^!8**L@** "B@ HH **
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MK\Q3^%_+\T?@-16YB%% !10 44 %% !10 5^H?\ P2G_ .2U?$'_ +)=<_\
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M%62%% !10 44 %% !7ZT?\$W_P!J"[T37;;]GWQIJ,DN@:]+<2_#J]NY"_\
M8VOR,;FX\,"25P(M,US%S<Z=$I80:X3;PPLVLL\,R3<7;?\ X/\ D5!VEZZ/
M^O4_<"BL38** "B@#\V?^"G?Q%_X1;X%:5X&MIGCU#XF>*+2VN(P!B3P]X5:
M#7=3??DLKKK'_",PE4&UX)YD>0*H23^?VM8;==^OHE^AE.][=DOZ]0HJR HH
M FMKB>SN+>[M97@N;6>*YMYHR5DAGAD66&5#GAXY$5U;^\N?:OZV?A#X\M_B
MA\+? 7Q MRG_ !5?A?2-6N410$M]3GM(UU:SVJ6 -EJB7MDZJ[ -"R;B>F<^
MGS_0TIOIYK\]?ZNO5;GI-%9F@44 %% !7SU^UE_R;5\;O^R=>(__ $B>FMUZ
MK\P/Y7**W.<** "B@ HH ** "B@#W?\ 9S^/7B;]GGXDZ5XUT22YNM'DE@L?
M&'AQ)C';>)/#KR@W=HZL?)74+56:[T:]<'[#J"(S+):R7EM<_P!2/AGQ)HOC
M'P]H?BKP[?1:EH?B'2[+6=)OX22ES8ZA;I<V\@4@,CF.0*\3A9(9!+#(B/')
M'64]+/OO]Z7RT_+U9K!W5NM_+;3OIZO<Z"BH+/GK]K+_ )-J^-W_ &3KQ'_Z
M1/7\KE:PV^?Z(SJ=/G^@459F%% !10 44 %% !10!]5?L1?\G4_!O_L8-0_]
M1S6J_I^K*>_R_5FL-OG^B"BH+/A7_@HY_P FK>+_ /L8/!?_ *D=C7\X-:PV
M^?Z(RGO\OU8459 44 ?IC_P38_: /@/XBS_![Q!>"/PM\2[J%M!DN)BL.E^.
MHHO)LHH]SA%3Q3;*FD.H#R3ZM;:#%&%5Y2_[[UE--2];?D;1=XKR;7Y?U^G5
ME%04%% 'X-?\%6/^2U?#[_LEUM_ZEGBBOR\K=;+T7Y&,_B?R_)!7O/[+?_)Q
M_P #O^RH^"__ $^V=,2W7JOS/ZKZ*YS<** "OYS/^"DO_)T>O_\ 8J>#O_34
M*N&_R_5$S^%_+\T?!5%:F(44 %% !10 44 %?I?_ ,$K?^3A/&/_ &1KQ#_Z
MF_P\J9_"_E^:&MUZK\S]^:*Q-PKG_%G_ "*OB;_L7]9_]-US0!_'O170<X44
M %% !10 44 %% ':_#GXB>*_A3XTT+QYX*U&72]?T"\2YMI1O-O=0ME+O3M0
M@#(+K3=1MVDM+^U9@LUO+(H*2"-U_J>^"OQ8T'XV_#/PM\2?#P\JUU^RW7FG
M-,LUQHVLVLK6FL:/<NNPM)87\4L44KQPB\M/LU_'$L%U$*SJ+5/[]M]+?JO\
MC2#W5K]5IYK?OY::>6K/5:*S- HH ^&/V]/VAKGX&_"7^R_#5\;3Q_\ $62[
MT#P]<12[;K1M)AA0^(_$<&W#+<65O<VVG6$H:.6VU/5;:_A,@L)5'\WW.222
M23DD\DD]23Z_Y^FL-GYLRF[V7;SONEK\[7_RV"BK("OH#P/^RI^T5\1;>"]\
M*?"3Q;=6%TN^TU+5;6W\,:7=QY(\VUU/Q1<Z-8W4659/-@N9(]Z^67W\4FTM
M]!I-[+^O5GK3?\$[_P!K%49A\/-.9@A81KXW\$"1B!D1J6U]8MY/RKND$>>K
M!?GKQOQU^S!^T%\-X;BZ\7_"?Q?86%H'>[U6QT]?$&C6J(2K27.L^')M6TN"
M+@XDFNTC?JCG*TE*+>_X-=NZWU_JS'R2MMMV^73Y]NYX315$A2H[QNDL3O')
M&ZR1R1L8WC>,[D='7#(R, 000RL/2@#^C_\ 83_:3E^._P ,VT;Q/??:/B3\
M/UL]+\133RJ;KQ#I4BM'HWB<JSF6:XNHX'LM:F.XG5;=[MO*34[:,?=%8-6;
M1NG=)]^OFDDU\G?MI;0**0PHH ** "B@ HH ** "B@ HH *_F\_;V_9Z_P"%
M*?%V?7- L?(\ ?$B2]\0:"((V6TT?5S,LGB'PZ/E$<*6US<+?Z;;QXBCTK4+
M>TA!%E.([@]?E_7ZD3^'TM^=CX:HK4R"B@ HH ** "OTF_88_8PD^+^H6GQ4
M^)6GM'\+=+NW.CZ-<!XI/'FJV<@5D:,%7'A:PG4KJ-QN3^U+J,Z3;F2)=2:W
MF3LK^B7S_P MRHIM^2U?I=?K8_?N&&&UAAM[>&."W@C2&""%%BA@AB41QQ11
MH!''%'&JK'&BJB*N%XJ>L%IIVT_ VUW[O\=/\_Z=PHI@%% !10 44 %% 'Y+
M?\%4_BA_9G@[P'\([&7%UXIU27QCKRHQ$B:/X?#6.D6TJA@K0:EJ][<W8)5B
ML_AY"'C'W_Q K:"LO74QF[R^2_(**HD*V/#>@:EXJ\0Z#X7T6W:ZUCQ'K.F:
M#I5LH8M/J&KWL%A90J%#,3)<W$:816/.,=*!K5I=V?UQ^!/"&G> /!?A3P/H
MX TOPEX>TCP]9.(EA:>'2K""S%U+&A8"XNWA:ZN79W>2XED>22221W;K:Y]?
MZ_KN;_?\_1?UO]SN%% !10 44 %% 'XK?\%7/AWY&K_"_P"*MI"-NH6>H^ ]
M;E6/:%GTZ5]<\/-(X)\V6Z@O?$49+A72'3X4WRI\L'Y 5M!^ZC&?Q?)?DE^:
M>X451(44 %% !10!L^&]?U+PIXBT'Q1HT[VVK^&]:TS7M+N$8H\&HZ1>P7]E
M,C*<JT=Q;QN#UR >*_KH\&>*=.\<^$/"WC32=W]E>+/#VC^(]/#,&=+/6=/M
M]1@CE*@+YL44ZQS*0-LJO&>X&=3I\_T-:;W]4_\ /_@+0Z>BLRPHH ** "B@
M HH *_('_@H#^QN=735OCW\+-*/]K0I+?_$GPOI\)+:K#'OFN?&NFV\8+-J<
M$?[SQ':Q+MO[6-M96-+Z#5'U*HMJ2^[[R9*ZVN^GEJOTW_JWXJT5L8A10 44
M ?HW^R[_ ,%"/%7P:TNT\#?$C3-1\?\ @.QBBMM$NK6[B3Q9X6LX%2..PLWO
MF2TUK288T\NRTR]NK"6Q#!;;5!90PV"_7/CO_@JE\+['1)S\.?!'C'Q#XCD2
M1;9/%,&F>'M"LW(PEQ=RZ=J^LZC=K&Q\S[%;V]L;A5:/^TK0LLE9N%WIMIY>
MMOZ^1JIJUVFVEY6^S;IZW;NO)MZ?CK\5_B]X^^-7BZ\\9_$+6YM7U6YS':P(
M#!I.C6(;,.EZ+IRL8=/L85 "QQ[Y[F4R75]/>7LUQ=3>:UILDNQFVV[O4]>^
M _P@UKXZ?%+PK\.=%6:)=7O!/K>IQQ[TT3PW9$3ZWJ\I8&(&VLPT=HDQ1+S4
MY[&Q5_-NHZ_JI\*^&-%\%^&M"\)>&[)--T'PWI5EHVD648&V"QL($MX$9L!I
M9F2,23SR9EN)GDFE=Y9'>LJCU7S_ $_K7_.VD$K-^?GTL_\ /\=G8Z&BH+"B
M@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** /Q
M+_X*R_\ (U?!C_L7_&'_ *<=#K\BZVA\*^?YLQG\3^7Y(**HD_JC_9-_Y-J^
M"/\ V3KPY_Z1)7T+7.;K9>B_(**!A7YR?\%0O^3<-*_[*CX9_P#3%XLIK=>J
M_,F?POY?FC^?*BMS$** "KVDZKJ6A:IINMZ->W&G:MI%_::GIFH6LABNK'4+
M"XCN;.[MY!@QSV]Q%'-&P&5D3B@#^I[]FKXVZ;\?OA'X:\?6S6\.LM"=(\8:
M7 1_Q*?%>FQQIJMN(]\K0VEYO@U?2T=WD_LK4;'SF\_S$7WRL'H[&ZV7HOR7
M^?Z;IA12&%?@-_P52_Y.$\'?]D:\/?\ J;_$.KAO\OU1,_A?R_-'YH45J8GT
MA^R!_P G-_!3_L>M+_\ 09J_J8K*>_R_5FL-OG^B"BH+"OP-_P""H_PX;P[\
M9/#/Q$M8MEE\1O#*VUY(%'[SQ!X-^RZ9=/(X;^+0+SPY'$K*K$VTQ1G52([@
M_>^_^MG_ %]Q,E=/R_5KY_\  /S)HK4Q"OZ/?^"=?CT^-?V9_#NG3RF74/A_
MK6M^"KHLP,AM[>:/6](;8#N$,6CZY9:?"V-CFP?&9$DJ)K2_;]?Z1<'J_3]5
M^E_ZT?W7161J%% !7Q'_ ,%!?B*/ '[-/BRT@F,6J_$"YL/ 6G!9"CF'57DO
M->W(I#R02>'--U:SD(.Q9+R$2%TD\N1K=>J_,3=DWY>?=?I=>6Y_-G16Y@%?
MJ+_P2U^&?]O?%/Q;\3[ZWW6/@#0%TK2I7R-OB3Q;Y]L9H3C#FUT"RUJWN% P
M@U6V<D%ES,G:+^7YE05Y)6_KI^)^\=%8FP44 ?R.?&#_ )*U\4?^RB^-O_4E
MU.O.JW6R]%^1SA7T1^R;X3\.^.?VB/A?X4\6Z5;:[X=UG6KZWU72;SS/LUY!
M'H6JW21R^2\<N$G@BE78ZG<B\T/9^C''XE?:ZO\ ?YG] /\ PQ=^RY_T1CPI
M^>J__+*C_AB[]ES_ *(QX4_/5?\ Y95CS/N_O-K+LON#_AB[]ES_ *(QX4_/
M5?\ Y94?\,7?LN?]$8\*?GJO_P LJ.9]W]X679?<'_#%W[+G_1&/"GYZK_\
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MV7/^B,>%/SU7_P"65'_#%W[+G_1&/"GYZK_\LJ.9]W]X679?<?-G[7O[+WP
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M7%KI-AYWV:&:]G>YNY$\^:>3=-/(\K9<\L!T&*3;?5C22V2^X["B@ HH **
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MES_HC'A3\]5_^65'_#%W[+G_ $1CPI^>J_\ RRHYGW?WBLNR^X/^&+OV7/\
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MO\TUN?SAT5N8%N'3[NXL[V_BA9K/3OLRW<_(2)[R1HK:,GO),R2LB]TAE?\
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M^!'_ &1KX8?^H1H=>RUSFZV7HOR"B@844 %% !10 44 %% !10!^6'_!5O\
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MJL;AFBLK?5(E$C1*!=.5E+A(9E+X7_7]=RH7YH^O]??^=C^@>BL#8** "B@
MKG_%G_(J^)O^Q?UG_P!-US0!_'O170<X5^E__!*W_DX3QC_V1KQ#_P"IO\/*
MF?POY?FAK=>J_,_?FBL3<** "B@ HH ^%?\ @HY_R:MXO_[&#P7_ .I'8U_.
M#6L-OG^B,I[_ "_5A15D!10 5]F_L-_M _\ "C/C)81:U>_9_ 7CXVGACQ<9
MY3%::9))<YT/Q+(698T_L2]E:.]FD++%HE_JS+&THA*)JZ:'%VDO7\-G^9_2
MW16!N%% 'X-?\%6/^2U?#[_LEUM_ZEGBBOR\K=;+T7Y&,_B?R_)!7O/[+?\
MR<?\#O\ LJ/@O_T^V=,2W7JOS/ZKZ*YS<** "OYS/^"DO_)T>O\ _8J>#O\
MTU"KAO\ +]43/X7\OS1\%45J8A7]E%9U.GS_ $-*?7Y?J%%9F@44 %% !10
M44 %<_XL_P"15\3?]B_K/_INN: /X]Z*Z#G"OT/_ ."8W_)RLO\ V3KQ5_Z6
MZ#4S^%_+\T-;KU7YG]#-%8FX44 %?._[3_P)TC]H'X3Z]X/N[: >([2WGUCP
M/JCB-)M+\4VEO*;!3<2<1Z?J9_XEFK(QV/97+S*%N;:UFB:=FF%KII]?\_\
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MJ^8I.J'Q)=HSMMFMKVV=(PC>9+,_A^[\RX;_ "_5?UKIZ;GZ0T5B:A10 44
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M<-YEW;(]E=.]]:-<7E0=GKU_K_/^M29JZO\ ._RBGMZW[V6G51^$:*V,0HH
M** "OKW]BK]GR3X]_&'3[?5;.67P#X+:V\1^-I]FZWN8(YF;2?#CN2@\WQ%>
MV[PRQAA+_95KJUQ'N>V I-V3?W>NR'%7:^_Y+5_E;Y_-?TSHBQ*L<:JB(JHB
M(H5411A451@*J@851PH]NDE8>7;0W_K\%K\_SOTL%% !10 44 %% !10 44
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MJOV(O^3J?@W_ -C!J'_J.:U0]GZ/\AK=>J_,_I^HK W"B@ HH ** "B@ HH
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M#S;NZFEFD+%F6LIO5+M^;M96M8UIK2]GJTMMU=;=]_R?0[.BH+"B@ HH **
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M^J_KRWL?4-%9&@44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %%
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M_L%^'O\ U,_#=?S&UK#;Y_HC*>_R_5A15D'[?_\ !)W_ )$?XO\ _8U^'/\
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MM#X5\_S9C/XG\OR0451)_6'^SG_R;W\"/^R-?##_ -0C0Z]EKG-ULO1?D%%
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M_4WBT[/LU?7T_#1O9[M+31Z%%2,** "B@ HH ** "B@ HH ** "B@ HH **
M"B@ HH *_+;_ (*5_L]?\)IX)M?C;X9T_P SQ+\/K7['XLBMH2T^J>!WFDE%
M^^TDR2^%+Z:6[DQ%\ND:AJ=U<3B'3(%-1=I+[OE=?UW$]4UUMI\FC\(**V,
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MOI=:MP2J,VB.&W#]T_\ 1?64W[WI9?A?]3:'P_-_I_5O\PHJ"@HH ** "B@
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M% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 ?B7_P %9?\
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M1*^J\M_^&^?D=37"_%#_ ))G\1/^Q%\7?^F#4*S+/Y$:*Z#G"OWY_P""5O\
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MPOY?FBH?$OG^3/V4HK$V"B@"E?7MGIMI=:CJ5Y::?I]E!)=W=_>W$5K96EK
MADFN+JYG:*&""&-6DDEED6.-%9G=4K\(/V]_VQ])^+:Q?"/X7:A)>> =-U!+
MWQ3XCB$D-OXNU6QE+65CIP?9)-X=TN<?;#=2((]6U-+2ZM8_L>G6MU?5!7=]
MK:_/3J3+2/K]S?NZ_<MNETFWK?\ ,.BMC$*_=K_@EK\+9?#WPT\7_%/4;5X;
MKX@:U#H^A/+&R[_#GA5KF*:\M68 &&_U^\U&TFV[E=]#B.1@U,_A+A\5[;+3
M[T?J=16)J%% !10 5S_BS_D5?$W_ &+^L_\ INN: /X]Z*Z#G"OTO_X)6_\
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M?_E;1_PVC^RY_P!%G\*?EJO_ ,K:+/L_N#F7=?>'_#:/[+G_ $6?PI^6J_\
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M:3S+.\BGM9@LT3I653H[/^FOZ^\UIN^GG^=OP\N_3OU%?@-_P52_Y.$\'?\
M9&O#W_J;_$.B&_R_5#G\+^7YH_-"BM3$^D/V0/\ DYOX*?\ 8]:7_P"@S5_4
MQ64]_E^K-8;?/]$%%06%% 'GGQ7\"6?Q.^&OCKP!>!/*\6^%]7T>&1RP6VO;
MJTD_LR_!'\>GZDMK>Q_>0O @D1X_D/\ )%?65WIM[=Z=?V[VM_874]E>6TH
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MH <B"QTZUBL[2$'J1'!#'&/7;TK2KG[F_P#77]0HH ** /Y'/C!_R5KXH_\
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M4 %% !10 5^[/_!*3_DDOQ*_[*+%_P"HUI%3/X7\OS1<-_E^J/U/HK$U"B@
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M0MU.UQF7E) 2A_K-1TE59(V5T=5>-U8,K(PRKHPW JRG*LO##CIUSJ;KSO\
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MSX9CB\,Z'<6[\M:W\&DK!<ZQ;LP#^5K=WJ2A@OR_)&:^:ZM)+8AMO?\ X"]
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M+% _R37MA]MTW<4\N\D5T9_<JR::T9K=6TV_X"5_73] HI %% !10 44 %%
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MK,3A3?N_=^8X*\EY=.[NDOQ_X.A^N-%8FP44 %% !10 44 %% !10 44 %%
M!10 44 %% !10 44 %% !10 44 %% !10 44 %% 'XE_\%9?^1J^#'_8O^,/
M_3CH=?D76T/A7S_-F,_B?R_)!15$G]4?[)O_ ";5\$?^R=>'/_2)*^A:YS=;
M+T7Y!10,*_.3_@J%_P FX:5_V5'PS_Z8O%E-;KU7YDS^%_+\T?SY45N8A7]8
M?[.?_)O?P(_[(U\,/_4(T.LZG3Y_H7#?Y?JCV6OS&_X*3?L]'Q[X!M_C)X:L
MO,\6?#:SDC\11PHS3:OX#>5KBXD8#=NE\*W<MQJL9"QJ-*O-<DFDE>WM(1$7
M:2];/YO]/4T:NFO+3NW=62]?ZTNU^"%%;F 5^QO_  3#_:"\N75/V?/$]_A)
M?MOB7X<2W,W E&;GQ+X7M][_ /+15?Q+I]M%&JAD\22RRL\MM%4S5XORL_Q_
MRN5#?UT_%6]=>GZ'[-U^ W_!5+_DX3P=_P!D:\/?^IO\0ZB&_P OU1I/X7\O
MS1^:%%:F)](?L@?\G-_!3_L>M+_]!FK^IBLI[_+]6:PV^?Z(**@L** "OYF/
MV[OAP?AQ^TMX[BM[;[/I/C.2W^(&D#8422+Q-YLFL-&O*B-/%%OKT"*IVHD*
MC9&08UN&_P OU1$]OG?]/U/CZBM3([?X9>,[GX=_$7P/X[M#(9O"/BK0O$'E
M(64W$.F:E;W5U:,1C,=[:QRVDJG[T<SI_%7]<]G>6VHVEK?V4\=S97MO!>6E
MS"VZ*XMKB-)X)HW_ (XY8G1T8<,C<BLZFZVV?KT_S^7S-8/2WG?[[?Y:^6VI
M:KRSXV_$"+X5_"7XA?$*26.*;PMX6U74-.\X*8YM<:W-IX?LW#91A?:W<:?9
M[7!#&X7@X K-:M+NT:?T_O/Y+9II;F:6XN)9)9YY9)III6+2S32L7DED=B2[
MR.69F;EB<]>:970<P5^E?_!,#X9CQ3\:];^(5Y!YFG_#+PX[6DC#*IXE\6BZ
MTC3OE/RD+HD'B:3/WXIQ:N.U*7PO^NJ*C\2];_=J?O[16!L%% !10!_(Y\8/
M^2M?%'_LHOC;_P!274Z\ZK=;+T7Y'.%%, HH ** "NK\!_\ (\>#/^QK\._^
MG>SH&MUZK\S^OVBN<W"B@ HH *K7=I;7]M<V-];6]Y8WEO-:7EG=P1W-K=VM
MS&T-Q;7-O,KQ3V\\3M%-#*K12Q,Z.C(U ?U_7]?YGY,_M&_\$SM(U^>_\6_
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M169H%% !7SU^UE_R;5\;O^R=>(__ $B>FMUZK\P/Y7**W.<** "B@ HH **
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M[+?_ "<?\#O^RH^"_P#T^V=,2W7JOS/ZKZ*YS<** "OYS/\ @I+_ ,G1Z_\
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M $P:A64][]_^&-H.\?1M?<DU^?X'\B-%:F(5^_/_  2M_P"3>_&/_99?$/\
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M;Z#2;V0?\,@?M-_]$4\=?^"L?_'J/^&0/VF_^B*>.O\ P5C_ ./4N:/?\_\
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M*D&J74MO^Z58R5GY/_AC:#NOP_KY6"BI*"B@ HH ** "B@ HH ** "B@ HH
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MZA&AU[+7.;K9>B_(**!A10 44 %% !10 44 %% 'Y8?\%6_^22_#7_LHLO\
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MP4>29KG0O"Z2!6W+)!'%XFF>.0Y\N\M)0G*.:BKR7EK_ %\R9?"_3]5^E_\
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M]C!J'_J.:U0]GZ/\AK=>J_,_I^HK W"B@ HH ** "B@ HH ** "B@ HH **
M(I8HYXWAF1)(9$>.6*1 T;QL&62.2-E*NCJ=KHV592>/7\5OV]_V*]%\*Z5J
M/QQ^$>E0Z5I-K,DOCWP7IT"Q:=IT5S*4/BCP_;1X2QLHYY(HM8TBWC6TM(Y1
MJ-E':VD-Y&M0=FE\MOR)DKK;\.NGZ?H?D+16QB%?N7_P2C\5SW_PX^*/@N20
MR1^&?%^D:_;*QR88O%NDS6;Q)ERRQ>=X3DF6/8B"6:=U=W>39,_A?R_,N'Q?
MUW7];?A<_5VBL34** "B@#Y)_;K_ .33_C!_V"_#W_J9^&Z_F-K6&WS_ $1E
M/?Y?JPHJR#]O_P#@D[_R(_Q?_P"QK\.?^FB]K]::QG\3^7Y(W6R]%^045(PH
MH ** "OQK_X*W?\ -OW_ '5;_P!YM50^)?/\F3/X7\OS1^-=%;&)Z+\'_P#D
MK7PN_P"RB^"?_4ETROZXZSJ=/G^AK#;Y_H@K^:G_ (* ?#K_ (5_^TUXRFMX
M6ATOQY#8?$#3BP.'EUU9(->;> %8R>*+#6YPHPT<4\2.9"-[*'Q?)_F@GMZ?
M\,?%M%:F1_39^PQ\0_\ A8G[,_PZNI[@W.J^%K2X\":N78.\4_A61;/3$E<
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M\P/[;O\ R=3\9/\ L8-/_P#4<T6OE6MULO1?D8/=^K_,*^]?^";7_)T>@?\
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M\D%%42?UA_LY_P#)O?P(_P"R-?##_P!0C0Z]EKG-ULO1?D%% PHH ** "B@
MHH ** "B@#\L/^"K?_))?AK_ -E%E_\ 4:U>OPFK6&WS_1&,_B?R_)!15DG]
M'W_!./\ Y-6\(?\ 8P>-/_4COJ^ZJP>[]7^9NMEZ+\@HI#"B@ HH ** "B@
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M "B@#X5_X*.?\FK>+_\ L8/!?_J1V-?S@UK#;Y_HC*>_R_5A15D']1/[%_\
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MFZ_.VO?1/Y:-:!10,** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH **
M"B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** /Q+_X*R_\
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M "B@#Z0_9 _Y.;^"G_8]:7_Z#-7]3%93W^7ZLUAM\_T045!844 %% 'XL?\
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MP2$]0T4=W<J,';^]PW5,3/X7\OS14?B7]?U_5M3]L**Q-@HH ** /DG]NO\
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M.OAKQ#<%-)T3PM)\7;=#*B".V\+VLMCXK\M7(WW%S:3>'_*"\A;)]ZL#F/\
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MY?D@HJR3^C[_ ()Q_P#)JWA#_L8/&G_J1WU?=58/=^K_ #-ULO1?D%%(844
M%% !10 44 %?SP?\%*_B,/&/[0K>%;.<RZ9\-/#FF>'BB/OA.N:H#X@UF=,8
M"S+%J&EZ7<H.$FTHJWS*ZBX?%Z)OKY+]29_#]R_&_P"G]:'Y[45J8A10 44
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MK_\ V*G@[_TU"KAO\OU1,_A?R_-'P516IB%?V45G4Z?/]#2GU^7ZA169H%%
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M(/D:IG\+^7YHJ'Q+Y_DS]QJ*Q-@HH ** "B@ HH ** "B@ HH ** "B@ HH
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M ,)__*FLI-\SU?1;^2-8)<NJ3N[[=-/G\NGK</\ A1_P5_Z)!\+O_#?^$_\
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MT\[0Q\*J0Q%(HXT1$1415'-5N8-W_J_0*_?S_@FS\>K7QU\+3\)-:O?^*O\
MADC1Z9'/)F?5?!%U<L^FS0;SF1O#]S,VAW$2*$M=/&AN6=KF0QQ-7C?M9_C8
MN#LVNZM^*=_N3/TLHK(U"B@ K \3^(M*\'^'->\5Z[<+::-X;T?4M=U6X.T>
M38:5:2WMW(ID>.,N((I/+C9UWR$*#DT:@M_+K]Z?Z'\A&N:M/KVMZOKET/\
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M#2O^RH^&?_3%XLIK=>J_,F?POY?FC^?*BMS$*_K#_9S_ .3>_@1_V1KX8?\
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M]6%%60?M_P#\$G?^1'^+_P#V-?AS_P!-%[7ZTUC/XG\OR1NMEZ+\@HJ1A10
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M/O\ I;Y_\-8UIO3T>WD[+K\]M=WV+%%06%% !10 5S_BS_D5?$W_ &+^L_\
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M5V;YF@N='T>TU:U5<Q*FJ-(!OEEWQ-V7JU]W4N&K?I^J?Z'W;161J%% !10
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M.OQD_:D_;0\=_M(F'018Q>#?ASI]Z+VT\*V=VU[<ZG>0[TMM0\1ZH8K;[?/
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MN<W"B@ K^<S_ (*2_P#)T>O_ /8J>#O_ $U"KAO\OU1,_A?R_-'P516IB%%
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MM"I)VQP6\4<4:]5"\YS651ZI=O\ @:?U^!K36E^^Z]+:I]]UMMK8O45!844
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M(9_#VIK=Z299!N4W4=K'=JK.8KA&.\_IK\)/^"J4$GV73/C7X#>%OECF\5^
MG,D1X(62[\+:O<"2,;@KW<]CKLV0S_9M)39' \RBGJM'^'G?S_K8N,[6OJNE
M[W6UO/2WRZ'Z>?"WXT_"_P"-.DW.L_#/QAI?BFVL#:KJEO;^?:ZMH[WBRO:+
MJVC7\-KJFG?:OLUR+22ZLXH+QK.\^QRS_99_+]3K'78UZ+KHM?D%% !10 44
M %>>?$?XJ?#SX1Z(GB+XD>+=(\)Z5)*UO;3:C-(;F_G1#*]MIFFVL5SJ6JW*
M1 2R6VFVES.(P7,>S@BU:7=K\^OEWZ6WT#S_ *O=6_JZ/S+^+/\ P50\/V/V
MG3?@QX'NM>N<%(_%/C9GTO28Y 01):^'+":34]2@8'"M>:IH,L4BG-K(IR?S
M'^*_[3GQQ^-+S0^/?'NL7FCR.67PQI3+H?A>-07,2OHFEK;6E\\ =TBNM5&H
M7RHY1KM\FM80MJ]_PZ=WOY]/O9G*=]%M^>WW:K=:^FQX-15F844 %% !10 4
M4 %% !10![+\&/C]\4/@+KZZY\/?$4]E%-+&^K>';WS+WPQK\:%1Y6KZ.TL<
M4K[%,<>H6KVNJV<;N++4+8N2W[X?LR_ML_#?]H8VGAJ6-_!GQ/:WFDD\(ZA-
M]HMM8^QVTEU?77A75O+CCU*&"UAFNY]/N([75K2"*ZE^RWEG9S:BV<XW][[U
M]VOR_P""MF:0ET?3;UTT?RV_X:WVG169H%% !10 44 %% !10 44 %% !10
M44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10
M44 ?B7_P5E_Y&KX,?]B_XP_]..AU^1=;0^%?/\V8S^)_+\D%%42?U1_LF_\
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M HH V_"_AW4_%_B;P]X3T6%KC6/$^N:7H&EP*#^]O]7OH-/M(SCD SW"!B.
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M%?3/[(GQK;X$_''PKXIO;N2W\*ZK*WA;QJNX^2?#FM211R7TR@99=#OTL==
M13(ZZ:\$?^N='35TT./Q*^UU?TN?U%HZ2JLD;*Z.JO&ZL&5D895T8;@593E6
M7AAQTZR5@;_U^"_+\[]+!10 44 %<_XL_P"15\3?]B_K/_INN: /X]Z*Z#G"
MOTO_ ."5O_)PGC'_ +(UXA_]3?X>5,_A?R_-#6Z]5^9^_-%8FX44 %% !10!
M\*_\%'/^35O%_P#V,'@O_P!2.QK^<&M8;?/]$93W^7ZL**L@_J)_8O\ ^37/
M@Q_V*A_].NI5]/USFZV7HOR"B@844 %?SA?M]_L]'X+_ !:F\2^'['R/A_\
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MRL-KK4 #P^3?1W=E!<'JUT_73]/T(FKJ]GI_FK_=^7R/BFBM3(** "B@ HH
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M044#"OR6_P""L7_(C_"#_L:_$?\ Z:+*FMUZK\R9_"_E^:/Q HK<Q"B@ HH
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MO%__ &,'@O\ ]2.QK^<&M8;?/]$93W^7ZL**L@_J)_8O_P"37/@Q_P!BH?\
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M]69$FNW4O(T%K&+?3K(SS+86-LDC1'*4N9I+;3;K^'Z>>YK&-M]_RU7W^?\
M5_7Z*@L** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH **
M"N7\2^!_!7C/[%_PF'@_POXK_LW[3_9W_"2^'])UW[!]L\C[7]B_M2TNOLOV
MK[+:_:?(\OS_ +-!YN[R8]I<#EO^%'_!7_HD'PN_\-_X3_\ E31_PH_X*_\
M1(/A=_X;_P )_P#RII\S[O[Q679?<'_"C_@K_P!$@^%W_AO_  G_ /*FC_A1
M_P %?^B0?"[_ ,-_X3_^5-',^[^\++LON#_A1_P5_P"B0?"[_P -_P"$_P#Y
M4T?\*/\ @K_T2#X7?^&_\)__ "IHYGW?WA9=E]P?\*/^"O\ T2#X7?\ AO\
MPG_\J:/^%'_!7_HD'PN_\-_X3_\ E31S/N_O"R[+[@_X4?\ !7_HD'PN_P##
M?^$__E31_P */^"O_1(/A=_X;_PG_P#*FCF?=_>%EV7W!_PH_P""O_1(/A=_
MX;_PG_\ *FC_ (4?\%?^B0?"[_PW_A/_ .5-',^[^\++LON.I\->!_!7@S[;
M_P (?X/\+^%/[2^S?VC_ ,(UX?TG0OM_V/S_ +)]M_LNTM?M7V7[5=?9O/\
M,\C[3/Y6WSI-W44KC"B@ HH ** "N:\1^#?"'C&*WM_%WA3PWXIM[*5YK.#Q
M'H6EZY#:32HJ22VT6IVMTD$LB (\D2HSJ K$@8H Y/\ X4?\%?\ HD'PN_\
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MO[PLNR^X/^%'_!7_ *)!\+O_  W_ (3_ /E31_PH_P""O_1(/A=_X;_PG_\
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M=B2:+M;!ONOZ_K0J?\*/^"O_ $2#X7?^&_\ "?\ \J:/^%'_  5_Z)!\+O\
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M^&?_  3B^!OBP:I/JOB7XI8TZ6R$4-KKOA:&*9;A;EI%G)\%22D PIM,,L)
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M-IB3Q7:Z=X@TFPUFQ6ZB66.*Y6TU*WN;<7$22RI',(Q(B2R*K .P/%_\*/\
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M .5-',^[^\++LON#_A1_P5_Z)!\+O_#?^$__ )4T?\*/^"O_ $2#X7?^&_\
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MT[M;-BWO=)V?;R3#_A1_P5_Z)!\+O_#?^$__ )4T?\*/^"O_ $2#X7?^&_\
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M9"L:\* *+M;70&/_ ,*/^"O_ $2#X7?^&_\ "?\ \J:/^%'_  5_Z)!\+O\
MPW_A/_Y4T^9]W]XK+LON#_A1_P %?^B0?"[_ ,-_X3_^5-'_  H_X*_]$@^%
MW_AO_"?_ ,J:.9]W]X679?<'_"C_ (*_]$@^%W_AO_"?_P J:/\ A1_P5_Z)
M!\+O_#?^$_\ Y4T<S[O[PLNR^X/^%'_!7_HD'PN_\-_X3_\ E31_PH_X*_\
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=DD=LN[LS,3+DWN_T_!>A226R.NHI#"B@ HH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352284208608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>May 01, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-10994<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">VIRTUS INVESTMENT PARTNERS, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">26-3962811<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One Financial Plaza<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Hartford<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">06103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">248-7971<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">VRTS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,127,881<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000883237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352191579056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable, net</a></td>
<td class="nump">$ 116,387<span></span>
</td>
<td class="nump">$ 109,076<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Furniture, equipment and leasehold improvements, net</a></td>
<td class="nump">26,088<span></span>
</td>
<td class="nump">26,216<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">416,784<span></span>
</td>
<td class="nump">432,119<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">397,098<span></span>
</td>
<td class="nump">397,098<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred taxes, net</a></td>
<td class="nump">23,974<span></span>
</td>
<td class="nump">25,024<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">3,548,125<span></span>
</td>
<td class="nump">3,678,629<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent', window );">Accrued compensation and benefits</a></td>
<td class="nump">95,591<span></span>
</td>
<td class="nump">200,837<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">44,282<span></span>
</td>
<td class="nump">38,756<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrentAndNoncurrent', window );">Dividends payable</a></td>
<td class="nump">16,553<span></span>
</td>
<td class="nump">17,291<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">66,704<span></span>
</td>
<td class="nump">90,938<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt</a></td>
<td class="nump">253,008<span></span>
</td>
<td class="nump">253,412<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Other liabilities</a></td>
<td class="nump">67,460<span></span>
</td>
<td class="nump">91,471<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">2,556,937<span></span>
</td>
<td class="nump">2,705,471<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies (Note 14)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Redeemable noncontrolling interests</a></td>
<td class="nump">115,185<span></span>
</td>
<td class="nump">104,869<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Equity attributable to Virtus Investment Partners, Inc.:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value, 1,000,000,000 shares authorized; 12,224,489 shares issued and 7,127,881 shares outstanding at March&#160;31, 2024; and 12,163,228 shares issued and 7,087,728 shares outstanding at December&#160;31, 2023</a></td>
<td class="nump">122<span></span>
</td>
<td class="nump">122<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">1,298,157<span></span>
</td>
<td class="nump">1,300,999<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings (accumulated deficit)</a></td>
<td class="nump">223,023<span></span>
</td>
<td class="nump">207,356<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss)</a></td>
<td class="num">(187)<span></span>
</td>
<td class="num">(87)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Treasury stock, at cost, 5,096,608 and 5,075,500 shares at March&#160;31, 2024 and December&#160;31, 2023, respectively</a></td>
<td class="num">(649,463)<span></span>
</td>
<td class="num">(644,464)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total equity attributable to Virtus Investment Partners, Inc.</a></td>
<td class="nump">871,652<span></span>
</td>
<td class="nump">863,926<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">876,003<span></span>
</td>
<td class="nump">868,289<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">3,548,125<span></span>
</td>
<td class="nump">3,678,629<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=vrts_ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember', window );">Consolidated Entity excluding Consolidated Investment Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">123,880<span></span>
</td>
<td class="nump">239,602<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="nump">127,448<span></span>
</td>
<td class="nump">132,696<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other assets</a></td>
<td class="nump">79,596<span></span>
</td>
<td class="nump">89,438<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember', window );">Consolidated Investment Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">123,030<span></span>
</td>
<td class="nump">100,732<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="nump">2,081,225<span></span>
</td>
<td class="nump">2,082,713<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Cash pledged or on deposit of CIP</a></td>
<td class="nump">767<span></span>
</td>
<td class="nump">680<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other assets</a></td>
<td class="nump">31,848<span></span>
</td>
<td class="nump">43,235<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Notes payable of CIP</a></td>
<td class="nump">1,922,051<span></span>
</td>
<td class="nump">1,922,243<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vrts_SecuritiesPurchasedPayableAndOtherLiabilities', window );">Securities purchased payable and other liabilities of CIP</a></td>
<td class="nump">91,288<span></span>
</td>
<td class="nump">90,523<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Equity attributable to Virtus Investment Partners, Inc.:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">$ 4,351<span></span>
</td>
<td class="nump">$ 4,363<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(1),(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480833/946-310-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481058/954-310-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-6<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479613/805-30-35-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 405<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480191/946-405-45-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(h))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.16)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 40: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 41: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-15<br><br>Reference 42: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16<br><br>Reference 43: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.27(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481520/505-30-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vrts_SecuritiesPurchasedPayableAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities Purchased Payable And Other Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vrts_SecuritiesPurchasedPayableAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vrts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=vrts_ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=vrts_ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352191524080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">12,224,489<span></span>
</td>
<td class="nump">12,163,228<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">7,127,881<span></span>
</td>
<td class="nump">7,087,728<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, shares (in shares)</a></td>
<td class="nump">5,096,608<span></span>
</td>
<td class="nump">5,075,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352192164736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 222,042<span></span>
</td>
<td class="nump">$ 197,874<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LaborAndRelatedExpense', window );">Employment expenses</a></td>
<td class="nump">115,163<span></span>
</td>
<td class="nump">98,614<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees', window );">Distribution and other asset-based expenses</a></td>
<td class="nump">24,348<span></span>
</td>
<td class="nump">23,715<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring expense</a></td>
<td class="nump">797<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">2,028<span></span>
</td>
<td class="nump">1,145<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vrts_AmortizationOfIntangibleAssetsAndContingentAmortization', window );">Amortization expense</a></td>
<td class="nump">15,335<span></span>
</td>
<td class="nump">14,391<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">189,736<span></span>
</td>
<td class="nump">169,295<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="nump">32,306<span></span>
</td>
<td class="nump">28,579<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other Income (Expense)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">550<span></span>
</td>
<td class="num">(343)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense), net</a></td>
<td class="nump">5,501<span></span>
</td>
<td class="nump">4,923<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNetAbstract', window );"><strong>Interest Income (Expense)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Total interest income (expense), net</a></td>
<td class="nump">8,891<span></span>
</td>
<td class="nump">9,844<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (Loss) Before Income Taxes</a></td>
<td class="nump">46,698<span></span>
</td>
<td class="nump">43,346<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="nump">8,831<span></span>
</td>
<td class="nump">8,703<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income (Loss)</a></td>
<td class="nump">37,867<span></span>
</td>
<td class="nump">34,643<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Noncontrolling interests</a></td>
<td class="num">(8,009)<span></span>
</td>
<td class="nump">3,981<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net Income (Loss) Attributable to Virtus Investment Partners, Inc.</a></td>
<td class="nump">$ 29,858<span></span>
</td>
<td class="nump">$ 38,624<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings (Loss) per Share&#8212;Basic (in dollars per share)</a></td>
<td class="nump">$ 4.19<span></span>
</td>
<td class="nump">$ 5.33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings (Loss) per Share&#8212;Diluted (in dollars per share)</a></td>
<td class="nump">$ 4.10<span></span>
</td>
<td class="nump">$ 5.21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Shares Outstanding&#8212;Basic (in shares)</a></td>
<td class="nump">7,119<span></span>
</td>
<td class="nump">7,245<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Shares Outstanding&#8212;Diluted (in shares)</a></td>
<td class="nump">7,287<span></span>
</td>
<td class="nump">7,410<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=vrts_ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember', window );">Consolidated Entity excluding Consolidated Investment Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCostAndExpenseOperating', window );">Other operating expenses</a></td>
<td class="nump">$ 31,375<span></span>
</td>
<td class="nump">$ 30,730<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other Income (Expense)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Realized and unrealized gain (loss) on investments, net</a></td>
<td class="nump">3,416<span></span>
</td>
<td class="nump">2,670<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNetAbstract', window );"><strong>Interest Income (Expense)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(5,681)<span></span>
</td>
<td class="num">(5,005)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Interest and dividend income</a></td>
<td class="nump">3,469<span></span>
</td>
<td class="nump">3,238<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember', window );">Consolidated Investment Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCostAndExpenseOperating', window );">Other operating expenses</a></td>
<td class="nump">690<span></span>
</td>
<td class="nump">700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other Income (Expense)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Realized and unrealized gain (loss) on investments, net</a></td>
<td class="nump">1,535<span></span>
</td>
<td class="nump">2,596<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNetAbstract', window );"><strong>Interest Income (Expense)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(40,012)<span></span>
</td>
<td class="num">(35,203)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Interest and dividend income</a></td>
<td class="nump">51,115<span></span>
</td>
<td class="nump">46,814<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vrts_InvestmentManagementFeesMember', window );">Investment management fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">188,360<span></span>
</td>
<td class="nump">164,478<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vrts_DistributionAndServiceFeesMember', window );">Distribution and service fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">14,030<span></span>
</td>
<td class="nump">14,153<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vrts_AdministrationAndShareholderServiceFeesMember', window );">Administration and shareholder service fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">18,678<span></span>
</td>
<td class="nump">18,359<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vrts_OtherIncomeAndfeesMember', window );">Other income and fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 974<span></span>
</td>
<td class="nump">$ 884<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expense related to distribution, servicing and underwriting fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.14)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterestAndDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterestAndDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LaborAndRelatedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LaborAndRelatedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCostAndExpenseOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCostAndExpenseOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482047/420-10-45-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vrts_AmortizationOfIntangibleAssetsAndContingentAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization of Intangible Assets and Contingent Amortization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vrts_AmortizationOfIntangibleAssetsAndContingentAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vrts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=vrts_ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=vrts_ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vrts_InvestmentManagementFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vrts_InvestmentManagementFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vrts_DistributionAndServiceFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vrts_DistributionAndServiceFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vrts_AdministrationAndShareholderServiceFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vrts_AdministrationAndShareholderServiceFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vrts_OtherIncomeAndfeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vrts_OtherIncomeAndfeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352195158848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income (Loss)</a></td>
<td class="nump">$ 37,867<span></span>
</td>
<td class="nump">$ 34,643<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment, net of tax of $36 and $(35) for the three months ended March 31, 2024 and 2023, respectively</a></td>
<td class="num">(100)<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(100)<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income (loss)</a></td>
<td class="nump">37,767<span></span>
</td>
<td class="nump">34,742<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Comprehensive (income) loss attributable to noncontrolling interests</a></td>
<td class="num">(8,009)<span></span>
</td>
<td class="nump">3,981<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive Income (Loss) Attributable to Virtus Investment Partners, Inc.</a></td>
<td class="nump">$ 29,758<span></span>
</td>
<td class="nump">$ 38,723<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-4<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482739/220-10-55-15<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352192204176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Foreign currency translation adjustment, tax</a></td>
<td class="nump">$ 36<span></span>
</td>
<td class="num">$ (35)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481956/830-20-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352192171040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Cash Flows from Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 37,867<span></span>
</td>
<td class="nump">$ 34,643<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation expense, intangible asset and other amortization</a></td>
<td class="nump">18,164<span></span>
</td>
<td class="nump">16,410<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">6,831<span></span>
</td>
<td class="nump">5,749<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings of equity method investments</a></td>
<td class="num">(498)<span></span>
</td>
<td class="nump">554<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred taxes, net</a></td>
<td class="nump">1,086<span></span>
</td>
<td class="nump">1,441<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForTradingSecurities', window );">Sales (purchases) of investments, net</a></td>
<td class="nump">5,987<span></span>
</td>
<td class="nump">5,217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingAssets', window );">Accounts receivable, net and other assets</a></td>
<td class="num">(341)<span></span>
</td>
<td class="nump">8,725<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLiabilities', window );">Accrued compensation and benefits, accounts payable, accrued liabilities and other liabilities</a></td>
<td class="num">(120,631)<span></span>
</td>
<td class="num">(115,514)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities of consolidated investment products ("CIP"):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="num">(34,528)<span></span>
</td>
<td class="num">(42,959)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract', window );"><strong>Cash Flows from Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(1,923)<span></span>
</td>
<td class="num">(1,448)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Purchase of equity method investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(11,645)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="num">(2,460)<span></span>
</td>
<td class="num">(13,145)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Cash Flows from Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayments on credit agreement</a></td>
<td class="num">(688)<span></span>
</td>
<td class="num">(688)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Common stock dividends paid</a></td>
<td class="num">(14,929)<span></span>
</td>
<td class="num">(14,083)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common shares</a></td>
<td class="num">(5,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payment of contingent consideration</a></td>
<td class="num">(24,234)<span></span>
</td>
<td class="num">(27,179)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Taxes paid related to net share settlement of restricted stock units</a></td>
<td class="num">(9,854)<span></span>
</td>
<td class="num">(12,209)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vrts_DisposalOfPaymentsForAffiliateEquity', window );">Affiliate equity sales (purchases)</a></td>
<td class="num">(419)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsToMinorityShareholders', window );">Net contributions from (distributions to) noncontrolling interests</a></td>
<td class="nump">16,772<span></span>
</td>
<td class="nump">294<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="num">(56,146)<span></span>
</td>
<td class="num">(115,078)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash, cash equivalents and restricted cash</a></td>
<td class="num">(203)<span></span>
</td>
<td class="nump">180<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="num">(93,337)<span></span>
</td>
<td class="num">(171,002)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, beginning of period</a></td>
<td class="nump">341,014<span></span>
</td>
<td class="nump">589,179<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, end of period</a></td>
<td class="nump">247,677<span></span>
</td>
<td class="nump">418,177<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vrts_NoncashFinancingItemsAbstract', window );"><strong>Non-Cash Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestChangeInRedemptionValue', window );">Increase (decrease) to noncontrolling interests due to consolidation (deconsolidation) of CIP, net</a></td>
<td class="num">(13,624)<span></span>
</td>
<td class="num">(3,447)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vrts_CommonStockDividendsAccruedButNotYetPaid', window );">Common stock dividends payable</a></td>
<td class="nump">13,467<span></span>
</td>
<td class="nump">11,850<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Reconciliation of cash, cash equivalents and restricted cash</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">247,677<span></span>
</td>
<td class="nump">418,177<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=vrts_ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember', window );">Consolidated Entity excluding Consolidated Investment Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtAndEquitySecuritiesGainLoss', window );">Realized and unrealized (gains) losses on investments, net</a></td>
<td class="num">(3,393)<span></span>
</td>
<td class="num">(2,670)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities of consolidated investment products ("CIP"):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtAndEquitySecuritiesGainLoss', window );">Realized and unrealized (gains) losses on investments of CIP, net</a></td>
<td class="num">(3,393)<span></span>
</td>
<td class="num">(2,670)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Reconciliation of cash, cash equivalents and restricted cash</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">123,880<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember', window );">Consolidated Investment Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtAndEquitySecuritiesGainLoss', window );">Realized and unrealized (gains) losses on investments, net</a></td>
<td class="num">(3,732)<span></span>
</td>
<td class="num">(3,844)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities of consolidated investment products ("CIP"):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtAndEquitySecuritiesGainLoss', window );">Realized and unrealized (gains) losses on investments of CIP, net</a></td>
<td class="num">(3,732)<span></span>
</td>
<td class="num">(3,844)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities', window );">Purchases of investments by CIP</a></td>
<td class="num">(304,516)<span></span>
</td>
<td class="num">(320,808)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities', window );">Sales of investments by CIP</a></td>
<td class="nump">323,720<span></span>
</td>
<td class="nump">323,380<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vrts_ProceedsFromPaymentsForOtherInvestmentsOperatingActivities', window );">Net proceeds (purchases) of short-term investments and securities sold short by CIP</a></td>
<td class="nump">206<span></span>
</td>
<td class="num">(218)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Change in other assets and liabilities of CIP</a></td>
<td class="nump">4,722<span></span>
</td>
<td class="nump">3,976<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract', window );"><strong>Cash Flows from Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vrts_IncreaseDecreaseInCashAndCashEquivalentsOfSubsidiariesDueToConsolidation', window );">Change in cash and cash equivalents of CIP due to consolidation (deconsolidation), net</a></td>
<td class="num">(537)<span></span>
</td>
<td class="num">(52)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Cash Flows from Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfOtherDebt', window );">Payments on borrowings by CIP</a></td>
<td class="num">(17,794)<span></span>
</td>
<td class="num">$ (61,213)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Reconciliation of cash, cash equivalents and restricted cash</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">123,030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Cash pledged or on deposit of CIP</a></td>
<td class="nump">$ 767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndEquitySecuritiesGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndEquitySecuritiesGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of assets used to generate operating income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities that result from activities that generate operating income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestChangeInRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in noncontrolling interest during the period as a result of a change in the redemption value of redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Subparagraph 14<br> -Paragraph 3A<br> -Section S99<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-3A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Subparagraph 15<br> -Paragraph 3A<br> -Section S99<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-3A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 16(c)<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestChangeInRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash paid to purchase debt and equity securities, classified as operating activities, during the period; includes trading securities and any other investments classified as operating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForTradingSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from sales and purchases of trading securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForTradingSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from (to) a noncontrolling interest. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received from sale of investments in debt and equity securities, classified as operating activities, during the period; includes trading securities and any other investments classified as operating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfOtherDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for the payment of debt classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfOtherDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vrts_CommonStockDividendsAccruedButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock Dividends Accrued But Not Yet Paid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vrts_CommonStockDividendsAccruedButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vrts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vrts_DisposalOfPaymentsForAffiliateEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Of (Payments For) Affiliate Equity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vrts_DisposalOfPaymentsForAffiliateEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vrts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vrts_IncreaseDecreaseInCashAndCashEquivalentsOfSubsidiariesDueToConsolidation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Cash And Cash Equivalents Of Subsidiaries Due To Consolidation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vrts_IncreaseDecreaseInCashAndCashEquivalentsOfSubsidiariesDueToConsolidation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vrts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vrts_NoncashFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash Financing Items</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vrts_NoncashFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vrts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vrts_ProceedsFromPaymentsForOtherInvestmentsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From (Payments For) Other Investments, Operating Activities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vrts_ProceedsFromPaymentsForOtherInvestmentsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vrts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=vrts_ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=vrts_ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352198461344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Total Attributed To Virtus Investment Partners, Inc.</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Retained Earnings (Accumulated Deficit)</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Non- controlling Interests</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at beginning of period, common stock (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,181,554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Dec. 31, 2022</a></td>
<td class="nump">$ 822,936<span></span>
</td>
<td class="nump">$ 817,019<span></span>
</td>
<td class="nump">$ 120<span></span>
</td>
<td class="nump">$ 1,286,244<span></span>
</td>
<td class="nump">$ 130,261<span></span>
</td>
<td class="num">$ (358)<span></span>
</td>
<td class="num">$ (599,248)<span></span>
</td>
<td class="nump">$ 5,917<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Balance at beginning of period, treasury stock (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,851,693<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net income (loss)</a></td>
<td class="nump">39,389<span></span>
</td>
<td class="nump">38,624<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,624<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">765<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="nump">99<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestPeriodIncreaseDecrease', window );">Net subscriptions (redemptions) and other</a></td>
<td class="num">(300)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(300)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared, common</a></td>
<td class="num">(13,093)<span></span>
</td>
<td class="num">(13,093)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,093)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common shares related to employee stock transactions (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common shares related to employee stock transactions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Taxes paid on stock-based compensation</a></td>
<td class="num">(12,209)<span></span>
</td>
<td class="num">(12,209)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,209)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">7,475<span></span>
</td>
<td class="nump">7,475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at end of period, common stock (in shares) at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,288,394<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Mar. 31, 2023</a></td>
<td class="nump">844,297<span></span>
</td>
<td class="nump">837,915<span></span>
</td>
<td class="nump">$ 121<span></span>
</td>
<td class="nump">1,281,509<span></span>
</td>
<td class="nump">155,792<span></span>
</td>
<td class="num">(259)<span></span>
</td>
<td class="num">$ (599,248)<span></span>
</td>
<td class="nump">6,382<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Balance at end of period, treasury stock (in shares) at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,851,693<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance at Dec. 31, 2022</a></td>
<td class="nump">113,718<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Redeemable Non-controlling Interests [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income (loss)</a></td>
<td class="num">(4,746)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vrts_NoncontrollingInterestSubscriptionsRedemptions', window );">Net subscriptions (redemptions) and other</a></td>
<td class="num">(2,342)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance at Mar. 31, 2023</a></td>
<td class="nump">$ 106,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at beginning of period, common stock (in shares) at Dec. 31, 2023</a></td>
<td class="nump">12,163,228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,087,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Dec. 31, 2023</a></td>
<td class="nump">$ 868,289<span></span>
</td>
<td class="nump">863,926<span></span>
</td>
<td class="nump">$ 122<span></span>
</td>
<td class="nump">1,300,999<span></span>
</td>
<td class="nump">207,356<span></span>
</td>
<td class="num">(87)<span></span>
</td>
<td class="num">$ (644,464)<span></span>
</td>
<td class="nump">4,363<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Balance at beginning of period, treasury stock (in shares) at Dec. 31, 2023</a></td>
<td class="nump">5,075,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,075,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net income (loss)</a></td>
<td class="nump">$ 30,249<span></span>
</td>
<td class="nump">29,858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">391<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="num">(100)<span></span>
</td>
<td class="num">(100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestPeriodIncreaseDecrease', window );">Net subscriptions (redemptions) and other</a></td>
<td class="num">(403)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(403)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared, common</a></td>
<td class="num">(14,191)<span></span>
</td>
<td class="num">(14,191)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,191)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchases of common shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Repurchases of common shares</a></td>
<td class="num">(4,999)<span></span>
</td>
<td class="num">(4,999)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,999)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common shares related to employee stock transactions (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,261<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common shares related to employee stock transactions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Taxes paid on stock-based compensation</a></td>
<td class="num">(9,852)<span></span>
</td>
<td class="num">(9,852)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,852)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">$ 7,010<span></span>
</td>
<td class="nump">7,010<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,010<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at end of period, common stock (in shares) at Mar. 31, 2024</a></td>
<td class="nump">12,224,489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,127,881<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Mar. 31, 2024</a></td>
<td class="nump">$ 876,003<span></span>
</td>
<td class="nump">$ 871,652<span></span>
</td>
<td class="nump">$ 122<span></span>
</td>
<td class="nump">$ 1,298,157<span></span>
</td>
<td class="nump">$ 223,023<span></span>
</td>
<td class="num">$ (187)<span></span>
</td>
<td class="num">$ (649,463)<span></span>
</td>
<td class="nump">$ 4,351<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Balance at end of period, treasury stock (in shares) at Mar. 31, 2024</a></td>
<td class="nump">5,096,608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,096,608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance at Dec. 31, 2023</a></td>
<td class="nump">$ 104,869<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Redeemable Non-controlling Interests [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income (loss)</a></td>
<td class="nump">7,618<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vrts_NoncontrollingInterestSubscriptionsRedemptions', window );">Net subscriptions (redemptions) and other</a></td>
<td class="nump">2,698<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance at Mar. 31, 2024</a></td>
<td class="nump">$ 115,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (3)<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-3A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 40: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 41: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-15<br><br>Reference 42: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16<br><br>Reference 43: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.27(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityNetIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of net income or loss attributable to temporary equity interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityNetIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vrts_NoncontrollingInterestSubscriptionsRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Subscriptions (Redemptions)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vrts_NoncontrollingInterestSubscriptionsRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vrts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352284167184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Changes in Stockholders' Equity (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 21, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Cash dividends declared per common share (in dollars per share)</a></td>
<td class="nump">$ 1.90<span></span>
</td>
<td class="nump">$ 1.90<span></span>
</td>
<td class="nump">$ 1.65<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352192536240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Business<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Organization and Business</a></td>
<td class="text">Organization and Business<div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Virtus Investment Partners, Inc. (the "Company," "we," "us," "our" or "Virtus"), a Delaware corporation, operates in the investment management industry through its subsidiaries.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides investment management and related services to institutions and individuals.  The Company's investment strategies are offered to institutional clients through institutional separate and commingled accounts, including structured products.  The Company&#8217;s retail investment management services are provided to individuals through products consisting of: mutual funds registered pursuant to the Investment Company Act of 1940, as amended ("U.S. retail funds"); Undertaking for Collective Investment in Transferable Securities and Qualifying Investor Funds (collectively, "global funds") and collectively with U.S. retail funds, variable insurance funds, and exchange-traded funds ("ETFs"), (the "open-end funds"); closed-end funds (collectively, with open-end funds, the "funds"); and retail separate accounts that include intermediary-sold and private client accounts.  The Company also provides subadvisory services to other investment advisers.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//275/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352191664272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation and Significant Accounting Policies</a></td>
<td class="text">Basis of Presentation and Significant Accounting Policies<div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") for interim financial information.  Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements.  In the opinion of management, these financial statements contain all adjustments, consisting only of normal recurring adjustments, necessary for a fair statement of the Company&#8217;s financial condition and results of operations.  Operating results for the three months ended March&#160;31, 2024 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2024.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2023 (the "2023 Annual Report on Form 10-K") filed with the Securities and Exchange Commission (the "SEC").  The Company&#8217;s significant accounting policies, which have been consistently applied, are summarized in its 2023 Annual Report on Form 10-K.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Standards Not Yet Implemented</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the Financial Accounting Standards Board (the "FASB") issued Accounting Standards Update ("ASU") 2023-07, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting (Topic 280)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  This standard updates reportable segment disclosure requirements, clarifies circumstances in which an entity can disclose multiple segment measures of profit or loss and provides new segment disclosure requirements for entities with a single reportable segment.  This standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024.  Early adoption is permitted, with the amendments to be applied retrospectively to all prior periods presented in the financial statements.  The Company is in the process of evaluating the impact of adopting this standard and, at this time, does not anticipate it will have a material impact on its consolidated financial statements.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740).</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  This standard updates income tax disclosure requirements by requiring disaggregated information about a reporting entity's effective tax rate reconciliation as well as information on income taxes paid.  This standard is effective for fiscal years beginning after December 15, 2024.  Early adoption is permitted.  The Company is in the process of evaluating the impact of adopting this standard and, at this time, does not anticipate it will have a material impact on its consolidated financial statements.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2024, the FASB issued ASU 2024-01, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Stock Compensation (Topic 718), Scope Application of Profits Interest and Similar Awards.  </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This standard provides clarity regarding whether profits interest and similar awards are within the scope of Topic 718 of the Accounting Standards Codification.  This standard is effective for fiscal years beginning after December 15, 2024.  Early adoption is permitted.  The Company is in the process of evaluating the impact of adopting this standard and, at this time, does not anticipate it will have a material impact on its consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352195455280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenues</a></td>
<td class="text">Revenues<div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's revenues are recognized when a performance obligation is satisfied, which occurs when control of the services is transferred to customers.  Investment management fees, distribution and service fees, and administration and shareholder service fees are generally calculated as a percentage of average net assets of the investment portfolios managed.  The net asset values from which these fees are calculated are variable in nature and subject to factors outside of the Company's control, such as additional investments, withdrawals and market performance.  Because of this, these fees are considered constrained until the end of the contractual measurement period (monthly or quarterly), which is when asset values are generally determinable.</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investment Management Fees by Source&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes investment management fees by source:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.444%"><tr><td style="width:1.0%"></td><td style="width:61.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.215%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.852%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.218%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investment management fees</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Open-end funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Closed-end funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retail separate accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,079&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Institutional accounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,305&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total investment management fees</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">188,360</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">164,478</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-15<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352188000112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisitions</a></td>
<td class="text">Acquisitions<div style="margin-bottom:3pt;padding-left:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">AlphaSimplex Group, LLC</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2023, the Company completed the acquisition of AlphaSimplex Group, LLC ("AlphaSimplex"), which was accounted for in accordance with Accounting Standards Codification ("ASC") 805, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">("ASC 805"). </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price paid of $113.4&#160;million was allocated to the assets acquired and liabilities assumed based upon their estimated fair values at the date of the acquisition.  Goodwill of $48.3&#160;million and intangible assets of $55.4&#160;million were recorded for the acquisition.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//805/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352191664272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets, Net</a></td>
<td class="text">Intangible Assets, Net<div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of intangible assets, net:</span></div><div style="margin-bottom:3pt;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.473%"><tr><td style="width:1.0%"></td><td style="width:30.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.971%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.616%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.971%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.616%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.971%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.616%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.971%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.616%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.980%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Definite-Lived</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Indefinite-Lived</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Book Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Book Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Book Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Book Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances at December 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">806,655&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(416,834)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389,821&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432,119&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,335)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,335)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,335)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances at March 31, 2024</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">806,655</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(432,169)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">374,486</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">42,298</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">416,784</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Definite-lived intangible asset amortization for the remainder of fiscal year 2024 and succeeding fiscal years is estimated as follows: </span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.912%"><tr><td style="width:1.0%"></td><td style="width:53.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.631%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.857%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount<br/></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,964&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 and thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">374,486</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//350-30/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352192475232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsAbstract', window );"><strong>Schedule of Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTextBlock', window );">Investments</a></td>
<td class="text">Investments<div style="margin-bottom:5pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments consist primarily of investments in the Company's sponsored products.  The Company's investments, excluding the assets of consolidated investment products ("CIP") discussed in Note 16, at March&#160;31, 2024 and December&#160;31, 2023 were as follows:</span></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.602%"><tr><td style="width:1.0%"></td><td style="width:62.616%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.599%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.684%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment securities - fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,497&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonqualified retirement plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,682&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">127,448</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">132,696</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:63pt;padding-right:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The Company's equity method investments are valued on a three-month lag based upon the availability of financial information.</span></div><div style="margin-bottom:3pt;text-indent:11.25pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investment Securities - fair value</span></div><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment securities - fair value consist of investments in the Company's sponsored funds and separately managed accounts.  The composition of the Company&#8217;s investment securities - fair value was as follows:</span></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.304%"><tr><td style="width:1.0%"></td><td style="width:39.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.303%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.627%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.972%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.627%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.972%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.627%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.978%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investment Securities - fair value</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sponsored funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,067&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,794&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,983&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,353&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,871&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total investment securities - fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">85,942</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">90,497</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">97,147</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">97,304</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2024 and 2023, the Company recognized net realized losses of $0.4&#160;million and net realized gains $1.3&#160;million, respectively, related to its investment securities - fair value.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//320/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Topic 321<br> -Publisher FASB<br> -URI https://asc.fasb.org//321/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Topic 325<br> -Publisher FASB<br> -URI https://asc.fasb.org//325/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352188211056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div style="margin-bottom:5pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s assets and liabilities measured at fair value on a recurring basis, excluding the assets and liabilities of CIP discussed in Note 16, as of March&#160;31, 2024 and December&#160;31, 2023 by fair value hierarchy level were as follows:</span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">March&#160;31, 2024 &#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investment securities - fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sponsored funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,983&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,983&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonqualified retirement plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">196,698</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">196,698</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,708&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,708&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41,708</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41,708</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December&#160;31, 2023 </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investment securities - fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sponsored funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,871&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,871&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonqualified retirement plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">307,226</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">307,226</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">56,200</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">56,200</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a discussion of the valuation methodologies used for the Company&#8217;s assets measured at fair value:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash equivalents </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">represent investments in money market funds.  Cash investments in money market funds are valued using published net asset values and are classified as Level 1.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sponsored funds </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">represent investments in open-end funds, closed-end funds and ETFs for which the Company acts as the investment manager.  The fair value of open-end funds is determined based on their published net asset values and are categorized as Level 1.  The fair value of closed-end funds and ETFs is determined based on the official closing price on the exchange on which they are traded and are categorized as Level 1.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity securities</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> represent securities traded on active markets, are valued at the official closing price (typically the last sale or bid) on the exchange on which the securities are primarily traded and are categorized as Level 1.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nonqualified retirement plan assets </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">represent mutual funds within the Company's nonqualified retirement plan whose fair value is determined based on their published net asset value and are categorized as Level 1.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent consideration </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">represents</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">liabilities associated with the Company's Westchester Capital Management ("WCM") and NFJ Investment Group ("NFJ")  transactions .  The continent consideration related to the WCM transaction as of March&#160;31, 2024 was $11.1&#160;million and represents the fair value of future potential earn-out payments based on pre-established performance metrics related to revenue growth rates.  The estimated fair value of the WCM liability is measured using an options pricing model valuation technique utilizing unobservable market data inputs prepared with the assistance of an independent valuation firm.  The most significant unobservable inputs used relate to the aforementioned revenue growth rates, discount rate (range of 6%-7%) and the market price of risk adjustment (9%).  The NFJ contingent consideration liability as of March&#160;31, 2024 was $30.6&#160;million and represents the fair value of the projected future revenue participation payments.  The NFJ revenue participation payments consist of variable payments based on a percentage of the investment management fees earned on certain NFJ managed assets.  The estimated fair value of the NFJ liability is measured using an options pricing model valuation technique utilizing unobservable market data inputs prepared with the assistance of an independent valuation firm.  The most significant unobservable inputs used relate to the revenue growth rates, discount rates (range of 6% - 7%) and the market price of risk adjustment (7%).  These liabilities are categorized as Level 3. </span></div><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of beginning and ending balances of the Company's contingent consideration liabilities:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.801%"><tr><td style="width:1.0%"></td><td style="width:75.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.031%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.034%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,200&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reduction for payments made</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,492)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,390)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent consideration, end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41,708</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">61,710</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, accounts receivable, accounts payable and accrued liabilities equal or approximate fair value based on the short-term nature of these instruments.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352188206592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Transactions<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Equity Transactions</a></td>
<td class="text">Equity Transactions <div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends Declared</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 21, 2024, the Company declared a quarterly cash dividend of $1.90 per common share to be paid on May 15, 2024 to shareholders of record at the close of business on April 30, 2024. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock Repurchases</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2024, the Company repurchased 21,108 common shares at a weighted average price of $236.84 per share for a total cost, including fees and expenses, of $5.0 million under its share repurchase program.  As of March&#160;31, 2024, 583,437 shares remained available for repurchase.  Under the terms of the program, the Company may repurchase shares of its common stock from time to time at its discretion through open market repurchases, privately negotiated transactions and/or other mechanisms, depending on price and prevailing market and business conditions.  The program, which has no specified term, may be suspended or terminated at any time.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352284159744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Loss)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text">Accumulated Other Comprehensive Income (Loss)<div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in accumulated other comprehensive income (loss) were as follows: </span></div><div style="margin-bottom:3pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.842%"><tr><td style="width:1.0%"></td><td style="width:74.994%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.641%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.978%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(358)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss) (1)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at end of period</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(187)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(259)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:54pt;padding-right:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;Consists of foreign currency translation adjustments, net of tax of $36 and $(35) for the </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> months ended March&#160;31, 2024 and 2023, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//220/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352195085024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">Stock-Based Compensation<div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity-based awards, including restricted stock units ("RSUs"), performance stock units ("PSUs"), stock options and unrestricted shares of common stock, may be granted to officers, employees and directors of the Company pursuant to the Company's Omnibus Incentive and Equity Plan (the "Omnibus Plan").  At March&#160;31, 2024, 375,169 shares of common stock remained available for issuance of the 3,370,000 shares that are authorized for issuance under the Omnibus Plan. </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:5pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense is summarized as follows:</span></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:58.771%"><tr><td style="width:1.0%"></td><td style="width:61.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.059%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.061%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,831&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,749&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each RSU entitles the holder to one share of common stock when the restriction expires.  RSUs may be time-vested or performance-contingent PSUs that convert into RSUs after performance measurement is complete and generally vest in <span style="-sec-ix-hidden:f-529">one</span> to three years.  Shares that are issued upon vesting are newly issued shares from the Omnibus Plan and are not issued from treasury stock.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSU activity, inclusive of PSUs, for the three months ended March&#160;31, 2024 is summarized as follows:&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:76.169%"><tr><td style="width:1.0%"></td><td style="width:58.017%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.861%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.863%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number<br/>of&#160;Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant&#160;Date<br/>Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344,717&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204.48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,658&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,333)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261.65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103,849)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229.92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at March 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">341,193</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">205.10</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2024 and 2023, a total of 42,588 and 70,716 RSUs, respectively, were withheld by the Company as a result of net share settlements to settle minimum employee tax withholding obligations and for which the Company paid $9.9 million and $12.2 million respectively, in minimum employee tax withholding obligations.  These net share settlements had the effect of share repurchases by the Company as they reduced the number of shares that would have otherwise been issued as a result of the vesting.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2024 and 2023, the Company granted 26,733 and 44,291 PSUs, respectively, that contain performance-based metrics in addition to a service condition.  Compensation expense for PSUs is generally recognized over a three-year service period based upon the value determined using a combination of (i) the intrinsic value method for awards that contain a performance metric that represents a "performance condition" in accordance with ASC 718, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Compensation </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">("ASC 718") and (ii) the Monte Carlo simulation valuation model for awards that contain a "market condition" performance metric under ASC 718.  Compensation expense for PSU awards that contain a market condition is fixed at the date of grant and will not be adjusted in future periods based upon the achievement of the market condition.  Compensation expense for PSU awards with a performance condition is recorded each period based upon a probability assessment of the expected outcome of the performance metric with a final adjustment upon measurement at the end of the performance period.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2024, unamortized stock-based compensation expense for unvested RSUs and PSUs was $45.5 million with a weighted-average remaining contractual life of 1.6 years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352188215392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Share<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings (Loss) Per Share</a></td>
<td class="text">Earnings (Loss) Per Share<div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings (loss) per share ("EPS") is calculated in accordance with ASC 260, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings per Share</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Basic EPS is computed by dividing net income (loss) attributable to Virtus Investment Partners, Inc. by the weighted-average number of common shares outstanding for the period, excluding dilution for potential common stock issuances.  Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock, including shares issuable upon the vesting of RSUs and stock option exercises using the treasury stock method, as determined under the if-converted method.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The computation of basic and diluted EPS is as follows:&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.748%"><tr><td style="width:1.0%"></td><td style="width:77.168%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Income (Loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,867&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,643&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,009)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Income (Loss) Attributable to Virtus Investment Partners, Inc.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,858&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,624&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic: Weighted-average number of shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: Incremental shares from assumed conversion of dilutive instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted: Weighted-average number of shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,287&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,410&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (Loss) per Share&#8212;Basic</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.19</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.33</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (Loss) per Share&#8212;Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.10</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.21</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table details the securities that have been excluded from the above computation of weighted-average number of shares for diluted EPS, because the effect would be anti-dilutive.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.871%"><tr><td style="width:1.0%"></td><td style="width:76.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.435%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.438%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total anti-dilutive securities</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">40</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352188208064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In calculating the provision for income taxes, the Company uses an estimate of the annual effective tax rate based upon the facts and circumstances at each interim period.  On a quarterly basis, the estimated annual effective tax rate is adjusted, as appropriate, based upon changes in facts and circumstances, if any, compared to those forecasted at the beginning of the fiscal year and at each interim period thereafter.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes reflected U.S. federal, state and local taxes at an estimated effective tax rate of 18.9% and 20.1% for the three months ended March&#160;31, 2024 and 2023, respectively.  The lower estimated effective tax rate for the three months ended March 31, 2024 was primarily due to excess tax benefits associated with stock-based compensation and the change in valuation allowances in the current year related to the tax effects of unrealized gains on certain Company investments.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352305636352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text">Debt<div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Agreement </span></div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's credit agreement, as amended (the "Credit Agreement"), comprises (i) a $275.0 million term loan with a seven-year term (the "Term Loan") expiring in September 2028, and (ii) a $175.0 million revolving credit facility with a five-year term expiring in September 2026.  The Company repaid $0.7&#160;million outstanding under the Term Loan during the three months ended March&#160;31, 2024 and had $258.1 million outstanding under the Term Loan at March&#160;31, 2024.  In accordance with ASC 835, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest</span>, the amounts outstanding under the Company's Term Loan are presented on the Condensed Consolidated Balance Sheet net of related debt issuance costs, which were $5.1 million as of March&#160;31, 2024.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//470/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352191023600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Matters</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved from time to time in litigation and arbitration, as well as examinations, inquiries and investigations by various regulatory bodies, involving its compliance with, among other things, securities laws, client investment guidelines, laws governing the activities of broker-dealers and other laws and regulations affecting its products and other activities.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records a liability when it is both probable that a liability has been incurred and the amount of the liability can be reasonably estimated.  Significant judgment is required in both the determination of probability and the determination as to whether a loss is reasonably estimable.  Based on information currently available, available insurance coverage, indemnities and established reserves, the Company believes that the outcomes of its legal and regulatory proceedings are not likely, either individually or in the aggregate, to have a material adverse effect on the Company's results of operations, cash flows or its consolidated financial condition.  However, in the event of unexpected subsequent developments, and given the inherent unpredictability of these legal and regulatory matters, the Company can provide no assurance that its assessment of any legal matter will reflect the ultimate outcome, and an adverse outcome in certain matters could have a material adverse effect on the Company's results of operations or cash flows in particular quarterly or annual periods.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352287391152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDisclosureTextBlock', window );">Redeemable Noncontrolling Interests</a></td>
<td class="text">Redeemable Noncontrolling Interests<div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redeemable noncontrolling interests represent third-party investments in the Company's CIP and minority interests held in a consolidated affiliate.  Minority interests held in the affiliate are subject to holder put rights and Company call rights at established multiples of earnings before interest, taxes, depreciation and amortization and, as such, are considered redeemable at other than fair value.  The rights are exercisable at pre-established intervals or upon certain conditions, such as retirement.  The put and call rights are not legally detachable or separately exercisable and are deemed to be embedded in the related noncontrolling interests.  The Company, in purchasing affiliate equity, has the option to settle in cash or shares of the Company's common stock and is entitled to the cash flow associated with any purchased equity.  These minority interests in the affiliate are recorded at estimated redemption value within redeemable noncontrolling interests on the Company's Condensed Consolidated Balance Sheets, and any changes in the estimated redemption value are recorded on the Condensed Consolidated Statements of Operations within noncontrolling interests.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redeemable noncontrolling interests for the three months ended March&#160;31, 2024 included the following amounts:</span></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.906%"><tr><td style="width:1.0%"></td><td style="width:50.881%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.143%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.143%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.147%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CIP</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Affiliate Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances at December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,643&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,869&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to noncontrolling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,829&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in redemption value (1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net income (loss) attributable to noncontrolling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,429&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,189&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,618&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Affiliate equity sales (purchases)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(419)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(419)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net subscriptions (redemptions) and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances at March 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">35,189</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">79,996</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">115,185</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;Relates to noncontrolling interests redeemable at other than fair value.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//810/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352195067904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialStatementsTextBlock', window );">Consolidation</a></td>
<td class="text">Consolidation<div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include the accounts of the Company, its subsidiaries and investment products that are consolidated.  A voting interest entity ("VOE") is consolidated when the Company is considered to have a controlling financial interest, which is typically present when the Company owns a majority of the voting interest in an entity or otherwise has the power to govern the financial and operating policies of the entity.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates any variable interest entity ("VIE") in which the Company has a variable interest for consolidation.  A VIE is an entity in which either (i) the equity investment at risk is not sufficient to permit the entity to finance its own activities without additional financial support, or (ii) where as a group, the holders of the equity investment at risk do not possess any one of the following: (a) the power through voting or similar rights to direct the activities that most significantly impact the entity's economic performance, (b) the obligation to absorb expected losses or the right to receive expected residual returns of the entity, or (c) proportionate voting and economic interests and where substantially all of the entity's activities either involve or are conducted on behalf of an investor with disproportionately fewer voting rights.  If an entity has any of these characteristics, it is considered a VIE and is required to be consolidated by its primary beneficiary.  The primary beneficiary is the entity that has both the power to direct the activities that most significantly impact the VIE's economic performance and has the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of its business, the Company sponsors various investment products, some of which are consolidated by the Company.  CIP includes both VOEs, made up primarily of U.S. retail funds and ETFs in which the Company holds a controlling financial interest, and VIEs, which consist of collateralized loan obligations ("CLO") and certain global and private funds ("GF") of which the Company is considered the primary beneficiary.  The consolidation and deconsolidation of these investment products have no impact on the Company's net income (loss).  The Company's risk with respect to these investment products is limited to its beneficial interests in these products.  The Company has no right to the benefits from, and does not bear the risks associated with, these investment products beyond the Company's investments in, and fees generated from, these products.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the balances of CIP that, after intercompany eliminations, were reflected on the Condensed Consolidated Balance Sheets as of March&#160;31, 2024 and December&#160;31, 2023:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.321%"><tr><td style="width:1.0%"></td><td style="width:30.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.102%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.873%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.096%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.873%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.096%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.873%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.102%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.026%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.096%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.026%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.103%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">VOEs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">VIEs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">VOEs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">VIEs</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CLOs </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GFs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CLOs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GFs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,914&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,612&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,223&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,088&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,591&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,962,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,937&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,985&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,972,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,064&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,985&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,922,051)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,922,243)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securities purchased payable and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,019)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88,270)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,999)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(740)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89,167)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(616)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,311)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,351)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,878)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,316)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,363)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,327)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net interests in CIP</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29,148</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">98,003</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">56,840</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24,326</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">96,655</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">58,607</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consolidated CLOs</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the Company's CIP that are VIEs are CLOs.  The financial information of certain CLOs is included on the Company's condensed consolidated financial statements on a one-month lag based upon the availability of their financial information.  A majority-owned consolidated private fund, whose primary purpose is to invest in CLOs for which the Company serves as the collateral manager, is also included.  At March&#160;31, 2024, the Company consolidated seven CLOs.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments of CLOs</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CLOs held investments of $2.0 billion at March&#160;31, 2024, consisting of bank loan investments that comprise the majority of the CLOs' portfolio asset collateral and are senior secured corporate loans across a variety of industries.  These bank loan investments mature at various dates between 2024 and 2032 and generally pay interest at SOFR plus a spread.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Notes Payable of CLOs</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CLOs held notes payable with a total value, at par, of $2.1 billion at March&#160;31, 2024, consisting of senior secured floating rate notes payable with a par value of $1.9 billion and subordinated notes with a par value of $215.1 million.  These note obligations bear interest at variable rates based on SOFR plus a pre-defined spread. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's beneficial interests and maximum exposure to loss related to these consolidated CLOs is limited to (i) ownership in the subordinated notes and (ii) accrued management fees.  The secured notes of the consolidated CLOs have contractual recourse only to the related assets of the CLO and are classified as financial liabilities.  Although these beneficial interests are eliminated upon consolidation, the application of the measurement alternative prescribed by ASU 2014-13, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidation (Topic 810)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASU 2014-13"), results in the net assets of the consolidated CLOs shown above to be equivalent to the beneficial interests retained by the Company at March&#160;31, 2024, as shown in the table below:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.818%"><tr><td style="width:1.0%"></td><td style="width:70.053%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.747%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subordinated notes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,416&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued investment management fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Beneficial Interests</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">98,003</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents income and expenses of the consolidated CLOs included on the Company&#8217;s Condensed Consolidated Statements of Operations for the period indicated:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.719%"><tr><td style="width:1.0%"></td><td style="width:67.897%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.903%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized gain (loss), net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,280&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,281&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,510&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(391)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Income (Loss) Attributable to CLOs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,380</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the Company&#8217;s own economic interests in the consolidated CLOs, which are eliminated upon consolidation:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.719%"><tr><td style="width:1.0%"></td><td style="width:67.897%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.903%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions received and unrealized gains (losses) on the subordinated notes held by the Company</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,083&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment management fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Economic Interests</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,380</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:36pt;text-indent:11.25pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements of CIP</span></div><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assets and liabilities of CIP measured at fair value on a recurring basis as of March&#160;31, 2024 and December&#160;31, 2023 by fair value hierarchy level were as follows:</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As of March&#160;31, 2024 </span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.812%"><tr><td style="width:1.0%"></td><td style="width:45.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.479%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.798%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.479%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.800%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,914&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,914&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,003,579&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,551&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,051,130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,095&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">149,383</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,003,963</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47,793</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,201,139</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,922,051&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,922,051&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">485</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,922,051</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,922,536</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As of December&#160;31, 2023 </span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.812%"><tr><td style="width:1.0%"></td><td style="width:45.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.479%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.798%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.479%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.800%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,012,760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,616&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,049,617&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,096&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">130,984</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,012,768</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">37,062</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,180,814</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,922,243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,922,243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">518</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,922,243</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,922,761</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a discussion of the valuation methodologies used for the assets and liabilities of the Company&#8217;s CIP measured at fair value:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 assets represent cash investments in money market funds and debt and equity investments that are valued using published net asset values or the official closing price on the exchange on which the securities are traded.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 assets represent most debt securities (including bank loans) and certain equity securities (including non-U.S. securities), for which closing prices are not readily available or are deemed to not reflect readily available market prices, and are valued using an independent pricing service.  Debt investments, other than bank loans, are valued based on quotations received from independent pricing services or from dealers who make markets in such securities.  Bank loan investments, which are included as debt investments, are generally priced at the average mid-point of bid and ask quotations obtained from a third-party pricing service.  Fair value may also be based upon valuations obtained from independent third-party brokers or dealers utilizing matrix pricing models that consider information regarding securities with similar characteristics.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 assets include debt and equity securities that are not widely traded, are illiquid or are priced by dealers based on pricing models used by market makers in the security.  These securities are valued using unadjusted prices from an independent pricing service.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 liabilities consist of short sales transactions in which a security is sold that is not owned or is owned but there is no intention to deliver, in anticipation that the price of the security will decline.  Short sales are recorded on the Condensed Consolidated Balance Sheets within other liabilities of CIP and are classified as Level 1 based on the underlying equity security.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 liabilities consist of notes payable issued by CLOs and are measured using the measurement alternative in ASU 2014-13.  Accordingly, the fair value of CLO liabilities was measured as the fair value of CLO assets less the sum of (i) the fair value of the beneficial interests held by the Company, and (ii) the carrying value of any beneficial interests that represent compensation for services.  The fair value of the beneficial interests held by the Company is based on third-party pricing information without adjustment.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The securities purchased payable at March&#160;31, 2024 and December&#160;31, 2023 approximated fair value due to the short-term nature of the instruments. </span></div><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a reconciliation of assets of CIP for Level 3 investments for which significant unobservable inputs were used to determine fair value:</span></div><div style="margin-bottom:3pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.912%"><tr><td style="width:1.0%"></td><td style="width:64.890%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.926%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.343%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,062&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,581&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized gains (losses), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(324)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,625)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,195)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers to Level 2</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,468)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,747)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers from Level 2</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,904&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at end of period (1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47,793</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,658</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:108pt;padding-right:90pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8pt">The investments that are categorized as Level 3 were valued utilizing third-party pricing information without adjustment.  Transfers in and/or out of levels are reflected when significant inputs, including market inputs or performance attributes, used for the fair value measurement become observable/unobservable at period end.</span></div><div style="text-indent:11.25pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nonconsolidated VIEs</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company serves as the collateral manager for other CLOs that are not consolidated.  The assets and liabilities of these CLOs reside in bankruptcy remote, special purpose entities in which the Company has no ownership of, nor holds any notes issued by, the CLOs, and provides neither recourse nor guarantees.  The Company has determined that the investment management fees it receives for serving as collateral manager for these CLOs did not represent a variable interest as (i) the fees the Company earns are compensation for services provided and are commensurate with the level of effort required to provide the investment management services, (ii) the Company does not hold other interests in the CLOs that individually, or in the aggregate, would absorb more than an insignificant amount of the CLOs' expected losses or receive more than an insignificant amount of the CLOs' expected residual return, and (iii) the investment management arrangement only includes terms, conditions and amounts that are customarily present in arrangements for similar services negotiated at arm's length. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div>The Company has interests in certain other VIEs that the Company does not consolidate as it is not the primary beneficiary since its interest in these entities does not provide the Company with the power to direct the activities that most significantly impact the entities' economic performance.  At March&#160;31, 2024, the carrying value and maximum risk of loss related to the Company's interest in these VIEs was $29.1 million.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialStatementsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for condensed financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 04<br> -Paragraph a<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialStatementsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352195582224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352289382336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") for interim financial information.  Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements.  In the opinion of management, these financial statements contain all adjustments, consisting only of normal recurring adjustments, necessary for a fair statement of the Company&#8217;s financial condition and results of operations.  Operating results for the three months ended March&#160;31, 2024 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2024.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2023 (the "2023 Annual Report on Form 10-K") filed with the Securities and Exchange Commission (the "SEC").  The Company&#8217;s significant accounting policies, which have been consistently applied, are summarized in its 2023 Annual Report on Form 10-K.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Standards Not Yet Implemented</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Standards Not Yet Implemented</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the Financial Accounting Standards Board (the "FASB") issued Accounting Standards Update ("ASU") 2023-07, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting (Topic 280)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  This standard updates reportable segment disclosure requirements, clarifies circumstances in which an entity can disclose multiple segment measures of profit or loss and provides new segment disclosure requirements for entities with a single reportable segment.  This standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024.  Early adoption is permitted, with the amendments to be applied retrospectively to all prior periods presented in the financial statements.  The Company is in the process of evaluating the impact of adopting this standard and, at this time, does not anticipate it will have a material impact on its consolidated financial statements.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740).</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  This standard updates income tax disclosure requirements by requiring disaggregated information about a reporting entity's effective tax rate reconciliation as well as information on income taxes paid.  This standard is effective for fiscal years beginning after December 15, 2024.  Early adoption is permitted.  The Company is in the process of evaluating the impact of adopting this standard and, at this time, does not anticipate it will have a material impact on its consolidated financial statements.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2024, the FASB issued ASU 2024-01, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Stock Compensation (Topic 718), Scope Application of Profits Interest and Similar Awards.  </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This standard provides clarity regarding whether profits interest and similar awards are within the scope of Topic 718 of the Accounting Standards Codification.  This standard is effective for fiscal years beginning after December 15, 2024.  Early adoption is permitted.  The Company is in the process of evaluating the impact of adopting this standard and, at this time, does not anticipate it will have a material impact on its consolidated financial statements.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's revenues are recognized when a performance obligation is satisfied, which occurs when control of the services is transferred to customers.  Investment management fees, distribution and service fees, and administration and shareholder service fees are generally calculated as a percentage of average net assets of the investment portfolios managed.  The net asset values from which these fees are calculated are variable in nature and subject to factors outside of the Company's control, such as additional investments, withdrawals and market performance.  Because of this, these fees are considered constrained until the end of the contractual measurement period (monthly or quarterly), which is when asset values are generally determinable.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a discussion of the valuation methodologies used for the Company&#8217;s assets measured at fair value:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash equivalents </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">represent investments in money market funds.  Cash investments in money market funds are valued using published net asset values and are classified as Level 1.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sponsored funds </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">represent investments in open-end funds, closed-end funds and ETFs for which the Company acts as the investment manager.  The fair value of open-end funds is determined based on their published net asset values and are categorized as Level 1.  The fair value of closed-end funds and ETFs is determined based on the official closing price on the exchange on which they are traded and are categorized as Level 1.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity securities</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> represent securities traded on active markets, are valued at the official closing price (typically the last sale or bid) on the exchange on which the securities are primarily traded and are categorized as Level 1.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nonqualified retirement plan assets </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">represent mutual funds within the Company's nonqualified retirement plan whose fair value is determined based on their published net asset value and are categorized as Level 1.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent consideration </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">represents</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">liabilities associated with the Company's Westchester Capital Management ("WCM") and NFJ Investment Group ("NFJ")  transactions .  The continent consideration related to the WCM transaction as of March&#160;31, 2024 was $11.1&#160;million and represents the fair value of future potential earn-out payments based on pre-established performance metrics related to revenue growth rates.  The estimated fair value of the WCM liability is measured using an options pricing model valuation technique utilizing unobservable market data inputs prepared with the assistance of an independent valuation firm.  The most significant unobservable inputs used relate to the aforementioned revenue growth rates, discount rate (range of 6%-7%) and the market price of risk adjustment (9%).  The NFJ contingent consideration liability as of March&#160;31, 2024 was $30.6&#160;million and represents the fair value of the projected future revenue participation payments.  The NFJ revenue participation payments consist of variable payments based on a percentage of the investment management fees earned on certain NFJ managed assets.  The estimated fair value of the NFJ liability is measured using an options pricing model valuation technique utilizing unobservable market data inputs prepared with the assistance of an independent valuation firm.  The most significant unobservable inputs used relate to the revenue growth rates, discount rates (range of 6% - 7%) and the market price of risk adjustment (7%).  These liabilities are categorized as Level 3. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a discussion of the valuation methodologies used for the assets and liabilities of the Company&#8217;s CIP measured at fair value:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 assets represent cash investments in money market funds and debt and equity investments that are valued using published net asset values or the official closing price on the exchange on which the securities are traded.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 assets represent most debt securities (including bank loans) and certain equity securities (including non-U.S. securities), for which closing prices are not readily available or are deemed to not reflect readily available market prices, and are valued using an independent pricing service.  Debt investments, other than bank loans, are valued based on quotations received from independent pricing services or from dealers who make markets in such securities.  Bank loan investments, which are included as debt investments, are generally priced at the average mid-point of bid and ask quotations obtained from a third-party pricing service.  Fair value may also be based upon valuations obtained from independent third-party brokers or dealers utilizing matrix pricing models that consider information regarding securities with similar characteristics.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 assets include debt and equity securities that are not widely traded, are illiquid or are priced by dealers based on pricing models used by market makers in the security.  These securities are valued using unadjusted prices from an independent pricing service.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 liabilities consist of short sales transactions in which a security is sold that is not owned or is owned but there is no intention to deliver, in anticipation that the price of the security will decline.  Short sales are recorded on the Condensed Consolidated Balance Sheets within other liabilities of CIP and are classified as Level 1 based on the underlying equity security.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 liabilities consist of notes payable issued by CLOs and are measured using the measurement alternative in ASU 2014-13.  Accordingly, the fair value of CLO liabilities was measured as the fair value of CLO assets less the sum of (i) the fair value of the beneficial interests held by the Company, and (ii) the carrying value of any beneficial interests that represent compensation for services.  The fair value of the beneficial interests held by the Company is based on third-party pricing information without adjustment.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vrts_NoncontrollingInterestPolicyTextBlock', window );">Noncontrolling Interest</a></td>
<td class="text">Redeemable noncontrolling interests represent third-party investments in the Company's CIP and minority interests held in a consolidated affiliate.  Minority interests held in the affiliate are subject to holder put rights and Company call rights at established multiples of earnings before interest, taxes, depreciation and amortization and, as such, are considered redeemable at other than fair value.  The rights are exercisable at pre-established intervals or upon certain conditions, such as retirement.  The put and call rights are not legally detachable or separately exercisable and are deemed to be embedded in the related noncontrolling interests.  The Company, in purchasing affiliate equity, has the option to settle in cash or shares of the Company's common stock and is entitled to the cash flow associated with any purchased equity.  These minority interests in the affiliate are recorded at estimated redemption value within redeemable noncontrolling interests on the Company's Condensed Consolidated Balance Sheets, and any changes in the estimated redemption value are recorded on the Condensed Consolidated Statements of Operations within noncontrolling interests.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationVariableInterestEntityPolicy', window );">Nonconsolidated VIEs</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nonconsolidated VIEs</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company serves as the collateral manager for other CLOs that are not consolidated.  The assets and liabilities of these CLOs reside in bankruptcy remote, special purpose entities in which the Company has no ownership of, nor holds any notes issued by, the CLOs, and provides neither recourse nor guarantees.  The Company has determined that the investment management fees it receives for serving as collateral manager for these CLOs did not represent a variable interest as (i) the fees the Company earns are compensation for services provided and are commensurate with the level of effort required to provide the investment management services, (ii) the Company does not hold other interests in the CLOs that individually, or in the aggregate, would absorb more than an insignificant amount of the CLOs' expected losses or receive more than an insignificant amount of the CLOs' expected residual return, and (iii) the investment management arrangement only includes terms, conditions and amounts that are customarily present in arrangements for similar services negotiated at arm's length. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div>The Company has interests in certain other VIEs that the Company does not consolidate as it is not the primary beneficiary since its interest in these entities does not provide the Company with the power to direct the activities that most significantly impact the entities' economic performance.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationVariableInterestEntityPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-5A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2AA<br> -Subparagraph a<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-2AA<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationVariableInterestEntityPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vrts_NoncontrollingInterestPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest Policy [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vrts_NoncontrollingInterestPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vrts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352305424704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Summary of Disaggregation of Revenue</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes investment management fees by source:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.444%"><tr><td style="width:1.0%"></td><td style="width:61.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.215%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.852%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.218%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investment management fees</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Open-end funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Closed-end funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retail separate accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,079&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Institutional accounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,305&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total investment management fees</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">188,360</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">164,478</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352192623024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Goodwill and Intangible Assets, Net</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of intangible assets, net:</span></div><div style="margin-bottom:3pt;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.473%"><tr><td style="width:1.0%"></td><td style="width:30.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.971%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.616%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.971%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.616%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.971%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.616%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.971%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.616%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.980%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Definite-Lived</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Indefinite-Lived</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Book Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Book Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Book Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Book Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances at December 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">806,655&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(416,834)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389,821&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432,119&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,335)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,335)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,335)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances at March 31, 2024</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">806,655</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(432,169)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">374,486</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">42,298</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">416,784</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Estimated Amortization Expense of Intangible Assets Succeeding Years</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Definite-lived intangible asset amortization for the remainder of fiscal year 2024 and succeeding fiscal years is estimated as follows: </span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.912%"><tr><td style="width:1.0%"></td><td style="width:53.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.631%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.857%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount<br/></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,964&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 and thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">374,486</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352195432352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsAbstract', window );"><strong>Schedule of Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTableTextBlock', window );">Schedule of Investments</a></td>
<td class="text">The Company's investments, excluding the assets of consolidated investment products ("CIP") discussed in Note 16, at March&#160;31, 2024 and December&#160;31, 2023 were as follows:<div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.602%"><tr><td style="width:1.0%"></td><td style="width:62.616%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.599%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.684%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment securities - fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,497&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonqualified retirement plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,682&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">127,448</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">132,696</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:63pt;padding-right:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The Company's equity method investments are valued on a three-month lag based upon the availability of financial information.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock', window );">Schedule of Marketable Securities</a></td>
<td class="text">The composition of the Company&#8217;s investment securities - fair value was as follows:<div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.304%"><tr><td style="width:1.0%"></td><td style="width:39.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.303%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.627%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.972%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.627%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.972%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.627%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.978%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investment Securities - fair value</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sponsored funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,067&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,794&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,983&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,353&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,871&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total investment securities - fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">85,942</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">90,497</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">97,147</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">97,304</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//320/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Topic 321<br> -Publisher FASB<br> -URI https://asc.fasb.org//321/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Topic 325<br> -Publisher FASB<br> -URI https://asc.fasb.org//325/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352195079632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis</a></td>
<td class="text"><div style="margin-bottom:5pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s assets and liabilities measured at fair value on a recurring basis, excluding the assets and liabilities of CIP discussed in Note 16, as of March&#160;31, 2024 and December&#160;31, 2023 by fair value hierarchy level were as follows:</span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">March&#160;31, 2024 &#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investment securities - fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sponsored funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,983&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,983&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonqualified retirement plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">196,698</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">196,698</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,708&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,708&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41,708</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41,708</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December&#160;31, 2023 </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investment securities - fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sponsored funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,871&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,871&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonqualified retirement plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">307,226</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">307,226</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">56,200</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">56,200</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assets and liabilities of CIP measured at fair value on a recurring basis as of March&#160;31, 2024 and December&#160;31, 2023 by fair value hierarchy level were as follows:</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As of March&#160;31, 2024 </span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.812%"><tr><td style="width:1.0%"></td><td style="width:45.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.479%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.798%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.479%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.800%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,914&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,914&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,003,579&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,551&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,051,130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,095&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">149,383</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,003,963</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47,793</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,201,139</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,922,051&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,922,051&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">485</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,922,051</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,922,536</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As of December&#160;31, 2023 </span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.812%"><tr><td style="width:1.0%"></td><td style="width:45.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.479%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.798%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.479%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.800%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,012,760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,616&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,049,617&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,096&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">130,984</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,012,768</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">37,062</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,180,814</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,922,243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,922,243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">518</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,922,243</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,922,761</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of Liabilities of Consolidated Sponsored Investment Products For Level 3 Investments, Unobservable Inputs Used to Determine Fair Value</a></td>
<td class="text"><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of beginning and ending balances of the Company's contingent consideration liabilities:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.801%"><tr><td style="width:1.0%"></td><td style="width:75.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.031%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.034%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,200&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reduction for payments made</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,492)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,390)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent consideration, end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41,708</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">61,710</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352188201904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Loss) (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Changes in Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in accumulated other comprehensive income (loss) were as follows: </span></div><div style="margin-bottom:3pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.842%"><tr><td style="width:1.0%"></td><td style="width:74.994%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.641%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.978%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(358)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss) (1)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at end of period</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(187)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(259)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:54pt;padding-right:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;Consists of foreign currency translation adjustments, net of tax of $36 and $(35) for the </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> months ended March&#160;31, 2024 and 2023, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352192467760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vrts_StockBasedCompensationExpenseTableTextBlock', window );">Schedule of Stock Based Compensation Expense</a></td>
<td class="text"><div style="margin-bottom:5pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense is summarized as follows:</span></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:58.771%"><tr><td style="width:1.0%"></td><td style="width:61.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.059%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.061%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,831&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,749&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Restricted Stock Units Activity</a></td>
<td class="text"><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSU activity, inclusive of PSUs, for the three months ended March&#160;31, 2024 is summarized as follows:&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:76.169%"><tr><td style="width:1.0%"></td><td style="width:58.017%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.861%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.863%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number<br/>of&#160;Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant&#160;Date<br/>Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344,717&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204.48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,658&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,333)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261.65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103,849)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229.92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at March 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">341,193</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">205.10</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vrts_StockBasedCompensationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Based Compensation Expense Table [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vrts_StockBasedCompensationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vrts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352312100336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Computation of Basic and Diluted Earnings Per Share</a></td>
<td class="text"><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The computation of basic and diluted EPS is as follows:&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.748%"><tr><td style="width:1.0%"></td><td style="width:77.168%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Income (Loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,867&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,643&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,009)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Income (Loss) Attributable to Virtus Investment Partners, Inc.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,858&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,624&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic: Weighted-average number of shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: Incremental shares from assumed conversion of dilutive instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted: Weighted-average number of shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,287&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,410&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (Loss) per Share&#8212;Basic</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.19</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.33</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (Loss) per Share&#8212;Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.10</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.21</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</a></td>
<td class="text"><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table details the securities that have been excluded from the above computation of weighted-average number of shares for diluted EPS, because the effect would be anti-dilutive.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.871%"><tr><td style="width:1.0%"></td><td style="width:76.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.435%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.438%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total anti-dilutive securities</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">40</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352188206592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestTableTextBlock', window );">Schedule of Redeemable Noncontrolling Interest</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redeemable noncontrolling interests for the three months ended March&#160;31, 2024 included the following amounts:</span></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.906%"><tr><td style="width:1.0%"></td><td style="width:50.881%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.143%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.143%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.147%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CIP</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Affiliate Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances at December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,643&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,869&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to noncontrolling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,829&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in redemption value (1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net income (loss) attributable to noncontrolling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,429&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,189&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,618&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Affiliate equity sales (purchases)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(419)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(419)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net subscriptions (redemptions) and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances at March 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">35,189</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">79,996</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">115,185</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;Relates to noncontrolling interests redeemable at other than fair value.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352195160944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidation (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfCondensedBalanceSheetTableTextBlock', window );">Schedule of Condensed Consolidated Balance Sheets</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the balances of CIP that, after intercompany eliminations, were reflected on the Condensed Consolidated Balance Sheets as of March&#160;31, 2024 and December&#160;31, 2023:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.321%"><tr><td style="width:1.0%"></td><td style="width:30.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.102%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.873%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.096%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.873%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.096%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.873%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.102%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.026%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.096%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.026%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.103%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">VOEs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">VIEs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">VOEs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">VIEs</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CLOs </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GFs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CLOs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GFs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,914&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,612&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,223&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,088&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,591&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,962,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,937&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,985&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,972,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,064&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,985&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,922,051)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,922,243)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securities purchased payable and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,019)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88,270)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,999)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(740)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89,167)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(616)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,311)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,351)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,878)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,316)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,363)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,327)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net interests in CIP</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29,148</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">98,003</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">56,840</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24,326</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">96,655</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">58,607</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock', window );">Schedule of VIE Consolidated Investment Product</a></td>
<td class="text">Although these beneficial interests are eliminated upon consolidation, the application of the measurement alternative prescribed by ASU 2014-13, <span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidation (Topic 810)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASU 2014-13"), results in the net assets of the consolidated CLOs shown above to be equivalent to the beneficial interests retained by the Company at March&#160;31, 2024, as shown in the table below:</span><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.818%"><tr><td style="width:1.0%"></td><td style="width:70.053%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.747%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subordinated notes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,416&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued investment management fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Beneficial Interests</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">98,003</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents income and expenses of the consolidated CLOs included on the Company&#8217;s Condensed Consolidated Statements of Operations for the period indicated:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.719%"><tr><td style="width:1.0%"></td><td style="width:67.897%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.903%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized gain (loss), net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,280&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,281&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,510&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(391)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Income (Loss) Attributable to CLOs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,380</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the Company&#8217;s own economic interests in the consolidated CLOs, which are eliminated upon consolidation:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.719%"><tr><td style="width:1.0%"></td><td style="width:67.897%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.903%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions received and unrealized gains (losses) on the subordinated notes held by the Company</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,083&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment management fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Economic Interests</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,380</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis</a></td>
<td class="text"><div style="margin-bottom:5pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s assets and liabilities measured at fair value on a recurring basis, excluding the assets and liabilities of CIP discussed in Note 16, as of March&#160;31, 2024 and December&#160;31, 2023 by fair value hierarchy level were as follows:</span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">March&#160;31, 2024 &#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investment securities - fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sponsored funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,983&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,983&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonqualified retirement plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">196,698</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">196,698</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,708&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,708&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41,708</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41,708</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December&#160;31, 2023 </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investment securities - fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sponsored funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,871&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,871&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonqualified retirement plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">307,226</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">307,226</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">56,200</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">56,200</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assets and liabilities of CIP measured at fair value on a recurring basis as of March&#160;31, 2024 and December&#160;31, 2023 by fair value hierarchy level were as follows:</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As of March&#160;31, 2024 </span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.812%"><tr><td style="width:1.0%"></td><td style="width:45.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.479%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.798%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.479%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.800%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,914&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,914&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,003,579&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,551&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,051,130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,095&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">149,383</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,003,963</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47,793</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,201,139</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,922,051&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,922,051&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">485</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,922,051</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,922,536</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As of December&#160;31, 2023 </span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.812%"><tr><td style="width:1.0%"></td><td style="width:45.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.479%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.798%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.479%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.800%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,012,760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,616&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,049,617&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,096&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">130,984</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,012,768</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">37,062</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,180,814</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,922,243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,922,243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">518</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,922,243</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,922,761</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of Reconciliation of Assets of Consolidated Sponsored Investment Products For Level 3 Investments, Unobservable Inputs Used to Determine Fair Value</a></td>
<td class="text"><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a reconciliation of assets of CIP for Level 3 investments for which significant unobservable inputs were used to determine fair value:</span></div><div style="margin-bottom:3pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.912%"><tr><td style="width:1.0%"></td><td style="width:64.890%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.926%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.343%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,062&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,581&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized gains (losses), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(324)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,625)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,195)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers to Level 2</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,468)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,747)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers from Level 2</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,904&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at end of period (1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47,793</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,658</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:108pt;padding-right:90pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8pt">The investments that are categorized as Level 3 were valued utilizing third-party pricing information without adjustment.  Transfers in and/or out of levels are reflected when significant inputs, including market inputs or performance attributes, used for the fair value measurement become observable/unobservable at period end.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfCondensedBalanceSheetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 04<br> -Paragraph (a)<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfCondensedBalanceSheetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-5A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-9<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfVariableInterestEntitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352284222432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 222,042<span></span>
</td>
<td class="nump">$ 197,874<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vrts_InvestmentManagementFeesMember', window );">Investment management fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">188,360<span></span>
</td>
<td class="nump">164,478<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vrts_OpenEndFundsMember', window );">Open-end funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">78,680<span></span>
</td>
<td class="nump">71,266<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vrts_ClosedEndFundsMember', window );">Closed-end funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">14,394<span></span>
</td>
<td class="nump">14,678<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vrts_RetailSeparateAccountsMember', window );">Retail separate accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">48,981<span></span>
</td>
<td class="nump">40,079<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vrts_InstitutionalAccountsMember', window );">Institutional accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 46,305<span></span>
</td>
<td class="nump">$ 38,455<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vrts_InvestmentManagementFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vrts_InvestmentManagementFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vrts_OpenEndFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vrts_OpenEndFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vrts_ClosedEndFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vrts_ClosedEndFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vrts_RetailSeparateAccountsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vrts_RetailSeparateAccountsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vrts_InstitutionalAccountsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vrts_InstitutionalAccountsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352284213648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 397,098<span></span>
</td>
<td class="nump">$ 397,098<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vrts_AlphaSimplexGroupLLCMember', window );">AlphaSimplex Group, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase price</a></td>
<td class="nump">$ 113,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">48,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Definite-lived intangible assets acquired</a></td>
<td class="nump">$ 55,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=vrts_AlphaSimplexGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=vrts_AlphaSimplexGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352305201008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net - Goodwill and Intangible Assets, Net (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRollForward', window );"><strong>Definite-Lived</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross book value, beginning of period</a></td>
<td class="nump">$ 806,655<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization, beginning of period</a></td>
<td class="num">(416,834)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Definite-Lived net book value, beginning of period</a></td>
<td class="nump">389,821<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible amortization</a></td>
<td class="num">(15,335)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross book value balance, end of period</a></td>
<td class="nump">806,655<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization, end of period</a></td>
<td class="num">(432,169)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Definite-Lived net book value, end of period</a></td>
<td class="nump">374,486<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsRollForward', window );"><strong>Indefinite-Lived</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Net book value, beginning of period</a></td>
<td class="nump">42,298<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Net book value, end of period</a></td>
<td class="nump">42,298<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vrts_IntangibleAssetsNetExcludingGoodwillRollForward', window );"><strong>Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net book value, beginning of period</a></td>
<td class="nump">432,119<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible amortization</a></td>
<td class="num">(15,335)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net book value, end of period</a></td>
<td class="nump">$ 416,784<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483147/928-340-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vrts_IntangibleAssetsNetExcludingGoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intangible Assets, Net (Excluding Goodwill) [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vrts_IntangibleAssetsNetExcludingGoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vrts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352195316704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets, Net - Estimated Amortization Expense of Intangible Assets Succeeding Years (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Remainder of 2024</a></td>
<td class="nump">$ 40,964<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2025</a></td>
<td class="nump">51,532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2026</a></td>
<td class="nump">50,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2027</a></td>
<td class="nump">47,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2028</a></td>
<td class="nump">41,787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vrts_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour', window );">2029 and thereafter</a></td>
<td class="nump">142,201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 374,486<span></span>
</td>
<td class="nump">$ 389,821<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vrts_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Asset, Expected Amortization, After Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vrts_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vrts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352195745648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Investments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investment securities - fair value</a></td>
<td class="nump">$ 90,497<span></span>
</td>
<td class="nump">$ 97,304<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember', window );">Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investment securities - fair value</a></td>
<td class="nump">90,497<span></span>
</td>
<td class="nump">97,304<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="nump">23,208<span></span>
</td>
<td class="nump">22,710<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vrts_InvestmentsInNonqualifiedRetirementPlanAssets', window );">Nonqualified retirement plan assets</a></td>
<td class="nump">13,743<span></span>
</td>
<td class="nump">12,682<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Total investments</a></td>
<td class="nump">$ 127,448<span></span>
</td>
<td class="nump">$ 132,696<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482736/825-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(h))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column B)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column D))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 1)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column B)(Footnote 10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 5)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-19<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vrts_InvestmentsInNonqualifiedRetirementPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investments In Nonqualified Retirement Plan Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vrts_InvestmentsInNonqualifiedRetirementPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vrts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352192103920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Marketable Securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesAbstract', window );"><strong>Investment Securities - fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCost', window );">Cost</a></td>
<td class="nump">$ 85,942<span></span>
</td>
<td class="nump">$ 97,147<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Fair Value</a></td>
<td class="nump">90,497<span></span>
</td>
<td class="nump">97,304<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=vrts_SponsoredFundsMember', window );">Sponsored funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesAbstract', window );"><strong>Investment Securities - fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCost', window );">Cost</a></td>
<td class="nump">69,067<span></span>
</td>
<td class="nump">80,794<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Fair Value</a></td>
<td class="nump">69,514<span></span>
</td>
<td class="nump">77,433<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember', window );">Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesAbstract', window );"><strong>Investment Securities - fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCost', window );">Cost</a></td>
<td class="nump">16,875<span></span>
</td>
<td class="nump">16,353<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Fair Value</a></td>
<td class="nump">$ 20,983<span></span>
</td>
<td class="nump">$ 19,871<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482736/825-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Excludes equity method investment and investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=vrts_SponsoredFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=vrts_SponsoredFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352192646800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsAbstract', window );"><strong>Schedule of Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss', window );">Realized (losses) gains on trading securities</a></td>
<td class="num">$ (0.4)<span></span>
</td>
<td class="nump">$ 1.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment in debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column C)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column C)(Footnote 6)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column C))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndEquitySecuritiesRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352197226176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Changes in Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">$ 92,458<span></span>
</td>
<td class="nump">$ 197,240<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesAbstract', window );"><strong>Investment securities - fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Fair Value</a></td>
<td class="nump">90,497<span></span>
</td>
<td class="nump">97,304<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">196,698<span></span>
</td>
<td class="nump">307,226<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">41,708<span></span>
</td>
<td class="nump">56,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=vrts_ContingentConsiderationLiabilityMember', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">41,708<span></span>
</td>
<td class="nump">56,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=vrts_SponsoredFundsMember', window );">Sponsored funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesAbstract', window );"><strong>Investment securities - fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Fair Value</a></td>
<td class="nump">69,514<span></span>
</td>
<td class="nump">77,433<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember', window );">Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesAbstract', window );"><strong>Investment securities - fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Fair Value</a></td>
<td class="nump">20,983<span></span>
</td>
<td class="nump">19,871<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=vrts_NonqualifiedRetirementPlanAssetsMember', window );">Nonqualified retirement plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesAbstract', window );"><strong>Investment securities - fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vrts_InvestmentsInNonqualifiedRetirementPlanAssets', window );">Nonqualified retirement plan assets</a></td>
<td class="nump">13,743<span></span>
</td>
<td class="nump">12,682<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">92,458<span></span>
</td>
<td class="nump">197,240<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesAbstract', window );"><strong>Investment securities - fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">196,698<span></span>
</td>
<td class="nump">307,226<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Sponsored funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesAbstract', window );"><strong>Investment securities - fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Fair Value</a></td>
<td class="nump">69,514<span></span>
</td>
<td class="nump">77,433<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesAbstract', window );"><strong>Investment securities - fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Fair Value</a></td>
<td class="nump">20,983<span></span>
</td>
<td class="nump">19,871<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Nonqualified retirement plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesAbstract', window );"><strong>Investment securities - fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vrts_InvestmentsInNonqualifiedRetirementPlanAssets', window );">Nonqualified retirement plan assets</a></td>
<td class="nump">13,743<span></span>
</td>
<td class="nump">12,682<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesAbstract', window );"><strong>Investment securities - fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | Sponsored funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesAbstract', window );"><strong>Investment securities - fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesAbstract', window );"><strong>Investment securities - fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | Nonqualified retirement plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesAbstract', window );"><strong>Investment securities - fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vrts_InvestmentsInNonqualifiedRetirementPlanAssets', window );">Nonqualified retirement plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesAbstract', window );"><strong>Investment securities - fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">41,708<span></span>
</td>
<td class="nump">56,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">41,708<span></span>
</td>
<td class="nump">56,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Sponsored funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesAbstract', window );"><strong>Investment securities - fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesAbstract', window );"><strong>Investment securities - fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Nonqualified retirement plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesAbstract', window );"><strong>Investment securities - fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vrts_InvestmentsInNonqualifiedRetirementPlanAssets', window );">Nonqualified retirement plan assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482736/825-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vrts_InvestmentsInNonqualifiedRetirementPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investments In Nonqualified Retirement Plan Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vrts_InvestmentsInNonqualifiedRetirementPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vrts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=vrts_ContingentConsiderationLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=vrts_ContingentConsiderationLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=vrts_SponsoredFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=vrts_SponsoredFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=vrts_NonqualifiedRetirementPlanAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=vrts_NonqualifiedRetirementPlanAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352192184416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">$ 66,704<span></span>
</td>
<td class="nump">$ 90,938<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vrts_WestchesterCapitalManagementMember', window );">Westchester | Measurement Input, Comparability Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business combination, contingent consideration, liability, measurement input</a></td>
<td class="nump">0.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vrts_WestchesterCapitalManagementMember', window );">Westchester | Minimum | Measurement Input, Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business combination, contingent consideration, liability, measurement input</a></td>
<td class="nump">0.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vrts_WestchesterCapitalManagementMember', window );">Westchester | Maximum | Measurement Input, Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business combination, contingent consideration, liability, measurement input</a></td>
<td class="nump">0.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vrts_WestchesterCapitalManagementMember', window );">Westchester | Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">$ 11,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vrts_NFJInvestmentGroupMember', window );">NFJ Investment Group | Measurement Input, Comparability Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business combination, contingent consideration, liability, measurement input</a></td>
<td class="nump">0.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vrts_NFJInvestmentGroupMember', window );">NFJ Investment Group | Minimum | Measurement Input, Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business combination, contingent consideration, liability, measurement input</a></td>
<td class="nump">0.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vrts_NFJInvestmentGroupMember', window );">NFJ Investment Group | Maximum | Measurement Input, Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business combination, contingent consideration, liability, measurement input</a></td>
<td class="nump">0.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vrts_NFJInvestmentGroupMember', window );">NFJ Investment Group | Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">$ 30,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-6<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479613/805-30-35-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=vrts_WestchesterCapitalManagementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=vrts_WestchesterCapitalManagementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputComparabilityAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputComparabilityAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=vrts_NFJInvestmentGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=vrts_NFJInvestmentGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352192829504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Rollforward of the Contingent Consideration Liabilities Valued Using Level 3 Inputs (Details) - Level&#160;3 - Contingent consideration - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Contingent consideration, beginning of period</a></td>
<td class="nump">$ 56,200<span></span>
</td>
<td class="nump">$ 78,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vrts_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReductionOfLiability', window );">Reduction for payments made</a></td>
<td class="num">(14,492)<span></span>
</td>
<td class="num">(16,390)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Contingent consideration, end of period</a></td>
<td class="nump">$ 41,708<span></span>
</td>
<td class="nump">$ 61,710<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vrts_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReductionOfLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Reduction Of Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vrts_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReductionOfLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vrts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=vrts_ContingentConsiderationLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=vrts_ContingentConsiderationLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352290198192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Transactions (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 21, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Cash dividends declared per common share (in dollars per share)</a></td>
<td class="nump">$ 1.90<span></span>
</td>
<td class="nump">$ 1.90<span></span>
</td>
<td class="nump">$ 1.65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock repurchased during period, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Weighted average price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 236.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Stock repurchased during period, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased', window );">Shares available for repurchase (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">583,437<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The remaining number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352284038624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="nump">$ 868,289<span></span>
</td>
<td class="nump">$ 822,936<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current-period other comprehensive income (loss)</a></td>
<td class="num">(100)<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="nump">876,003<span></span>
</td>
<td class="nump">844,297<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Accumulated Foreign Currency Adjustment Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="num">(87)<span></span>
</td>
<td class="num">(358)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current-period other comprehensive income (loss)</a></td>
<td class="num">(100)<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="num">(187)<span></span>
</td>
<td class="num">(259)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Other comprehensive income (loss), before reclassifications, tax</a></td>
<td class="nump">$ 36<span></span>
</td>
<td class="num">$ (35)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-4<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482739/220-10-55-15<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 40: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 41: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-15<br><br>Reference 42: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16<br><br>Reference 43: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352192241264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Additional Information (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares of common stock available for issuance (in shares)</a></td>
<td class="nump">375,169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares of common stock reserved for issuance (in shares)</a></td>
<td class="nump">3,370,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=vrts_RestrictedStockUnitsandPerformanceSharesUnitsMember', window );">RSUs and PSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unamortized stock-based compensation expense | $</a></td>
<td class="nump">$ 45.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted-average remaining amortization period</a></td>
<td class="text">1 year 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Share settlement under RSUs (in shares)</a></td>
<td class="nump">42,588<span></span>
</td>
<td class="nump">70,716<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vrts_PaymentOfWithholdingTaxesRelatedToRestrictedStock', window );">Cash used for employee withholding tax payments | $</a></td>
<td class="nump">$ 9.9<span></span>
</td>
<td class="nump">$ 12.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=vrts_RestrictedStockUnitsRSUsPerformanceBasedMember', window );">Restricted stock units (RSUs), performance-based</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Awards granted (in shares)</a></td>
<td class="nump">26,733<span></span>
</td>
<td class="nump">44,291<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=vrts_PerformanceStockUnitsIncentiveMember', window );">Performance Stock Units, Incentive</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Period for recognition of compensation expense</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock | Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vrts_ConversionOfStockConversionRatio', window );">Conversion ratio</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of non-option equity instruments granted to participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vrts_ConversionOfStockConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conversion Of Stock, Conversion Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vrts_ConversionOfStockConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vrts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vrts_PaymentOfWithholdingTaxesRelatedToRestrictedStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment Of Withholding Taxes Related To Restricted Stock</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vrts_PaymentOfWithholdingTaxesRelatedToRestrictedStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vrts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=vrts_RestrictedStockUnitsandPerformanceSharesUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=vrts_RestrictedStockUnitsandPerformanceSharesUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=vrts_RestrictedStockUnitsRSUsPerformanceBasedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=vrts_RestrictedStockUnitsRSUsPerformanceBasedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=vrts_PerformanceStockUnitsIncentiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=vrts_PerformanceStockUnitsIncentiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352195476960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Stock Based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 6,831<span></span>
</td>
<td class="nump">$ 5,749<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352195412128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Restricted Stock Units Activity (Details) - Restricted Stock Units (RSUs)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of&#160;Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of shares, outstanding (in shares) | shares</a></td>
<td class="nump">344,717<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of shares, granted (in shares) | shares</a></td>
<td class="nump">108,658<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Number of shares, forfeited (in shares) | shares</a></td>
<td class="num">(8,333)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Number of shares, settled (in shares) | shares</a></td>
<td class="num">(103,849)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of shares, outstanding (in shares) | shares</a></td>
<td class="nump">341,193<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant&#160;Date Fair&#160;Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, outstanding (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 204.48<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant-date fair value (in dollars per share) | $ / shares</a></td>
<td class="nump">235.14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">261.65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, settled (in dollars per share) | $ / shares</a></td>
<td class="nump">229.92<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, outstanding (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 205.10<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352195588944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Share - Schedule of Computation of Basic and Diluted Earnings Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income (Loss)</a></td>
<td class="nump">$ 37,867<span></span>
</td>
<td class="nump">$ 34,643<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Noncontrolling interests</a></td>
<td class="num">(8,009)<span></span>
</td>
<td class="nump">3,981<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net Income (Loss) Attributable to Virtus Investment Partners, Inc.</a></td>
<td class="nump">$ 29,858<span></span>
</td>
<td class="nump">$ 38,624<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic: Weighted-average number of shares outstanding (in shares)</a></td>
<td class="nump">7,119<span></span>
</td>
<td class="nump">7,245<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Plus: Incremental shares from assumed conversion of dilutive instruments (in shares)</a></td>
<td class="nump">168<span></span>
</td>
<td class="nump">165<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted: Weighted-average number of shares outstanding (in shares)</a></td>
<td class="nump">7,287<span></span>
</td>
<td class="nump">7,410<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings (Loss) per Share&#8212;Basic (in dollars per share)</a></td>
<td class="nump">$ 4.19<span></span>
</td>
<td class="nump">$ 5.33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings (Loss) per Share&#8212;Diluted (in dollars per share)</a></td>
<td class="nump">$ 4.10<span></span>
</td>
<td class="nump">$ 5.21<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480454/718-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-22<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-28A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352195111792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total anti-dilutive securities (in shares)</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total anti-dilutive securities (in shares)</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352192536240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Estimated effective income tax rate (as percent)</a></td>
<td class="nump">18.90%<span></span>
</td>
<td class="nump">20.10%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352192219296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 28, 2021</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=vrts_TermLoanMember', window );">Term loan | Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Debt repayments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Outstanding borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">258,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=vrts_TermLoanMember', window );">Term loan | Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 275,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=vrts_TermLoanMember', window );">Term loan | Credit Facility 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving credit facility | Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 175,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=vrts_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=vrts_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vrts_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vrts_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vrts_CreditFacility2017Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vrts_CreditFacility2017Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352178514960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests - Schedule of Redeemable Noncontrolling Interest (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Redeemable Non-controlling Interests [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue', window );">Balance at beginning of period</a></td>
<td class="nump">$ 104,869<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net income (loss) attributable to noncontrolling interests</a></td>
<td class="nump">3,258<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestChangeInRedemptionValue', window );">Changes in redemption value</a></td>
<td class="num">(13,624)<span></span>
</td>
<td class="num">$ (3,447)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Total net income (loss) attributable to noncontrolling interests</a></td>
<td class="nump">7,618<span></span>
</td>
<td class="num">$ (4,746)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates', window );">Affiliate equity sales (purchases)</a></td>
<td class="num">(419)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vrts_NoncontrollingInterestSubscriptionsRedemptionsAndOther', window );">Net subscriptions (redemptions) and other</a></td>
<td class="nump">3,117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue', window );">Balance at end of period</a></td>
<td class="nump">115,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember', window );">CIP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Redeemable Non-controlling Interests [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue', window );">Balance at beginning of period</a></td>
<td class="nump">30,643<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net income (loss) attributable to noncontrolling interests</a></td>
<td class="nump">1,429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Total net income (loss) attributable to noncontrolling interests</a></td>
<td class="nump">1,429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates', window );">Affiliate equity sales (purchases)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vrts_NoncontrollingInterestSubscriptionsRedemptionsAndOther', window );">Net subscriptions (redemptions) and other</a></td>
<td class="nump">3,117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue', window );">Balance at end of period</a></td>
<td class="nump">35,189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_AffiliatedEntityMember', window );">Affiliate Noncontrolling Interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Redeemable Non-controlling Interests [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue', window );">Balance at beginning of period</a></td>
<td class="nump">74,226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net income (loss) attributable to noncontrolling interests</a></td>
<td class="nump">1,829<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Total net income (loss) attributable to noncontrolling interests</a></td>
<td class="nump">6,189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates', window );">Affiliate equity sales (purchases)</a></td>
<td class="num">(419)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vrts_NoncontrollingInterestSubscriptionsRedemptionsAndOther', window );">Net subscriptions (redemptions) and other</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue', window );">Balance at end of period</a></td>
<td class="nump">79,996<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember', window );">Portion at Other than Fair Value Measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Redeemable Non-controlling Interests [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestChangeInRedemptionValue', window );">Changes in redemption value</a></td>
<td class="nump">4,360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember', window );">Portion at Other than Fair Value Measurement | CIP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Redeemable Non-controlling Interests [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestChangeInRedemptionValue', window );">Changes in redemption value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember', window );">Portion at Other than Fair Value Measurement | Affiliate Noncontrolling Interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Redeemable Non-controlling Interests [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestChangeInRedemptionValue', window );">Changes in redemption value</a></td>
<td class="nump">$ 4,360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestChangeInRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in noncontrolling interest during the period as a result of a change in the redemption value of redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Subparagraph 14<br> -Paragraph 3A<br> -Section S99<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-3A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Subparagraph 15<br> -Paragraph 3A<br> -Section S99<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-3A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 16(c)<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestChangeInRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of or advances to an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, and joint venture or equity method investment) or the acquisition of an additional interest in a subsidiary (controlled entity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Redemption value, as if currently redeemable, of redeemable noncontrolling interest classified as temporary equity and the election has been made to accrete changes in redemption value to the earliest redemption date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 24(b)<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityNetIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of net income or loss attributable to temporary equity interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityNetIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vrts_NoncontrollingInterestSubscriptionsRedemptionsAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Subscriptions (Redemptions) And Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vrts_NoncontrollingInterestSubscriptionsRedemptionsAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vrts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352290067008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidation - Condensed Consolidated Balance Sheets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Noncontrolling interests</a></td>
<td class="num">$ (115,185)<span></span>
</td>
<td class="num">$ (104,869)<span></span>
</td>
<td class="num">$ (106,630)<span></span>
</td>
<td class="num">$ (113,718)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=vrts_VotingInterestEntityVOEMember', window );">VOEs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">1,271<span></span>
</td>
<td class="nump">1,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="nump">40,591<span></span>
</td>
<td class="nump">30,985<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other assets</a></td>
<td class="nump">616<span></span>
</td>
<td class="nump">174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vrts_SecuritiesPurchasedPayable', window );">Securities purchased payable and other liabilities</a></td>
<td class="num">(1,019)<span></span>
</td>
<td class="num">(740)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Noncontrolling interests</a></td>
<td class="num">(12,311)<span></span>
</td>
<td class="num">(7,316)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vrts_NetInterestInInvestmentProducts', window );">Net interests in CIP</a></td>
<td class="nump">29,148<span></span>
</td>
<td class="nump">24,326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember', window );">CLOs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">119,914<span></span>
</td>
<td class="nump">98,101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="nump">1,962,697<span></span>
</td>
<td class="nump">1,972,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other assets</a></td>
<td class="nump">30,064<span></span>
</td>
<td class="nump">41,985<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes payable</a></td>
<td class="num">(1,922,051)<span></span>
</td>
<td class="num">(1,922,243)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vrts_SecuritiesPurchasedPayable', window );">Securities purchased payable and other liabilities</a></td>
<td class="num">(88,270)<span></span>
</td>
<td class="num">(89,167)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Noncontrolling interests</a></td>
<td class="num">(4,351)<span></span>
</td>
<td class="num">(4,363)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vrts_NetInterestInInvestmentProducts', window );">Net interests in CIP</a></td>
<td class="nump">98,003<span></span>
</td>
<td class="nump">96,655<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=vrts_VariableInterestEntityPrimaryBeneficiaryGlobalAndPrivateFundsMember', window );">GFs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">2,612<span></span>
</td>
<td class="nump">2,088<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="nump">77,937<span></span>
</td>
<td class="nump">79,386<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other assets</a></td>
<td class="nump">1,168<span></span>
</td>
<td class="nump">1,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vrts_SecuritiesPurchasedPayable', window );">Securities purchased payable and other liabilities</a></td>
<td class="num">(1,999)<span></span>
</td>
<td class="num">(616)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Noncontrolling interests</a></td>
<td class="num">(22,878)<span></span>
</td>
<td class="num">(23,327)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vrts_NetInterestInInvestmentProducts', window );">Net interests in CIP</a></td>
<td class="nump">$ 56,840<span></span>
</td>
<td class="nump">$ 58,607<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(h))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.27(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481420/860-30-50-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481420/860-30-50-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481420/860-30-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vrts_NetInterestInInvestmentProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Interest in Investment Products</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vrts_NetInterestInInvestmentProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vrts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vrts_SecuritiesPurchasedPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities Purchased Payable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vrts_SecuritiesPurchasedPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vrts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=vrts_VotingInterestEntityVOEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=vrts_VotingInterestEntityVOEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=vrts_VariableInterestEntityPrimaryBeneficiaryGlobalAndPrivateFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=vrts_VariableInterestEntityPrimaryBeneficiaryGlobalAndPrivateFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352287615024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidation - Additional Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($) </div>
<div>collateralized_loan_obligation</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember', window );">CLOs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vrts_NumberofCollateralizedLoanObligationsConsolidated', window );">Number of consolidated CLOs | collateralized_loan_obligation</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="nump">$ 1,962,697<span></span>
</td>
<td class="nump">$ 1,972,342<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember', window );">CLOs | CLO subordinated notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt par value</a></td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember', window );">CLOs | Senior Notes | CLO senior secured floating rate notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt par value</a></td>
<td class="nump">1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember', window );">CLOs | Subordinated Debt | CLO subordinated notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt par value</a></td>
<td class="nump">215,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember', window );">Nonconsolidated VIEs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount', window );">Carrying value and maximum risk of loss</a></td>
<td class="nump">$ 29,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(h))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph b<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481420/860-30-50-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481420/860-30-50-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481420/860-30-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vrts_NumberofCollateralizedLoanObligationsConsolidated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Collateralized Loan Obligations Consolidated</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vrts_NumberofCollateralizedLoanObligationsConsolidated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vrts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vrts_SubordinatedNotesNewfleetCLO20161Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vrts_SubordinatedNotesNewfleetCLO20161Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vrts_SeniorSecuredFloatingRateNotesNewfleetCLO20161Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vrts_SeniorSecuredFloatingRateNotesNewfleetCLO20161Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SubordinatedDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SubordinatedDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352192030672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidation - Beneficial Interests of Consolidated Investment Product (Details) - CLOs<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsSubordinatedDebtAmount', window );">Subordinated notes</a></td>
<td class="nump">$ 96,416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsDeferredRevenueAmount', window );">Accrued investment management fees</a></td>
<td class="nump">1,587<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsAmount', window );">Total Beneficial Interests</a></td>
<td class="nump">$ 98,003<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481420/860-30-50-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481420/860-30-50-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481420/860-30-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Variable Interest Entity, Reporting Entity Involvement, Beneficial Interests, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vrts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsDeferredRevenueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Variable Interest Entity, Reporting Entity Involvement, Beneficial Interests, Deferred Revenue, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsDeferredRevenueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vrts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsSubordinatedDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Variable Interest Entity, Reporting Entity Involvement, Beneficial Interests, Subordinated Debt, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsSubordinatedDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vrts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352191222256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidation - Revenue and Expenses of Consolidated Investment Product (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vrts_ExpensesAbstract', window );"><strong>Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Noncontrolling interests</a></td>
<td class="num">$ (8,009)<span></span>
</td>
<td class="nump">$ 3,981<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net Income (Loss) Attributable to Virtus Investment Partners, Inc.</a></td>
<td class="nump">29,858<span></span>
</td>
<td class="nump">$ 38,624<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember', window );">CLOs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Realized and unrealized gain (loss), net</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Interest income</a></td>
<td class="nump">49,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Income</a></td>
<td class="nump">49,281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vrts_ExpensesAbstract', window );"><strong>Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCostAndExpenseOperating', window );">Other operating expenses</a></td>
<td class="nump">499<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">40,011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vrts_OperatingandNonoperatingExpense', window );">Total Expense</a></td>
<td class="nump">40,510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Noncontrolling interests</a></td>
<td class="num">(391)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net Income (Loss) Attributable to Virtus Investment Partners, Inc.</a></td>
<td class="nump">$ 8,380<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterestAndDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterestAndDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCostAndExpenseOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCostAndExpenseOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vrts_ExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenses [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vrts_ExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vrts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vrts_OperatingandNonoperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating and Nonoperating Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vrts_OperatingandNonoperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vrts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352190813616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidation - Economic Interests of Consolidated Investment Product (Details) - CLOs<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_vrts_VariableInterestEntityMeasureofActivityDistributionsReceivedandUnrealizedGainsLossesOnInvestment', window );">Distributions received and unrealized gains (losses) on the subordinated notes held by the Company</a></td>
<td class="nump">$ 6,083<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues', window );">Investment management fees</a></td>
<td class="nump">2,297<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax', window );">Total Economic Interests</a></td>
<td class="nump">$ 8,380<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the amount of pre-tax income (loss) derived by the reporting entity from the Variable Interest Entity (VIE).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph d<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income between the reporting entity and the Variable Interest Entity (VIE).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph d<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481420/860-30-50-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481420/860-30-50-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481420/860-30-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vrts_VariableInterestEntityMeasureofActivityDistributionsReceivedandUnrealizedGainsLossesOnInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Variable Interest Entity, Measure of Activity, Distributions Received and Unrealized Gains (Losses) On Investment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vrts_VariableInterestEntityMeasureofActivityDistributionsReceivedandUnrealizedGainsLossesOnInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vrts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352186430944">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidation - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">$ 92,458<span></span>
</td>
<td class="nump">$ 197,240<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">196,698<span></span>
</td>
<td class="nump">307,226<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">41,708<span></span>
</td>
<td class="nump">56,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">92,458<span></span>
</td>
<td class="nump">197,240<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">196,698<span></span>
</td>
<td class="nump">307,226<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">41,708<span></span>
</td>
<td class="nump">56,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Consolidated Investment Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">119,914<span></span>
</td>
<td class="nump">98,101<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">2,201,139<span></span>
</td>
<td class="nump">2,180,814<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableFairValueDisclosure', window );">Notes payable</a></td>
<td class="nump">1,922,051<span></span>
</td>
<td class="nump">1,922,243<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsSoldNotYetPurchasedAtFairValue', window );">Short sales</a></td>
<td class="nump">485<span></span>
</td>
<td class="nump">518<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">1,922,536<span></span>
</td>
<td class="nump">1,922,761<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Debt investments | Consolidated Investment Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments</a></td>
<td class="nump">2,051,130<span></span>
</td>
<td class="nump">2,049,617<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Equity investments | Consolidated Investment Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments</a></td>
<td class="nump">30,095<span></span>
</td>
<td class="nump">33,096<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level&#160;1 | Consolidated Investment Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">119,914<span></span>
</td>
<td class="nump">98,101<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">149,383<span></span>
</td>
<td class="nump">130,984<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableFairValueDisclosure', window );">Notes payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsSoldNotYetPurchasedAtFairValue', window );">Short sales</a></td>
<td class="nump">485<span></span>
</td>
<td class="nump">518<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">485<span></span>
</td>
<td class="nump">518<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level&#160;1 | Debt investments | Consolidated Investment Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">241<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level&#160;1 | Equity investments | Consolidated Investment Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments</a></td>
<td class="nump">29,469<span></span>
</td>
<td class="nump">32,642<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level&#160;2 | Consolidated Investment Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">2,003,963<span></span>
</td>
<td class="nump">2,012,768<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableFairValueDisclosure', window );">Notes payable</a></td>
<td class="nump">1,922,051<span></span>
</td>
<td class="nump">1,922,243<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsSoldNotYetPurchasedAtFairValue', window );">Short sales</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">1,922,051<span></span>
</td>
<td class="nump">1,922,243<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level&#160;2 | Debt investments | Consolidated Investment Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments</a></td>
<td class="nump">2,003,579<span></span>
</td>
<td class="nump">2,012,760<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level&#160;2 | Equity investments | Consolidated Investment Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments</a></td>
<td class="nump">384<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level&#160;3 | Consolidated Investment Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">47,793<span></span>
</td>
<td class="nump">37,062<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableFairValueDisclosure', window );">Notes payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsSoldNotYetPurchasedAtFairValue', window );">Short sales</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level&#160;3 | Debt investments | Consolidated Investment Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments</a></td>
<td class="nump">47,551<span></span>
</td>
<td class="nump">36,616<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level&#160;3 | Equity investments | Consolidated Investment Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments</a></td>
<td class="nump">$ 242<span></span>
</td>
<td class="nump">$ 446<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsSoldNotYetPurchasedAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of obligations incurred from short sales.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481992/940-320-35-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsSoldNotYetPurchasedAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of notes payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20,22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140352192514272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidation - Assets Related to Consolidated Sponsored Investment Products, Unobservable Input Reconciliation (Details) - Debt investments - Consolidated Investment Products - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Balance at beginning of period</a></td>
<td class="nump">$ 37,062<span></span>
</td>
<td class="nump">$ 43,581<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements', window );">Realized and unrealized gain (loss) on investments, net</a></td>
<td class="num">(324)<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchases</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales', window );">Sales</a></td>
<td class="num">(14,625)<span></span>
</td>
<td class="num">(7,195)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3', window );">Transfers to Level 2</a></td>
<td class="num">(13,468)<span></span>
</td>
<td class="num">(35,747)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3', window );">Transfers from Level 2</a></td>
<td class="nump">39,148<span></span>
</td>
<td class="nump">9,904<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Balance at end of period</a></td>
<td class="nump">$ 47,793<span></span>
</td>
<td class="nump">$ 10,658<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sale of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of settlement of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>75
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M0=5 Y3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%
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MJL0#-(O>I[ $].[[D]V-49ON$XY[98Q:=Y<KP4NAK0$\?U"PL_8W]JN0PU=
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M#LH&X/VYE&8SL:VB_3)(_@%02P,$%     @ )$.H6"Z+2.7N!P  :2T  !@
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MCQ[41YVCA'3KA(J&;VGXG@-'>XJ:W5]VD>\_YU$]$]A6* 9M* 9'CXIJ)%5
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MZ5Q9:GF_+&DHHW8.=+Y0RFX-=T$WYK/?4$L#!!0    ( "1#J%C]/C4:\ D
M * V   8    >&PO=V]R:W-H965T<R]S:&5E=#<N>&ULS5M9<]LX$OXK*.W4
MEET51\3!0UG;58Z2U/HA,ZYD9O>9)B$)&XK0@)"=S*]?@*0%'@ D99C9?;%)
MJM'L"]T?&N#U,Q=?J@VE$GS=%F5U,]M(N7LSGU?9AF[3ZC7?T5+]LN)BFTIU
M*];S:B=HFM>#ML4<!4$TWZ:LG-U>U\\>Q.TUW\N"E?1!@&J_W:;BVUM:\.>;
M&9R]//C$UANI'\QOKW?IFGZF\K?=@U!W\P.7G&UI63%> D%7-[,[^&89!7I
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M@E)7Z*$QGKB*DF%Z.T;5%]>@#N1''4N^W2HY*[V" #G3X5?FNDRSW"JK!6=
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M1;$C*1(#K@C\ZSOBQ OHSG7W5-SZ%C)0C?BAVG>Y^UCQ)K:M'XO7+60>KQO
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M+8+28A2M*]/682#NMUCW=RQE;)/<KYG6++^3KKX;8.43Y*3Y'$KSH;0%E!9
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M1#>$.U+NZ$!CS5KF"?0IM.BI)38><XC9D8)$O2%IYZ4/D9A+0F16$E#@ZMC
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M&4\C.2TK^@="&P7HO##&[SZB@?ZO:O$W4$L#!!0    ( "1#J%@F6IL_A08
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MP7XB;/SH$6^\J<*'AKGQWI3A,L=1EBP;X/W"X#3:W+"#[LO3R>]02P,$%
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MC 6X9E VFV#+.)S6-M"HB\N<OBWHV('.-]:&QPT':+]6L]]02P,$%     @
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M,RP"T/TST"^LVOC1NU26!KD7U_1RHG8*=-XH9?<+=\'A+9[]!%!+ P04
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MZ-,PS/.16V4D-1[XF_:?!(]:Q2@^WI<27"6DV&C$#Y5+7A!LZ>M:"0T]>ON
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M=#?"7+2=^TF\G7\H+DMGM, %J<:](4T,NITIVHU5M>_C<V5I*O#+%8UAJ)T
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M/1@0IRT%G(;7(A;Y7.AF=LCFZRZ@5 I-J]8L$_<"FTEH0L 6*D/Y,9</=9[
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M610^00E#E/Q]/J/XF2:WF^/AR7T$@)= H878^B[T\"KE-I>[8^T[OH(.-,
MHZ5*NMWX9!J$&'P42>4/"NH-V\V0HR%@)^$H&,VB4PS&P7 V.#U@C3JRKIWV
M=CC&(!RX]AF-3NR22]4_%M(QI#,)ZR[B[LB.8TW]4#=S@KH%:G5XB0KQW>VE
M[E;::OI,JK0]HWZ!%=P5$9\-0YPT5E>^=#SVP:G?^2Z8"[UT7S\I>4#I/Q&V
ML^T'UI?^N^)&W'^=13U$%M!!B 66#LXG%ST0U7WQ] ]6E>XKXUQ9JW(W3 6"
MKTD [Q<*!V[]0 ;:S\XW_P-02P,$%     @ )$.H6$DB3N&S P  *0@  !D
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M 0>"(KGP=+!1U"1=:V,K06PY!)I\9!34D95:;P0;A9J @D&&J02V=<7FF(/
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M$)]J4Y)^!D6"MOF1_+YOCP"+<[;SX?D,/F'GV SG>:$>F.8^("FE#\T_T#*
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M<SJ<HF$#6L\T26W[P &ZX^[B7U!+ P04    "  D0ZA8<@'Q'XP#   J"
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M_.WK#%R:3&D3;!^GP<8&FBUQV=(P1\<"=%];&PX;-G#\>[#^#U!+ P04
M"  D0ZA8?0$@:]P"  !Z!@  &0   'AL+W=O<FMS:&5E=',O<VAE970R,BYX
M;6R-55%OVC 0_BNGK-I6B1$(T*(.D(!N6J55JDJW/4Q[,,E!K#IV9A]0_OW.
M,62T*FPOX//=]]UW]ODRV!C[Z')$@J=":3>,<J+R*HY=FF,A7-.4J-FS,+80
MQ*9=QJZT*+(*5*@X:;4NXD)('8T&U=Z='0W,BI34>&?!K8I"V.T$E=D,HW:T
MW[B7RYS\1CP:E&*),Z1OY9UE*ZY9,EF@=M)HL+@81N/VU:3KXZN [Q(W[F -
MOI*Y,8_>N,F&4<L+0H4I>0;!?VN<HE*>B&7\WG%&=4H//%SOV3]7M7,M<^%P
M:M0/F5$^C/H19+@0*T7W9O,%=_7T/%]JE*M^81-BD\L(TI4C4^S K*"0.OR+
MI]TY' #ZK2. 9 =(*MTA4:7R6I 8#:S9@/71S.875:D5FL5)[2]E1I:]DG$T
MNL8Y#6)B)F_'Z0XU":CD"*H#MT93[N"3SC![CH]902TCV<N8)"<);X5M0J?=
M@*25=$_P=>JR.A5?YT19<"U=JHQ;682?X[DCRRWPZ[5B U?W=2[_+*Y<*5(<
M1MSW#NT:H]';-^V+UL<32KNUTNXI]J,7\&\43"UFDF"\M(C\3@@><H2I*4JA
MM^\<I,$M]NX&" >"5WQE\)XX-GK)$)TW(&4"*QTZ>"_/0<!9<MEKMKCWE/+/
MB- 6H(S0W*B4L]_A&O6'+0H;?('YP2^_<EAT#OA42BOU$J2&&9:$Q1RMO^D^
M2]*L189$[6>)+*Z-6GO8KI"%2*62M-TG7O!S/LA[-,M%\_!@F+<4,H.S5O.R
MSL73RA%+\? 5GP]3,J*N ;)5Q>PW*>>S@B*T?SA+;MXTK[NW*BD7G"'I]9OM
M_\XAZ 51$V[\U$J-S81.,90]GDVAW^DUV,=5HZ/76C ^F <%VF4U];@AS$I3
M& WU;CU8QV&>_ T/4YDE+:5VH'#!4#ZS7@0V3+I@D"FKZ3(WQ+.J6N;\<4#K
M ]B_,(;VAD]0?VY&?P!02P,$%     @ )$.H6)0=B+NL!   IPH  !D   !X
M;"]W;W)K<VAE971S+W-H965T,C,N>&ULK5;;;ALW$/V5P19H7U1)ENTT2&4!
ML=,B!6(@2'IY*/K 78YV67-)F>1*UM_W#*F5Y<(QT,N+M"1GSIPY,[PL=S[<
MQ8XYT4-O7;RJNI0V;V:SV'3<JSCU&W986?O0JX1A:&=Q$UCI[-3;V6(^?S7K
ME7'5:IGG/H;5T@_)&L<? \6A[U787[/UNZOJK!HG/IFV2S(Q6RTWJN7/G'[9
M? P8S8XHVO3LHO&. J^OJK=G;ZXOQ#X;_&IX%T^^23*IO;^3P4_ZJIH+(;;<
M)$%0^-OR#5LK0*!Q?\"LCB'%\?1[1/\QYXY<:A7YQMO?C$[=5?6Z(LUK-=CT
MR>_>\R&?2\%KO(WYEW;%]G)143/$Y/N#,QCTQI5_]7#0X<3A]?P+#HN#PR+S
M+H$RRW<JJ=4R^!T%L0::?.14LS?(&2=%^9P"5@W\TNK&][U)4#E%4D[3C7?)
MN)9=8S@N9PDAQ'#6'."N"]SB"W#G= N +M(/3K-^ZC\#M2._Q<CO>O$BX*T*
M4SH_F]!BOKAX >_\F.]YQCO_-_G2.Q,;Z^,0F'Y_6\<4T#1_/*=""7+Q?!#9
M2&_B1C5\56&G1 Y;KE9??W7V:O[]"RE<'%.X> G]GY?L/\#1!VZ5I5N5$H=(
M/W>,]7ZCW)Y,)..VWFY9TSKXGA(V*R5?_HTC:Y)I5=E[P%6A-A!4QA-2D7;8
MB?+/#PI]G>?C!'[W@PD267P0@..($JG>TU8%XX>(\Z =K$H^[*GV&O:3 QM0
M)X-4&M"T1KF&L:-2AY"]QY)/'0=*'<S@$KD9 F@BG%4[3#360(A#7-&$VL%H
M%LVP*C;4^BT')V$ 54Z5@N#75 =_Q^%;S<J*7))""9@]97C@G=-1Z[6<30?"
MF^#UT*13KT?PZ1/I S<^:%A"8U4;"+VG7<<..%*6&MX"5ZO:HB*=2D\L.XA>
MLU@[9!]0/HF8D^G]@)21B(P>/1KEX(&P*GH'T#U)57 DLI[29],ZLS:P2?3G
MH-NLFI$*2259BE@8":9F]-%8;@E4:)8P(XVG1F"+ID)Z11+"_HP%_V]LD.R4
MKG%"0SY)KMQ8 I'3= F6:JN,%<O)XR=,L>-SIS126]Q%TDR:>U<**[P0 K8&
M!ZW4,&]I-$0Z*4J-+F',%L%E!7<@NK!TAE38YKUTT@72O1"@8=;2C]@B3,XG
M*'_'=C\A-CEG<$$;Z$%99.!E7*K5ML!!$28B4*>VF"(I2C 21B.5R,2YR421
M$[+?B'P1%U?FAAL^C/NO4;&C-:[JF"/EC>2BMT9+M6F-JN!@ #ZFM1&G*;WW
M.R0>)B,Q#$H7#8X?-H@.QSC4$0TA"QKKUF_RB3/)<K2XF(NK<4A8C :'DU.;
M)HW-49H2"3VK8E\.J*<5D;:%O)!.9$4CC67.%9+<,,4Q]@>ZXE/0"QP.#AQ1
M>"7($R(C0['<]F-I"WV$&=4^S(L2#8>$1]%(#8(-5O\_99+2G!0*038J)--
MC4#W [XYE%91SJ%M")[&ZSA][O:9G3P>>@YM?B)ENBZ5=\1Q]O@*>UL>'X_F
MY0F'R[K%9H*(:[C.I]]=5A3*LZ@,DM_DIPC. SQL\F>'ER0',<#ZVOLT#B3
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M]HP$!@UG;@M?'#SQ\E/TM&=3# >R,.H7_96 MSC9DX?'^]M\S,KX3G_=:L6
M+?*=E(%!>K'P9J%%]1G@F:&2@ZA^\''QMP>Y'=,ZGO0#T.$@;&7C9-B:(<@2
M5FB2F@8&P6VK;?E-?O*_M-;_&_8CN(F$W6H\#P^.D>U)4. :T?T!XKHK/J\^
M3!9U\G0?4;T E%/GY+5%W"^J""AF!JP+CDWH8H586P1H=7Y-:6)]!X>8RD&\
M(W-;:,;<B-V&4$Z,Q$$"5*(:(E7-5#G)#Q$0896Y T<#RPD2;DQ=%ZYDH"&H
M_]\F=G\3VP&3'@\PZ?%.(//17)FF-\ 'A0/@VU:4[B:2Z?$!@0<F*6;AA2YA
M/U@4P@WIG\,,%9=N5MF%3CM#EA[F#!L%.;@".#;(1"JOO!L*/BK/+<,,*-KK
M)LR-ITH/&4LZ,L:S"UX9*:NR*D[-#>%7Q-/.VUD_%$J19'Q-3W19HPJDAL(X
M: FIEJXJ867Y!!9V+(AAHT5?\<XAL++0!57K"_8+;+NGCPV H@[!2'4F=>S
M,,7R.?;?A<A[--AADB+CQ,IS[^JHL%B>)GYR+O#U"C[.N >&WNB.T@V+U,]^
MAX>1ZN8P/P>-(Y\$Q(6U4O-!2+LPQ21"=EBFE%*3B_?$>Q"L47K$ATK0&PJ
MSV YV_Q#]<H4N@]Q%1NFM]BGB@**CL49M@%VAP0*1ZJ8+Z"8Q"(S!NZIHHA
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MYD2@-J+ PSDM:YO2M-0A;;ILL;GUM4A5.W+;K%VYLF9<AS.=*"EMK882V8Y
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M_G2@=@IT7BIZ;G8+=T'_-V;Q'U!+ P04    "  D0ZA8XGKH86X%   7$0
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M&A_2=E@ .BG- IQ?""SA[L,8&/X7,OL/4$L#!!0    ( "1#J%BD>R>O\0(
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MHRS5:M^MZ7%$[0QHO5+*'@9N@^&Y7?T'4$L#!!0    ( "1#J%BB<X<(B@D
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M"QJO'<9GM5!,EOC-JN6*EP],%!+Q;>RO'78OE*"DI^R%[/ ),7N29HR;S1!
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M>(XV*^'.-MS;[;.^"4V&ZD5U#^B?5A"BKJ!N+T.)8,#KD V4J%'L6'DM*%D
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M9I'7_OOM?] &2.NV5_OE7NH[X9@*B75UU']J!WM1J#>UT_.^]),5)169>=9
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MVD!=7S(F7R;Z!DW#:?8?4$L#!!0    ( "1#J%C![0T.Z0(  -(+   9
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MS+P#18Y#T)1Q=4+.R,,\),=')^2(L(Q\2T2A:!:KL:TQJ)':T3; =17 ?2M
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M-K.^79G&'J2=8-XOA-#W [M ]U<A^P502P,$%     @ )$.H6!5DY5#V @
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MI@+D^SFEXF6B^KNFGX^> 5!+ P04    "  D0ZA8NR!VEFP"  #"!0  &0
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MR()Q#G2^TAJW&Q>@']OI;U!+ P04    "  D0ZA8EQ/)^^$'  #H1   &0
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MV$/B['%AR29)(8-*S8P5($.V.6_2;\DFFWQA.X1N,4,.H<O:EVY:HXCHV&'
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M#-(8X/Y""/TZ,0[JQCK\"U!+ P04    "  D0ZA83D1XSXL#  !>#   &0
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M9OY)P ]$7D/0NP3?\_L=?.8_[AZ<H!,T"@<E7G!,X?OY'4RUEG11:+)@"%K
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MW7X-O!47-$J"Y0BB(#:_^"T1(A> #@6@) !]-L!- EQ-U(Q,TWK  @\'C&Z
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M*]T7VL>9[L1!F 7Z_81SM1Z8 &5O/_P+4$L#!!0    ( "1#J%B)U+==ZP,
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M/K28,Z@]-3!\PR-\_P)/4<)(AGZB!40%AQAI[W58=F5ETI%Y(7(2P<Q1H2>
M;\$)7_R%1][;+ID]D;5$#VO10\,^."+ZH^HCMD)SI99*](Y$-*'R 7TU+SY(
M2,6W+@<,^W1 3V0M!P2U P+KJIOXX)"3!_7MDJ)+JY7@5*TEV<B0Z4_P-AQ[
M^F_J;CM4C&H5(ZN*3X44DF0QS=9HR;A"JU:G&"O/J6)*LN! C!],L$7/N-8S
M?G0L5EOS<LT!]!IUJ;*RG:JJ)[*6\$DM?/(L\3CITP$]D;4<<%X[X-RZ\C?D
MGJ9%VNQB%!$UF?)!E^SSWZ+)'P=>>P.6FJRS/E$3]IHD[/UY/ZMEC8_DDS_
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M) :N!ZCW*\;DOJ,GJ&]DPE]02P,$%     @ )$.H6#*CC;.0!0  7B,  !D
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MTEL(QCG0>J'I=%K#]6?WNJ9_ %!+ P04    "  D0ZA8#%=I7=,#  #:#P
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M    >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;'U5;6_:,!#^*U963:VT-2%
MRCJ(5*#3*K4:ZML^3/M@DH-8]4MF.U#VZW=VTI1M*5^(S[Y[[GE\OF.\5?K)
M% "6/ LNS20HK"W/P]!D!0AJ3E4)$D]62@MJT=3KT)0::.Z#! _C*$I"09D,
MTK'?6^ATK"K+F82%)J82@NK=%+C:3H)>\+)QR]:%=1MA.B[I&N[ /I0+C5;8
MHN1,@#1,2:)A-0DN>N?3Q/E[AT<&6[.W)D[)4JDG9USEDR!RA(!#9AT"Q<\&
M9L"Y T(:OQK,H$WI O?7+^A?O';4LJ0&9HI_9[DM)L$H(#FL:,7MK=I^A4;/
MT.%EBAO_2[:-;Q20K#)6B288&0@FZR]];NYA+R".WPB(FX#8\ZX3>99S:FDZ
MUFI+M/-&-+?P4GTTDF/2%>7.:CQE&&?3F9)&<993?T<?R66FI!(L(U?2@@9C
M#5$K\NH%.9YL<!\+8\E"J[S*+#F>@Z6,FQ-$F%U_,^2(,$GN"U49*G,S#BU2
M=0G#K*$UK6G%;]#JDQLE;6'(I<PA_SL^1(FMSOA%YS0^"'A#]2GI]SZ0.(H'
MY.%N3HZ/3@[@]MO[ZWO<_ANXCU0SNN30WA<RMLSNR(]K]"17%H3YV:6_AAUT
MP[I6/#<ES6 28*\9T!L(TO?O>DGT^0#I04MZ< @]G3-C-5M6KN8&6RL#[(R<
M8*E();&U.?N-YAI;VI!CKHP!K"P^#UL =N]2Z9Q)_Q2DLF!( 3PGRYT_GBE1
M4KGK4EQS2CPG-RLV:1*-^N-PTZ%DV"H9'E2R]Q8%E3A%_'(%T/GF:JSA'H,X
M_G36S2!I&20'&=PK2WE'VW3E3_Z[@5%_%/V3/]QK9@%Z[4>6(9FJI*W[NMUM
MI^)%/0Q>W>N1BH]^[6K(886AT>D92M?UF*H-JTH_&I;*XJ#QRP(G.VCG@.<K
MA05N#)>@_:](_P!02P,$%     @ )$.H6/L>^V54"   044  !D   !X;"]W
M;W)K<VAE971S+W-H965T-C(N>&ULM9QM;]M&$H#_"J$K#BV0B\A]%7.V@,:^
MH 6:0Y"TO<^TM+:(4J)+4G8#],<?*2D:+G<YE*C1ET2R9\<SN\.9AZ.A;E[S
MXH]R94P5_+7.-N7M9%55S^^FTW*Q,NND?)L_FTW]F\>\6"=5_;9XFI;/A4F6
MNT7K;,K"4$W72;J9S&]V/_M4S&_R;96E&_.I",KM>IT47]^;+'^]G423;S_X
MG#ZMJN8'T_G-<_)DOICJM^=/1?UN>M2R3-=F4Z;Y)BC,X^WDQ^C=W2QL%NPD
M?D_-:]EZ'32N/.3Y'\V;GY>WD["QR&1F434JDOJ_%W-GLJS15-OQYT'IY/@W
MFX7MU]^T?]@Y7SOSD)3F+L_^ERZKU>UD-@F6YC'99M7G_/4G<W!(-OH6>5;N
M_@U>#[+A)%ALRRI?'Q;7%JS3S?[_Y*_#1K061*)G 3LL8*<NX(<%?.?HWK*=
M6_=)E<QOBOPU*!KI6EOS8K<WN]6U-^FF.<8O55'_-JW75?.[?%/F6;I,=IOZ
MK^#'LC15&22;9?!+FCRD65JEI@P^FJ3<%F89)%7P(4F+X/<DVYJ@7O+9++9%
MD6Z>@O=)F9;!]_>F2M*L_*%6]MN7^^#[[WX(O@O23?#K*M^6M=[R9EK5AC=_
M?KHX&/E^;R3K,?)C4KP->/0F8"$3GN5W^/)[LS@NY_;R:;U=QSUCQSUC.WV\
M1]]^CWQN[-<)_[KFBGQ7/B<+<SNI+[G2%"]F,O_G/R(5_MOG%)$RRT5^=)%C
MVN=W2;D*S)_;]"7)S,;O[%Z#VFEHLL7+/&9"SFZF+VTO7*DHUDR$1S'+/G&T
M3Z#V_9I7218D^V!=MX+SL0G.ER8X?2;OE4K+&*7BKLVN& \U8\IOLSS:+-&P
M:5U//MLD9>P0*;/\5$<_U0EGD[6RQ^D'I)R=%Y$.N^?C2DE5URW_\>BCV1HU
M^Q?S8K+])D0^T]#5YYX/D3++T=G1T=G(]#6C=)%(F>5B?'0QOCA]Q4X0^=*7
M*X6EKRB$LAM>(X$=M YF,(\<EL*B%BY$ER2QPVJB$*+29OL*93Y"2^Q%B>R@
MNGT 8?>,,!';9"C;$5ZW6TF,><U"EY]]/D3:;&>! 2(Q,I%%*#V<[2:1-MM-
MP(8(K=8G);.#"C3<,!';-*CTT2FE_OPLYA9PQUI,Q+86"GRD+\I=I!6>2IOM
M*]3X"*VOE^6NV?#Q8"*VR5"S([QHMW(7]YJ%+C_[?(BTV7>04/]9./8>$@6'
MLV\BB;39;@(N,+1$GY2[#BJP<$-%;--:-_&G5/>S<Q<;+NRHB&TM%';&+\E=
MC+2N4VFS?86ZSDZYN1^7NYA[[^Z[@_2((;>0#&HUPVLU],;>?.N9K9NX?]/J
MD_T=0-.M=NGGS8LIJT8J^%3DR^VBYRHA[0]0:;.W";B!J;'9#P6.L]TDTF:[
M"<#!\);"2=E/NW=T41Q'HANQKEP\B\*H)V(!%-@IH'!^&G0!@+$PBGC<M=LC
M&,W"6<M!VW+@!19?E!))<8%*F]V-!5S@>+O@OWE5I\'GY&ORD'G/@_L: _6)
MR*C;C_4+,L']Y\&AUG.\UG]9Y445E'6H^]O%;@T7,]FUSA62T:S',BCU_'HW
M\MPMYLU^2:ZZIOL%M>JY1'FK%X_?U)]65.[-0Q6DQV)2CJPSN"WG7C94VNR=
M Y+@8SL$G+1#0*7-=A.H@^/4 4?K]]6]\V\20\2[X.H5%+&*=$\(0\'G>*/@
MM!#^3UTJJZ\404Q*$53:[+T#BN!XVP()8M*.!94VVTT $8Z#R% 0NQS!PS!V
M"HA'C(=Q3]^; VQPO#EQ6@"W/T,:&[JDV$*ES?Z0%K!%C.UR"-(N!Y4VVTT@
M'W%YET.X9./E?(\<POD"&$A<I=TA/%0C8C[C7;,]<O5U-^NA? 'P(RYJ? A2
M7*'29OO:&FK &Q^#E"_<MD6WAJ,BMEW %P+GBP&R%RXVN&3O$>HE>P%<(:XW
M:R \PP:NV9Y9@UZSH:0+O#$PJIH0 3YNVME7S#6@00 TB+&S#()TF(%*F^TF
MT(? Z6. C80[I>"D!5>$B9ZB(J&^2[PM,2J.R2@?-^[LD:EK,(0$AI#X8$5_
M)$O2F0HJ;;:;@"$2QY"!2)8N1K!8J&Y3T2/&F1*L)YX!-B1%IZ4]9#$V=$FQ
MA4J;O6N +7)LET62=EFHM-ENML8W+Y_#D,-S&*B(;1I@D+S*'(9TX8:%(8]5
ME^Z]@A'3JH>$))"0O&@F0Y+""I4VVU> %8EW. ;Q7KK-"W\3OT>PMXDO@30D
M3AH#J"^'20,5L0>*@3/4*=.2(T>*3_UDI$>P=U,5U':%]P=&E14BW,=-._<*
MHM)F;R30@QK[Y(4B??2"2IOM)F"(PC%D )(.J[MI6^HN)GD%F[3==T%"R5=X
MIV)41).!/V[<V8=]#:Q0@!4*?RP$B6G2D0\J;;:;K8="<$09BFF7,/BLVQOU
M"/4 B ( 4<2M&#XV:$E1ADJ;O6N ,FILWT61]EVHM-EN @VIRY\C4<-(A(K8
M#RL!$NFK/$"B7<@16L==X/>(<1VJGAML#22D+WI\1)/""I4VVU> %8VW.@9Q
M7P^/DJ(BMEU %QJGBP'$URXT.%9A(K950!3Z>D.?>OAC$53$-ADJMZ88]NR4
M#B*LQTT[^TJY!AMH8 ,]=AQ4DPYR4&FSW6P]8(JCQ@ ":7?"4VCIW*9ZQ+A2
M4<^$@X:2KO'NQ*AH)D-ZW+BS#_H:V* !&S0^F8K$,^ET!Y4V^S%B0) 9CB #
M\7Q8W7[TG[5:]'L7/$)"=&-YVOI^B^;+13XFQ5.Z*8/,/-:KPK=-^BKVW]>Q
M?U/ES[NOO'C(JRI?[UZN3+(T12-0__XQKVOSX4WS+1K';TV9_Q]02P,$%
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M%OA0 V4#\/M&2G/HV 3]TR_]'U!+ P04    "  D0ZA8X&+71R(#   .$@
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M"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ )$.H6)F?AB(!!0  ?2D   \
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M&@_A<'DAJ^+6BO"Q>4DAR\,4XZ*IJN^X[$9?&5ENWQ[<OOGX[5]02P,$%
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M4$L! A0#%     @ )$.H6/([&)7P    *P(  !$              ( !KP
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ )$.H6)E<G",0!@  G"<
M !,              ( !S@$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    "  D0ZA8-%EBELH%  #%'@  &               @($/"   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ )$.H6&FE'D7D!P  $20
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M965T-BYX;6Q02P$"% ,4    "  D0ZA8_3XU&O )  "@-@  &
M    @('2)P  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @
M)$.H6(N[;PI9"P  CV\  !@              ("!^#$  'AL+W=O<FMS:&5E
M=',O<VAE970X+GAM;%!+ 0(4 Q0    ( "1#J%A$Q([KH (  .<&   8
M          " @8<]  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4
M    "  D0ZA8ZD*38Q($  !A"0  &0              @(%=0   >&PO=V]R
M:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( "1#J%@F6IL_A08  (42
M   9              " @:9$  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL
M4$L! A0#%     @ )$.H6,+]$Z$:!   #0D  !D              ("!8DL
M 'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    "  D0ZA8%E>U
MY00#  "Y!@  &0              @(&S3P  >&PO=V]R:W-H965T<R]S:&5E
M=#$S+GAM;%!+ 0(4 Q0    ( "1#J%C@R;T03P,  )<'   9
M  " @>Y2  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @
M)$.H6%ZR+F 7!   Y D  !D              ("!=%8  'AL+W=O<FMS:&5E
M=',O<VAE970Q-2YX;6Q02P$"% ,4    "  D0ZA8R2O6[UL'  ""%@  &0
M            @('"6@  >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4
M Q0    ( "1#J%A)(D[ALP,  "D(   9              " @51B  !X;"]W
M;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ )$.H6!QR=\7< @
MD08  !D              ("!/F8  'AL+W=O<FMS:&5E=',O<VAE970Q."YX
M;6Q02P$"% ,4    "  D0ZA80Z6N [P&  !@$   &0              @(%1
M:0  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( "1#J%C%
M>\A.J@0  /H*   9              " @41P  !X;"]W;W)K<VAE971S+W-H
M965T,C N>&UL4$L! A0#%     @ )$.H6'(!\1^, P  *@@  !D
M     ("!)74  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( "1#J%@FVB\.1 (  (H&   9              "
M@0R8  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ )$.H
M6 NRJZS5$    C4  !D              ("!AYH  'AL+W=O<FMS:&5E=',O
M<VAE970R-RYX;6Q02P$"% ,4    "  D0ZA8+R:G.<<"   3!@  &0
M        @(&3JP  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0
M   ( "1#J%ABKH,N@ ,  'P(   9              " @9&N  !X;"]W;W)K
M<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ )$.H6#CS+O>P P  T@@
M !D              ("!2+(  'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q0
M2P$"% ,4    "  D0ZA8XGKH86X%   7$0  &0              @($OM@
M>&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( "1#J%BD>R>O
M\0(  (,&   9              " @=2[  !X;"]W;W)K<VAE971S+W-H965T
M,S(N>&UL4$L! A0#%     @ )$.H6#MQO$LF P  7@<  !D
M ("!_+X  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    "  D
M0ZA8;"FH">(#  !B"0  &0              @(%9P@  >&PO=V]R:W-H965T
M<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( "1#J%ARO=QF.P,  'H'   9
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M970S.2YX;6Q02P$"% ,4    "  D0ZA8%63E4/8"  #-"0  &0
M    @(%'W@  >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    (
M "1#J%B"_"$KW@(  *P)   9              " @73A  !X;"]W;W)K<VAE
M971S+W-H965T-#$N>&UL4$L! A0#%     @ )$.H6 -4_+G^ @  VPL  !D
M             ("!B>0  'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"
M% ,4    "  D0ZA8NR!VEFP"  #"!0  &0              @(&^YP  >&PO
M=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( "1#J%B7$\G[X0<
M .A$   9              " @6'J  !X;"]W;W)K<VAE971S+W-H965T-#0N
M>&UL4$L! A0#%     @ )$.H6"K8+R=Q!   ZAX  !D              ("!
M>?(  'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4    "  D0ZA8
M@25BO!0#  #X!P  &0              @($A]P  >&PO=V]R:W-H965T<R]S
M:&5E=#0V+GAM;%!+ 0(4 Q0    ( "1#J%CR4O5S00,  &0+   9
M      " @6SZ  !X;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%
M  @ )$.H6$Y$>,^+ P  7@P  !D              ("!Y/T  'AL+W=O<FMS
M:&5E=',O<VAE970T."YX;6Q02P$"% ,4    "  D0ZA8"\'*FDL%   M'@
M&0              @(&F 0$ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+
M 0(4 Q0    ( "1#J%B&THR:;0(  .,%   9              " @2@' 0!X
M;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @ )$.H6,4>SK]A
M P  YPL  !D              ("!S D! 'AL+W=O<FMS:&5E=',O<VAE970U
M,2YX;6Q02P$"% ,4    "  D0ZA8B=2W7>L#  ")#   &0
M@(%D#0$ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    ( "1#
MJ%@)4N GS@(  " )   9              " @881 0!X;"]W;W)K<VAE971S
M+W-H965T-3,N>&UL4$L! A0#%     @ )$.H6#UVMH=0 @  I04  !D
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M=#4X+GAM;%!+ 0(4 Q0    ( "1#J%@V8.[P:0(  &D%   9
M  " @>HJ 0!X;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%     @
M)$.H6 Q7:5W3 P  V@\  !D              ("!BBT! 'AL+W=O<FMS:&5E
M=',O<VAE970V,"YX;6Q02P$"% ,4    "  D0ZA8A'6GTK\"   W!@  &0
M            @(&4,0$ >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+ 0(4
M Q0    ( "1#J%C['OME5 @  $%%   9              " @8HT 0!X;"]W
M;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @ )$.H6 H'M%)G P
M!@H  !D              ("!%3T! 'AL+W=O<FMS:&5E=',O<VAE970V,RYX
M;6Q02P$"% ,4    "  D0ZA8X&+71R(#   .$@  #0              @ &S
M0 $ >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( "1#J%B7BKL<P    !,"   +
M              "  0!$ 0!?<F5L<R\N<F5L<U!+ 0(4 Q0    ( "1#J%B9
MGX8B 04  'TI   /              "  >E$ 0!X;"]W;W)K8F]O:RYX;6Q0
M2P$"% ,4    "  D0ZA8)V75I0P"  "$)0  &@              @ $72@$
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    "  D0ZA8[M7M
M&.8!  #U)   $P              @ %;3 $ 6T-O;G1E;G1?5'EP97-=+GAM
7;%!+!08     1P!' &@3  !R3@$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>201</ContextCount>
  <ElementCount>262</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>56</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Condensed Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations</Role>
      <ShortName>Condensed Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Condensed Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/CondensedConsolidatedStatementsofComprehensiveIncome</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Condensed Consolidated Statements of Comprehensive Income (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity</Role>
      <ShortName>Condensed Consolidated Statements of Changes in Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Changes in Stockholders' Equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Organization and Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/OrganizationandBusiness</Role>
      <ShortName>Organization and Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Basis of Presentation and Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/BasisofPresentationandSignificantAccountingPolicies</Role>
      <ShortName>Basis of Presentation and Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Revenues</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/Revenues</Role>
      <ShortName>Revenues</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Acquisitions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/Acquisitions</Role>
      <ShortName>Acquisitions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Intangible Assets, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/IntangibleAssetsNet</Role>
      <ShortName>Intangible Assets, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/Investments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Equity Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/EquityTransactions</Role>
      <ShortName>Equity Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Accumulated Other Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/AccumulatedOtherComprehensiveIncomeLoss</Role>
      <ShortName>Accumulated Other Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Earnings (Loss) Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/EarningsLossPerShare</Role>
      <ShortName>Earnings (Loss) Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Redeemable Noncontrolling Interests</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/RedeemableNoncontrollingInterests</Role>
      <ShortName>Redeemable Noncontrolling Interests</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Consolidation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/Consolidation</Role>
      <ShortName>Consolidation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9954471 - Disclosure - Basis of Presentation and Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/BasisofPresentationandSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Basis of Presentation and Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.virtus.com/role/BasisofPresentationandSignificantAccountingPolicies</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9954472 - Disclosure - Revenues (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/RevenuesTables</Role>
      <ShortName>Revenues (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.virtus.com/role/Revenues</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9954473 - Disclosure - Intangible Assets, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/IntangibleAssetsNetTables</Role>
      <ShortName>Intangible Assets, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.virtus.com/role/IntangibleAssetsNet</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9954474 - Disclosure - Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/InvestmentsTables</Role>
      <ShortName>Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.virtus.com/role/Investments</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9954475 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.virtus.com/role/FairValueMeasurements</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9954476 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/AccumulatedOtherComprehensiveIncomeLossTables</Role>
      <ShortName>Accumulated Other Comprehensive Income (Loss) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.virtus.com/role/AccumulatedOtherComprehensiveIncomeLoss</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9954477 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/StockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.virtus.com/role/StockBasedCompensation</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9954478 - Disclosure - Earnings (Loss) Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/EarningsLossPerShareTables</Role>
      <ShortName>Earnings (Loss) Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.virtus.com/role/EarningsLossPerShare</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9954479 - Disclosure - Redeemable Noncontrolling Interests (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/RedeemableNoncontrollingInterestsTables</Role>
      <ShortName>Redeemable Noncontrolling Interests (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.virtus.com/role/RedeemableNoncontrollingInterests</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9954480 - Disclosure - Consolidation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/ConsolidationTables</Role>
      <ShortName>Consolidation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.virtus.com/role/Consolidation</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9954481 - Disclosure - Revenues (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/RevenuesDetails</Role>
      <ShortName>Revenues (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.virtus.com/role/RevenuesTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9954482 - Disclosure - Acquisitions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/AcquisitionsDetails</Role>
      <ShortName>Acquisitions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.virtus.com/role/Acquisitions</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9954483 - Disclosure - Intangible Assets, Net - Goodwill and Intangible Assets, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/IntangibleAssetsNetGoodwillandIntangibleAssetsNetDetails</Role>
      <ShortName>Intangible Assets, Net - Goodwill and Intangible Assets, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9954484 - Disclosure - Intangible Assets, Net - Estimated Amortization Expense of Intangible Assets Succeeding Years (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/IntangibleAssetsNetEstimatedAmortizationExpenseofIntangibleAssetsSucceedingYearsDetails</Role>
      <ShortName>Intangible Assets, Net - Estimated Amortization Expense of Intangible Assets Succeeding Years (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9954485 - Disclosure - Investments - Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/InvestmentsInvestmentsDetails</Role>
      <ShortName>Investments - Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9954486 - Disclosure - Investments - Marketable Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/InvestmentsMarketableSecuritiesDetails</Role>
      <ShortName>Investments - Marketable Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9954487 - Disclosure - Investments - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/InvestmentsNarrativeDetails</Role>
      <ShortName>Investments - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9954488 - Disclosure - Fair Value Measurements - Changes in Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/FairValueMeasurementsChangesinAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Changes in Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9954489 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9954490 - Disclosure - Fair Value Measurements - Rollforward of the Contingent Consideration Liabilities Valued Using Level 3 Inputs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/FairValueMeasurementsRollforwardoftheContingentConsiderationLiabilitiesValuedUsingLevel3InputsDetails</Role>
      <ShortName>Fair Value Measurements - Rollforward of the Contingent Consideration Liabilities Valued Using Level 3 Inputs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9954491 - Disclosure - Equity Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/EquityTransactionsDetails</Role>
      <ShortName>Equity Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.virtus.com/role/EquityTransactions</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9954492 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/AccumulatedOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>Accumulated Other Comprehensive Income (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.virtus.com/role/AccumulatedOtherComprehensiveIncomeLossTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9954493 - Disclosure - Stock-Based Compensation - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/StockBasedCompensationAdditionalInformationDetails</Role>
      <ShortName>Stock-Based Compensation - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9954494 - Disclosure - Stock-Based Compensation - Stock Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails</Role>
      <ShortName>Stock-Based Compensation - Stock Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9954495 - Disclosure - Stock-Based Compensation - Restricted Stock Units Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Restricted Stock Units Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9954496 - Disclosure - Earnings (Loss) Per Share - Schedule of Computation of Basic and Diluted Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/EarningsLossPerShareScheduleofComputationofBasicandDilutedEarningsPerShareDetails</Role>
      <ShortName>Earnings (Loss) Per Share - Schedule of Computation of Basic and Diluted Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.virtus.com/role/EarningsLossPerShareTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9954497 - Disclosure - Earnings (Loss) Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails</Role>
      <ShortName>Earnings (Loss) Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.virtus.com/role/EarningsLossPerShareTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9954498 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.virtus.com/role/IncomeTaxes</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9954499 - Disclosure - Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/DebtDetails</Role>
      <ShortName>Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.virtus.com/role/Debt</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9954500 - Disclosure - Redeemable Noncontrolling Interests - Schedule of Redeemable Noncontrolling Interest (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/RedeemableNoncontrollingInterestsScheduleofRedeemableNoncontrollingInterestDetails</Role>
      <ShortName>Redeemable Noncontrolling Interests - Schedule of Redeemable Noncontrolling Interest (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9954501 - Disclosure - Consolidation - Condensed Consolidated Balance Sheets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/ConsolidationCondensedConsolidatedBalanceSheetsDetails</Role>
      <ShortName>Consolidation - Condensed Consolidated Balance Sheets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9954502 - Disclosure - Consolidation - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/ConsolidationAdditionalInformationDetails</Role>
      <ShortName>Consolidation - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9954503 - Disclosure - Consolidation - Beneficial Interests of Consolidated Investment Product (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/ConsolidationBeneficialInterestsofConsolidatedInvestmentProductDetails</Role>
      <ShortName>Consolidation - Beneficial Interests of Consolidated Investment Product (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9954504 - Disclosure - Consolidation - Revenue and Expenses of Consolidated Investment Product (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/ConsolidationRevenueandExpensesofConsolidatedInvestmentProductDetails</Role>
      <ShortName>Consolidation - Revenue and Expenses of Consolidated Investment Product (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>9954505 - Disclosure - Consolidation - Economic Interests of Consolidated Investment Product (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/ConsolidationEconomicInterestsofConsolidatedInvestmentProductDetails</Role>
      <ShortName>Consolidation - Economic Interests of Consolidated Investment Product (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>9954506 - Disclosure - Consolidation - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails</Role>
      <ShortName>Consolidation - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="vrts-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>9954507 - Disclosure - Consolidation - Assets Related to Consolidated Sponsored Investment Products, Unobservable Input Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.virtus.com/role/ConsolidationAssetsRelatedtoConsolidatedSponsoredInvestmentProductsUnobservableInputReconciliationDetails</Role>
      <ShortName>Consolidation - Assets Related to Consolidated Sponsored Investment Products, Unobservable Input Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 -  vrts-20240331.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" isDefinitelyFs="true" isUsgaap="true" original="vrts-20240331.htm">vrts-20240331.htm</File>
    <File>vrts-20240331.xsd</File>
    <File>vrts-20240331_cal.xml</File>
    <File>vrts-20240331_def.xml</File>
    <File>vrts-20240331_lab.xml</File>
    <File>vrts-20240331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>vrts-20240331_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://fasb.org/srt/2023</BaseTaxonomy>
    <BaseTaxonomy items="662">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/ecd/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>82
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "vrts-20240331.htm": {
   "nsprefix": "vrts",
   "nsuri": "http://www.virtus.com/20240331",
   "dts": {
    "inline": {
     "local": [
      "vrts-20240331.htm"
     ]
    },
    "schema": {
     "local": [
      "vrts-20240331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "vrts-20240331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "vrts-20240331_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "vrts-20240331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "vrts-20240331_pre.xml"
     ]
    }
   },
   "keyStandard": 239,
   "keyCustom": 23,
   "axisStandard": 17,
   "axisCustom": 0,
   "memberStandard": 27,
   "memberCustom": 27,
   "hidden": {
    "total": 6,
    "http://xbrl.sec.gov/dei/2023": 5,
    "http://fasb.org/us-gaap/2023": 1
   },
   "contextCount": 201,
   "entityCount": 1,
   "segmentCount": 56,
   "elementCount": 519,
   "unitCount": 5,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 662,
    "http://xbrl.sec.gov/dei/2023": 29,
    "http://xbrl.sec.gov/ecd/2023": 4,
    "http://fasb.org/srt/2023": 2
   },
   "report": {
    "R1": {
     "role": "http://www.virtus.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets",
     "longName": "0000002 - Statement - Condensed Consolidated Balance Sheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:AccountsReceivableNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:AccountsReceivableNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.virtus.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "longName": "0000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations",
     "longName": "0000004 - Statement - Condensed Consolidated Statements of Operations",
     "shortName": "Condensed Consolidated Statements of Operations",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LaborAndRelatedExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.virtus.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
     "longName": "0000005 - Statement - Condensed Consolidated Statements of Comprehensive Income",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.virtus.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeParenthetical",
     "longName": "0000006 - Statement - Condensed Consolidated Statements of Comprehensive Income (Parenthetical)",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows",
     "longName": "0000007 - Statement - Condensed Consolidated Statements of Cash Flows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity",
     "longName": "0000008 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity",
     "shortName": "Condensed Consolidated Statements of Changes in Stockholders' Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-24",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-24",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityParenthetical",
     "longName": "0000009 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Parenthetical)",
     "shortName": "Condensed Consolidated Statements of Changes in Stockholders' Equity (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-127",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R10": {
     "role": "http://www.virtus.com/role/OrganizationandBusiness",
     "longName": "0000010 - Disclosure - Organization and Business",
     "shortName": "Organization and Business",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.virtus.com/role/BasisofPresentationandSignificantAccountingPolicies",
     "longName": "0000011 - Disclosure - Basis of Presentation and Significant Accounting Policies",
     "shortName": "Basis of Presentation and Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.virtus.com/role/Revenues",
     "longName": "0000012 - Disclosure - Revenues",
     "shortName": "Revenues",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.virtus.com/role/Acquisitions",
     "longName": "0000013 - Disclosure - Acquisitions",
     "shortName": "Acquisitions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.virtus.com/role/IntangibleAssetsNet",
     "longName": "0000014 - Disclosure - Intangible Assets, Net",
     "shortName": "Intangible Assets, Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.virtus.com/role/Investments",
     "longName": "0000015 - Disclosure - Investments",
     "shortName": "Investments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InvestmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InvestmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.virtus.com/role/FairValueMeasurements",
     "longName": "0000016 - Disclosure - Fair Value Measurements",
     "shortName": "Fair Value Measurements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.virtus.com/role/EquityTransactions",
     "longName": "0000017 - Disclosure - Equity Transactions",
     "shortName": "Equity Transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.virtus.com/role/AccumulatedOtherComprehensiveIncomeLoss",
     "longName": "0000018 - Disclosure - Accumulated Other Comprehensive Income (Loss)",
     "shortName": "Accumulated Other Comprehensive Income (Loss)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.virtus.com/role/StockBasedCompensation",
     "longName": "0000019 - Disclosure - Stock-Based Compensation",
     "shortName": "Stock-Based Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.virtus.com/role/EarningsLossPerShare",
     "longName": "0000020 - Disclosure - Earnings (Loss) Per Share",
     "shortName": "Earnings (Loss) Per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.virtus.com/role/IncomeTaxes",
     "longName": "0000021 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.virtus.com/role/Debt",
     "longName": "0000022 - Disclosure - Debt",
     "shortName": "Debt",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.virtus.com/role/CommitmentsandContingencies",
     "longName": "0000023 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.virtus.com/role/RedeemableNoncontrollingInterests",
     "longName": "0000024 - Disclosure - Redeemable Noncontrolling Interests",
     "shortName": "Redeemable Noncontrolling Interests",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.virtus.com/role/Consolidation",
     "longName": "0000025 - Disclosure - Consolidation",
     "shortName": "Consolidation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "srt:CondensedFinancialStatementsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "srt:CondensedFinancialStatementsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrAdoptedFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrAdoptedFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.virtus.com/role/BasisofPresentationandSignificantAccountingPoliciesPolicies",
     "longName": "9954471 - Disclosure - Basis of Presentation and Significant Accounting Policies (Policies)",
     "shortName": "Basis of Presentation and Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.virtus.com/role/RevenuesTables",
     "longName": "9954472 - Disclosure - Revenues (Tables)",
     "shortName": "Revenues (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.virtus.com/role/IntangibleAssetsNetTables",
     "longName": "9954473 - Disclosure - Intangible Assets, Net (Tables)",
     "shortName": "Intangible Assets, Net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.virtus.com/role/InvestmentsTables",
     "longName": "9954474 - Disclosure - Investments (Tables)",
     "shortName": "Investments (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InvestmentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InvestmentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.virtus.com/role/FairValueMeasurementsTables",
     "longName": "9954475 - Disclosure - Fair Value Measurements (Tables)",
     "shortName": "Fair Value Measurements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.virtus.com/role/AccumulatedOtherComprehensiveIncomeLossTables",
     "longName": "9954476 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables)",
     "shortName": "Accumulated Other Comprehensive Income (Loss) (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.virtus.com/role/StockBasedCompensationTables",
     "longName": "9954477 - Disclosure - Stock-Based Compensation (Tables)",
     "shortName": "Stock-Based Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "vrts:StockBasedCompensationExpenseTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "vrts:StockBasedCompensationExpenseTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.virtus.com/role/EarningsLossPerShareTables",
     "longName": "9954478 - Disclosure - Earnings (Loss) Per Share (Tables)",
     "shortName": "Earnings (Loss) Per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.virtus.com/role/RedeemableNoncontrollingInterestsTables",
     "longName": "9954479 - Disclosure - Redeemable Noncontrolling Interests (Tables)",
     "shortName": "Redeemable Noncontrolling Interests (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.virtus.com/role/ConsolidationTables",
     "longName": "9954480 - Disclosure - Consolidation (Tables)",
     "shortName": "Consolidation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "srt:ScheduleOfCondensedBalanceSheetTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "srt:ScheduleOfCondensedBalanceSheetTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.virtus.com/role/RevenuesDetails",
     "longName": "9954481 - Disclosure - Revenues (Details)",
     "shortName": "Revenues (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-65",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.virtus.com/role/AcquisitionsDetails",
     "longName": "9954482 - Disclosure - Acquisitions (Details)",
     "shortName": "Acquisitions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:Goodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-73",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.virtus.com/role/IntangibleAssetsNetGoodwillandIntangibleAssetsNetDetails",
     "longName": "9954483 - Disclosure - Intangible Assets, Net - Goodwill and Intangible Assets, Net (Details)",
     "shortName": "Intangible Assets, Net - Goodwill and Intangible Assets, Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.virtus.com/role/IntangibleAssetsNetEstimatedAmortizationExpenseofIntangibleAssetsSucceedingYearsDetails",
     "longName": "9954484 - Disclosure - Intangible Assets, Net - Estimated Amortization Expense of Intangible Assets Succeeding Years (Details)",
     "shortName": "Intangible Assets, Net - Estimated Amortization Expense of Intangible Assets Succeeding Years (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.virtus.com/role/InvestmentsInvestmentsDetails",
     "longName": "9954485 - Disclosure - Investments - Investments (Details)",
     "shortName": "Investments - Investments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:EquitySecuritiesFvNi",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-75",
      "name": "us-gaap:EquitySecuritiesFvNi",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.virtus.com/role/InvestmentsMarketableSecuritiesDetails",
     "longName": "9954486 - Disclosure - Investments - Marketable Securities (Details)",
     "shortName": "Investments - Marketable Securities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:EquitySecuritiesFvNiCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:EquitySecuritiesFvNiCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.virtus.com/role/InvestmentsNarrativeDetails",
     "longName": "9954487 - Disclosure - Investments - Narrative (Details)",
     "shortName": "Investments - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtAndEquitySecuritiesRealizedGainLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtAndEquitySecuritiesRealizedGainLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.virtus.com/role/FairValueMeasurementsChangesinAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
     "longName": "9954488 - Disclosure - Fair Value Measurements - Changes in Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)",
     "shortName": "Fair Value Measurements - Changes in Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-97",
      "name": "us-gaap:LiabilitiesFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.virtus.com/role/FairValueMeasurementsNarrativeDetails",
     "longName": "9954489 - Disclosure - Fair Value Measurements - Narrative (Details)",
     "shortName": "Fair Value Measurements - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-118",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "us-gaap:FairValueMeasurementPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.virtus.com/role/FairValueMeasurementsRollforwardoftheContingentConsiderationLiabilitiesValuedUsingLevel3InputsDetails",
     "longName": "9954490 - Disclosure - Fair Value Measurements - Rollforward of the Contingent Consideration Liabilities Valued Using Level 3 Inputs (Details)",
     "shortName": "Fair Value Measurements - Rollforward of the Contingent Consideration Liabilities Valued Using Level 3 Inputs (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-113",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-113",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.virtus.com/role/EquityTransactionsDetails",
     "longName": "9954491 - Disclosure - Equity Transactions (Details)",
     "shortName": "Equity Transactions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-127",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockRepurchasedDuringPeriodShares",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.virtus.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
     "longName": "9954492 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Details)",
     "shortName": "Accumulated Other Comprehensive Income (Loss) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-128",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.virtus.com/role/StockBasedCompensationAdditionalInformationDetails",
     "longName": "9954493 - Disclosure - Stock-Based Compensation - Additional Information (Details)",
     "shortName": "Stock-Based Compensation - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.virtus.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails",
     "longName": "9954494 - Disclosure - Stock-Based Compensation - Stock Based Compensation Expense (Details)",
     "shortName": "Stock-Based Compensation - Stock Based Compensation Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "vrts:StockBasedCompensationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "vrts:StockBasedCompensationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.virtus.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails",
     "longName": "9954495 - Disclosure - Stock-Based Compensation - Restricted Stock Units Activity (Details)",
     "shortName": "Stock-Based Compensation - Restricted Stock Units Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-137",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-137",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.virtus.com/role/EarningsLossPerShareScheduleofComputationofBasicandDilutedEarningsPerShareDetails",
     "longName": "9954496 - Disclosure - Earnings (Loss) Per Share - Schedule of Computation of Basic and Diluted Earnings Per Share (Details)",
     "shortName": "Earnings (Loss) Per Share - Schedule of Computation of Basic and Diluted Earnings Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.virtus.com/role/EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails",
     "longName": "9954497 - Disclosure - Earnings (Loss) Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details)",
     "shortName": "Earnings (Loss) Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.virtus.com/role/IncomeTaxesDetails",
     "longName": "9954498 - Disclosure - Income Taxes (Details)",
     "shortName": "Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.virtus.com/role/DebtDetails",
     "longName": "9954499 - Disclosure - Debt (Details)",
     "shortName": "Debt (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-152",
      "name": "us-gaap:RepaymentsOfDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-152",
      "name": "us-gaap:RepaymentsOfDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.virtus.com/role/RedeemableNoncontrollingInterestsScheduleofRedeemableNoncontrollingInterestDetails",
     "longName": "9954500 - Disclosure - Redeemable Noncontrolling Interests - Schedule of Redeemable Noncontrolling Interest (Details)",
     "shortName": "Redeemable Noncontrolling Interests - Schedule of Redeemable Noncontrolling Interest (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:RedeemableNoncontrollingInterestEquityRedemptionValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:RedeemableNoncontrollingInterestEquityRedemptionValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.virtus.com/role/ConsolidationCondensedConsolidatedBalanceSheetsDetails",
     "longName": "9954501 - Disclosure - Consolidation - Condensed Consolidated Balance Sheets (Details)",
     "shortName": "Consolidation - Condensed Consolidated Balance Sheets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-161",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfCondensedBalanceSheetTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.virtus.com/role/ConsolidationAdditionalInformationDetails",
     "longName": "9954502 - Disclosure - Consolidation - Additional Information (Details)",
     "shortName": "Consolidation - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c-162",
      "name": "vrts:NumberofCollateralizedLoanObligationsConsolidated",
      "unitRef": "collateralized_loan_obligation",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-162",
      "name": "vrts:NumberofCollateralizedLoanObligationsConsolidated",
      "unitRef": "collateralized_loan_obligation",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.virtus.com/role/ConsolidationBeneficialInterestsofConsolidatedInvestmentProductDetails",
     "longName": "9954503 - Disclosure - Consolidation - Beneficial Interests of Consolidated Investment Product (Details)",
     "shortName": "Consolidation - Beneficial Interests of Consolidated Investment Product (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c-162",
      "name": "vrts:VariableInterestEntityReportingEntityInvolvementBeneficialInterestsSubordinatedDebtAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-162",
      "name": "vrts:VariableInterestEntityReportingEntityInvolvementBeneficialInterestsSubordinatedDebtAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.virtus.com/role/ConsolidationRevenueandExpensesofConsolidatedInvestmentProductDetails",
     "longName": "9954504 - Disclosure - Consolidation - Revenue and Expenses of Consolidated Investment Product (Details)",
     "shortName": "Consolidation - Revenue and Expenses of Consolidated Investment Product (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLossAttributableToNoncontrollingInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-170",
      "name": "us-gaap:GainLossOnInvestments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.virtus.com/role/ConsolidationEconomicInterestsofConsolidatedInvestmentProductDetails",
     "longName": "9954505 - Disclosure - Consolidation - Economic Interests of Consolidated Investment Product (Details)",
     "shortName": "Consolidation - Economic Interests of Consolidated Investment Product (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c-170",
      "name": "vrts:VariableInterestEntityMeasureofActivityDistributionsReceivedandUnrealizedGainsLossesOnInvestment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-170",
      "name": "vrts:VariableInterestEntityMeasureofActivityDistributionsReceivedandUnrealizedGainsLossesOnInvestment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.virtus.com/role/ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
     "longName": "9954506 - Disclosure - Consolidation - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)",
     "shortName": "Consolidation - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-174",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.virtus.com/role/ConsolidationAssetsRelatedtoConsolidatedSponsoredInvestmentProductsUnobservableInputReconciliationDetails",
     "longName": "9954507 - Disclosure - Consolidation - Assets Related to Consolidated Sponsored Investment Products, Unobservable Input Reconciliation (Details)",
     "shortName": "Consolidation - Assets Related to Consolidated Sponsored Investment Products, Unobservable Input Reconciliation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c-195",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-195",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vrts-20240331.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Policies [Abstract]",
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable and accrued liabilities",
        "label": "Accounts Payable and Accrued Liabilities",
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations."
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "us-gaap_AccountsReceivableNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableNet",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable, net",
        "label": "Accounts Receivable, after Allowance for Credit Loss",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business."
       }
      }
     },
     "auth_ref": [
      "r616",
      "r729",
      "r773",
      "r938"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "presentation": [
      "http://www.virtus.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r183",
      "r481",
      "r483",
      "r484",
      "r485",
      "r486",
      "r488"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive income (loss)",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37",
      "r109",
      "r176",
      "r546",
      "r575",
      "r576"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "presentation": [
      "http://www.virtus.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r183",
      "r481",
      "r483",
      "r484",
      "r485",
      "r486",
      "r488"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r16",
      "r37",
      "r457",
      "r460",
      "r491",
      "r571",
      "r572",
      "r878",
      "r879",
      "r880",
      "r893",
      "r894",
      "r895"
     ]
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedTranslationAdjustmentMember",
     "presentation": [
      "http://www.virtus.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Foreign Currency Adjustment Attributable to Parent",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r16",
      "r37",
      "r183",
      "r184",
      "r483",
      "r484",
      "r485",
      "r486",
      "r488",
      "r878"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r822"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital, Common Stock",
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-in Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r425",
      "r426",
      "r427",
      "r586",
      "r893",
      "r894",
      "r895",
      "r920",
      "r943"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r828"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r828"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r828"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r828"
     ]
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "crdr": "debit",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Taxes paid on stock-based compensation",
        "label": "Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r62",
      "r390"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net income to net cash provided by (used in) operating activities:",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "vrts_AdministrationAndShareholderServiceFeesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "AdministrationAndShareholderServiceFeesMember",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Administration and shareholder service fees",
        "label": "Administration And Shareholder Service Fees [Member]",
        "documentation": "Administration And Shareholder Service Fees [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_AffiliatedEntityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "AffiliatedEntityMember",
     "presentation": [
      "http://www.virtus.com/role/RedeemableNoncontrollingInterestsScheduleofRedeemableNoncontrollingInterestDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Affiliate Noncontrolling Interests",
        "label": "Affiliated Entity [Member]",
        "documentation": "An affiliate is a party that, directly or indirectly through one or more intermediaries, controls, is controlled by, or is under common control with the entity."
       }
      }
     },
     "auth_ref": [
      "r163",
      "r628",
      "r731",
      "r773",
      "r919",
      "r925",
      "r926",
      "r927"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r793",
      "r804",
      "r814",
      "r839"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r796",
      "r807",
      "r817",
      "r842"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r828"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r835"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r800",
      "r808",
      "r818",
      "r835",
      "r843",
      "r847",
      "r855"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.virtus.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r420",
      "r428"
     ]
    },
    "vrts_AlphaSimplexGroupLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "AlphaSimplexGroupLLCMember",
     "presentation": [
      "http://www.virtus.com/role/AcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AlphaSimplex Group, LLC",
        "label": "AlphaSimplex Group, LLC [Member]",
        "documentation": "AlphaSimplex Group, LLC"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.virtus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.virtus.com/role/IntangibleAssetsNetGoodwillandIntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Intangible amortization",
        "label": "Amortization of Intangible Assets",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r48",
      "r51"
     ]
    },
    "vrts_AmortizationOfIntangibleAssetsAndContingentAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "AmortizationOfIntangibleAssetsAndContingentAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization expense",
        "label": "Amortization of Intangible Assets and Contingent Amortization",
        "documentation": "Amortization of Intangible Assets and Contingent Amortization"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.virtus.com/role/EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total anti-dilutive securities (in shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r229"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://www.virtus.com/role/EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities [Axis]",
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://www.virtus.com/role/EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://www.virtus.com/role/EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities, Name [Domain]",
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r171",
      "r199",
      "r236",
      "r246",
      "r250",
      "r286",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r450",
      "r454",
      "r478",
      "r542",
      "r621",
      "r767",
      "r784",
      "r913",
      "r914",
      "r928"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets:",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/FairValueMeasurementsChangesinAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.virtus.com/role/ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.virtus.com/role/FairValueMeasurementsChangesinAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets measured at fair value",
        "label": "Assets, Fair Value Disclosure",
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsFairValueDisclosureAbstract",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.virtus.com/role/FairValueMeasurementsChangesinAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Assets",
        "terseLabel": "Assets",
        "label": "Assets, Fair Value Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r850"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r851"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r846"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r846"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r846"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r846"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r846"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r846"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.virtus.com/role/StockBasedCompensationAdditionalInformationDetails",
      "http://www.virtus.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Axis]",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r849"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r848"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r847"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r847"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.virtus.com/role/BasisofPresentationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.virtus.com/role/BasisofPresentationandSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation and Significant Accounting Policies",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://www.virtus.com/role/AcquisitionsDetails",
      "http://www.virtus.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition, Acquiree [Domain]",
        "label": "Business Acquisition, Acquiree [Domain]",
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r446",
      "r760",
      "r761"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://www.virtus.com/role/AcquisitionsDetails",
      "http://www.virtus.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition [Axis]",
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r64",
      "r446",
      "r760",
      "r761"
     ]
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionLineItems",
     "presentation": [
      "http://www.virtus.com/role/AcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition [Line Items]",
        "label": "Business Acquisition [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r446"
     ]
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationConsiderationTransferred1",
     "crdr": "credit",
     "presentation": [
      "http://www.virtus.com/role/AcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase price",
        "label": "Business Combination, Consideration Transferred",
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r2",
      "r15"
     ]
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.virtus.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent consideration",
        "label": "Business Combination, Contingent Consideration, Liability",
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r67",
      "r448"
     ]
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
     "presentation": [
      "http://www.virtus.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business combination, contingent consideration, liability, measurement input",
        "label": "Business Combination, Contingent Consideration, Liability, Measurement Input",
        "documentation": "Value of input used to measure contingent consideration liability from business combination."
       }
      }
     },
     "auth_ref": [
      "r472"
     ]
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationDisclosureTextBlock",
     "presentation": [
      "http://www.virtus.com/role/Acquisitions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquisitions",
        "label": "Business Combination Disclosure [Text Block]",
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)."
       }
      }
     },
     "auth_ref": [
      "r136",
      "r447"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "crdr": "debit",
     "presentation": [
      "http://www.virtus.com/role/AcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Definite-lived intangible assets acquired",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r66"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.virtus.com/role/ConsolidationCondensedConsolidatedBalanceSheetsDetails": {
       "parentTag": "vrts_NetInterestInInvestmentProducts",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.virtus.com/role/ConsolidationCondensedConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents",
        "netLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r167",
      "r736"
     ]
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/FairValueMeasurementsChangesinAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.virtus.com/role/ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.virtus.com/role/FairValueMeasurementsChangesinAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash equivalents",
        "netLabel": "Cash equivalents",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash, cash equivalents and restricted cash, beginning of period",
        "periodEndLabel": "Cash, cash equivalents and restricted cash, end of period",
        "totalLabel": "Cash, cash equivalents and restricted cash at end of period",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r122",
      "r196"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of cash, cash equivalents and restricted cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r122"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r826"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.virtus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.virtus.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Domain]",
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r161",
      "r173",
      "r174",
      "r175",
      "r199",
      "r219",
      "r223",
      "r226",
      "r228",
      "r234",
      "r235",
      "r286",
      "r308",
      "r310",
      "r311",
      "r312",
      "r315",
      "r316",
      "r346",
      "r347",
      "r349",
      "r352",
      "r359",
      "r478",
      "r578",
      "r579",
      "r580",
      "r581",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r608",
      "r630",
      "r648",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r862",
      "r888",
      "r896"
     ]
    },
    "vrts_ClosedEndFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "ClosedEndFundsMember",
     "presentation": [
      "http://www.virtus.com/role/RevenuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Closed-end funds",
        "label": "Closed End Funds [Member]",
        "documentation": "Closed End Funds [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r827"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r827"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies (Note 14)",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r97",
      "r543",
      "r607"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]",
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.virtus.com/role/CommitmentsandContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r302",
      "r303",
      "r730",
      "r909"
     ]
    },
    "vrts_CommonStockDividendsAccruedButNotYetPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "CommonStockDividendsAccruedButNotYetPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock dividends payable",
        "label": "Common Stock Dividends Accrued But Not Yet Paid",
        "documentation": "Common Stock Dividends Accrued But Not Yet Paid"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockDividendsPerShareDeclared",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityParenthetical",
      "http://www.virtus.com/role/EquityTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash dividends declared per common share (in dollars per share)",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding."
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.virtus.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r770",
      "r771",
      "r772",
      "r774",
      "r775",
      "r776",
      "r777",
      "r893",
      "r894",
      "r920",
      "r940",
      "r943"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in dollars per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r608"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares issued (in shares)",
        "periodStartLabel": "Balance at beginning of period, common stock (in shares)",
        "periodEndLabel": "Balance at end of period, common stock (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares outstanding (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r102",
      "r608",
      "r627",
      "r943",
      "r944"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, $0.01 par value, 1,000,000,000 shares authorized; 12,224,489 shares issued and 7,127,881 shares outstanding at March\u00a031, 2024; and 12,163,228 shares issued and 7,087,728 shares outstanding at December\u00a031, 2023",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r545",
      "r767"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r832"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r831"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r833"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r830"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive Income (Loss) Attributable to Virtus Investment Partners, Inc.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r179",
      "r181",
      "r190",
      "r534",
      "r560"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Comprehensive (income) loss attributable to noncontrolling interests",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r70",
      "r85",
      "r179",
      "r181",
      "r189",
      "r533",
      "r559"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive income (loss)",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r138",
      "r179",
      "r181",
      "r188",
      "r532",
      "r558"
     ]
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "presentation": [
      "http://www.virtus.com/role/AccumulatedOtherComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r187",
      "r531",
      "r556"
     ]
    },
    "srt_CondensedFinancialStatementsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CondensedFinancialStatementsTextBlock",
     "presentation": [
      "http://www.virtus.com/role/Consolidation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation",
        "label": "Condensed Financial Statements [Text Block]",
        "documentation": "The entire disclosure for condensed financial statements."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r201"
     ]
    },
    "srt_ConsolidatedEntitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ConsolidatedEntitiesAxis",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.virtus.com/role/ConsolidationAdditionalInformationDetails",
      "http://www.virtus.com/role/ConsolidationAssetsRelatedtoConsolidatedSponsoredInvestmentProductsUnobservableInputReconciliationDetails",
      "http://www.virtus.com/role/ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.virtus.com/role/ConsolidationBeneficialInterestsofConsolidatedInvestmentProductDetails",
      "http://www.virtus.com/role/ConsolidationCondensedConsolidatedBalanceSheetsDetails",
      "http://www.virtus.com/role/ConsolidationEconomicInterestsofConsolidatedInvestmentProductDetails",
      "http://www.virtus.com/role/ConsolidationRevenueandExpensesofConsolidatedInvestmentProductDetails",
      "http://www.virtus.com/role/InvestmentsInvestmentsDetails",
      "http://www.virtus.com/role/RedeemableNoncontrollingInterestsScheduleofRedeemableNoncontrollingInterestDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated Entities [Axis]",
        "label": "Consolidated Entities [Axis]",
        "documentation": "Information by consolidated entity or group of entities."
       }
      }
     },
     "auth_ref": [
      "r163",
      "r201",
      "r450",
      "r451",
      "r454",
      "r455",
      "r492",
      "r731",
      "r874",
      "r875",
      "r876",
      "r912",
      "r915",
      "r916"
     ]
    },
    "srt_ConsolidatedEntitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ConsolidatedEntitiesDomain",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.virtus.com/role/ConsolidationAdditionalInformationDetails",
      "http://www.virtus.com/role/ConsolidationAssetsRelatedtoConsolidatedSponsoredInvestmentProductsUnobservableInputReconciliationDetails",
      "http://www.virtus.com/role/ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.virtus.com/role/ConsolidationBeneficialInterestsofConsolidatedInvestmentProductDetails",
      "http://www.virtus.com/role/ConsolidationCondensedConsolidatedBalanceSheetsDetails",
      "http://www.virtus.com/role/ConsolidationEconomicInterestsofConsolidatedInvestmentProductDetails",
      "http://www.virtus.com/role/ConsolidationRevenueandExpensesofConsolidatedInvestmentProductDetails",
      "http://www.virtus.com/role/InvestmentsInvestmentsDetails",
      "http://www.virtus.com/role/RedeemableNoncontrollingInterestsScheduleofRedeemableNoncontrollingInterestDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated Entities [Domain]",
        "label": "Consolidated Entities [Domain]",
        "documentation": "Entity or group of entities consolidated into reporting entity."
       }
      }
     },
     "auth_ref": [
      "r163",
      "r201",
      "r450",
      "r451",
      "r454",
      "r455",
      "r492",
      "r731",
      "r874",
      "r875",
      "r876",
      "r912",
      "r915",
      "r916"
     ]
    },
    "vrts_ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated Entity excluding Consolidated Investment Products",
        "label": "Consolidated Entity Excluding Variable Interest Entities (VIE) and Voting Interest Entities (VOE) [Member]",
        "documentation": "Consolidated Entity Excluding Variable Interest Entities (VIE) and Voting Interest Entities (VOE) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConsolidationVariableInterestEntityPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationVariableInterestEntityPolicy",
     "presentation": [
      "http://www.virtus.com/role/BasisofPresentationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nonconsolidated VIEs",
        "label": "Consolidation, Variable Interest Entity, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined)."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r75",
      "r78"
     ]
    },
    "vrts_ContingentConsiderationLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "ContingentConsiderationLiabilityMember",
     "presentation": [
      "http://www.virtus.com/role/FairValueMeasurementsChangesinAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.virtus.com/role/FairValueMeasurementsRollforwardoftheContingentConsiderationLiabilitiesValuedUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent consideration",
        "label": "Contingent Consideration Liability [Member]",
        "documentation": "Contingent Consideration Liability"
       }
      }
     },
     "auth_ref": []
    },
    "vrts_ConversionOfStockConversionRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "ConversionOfStockConversionRatio",
     "presentation": [
      "http://www.virtus.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion ratio",
        "label": "Conversion Of Stock, Conversion Ratio",
        "documentation": "Conversion Of Stock, Conversion Ratio"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "vrts_CreditAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "CreditAgreementMember",
     "presentation": [
      "http://www.virtus.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Agreement",
        "label": "Credit Agreement [Member]",
        "documentation": "Credit Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "vrts_CreditFacility2017Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "CreditFacility2017Member",
     "presentation": [
      "http://www.virtus.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility 2017",
        "label": "Credit Facility 2017 [Member]",
        "documentation": "Credit Facility 2017 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditFacilityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CreditFacilityAxis",
     "presentation": [
      "http://www.virtus.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Axis]",
        "label": "Credit Facility [Axis]",
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditFacilityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CreditFacilityDomain",
     "presentation": [
      "http://www.virtus.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Domain]",
        "label": "Credit Facility [Domain]",
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.virtus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtAndEquitySecuritiesGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtAndEquitySecuritiesGainLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Realized and unrealized (gains) losses on investments, net",
        "negatedTerseLabel": "Realized and unrealized (gains) losses on investments of CIP, net",
        "label": "Debt and Equity Securities, Gain (Loss)",
        "documentation": "Amount of unrealized and realized gain (loss) on investment in debt and equity securities."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r114"
     ]
    },
    "us-gaap_DebtAndEquitySecuritiesRealizedGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtAndEquitySecuritiesRealizedGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.virtus.com/role/InvestmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Realized (losses) gains on trading securities",
        "label": "Debt and Equity Securities, Realized Gain (Loss)",
        "documentation": "Amount of realized gain (loss) on investment in debt and equity securities."
       }
      }
     },
     "auth_ref": [
      "r634",
      "r635",
      "r713",
      "r714",
      "r715",
      "r881",
      "r882"
     ]
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Disclosure [Abstract]",
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://www.virtus.com/role/Debt"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt",
        "label": "Debt Disclosure [Text Block]",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r131",
      "r197",
      "r317",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r333",
      "r340",
      "r341",
      "r343"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAdditionalInformationDetails",
      "http://www.virtus.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Axis]",
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r98",
      "r99",
      "r145",
      "r147",
      "r201",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r324",
      "r329",
      "r330",
      "r331",
      "r332",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r490",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r889"
     ]
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt par value",
        "label": "Debt Instrument, Face Amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r91",
      "r318",
      "r490",
      "r745",
      "r746"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAdditionalInformationDetails",
      "http://www.virtus.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Name [Domain]",
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r201",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r324",
      "r329",
      "r330",
      "r331",
      "r332",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r490",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r889"
     ]
    },
    "us-gaap_DebtInstrumentTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentTerm",
     "presentation": [
      "http://www.virtus.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term of debt",
        "label": "Debt Instrument, Term",
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "presentation": [
      "http://www.virtus.com/role/InvestmentsMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Available-for-sale Securities [Table]",
        "label": "Debt Securities, Available-for-Sale [Table]",
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266"
     ]
    },
    "us-gaap_DebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesMember",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAssetsRelatedtoConsolidatedSponsoredInvestmentProductsUnobservableInputReconciliationDetails",
      "http://www.virtus.com/role/ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt investments",
        "label": "Debt Securities [Member]",
        "documentation": "Debt instrument issued by corporations, governments and governmental agencies, municipalities, and other institutions."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r772",
      "r945"
     ]
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredFinanceCostsGross",
     "crdr": "debit",
     "presentation": [
      "http://www.virtus.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt issuance costs",
        "label": "Debt Issuance Costs, Gross",
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs."
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred taxes, net",
        "label": "Deferred Income Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r430",
      "r431"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred taxes, net",
        "label": "Deferred Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r135",
      "r157",
      "r441",
      "r442",
      "r891"
     ]
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Depreciation",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation expense",
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r52"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation expense, intangible asset and other amortization",
        "label": "Depreciation, Depletion and Amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r240"
     ]
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisaggregationOfRevenueLineItems",
     "presentation": [
      "http://www.virtus.com/role/RevenuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue [Line Items]",
        "label": "Disaggregation of Revenue [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r378",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisaggregationOfRevenueTable",
     "presentation": [
      "http://www.virtus.com/role/RevenuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue [Table]",
        "label": "Disaggregation of Revenue [Table]",
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r378",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "presentation": [
      "http://www.virtus.com/role/RevenuesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Disaggregation of Revenue",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r918"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.virtus.com/role/StockBasedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Compensation",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r388",
      "r393",
      "r421",
      "r422",
      "r424",
      "r763"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement [Abstract]",
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "vrts_DisposalOfPaymentsForAffiliateEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "DisposalOfPaymentsForAffiliateEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Affiliate equity sales (purchases)",
        "label": "Disposal Of (Payments For) Affiliate Equity",
        "documentation": "Disposal Of (Payments For) Affiliate Equity"
       }
      }
     },
     "auth_ref": []
    },
    "vrts_DistributionAndServiceFeesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "DistributionAndServiceFeesMember",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Distribution and service fees",
        "label": "Distribution And Service Fees [Member]",
        "documentation": "Distribution And Service Fees [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DividendsCommonStockCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DividendsCommonStockCash",
     "crdr": "debit",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cash dividends declared, common",
        "label": "Dividends, Common Stock, Cash",
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash."
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "us-gaap_DividendsPayableCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DividendsPayableCurrentAndNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends payable",
        "label": "Dividends Payable",
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r100",
      "r146",
      "r781",
      "r936"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.virtus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.virtus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.virtus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://www.virtus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Quarterly Report",
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r788"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.virtus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r821"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.virtus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings Per Share [Abstract]",
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.virtus.com/role/EarningsLossPerShareScheduleofComputationofBasicandDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Earnings (Loss) per Share\u2014Basic (in dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r191",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r216",
      "r219",
      "r226",
      "r227",
      "r228",
      "r232",
      "r465",
      "r466",
      "r535",
      "r561",
      "r738"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.virtus.com/role/EarningsLossPerShareScheduleofComputationofBasicandDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings (Loss) per Share\u2014Diluted (in dollars per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r191",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r219",
      "r226",
      "r227",
      "r228",
      "r232",
      "r465",
      "r466",
      "r535",
      "r561",
      "r738"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.virtus.com/role/EarningsLossPerShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings (Loss) Per Share",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r215",
      "r229",
      "r230",
      "r231"
     ]
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of exchange rate changes on cash, cash equivalents and restricted cash",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r480"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "presentation": [
      "http://www.virtus.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated effective income tax rate (as percent)",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r433"
     ]
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeRelatedLiabilitiesCurrentAndNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued compensation and benefits",
        "label": "Employee-related Liabilities",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r936"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "crdr": "debit",
     "presentation": [
      "http://www.virtus.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unamortized stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r423"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://www.virtus.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Period for recognition of compensation expense",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r423"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock Option",
        "label": "Employee Stock Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.virtus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.virtus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.virtus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.virtus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.virtus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r786"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.virtus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.virtus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.virtus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r786"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.virtus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.virtus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r786"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.virtus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.virtus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r860"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.virtus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r786"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.virtus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r786"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.virtus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r786"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.virtus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r786"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity [Abstract]",
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.virtus.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r164",
      "r182",
      "r183",
      "r184",
      "r202",
      "r203",
      "r204",
      "r206",
      "r212",
      "r214",
      "r233",
      "r287",
      "r288",
      "r360",
      "r425",
      "r426",
      "r427",
      "r437",
      "r438",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r464",
      "r481",
      "r483",
      "r484",
      "r485",
      "r486",
      "r488",
      "r491",
      "r571",
      "r572",
      "r573",
      "r586",
      "r648"
     ]
    },
    "us-gaap_EquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/InvestmentsInvestmentsDetails": {
       "parentTag": "us-gaap_Investments",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/InvestmentsInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Equity method investments",
        "label": "Equity Method Investments",
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r285",
      "r877",
      "r903"
     ]
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquitySecuritiesFvNi",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/InvestmentsInvestmentsDetails": {
       "parentTag": "us-gaap_Investments",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.virtus.com/role/FairValueMeasurementsChangesinAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/FairValueMeasurementsChangesinAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.virtus.com/role/InvestmentsInvestmentsDetails",
      "http://www.virtus.com/role/InvestmentsMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment securities - fair value",
        "verboseLabel": "Fair Value",
        "label": "Equity Securities, FV-NI, Current",
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current."
       }
      }
     },
     "auth_ref": [
      "r172",
      "r476",
      "r737"
     ]
    },
    "us-gaap_EquitySecuritiesFvNiCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquitySecuritiesFvNiCost",
     "crdr": "debit",
     "presentation": [
      "http://www.virtus.com/role/InvestmentsMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost",
        "label": "Equity Securities, FV-NI, Cost",
        "documentation": "Cost of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Excludes equity method investment and investment in equity security without readily determinable fair value."
       }
      }
     },
     "auth_ref": [
      "r540"
     ]
    },
    "us-gaap_EquitySecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquitySecuritiesMember",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.virtus.com/role/FairValueMeasurementsChangesinAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.virtus.com/role/InvestmentsMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity securities",
        "verboseLabel": "Equity investments",
        "label": "Equity Securities [Member]",
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r778",
      "r779",
      "r780",
      "r945"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r829"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r793",
      "r804",
      "r814",
      "r839"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r790",
      "r801",
      "r811",
      "r836"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r835"
     ]
    },
    "us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ExpenseRelatedToDistributionOrServicingAndUnderwritingFees",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Distribution and other asset-based expenses",
        "label": "Expense Related to Distribution or Servicing and Underwriting Fees",
        "documentation": "Expense related to distribution, servicing and underwriting fees."
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "vrts_ExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "ExpensesAbstract",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationRevenueandExpensesofConsolidatedInvestmentProductDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expenses:",
        "label": "Expenses [Abstract]",
        "documentation": "Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r468",
      "r469",
      "r474"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r468",
      "r469",
      "r474"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "presentation": [
      "http://www.virtus.com/role/FairValueMeasurementsChangesinAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.virtus.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "presentation": [
      "http://www.virtus.com/role/FairValueMeasurementsChangesinAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.virtus.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAssetsRelatedtoConsolidatedSponsoredInvestmentProductsUnobservableInputReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAssetsRelatedtoConsolidatedSponsoredInvestmentProductsUnobservableInputReconciliationDetails",
      "http://www.virtus.com/role/FairValueMeasurementsRollforwardoftheContingentConsiderationLiabilitiesValuedUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAssetsRelatedtoConsolidatedSponsoredInvestmentProductsUnobservableInputReconciliationDetails",
      "http://www.virtus.com/role/FairValueMeasurementsRollforwardoftheContingentConsiderationLiabilitiesValuedUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of assets using significant unobservable inputs (level 3). Such reconciliation, separately presenting changes during the period, at a minimum, may include, but is not limited to: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income, and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r88"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Reconciliation of Assets of Consolidated Sponsored Investment Products For Level 3 Investments, Unobservable Inputs Used to Determine Fair Value",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r88"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.virtus.com/role/FairValueMeasurementsChangesinAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.virtus.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.virtus.com/role/FairValueMeasurementsRollforwardoftheContingentConsiderationLiabilitiesValuedUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r331",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r469",
      "r496",
      "r497",
      "r498",
      "r745",
      "r746",
      "r757",
      "r758",
      "r759"
     ]
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByLiabilityClassAxis",
     "presentation": [
      "http://www.virtus.com/role/FairValueMeasurementsChangesinAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.virtus.com/role/FairValueMeasurementsRollforwardoftheContingentConsiderationLiabilitiesValuedUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liability Class [Axis]",
        "label": "Liability Class [Axis]",
        "documentation": "Information by class of liability."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r141"
     ]
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByMeasurementBasisAxis",
     "presentation": [
      "http://www.virtus.com/role/RedeemableNoncontrollingInterestsScheduleofRedeemableNoncontrollingInterestDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Basis [Axis]",
        "label": "Measurement Basis [Axis]",
        "documentation": "Information by measurement basis."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r86",
      "r331",
      "r745",
      "r746"
     ]
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByMeasurementFrequencyAxis",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Frequency [Axis]",
        "label": "Measurement Frequency [Axis]",
        "documentation": "Information by measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r468",
      "r469",
      "r471",
      "r472",
      "r475"
     ]
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosureItemAmountsDomain",
     "presentation": [
      "http://www.virtus.com/role/RedeemableNoncontrollingInterestsScheduleofRedeemableNoncontrollingInterestDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurement [Domain]",
        "label": "Fair Value Measurement [Domain]",
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value."
       }
      }
     },
     "auth_ref": [
      "r331",
      "r745",
      "r746"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Disclosures [Abstract]",
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://www.virtus.com/role/FairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r467"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.virtus.com/role/FairValueMeasurementsChangesinAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level\u00a01",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r331",
      "r381",
      "r386",
      "r469",
      "r496",
      "r757",
      "r758",
      "r759"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.virtus.com/role/FairValueMeasurementsChangesinAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level\u00a02",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r331",
      "r381",
      "r386",
      "r469",
      "r497",
      "r745",
      "r746",
      "r757",
      "r758",
      "r759"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.virtus.com/role/FairValueMeasurementsChangesinAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.virtus.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.virtus.com/role/FairValueMeasurementsRollforwardoftheContingentConsiderationLiabilitiesValuedUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level\u00a03",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r331",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r469",
      "r498",
      "r745",
      "r746",
      "r757",
      "r758",
      "r759"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "presentation": [
      "http://www.virtus.com/role/FairValueMeasurementsChangesinAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.virtus.com/role/FairValueMeasurementsRollforwardoftheContingentConsiderationLiabilitiesValuedUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value by Liability Class [Domain]",
        "label": "Fair Value by Liability Class [Domain]",
        "documentation": "Represents classes of liabilities measured and disclosed at fair value."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "presentation": [
      "http://www.virtus.com/role/FairValueMeasurementsRollforwardoftheContingentConsiderationLiabilitiesValuedUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "presentation": [
      "http://www.virtus.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Liabilities of Consolidated Sponsored Investment Products For Level 3 Investments, Unobservable Inputs Used to Determine Fair Value",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r88"
     ]
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementFrequencyDomain",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Frequency [Domain]",
        "label": "Measurement Frequency [Domain]",
        "documentation": "Measurement frequency."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "presentation": [
      "http://www.virtus.com/role/BasisofPresentationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases",
     "crdr": "debit",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAssetsRelatedtoConsolidatedSponsoredInvestmentProductsUnobservableInputReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchases",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases",
        "documentation": "Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales",
     "crdr": "credit",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAssetsRelatedtoConsolidatedSponsoredInvestmentProductsUnobservableInputReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Sales",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales",
        "documentation": "Amount of sale of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements",
     "crdr": "credit",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAssetsRelatedtoConsolidatedSponsoredInvestmentProductsUnobservableInputReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Realized and unrealized gain (loss) on investments, net",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements",
        "documentation": "Amount of settlement of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3",
     "crdr": "debit",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAssetsRelatedtoConsolidatedSponsoredInvestmentProductsUnobservableInputReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transfers from Level 2",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3",
        "documentation": "Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy."
       }
      }
     },
     "auth_ref": [
      "r473"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3",
     "crdr": "credit",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAssetsRelatedtoConsolidatedSponsoredInvestmentProductsUnobservableInputReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Transfers to Level 2",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3",
        "documentation": "Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy."
       }
      }
     },
     "auth_ref": [
      "r473"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
     "crdr": "debit",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAssetsRelatedtoConsolidatedSponsoredInvestmentProductsUnobservableInputReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance at beginning of period",
        "periodEndLabel": "Balance at end of period",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value",
        "documentation": "Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "vrts_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReductionOfLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReductionOfLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.virtus.com/role/FairValueMeasurementsRollforwardoftheContingentConsiderationLiabilitiesValuedUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Reduction for payments made",
        "label": "Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Reduction Of Liability",
        "documentation": "Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Reduction Of Liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "crdr": "credit",
     "presentation": [
      "http://www.virtus.com/role/FairValueMeasurementsRollforwardoftheContingentConsiderationLiabilitiesValuedUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Contingent consideration, beginning of period",
        "periodEndLabel": "Contingent consideration, end of period",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.virtus.com/role/FairValueMeasurementsChangesinAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.virtus.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.virtus.com/role/FairValueMeasurementsRollforwardoftheContingentConsiderationLiabilitiesValuedUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r331",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r496",
      "r497",
      "r498",
      "r745",
      "r746",
      "r757",
      "r758",
      "r759"
     ]
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsRecurringMember",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Measurements, Recurring",
        "label": "Fair Value, Recurring [Member]",
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r467",
      "r475"
     ]
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAssetsRelatedtoConsolidatedSponsoredInvestmentProductsUnobservableInputReconciliationDetails",
      "http://www.virtus.com/role/ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.virtus.com/role/FairValueMeasurementsChangesinAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.virtus.com/role/InvestmentsMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instrument [Axis]",
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r342",
      "r357",
      "r462",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r557",
      "r742",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r899",
      "r900",
      "r901",
      "r902"
     ]
    },
    "us-gaap_FinancialInstrumentsSoldNotYetPurchasedAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancialInstrumentsSoldNotYetPurchasedAtFairValue",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails": {
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Short sales",
        "label": "Financial Instruments Sold, Not yet Purchased, at Fair Value",
        "documentation": "Fair value of obligations incurred from short sales."
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "vrts_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/IntangibleAssetsNetEstimatedAmortizationExpenseofIntangibleAssetsSucceedingYearsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/IntangibleAssetsNetEstimatedAmortizationExpenseofIntangibleAssetsSucceedingYearsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029 and thereafter",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, After Year Four",
        "documentation": "Finite-Lived Intangible Asset, Expected Amortization, After Year Four"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/IntangibleAssetsNetGoodwillandIntangibleAssetsNetDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/IntangibleAssetsNetGoodwillandIntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedPeriodStartLabel": "Accumulated amortization, beginning of period",
        "negatedPeriodEndLabel": "Accumulated amortization, end of period",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r169",
      "r299"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/IntangibleAssetsNetEstimatedAmortizationExpenseofIntangibleAssetsSucceedingYearsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/IntangibleAssetsNetEstimatedAmortizationExpenseofIntangibleAssetsSucceedingYearsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/IntangibleAssetsNetEstimatedAmortizationExpenseofIntangibleAssetsSucceedingYearsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/IntangibleAssetsNetEstimatedAmortizationExpenseofIntangibleAssetsSucceedingYearsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remainder of 2024",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/IntangibleAssetsNetEstimatedAmortizationExpenseofIntangibleAssetsSucceedingYearsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/IntangibleAssetsNetEstimatedAmortizationExpenseofIntangibleAssetsSucceedingYearsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/IntangibleAssetsNetEstimatedAmortizationExpenseofIntangibleAssetsSucceedingYearsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/IntangibleAssetsNetEstimatedAmortizationExpenseofIntangibleAssetsSucceedingYearsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/IntangibleAssetsNetEstimatedAmortizationExpenseofIntangibleAssetsSucceedingYearsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/IntangibleAssetsNetEstimatedAmortizationExpenseofIntangibleAssetsSucceedingYearsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/IntangibleAssetsNetGoodwillandIntangibleAssetsNetDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/IntangibleAssetsNetGoodwillandIntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Gross book value, beginning of period",
        "periodEndLabel": "Gross book value balance, end of period",
        "label": "Finite-Lived Intangible Assets, Gross",
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r529"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/IntangibleAssetsNetGoodwillandIntangibleAssetsNetDetails": {
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.virtus.com/role/IntangibleAssetsNetEstimatedAmortizationExpenseofIntangibleAssetsSucceedingYearsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.virtus.com/role/IntangibleAssetsNetEstimatedAmortizationExpenseofIntangibleAssetsSucceedingYearsDetails",
      "http://www.virtus.com/role/IntangibleAssetsNetGoodwillandIntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Definite-Lived net book value, beginning of period",
        "periodEndLabel": "Definite-Lived net book value, end of period",
        "totalLabel": "Total",
        "label": "Finite-Lived Intangible Assets, Net",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r528"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsRollForward",
     "presentation": [
      "http://www.virtus.com/role/IntangibleAssetsNetGoodwillandIntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Definite-Lived",
        "label": "Finite-Lived Intangible Assets [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r797",
      "r808",
      "r818",
      "r843"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r797",
      "r808",
      "r818",
      "r843"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r797",
      "r808",
      "r818",
      "r843"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r797",
      "r808",
      "r818",
      "r843"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r797",
      "r808",
      "r818",
      "r843"
     ]
    },
    "us-gaap_GainLossOnInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainLossOnInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/ConsolidationRevenueandExpensesofConsolidatedInvestmentProductDetails": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.virtus.com/role/ConsolidationRevenueandExpensesofConsolidatedInvestmentProductDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Realized and unrealized gain (loss) on investments, net",
        "verboseLabel": "Realized and unrealized gain (loss), net",
        "label": "Gain (Loss) on Investments",
        "documentation": "Amount of realized and unrealized gain (loss) on investment."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r861"
     ]
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/AcquisitionsDetails",
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "label": "Goodwill",
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r168",
      "r297",
      "r530",
      "r743",
      "r767",
      "r905",
      "r906"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income (Loss) Before Income Taxes",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r110",
      "r151",
      "r236",
      "r245",
      "r249",
      "r251",
      "r536",
      "r552",
      "r740"
     ]
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromEquityMethodInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Equity in earnings of equity method investments",
        "label": "Income (Loss) from Equity Method Investments",
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss)."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r111",
      "r150",
      "r241",
      "r285",
      "r551"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement [Abstract]",
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Disclosure [Abstract]",
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.virtus.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information."
       }
      }
     },
     "auth_ref": [
      "r200",
      "r429",
      "r434",
      "r435",
      "r436",
      "r439",
      "r443",
      "r444",
      "r445",
      "r583"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax expense (benefit)",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r155",
      "r158",
      "r213",
      "r214",
      "r242",
      "r432",
      "r440",
      "r563"
     ]
    },
    "vrts_IncreaseDecreaseInCashAndCashEquivalentsOfSubsidiariesDueToConsolidation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "IncreaseDecreaseInCashAndCashEquivalentsOfSubsidiariesDueToConsolidation",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in cash and cash equivalents of CIP due to consolidation (deconsolidation), net",
        "label": "Increase (Decrease) In Cash And Cash Equivalents Of Subsidiaries Due To Consolidation",
        "documentation": "Increase (Decrease) In Cash And Cash Equivalents Of Subsidiaries Due To Consolidation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Accounts receivable, net and other assets",
        "label": "Increase (Decrease) in Operating Assets",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of assets used to generate operating income."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued compensation and benefits, accounts payable, accrued liabilities and other liabilities",
        "label": "Increase (Decrease) in Operating Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities that result from activities that generate operating income."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in other assets and liabilities of CIP",
        "label": "Increase (Decrease) in Other Operating Assets",
        "documentation": "Amount of increase (decrease) in operating assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.virtus.com/role/RedeemableNoncontrollingInterestsScheduleofRedeemableNoncontrollingInterestDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Redeemable Non-controlling Interests [Roll Forward]",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "presentation": [
      "http://www.virtus.com/role/EarningsLossPerShareScheduleofComputationofBasicandDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plus: Incremental shares from assumed conversion of dilutive instruments (in shares)",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method."
       }
      }
     },
     "auth_ref": [
      "r220",
      "r221",
      "r222",
      "r228",
      "r392"
     ]
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/IntangibleAssetsNetGoodwillandIntangibleAssetsNetDetails": {
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/IntangibleAssetsNetGoodwillandIntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Net book value, beginning of period",
        "periodEndLabel": "Net book value, end of period",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit."
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IndefiniteLivedIntangibleAssetsRollForward",
     "presentation": [
      "http://www.virtus.com/role/IntangibleAssetsNetGoodwillandIntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Indefinite-Lived",
        "label": "Indefinite-Lived Intangible Assets [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r800",
      "r808",
      "r818",
      "r835",
      "r843",
      "r847",
      "r855"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r789",
      "r859"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r789",
      "r859"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r789",
      "r859"
     ]
    },
    "vrts_InstitutionalAccountsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "InstitutionalAccountsMember",
     "presentation": [
      "http://www.virtus.com/role/RevenuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Institutional accounts",
        "label": "Institutional Accounts [Member]",
        "documentation": "Institutional Accounts [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.virtus.com/role/IntangibleAssetsNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible Assets, Net",
        "label": "Intangible Assets Disclosure [Text Block]",
        "documentation": "The entire disclosure for all or part of the information related to intangible assets."
       }
      }
     },
     "auth_ref": [
      "r298"
     ]
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.virtus.com/role/IntangibleAssetsNetGoodwillandIntangibleAssetsNetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.virtus.com/role/IntangibleAssetsNetGoodwillandIntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets, net",
        "periodStartLabel": "Net book value, beginning of period",
        "periodEndLabel": "Net book value, end of period",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r49"
     ]
    },
    "vrts_IntangibleAssetsNetExcludingGoodwillRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "IntangibleAssetsNetExcludingGoodwillRollForward",
     "presentation": [
      "http://www.virtus.com/role/IntangibleAssetsNetGoodwillandIntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total",
        "label": "Intangible Assets, Net (Excluding Goodwill) [Roll Forward]",
        "documentation": "Intangible Assets, Net (Excluding Goodwill) [Roll Forward]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_InterestIncomeExpenseNonoperatingNet",
       "weight": -1.0,
       "order": 1.0
      },
      "http://www.virtus.com/role/ConsolidationRevenueandExpensesofConsolidatedInvestmentProductDetails": {
       "parentTag": "vrts_OperatingandNonoperatingExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.virtus.com/role/ConsolidationRevenueandExpensesofConsolidatedInvestmentProductDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Interest expense",
        "verboseLabel": "Interest expense",
        "label": "Interest Expense",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r154",
      "r185",
      "r239",
      "r489",
      "r633",
      "r782",
      "r942"
     ]
    },
    "us-gaap_InterestIncomeExpenseNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestIncomeExpenseNetAbstract",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest Income (Expense)",
        "label": "Interest Income (Expense), Net [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestIncomeExpenseNonoperatingNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestIncomeExpenseNonoperatingNet",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total interest income (expense), net",
        "label": "Interest Income (Expense), Nonoperating, Net",
        "documentation": "The net amount of nonoperating interest income (expense)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentIncomeInterestAndDividend": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentIncomeInterestAndDividend",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_InterestIncomeExpenseNonoperatingNet",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.virtus.com/role/ConsolidationRevenueandExpensesofConsolidatedInvestmentProductDetails": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.virtus.com/role/ConsolidationRevenueandExpensesofConsolidatedInvestmentProductDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest and dividend income",
        "verboseLabel": "Interest income",
        "label": "Investment Income, Interest and Dividend",
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "vrts_InvestmentManagementFeesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "InvestmentManagementFeesMember",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.virtus.com/role/RevenuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment management fees",
        "verboseLabel": "Investment management fees",
        "label": "Investment Management Fees [Member]",
        "documentation": "Investment Management Fees [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentTableTextBlock",
     "presentation": [
      "http://www.virtus.com/role/InvestmentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Investments",
        "label": "Investment [Table Text Block]",
        "documentation": "Tabular disclosure of investment."
       }
      }
     },
     "auth_ref": [
      "r864",
      "r865",
      "r898"
     ]
    },
    "us-gaap_InvestmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentTextBlock",
     "presentation": [
      "http://www.virtus.com/role/Investments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments",
        "label": "Investment [Text Block]",
        "documentation": "The entire disclosure for investment."
       }
      }
     },
     "auth_ref": [
      "r864",
      "r865",
      "r898"
     ]
    },
    "us-gaap_Investments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Investments",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/ConsolidationCondensedConsolidatedBalanceSheetsDetails": {
       "parentTag": "vrts_NetInterestInInvestmentProducts",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      },
      "http://www.virtus.com/role/InvestmentsInvestmentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.virtus.com/role/ConsolidationAdditionalInformationDetails",
      "http://www.virtus.com/role/ConsolidationCondensedConsolidatedBalanceSheetsDetails",
      "http://www.virtus.com/role/InvestmentsInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments",
        "totalLabel": "Total investments",
        "netLabel": "Investments",
        "label": "Investments",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments."
       }
      }
     },
     "auth_ref": [
      "r539"
     ]
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments",
        "label": "Investments, Fair Value Disclosure",
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method."
       }
      }
     },
     "auth_ref": [
      "r468"
     ]
    },
    "vrts_InvestmentsInNonqualifiedRetirementPlanAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "InvestmentsInNonqualifiedRetirementPlanAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/InvestmentsInvestmentsDetails": {
       "parentTag": "us-gaap_Investments",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.virtus.com/role/FairValueMeasurementsChangesinAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/FairValueMeasurementsChangesinAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.virtus.com/role/InvestmentsInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nonqualified retirement plan assets",
        "verboseLabel": "Nonqualified retirement plan assets",
        "label": "Investments In Nonqualified Retirement Plan Assets",
        "documentation": "Investments In Nonqualified Retirement Plan Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LaborAndRelatedExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LaborAndRelatedExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employment expenses",
        "label": "Labor and Related Expense",
        "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit."
       }
      }
     },
     "auth_ref": [
      "r883"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r199",
      "r286",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r451",
      "r454",
      "r455",
      "r478",
      "r606",
      "r739",
      "r784",
      "r913",
      "r928",
      "r929"
     ]
    },
    "us-gaap_LiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAbstract",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities:",
        "label": "Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r149",
      "r549",
      "r767",
      "r890",
      "r904",
      "r922"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities and Equity",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.virtus.com/role/FairValueMeasurementsChangesinAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total liabilities measured at fair value",
        "totalLabel": "Total liabilities measured at fair value",
        "label": "Liabilities, Fair Value Disclosure",
        "documentation": "Fair value of financial and nonfinancial obligations."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.virtus.com/role/FairValueMeasurementsChangesinAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities",
        "label": "Liabilities, Fair Value Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCredit",
     "crdr": "credit",
     "presentation": [
      "http://www.virtus.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding borrowings",
        "label": "Long-Term Line of Credit",
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r147",
      "r937"
     ]
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityLineItems",
     "presentation": [
      "http://www.virtus.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of Credit Facility [Line Items]",
        "label": "Line of Credit Facility [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r889"
     ]
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.virtus.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum borrowing capacity",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityTable",
     "presentation": [
      "http://www.virtus.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of Credit Facility [Table]",
        "label": "Line of Credit Facility [Table]",
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r889"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.virtus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt",
        "label": "Long-Term Debt",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r147",
      "r330",
      "r344",
      "r745",
      "r746",
      "r937"
     ]
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAdditionalInformationDetails",
      "http://www.virtus.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Axis]",
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAdditionalInformationDetails",
      "http://www.virtus.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Domain]",
        "label": "Long-Term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r53"
     ]
    },
    "us-gaap_MarketableSecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MarketableSecuritiesAbstract",
     "presentation": [
      "http://www.virtus.com/role/FairValueMeasurementsChangesinAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.virtus.com/role/InvestmentsMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment Securities - fair value",
        "verboseLabel": "Investment securities - fair value",
        "label": "Marketable Securities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAdditionalInformationDetails",
      "http://www.virtus.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.virtus.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]",
        "documentation": "Upper limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r304",
      "r305",
      "r306",
      "r307",
      "r387",
      "r526",
      "r570",
      "r598",
      "r599",
      "r656",
      "r675",
      "r679",
      "r680",
      "r709",
      "r732",
      "r733",
      "r741",
      "r749",
      "r762",
      "r769",
      "r917",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r935"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r827"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r827"
     ]
    },
    "us-gaap_MeasurementInputComparabilityAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputComparabilityAdjustmentMember",
     "presentation": [
      "http://www.virtus.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input, Comparability Adjustment",
        "label": "Measurement Input, Comparability Adjustment [Member]",
        "documentation": "Measurement input using adjustment to observed price for similar asset or liability when identical transaction does not exist."
       }
      }
     },
     "auth_ref": [
      "r921"
     ]
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputDiscountRateMember",
     "presentation": [
      "http://www.virtus.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input, Discount Rate",
        "label": "Measurement Input, Discount Rate [Member]",
        "documentation": "Measurement input using interest rate to determine present value of future cash flows."
       }
      }
     },
     "auth_ref": [
      "r921"
     ]
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputTypeAxis",
     "presentation": [
      "http://www.virtus.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input Type [Axis]",
        "label": "Measurement Input Type [Axis]",
        "documentation": "Information by type of measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r470"
     ]
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputTypeDomain",
     "presentation": [
      "http://www.virtus.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input Type [Domain]",
        "label": "Measurement Input Type [Domain]",
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAdditionalInformationDetails",
      "http://www.virtus.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.virtus.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]",
        "documentation": "Lower limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r304",
      "r305",
      "r306",
      "r307",
      "r387",
      "r526",
      "r570",
      "r598",
      "r599",
      "r656",
      "r675",
      "r679",
      "r680",
      "r709",
      "r732",
      "r733",
      "r741",
      "r749",
      "r762",
      "r769",
      "r917",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r935"
     ]
    },
    "us-gaap_MinorityInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Noncontrolling interests",
        "label": "Equity, Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r148",
      "r199",
      "r286",
      "r308",
      "r310",
      "r311",
      "r312",
      "r315",
      "r316",
      "r478",
      "r548",
      "r610"
     ]
    },
    "us-gaap_MinorityInterestChangeInRedemptionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterestChangeInRedemptionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.virtus.com/role/RedeemableNoncontrollingInterestsScheduleofRedeemableNoncontrollingInterestDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (decrease) to noncontrolling interests due to consolidation (deconsolidation) of CIP, net",
        "verboseLabel": "Changes in redemption value",
        "label": "Noncontrolling Interest, Change in Redemption Value",
        "documentation": "Change in noncontrolling interest during the period as a result of a change in the redemption value of redeemable noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r54",
      "r55",
      "r56"
     ]
    },
    "us-gaap_MinorityInterestDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterestDisclosureTextBlock",
     "presentation": [
      "http://www.virtus.com/role/RedeemableNoncontrollingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redeemable Noncontrolling Interests",
        "label": "Noncontrolling Interest Disclosure [Text Block]",
        "documentation": "The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock."
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "us-gaap_MinorityInterestLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterestLineItems",
     "presentation": [
      "http://www.virtus.com/role/RedeemableNoncontrollingInterestsScheduleofRedeemableNoncontrollingInterestDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Noncontrolling Interest [Line Items]",
        "label": "Noncontrolling Interest [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MinorityInterestPeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterestPeriodIncreaseDecrease",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net subscriptions (redemptions) and other",
        "label": "Noncontrolling Interest, Period Increase (Decrease)",
        "documentation": "Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_MinorityInterestTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterestTable",
     "presentation": [
      "http://www.virtus.com/role/RedeemableNoncontrollingInterestsScheduleofRedeemableNoncontrollingInterestDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Noncontrolling Interest [Table]",
        "label": "Noncontrolling Interest [Table]",
        "documentation": "Schedule of noncontrolling interest disclosure which includes the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r69",
      "r71",
      "r115"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r846"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "vrts_NFJInvestmentGroupMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "NFJInvestmentGroupMember",
     "presentation": [
      "http://www.virtus.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NFJ Investment Group",
        "label": "NFJ Investment Group [Member]",
        "documentation": "NFJ Investment Group"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r828"
     ]
    },
    "us-gaap_NatureOfOperations": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NatureOfOperations",
     "presentation": [
      "http://www.virtus.com/role/OrganizationandBusiness"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization and Business",
        "label": "Nature of Operations [Text Block]",
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r159"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by (used in) financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r195"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash Flows from Financing Activities:",
        "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by (used in) investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r195"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash Flows from Investing Activities:",
        "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by (used in) operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r123",
      "r124"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating activities of consolidated investment products (\"CIP\"):",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash Flows from Operating Activities:",
        "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Income (Loss)",
        "label": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r124",
      "r152",
      "r166",
      "r177",
      "r180",
      "r184",
      "r199",
      "r205",
      "r207",
      "r208",
      "r209",
      "r210",
      "r213",
      "r214",
      "r224",
      "r236",
      "r245",
      "r249",
      "r251",
      "r286",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r466",
      "r478",
      "r555",
      "r629",
      "r646",
      "r647",
      "r740",
      "r782",
      "r913"
     ]
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.virtus.com/role/ConsolidationRevenueandExpensesofConsolidatedInvestmentProductDetails": {
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.virtus.com/role/ConsolidationRevenueandExpensesofConsolidatedInvestmentProductDetails",
      "http://www.virtus.com/role/EarningsLossPerShareScheduleofComputationofBasicandDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Noncontrolling interests",
        "negatedTerseLabel": "Noncontrolling interests",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r139",
      "r177",
      "r180",
      "r213",
      "r214",
      "r554",
      "r880"
     ]
    },
    "us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAttributableToRedeemableNoncontrollingInterest",
     "crdr": "debit",
     "presentation": [
      "http://www.virtus.com/role/RedeemableNoncontrollingInterestsScheduleofRedeemableNoncontrollingInterestDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net income (loss) attributable to noncontrolling interests",
        "label": "Net Income (Loss) Attributable to Redeemable Noncontrolling Interest",
        "documentation": "Amount of Net Income (Loss) attributable to redeemable noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.virtus.com/role/ConsolidationRevenueandExpensesofConsolidatedInvestmentProductDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.virtus.com/role/ConsolidationRevenueandExpensesofConsolidatedInvestmentProductDetails",
      "http://www.virtus.com/role/EarningsLossPerShareScheduleofComputationofBasicandDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Income (Loss) Attributable to Virtus Investment Partners, Inc.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r192",
      "r207",
      "r208",
      "r209",
      "r210",
      "r216",
      "r217",
      "r225",
      "r228",
      "r236",
      "r245",
      "r249",
      "r251",
      "r740"
     ]
    },
    "us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest",
     "crdr": "credit",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net income (loss)",
        "label": "Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest",
        "documentation": "Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r139",
      "r140"
     ]
    },
    "vrts_NetInterestInInvestmentProducts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "NetInterestInInvestmentProducts",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/ConsolidationCondensedConsolidatedBalanceSheetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.virtus.com/role/ConsolidationCondensedConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net interests in CIP",
        "label": "Net Interest In Investment Products",
        "documentation": "Net Interest in Investment Products"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.virtus.com/role/BasisofPresentationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New Accounting Standards Not Yet Implemented",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r827"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r797",
      "r808",
      "r818",
      "r835",
      "r843"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r825"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r824"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r835"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "vrts_NoncashFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "NoncashFinancingItemsAbstract",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Cash Financing Activities:",
        "label": "Noncash Financing Items [Abstract]",
        "documentation": "Noncash Financing Items"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncontrollingInterestAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncontrollingInterestAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Noncontrolling Interest [Abstract]",
        "label": "Noncontrolling Interest [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncontrollingInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncontrollingInterestMember",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non- controlling Interests",
        "label": "Noncontrolling Interest [Member]",
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r360",
      "r893",
      "r894",
      "r895",
      "r943"
     ]
    },
    "vrts_NoncontrollingInterestPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "NoncontrollingInterestPolicyTextBlock",
     "presentation": [
      "http://www.virtus.com/role/BasisofPresentationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Noncontrolling Interest",
        "label": "Noncontrolling Interest [Policy Text Block]",
        "documentation": "Noncontrolling Interest Policy [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "vrts_NoncontrollingInterestSubscriptionsRedemptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "NoncontrollingInterestSubscriptionsRedemptions",
     "crdr": "credit",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net subscriptions (redemptions) and other",
        "label": "Noncontrolling Interest, Subscriptions (Redemptions)",
        "documentation": "Noncontrolling Interest, Subscriptions (Redemptions)"
       }
      }
     },
     "auth_ref": []
    },
    "vrts_NoncontrollingInterestSubscriptionsRedemptionsAndOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "NoncontrollingInterestSubscriptionsRedemptionsAndOther",
     "crdr": "credit",
     "presentation": [
      "http://www.virtus.com/role/RedeemableNoncontrollingInterestsScheduleofRedeemableNoncontrollingInterestDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Net subscriptions (redemptions) and other",
        "label": "Noncontrolling Interest, Subscriptions (Redemptions) And Other",
        "documentation": "Noncontrolling Interest, Subscriptions (Redemptions) And Other"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other income (expense), net",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "vrts_NonqualifiedRetirementPlanAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "NonqualifiedRetirementPlanAssetsMember",
     "presentation": [
      "http://www.virtus.com/role/FairValueMeasurementsChangesinAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nonqualified retirement plan assets",
        "label": "Nonqualified Retirement Plan Assets [Member]",
        "documentation": "Nonqualified Retirement Plan Assets [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NotesPayable",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/ConsolidationCondensedConsolidatedBalanceSheetsDetails": {
       "parentTag": "vrts_NetInterestInInvestmentProducts",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/ConsolidationCondensedConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Notes payable",
        "label": "Notes Payable",
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r147",
      "r937"
     ]
    },
    "us-gaap_NotesPayableFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NotesPayableFairValueDisclosure",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails": {
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notes payable",
        "label": "Notes Payable, Fair Value Disclosure",
        "documentation": "Fair value portion of notes payable."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "vrts_NumberofCollateralizedLoanObligationsConsolidated": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "NumberofCollateralizedLoanObligationsConsolidated",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of consolidated CLOs",
        "label": "Number of Collateralized Loan Obligations Consolidated",
        "documentation": "Number of Collateralized Loan Obligations Consolidated"
       }
      }
     },
     "auth_ref": []
    },
    "vrts_OpenEndFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "OpenEndFundsMember",
     "presentation": [
      "http://www.virtus.com/role/RevenuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Open-end funds",
        "label": "Open End Funds [Member]",
        "documentation": "Open End Funds [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Expenses",
        "label": "Operating Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating Income (Loss)",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r236",
      "r245",
      "r249",
      "r251",
      "r740"
     ]
    },
    "vrts_OperatingandNonoperatingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "OperatingandNonoperatingExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/ConsolidationRevenueandExpensesofConsolidatedInvestmentProductDetails": {
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/ConsolidationRevenueandExpensesofConsolidatedInvestmentProductDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Expense",
        "label": "Operating and Nonoperating Expense",
        "documentation": "Operating and Nonoperating Expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/ConsolidationCondensedConsolidatedBalanceSheetsDetails": {
       "parentTag": "vrts_NetInterestInInvestmentProducts",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.virtus.com/role/ConsolidationCondensedConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets",
        "netLabel": "Other assets",
        "label": "Other Assets",
        "documentation": "Amount of assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r170",
      "r541",
      "r784"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax",
     "crdr": "debit",
     "presentation": [
      "http://www.virtus.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income (loss), before reclassifications, tax",
        "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax",
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r182",
      "r556"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency translation adjustment, net of tax of $36 and $(35) for the three months ended March 31, 2024 and 2023, respectively",
        "verboseLabel": "Foreign currency translation adjustments",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax",
     "crdr": "debit",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Foreign currency translation adjustment, tax",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax",
        "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r8",
      "r479",
      "r487"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Other comprehensive income (loss)",
        "verboseLabel": "Net current-period other comprehensive income (loss)",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r22",
      "r178",
      "r181",
      "r187",
      "r481",
      "r482",
      "r488",
      "r531",
      "r556",
      "r878",
      "r879"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income (loss), net of tax:",
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCostAndExpenseOperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCostAndExpenseOperating",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.virtus.com/role/ConsolidationRevenueandExpensesofConsolidatedInvestmentProductDetails": {
       "parentTag": "vrts_OperatingandNonoperatingExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.virtus.com/role/ConsolidationRevenueandExpensesofConsolidatedInvestmentProductDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other operating expenses",
        "verboseLabel": "Other operating expenses",
        "label": "Other Cost and Expense, Operating",
        "documentation": "The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r562"
     ]
    },
    "vrts_OtherIncomeAndfeesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "OtherIncomeAndfeesMember",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income and fees",
        "label": "Other Income And fees [Member]",
        "documentation": "Other Income And fees [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other liabilities",
        "label": "Other Liabilities",
        "documentation": "Amount of liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r538",
      "r602",
      "r603",
      "r784",
      "r941"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income (expense), net",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Income (Expense)",
        "label": "Other Nonoperating Income (Expense) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r827"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r795",
      "r806",
      "r816",
      "r841"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r798",
      "r809",
      "r819",
      "r844"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r798",
      "r809",
      "r819",
      "r844"
     ]
    },
    "srt_ParentCompanyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ParentCompanyMember",
     "presentation": [
      "http://www.virtus.com/role/InvestmentsInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Parent",
        "label": "Parent Company [Member]",
        "documentation": "Registrant with controlling financial interest in one or more subsidiaries. Controlling interest in subsidiary includes, but is not limited to, primary beneficiary of variable interest entity (VIE). Controlling interest in subsidiary excludes broker-dealer with controlling financial interest in subsidiary but control is likely to be temporary."
       }
      }
     },
     "auth_ref": [
      "r201"
     ]
    },
    "us-gaap_ParentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ParentMember",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Attributed To Virtus Investment Partners, Inc.",
        "label": "Parent [Member]",
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payment of contingent consideration",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "vrts_PaymentOfWithholdingTaxesRelatedToRestrictedStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "PaymentOfWithholdingTaxesRelatedToRestrictedStock",
     "crdr": "credit",
     "presentation": [
      "http://www.virtus.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash used for employee withholding tax payments",
        "label": "Payment Of Withholding Taxes Related To Restricted Stock",
        "documentation": "Payment Of Withholding Taxes Related To Restricted Stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForPurchaseOfSecuritiesOperatingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchases of investments by CIP",
        "label": "Payments for Purchase of Securities, Operating Activities",
        "documentation": "Cash paid to purchase debt and equity securities, classified as operating activities, during the period; includes trading securities and any other investments classified as operating."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repurchase of common shares",
        "label": "Payments for Repurchase of Common Stock",
        "documentation": "The cash outflow to reacquire common stock during the period."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfDividendsCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Common stock dividends paid",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Taxes paid related to net share settlement of restricted stock units",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r193"
     ]
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of equity method investment",
        "label": "Payments to Acquire Equity Method Investments",
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireInterestInSubsidiariesAndAffiliates",
     "crdr": "credit",
     "presentation": [
      "http://www.virtus.com/role/RedeemableNoncontrollingInterestsScheduleofRedeemableNoncontrollingInterestDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Affiliate equity sales (purchases)",
        "label": "Payments to Acquire Interest in Subsidiaries and Affiliates",
        "documentation": "The cash outflow associated with the acquisition of or advances to an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, and joint venture or equity method investment) or the acquisition of an additional interest in a subsidiary (controlled entity)."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Capital expenditures",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r826"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r826"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r825"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r835"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r828"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r824"
     ]
    },
    "vrts_PerformanceStockUnitsIncentiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "PerformanceStockUnitsIncentiveMember",
     "presentation": [
      "http://www.virtus.com/role/StockBasedCompensationAdditionalInformationDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performance Stock Units, Incentive",
        "label": "Performance Stock Units, Incentive [Member]",
        "documentation": "Performance Stock Units, Incentive [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "presentation": [
      "http://www.virtus.com/role/RedeemableNoncontrollingInterestsScheduleofRedeemableNoncontrollingInterestDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Portion at Fair Value Measurement",
        "label": "Portion at Fair Value Measurement [Member]",
        "documentation": "Measured at fair value for financial reporting purposes."
       }
      }
     },
     "auth_ref": [
      "r477"
     ]
    },
    "us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PortionAtOtherThanFairValueFairValueDisclosureMember",
     "presentation": [
      "http://www.virtus.com/role/RedeemableNoncontrollingInterestsScheduleofRedeemableNoncontrollingInterestDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Portion at Other than Fair Value Measurement",
        "label": "Portion at Other than Fair Value Measurement [Member]",
        "documentation": "Not measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r477"
     ]
    },
    "vrts_ProceedsFromPaymentsForOtherInvestmentsOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "ProceedsFromPaymentsForOtherInvestmentsOperatingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net proceeds (purchases) of short-term investments and securities sold short by CIP",
        "label": "Proceeds From (Payments For) Other Investments, Operating Activities",
        "documentation": "Proceeds From (Payments For) Other Investments, Operating Activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromPaymentsForTradingSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromPaymentsForTradingSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sales (purchases) of investments, net",
        "label": "Proceeds from (Payments for) Trading Securities, Short-Term",
        "documentation": "Amount of cash inflow (outflow) from sales and purchases of trading securities."
       }
      }
     },
     "auth_ref": [
      "r884",
      "r885",
      "r887"
     ]
    },
    "us-gaap_ProceedsFromPaymentsToMinorityShareholders": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromPaymentsToMinorityShareholders",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net contributions from (distributions to) noncontrolling interests",
        "label": "Proceeds from (Payments to) Noncontrolling Interests",
        "documentation": "Amount of cash inflow (outflow) from (to) a noncontrolling interest. Excludes dividends paid to the noncontrolling interest."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromSaleOfSecuritiesOperatingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sales of investments by CIP",
        "label": "Proceeds from Sale of Securities, Operating Activities",
        "documentation": "Cash received from sale of investments in debt and equity securities, classified as operating activities, during the period; includes trading securities and any other investments classified as operating."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.virtus.com/role/RevenuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Axis]",
        "label": "Product and Service [Axis]",
        "documentation": "Information by product and service, or group of similar products and similar services."
       }
      }
     },
     "auth_ref": [
      "r252",
      "r527",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r735",
      "r750",
      "r768",
      "r863",
      "r910",
      "r911",
      "r918",
      "r939"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.virtus.com/role/RevenuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Domain]",
        "label": "Product and Service [Domain]",
        "documentation": "Product or service, or a group of similar products or similar services."
       }
      }
     },
     "auth_ref": [
      "r252",
      "r527",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r735",
      "r750",
      "r768",
      "r863",
      "r910",
      "r911",
      "r918",
      "r939"
     ]
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.virtus.com/role/EarningsLossPerShareScheduleofComputationofBasicandDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "verboseLabel": "Net income (loss)",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r177",
      "r180",
      "r194",
      "r199",
      "r205",
      "r213",
      "r214",
      "r236",
      "r245",
      "r249",
      "r251",
      "r286",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r449",
      "r452",
      "r453",
      "r466",
      "r478",
      "r536",
      "r553",
      "r585",
      "r629",
      "r646",
      "r647",
      "r740",
      "r765",
      "r766",
      "r783",
      "r880",
      "r913"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Furniture, equipment and leasehold improvements, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r537",
      "r550",
      "r767"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAdditionalInformationDetails",
      "http://www.virtus.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.virtus.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]",
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r304",
      "r305",
      "r306",
      "r307",
      "r380",
      "r387",
      "r416",
      "r417",
      "r418",
      "r499",
      "r526",
      "r570",
      "r598",
      "r599",
      "r656",
      "r675",
      "r679",
      "r680",
      "r709",
      "r732",
      "r733",
      "r741",
      "r749",
      "r762",
      "r769",
      "r772",
      "r907",
      "r917",
      "r931",
      "r932",
      "r933",
      "r934",
      "r935"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeMember",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAdditionalInformationDetails",
      "http://www.virtus.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.virtus.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]",
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r304",
      "r305",
      "r306",
      "r307",
      "r380",
      "r387",
      "r416",
      "r417",
      "r418",
      "r499",
      "r526",
      "r570",
      "r598",
      "r599",
      "r656",
      "r675",
      "r679",
      "r680",
      "r709",
      "r732",
      "r733",
      "r741",
      "r749",
      "r762",
      "r769",
      "r772",
      "r907",
      "r917",
      "r931",
      "r932",
      "r933",
      "r934",
      "r935"
     ]
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract",
     "presentation": [
      "http://www.virtus.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r790",
      "r801",
      "r811",
      "r836"
     ]
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RedeemableNoncontrollingInterestEquityRedemptionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.virtus.com/role/RedeemableNoncontrollingInterestsScheduleofRedeemableNoncontrollingInterestDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance at beginning of period",
        "periodEndLabel": "Balance at end of period",
        "label": "Redeemable Noncontrolling Interest, Equity, Redemption Value",
        "documentation": "Redemption value, as if currently redeemable, of redeemable noncontrolling interest classified as temporary equity and the election has been made to accrete changes in redemption value to the earliest redemption date."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "us-gaap_RedeemableNoncontrollingInterestTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RedeemableNoncontrollingInterestTableTextBlock",
     "presentation": [
      "http://www.virtus.com/role/RedeemableNoncontrollingInterestsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Redeemable Noncontrolling Interest",
        "label": "Redeemable Noncontrolling Interest [Table Text Block]",
        "documentation": "Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RepaymentsOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfDebt",
     "crdr": "credit",
     "presentation": [
      "http://www.virtus.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt repayments",
        "label": "Repayments of Debt",
        "documentation": "Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation."
       }
      }
     },
     "auth_ref": [
      "r886"
     ]
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfLinesOfCredit",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Repayments on credit agreement",
        "label": "Repayments of Lines of Credit",
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r889"
     ]
    },
    "us-gaap_RepaymentsOfOtherDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfOtherDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments on borrowings by CIP",
        "label": "Repayments of Other Debt",
        "documentation": "Amount of cash outflow for the payment of debt classified as other."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r791",
      "r802",
      "r812",
      "r837"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r792",
      "r803",
      "r813",
      "r838"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r799",
      "r810",
      "r820",
      "r845"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash pledged or on deposit of CIP",
        "verboseLabel": "Cash pledged or on deposit of CIP",
        "label": "Restricted Cash and Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r142",
      "r167",
      "r196",
      "r544"
     ]
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://www.virtus.com/role/EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails",
      "http://www.virtus.com/role/StockBasedCompensationAdditionalInformationDetails",
      "http://www.virtus.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Stock Units (RSUs)",
        "verboseLabel": "Restricted stock units",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "vrts_RestrictedStockUnitsRSUsPerformanceBasedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "RestrictedStockUnitsRSUsPerformanceBasedMember",
     "presentation": [
      "http://www.virtus.com/role/StockBasedCompensationAdditionalInformationDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted stock units (RSUs), performance-based",
        "label": "Restricted Stock Units (RSUs), Performance-Based [Member]",
        "documentation": "Restricted Stock Units (RSUs), Performance-Based [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "vrts_RestrictedStockUnitsandPerformanceSharesUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "RestrictedStockUnitsandPerformanceSharesUnitsMember",
     "presentation": [
      "http://www.virtus.com/role/StockBasedCompensationAdditionalInformationDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RSUs and PSUs",
        "label": "Restricted Stock Units and Performance Shares Units [Member]",
        "documentation": "Restricted Stock Units and Performance Shares Units [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringCharges",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring expense",
        "label": "Restructuring Charges",
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r300",
      "r301",
      "r908"
     ]
    },
    "vrts_RetailSeparateAccountsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "RetailSeparateAccountsMember",
     "presentation": [
      "http://www.virtus.com/role/RevenuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retail separate accounts",
        "label": "Retail Separate Accounts [Member]",
        "documentation": "Retail Separate Accounts [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retained earnings (accumulated deficit)",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r133",
      "r547",
      "r574",
      "r576",
      "r582",
      "r609",
      "r767"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retained Earnings (Accumulated Deficit)",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r164",
      "r202",
      "r203",
      "r204",
      "r206",
      "r212",
      "r214",
      "r287",
      "r288",
      "r425",
      "r426",
      "r427",
      "r437",
      "r438",
      "r456",
      "r458",
      "r459",
      "r461",
      "r464",
      "r571",
      "r573",
      "r586",
      "r943"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from Contract with Customer [Abstract]",
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.virtus.com/role/RevenuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenues",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r237",
      "r238",
      "r244",
      "r247",
      "r248",
      "r252",
      "r253",
      "r254",
      "r377",
      "r378",
      "r527"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "presentation": [
      "http://www.virtus.com/role/BasisofPresentationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Recognition",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue from contract with customer."
       }
      }
     },
     "auth_ref": [
      "r160",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r734"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "presentation": [
      "http://www.virtus.com/role/Revenues"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenues",
        "label": "Revenue from Contract with Customer [Text Block]",
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts."
       }
      }
     },
     "auth_ref": [
      "r160",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r379"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/ConsolidationRevenueandExpensesofConsolidatedInvestmentProductDetails": {
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/ConsolidationRevenueandExpensesofConsolidatedInvestmentProductDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Income",
        "label": "Revenues",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r186",
      "r199",
      "r237",
      "r238",
      "r244",
      "r247",
      "r248",
      "r252",
      "r253",
      "r254",
      "r286",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r478",
      "r536",
      "r913"
     ]
    },
    "us-gaap_RevenuesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenuesAbstract",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.virtus.com/role/ConsolidationRevenueandExpensesofConsolidatedInvestmentProductDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenues",
        "verboseLabel": "Income:",
        "label": "Revenues [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevolvingCreditFacilityMember",
     "presentation": [
      "http://www.virtus.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revolving credit facility",
        "label": "Revolving Credit Facility [Member]",
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "presentation": [
      "http://www.virtus.com/role/AccumulatedOtherComprehensiveIncomeLossTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Changes in Accumulated Other Comprehensive Income (Loss)",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r923",
      "r924"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://www.virtus.com/role/EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://www.virtus.com/role/EarningsLossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "presentation": [
      "http://www.virtus.com/role/InvestmentsMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]",
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266"
     ]
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "presentation": [
      "http://www.virtus.com/role/AcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r64",
      "r446"
     ]
    },
    "srt_ScheduleOfCondensedBalanceSheetTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScheduleOfCondensedBalanceSheetTableTextBlock",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Condensed Consolidated Balance Sheets",
        "label": "Condensed Balance Sheet [Table Text Block]",
        "documentation": "Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations."
       }
      }
     },
     "auth_ref": [
      "r873",
      "r892"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.virtus.com/role/EarningsLossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Computation of Basic and Diluted Earnings Per Share",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r897"
     ]
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationTables",
      "http://www.virtus.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r468",
      "r469"
     ]
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "presentation": [
      "http://www.virtus.com/role/IntangibleAssetsNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Goodwill and Intangible Assets, Net",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "us-gaap_ScheduleOfInvestmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfInvestmentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Investments [Abstract]",
        "label": "Schedule of Investments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfInvestmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfInvestmentsLineItems",
     "presentation": [
      "http://www.virtus.com/role/InvestmentsInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Investments [Line Items]",
        "label": "Schedule of Investments [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721"
     ]
    },
    "us-gaap_ScheduleOfInvestmentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfInvestmentsTable",
     "presentation": [
      "http://www.virtus.com/role/InvestmentsInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Investments [Table]",
        "label": "Schedule of Investments [Table]",
        "documentation": "Disclosure of information about investments owned by investment company."
       }
      }
     },
     "auth_ref": [
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.virtus.com/role/StockBasedCompensationAdditionalInformationDetails",
      "http://www.virtus.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r389",
      "r391",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419"
     ]
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "presentation": [
      "http://www.virtus.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Restricted Stock Units Activity",
        "label": "Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]",
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAdditionalInformationDetails",
      "http://www.virtus.com/role/ConsolidationBeneficialInterestsofConsolidatedInvestmentProductDetails",
      "http://www.virtus.com/role/ConsolidationCondensedConsolidatedBalanceSheetsDetails",
      "http://www.virtus.com/role/ConsolidationEconomicInterestsofConsolidatedInvestmentProductDetails",
      "http://www.virtus.com/role/ConsolidationRevenueandExpensesofConsolidatedInvestmentProductDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Variable Interest Entities [Table]",
        "label": "Schedule of Variable Interest Entities [Table]",
        "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r74",
      "r77",
      "r79",
      "r82",
      "r450",
      "r451",
      "r454",
      "r455",
      "r507",
      "r508",
      "r509"
     ]
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfVariableInterestEntitiesTextBlock",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of VIE Consolidated Investment Product",
        "label": "Schedule of Variable Interest Entities [Table Text Block]",
        "documentation": "Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r74",
      "r77",
      "r79",
      "r82"
     ]
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "presentation": [
      "http://www.virtus.com/role/IntangibleAssetsNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Estimated Amortization Expense of Intangible Assets Succeeding Years",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "us-gaap_SecuredDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SecuredDebtMember",
     "presentation": [
      "http://www.virtus.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Secured Debt",
        "label": "Secured Debt [Member]",
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets."
       }
      }
     },
     "auth_ref": []
    },
    "vrts_SecuritiesPurchasedPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "SecuritiesPurchasedPayable",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/ConsolidationCondensedConsolidatedBalanceSheetsDetails": {
       "parentTag": "vrts_NetInterestInInvestmentProducts",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/ConsolidationCondensedConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Securities purchased payable and other liabilities",
        "label": "Securities Purchased Payable",
        "documentation": "Securities Purchased Payable"
       }
      }
     },
     "auth_ref": []
    },
    "vrts_SecuritiesPurchasedPayableAndOtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "SecuritiesPurchasedPayableAndOtherLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Securities purchased payable and other liabilities of CIP",
        "label": "Securities Purchased Payable And Other Liabilities",
        "documentation": "Securities Purchased Payable And Other Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.virtus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r785"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.virtus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r787"
     ]
    },
    "us-gaap_SeniorNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SeniorNotes",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notes payable of CIP",
        "label": "Senior Notes",
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r937"
     ]
    },
    "us-gaap_SeniorNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SeniorNotesMember",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Notes",
        "label": "Senior Notes [Member]",
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors."
       }
      }
     },
     "auth_ref": []
    },
    "vrts_SeniorSecuredFloatingRateNotesNewfleetCLO20161Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "SeniorSecuredFloatingRateNotesNewfleetCLO20161Member",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CLO senior secured floating rate notes",
        "label": "Senior Secured Floating Rate Notes - Newfleet CLO 2016-1 [Member]",
        "documentation": "Senior Secured Floating Rate Notes - Newfleet CLO 2016-1 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://www.virtus.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r763"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "presentation": [
      "http://www.virtus.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number of shares, forfeited (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r410"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.virtus.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average grant date fair value, forfeited (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r410"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://www.virtus.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares, granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r408"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.virtus.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average grant-date fair value (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r408"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://www.virtus.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Number of shares, outstanding (in shares)",
        "periodEndLabel": "Number of shares, outstanding (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r405",
      "r406"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "presentation": [
      "http://www.virtus.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of\u00a0Shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.virtus.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted average grant date fair value, outstanding (in dollars per share)",
        "periodEndLabel": "Weighted average grant date fair value, outstanding (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r405",
      "r406"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "presentation": [
      "http://www.virtus.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Grant\u00a0Date Fair\u00a0Value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://www.virtus.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number of shares, settled (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r409"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.virtus.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average grant date fair value, settled (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement."
       }
      }
     },
     "auth_ref": [
      "r409"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.virtus.com/role/StockBasedCompensationAdditionalInformationDetails",
      "http://www.virtus.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r389",
      "r391",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
     "presentation": [
      "http://www.virtus.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted",
        "documentation": "Net number of non-option equity instruments granted to participants."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "presentation": [
      "http://www.virtus.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares of common stock reserved for issuance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r764"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://www.virtus.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares of common stock available for issuance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.virtus.com/role/StockBasedCompensationAdditionalInformationDetails",
      "http://www.virtus.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419"
     ]
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.virtus.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average remaining amortization period",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "presentation": [
      "http://www.virtus.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share settlement under RSUs (in shares)",
        "label": "Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "vrts_SponsoredFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "SponsoredFundsMember",
     "presentation": [
      "http://www.virtus.com/role/FairValueMeasurementsChangesinAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.virtus.com/role/InvestmentsMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sponsored funds",
        "verboseLabel": "Sponsored funds",
        "label": "Sponsored Funds [Member]",
        "documentation": "Sponsored Funds [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.virtus.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Axis]",
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r161",
      "r173",
      "r174",
      "r175",
      "r199",
      "r219",
      "r223",
      "r226",
      "r228",
      "r234",
      "r235",
      "r286",
      "r308",
      "r310",
      "r311",
      "r312",
      "r315",
      "r316",
      "r346",
      "r347",
      "r349",
      "r352",
      "r359",
      "r478",
      "r578",
      "r579",
      "r580",
      "r581",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r608",
      "r630",
      "r648",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r862",
      "r888",
      "r896"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.virtus.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r33",
      "r164",
      "r182",
      "r183",
      "r184",
      "r202",
      "r203",
      "r204",
      "r206",
      "r212",
      "r214",
      "r233",
      "r287",
      "r288",
      "r360",
      "r425",
      "r426",
      "r427",
      "r437",
      "r438",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r464",
      "r481",
      "r483",
      "r484",
      "r485",
      "r486",
      "r488",
      "r491",
      "r571",
      "r572",
      "r573",
      "r586",
      "r648"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r202",
      "r203",
      "r204",
      "r233",
      "r527",
      "r577",
      "r597",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r608",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r617",
      "r618",
      "r619",
      "r620",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r628",
      "r631",
      "r632",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r648",
      "r773"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Cash Flows [Abstract]",
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position [Abstract]",
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Comprehensive Income [Abstract]",
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Stockholders' Equity [Abstract]",
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r202",
      "r203",
      "r204",
      "r233",
      "r527",
      "r577",
      "r597",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r608",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r617",
      "r618",
      "r619",
      "r620",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r628",
      "r631",
      "r632",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r648",
      "r773"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r794",
      "r805",
      "r815",
      "r840"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "vrts_StockBasedCompensationExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "StockBasedCompensationExpenseTableTextBlock",
     "presentation": [
      "http://www.virtus.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock Based Compensation Expense",
        "label": "Stock Based Compensation Expense [Table Text Block]",
        "documentation": "Stock Based Compensation Expense Table [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common shares related to employee stock transactions (in shares)",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r101",
      "r102",
      "r133"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "crdr": "credit",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common shares related to employee stock transactions",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r101",
      "r102",
      "r133"
     ]
    },
    "us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased",
     "presentation": [
      "http://www.virtus.com/role/EquityTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares available for repurchase (in shares)",
        "label": "Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased",
        "documentation": "The remaining number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchasedDuringPeriodShares",
     "presentation": [
      "http://www.virtus.com/role/EquityTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock repurchased during period, shares",
        "label": "Stock Repurchased During Period, Shares",
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r101",
      "r102",
      "r133",
      "r581",
      "r648",
      "r725"
     ]
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchasedDuringPeriodValue",
     "crdr": "debit",
     "presentation": [
      "http://www.virtus.com/role/EquityTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock repurchased during period, value",
        "label": "Stock Repurchased During Period, Value",
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r101",
      "r102",
      "r133",
      "r586",
      "r648",
      "r725",
      "r783"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total equity attributable to Virtus Investment Partners, Inc.",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r105",
      "r106",
      "r126",
      "r610",
      "r627",
      "r649",
      "r650",
      "r767",
      "r784",
      "r890",
      "r904",
      "r922",
      "r943"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity attributable to Virtus Investment Partners, Inc.:",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total equity",
        "periodStartLabel": "Balance at beginning of period",
        "periodEndLabel": "Balance at end of period",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r69",
      "r83",
      "r164",
      "r165",
      "r183",
      "r202",
      "r203",
      "r204",
      "r206",
      "r212",
      "r287",
      "r288",
      "r360",
      "r425",
      "r426",
      "r427",
      "r437",
      "r438",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r464",
      "r481",
      "r483",
      "r488",
      "r491",
      "r572",
      "r573",
      "r584",
      "r610",
      "r627",
      "r649",
      "r650",
      "r727",
      "r783",
      "r890",
      "r904",
      "r922",
      "r943"
     ]
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity:",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.virtus.com/role/EquityTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Transactions",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r132",
      "r198",
      "r345",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r358",
      "r360",
      "r463",
      "r651",
      "r652",
      "r728"
     ]
    },
    "us-gaap_SubordinatedDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubordinatedDebtMember",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subordinated Debt",
        "label": "Subordinated Debt [Member]",
        "documentation": "This element represents domestic or foreign subordinated debt. Subordinated debt has a lower priority of repayment in liquidation of the entity's assets."
       }
      }
     },
     "auth_ref": []
    },
    "vrts_SubordinatedNotesNewfleetCLO20161Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "SubordinatedNotesNewfleetCLO20161Member",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CLO subordinated notes",
        "label": "Subordinated Notes - Newfleet CLO 2016-1 [Member]",
        "documentation": "Subordinated Notes - Newfleet CLO 2016-1 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r834"
     ]
    },
    "us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.virtus.com/role/ConsolidationCondensedConsolidatedBalanceSheetsDetails": {
       "parentTag": "vrts_NetInterestInInvestmentProducts",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.virtus.com/role/ConsolidationCondensedConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Redeemable noncontrolling interests",
        "periodStartLabel": "Balance",
        "periodEndLabel": "Balance",
        "negatedLabel": "Noncontrolling interests",
        "label": "Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests",
        "documentation": "Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r199",
      "r286",
      "r478"
     ]
    },
    "us-gaap_TemporaryEquityNetIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquityNetIncome",
     "crdr": "credit",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.virtus.com/role/RedeemableNoncontrollingInterestsScheduleofRedeemableNoncontrollingInterestDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net income (loss)",
        "terseLabel": "Total net income (loss) attributable to noncontrolling interests",
        "label": "Temporary Equity, Net Income",
        "documentation": "The portion of net income or loss attributable to temporary equity interest."
       }
      }
     },
     "auth_ref": []
    },
    "vrts_TermLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "TermLoanMember",
     "presentation": [
      "http://www.virtus.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term loan",
        "label": "Term Loan [Member]",
        "documentation": "Term Loan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r826"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r833"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TradingSecuritiesAndCertainTradingAssetsTextBlock",
     "presentation": [
      "http://www.virtus.com/role/InvestmentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Marketable Securities",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block]",
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)."
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.virtus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAssetsRelatedtoConsolidatedSponsoredInvestmentProductsUnobservableInputReconciliationDetails",
      "http://www.virtus.com/role/ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.virtus.com/role/FairValueMeasurementsChangesinAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.virtus.com/role/InvestmentsMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instruments [Domain]",
        "label": "Financial Instruments [Domain]",
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r342",
      "r357",
      "r462",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r557",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r899",
      "r900",
      "r901",
      "r902"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r856"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r857"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r858"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r856"
     ]
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "presentation": [
      "http://www.virtus.com/role/EquityTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average price (in dollars per share)",
        "label": "Shares Acquired, Average Cost Per Share",
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_TreasuryStockCommonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockCommonMember",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury Stock",
        "label": "Treasury Stock, Common [Member]",
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_TreasuryStockCommonShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockCommonShares",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury stock, shares (in shares)",
        "periodStartLabel": "Balance at beginning of period, treasury stock (in shares)",
        "periodEndLabel": "Balance at end of period, treasury stock (in shares)",
        "label": "Treasury Stock, Common, Shares",
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_TreasuryStockCommonValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockCommonValue",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Treasury stock, at cost, 5,096,608 and 5,075,500 shares at March\u00a031, 2024 and December\u00a031, 2023, respectively",
        "label": "Treasury Stock, Common, Value",
        "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r57",
      "r58"
     ]
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockSharesAcquired",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repurchases of common shares (in shares)",
        "label": "Treasury Stock, Shares, Acquired",
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r102",
      "r133"
     ]
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "crdr": "debit",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Repurchases of common shares",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r57",
      "r133"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r852"
     ]
    },
    "us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/ConsolidationEconomicInterestsofConsolidatedInvestmentProductDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.virtus.com/role/ConsolidationEconomicInterestsofConsolidatedInvestmentProductDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Economic Interests",
        "label": "Variable Interest Entity, Measure of Activity, Income or Loss before Tax",
        "documentation": "Description of the amount of pre-tax income (loss) derived by the reporting entity from the Variable Interest Entity (VIE)."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableInterestEntityActivityBetweenVIEAndEntityRevenues",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/ConsolidationEconomicInterestsofConsolidatedInvestmentProductDetails": {
       "parentTag": "us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/ConsolidationEconomicInterestsofConsolidatedInvestmentProductDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment management fees",
        "label": "Variable Interest Entity, Measure of Activity, Revenues",
        "documentation": "The amount of income between the reporting entity and the Variable Interest Entity (VIE)."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableInterestEntityEntityMaximumLossExposureAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Carrying value and maximum risk of loss",
        "label": "Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount",
        "documentation": "The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE)."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r80"
     ]
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableInterestEntityLineItems",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAdditionalInformationDetails",
      "http://www.virtus.com/role/ConsolidationBeneficialInterestsofConsolidatedInvestmentProductDetails",
      "http://www.virtus.com/role/ConsolidationCondensedConsolidatedBalanceSheetsDetails",
      "http://www.virtus.com/role/ConsolidationEconomicInterestsofConsolidatedInvestmentProductDetails",
      "http://www.virtus.com/role/ConsolidationRevenueandExpensesofConsolidatedInvestmentProductDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Interest Entity [Line Items]",
        "label": "Variable Interest Entity [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r450",
      "r451",
      "r454",
      "r455",
      "r507",
      "r508",
      "r509"
     ]
    },
    "vrts_VariableInterestEntityMeasureofActivityDistributionsReceivedandUnrealizedGainsLossesOnInvestment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "VariableInterestEntityMeasureofActivityDistributionsReceivedandUnrealizedGainsLossesOnInvestment",
     "crdr": "credit",
     "calculation": {
      "http://www.virtus.com/role/ConsolidationEconomicInterestsofConsolidatedInvestmentProductDetails": {
       "parentTag": "us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/ConsolidationEconomicInterestsofConsolidatedInvestmentProductDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Distributions received and unrealized gains (losses) on the subordinated notes held by the Company",
        "label": "Variable Interest Entity, Measure of Activity, Distributions Received and Unrealized Gains (Losses) On Investment",
        "documentation": "Variable Interest Entity, Measure of Activity, Distributions Received and Unrealized Gains (Losses) On Investment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableInterestEntityNotPrimaryBeneficiaryMember",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nonconsolidated VIEs",
        "label": "Variable Interest Entity, Not Primary Beneficiary [Member]",
        "documentation": "Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary. VIEs of which the entity is not the primary beneficiary because it does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance and for which it does not have the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE are not included in the consolidated financial statements of the entity."
       }
      }
     },
     "auth_ref": []
    },
    "vrts_VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationAdditionalInformationDetails",
      "http://www.virtus.com/role/ConsolidationBeneficialInterestsofConsolidatedInvestmentProductDetails",
      "http://www.virtus.com/role/ConsolidationCondensedConsolidatedBalanceSheetsDetails",
      "http://www.virtus.com/role/ConsolidationEconomicInterestsofConsolidatedInvestmentProductDetails",
      "http://www.virtus.com/role/ConsolidationRevenueandExpensesofConsolidatedInvestmentProductDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CLOs",
        "label": "Variable Interest Entity, Primary Beneficiary, Collateralized Loan Obligation [Member]",
        "documentation": "Variable Interest Entity, Primary Beneficiary, Collateralized Loan Obligation [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "vrts_VariableInterestEntityPrimaryBeneficiaryGlobalAndPrivateFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "VariableInterestEntityPrimaryBeneficiaryGlobalAndPrivateFundsMember",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationCondensedConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "GFs",
        "label": "Variable Interest Entity, Primary Beneficiary, Global and Private Funds [Member]",
        "documentation": "Variable Interest Entity, Primary Beneficiary, Global and Private Funds"
       }
      }
     },
     "auth_ref": []
    },
    "vrts_VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.virtus.com/role/ConsolidationAssetsRelatedtoConsolidatedSponsoredInvestmentProductsUnobservableInputReconciliationDetails",
      "http://www.virtus.com/role/ConsolidationAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.virtus.com/role/RedeemableNoncontrollingInterestsScheduleofRedeemableNoncontrollingInterestDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated Investment Products",
        "verboseLabel": "CIP",
        "label": "Variable Interest Entity, Primary Beneficiary, and Voting Interest Entity [Member]",
        "documentation": "Variable Interest Entity (VIE), Primary Beneficiary, and Voting Interest Entity (VOE) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "VariableInterestEntityReportingEntityInvolvementBeneficialInterestsAmount",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/ConsolidationBeneficialInterestsofConsolidatedInvestmentProductDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.virtus.com/role/ConsolidationBeneficialInterestsofConsolidatedInvestmentProductDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Beneficial Interests",
        "label": "Variable Interest Entity, Reporting Entity Involvement, Beneficial Interests, Amount",
        "documentation": "Variable Interest Entity, Reporting Entity Involvement, Beneficial Interests, Amount"
       }
      }
     },
     "auth_ref": []
    },
    "vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsDeferredRevenueAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "VariableInterestEntityReportingEntityInvolvementBeneficialInterestsDeferredRevenueAmount",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/ConsolidationBeneficialInterestsofConsolidatedInvestmentProductDetails": {
       "parentTag": "vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsAmount",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/ConsolidationBeneficialInterestsofConsolidatedInvestmentProductDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued investment management fees",
        "label": "Variable Interest Entity, Reporting Entity Involvement, Beneficial Interests, Deferred Revenue, Amount",
        "documentation": "Variable Interest Entity, Reporting Entity Involvement, Beneficial Interests, Deferred Revenue, Amount"
       }
      }
     },
     "auth_ref": []
    },
    "vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsSubordinatedDebtAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "VariableInterestEntityReportingEntityInvolvementBeneficialInterestsSubordinatedDebtAmount",
     "crdr": "debit",
     "calculation": {
      "http://www.virtus.com/role/ConsolidationBeneficialInterestsofConsolidatedInvestmentProductDetails": {
       "parentTag": "vrts_VariableInterestEntityReportingEntityInvolvementBeneficialInterestsAmount",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.virtus.com/role/ConsolidationBeneficialInterestsofConsolidatedInvestmentProductDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subordinated notes",
        "label": "Variable Interest Entity, Reporting Entity Involvement, Beneficial Interests, Subordinated Debt, Amount",
        "documentation": "Variable Interest Entity, Reporting Entity Involvement, Beneficial Interests, Subordinated Debt, Amount"
       }
      }
     },
     "auth_ref": []
    },
    "vrts_VotingInterestEntityVOEMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "VotingInterestEntityVOEMember",
     "presentation": [
      "http://www.virtus.com/role/ConsolidationCondensedConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "VOEs",
        "label": "Voting Interest Entity (VOE) [Member]",
        "documentation": "Voting Interest Entity (VOE) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.virtus.com/role/EarningsLossPerShareScheduleofComputationofBasicandDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted Average Shares Outstanding\u2014Diluted (in shares)",
        "terseLabel": "Diluted: Weighted-average number of shares outstanding (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r218",
      "r228"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "presentation": [
      "http://www.virtus.com/role/EarningsLossPerShareScheduleofComputationofBasicandDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares:",
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://www.virtus.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.virtus.com/role/EarningsLossPerShareScheduleofComputationofBasicandDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted Average Shares Outstanding\u2014Basic (in shares)",
        "terseLabel": "Basic: Weighted-average number of shares outstanding (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r216",
      "r228"
     ]
    },
    "vrts_WestchesterCapitalManagementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.virtus.com/20240331",
     "localname": "WestchesterCapitalManagementMember",
     "presentation": [
      "http://www.virtus.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Westchester",
        "label": "Westchester Capital Management [Member]",
        "documentation": "Westchester Capital Management"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "940",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "7",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "8",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479613/805-30-35-1"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a),(b),(c)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(f)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(g)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c),(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(1)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(3)",
   "SubTopic": "10",
   "Topic": "480",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "16(c)",
   "SubTopic": "10",
   "Topic": "480",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "24(b)",
   "SubTopic": "10",
   "Topic": "480",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19,20,22)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.25)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.27(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.30)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "320",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//320/tableOfContent"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "((a)(1),(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Paragraph": "3A",
   "Section": "S99",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Paragraph": "3A",
   "Section": "S99",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "37",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479303/805-10-55-37"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "25",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479668/805-30-25-6"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-21"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2AA",
   "Subparagraph": "a",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-2AA"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-4"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-4"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "b",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-4"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-5A"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-5A"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-6"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-6"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "d",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-6"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-9"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "940",
   "SubTopic": "320",
   "Section": "35",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481992/940-320-35-1"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.15(1),(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.15)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.16)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.17)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//220/tableOfContent"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.19)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7(c),9(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//235/tableOfContent"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//440/tableOfContent"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//470/tableOfContent"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//505/tableOfContent"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//805/tableOfContent"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//810/tableOfContent"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r152": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r153": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.14)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r154": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//275/tableOfContent"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//606/tableOfContent"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "04",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(210.5-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//260/tableOfContent"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-28A"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//350-30/tableOfContent"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-1"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-15"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-9"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//718/tableOfContent"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480454/718-10-45-1"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//740/tableOfContent"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-1A"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-2"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-5"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-21"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(h))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(7)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(5)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column B)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "19",
   "Subparagraph": "(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "19",
   "Subparagraph": "(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column C)(Footnote 6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 5)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481058/954-310-45-1"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "405",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480191/946-405-45-2"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii",
   "Section": "6"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3"
  },
  "r863": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4H",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H"
  },
  "r864": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Topic": "321",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//321/tableOfContent"
  },
  "r865": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Topic": "325",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//325/tableOfContent"
  },
  "r866": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r867": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r868": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r869": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r870": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r871": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r872": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r873": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "04",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r874": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "(a)",
   "Subparagraph": "(4)(i)",
   "Publisher": "SEC"
  },
  "r875": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "(a)",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r876": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "(a)",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r877": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r878": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r879": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r880": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r881": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r882": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r883": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(b)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r884": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r885": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r886": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r887": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-9"
  },
  "r888": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r889": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r890": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r891": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r892": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r893": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r894": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r895": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r896": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55"
  },
  "r897": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r898": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//320/tableOfContent"
  },
  "r899": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9"
  },
  "r900": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r901": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r902": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r903": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r904": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r905": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r906": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r907": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10"
  },
  "r908": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482047/420-10-45-3"
  },
  "r909": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//450/tableOfContent"
  },
  "r910": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r911": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r912": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r913": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r914": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r915": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r916": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r917": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r918": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r919": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r920": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r921": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r922": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r923": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r924": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r925": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r926": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r927": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r928": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r929": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r930": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r931": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r932": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r933": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r934": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r935": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r936": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r937": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r938": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r939": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B"
  },
  "r940": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r941": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r942": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r943": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r944": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r945": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>83
<FILENAME>0000883237-24-000050-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000883237-24-000050-xbrl.zip
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M.-R%6X;@UKZYI4_,E-VY97*G-:K"89>OF57(,ZN&$E8H1J]WQ!\A\OH%AW@
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M%Q3["R&CNXBP1-'D-AEB\CA$X?31Z2^T&$ 0T4YVU8GO X=IQ=\0\5$_P-=
M:8+C),//'?%'B+Q^P2$>0-?P*PJ]WR)Z/.QMPX8"C;M85^4J@'-HUQ4XW ;4
M!!M+L+'+75B,!Q-@3\9ME[OHU";+9L%:^-OM57V(SEW\IT);Y3(*Z,D<@@+_
M3^Q1Y_*V'_A/;*^O/ASB+CY3(8?^'D1]%%R$'GSU#'WM_Z:]2EG#792%4XU5
MI5O>K5D,I!X:JU(.U2QPPKG&JI0UW$9.5H9K'])^1#P_I'R[B1(<W^ ?@P#C
MY/*76TT!JY&CX$@S# [N@A[K,8)#/R+Y1LVW($)TB:,U-/<"F$VWC>B8V  $
M0BM&*+?1E5/78E7)SARU:K7O:M4L8,2Q[N A_F=Q%Y+BZA[=HV\K;4.NN:CW
M-X+_2''HOJZ@U5S3^)X:%P0&6!]=Q%UH[Y W]PGPUAN\W$4]N;J!1("7:_!R
M%Q<^/#?XAS!'>.$NI"W,3,Z5W>9#6G6-^GS(8G:PL3XRP]TF@[!NA<QP+C/<
M[OX(HUK(#*<RP]UNF("I@.DR3+G=$EM+\:S ]L8T%[Y+W865'ZFQN=NN:X34
M".^EV5+#[ZYHG:5&^"_-EAI^MV,/+34"J%P#M=%;K\*BYPZ\52:XVW78>A6&
MM0!O(7@;O0\L[-MF@[<.&[+'#D,?'<(<X:71FY'"S!2[/'N0&>XV(X5U*V2&
M<YGA=V=4&-5"9KB4&8>[?5$!4P'399B*C4CAN]1$6#F2&K$1*;P7(35EI8;?
M7=$Z2XWP7YHM-?QNQXJD%P'4.:!RM_5:([PTU;WD;D=38&(;3&A58H*[74N!
MB8TQP4-),8>[+3P!H.T =*3[EQWN]K,$@(Z<LJTI8K^F$9C0J\0$=YLC[V-B
M0NYB6-Q$R3(R>)3/C_[+.0P[2HF+X^S/(48>&X_G/_<^PP_&(K]O]FUD:8S$
MAJFHCC88(#1 NJ&KFNHH_Z8,G#T3)Z\!L&KDA^TA]I^&R;FA=2QSG'SZX7O)
M\%Q5E/_38DU[G^,Q"GN?^^0C=)#]GO6SW!LB3]!A$HW/G7$"CR>4])-O:1%>
M3-HNK?LZCO'YY)=/GA^/ _0*1 G\$+?90Y_ROOI1DD2C<SJP9TP2WT5!&P7^
M4WA."91_G8_9<3J&:M)A)T"?Q)N\.)]1!V;TL>!SN^,HQ5\I';7X$='5RJX^
M,MJ3R9<YN/0,#IX$3*<0^KFEFJT%8.2L5L>)Q(1:^DEA_WW*OZ>P6OYRC#P/
MM/FY(L%WTP%\9"!Z'Z(&8(J!*,.3BZF*:&5PGS2'X4;D?/*N 8AE>X!&?O!Z
M_K=+>*Q/_+_),0KC=@P"/,@:Q/Z?^%SM0N_LSQ\9!2QXGL$[IXBJ40'[]>;Z
M\>JK]/!X\7CU\%:ZY@9][%$^7%W^>G_]>'WU(%W<?)6N_O?ROR]N_GXE7=Y^
M_W[]\'!]>W.$H2L;#?V?*!X"/)(HE*6OG<N.I"FFX:P<[AP\S!7P.*Q.TTRU
MHYF9]!0KM0SUBU\8=O98L7"7_$)T-GUF4_6F+VJW#;67Z&-+;:YJ>U7G]D;:
MYMOM_7?I,QAI813>@/%/?%?*;;E[/& .=TL*$362/>R??XU<YB'0*PM:S(P;
M0(.>JK3_P4R]62\]:1.5I5I"9XG.A,ZJB\XRC^,DV:9>UDDRP#?L5N)".'I'
M,8Q-7(A5S)C06QN_4(K/*[P #Y9)$(TK6P6TA57 6%P%,J^Y] +PCQ01T-3!
MZST>1R1I28.(C% ";OU+<C[P7[#73D@Z72.T5N^O/SF6T?VTN$Q,5XG$VX)\
MV7IQ2 (N+:.,@/_X]>+^\>K^EW])]U=WM_>/TMVO]P^_7MP\2H^W$C@CC^!Q
M2*HNW=Y+JGGF?9!NOTF/_WTES?DI4Q_EXO*1?JTZNO&&.+P8%INY,=\B(B5#
M+/TQ 8J418PD''K8V\+DN&./7V5;!V_Q1J-I[1%T,:2/M3WTVG[%B+1Q.,&?
MWNI]IVE9?_U)[2J?=%66:(1K.Y.%!^K>WF_H$ IM+;0UF.L$7N?3>ZI6J^L!
M"N*IOC9R?6TT5%\_WE_</%PSK2P4]EN%G4RQ,M'8 Q*-IJKQ<$/**.)A-R+L
MBK7S%%8.0EM1<%(]OOO/P\^JU9.2J.'4Y![KE]%HY,=T5T[ZYL/B",JMC\EY
M":LDVY6C#V?/3A2G23<-U;:J.,YJ\^) BP6;ZN:<$>%CT9D(Q1R[C_>-AB+Y
M]$=/4DS<GULTJZ1-_1I%U]5_/ZF=_XR?6A(*DNRK('J*-$5UD*)EW[QE:5<=
MOVPEL+8]?F$C/]A.FK:9EB^KS>_QDQ]3\R>Y@6\F&KW;ZOUV??_XZX-T??/;
MU</C]RLP$N_ W;^YNG^0X</+SN9^Y+$7OK.K%^0F;.92-)#(=,82BJ5XC%V:
MVN))?BCY22RY0^:[?Q"K!]\ZFM_.Q.K!P^I1DQB0W3%UO500:-7G6L>TRSVQ
M<E#=CF&_'YDJQKAJO@/R#7F_;;/M US[C\^L7:=*AKBRI?LZ!+]VG+NV#PE*
M\&64A@F]L]U[&RR&$;DT5SW!8Q(]TWYF46*KU?N* _0#$5QMV*LH;IA)S-[H
M6APZ7/ &.8WA[0<CC^CE.L_>=1E.WGKN=JNG==NZT]5L57V7_56+5[5(6)OW
MP8AWQH1$BH@4)4-,I/^DQ(\]WV5QOVC <F?]>:%B3<D3"OT_V=\?>)>(13H<
M6B".PM7KSGWGH2-=C<9!](H)8^-;T$LW4>=#C</49:7^PO,(CN/\GU^@/W4B
M\4ZK=QMB:7H 0KH+T)]H4?3ETE'!_%V7\.LM>8Q^3-<756GU_AM<*EB.O,I>
MPP3YEMS!:@8".\O*4EN]R\=ESW2[E]Q%L&0&_Y\_SM;3_!5:JZ=T547GP/_=
M+-OM+)\.]7W'!,CECX'M^ 6[:>(_4Y<8Q 3',CC ;I!2>9=@SA*=]$9.,!<2
M<K8YCRE$+PA&;[BJMWJVHBSR]$,)Z/P2@1J\&T;A0G!<-6"-->RVY5A+*RR_
MF)F%A?[ZDZVIUJ=82G" QW1^4L@F. \8,!X1$&=#Q(BPB>A,A$V.W4?YH/N!
MG+;L,,OT\&4>L,4$>](X)7%*([=))$$+9MNIVEG_ UW<Z$;^A9N<;ZV"LD_\
MD-J.YYK!#MH=7"W99D?3R\>1%!BM5DD<2>ET3:N2.)*F=BRUFN!6=8/2M8ZI
MO?]ROGW=#:,>CWX2L/T.C-RAY 8HCDMX?!M&WS@G 4',.GEX'?6CX"PNX[XW
M@@ W^987@P!^<8<H?((/0NG'T(=/9HJU*-1SX(7X@.OD_I;3NBN-S=V=?'U^
M5;4^TS13=\?,,HT 9 ])Y/XN2W]1.HHJC1&1GFG)N-4^T(D(Y>8TSO57IKZF
M!*9[\_>/#SL$ZT^,C!.H7N4*,$MT6-P>H>KQ[<Z(:H$&Q3^D?T7D]PS,TJ2+
M]:'R<K'%)9OSD*;V=>C1."F6^J^2.\0P31CC[[!&8!8EIV;U7,[$F?HABQ\/
M42P-_ "L<A0$T(+F6%-C_8_4IZ8Z6.A]G#> CG-K/7M4U6ED/<LQS@WW.7M_
M0F1JS-.O:8ZQY*6TM"1K.B;8Q6QA5S6)G8"(I3/H#S@JQ2FL:_$PHBD<DU3>
M9(B2Q5G\0&^'2L>9/9Q/Y(,LH="3SK2YV?8!'-"H_Q^8"WV(M8<GZ5#RSE@E
M3#82-E(4)Y*C2!YZC3LK$TA+1B<O4T+@+5E2.U4/"4K2> I:N]7[%XX7 ;J'
MS-^U>PT%J9B'A'5^]DJZB=[2/,_P+Q/8K)%X4IP"1$=^D@"R<0!0)5%(E77P
M*F%0W*\2*[*#7!;\_8H2E*4#+PCNK(]YG_L^A9:&8E*QO,=/:9!MKSRT'Z4S
M2E_KDP;^5=X@&?HLG6I,TZGV+<#9>*<BB>,/E0G<'+THN7+YFPJ<\X[ S6&N
MNS*#_+0 "IA 4@"3P!)R70 HH66A&,\(U;F%GTI V7;A%_$(D UO(1-U"/P<
MP>1?9;K$0'>@DBG!GJ0G$OU(AI.O.Q(L.9@-SL,#/V2'/]@>26O5X%I2J_##
MU4-HL36DM6((+9IRR"0*C.BV-ED)YY>_SA(,CIE(?^"$*KO3M8VR@3 0 5LS
M*XHYF48U!9D,M:-J547GJAH4EY32.EW%KNE!QJK]EMEQ&W()&N<I(J\%;@MK
MQ'21FS>:>3":TNK]4JS-CN(^\L&!Z:'\DYGQQ8S[F4;/(7"TB,&1F&Y\VB#0
MV=TVA[5[J&9U5X$W1<;<"8EC$1:;/>.'S$3.E,_43L[^S*WAD])&98T 1K\O
M:0P=Q?':0@::NEDE@XKU7[.;;:AT>9X+M^KAJMA!%BKA'94PH=G?&<DN)R&%
M=:I!*Z$:ZK2',7@GUD,S%0M#5/Z@*'S*@J9@EH01BWFF<18F@CEF99P*BH5$
MA+TK>*4O_^'#J^&U4HA_T" 4P<]^S,R<2<XU&#_TI YM3 N,>XAXL42/YOC>
MJB0G_0Q]*(P02=*;N.$V12GJ%CV,AS@()LR5SH!E+(27G>%]/Z"V.BK\+QSO
M$B1^H&/:6 KUE5)8(DC<K1.;'X>3O&'*EGB("(ZE*$T8_JD@1(NR.$T\=K-T
M@ICMP-*X?\Z;;RPH#]^DH9]Q)NNVM< MK07X<'TPH>*?6]<WWPJVU-@;V!;O
M ^OB=C:PM\R$*;2]B-64H1W" @-K!O2E3%EKM'J6K&J6;-O3?._)2'OTQ#E,
M]#MZS3="LYILRV'>(D;R4396E._GH*NM4[0JJMXOWL'7.ZHYSE9T>XCHYG2[
M6;AR9AQE5N\YP73?_QDO74(S S=#M3)[!/4!P6FR_,BZ>VO*WI]C3>_/&4[5
MXQ@]X7:?8/1[&PU@]N<H^(%>8RHXVURR4V R#0:5FTSOU:[[C(X^!FE(J'7U
MTT8<>606"A@^E]0P"Y/X\T?4.T9.D%0$,8Y*%:TONK1"5(\]\.N;KU?_NWR<
MD>.R?S4I$FQW-*L:L](V:&)6-?D,'65-YD"U6U2U+1M2O\FLLTMY2PXOK@EQ
MAVB.]O)6Q]M9.[M%R/=H$!3-ZM &0<DQ;&X0T(H0=X@D&2:O.]*WZYN+F\OK
MBU]@C:-W\UP\LKO*T*)!N%L=&CZV.JX3/,IC/YT]ZI9#&JM'P&;),93 IM[J
MS6JCL#(CHT6#=0Z-1]D[W (+"UVT:7MV6]9J] N4O(.2+CWD1L/I=%]G_GI;
MZ0L* #Q8>AABG,32V:\A2CT?OOF0QWX9DNHV67:/2"U'+NFU'+9:RU&SW8Q:
MCMRHY:C9\8*OV,UNW<YO^*GE3/2M%M@=5L*Y1PB=CE@(=U-56UOJPNBI"Z^=
ME4;/S$ZF%L[M&&>O>6O^3 [%/L(;L?0]8L?^KEA&#3,O)OK+8%H-?A$ZH;8X
MT7C2"=-HC5 (E3*:YA)NI!!H6A3!0VA'CQS3LM4C+%3#B2)F%>N$:F@8HS=3
M#2@>2M^"Z(>P%4X2)^;$]18*H=F,MC=5""Q5.Z:9W"P?=Q@%\+;X;]+5'ZF?
MO HM<:+@,866:#ZC=94>#DY _)-(6J$NBG;GYK6"$/%:<MYH];J-W_+7Q)8_
M?]!S#+J_&:(GIDNFIXZ^^K&;9M<E4^OA(D3!:^PS&V6F@JB.RDX"TC;W.$Z#
MQ1BHT$=U!85J-UXAZ4(A\8<]Z*C5^P<] >PG[)P%4R[P03#YF^JF((I3>H;R
MHA^E"?5W?L>)=._'OPN%4UNF:\W7.(;0.#R"3V?AF80 +YBVN2.1BSVJ8(0Z
MJ2U'UZF3A7-^!;?W+F?(OY_3*C+J*QQ#&6YWWZ347W>DV\?_OKH7^?1B93FV
M'G):O5_P$[UHE"XIK.RW6%/JRTO-:;XBN1":A$/TT9MWJ7\K?4-N$A&A1.K+
MQA-0(B+4SR7XS%;OUW#N0M$'%& 6L,_3"V;7$-7O& 6=''/>ZSGT7V-6(B0W
M$X5ZKZ^$-5J]2Z;0[#SBSF[U;EG%T.LP*]@(70D=4EM>ZDJ#=4AF(G:%(N$0
M?+1X_M7+T._[6U9]$/J#!Q;NJC_V=RQ5\'0KGAJMW@.0$B5B4[+63-3?/2]>
MHRL'6O_$]/;'-*8_HY1>!4D/([0NWU[^^)M/V/6\**8W"; 2]>QBU'^DB-YQ
M&KQ*V4V^4A1*W\!PE52E_0_IC'5%?VU]D("^M!)^)&5]@87[C..$9BM*=-,O
MQ"26Z;'*#KT0\RL.T ]$,$@"&>?<RNXRA@6-7I,:^YZ/B(_CM57')T7@:.'Q
MA4+DS2T@2ZN3B0JRHH)LR0JRARVW2JO"2M<22U96/ZTJH+<@E1L/\=$?X5BZ
MP3^D^VB$PA5#[6Y$KU4U63<41KUU-!K/9Q:LNI6CN%3<EG/MM@I4Z)SE<9R*
MQ&N6'&XK$F]4GXW;T;\YT/3^*IW7,RXL\G[@"L?=CF67KG!L&1U#>__.WXUO
MSE ZIE[VZN*55QJ;U11+AD$Y=K>VU9*="5Y91^=^ JW=M6EM@&!FZ$8I=.J!
MKL O+J;%A.GU.A*((OJP6_#K$,6&G76BRB8Z/6K,3%!ZW/B(]]8=@P#S!>@F
M--#75U^>JSF-W-^?2 2F83L?JNMB#-;H\8*YF\W\(HYA$3G?I*SVJBE6<I?,
M.OIM^_P6E]"4X?* _<<1EXLC]JQ&"76@7?H+_B/UGU'PQM++^5YFHHIT7&W^
M[HS_LM/,/BU&RWB8TLH[X]+86[PP3I^_,([^E=T7E\;M)X3&YQ0/%Z%'_[F:
M@>$BN42$T L@?T-!BC>[-DZ?7!NG*ZV>JNFR;2M+E\85U^XO*552*=:44!4+
MKYM7-4(>FB$/QA'D06WU--V1N[2>+1?R4'\;9L5^]-2S7UK/IM/4RDVS4)9K
MB?PU*\$<[<KB6Z/ZWI(-P]X5W\4XVYN^W\2T/%F\K-&4.^!%![SHFMQUNIS@
MI:G6_D5V-W<L$7!K83'K!UB60IQLI1PW-71J"7;S?;!/"'D_I>,-3LK"GI;A
M4+NR;EN<F $5F,4".=T#(,<$Y"B.K%@[*TQA0+ZO,%D0C.[-NO,;+?YLQVA,
M(B]U:9FVUN7U76N3R._>0EJ5/U_1.IC)MM;13 Y9O#("QG;DK^_$VKBHX:PC
MN,S=+(2DZ T*(0DDV4= DD773D6V](8%7_A7LN, >T^P>D:$Y@-ZF.6_[:)E
M&^UNK]&R]V" $-\%:Z182@J0;[=Z5G=G7T.$9/C!R!K]N05&G%:ON_LV#5]A
M&*XUXUS83!B<VZG"[2./!JU+*"NV*FN:R8DY( S+_2O&'1"C9HC19$O5.4',
M*1B0V?%G- W'").QO)YD-,PB6F513^^V4F5;;.@U"2YKE.0.<-%;/4.7-7WG
M-94O0Y([K?@M)<#?E&"9!2['+")-8YD!1C&FUPM)_FA,HN?L](;8Z]MFK^^.
M1&.8T.M=@,($G*BK":7+;]P8!E@/73 ?=M:CPMCD!S]K=ORJQ(_)\*.I-=GW
MFQR^@8'BU7#;9ZNF;DQ>APD*GWQZ BHSBK?7[8VV<=;H]AD9,T,'1/+JQ0U2
M2HF_1Y'WPP^"LC+:!>-'[<J6;7!B_0AC>?]*?A] LJ@5K<FJZG "I*::T1,&
M"=.XI/K<%MFT!IICR8HC[. &@66-BMP6+ YO8&FJ3?F5EN*AA8,3](*%0;F5
M1IS0\#ITHQ%^1"]3<Z D[$VZ-:7+CB6LR :A9XV*K X]=)O*E-EY?2[0TU33
M<7Y?2IB/)8^8;;_#8&JMGN7(YNXGAH0!R0]<UIPPVP$N>JMG.[*A-\R$S#CO
M<*@7'Z,$!2OT8B65.1ITKK[TM&LOZ.M.UVTEX[3^JFP:MJSNGLM5EB5',JB%
M))VZ)*T[;;B5))E4DKJ6+7>UJD+/>Y6DICH7O_BH[P?LQB:6U9'=X[35"<-\
MQG-LT('07I32'<2=2W)M8M56/[KZQ^&**Z_-L7VG\FM-/4[*G9Q>N"Y),9W3
M:(S#F!6#9@+;QR$>^**8VHJ9U7[U76/'7HW&0?2*\3TM"8^].;F^3 G!+!OH
M)@K=[(^RJW2WU7-,V7143GQ:451-R,5F5NE^Y<)J]31%D6V=E[(J];=3UE03
M&J-75HN;+GDH7PN#&5/%)N*6U87N,KJ"-.061L628K=ZAB%K]LXGX<46(S_8
MVK#^T+ZQ1;,V;-DR14FW/2=M^,^^AT-OJH7%+F39E(T)!7.1J #]75KQN"N;
M)B]'1,7VY &2-_: (Q5P9,D:-SY>4TU9>O,6C(\>GZ.%WH"/V95>DK!=2VK3
M+VD,W<?Q933J^R$CXHRXE_.TG1@<KV6%0FOUNEW94GC);1)FZ_Z5ZP%@I;=Z
MCB([N^>("(MU39IQ7QQ"+JM6?XG"IT=,1I1X98%-#QV;NJPHO&0_"6MT_PIS
M%\"8&6 ,M6$E$KE3A5GVL B5;J\7&07G0E=EH=X%6]*2C2XO)>^$+;E_U;@K
M9BPP%%79L'9VRH6AN''ZTYJ27P=(3JK\^5,HVW83)7BV/RCJMFU5M^T!AWY$
M&"G+JBJ[U5-E1]-DQ>1%6XD5;O^EVW9 C#-!C&;LO'G!U_K&M:)\P&Y*LJ5N
MG!)WB.CE[O-Y%=&BJR"J!9?3IL\DB<]G9+Z;4'FV$;ZC76@IS"[41'&W)J%I
MA:;=/YI4%HXV-5ZVD$_DR&)%P9C=3E[54E+61;"W%P6-UMPVS:[L[)[369.3
M?0)K.P6_M\>:3K%F*6:%\1UQ]FVKC(S1R,_OQ:#V[W2WUZ6V[QGU;235V.ZZ
MO>7C9JOYD@EE647X$OOGH1_\W$H(O:%JX5JKV=3HG2SS$YO"T,AX>_@PU[Z(
MTJV *.:4*$W=$+K''L8CYO0!82D%211 LR?)!V(2'(N+S$L;'H]X-(X((J_9
M\=G)Y7$7(YH'?1WF13KO(D)?=)$DQ.^G"67!8W3SA@?7$Q:475/HY86J*:LV
M+_7P10QN_S;(\6'';CHT9+LKZL?N]\!VQN'MSFHW?'?J&+QB'9W[X,W[[@8R
MGW%/0G,B*"61])M/DC269E=%27>()"$FL0P?NAUQ-']KT?3\YX/[$A%]6>3^
M+DM_>4_)WV'R,$0$OVMC7-]\*S)?H_"!O@%@<DL>$GJRE5U0.^LRU]#*5$/;
M[Z\XJP;3W<M@G%9/Z2C+3N_2!](8$>F9]B9+*X<?T[?$.Y"1#3.^2)-A1(#5
MWF:KWW0ZMO(.;8L'5X*LNPZ.GNN0 >N3_V] ]&S,$IJ^\]/>B7\=QVGYN6GT
MJFY9TPS9L)<MC\D\?-8W<^WW/8W;-(D3>!'HJ;)ST5L]2U8U2[;M9<&83"6:
M]0^KB/0=$7>8&5BZ*DN:HAF?MIEG:3ANQRZ#L4OMZL"RY9VKW=E5>AH[L,ND
M[%)L2[;>F<H"N[YB%X_ZF+SAF#Y=W-E:)397-_2UYYB97\Z^Z)78U!G6>$DL
M%END^W>$-\"$Q1,F:NSYO%^N X9'R8H",.!\K^V'DHO&U$T2(<6R!3JFI+P#
M2EZ'EQD=YY!>,E9CLT0]S;%EU:QJBU,$"3D TKIJ')4#B>7OZ>!5.(X(^^U[
MLR9!\*$G841"&&@LG2'734<IJVH%?!_XKI^LWJ(\68-AC7:=T/4J)^O%C*A?
M,YJ6% J'WJ6BZ;+"33*5L#OWKUNKAQ&]5$6Q9'WWHD;"5%U766ZJ1K/$9UI:
ME> A#F/_&4L^NQ]'.@NB.-Y.O];.Z#C;2<'&,&SXK: 8V(3.+%WU<I[*V25$
MOP");W!R.WA$+P4B08-]]K+%NL048:S6 3=+&G5ON*$7LG  FT9O>ST2C.*4
MO$XVOA M;A0GE6_:3-[#_)7<=<D[*A6^=8Q6SY05IRMW"TI5["/V7-G(339R
MRY3-@KV<Z=9-X=X FU=Q$%J6X+$QAEZ><?!Z2B'IW5:[M4S.XY#EK#]:*L!P
M9*.[[$1LKK>$_\ 1<-9E<%4$'(L"QP#@+!<L.SAPFNHQ9(=W\':I/.*@3Y7A
M&R8NPR@ LL19;E59@;&I<:C*7;.JPM3BM$^M ;=&3^\.. < U]5E1ZNJ6K4X
M\K-5L9 *3SS4SG*IL&#(=S^,"(C!)'.\I#C >%H]0]9W+QDBK%U^,+.F9,C.
MF%$99@J<(Q$:WYNA*PS7_1JNVQS3*2TX&K5VN[*B5%5O1UB[M49I:6OW("BE
M ?NN+6L%*=T<HK32DE&U*%;"PLBX\(+8#8]\9]0KNGGUU*Z1KIXNM5=*FQ=W
MN0B]G1UR5:GR,O?*V7DD'T;(L9#CPQ7.J4:.J[Q*G@LY9I;%1V9;3;9BX<=D
MT'/]N)B:6CD2>I_[A#X\OX.[P6,[ TA5UB%(8];$$-.+.Z,1O),6*9!"5K<7
M$5I[D@7BG@@[-D 26G8R&>(84V!Y.(S9O=<A(S++UQKX(0I='YK']-@IJ^C2
M63GS?!AZ%\8YCF*6#'U.Z+VP_C/^],/WDN$$Y7-/Y;Q79H^@/HP@358_<FP2
MJPO;]W,_Z2BIO/A]LV\C2X,!V+9A*JJC#08(#9!NZ*JF.LJ_5:<U>6A()B,?
MHR?<[A.,?F^C 4SL' 4_T&M,P3HW_Y$?MN>)O4BGE=08#"JG1B9NH#6B[,J>
M<Q!R3&@K& LZ^ABD(:'*\J?U_+! =*:5K:F>#6FT&DT%_9  DXH =A0!6"J2
MP<:W\28L;P._G.JYRWD]]S#5;I3[M^/\^JF8VWF<_1JBU/-A[!]6CG&$R!,H
M"KIT+E1)G@XYVU6?*F*VU,+0 S2.\?GDET^>'X\#]'KNAVP@[*%/>>^Y]J8O
M6'2CZ?NRKW,%96L=M:M3'95[\_F+<_75@8E]7/[<,N"I;N%72D<M_'Q55ZK2
ML;7B1U9UM?KSKNU4-RAC75<%_L:$+6"%X>.T6A.9>3=>Z"PU*W!3,J >UBXO
M+@OT".L(EKY#NV$L78$2\9@5R'( )5V5-R@@LU<:']?'8QT55>DI)N:9'X+=
M&:70J0<K!GYQ,5COH'6S[$H)E#+:J!ID">> 3UC1I-&J)KJN?E 3B*7O3<X.
M*+-5[5<>@P?W^!F'Z3OUM#>89B5HWE<UK2H&5T,$;I=6=(P(V9S3,4(A^,OL
MUP%>QN3.N2&\3+ETE+19<4YGW=E0II*^D6A$_7;:XS_]9'B9QC K3*Y>\AW5
MBSC&\#^/'6(J&?JDA6YL6]9WOUN0GS0J(1[-$ ]5.;Y\T*(_74,V++[ORZGA
MPLRC:;CB+G _SG)5*&!I!@-T\^R[N'!M+I,WU,S4(%4]OMC22D6&K.CBQMPF
M 4L[/K <!BS5Y.7:P<8L!_7QTRZ\D1_2)0'-%@0:W<MR$'9?'!J=X*_J1Y=A
M,"O!YZ'Y'ER;=.+D2#E@&<<'ELJ I9M5)1&)Q:%VO@*K-#,I_427!N$C%$KK
MVNIZ6TCKLD!JK9YC+1<TX,E4$SY .>"LK:=7"7#H01*;;^#44(W7Q\;/3JZ0
M=7N"&UA;)W@V[/CQ'S &>YJFR8I15;UVWH]="$B^#\DUQ0@.@4D3O /'DNW=
M#9+C8;*&BPZ/OD-Q"DJ>GAL^25<O8YK,*Y)11#+*D93KU6@<1*\L P6O ^/I
MQIS6G%-# /.+T+O'K AM+M2EUXW)Q;S<5"T1\<H#6"05@<=J]1Q;[JI5V1S"
MK.#8K-@P?2$K5H_ CDW:?43/#.VDXIL=;WI?2G.QS(7T,9JG]2UY8%N!U&T(
MO5_IR;T?Q*?VW3>\:?'F.4FVP:4U9-W8>==*A#,Y@M>:5>" ^'( 7[ILJ3M7
MLA!1S[H:_=GF531U0X7EOU)NUQ0JS"^<B!.0S%R&I]Y]6<G4E%9/5V7=JJK&
MC+#_>4#0FN3_2A&D H(4V=H]'5)X 77U E;I=EH7X$UI%']V#&E,(B]UDU@Z
M:UU>W[5.Y!*K,E*LK3FB\+X4+PNJUNIU'9&TW"2$K/$@RR)$;_6L@NM[>$((
M]WK\^ /DM56#G9M[6-4(K&8IF5O^A&=3.GECCHJ70T2>:*AA64T9H*:<G2\)
M%PX+1\!8FT)1A(QY1V7@OV"O_2<F41%BS!:@P]94[1/7J*FACJZ/D_(5CPE
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M2^N#L-BW"D!26MY$8?0V*C2M;+$L?W:K9YI\&UC"-.^=[18RC&'<\-ON:''
ME3.6:^0LQ8*$)=XX2SS//:A869_PGO#[FOP=L2QG81D*:'C95'9.&Q*I"(V
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MWN5<G?ZRTJ0KK9XCVP6740L3OIZXVM"&WSNP:&* )FO*+FKZ,(9](^SFB\$
M5EA@Z23#-EZ\?TZ8S9LJ898<_Q6<KPB(>#N8<WNG5,XR)(MPK[5ZALJ!;2),
MWSU&1$H@9.. B*[SEGU]"N8MRYF%5L3OIY34>1K5F>?'<Y\ET0<)^,$:1D%
MTZM\P FU=D_$N-WS'9Z/T7<_C BMC4_-#VJ-8%+:-]3I!F17MBQ1=*M)<-KB
M&L]5>%J&C-GJ:<ZR^\-E"+K^EQ7-TE/?7E9T>7TG[B&JV]IY-Y?.V8\(B7[
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M.O<3:.YN@)="CO"\XJ<3^[Q,8$8:(E@R^AB'H*>H(L1TJ6?ZC'A,7S-EBF;
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M@.HUUR=N.J*=N5ET*]-&,!]HZ2>O$NBM23^P4,/Z2DVRZ1M&&-'NV9(/_N?
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MKC:HHURMUY'E:K)<;>]RM7.?-7:KGC5^8\_,"=E[SUT@;3U0G?\$._08^K
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M?E86KL-6RL+T?K* H[^V%86F7/I%Q?0X0\"6ACXRS1*$W/+G\+L#7Z)MYU^
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MOHIO\$^CCG$HM:&3'C8NVTR7;,9EC$]@CT2#4FK_#;Z*JK#%TG9742WQU/)
M^EUOLW.+L@P]/\0N<*++6]+1Y<O" ;_&QY(X;./YS.LQQ76:K]@6^@8?:$7?
MPX]:V)#K(3A-$6_,Y&FV?/"H QTR_=M51@X></,VRGNC0MOWKO</)&35LEZ]
M"R9IV%>U0=:;*]BYHC)?R\>]F$3WT)I*L;@@NC*I>D JM3OLJ)V<K&Q$K&".
M];=8W1>_:)TZ85P G>:]]K%L?\5+)T4NY1[5HP2$0PHXLVOO^.6 @C)11-:I
MTIRJ6?J6FQRN;B>I-4<W(K#?IA\N8-)1>[^H"/20&M"3EWSVC?9P6+GEU$"K
MK^74L-WICVJIP817]+JU36I0^O+F7M)^M2VG%-ENZC25H4VN3Y3MIHY#K:MH
M-W4A8&;Y!]5E3HD$V'\=56G[W\/-I'0?P&G%/M73_,!,N/A5\7]T;&FN&EWM
M<C&Y9?FG%+1J@C8\BZ0-6_=]==@[N'3HU:/?;T>VRKUT72]&2<DX&YWHEZY/
ME\[O/$RZ6\\LTYL^\3[IS9WD$7,,^QH&Q8\4@7>=*ON"N'%KQT.I?^=>$FL]
ML=NQQ\R?M^8,)GEGVB_FRL<=3=,?B+]!N\UE%RYN-JM]<7SWIPB=0XQT1YE$
M_!;,Q3S['!2(J4&=_:7\, L4#V7^,%&,*+MXQ//??S=/#?#'3R'SV*7X_"?_
MI*?)*$+?DH,8CB3T!Y[>-!5#Z)TYF2O?OO^AX*%-8%,^G2F\A 4/>0K-JD-)
M_NP9?Z_@5(&2T\!\8'%\ E@GXB0??,.=7S.IL*0)FM47L',^<_(."(S6/=B%
M@J.!S#'*RYQQ)+_HK$S$8Q;\WE:0"GYT1H98'K?/\#4.]I$ZDKOEC$HPU7@>
MQ\\?)K2.0+$<H!D-1&IN[2QOD:!\8DH:HT*;!?R<#(9CGFG;*P5?BO &:UR
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MTM#9Q!H KK4LKM3 "?0088^DFYJR1=J!+X<OCIKDA@[(MTWM<)],RX'/0/F
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M[YZ.&'0TF8ZX%+:ZJ=5KV(^QL@RD0\2H95V&C*Z0?',9?',:KNDVA&NN.<&
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MOM,/N)ZVHN"C,\LQG8EEVHKE<.E#$8=Q)L R)IZC80]P"X_4\*@4B.$Z&^\
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M;#R;P2M#,JZP8X-H%.;X(6F!63J6YL65U,#99G#!M@+0!YB6$&GDAZ,\!(8
M"]("8C!]OQV9*4WY(_-__,/5-6V_F#K=2:T9BJ7CTEE!]M4";'$,5NM9BA/I
MB9"_X"<P6VB74D'S_=&\+<D>V#!/@CBY^COWDPQ,%8FHJ1$\V#\/6G(Z*T5
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MU#+-W:%4223\'9XKAB5R8SGCBJ$)EG#&$DUQ1&(L%SX#KZ-.-@+S/9N"RU+
MZ*,G<T:1%\\1->^<L<1U!4LX8XDG8I.<<413.Q?RB-C+>8TZV=@+2^19:P+3
M[2ZU:F>SVAUL<*W$MP3@/B)A^C8G+1#MNBZKIE[2Y9B6[%77_GO@"*<HC$(7
MSU47-<^17<<4NBAT4>ABW_NB*6NV*U21RQ#ZQL4.+2^R92_0E5-QRH:6J2GZ
MTASHW-W:=+@0 ]:$U3)76I->:>[.;5F77E1[SQZEAKZIJ55:6ZOB1:W-UZK6
MYC/9T+FU]^;*;=5!DI\0B?@)=O*]9^UY(\G'?L383PJ;'<>3UG['>*F"S\]]
ML ;S/$ES'WY;-/+-2#)+\6G\1T+2.1EEP2-IJ53R'Q)"?TIEZ6D:C*;2 XE(
M0IL()^3O/(#/S&"=4VPJG)2=BN$?<_^9/J9(TH955MV'[Y^E-[I1=866\768
MPOZ++$W@1SIUVIJ1?BZ5"+9FE&A;1F99#4TNNE*O-G1._1DIFST7C97K/9X7
MC92+=L=T0#DS?."%_M*PQ*X"-GQE6\NCOBMRD'C6MXW)WU1E4C\DZ173(.3V
M%5,^^O="'6D+\WBID0V54&#:7X3VS\:G6TE03,C4&5C1/$YI7^WW"0E]5,2B
M"3+;&NL/%M*@5H_X][#AYUG[(VTMYX]%[UJ/0DJ&^G^G2;5'/9"K>]"VOZ[\
M"4SRO1\^^<\I;FYUG0"%6*'=ZK);%S>9['UQ3"/'9!2SG+SWU"K@*)B+W_L<
M)#"5DW]=_".XM^Y=W]%A JYK6JKFZ9.)[T]\PS0T7?/4_W8N/OZ@[;UA2[B!
M#Q(*3>5_/+*+3.5%:A*738P]R"S&=2M16 C<QS9;CX3,_ #MPRB.4AB)>]PX
M3] >'&SO4LYOWVG(A+VK9<(.81?JD,P+4C4''VWA+Y5;$/ ?-Q[)W^I5:;%G
MY8GTIW*GP$LIK"[=NF3ITX_/*7UR!&=!$&%IM-*2 D3_\_8?:W+L5,58]NL4
MY_AN'?X=3T-T\F#LKL/YU+\+9O.0_%Q7I%/1%Y9M]:7*MN)9,QI3PVJ<7-$&
MZC(Q>8CID_#;*U01ZH0Q9YT*-GP8?H7/4?].&H'8/JQX=.S\ ](#$D9F<Y02
M>DPJM8**>HHAEK'T%&!+;C@=X:.P*%25^IM!8YJ7PL<FL9ML]]D*72^:1Z+I
M 5I]^@GN=[I!CI<G;ZTH9A^2O9@[*>:.AG$$XOL0)\_2$TGP> DF,0SCI_1]
M5XNSXN/3:%!U;J Q0EAAZ,]3\K[\X4,920HB.E_ZT(=URJTF8.#WV)\+!]QQ
M%-.UT <OTC^*#Q?NN0+K?[?^>]-2+-5H_).J:(V_;WN5IBF6V?Q(VZO:?^^8
M8E(]3,IZZ55<!E]Y'?5",M;&6R)O;5C#=0X_7>U_T#WS*]LS/^&>2?<UNF]*
ML&5N<;EP2N2XF?K@Z0SB1F5+(>WE=M_K[J.P^F3J?L4YO'2<KA4J-]WD;GN#
MQZ>XH3^ZEU6^U)-^\&0R7FN(MB#&8.BQEA4C9$9<BXORN:W*Y]9.DMOH4MMR
MMS(E+^G93@4R)SLY?F?687+]*S"OH\ZA[]ZGV3R,:?Y&JY'ILEQ>,G2;%]LY
M0Y>K'-N6>CW-DC6[*Y@8/Z@/0KIXEB[/E6VM:]6T$"XA7-MA2<N6*?!JN..*
MT@?8EB@ '\ZH<^CDN)8"QO(.ZJFB+Y[*3PL90C=EP^QJ&@1>QZ&Y8LB.)MH[
M<L85VQ#PSIRQ1.^,PR=P;<YKU#G$^UBR8KS]S<)I'6X,33:<'7NEB"/GP;BB
MRD[G+A6"*X?V84RA*)RQ1%<T$9KAPE?@==0YA&;:?!A:U_CECS,)Q]@".Y4W
MECBJ8 EG++G45-'3B2-N**;HZ=2WC\#KJ'.(O]R2-$OR4<8J00O/Y4R"+X[7
M1R<4<:#<P)+_^(>K:_H'P1:^V'(2FO(Z1'A^F/'MW5>QK1]N6^]_@F+4:8PZ
MA]C7;XB+,@H8+L]KW,?A'1YU6=5%^A%G3-%DK?,UD6#*@9GBNB+[B#.6.$[G
MJSL1_CJO4><0_KJ>Q3"#?[_>?1G>F5ZS9,,0&16\<<64#:^/I K!E4UEA^9P
M:PY/E"6V8HO4(R[\!%Y'G2P."VL+^G+.]$L+%8W0#D^8O@U+2R,JUY,=PQY
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MA6&JLH(&M2RU<D(K)PJEA']4WO&R7E)QI[D8R7(%W[8"1U] EU,>FC'<3'4
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MUZ-1G-,>@.6 5Y^I^S@V]WY"UMI/R._NX_$S_&^:S<*/_P]02P,$%     @
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MIKZ0V'>6O%W)N_)U3D0Q#5S>4Y>5G/UN[Z";2%I2]LVDO6ZOW]T'4BPEIZ-
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MUBR2U>)I!*^@?E9K(;.%L!:O0PY<5PO WHVOSI;6/]:"=@V^1GAS1;7254]
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ML"1LWJ9(]R'I97[])+C(LDQ97/)01^ZHEBR*XOF0^2&1"20R__H?GRXF#SY
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MFML=L-+J-SO.DA;MW-,%(PUD;JASKNA',8B.HKT3\XZU3U=6>[9 <[RQPJY
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M(TVM4V>UB9@/V]=/9<.9<PFTJQ:6L F\\!H25S9ZDU'J]2YKCKRO7Y]]H+/
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MXFH9D_3F!"=_X.E%=_-UUM0I8M)C/8>)N>Q DYO!MF/1<8>-K<O:HG;!H+*
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MHWO6.7>A:R"[;]Q-](]9?H=BUG45_3X"'_Q:N$Y?</0<&55?*J0;4"4(WBI
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MG/-"EIQ&\/5(9U>BL,(R'YI7"0_+TO?#,$GEN7LV]!3/QD^SU7S+7=:A.)-
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M+V.FJ,+3WM?'(Q\_8ET9&HJ[JF,?-% O_[C^$HFU__FO_P=02P,$%     @
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MWSE8>5VXQE#)<BV^I_>,=M^C \].F0!2%]?],@A/P.9T!"Z8+%BI3T0+0C:
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M[I+M.@-\G^7MEP[*1DVNLAQ),;422S@!GN&(JS"*+$]DA;T-(H\BYN#9@A"
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MM7QXDXYZV(W=RE&_QSLV)&>A-^H;Y6/C6_QM<6=; ;38I*A?%I1P,(FRR8+
MW0K!WBENA*Z.9FK5@6(ULJ/P:))8YU69-<2#&HG1=EA]Q,XN[QZA;5/IXG?=
M"Z9LMPO9K#=P//>3$'! NK#3WKN_.M2'YWBCUH>JGG?0@!C1EKV$RJ!^2ZF:
M/J#\C[TN</O."NQV3X>$2)J8ZH5^_Q,.7>$(FTY"G+P3TJQGUN=BRRW7%YXK
MKY&>89ZWY'=.$-_<NWS]=-N^HY^%!9SIOL#$QL Z7= KJL_0>!2,3L?.UC%5
MK=@F]1!Q1*&)&,W1T7VNC-6^/4W>HK,93E(D/,DR<YZ&BTXI;NN%[["(+VD9
M=ZQ M*[,W15,]3:"B@,R+O7SUCE!IJRW#&E<IJ%Q75+#""KVE7V+]C.S<,9@
MDT-NJEVW/%A>91^LUQRAV3.9;C:&M1!9;Z[=:CAHCWBK5_"5PZ*[!Z*WE.J?
MG]='LU*INB6+W_'9J$\MV @%S"G(AA9O7 >3,A09@T<-:W=MT2P:E5"$7!P9
M0;':S9@4)^.33+&$S,(!F76Q<1F7XT:R;J+CBC/7J 1<$JIOB*B?7%45Y& _
MO-(9, .%_F/.1#W#O4)R)&&L7TYE'T%3AFKL$QC#-\GUH1'/Q0KB24<A@J\V
M_ $)2#!9W"4@]E*B:I7D7DQ2V6"P=8.,PTHL7<FWHB%'P4BM:- A=B*0$Z96
M1)X9?WDT*;::ZT,]4PN*#:<A/F?P1+ "OJ+$_:7I(E.WRC1AON*[T0E>]_93
MWCKTY@[%[Y46$I$ZTK&("A-&=/T.PG+T'6];5S^9JA5]<H)[@F-&2(U5NM.[
MKA^YI))*,PVR,UX0,=\-[+YPP8)8S4Y+6N #T5__VC"XT:II-_/#UL[<SQ^Q
M4I];XY2MFO8]3CJN=/.#\FVEHU5'4P+V7[8;$YZ+$:QHLT!L-.^+BVW?,OR^
M#!_88*0\?6T>A.P1Y0.O(#]0)2] 3H;4QX%Y%PQCCC.ERJ\T27]Z'O02,B-4
M]Z,KG6Y3)M8FIMJ7O&:(JX$1Z,XI?^VO3MT"&NA@-+/VE7<)O(&$=)"L'N@H
MI26&[$K>!>FQBA@6Y1VWT*/M+$%U%'%D<(">9!/),: IG!VK<V#;#PI%SB]A
M%1R]TIOJM5.==Q 6D[H0$QTT<AT^#ER/084Q^,"870-<$:/";,Y<= ZVIJE&
MZG0(SS!/VR<9/,]']]GJ6=M?D7*K(-T[KCX_UMC7W2::\_/XIF2T#3F]5\.N
MB,!"EW<&6+_(R^_B.<>K>9&<]-$Y#F2=['*=?[J9:)3'34=<0U':6$U,@$&=
M;6>(TA!-@W7'*FMZ.'K/S7Q'Q62NR7HPX5B=E]KD#9"3_$>+,BBN4?^*^G43
M._76@C4L%XL8Z:0_#.4#+--8A \,6^5[1_O#5CM9J@AIH[$O#=Q98>1%+^LU
M4@E.>@^9-ZS,[-!_TVFH.C:HLM@YVM.;?=U;2;QL,'N:%1[H[(TNJQV\? &O
MF5@>Y#B=\A95ZSW,UJDL\0!M$&4PSHYRUA9NM,:L.Q='=L=N\N =*3>A,LV;
M;IJ-=<2F:3%<WV!;C-2\D7:=MH$V(=ITT0_//0I;\\6.;GLF\;FJ^X-'-8AB
MT%]^&O29JQR>XP.H>YTW*K8<V/:7+HIVL *<#6)K1O23Y!2EN'DD(<PQJ"G/
M>.LKSWY%.(-;P=OS.>GZ4^6T!D7-<C8LSE#MMNW$B&B'.#K4B?+4*2G 3<.$
M#^ 7'76^-?!@\X@TW* H3VP?9$(CSR$E(QH1"@'X2+F/"R>:\/7T^/J99JK$
M!FV/F*NY$/M,N8#JL!MTMY>%-#OYG8,R0.VD\_=H.S%YV-5+OS3:CR0A&!<E
MOOA/AZ:U( <FFUY#HA;J'4S?=[<*&A&1OAY*J2:U-4S?2-Z01)1+XH]/D[J;
M4X=W]>K6?^K;''5<.5K,IZ9VR+"2Q,N8(Y7XGR8L9:;VI9E6<B5#67:S<V![
MJYK2LW__T+FGDU#KWA!:FHD/#K/MU5;P,ZN*99_O\T>S2^"VW? ?O3\/3:W%
M/WKE-#!T>LQ?3Z;;5/V&GMI!_'>0)?U+JP$?\(4-.%7@13 W>_9R7Y$D!TH(
M+[MY!Z87I_B C'_&@1\.M)A 34*I+XNG^\5VG+ON^S#=+J$@9<!6M/W$!AV'
M9(<3%55SV;V>.654QU+VTPM;T&CS''.G/FQ5*!WMS.V8P[$V"&)!$Z\1QK!4
M$],SAXR9*G 1S-7TQB$OZCHC%7FD*,>B+'U8.?DBKYX0]K("5/2L?!LB;\VP
M+2@)S^IH>].GH>TY,$OC7BC!K#CQ@=*BE^^[+[3;EP@P,2HJ=_R''83_O0_]
MUSE+,R=9+MPLT NVQ6P$2X&-D!NPCR)V_<@'W%\QZ9$5):'>FG8;Y=N%K:N(
M^L3H .FMM!/(4Z1NPF8B,>5VQC!VAK<;@9_YR+O&!V[ (6TRRU<@$ L; [K
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M:D8@B:0;S-Y;_19]4?JG\)\_3>PH'-''JOGTWBQ&/'(KLCOUZ9>*SYG7B-A
M@T:9'6?*>N=D9NI(HB9,;)Q+.OQHWUK_A;>1VK7B/TZ[) :4.#@&:WI?CLHX
M%VT;S =Z=%1F,V9UJI9-E[H*M]M<$K)99W/)V\;RW3I38%VSD/XKO3^, *.#
M F-Y0=O9=ASMO@@)7B="E*/&=!R=KTQP_\RQO#KYH6!8^^@I<<)HN_/0W#)>
M-#BA7>6QY[ 28_AYWDSZK2!=.\8N^9LP025TBR,,UCF11[YB8W&OVZ-C0 _$
M@ @'R6QC>76;].%I9.&O]57$)D%2T#\?0I1U2.&2,MQ]2">@\-S&ZGF.1>Z
M"4U";(I=RK'),<^92L<_0BZLV%O8KYX@C0<L3(V[E#U>S9FH2"LA+H&9_Z3#
M<<,<]<L@3Z2#?3V"JKCW[6>R&^Q>UCYF7V:>DS&:AE08-G,?Q4:1I$+N)KN1
MQSJV7_$<5KP'.:JGW?JN&Y3&VT\F1IWMJG"<7*_%O<I[#V-X]#_P?YX'I;'&
MN,_H-7:8*+4,<B2J_)O5=Y*"W474;&B!(,G)3@DWRM7FYA8'7?Q.$F%DTFXD
MWEAN'B:*Y%X-=PWS=T+AKZ\%$%W=KEJ5U'X9(I7,9F6EA:VJYI#K04MRV>2L
M)%LQHHERR(-:CIAE,V9&_?.[U-3H4I[IAWN-]J!OFFR\>2@XFJ;W4+FWQJ_T
M^65.A]*E_GGOI! ?]]B=W][^3.X/>-Z^0M:KYI&%LC__4][)@ GJ_K*6V5&V
M33"*MZV#8C"2UN#[*$LQQE5&AF? J$PK07F471':,02AKZ2O*X4<+_YT #D'
M$_<*=7L^GH3S$E%ZR7,AWY" M,M9_LS1'HP9>R?'A6GWSB+4-BD,C$9(RJW0
MP(9--ZZ)(<XSY=LD&G%;!R?%=%B$EQRS-RX+35YWQL\^+LY;0/N3;09.5#G,
MKXBTRGOWP=UYR+S^=@-E4!5!E.#L@+$$QG0O/(: Q:*$2_%&<L5,QSIFT6A>
M#\D 0BHG?PU/[3IAWFBK&]C/V_:&]*8Q-" :ZX_:XN40)\T6^WED@JREMLLT
MC;>IKWMM/J#^_/D94E%AH(-!P& 1^UYLTG^<2QUD-B]4M<AI)YUKVWVKN?C3
M?..A0WLV5A\WL)2=T%@CO  %0=874B[@R.\MX=AT&QYD&PNHW)GL_AJ)D1,F
M&@$=6R(^.@0T?8H>ZY">*M]<J@XG::#[RDU>!@N?)=^)-MK2Z3#8XE=W$T=9
MZ[B']U;IHH-O85$(T8C=&!D&/#IB%T:9H1<I('9&C,Q'H;Y1'-C(D$S#208O
MT>WIM<KTB,RMVV+<$[-H"U.]\_32\:SYA9!Y]]2@ 36X;@IOO"#[^ZT+/CXK
M58Z8KNK%:KL%E,%*S]^F:;5FDEY$!VP]Z(G8C!R1P%(W\Q0Q5QD/VG2')&@2
MD?[8'8/VYL<CTQ?-DJT(Z9,F/?<'!\T5"W*^7IX^;.'KK2U[I&WKA3L@JO\I
MIYWW!<?PG)PM8IXB(*0BWL.D#!W9.E 66'&E;@0A(]H1BQ/15/%4S9(WV$4P
M8",?DJ3,G%V):989C3S=RHJ*2J(C2JPBVPVWJL<EDD?BJ(R+\"^*'59,Y"_!
M(!DJ&#7*5"LFRY&V#Y.QO-V#@P7FU&WFKFAO&G;]P)$CS6DD!*,C<K94,]?<
M42WCY5.;[(NDPI4YJC?)KCNBWT'SH0U;:[X$?D(ZG1Y1-(^T6[7\W?U@FPQS
M\Y+3TWWU]7TT%H]%$S504SNV_VUU3?7;E*O$RDIBI#,Z+BXF<U_4SL3<U+/G
MQLX&KD_GA(;>Y]7J\X3I';."TFS35[#.A.PUZ"391-)E5,:PU3&'>T<K27&-
M9/GAA>[FJJ@TOVU/?;3A#ZI^L'.&R[HJ1YTKJ?$Q7.?IMZ&F<NUQ%$(3.3WY
MZ[[R]5_VWW#E?E/#^R!BKJ V>,OD/C$3D #:3$,!1K>R]M0V3W_R@V&%]!.*
M\^V]RM;Y$!^P@^[[;%TXFI*HD:[@LI$06JM>I9%5/53K4[E<FZ8^30Q0D%T,
M"*H<2J.M.?2#GU&1&*51U/I@T)R!N\LY,DK?!-F=J337D&\PDNKTIXI#X+GR
M1]<,++3.=FG<6!H4]6AI_<G!T60'?,CA>V'IM;_;G[0TE_)K4=8ZFVQ\U-#:
M^)!ZHKE4K-6Y;_$-RHGO'[5^;[7I2;EZ$I8 5JIRMOGQ1 ALU\J24BAC)+*@
MCA[CD#YTGBIE!)A[,KI1R1>K#RQZ.71$JQ=K\A2@0AXMV"6);LG4NT^P<+9!
MWQ5_Z;W_XZ(9YT7$%Q3#RVXNGO' *TN9^[@F?(1.2:MCM?D%R$;Z-N'K\7%]
M+&83*]%7/!GO1<P28BJ=?*GQZFT9LS2YT"NY6*6E_ON*2M_ L9<A>M7T0JJ3
M8L;R#/EHG_1N;]D@><X8VF'8G.A=:<8'CI(E23*8\Y#:6#PX6M!$70<11PL:
M);8ZR<.W!>LUKXGGC9*W>UJG2&RKZEIV1*/SHF@RYAEJS^4=G2EF8D,_+PY:
M2'6\ZX-;:+SLE4FW\$IW6.F^F?W3O[M=4)L_[9 0_^(+6NX$=SZE:,JNLBKU
MZ<LIHO67:7V?'!=#0;)ER59VF?BYA[G[207)].LNF)ZH8>9^KM)7ZE_^Y7?#
M]0+#RB+I<C:E-:"$^8#/=T('9</([*:6<Z^@)O<R^EC!W1NG@B-Z:6:E!5$2
M<:$FV15BMS2+3J1A]Q$3YN<XQK2,N^XYF7O5=&!E<PO>&G;?^GT-=.+/^17A
M8[PG,BO"#0:SPZVJ$-5\X ZN E8'4J)'@Z(CM##KH+A1?"Q"#&,M:91" [<.
MQV4$5$6[#_IGVGXRB;;\7',J[\.^NN+@,(?R[N42E4DNS/)U9<8XWK5$'#7S
M=]WHB,P.2%^59XD80[$U$$)\8'E/-7Y1O[B W+;L;B$1A1KC X,_2EWZ5WT@
M?W" 3:D*W+J #[1J+DNPCY/C4&M8S''\E&V5/IS1P@?,3+?RCH.QJ(PM_WD&
M(O%!L )1WN8,@<+'N 0R0<<W!@0J4!LPQKW7PV)XFI@=,J H::]%N#):<EJ_
MMAE;T#[JNQ/U)"=A_QOF9"3F4F?N+74CYZ8-JQ>YK\&1;E^*[VAQ:$LLZ(*/
M4Y3A9M?H^91=H6 ,F%4#G,/0JT1UJ_?JVG-6"PM@M.+!-]8[]M36]ANN=T^:
M.);=!?HOZ-^R6@BB]I.H8 D]K&2O98MIL?]RPF"(8\'0 !^ XW;Q-G&N<3-K
MP@LYZM ,H[\9%.'M]:A&712P;G\U[@9;1_O]6:+AY[O4ON18F)\EA7GR@?*
M$EWS6B7K6)7T>M8$H(P_6.S4QP>"/H HI1+M+K0[<;G[\X'<W_;C&N5S4_C
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M?@'4:4/;A;IK@G2)E^$=9GN'/;?EV7Y<=$!;@1+L<Z;[SU)8 EA+%TUCU=/
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M>UW>R]P)1#ARI$OBTX7NS\0'%#<*K1]=]0E&:#C94C>W<3 PU$3L2'DO?GM
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MV2[SC]>?U\M&?05\D"M;_\.#</8F@+=]&@J%E]$A!:($L/#VV4<!C'"3^U4
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M79SHV%G58>8+))+&0O^]:>'_?1=,:^Y^?!,+Y<55@%K[^@^W86]BN1H\T=
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MB$]JD5N?^#)6\T/!\H V=8G$K/2]P- 6";$+;J&D0TLUB%*_<DHT)88@0CZ
M6P>&,5%AR)V\M4Q".+ -MS=$/9,IL1&DF%1V+<6(COK9?+7QMKR\?*'F%_6R
M&C0J9=JD=^;&O4O=1*RG2B@3I5G@F(Z<QDZO4DO4)S6^919 Z/XS4I=W_ ,4
M[8.:X/,NA!(4/T.E%LVWQ$O]#GJ@RR>*Y1NZ@<<2.1/YA_^"P_Z!<E,I'H3X
M%$KI7!W?HS&%VHAS*HQ@S=T]Y/#<-0E=$VK SU>N\L9XZB+=E7K5VW:3TMT*
M%@><PQW.[3R0[5=CS?RH?>-[1ZW568_9ISSRY\^?'3]?<73HU&SO_3PO_.FS
M\0+JYDW=6*4%U*&P+-N<A(&QQ+.N_GY^.J5H1ZB6-)T+]1%$7Z38[@UG CML
MCINUM ?/K0G(&>Y3L=1]6I/XF4<_^%L<_79L5F<7='8;F/J*USF9'EW[^0='
M U(X(.B-WXMOU]?4ZNN\F1\@/:N_&W--2L:2!6;I^<;_7$(,(Y8/G"XRK;XI
M_F!B/:"Q5*"%ISP[]K*@E_C*?A6Q0&H;E_I71UOK;Q3>]@;FSC[R#O KH^9+
M;3!Q74 ZW;Z;&8A*KU2)*?RB)EYV'NBQF[8[^_RVCN&\D181_O@EM7'A/"0[
M__T*WTKL,"GDY#+*WH>*WKMT-KJQYX<QK]SFM(%"_[XIG^,#QA0-?I8/<;+I
MCK^'TW]_4YM#C"[-WCG[Z?6EFSF3)5,GJST'B_E9+1Z$!$KJJSYYI/G)>.<I
MB(_\Y5G!A^]Z'0^)OF51H*WH@7EZD_7K@J"6)O'KTXT=QM<T[,2CO.0;^KJ=
MI3Q]*LA]A1S=)PV%B#EME_T"V"D/49V*KFH_QYCY4X:[P_Y$YJE"/.Q!AO$V
M4"_?4$%NQWJKS>=8HL&G:C/C5S=\B>T<O*1C/,%?YPL.VALPT,CV1[]?O0@T
M$,AHEMGW<VM) 2RB'RZ",\4IL;$-]L89#9TZ> ',BB5OHE#S M.ZH,PJ[TG
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ML?@(O*7R:S^V2)F.YT&NN&\IR>X;77W^;VUN2:?5KA\+\V+Q;/%UW*OAK'M
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M5@_>VWWXZ=$+*K2JDI(/KL[\W1",&8N27;4N6"1F6(QAOV #9*;T'?YRU[G
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M[''4'_-F"T$_<LWN( Q]H*SPT1P>X(3#(#S((HMQ-1<JLL*]]/O V?*U']X
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MAG, 6V8%;S\_*R/Q"^W>3A-E[RN@*5-&I0%?:E3;6$K ]AO5M$H\G]+TL-E
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MZ_$4+3?4;;;TBQHH+T\@&E<;&NA4Q)JE38ZNF>G]U)B=&[T:6Y;8PEFRX!+
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M% /5Q1 1J<(>@1=2 SEW@M4^Q%U-^\3"3IAM^4)'039,()UWP]\N_.N!6.5
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MP:_V$:9ERPIS.<\J<-\"$4G0C>X1M)3V4-'@8&\>2];'OH6P.U(-DNE3T$3
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M+XYR9HJV2AW6O8IB8-/'<N4LBR8.!J^,8]FVQJ_6)53=O,B>>&UX7-E.Y-'
MW,9@SFH?6Z=!RN?T&JF]!2("<-U<%I]K$I<>J-/H58E7-H8G+ML,PXX2L#7X
MRBB9+U"7@F:5\W+B;VJF;\Q )-TW05"K/SBDO..0''.4%KN7RM,""59VS[CE
M8]JBA#[9D^&E@8"C3U8B#+X<,SUFZFJ?-XUUCKL'+PUP1OJJ?>-EO[8X#V!7
MN\6X2!'K 0.P'HH;25N/U^#,?9WEZS,"YS+>GRF]:-6CN'])7_)9HS&OSI17
M4W[@A1EF*A,#),JW+C[#'V0?JRLU@!<#L=3I4>0'*N!^8S@+<!N)OVP>2[Q2
M^CKJ3L'RQ])WZTY>!3GUS-H9'+YCHWJK",R&#7[UW2F8]Q,G3!1M@JC7HH-A
MB,&&XTS;ABH>H4A'Q)@13^=Q(=-<E\A=9>2]=^ZY1OFKBMKR$?V"X][U3QG%
M*F.4Z6V_CGU2"BRW)+)0@>&QG%TMLY1"9[!*0QY3%,&!$"Y%$S5X+C0%>01(
M:+*PI$:E/HPI^5S>\:)+7+*/\C..]8%O0QRK'+_-UF[>(/-B0<4:/M$HK2FN
M%#\R%R#.4EX'!PO\R;TJP(AQ&MW1<(*5R833+W:.1HZ)[;)RI"5&".W'E1M6
MC'<KA"39C(ZWJ#QS8*4>T3^0>L^A#VD?;S+:P]@PH<H_9IZC#C?Y20>B#F<.
M3Z-%J:R79;V%1[\V"M1V/'B@4"J4,$E?FK0N6BR6]DY;6( 72<?J2]V]9#CG
M-LP64U=);H1:I&(3$7Y^S,2\P>Z;?WZ[^SW.SN2 VL:OV-)FG^(QRWD: S:M
M@HJ=Q>RI@^>ACM%66_$)>ZFZ+;F82C69O%GQ.V'<.2%U3J2A<G^CL@^'[%!7
M[&7KNK$:7<"QPEFWNL%O.3-S2R6#VJ-"E!,UJVMXNV2;1NV[+G_*6@&#'"3W
M@94%(<5 D)@A&/UQ=9_EM<\H?AKB<AFM=:5JK^M.?#-&Q)>] X@YL_0N]FJ)
M]AB,#P@T<82=49$X?-31>IS#5@D$,$_G!@7<M%;2 27CXQL6 0R@SJMM'/H7
M:P<.@MM]C]V__2VQ#/QV<4CF2M]3&V([%CR"NDJK+^0'7T2I 'H)[0:O^US[
M'LER?AH,/+G:[S$CV97D/B;:JEDC?$P=FS.5,_DAL(Z,K\-^7=P 3ZUK_^C]
MZT<$4#@WU,2*6X"X8H?Q=#=6FM3K-$;3J SP^'8A4^^<Y@-))2(7BE]@]"SP
MU*WHJ(.(3Y_:N738M$W Q%+KP8$*U]-#^ZN4+>C+9N83M;:PGNFD6ATCA'3Q
MZ@A;>F.U<;_2ZV97U_T6 P/=NCOKZW@+SVKN."T1?NC.L]/: GH<JI=^<=S<
M_&9Z#B[JX-_AV:T,FMH%J$BSC2'C,(8LA(/;5H_6%B^K;&7#52=#GF 89U6'
M?Q0P$_V+,+1L$S0_O-7V3N5GOZMJ(K(TRT_W8&&)L^YWE$,R-T$7Q7NUG7_\
M?BN^#I%JQ;-^39K"R?-.RC0##HP634YB@NDKF%,BW6QI5K4\Z_3NJ9V"80-_
M_ET6%M.8BE_B8"NW31"##[V- PO6R%EF&E++S*1X)*EC +QQRV@A/_S+7_V4
MME-5V0?.L]Z8TB&<&.@'M#>F'>YG-]+<Z86)-X'#8R\H15=5TK D;J/KOF@Y
MH'($;1U4F3@VM DB"4"'K25J>]4TQ_'<HV\_V#L9+>\IG%5/1.#Q[$,S+^L'
M&+4H#JA2:@K_^(=1G3(;O!Q(B(*,)2A#JHHIBDC:$S(V9'2<;LGZV;-3WI:6
M6_]$!=G2%4HG.O7725#3^4](U/6N!22VBD,B^<@7F;)(Q$M;7&'#A5[Y.[D(
MJ8G%-8_U>2<3BXC%WL5KFR!99M=*WU6K?F-!8UYS7MXKZ>F/\O/S0>8WE?*+
M]YUKU?C?3.S]']SZWXA;-:Q959"[(]+T!E8LQ-EHJ,"2H8:@^9,P8:AS&78C
M[LA,G[<VFR XP-_"%R@J0R**S&P<J.'?<:ZW"5L/&R\A&QV80Q^D">%)$'YX
MHHURF)H\SB5-C'8@TB]";"$.-YW8.U-3F>01_C'/\S8&\0"ADN=H?>?'O5L]
M#_C_Q=Y[AS69;F^C<<:.B(J @A"1IE*B2%%:QD(3$1LU0FP((4)4" 0(B14$
M!!0$% 90>@N1$B(0$NDB(ATD(02"TDM""2&-$V9_L\OLV?O;YYSKE.O:OW^>
M_PCO^[SK6>N^U[/6O;H$:5A;VW%3E\60X!48320_JB;SLO/??)>-"7$%DX/
M'KT9WY,]^HIR+IT([25)3:=.D(\?_?(Y2FF\1QFY:TGBQ/ZJ$A+AS2Y(<#+L
M1NJ6BZKA'?$NE,RY;T#1=J2PE'+[^&+,SYC.A#R^F^!@B=4=)H5]N\@/'$65
M_-6K.,-)<!9B>@HLEZE)#GS+%L7AIER>/S)&LOT3?4BPO??)CH6NI-3R'K&%
M_"1$EZ3HZV?'CHMFY,G40!HRY+*H&WP=Q-5LFSXJMJ"M[TM*N,KLVUV6W'?Z
M;RNZR1O0YV13MW&).29WFTR93N-R<GU& 5%:TPYG#).:ZH0W&US,W_K93-$@
MC]I!$PVP48+K*J"H2=/6(*D4@A=3@8?_MD&4N3S#X+NCNFI7 3)^H##&1A(T
M>+B/B[BK#Y+S2KKRWGHCGEGU2L@(0TK ;GXHZ?%+V=CPL5MOZGOJUQ$GRH=R
MRGLY%[6R@HN.03,W;DWCBQ>QTW ^PE74SBM;!4BAKP^#IBF*$T$;>JO5JX;G
M.U$>#EV+_&0%XW"/DHH$&_I6868W;O>I4B\'N?MOW(P+-@8'RPMW9:VU),)%
M&6($2&$MT'B#G'^ZW%QS_V84[[EOO*Z1\L<:,282[@@X&U%7?D;U8J'!Q CN
M</]I];#<<W.[K0N=ZXNHV[-.?#?DF$]'>FAG?8T7L 9H5_NO#C@/0@9<7*E7
M;;R1<-_=+Z[2KM8H1P0'/U/;HG6L[K")[^D#FO63X^.%A#+%GDI1RK;LPNZJ
M5<!'.C;MC8S,F=]:G?_O:,B&QU8NC%]Q3<-13,%#*Z[ BC(']9K?\G,+2V)3
M,.&*4?UF8I.I9I/_>U(0MKYM&^UJ&RB^1)TM]S1!4NIRA,&5S?6>8D09?;4E
MUOV8J[5JVJ%3C.1X$D9FO.IUBS5X"GDW_8WR[S"%(([JW#6QV,U2,Z!A8YLW
M@BA0$R<H\<'2-N(G'_TKT?R3%]Y0.UN9MB"K4DN@KO9 P[J!CF:AAL-E1G>O
M&)R(;'@K&V0VI*EC:!1I\+ CII6Q0U\S.$;%B6V>A)(ZJ1(&GY/1*@]HDWBT
M+4 6HV3K>^G1R<^M[DJ *>@7>[AD&G[\>?:23;GXB=&+HA=_D<SH#I@.87U!
M'Q*FB!2X]X.1CYVZRU ""'-GF//Y4F:&L%A5SOB]64=6_U6G\9+UZPQ@$2=?
MI.G:91=LG,/[OKN3./&=@N?>37^QIHPLY"-$?>6,=223P4TL\^^.0%F!S34W
M>M>MYB&<TMB79ZC0^4/*"8.NY[\WJ0:IIX#7/?9*O)A\_-KCBZ* HMG9N3D=
MQ%R1!ZFZ^D/2Y/SLJ+..CD]1D2JL2,='(S[5.B?5,5 ]P0*F9.D?N#>)\*B$
M%APXX<X3@54.52>VSOWP22$M3I\V=_Y[SVZUIK1<:O>< @/)1TF;[X*9R70J
M#6+WHFH]MR6X*#[Y0M.>:7\E1YU]6WPVR2TI.M3"6L<G\U$M=73T:)5Z8SR=
M@I_*^2)*).]#GV#%U&(W>8K6LRSB9>.&A;L&3J\_N&-@\/Q'!9S=I8JM4<'Y
MT,_;EHFQ&P*SM.POJ44?Y^>/+<SED:E!&!N>J.@_BF.;&L4?YP*V/[J%\TD8
M(7;CH/YRI@1L"1A.D2 (P;52@=LNT[X)SG1< DL+#'HRK0?U-+-0RV=8HV^G
MU8FO+.\P-0M@"E_MV+/=BZVGS;L)DD"'THHNI+<Z;^Y<]^+4MUM$4M>2PI;O
MA.J2JD?VSOLK"!415AKAM:1+C>,M%5X>'#=JM3=^K0$>OI*R&UA?#5Q9DT/0
MB7XJ$][^3V#L0QK+"DNU!\-!7(U-T^_8CY@"*#<6^I0'?4!"'CNF4,Z>J\WS
M,5/@%LWR#!.<;Z2Y])@<!3U[Y[Q'KU>^(:7[VNE[6XPN3\UC<R:C@Z:&0XK(
M?'"[4#6][)]FN5%:Q/A+6I@O-2..D!M.<D>I;ID(@31K9R'8 [3A2<IM8I29
M?"LZU2A!>N\173KZ<@\:J2JW4Y9O\:N6H=64_(U;,W)CB%9P5TX>3B:0IRX*
M O6DA?^U9M61,_;;:.I/(^ R[ R%:7MPEUD#WTB@2:IX=.X!M@3MRX9>+EMH
M/W-R%1#IF^$\Z7!N_A!T-\Q;RZOO;O-=^@K(; )3?:X ?&^%L)+#PU1+S?3^
M>UG._ZZ$<#XQT3\)F=4C%/94QT?%DY83B<2X)@3, X90:+N'1-XSSC3@]+(R
M6O0Z*\4<Y.MT+@F C=<0R$Z)MBJ#!;OM. /LQ"@34'Y; $MA^ B):\_:WJ5D
MCYM[4N9]ZG(A=^7:NKU%&#54.,+$>OWR1?.\AF'?85?I"U&WVE]*L^>+DTG)
MBX)=Q31;ERW(DLH^BTYO^-2/?Y2A",GC_XRI39,'#[VCE'D\H7BD/995LOV:
ML[^'Y#L2R7<N,M%GU7UT"#ABB4?1ZJ/VO0@L=FK0A4P8F03(+J>J].GXT;<V
M.A6!GK2O @JEIF/XA]'*P@B*QRH@C%(:4R.YV9.\@8O-DKB./!Z^1-D]M>S-
MP>_@MC48=EC*<1+#T;;Y)KR$/&3Q_L@O8;9=;TLZ[^@)S;H\"S27B73WOCZ;
M (A*0EE1-R+8:X:>A:B=*XJ"5RRFR%@H_P=>986$K>F#SL?-26'["]$'Q1;3
MQ,S"'NMY+M*8%[RDV0W%O+UXZ0_\?AU_17PD/J\"/KMBMF+[3;GB$Y)?6H\4
MI<27F<DL"/J;'+FQ*]B)@P?S_]7 @3\6=LXGB[D37_R+;JL ;P1?D20A_DG?
MX=;?Q&A[8]C@F6;LQ 6PTGAA]/L__NV4ATARBQA9MPASQ.RQ7WD5T),W%%2)
MW;68*(K]4H#=[O9>;+A,[-L0F;P_*:KY.RL>D>-?6 4T?\%T #FN9N+C,XEE
M;OV-)Q"DHE8!3T6>K$I-E=S?*<XL3;2-M0J(O<R_+R8'I[@JJX!<1OU9T9>"
MC/15P#;LXJM[5[@_)G=?^.6O_#:I3["/QM]NQ]<5#<IA@2:@3 6[I]ARR:)W
M;/G!8-2C;Q.,/7JAQ27<BDS#>.]=3;XXJ-LX9<?W!"8LFTQF9Q=_KXBNM7I[
MJ1?T?16@E-:7MS9_6:]OL&N^SP;D^D8P>-%)\>&__>(;:!)\H;JHQ;X3[[/8
M>OE<57FWWHRE7472UU6 ':7TC<Z=N4*$=JIFI$T5Y%G&A_(*8NR)MTEZ"1J.
M5X)$D91KJP#NB<><,6%\VDF61Q/\$P7>]KCR/LV)D%CO?=9&ZKF\P1O@2R4_
M4&2Q"\,KZ$?]3JT2;VY4#NHK<[J$6E<P82"Z^@(F]YG?0!4Y$I9FRW5_E;'Q
M@ZUA)3F/25*_$(\1NQR6L]2WRZ*M4O#L">AFL\,0KAVSIZ?2=.PC/@)[@Q50
MS]59?Z_ZBXO,\V6BD6$T;LA##6\B48AZ<'IKP>2%B4[BB[2\I9SL@DH:;^[;
M#UAVEP,<*?3Y=W=P8T!J\@@N<5K(BH2R7\?V"VS]*=\P6[J*-E_',H.YWV4[
MFWWNWB[IO&9-@+/J51-Z+;IU;9#;5P$_*!>Z000X?^;RY<HD_J7N.1VDY"G.
MJ$72Z#QGWJ.BJC+5H<7&M'[>6JOD*%TU>C80=PBGL' L.0B4YEJ(H[3-@1U6
M 4-Q@_)PO*+@*CL@X:=Q\JYVM(&:<L!CIO?M$-N,2Y@;A28'</M_N> =%GBU
MB;*\/?LW6;;<-3Z\"H#VU/Z6<OQCEGP^CL,31DE%S1" 8M/=NA@K.E;\L @=
M,%RP.1(<Z<='I4-G9G3HY\'#REW:8F(:_K3P8"O>Z6W">E%?V=$I&3D/+M;M
M2;.KF=!L20C-XE\5Z/Y>!PR^B[T&I*ER2R0-ASP:3"%F&B4/7 1@MD4&N)5I
MHWDW7.XIP?A-EC;HF?>!03WXF\WRA.<'&BU$O<0'DV(/N/0\/IG?RIQ]%/'R
MJ1@:SHCCSL$U0+TE<7H!'.%]3=<K;9O@=#8WW%D.W9H^>0D4MI2[ P!I/IT+
MX^$Z/GN'6>E<3?=&C#TBA-4M+$Q73:TE^8(9E*45B&C/P8+]_VL3)$TEG+M-
M3N#&!Y4[LV5YV0_S)ZA?4XZO7Y'CN7XW[+W_8&L:?>"D-*LEZNUWCJA2L)/9
M"FYRDV3AH_0*%8T;4A4[2.:WTD^"XC<6Y] F=]:H1H2_N2:G=(Y19>'\LF,D
MJBG1N;LKD3?86,9;@:\@L%.89.05!_>T,+'YVMN%4ZAN1UB;:B$*4;V#>SN+
M3*[C+?<5VA-"0JA-EN65,>E7)ZBV43W=EAO(K4Q  /H;,':IS#Z=M"1V@D-[
MFOGT(,0XGCMP,%]5D[X*N U^*O[5#Q@C@1%+K_V-7P$]2-NF_C10F37X* 8'
M?WGLO7L47DOK=M<,O>,5?? 7DPK#%1]#]WM-SFIT_!=1H6>1[]K$IA5-#D&8
M2P+S#5'*V>$X)/39H$HH4VH#RLM28_NZ"+N=7N./T2Y*\<K;+KS.ZBGB3/1&
M1W)H--EXZB_T./]*%V$KA"W"^:[DLBW#Q3QH+S?,F>T1H6^,\Z@W4^[VT3>%
M7*FZUD4?=#5;4;V67]RPZY8E K'M'HWZ\24$8BY#NMCX 4D1& [XK@+2EH18
MJ[\_A*8T#DJ81O+@G^'.=]6Z[0VU<56GV@139+G9-OYQMJS&Y_/QP17S;+6O
M[^[G:06=?U62R8OJ+&9L^%4N,8'2I5$+?4+>RM48PAW[F+J^2[;.ZOU%M9[N
MAZH]^KA+9\RK>@D%!*O6V:R@FU #U[QM1S(-#(Y0^UVHU*9?:95NB0)C?Y<5
MRC$7>-%RYZ C-'EEO.U\>NF?=F[\67_,E$@<K_B:JX"ZPZN &CN1&:S2[;4>
M8SW:NZI4F"[8_-*%D)7Q#7TYB;?0P**>VM3/)'1A#L)$)ITXY5)$:=UU=\]P
MF6Q,,T*7-DL9A)N3L4X$;@X/&/GJ3UJGEM>F!86*.F.*T!K"7.RMZIL7$FQB
M *BF.LH^DYT>QH&OV]'!.1I/T'#XC8:6TS<SIU)WL1H$"?DOZSBK +FK] 8R
MO*!<SHY)]%L%2"+YS^%HI2AP=>XJ8(;1!YU.C^C^\0<':?9_N5P#.I)3."6?
M]@P9X@CMG2O2-_6XVHTGA$ OD5ZT!N1Z!<5W$RN?+G6'O='1F1U-8 9*@;2B
MZR6_Y::VC"U0&?C%J'%\.$^'.+@*Z!MY]\;\EM]O&6/IT]OZ+IN+32MNP$[U
M;LWZHV6EMGJ%O^6I]6*;M9[G[?,L_/)EYT:X,%!\FA(I)7? Q:!I!;XAIDVZ
M7SLQ@J3-$C5=Y;[*D%)-VRWPU1O4XT;N2_S)VFU6^UA#T&C6NXE2O2>20)LN
M'#-: G6=&.:$Q$3.8_O<.%.M$/,]/-%6L!G>AK#L'++\+T2>_ROUZK!J4)8O
M6"#C3QNRJZ4QODD,!81_1GMQF]_6:339>EBF2+;581]7?OG)G/4D\6AS95,#
M5N;.]YU77>(-#<!2JN3*),W+3(84M)T>%U*%H-F1?YPRZ8Q8J%ITH5 0;T0A
MKQQ/#/P=QURTFR[F:Z%]A*5D0Q28@Q%[#R!R!/3,3;?RP/&:6-H9UF X0A5*
M4SK"#BW^82L5)E 9YMZ&I$ <*ASW5Q.>/B6(BK'9$T2<.CU18%8@4ES1C%./
MK>K7)(YW+55-C'6D3=Y;:PL5(U-/@8)X=<>T!0744@#FFYZ155%)DBHNW&'V
M[>";LC@VL$DVP79?+$0UZT>'0.ZM#1+K/I2V3:4$9G1GP971FHL*N]*G'V6W
MF$I<!3P@CX27TP>G#[[]CPK"_@>@_[\(T#%B-%9S<Q5PS10LVJK"ET);<:VS
M)OP3P7L$"@J""]R?\VQ5#4HA@O.LZJAA HM-2;YS 48VZRA"0M=/:@;L[\)]
M[RU$5CWEGP^_?L_G'_I)SO,2DG/'*Z-$,85.;A,NY/A@9/9DT.TLN&ET1O:D
MP;%F[^#K6'???8X& >4!1ZW7AKKN\Z6U*33HJF1D72P$^M#UIZO!;=5??S#\
MEMP23IHK_WNY15EOD$X9OP#"ERB(U.1K/@-IX>^,)5!GO\Y2[9,&1ZE,66O<
MK/;HF82]Z<C80S*J8C B+WH.'DH#LN[GS.3Q5:TS4 HC]-:VF0#6V5;M:;GS
M;,X'#E:.!+H6.KC3,%2D:>N>[^4RZ0Q1+4P"Q>#0%CJ<NNLY4ZD*Q(W(#Y^_
MTA7)$%><7A!$\&7,+JT9EY:0"'W,;YN-Y.P6FU(FIA'+N@B4C++A!'(S8*#G
M,UH.R_5I&P4>'+MM:%=6B=B&$0(5[:6.GL46__K[W)C: +(RJ]-J0@(N8?S,
M<MP;3L,MB2@:H_?UNF %^I7_('_[#SZX%3K3PS^5%@V5FYTNTURXQ^(/+]"Y
M ;61NVF%!)N&-XY0MLGU^S@A+O GB/.YK 17A?-=ZO67[.[&LUU]XF.[1,"\
MQP%!6.L[&!:VYC!)GR/U>!#,OA)>;K<3?=+HEL>-40AHNZ?\K?>MU;JM0)K^
MS%F9J+9/K*I\S$*P*-/ATEJOKD5'/YJBEGOQTI\)F__,5N$(A5'@]^H]8H1W
MJ'/KN*.N=3!;NI;JM[XH"JFY,;DAR#R%M-\R8\!@A7321T'>G4;.D8\R"W[5
MA54I\#1N"/2\J>^1W<;#QK2\_ZT8=A?-]6K_5=J@\\#5M32ZN2\<Z:WU6QI]
M_]IP7N:AM32ZZHM6A8+ZR>CH0DV>G# ,>T<3&^VR&R@E" R6I#3@MW][;J?9
M\!-JRHKP_'%!O\6M;=29S(/ >H,C&9I/C1J2M$F)";Q;MC , U>)(6?5]/=/
MS\P'N*X"<(1BWE[S6UYB[W5L!"0!$QFR8B),% H>^5%DN%AGULS*YJ(I6.'$
MLCRZ\\ 'S=$&Q9K875:T Q8G+W>MR+'%>!^XA1L#997C)2"3@PJ]!->?+S_L
M>?FN6R]R8I'_Z?-QATN)!O-YV_('[FN>12 7H(GX47/;1#H7-'_4$[?M=S*D
MR5MKYH4++)1TA2DS A#2=W22(F86>=Q[S "/#T8Z6?O9&\.0RB?J 9/RT2\]
MJQXZE=U^_M8\*E6#P#=KZ*+S,+G"3;GT3C68JOL9<X^7_8_RTY^75BF^/9S;
M<NQN1G2*KGZ?G?T*?FJA762']00_&V..->+#@3LN.22TN+'UYSC'S&;JZJ@^
MK<"Z_)KP@U/I3DZ!$557;$C;MJ<:0W")Z8+G"E6(M?$I^&]I7#7#.MUE["X,
M:)!&;D'A,$!4D+_Y+5@.'+H#]>N[:\[NCPX*CNVR^O7U;%&ZUKJ[O\FC>.9J
M-@?"A>BV?MYOXB@F&IPGW)6AN?Z18>%<E,GYJ4#L,=/$IZ2CDO5W)]W4>R.B
M$ORK'K_6PMDW]!;GZ5TROWY+8OT'4FKCY[F52.X[MG$C<(\) H=:!33)QWD9
MS1+,1IWJS&_F.-=O[8<9V1=8@[XMMIIM,X<AJAEAJ:.PV;%4INLA'*-%##0>
M/!_3CEW"/B4)Q(SEYX?I97\?6SC AVD_"^!BN--4KK21Y5Y28!1)][U::;TV
MAS'=\H ELL!KVZ_O+Q\^";O]Q!8;J&70H>L3>,.VWS5*LZR*,B7:(M1#[^2"
MAMH>#/[49;)IJ.64]LS#BIZER&?#\OAP_3</^&[%!;:[0&_NZ73(D/8>_>;4
M@+A^)UW"<ZIO2H)88 C]3J28BX*P*9W_<:'9RN95P&-QP'9_. +J[QL"SB#?
MP6J68AZ1C:NYSB/)KT\'S@V!(NYFC87-S95D'_,89NQ#^4L>;M=LVE_)?7CH
MT#T%N3([CXD5.$]F$ZQ)8!TRR\@3;+KHI%CSQ[A6GL9"0&?4@-/BG=MP09CF
MT8W?D!AJ=MRZ$//53>UV_'5I;&V7C15:QL?YH84%-R>3N^Z'P^%MGE_V6+^7
M#ZLG4:'!Y9E7>G47@Q$9=C[TMB6]]/+C?T@*2'V'B[;W"_,W/:3<!C]DE#@\
MS=M,H,28@2NYX2/!3NIF=[E(UDOMZ,3KN;0\@ M<!&9O#,^?Z+1.TQW[:!CQ
MV$_'<D7D8&^X@JT1I"WA*G,U3Y+G$2R;13%Z_>U?27UCK%501V/AJP#NH;"/
M=I*3E5!.8IUX$WG/*64:]>_9;[PMP\@R=!@O)JP0D7[46K(A[!E9S0TE5R<?
MGSFSVW<BJ('K^#+N<Z+08<IS0F9T3GRDL2R#$YK&G^FQ%/A<SN!N^[W_MLIH
M%EO3 9X/7P7(BR,^C L2(]\-=.R;'G=3$;3 R!.MNPH BFB ]+<#?_S:PC0Q
MSV:L&"(>I'',R;)B;"'YSN$53T"YG+R39*JQ\I&3I'GZ7X C [&C^8C]?!&,
M /%/4"*@O!<#W6U#8@2=L6+U-W!T_&#A^7\"1]-\T;89,4:)X0>L K[%L:36
MTG RA]^Q06G?_PX;(:\X-/U!(&'=BJ386C#B?UTD$+_6H^N"#16])D*%!FQ9
M6+VIX87W7#E6:G!.(![_2L%:@&72@B_TR;H!6/'U>;ZHSF9WPPC]/1FLQI@
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M$K7R)]2EMG'-&D==P39AK>2J9'OV1O%KN42W.[A5!>DEBT&NYESPKX0L_($
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M->+']RZ\@;593.[N**3$D:8[C@G+">5ONEU#0 N$J$.4TBZLK;V8/'!3E\0
M3V8E3,SV++@^:'-6<!UX9^%0 F0NS$V#KRUXV?0JLHY\!!)B-.D\\-,52[PS
MRF>SA" "H?Y]+\!#[G:UX\C;K'Q,--T )N1Y5DYBMG3\31W%\9W@ +M[%;!-
M=!"UJ8DEMPJ(L&L(TBF^_TS!CX?$36O8EYHY.[B3NFSIF1&9/L[])Q5/\M8$
MTHU7QGN;EJK7L^BG)1M('6T($YB>=.W4VCU'N$K"(17M?2^M%32;#AS3++CE
MR,0+9#R8)RK[1/*"@Z4?))7B<J"HL:NA)^R[!R=+;=+'=[;*QRI_*"U]WSNZ
M16/.A>$8<4[UOD7G=<E;53[D'PL+^G%>VMB/O>SJQ.SD)?"!@[@O8O;# W(N
M<-W,0&)ZC1R6>&TBW(M\U2>PBJX2[SN+6EZ<2VM[\=$R+]*JS,\;]V9I<^78
M_57 %?U?!_/\A;;760+&]T<17TI_97M$D$R'$))3;CILMSSO#%1 7:_T9%!1
M#HJO3" 0 ;&[;UN/)5G8!-M _&)'YR>=M+6O)S%1&=C11$ZQ,-?D--^*.US4
M-Q-D5S<GU7K/>PB_S5I%Y]/>?M4^PK.,!"=5]O:\/9=/G&+!.(^TS7I^[*2[
M05WU_1GFQ%1&P#!OI[%J8CH?AZ%C+#^_^IN*NWAQ':N3"L7H<*M&7.4^NFWN
MRNPFM/H,6136GG3/<5&V*_?BX;Y<_'1G$6>DOH#7>;,G_7##+IM[JCO.NC4O
MNEK$>:M5@;.!_43./19VFC&$9 T^3+&!=HM: T>D9-KD$@.9DI<.]CNVQ/@*
M(ZW>+ZA%VG3=#("@7$<_Q#)%H[.3B/2IC;0 P_%JN:%8@?<RH^?5I7_V22?F
MI+D%=1B)#@3:FDD/.,L:?)S]+G;9L1=Q[7WQ0RMC^YP*5$=V?%CB^IV)2<Q+
M+T_OBZU4NR;0YZ8,82/)LH\;L5+(;^B3P[3D&4N[:,Y!'9PJI%IWU@;RK$@+
M/UQ.+GWQ-'IT#UY[YD?"Y]&O$S>=?*[?UB?P8#@*GJMX^GS"W'RG$#F=MF(<
ML/@O[O-O86MJP"5H;$F,8/?<R-/LR&R#E"%PC*0'WP*U=Q==F>"$4;\Z*8UB
M?FV]85\>2CO/S<KBCE(;&^DW(=JJL/?/,BR>4YA(=_W;0NR9/KKO6B/=&?(/
M1 )M@\R&/UP) R=VK@(VXD6=ELQ5@$ ZXR)7.Q]*: L71XP(D3K+3W;AJFEK
MIP#,?:R"MF1%3>.5=<U]D,*;3=2-:=X+EMXWAS\H/XR5L;HF>JWY[DZUW/?H
MO9K6>/ $DM9]\.V+OX/ \10?(/7T.>&+5< M.ZH*)ZY':0#X!"MA8L?TWCXX
M<1HRB3D&/Y;%E3CUZMB!D7HEPVXT^-TC*\ DH)W$V5"4TL;NZD5&V=4;D0OP
M4P%]\JFE15Z.5#(^S\WJ=E6WONG920C]%&_R])=$N0!?FWLF88D)EC<V3CNX
M7UN>6P5("H/N!.!DJIR1TQ3<3Q&GQ4]4A/\X*,'6J(]1X!H/,Q[[]1/P<ES^
MVN1LZ%._X%NW/_20K)DI;EVGVQ<_[?RYRA:;#Z52Z_.?-UI?V:_Q4Q)CEM&#
M=<&<"N&I,N@>Q);OV.*VZ30^&(7@7!$F83:*OKI)[S2(8OD.YSPUV0:Z[KP;
M[E(4E_U+Z@&V:I[R -%-G2TQF:I,4KCYW'72=^5"G>RWN/&S T/_'A[\M_3-
M_KPB=GR/"-B:3]"-:_+,V%V";<(HD F(/<)Y84[N(,0HG41N)[(00X,9"@J0
M[*KJKK$C:'-V8\K!I#VDHYGTG+!%V_/J")G)KK8<5^[IRZL L%3D*F"/Z! :
MPXUBID6FR:,#F.!P\"ZT1ZY!#E.,I;*%2Y*02Q6'B^N3OW[2FM;"=1J;'CO[
M/K3K7&?A=6+7(LT8HHGR'OEZ?Z*3)U)*#IK#JOMU/HV-)_B7\RPFA81@'KIC
MU,_A]O!?RX^(TP0^$-,)+4^L#X8^Q9:":Z$RZ$OLJS%>U(+QWLA-82:';J(6
M++<7CR!D)W<Y<^$UU&/ZU;4->:C(*UVXV9RGA=-)DTL9Y2\;7+,8/.\5-?]Z
M:D15!V@"^U+8)\9U1\08OQ_X$%AJWA2*T<50 ZA2,RILXGFX]LUS7/B&S%+T
M>M9&W)X% *D+:76@BDO,_];\6&8LHDQH6'O4FJ*TC5)!*.[MXOWZ:(_W]5 J
M=0\.ATN/E@A&J3A=>[3YBN7N(PU[KD0<?&F_<^>9>XWY^>_,[\2>;1D;Y:T"
M/LXO5!W/TM (F'?QK()-X%><#XUG6_T/1?K_&4626<D0@[!SXK,$$QP6K\FB
M5BJQUFZ/?EJHF3K7D\Z-&0IH>'C;1U\JC&PX+[,^X-&^JUYF6]GG[C9D<+M^
M^1*)S'FM#U__N#Y(_6&ND\)$Q_A?JY4<P&5VTPMLL;OCMHRT/<#N(ZD%#K6%
M8[<3"J+DW#I]PMYXWRW@MX)=.O0W7$04<GW=BE'ZWC]?+=%UGJQT[<'12Z<3
M)9C(QQTTXHH.(\RW$O3&]<YT7RMH8@X_L/O2GTZ\^(?ESKC2_CZ21M&XZ""K
MO** ZU$_J-1=2,#]7.\&[,;[>0><Z=6C/9O3FX%8]BQ.S. 76\_7SAXL*L07
MYCR:[&4>'"/&N]L'P6<79O(7H'V#<8ODF-G.50#+3[S)PE;Q\=I'&?KA;=AT
MB6O)N27>NX@I*N;AR!9RT_ J8)VHFWBJ[QR+$:YV)9IVOA-CD!YHD+JOKRCS
M2GD84[OP BK@4I)36@.'NKMC$!5W6=1R[?_\D/LVUOB]\R:Q]R:Z"N!MK4@^
M+Z[CW(M_# D_STN)MM[CGTH!G>NB>,Q),&:J>V^6LC?5G\!E75<K?Q$SYFFF
M\"K[%^]+PQL)N1_/GDOP3SI^N+<RLVH5L'O*4],\<(KKL@K0>_EJD QE2=-&
M=]OOP%2)ZAG$@% 3J6%7C:'E1MB/3K\4:63.8\$]1=)R@C_5KV]7JU(XT\J[
M%UZ%*G1_D]&%A'BJET<WQW:*-*T*&Z97 <5N<FPQ!4=D9Q</K0*D/<T.=0X<
M<CU=1VT(+84MA![&^5XWK;]GY:];=O_(2]=;48F'&G5MP3II/T06'?&=Q/C%
M*KX1SY2,N)F3GOGVST/A\38@2J*6(2U0*4(I- 9=-:*$H4]ZJ*4L%>:O?^FS
MET@J>1.?U'6I^+5E0 [CU/K>Q(OF)N<*(]-&(9PWPE_1%_G'4:*1NB!\6AX*
M<CDXLFT#-_?4E#=NXA0B0>*-K.HCQ6!;RU!%KUK=];K-,MU;>PW+[[?XT:I<
ME2B)2WWPE_I^J4EJ7=E)PKD6+&7,2//R6NL(A_$ J&1RDV^*$M4UDF7?%&GO
M:_)@0K?;ZN5EHQ+-85L^E)"B]ARFG]H[JU<P$VN3X_8T_A+$_P/Q5Z^)[.-5
M>GS3$*.T+GPM/L)L![=Y*$2N2;2IVX%OWGN@I79F,Z43Q-R,\'.]/;C70S:(
M\"1:I8*HJUM2YF@P;^OABS 115WEX98-(9J!&!N1$ATTV>_FS<9^]&?LQNQ!
M+0\O?:63-5F-N,P:Y?TAR9<2>C([08&?Z#?SU5*&!O;Z;@VS. 7+N9WVNH]>
M3L:IK*A7$CX45U:4D$)M("TG1LLJB6_.VB+N>:N8F^B^VVM]('ZOHAW=O<DE
ME'CB;W4D4I,V'#"[E+L*X'AQS?$VQU/G:;7M7"_AX]!7@R@SYECM?/7GN H?
MG42K:/;C&5WMSO.4JO@]XN@L!ITQ$"9X1H$-K=>\JZ/E+;CH.URM-G+CFK=F
M+0P8.CU&7,^6F82%73PN088TJ\UW9!XH#8W%1&$T>62AP>U2S&27XPH$0>%]
M6_D<T?Y)_"S]>*Z:99VT(J4^YKEA[Y=M<_ AJ>U?V#-?C@B37=EZ+X\-IYY0
M-U-\>"MR\ZWRJJ>9_LZ[0-\F&Z'2HDJ%!A?--M>JS+ZE']0:>YW9&;\I".Z4
M:'+P<^WG07C+U%1S.J&LM(P0GOVAHN+#F]@UQ?2+HZF!*3<BU&*M5:-4\N1%
M^$D*WF:Q0C IHH$),W--C)W$QP+% *0'*Z8N@%:VJ.1-(A_M\5[6$*@&O=JE
MZFOIOA>FTNY'>\K8K2U\%[@OH$_3.T>P%]+@#)IRU;FI$< -871AC_RM*US,
M%:!#4@ 4D8F-],.N1P$M*WH%ED57<=4I*94S3CV8P#F$!_JT1W9_K3R3PQG.
M*"\KC[9V?VD/YSD)$\&W05M%K>0M,;8$B"NDR>7+CM81.SDM-??NHD1=G3?9
M975M!);H]>R-$J*9C>LG7)[;J<2 C0>/Y?*@!)%#B:A2_J2/"(+LXJVD7>AP
M3OKSPLJ F65F#)"!Z1"!68F1)G8%DY5RH4AM,\26\=*O!SK*O#6<VOVJW;[
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M.X:9^I %':9$8%2X4<O]J.#S,-R=,Y'[>&3<W1;OS/'>)]_W+FFN>,\\SO]
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MUD6FP]D>Q$A%[;M:_+.F>PAOL=?&EQJ'M^3AUEEK:?4AO'[,=?P;SBU4?F?
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MK4E;.T\0/$\9Z>=_O>CTZM&?JEG_W\R85.$)05J::3S2D,"6VS=P6>8U+=
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MQGAJN?YG2]!$KAXC)] ,,3P@!&W4;;3=%6"OZN8*RP2B[4J[<S3O9X[;Q([
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MZ,4SLZ>4Q NMLJHJTK?^'."U![8OWE^2^'3H^ACV\O,?[R51F8";@>A&D^T
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M>VYHMWLFZ<RD$2FJ<_\ ]>S7[Y!KU,\%>K5-Q(]LFRWYI>;[B/?W5<=?*=S
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M\$T(NJ7+W1*P+ 1MC.X06&?]GSJ1RM(1=.R]$#CP@)4Q_8&+HPAD)@2;NMV
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MV[#$O=83\>?"][DNSH?%.$M;S*>NFO2E"_'-VA_;:W]RV?$C_1Y^M/K,H$?
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M[QU+O=7N9SFYO-*HVSM[ZD.DQ;41-SDEC_4GZ,C=N/"0_<ZY%/KAAB48(&N
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M011&-1-]I,?S>24C-FR^X(?BO$;[FVG$T&9SD;#,NJ^-E]@S=?E3->X\T"T
MPA74DSN,IX&;9X0DP<X];"GJQ(5=NQ2:"7/)[N8?1U(1C:;R]\U>^ET(U2(A
M[*38X+EKS[6K*9E6"P5,<_MD5FR!_@&^7:YPDC&']BYB9-\!/0SA $B-"TW6
M>)5Z(U3TS8QHAO-UO^Q%'-0L&;EEP@]9*]I7MP\('(5N_?4W.BRHYCAUO\UA
MX3@ U4BV#)\ZO_^D66<:TIWD[OW+Y)WYY2T*3XFV/U)Y(#6\1V8Q\41YNP7"
MY,U2.46^^)],M_OG8<6O#MQ?KG.2H-17/-#H&\H>C%/6#,6!;K4 I7:(C[6$
M=!_3SJ,%WBS4UV&H?_LBX>LJ97B:SGU'&_I^>3("+'7KU#VSZ^*0X)]%FC:<
MR>=U6I,% U6!NC,SE6P>Z.JMM-_E9 K,#;#WX)DO$8-.W-W!K%, X1I16VXO
M$$=[:;@-_:,DS"V[&WOJG+Y\%NSMI:]Y.],R@.6Y^I%C=>E&$T:H##.5%Q=4
MB+/#<"/JB@6A?>W^^/O:N77SY>4-OQT2QB:?^4@-OZ!ZFR7';>'#=M3"\0"5
MXY[T7*I3V!I1N/7!(>UUKC[QL:9HJ.YYVMA)/QM*K#=.9$:D5G$[8D_2NMJU
M$<3_W?%K2DRO.D(A#R3*EL6P8R*$:(%>B"G*)JMOM[+\ZS_GE+XCCO;"!H_7
MJ6#)X#U$5]0>EQ#<;FY[^M;XUD:=ZT.50;!(L-1"&4)XYAK<_(0,/"&3#2T&
MGJBN7BVQ<QFH(H8L[0KMK'"!=N\NCVTHK4 0"1WP"8>8O!J*X]U:%7R[Y>J_
M!S?^MZZ#_K-5/T+\S+87##,495\O^UD5RI;[)@T)A<IH??="Q%:YIPD34%1H
ME-4IITN,]F;I4A\;6!,+[G>D+[?)DH%>; C(>W>7R"C(=S2S,YR[N<P#/7XX
MTY[DLKZ.HRL2X>#/T1*/R;\_IC;Y*'![%?]FX9@+_*LKMI<K 4Q0<0L& 53N
M&WDZH8424IX<OJ.B"1JR7K%KG?FL]>&,HVA$C=YIV!Y ^6;B:Z3!PPXO5EY&
M!E)Z+6WAPF NR7S3#M&^1)JZXR3G_'%]J&T8N<RMPL\)T'&TJ<:N6(006XB1
M3-4)+^6!]K// ''46KUF^ST,N9>*+#MSLU[JBKS:4T%5E)NCV*"K?V!#:\ ;
M5^T!_\#YD\-#%KLW+>X_^"\'DVOYQ]2$P2^R2EPA0989HEF_N(T6*X+9,:!V
M[<*5\A(X6P#PIB8&B66IBL,!?Z$DU21QVTN/YF_LRR9(]? /*<2[ JFES5PN
M+@. 7OCMCX9FC:,[^^0X2"U4L\QFQ&S?NUI1BLM&<EV<;[9WW<YFPP$7Y-L?
M KONW"C#VY"./.A1""X<^UZ8I]8>VKR,BW#!JGPI+QU)81$?/H>S8U=E,\O.
M_.OWN5&G-$QV!8MQCR"^VPY1K!'HJ>:!)*OR!!-/OJ?U),R*PX?AM@U=(LVU
M36HE1OHJW>TR65G%6I>8&]-EO>3H#?P;_FY=]MG([A2+:/H/]9NCQU^GP5A!
MG5#H:!QTNU90JDEL32"CJ_G]X*.-/"<&O(F[@Q+V:]R#$:%3"U6*GB7^Q,&4
M8:OUR2K)]C_77C="(A T;&! \#ZQ?[?.0((]B:OWQ(V&I?^LQ'Z$EK?AO.9N
MG9%V"H'>)VY#^UO_)CGCDNN"+_TE---:PP8MWIR@!R?#@7XA9['&3UB-NB3-
M:&X'-5;<EA *O]2G?P*5B^7H01,H[><R?]S%W_LY>U*TVI/]W7M8 $XOKRQ
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MD>%%B__)[GA_.="*>:#Z 5QQ/4!@[<% .3E>%B=_ ,E,.)#@7K70>T6Y#=Q
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M_W3]>J^NWFNG43?M0ZA)PTF'V8T95)7";T8V3TB!3_8?3*=,YK3YSCPH\ED
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M+%?0@/40\YA&]93KP0G.Z&\3J3X:ED)+J$QGJU94;#=-<8$%>=/ PEYLGVM
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M':-(F,K?O>"1CHFYW ,;M[P@%Q6M/3J].)]UL>VC3'.AJE%-U>')VKVORSD
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MOF/.FKW?G[LKAH8$C[G.PYT)'FO)+?DL#:P5_@J=/+]EK'J+PI!Q5N,IQ@]
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ME97#O@N0@JVO="/7X +<;CQ1LI'Q$VA-6XR>FR^*)$KY<DL4GZH_98J?S,\
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M:>=.P6K>N<#O,. 1HHU.NU^(1YAB8L7:MR]J 'VJ%>&-RT <$O=\2L%U46%
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M2:@(=IL*VY*^89(96KPJ]$Z9!Z%Y4@V3;8\("4?,W63I'E]N_&G6:D-FI/'
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ME#JY?1PF(=ZAM2"YM;UD>KH3DS'5IK\Y&:. \W/WJRS MMY2!LSN<&ZCKHA
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MT"4MGO^>OY3[_S]'^R.!V%RCF[2Y8,YT0X'7"?#Z8+NJ=$C0TBDFC. TC!S
MIKA*U,0!U+&JYPX>&8H YQK\=62K(1CA[AD\1MMG]'-$?FZL3QH<>5C)J',T
M92VV(*> ZSM88<L1@%,1YTWY7$K%ZH]",!_VTNJ:VQ_S3^L'! QQ,_,?PC$1
MO'KQ>D8.@*NCB0$%Z.L/,B3!>F!=]K$$O@$6%A@S43#0%WW=UM2-R-1DTOLX
MBN]:;KH/<$-?IAID#\WX4:VE[N%7D+.K^8179^,$4)S\@VBY9,*)6XD"#[/R
MZ12F-!!%7_BL]E1.GLA"U2,B>-+='%OZX<">0XU]:3CI893_?3ZDIGO%4W5>
M-UW9OLLKQ&E:ICJ&_2KX)]ODQ(::_'\_*O:_S;B!S4H7'\+;]YT;E0/0&@1V
MQ9-MGRXG:%A&R#@@MF-5A^T'OAPCLZBA*JHKJ'"=R:P'\1J>O@S$SN-$.EUA
MR<B9" ;G7!1KGDR4\9@F5"X@LMM.ZIH'3*].K^&;JO_2T_['?B<V@@_9V8"K
MM5/A"!5NMIZ?X^F#S^&@:>, D?=N0PW,OU5QDP2L1OLBGP05<@Z7?WSQ--R,
M%;J<@CT"F"1<W@^2/)TOV7Q,:911(::L>L-S??#-G 2NRMI/UA(YR\05! S4
M1J@]_Z?BNJ6X*)ID#12S"[P]1HG&2W#,<]':]/9ZU-Z9#!46+D+3I$O67->X
MRW,@('+G,=/*#?*![],Z+N^;<?DS9*U &_R.MI6),C$(+C&7(R'+VR,\1@!/
M*C'=QRSC,A1BERX#AIFB.SE2P,'5K6Y5NP&*465EHN&'E-:&ZP)64U%1PX)%
MJ=D&MC-$[LP/]!EVS@GN@^6WU":+14^/BD"X93U/^G"'0['I^ZM<@J?GTM]V
MA^OBPBC[,.XL'$,J!"N!.0=P^9!(3C!+JE%'*H0C2Z\^LXV&Q"JPY+)0V>XR
MF"W]QV**4%Z9QAGN\B12W-<,QJW"L82;?(BC&JAD/(>@P[X+L?5!W0UUT&6.
ML"(J]$/^.AC!B-*])W!#3ZF,N&>O?!&'P7><SPD_!H9G;YC??ET?H-*P[AI:
MQA0R6AH043]@7^M&"]8KS,+I#J[34DNQ,RN>OOT*-)Y943#E']B-+2!@2$(A
MN.8&WF<HV[#F"&[&V_DJ8F^U%"])_"JB(:Z=#S%Q94T;_NJW^>GU4X(#D8<O
M6T9L8GRUP]AO.D692BSMN6J6J96CLF5 T@09=&&%.1HTU<B]VO_^RGZ0+1JY
M_\.PNJ&,?5[\]OBZ%$O_Z=P1TMJA/G"S[FW9EK6>F$D\_Z]'SE"^IO'V_<*M
M9G"+85Y<.#TEA.BV GV"*#$+;*^#[;%T5V^[3>!<0OZ ,OB0J-L)YQ4CW298
M<J]<1JOU&;OOEE9UZ8DZY]M[\OKPF.8!M7;+)C[D3:%B $&!-KT^O8IO#_V'
M77P27($3JWV' RP"RLREFJ" %25B7>$##9U*LP/A&UH#M$$3Z;CZCF%BG. ^
M1B3G:P2YR#1EW=.7 Q_QAL<21@:O@D^V=PH@5/_5E!W^V!9>-0S.B<[7O30\
MP#G,AYABVIGZD3V;BT$)]:+@R90YMMY91AHT=D2Z^&0FNH6AHM3$&GRS.*<'
M_TEI3J?XLIFAT+/3G@/**=\ZWW\WT8BERKR/S(,%42_=+:) 9\>Q-ZS@A_X9
M>H#L_?K^O=W+4.MKIF?%?SNX-_FT90MQ3NX %Z]_'@T8*CWE'42OVI+2DYQ[
M;M0'IA<];XQKY4/$HV:#'%6,?RH=.6'=6B.5JC;2VN.N7<++"._9% Z'N/*Z
ML,=.'B\7?:(GO-LPX2)#5*PHRV_+X,LL$I!->';'_9/GX/%*8O3VY])/TYQQ
M>1RH("QD=!S56D)O,.:+\YX\\<]%P^I)]K"4D(NQ-+L^E";MW)C(9//KVI"K
M 4IN_N'Z VO+O!I&[P5KVE ?U3%HEEAMMZ+]E#**AY;00K5,M!^C,'9^:7Y.
M:'*#?=.;[F31W%L.TX$*:5^VORHC-VF]N>QJO/ZD#B=2(X<6D81M!\7KY,0N
M0I-EZS,.=VFXQC^X>-8\=^#BZ?DQ%85$W:KL#!,Y$P6/;]=1"_8^M'4^1+,\
M.Y-D,\];L*5XKG3>WX@\^5>+6L.CHH), ^;GI\*Z^KJDO52]O!2OJ# +1PU.
M4Z7$KUX_=SM,PUTAP>@6(\:T_/-E+BP_7\0+CZ+84(JX<5-C;!JWU$M?8R8%
M*L*3]9#RH^Q>3GNN*?RC?J!UC'N][TYK\(,",1^@]\6SN*SIQ%#ME%T536\@
M+]W[!ERG#'T,'^7#'6F%*5_J+.9G/:6&"KD.)_YWK]?^"H4\X&N4PB-EH^EC
M\[&W!G?]^#&1%)\4J7/NZ./:(>DN2@)B<(E]+Y&-!*?>V_WH\Q2JCY-+:Y?D
MZ+]RMO)T=;W00B+2W0;.W0G3!DA9YXADDJ7ZK65ABNB0@[G"ZG69EI*J&R-M
M6!W-U4$4Z!5]NE ?,6GJ->O$)5!=J83Z9=NC/_X!M4[3=F(/@FEC.,$-V<E1
M!J)U5PB'D/O=9Q]-U]"N=G<ZS=I141+94<&QX6\'1V:H\4V,@-=E:,_KR/(C
ML99SW?24^KB]&'D01X>%U>PMD73Z"?"+0[YU9Y'J'SX<CU-?N%Z-[M+ W^@E
MO"WO6=&-E^'F7ZNL>)6B?J<B3^6G:JFA)/8"3AE>>:[8\I;@MH]@*Q2[FU=J
M:J(7\@IC?_E/0^__R;+.HK[7L[&;DKA#9<.Z-XD!>KOI!X0B,-YG[/32T@ZY
M-J71:6<>2*+$$,9L[8NG;ZC&2Y8&>9DE7]+FI=V)/"=_Y?;EV$.=\I$G.DZ[
MRX3>&HO5O);W+,OC&-WZE['ND]77F5Q<?($6!9^+:G7"/U21V/&O]/YKN;C:
M=DK)9\X)!'AR7RX+8=B=W%U+(=H^]H%%)K=[';(W'!O>(?Z)#SE0MKSO3<W@
M0]\LMPR-GJMEG9J?8\A-T^7,PDG[QND@^)+IBF8VBZ!!=9KFX8'/2_'_!(O^
M!=#,'!4\PQGL%QK0(B!Y9K10^R9B-A_BRKG(S593W=PX>4B:^3:,?4&MR299
M"R&B,97L>I98@!#Q(>Q%FK@YD\):K5G[2L2&VC0;)VCSC3X^3B9JY;=&$RM1
ME1^M?OG_+4M_AO*O-G/HMG0\D["AC;'FINJ?'MA=I<C2KD^8CGAOB#K\+9L.
M.]#?*I=%MY3Y$:7P/+0/H\10-H?!B^.^1<HVE29:5*O=#O+?BQ^_O6'%:Z.(
MX^["XF@'<:ZP:!F#:3E=$,X(HHG.G#.2U.G];=#[-9A[.:F\ A!@EN7S GZ_
M_X?_]@B%;DU9;QW#!Z7U/[7?9992J]-K N&L'YY&-EX7YGC^)IP!W./1@S9*
MU_Y\8GKP'-D /F0'$E:":_R"<U:+Y<G_C/V&_XEC?@"0I!30KIS6%^7<[OTJ
M:5,X.:1KD LJ,S1:D=G(SGO*%Z"-T'Y]^;9TXD)D41&ETX8<564[Q$, *GS(
M-N?8S++!:66-C6$D2/M@9?;U?\0 @2T(*5SM)=Q=Z%[L,*YX0>"/^M,:D)XB
MM+@J)6^U$-^TI#7,&9;R+[Y4+!3]_,I[EU@1[48MF0>]6;]ET=R\9U*=*8G!
M)YRI7C7IN"VY]_#W\$/SN.>H:,Q1!BJ<I\JR_:W*/<L)[=^DOXLE5TX7E40'
M61E&675@S.F%%K-&U#(XV#EN7=6U8JI<*?O"UM=NU,7VU_.3^4*^:\&?'_G;
MCK"1\T[XYW^:++%C4'B#>YS7:MU%\%INNV%62>K18!I;EJ=^VQRM4?I*]?Y"
M 4HE0SG*M!+^+.LCJ9R<</YUJD:RDNW-0#[D2CMX!,^1)%_F5NK+32-*79GB
M#$^8&;<8*^>6.=!ZK<<UK)TG(U6GHYDJR<I(R%%&WF )7R5&#'[.D"U345F^
M9C+F* .=&XSQM@"^?1@NBK.>S2)RU6;F;MLYG4*TWET=L%E97$!6^\/>KI_Z
M]NN?O/997T_XU0Z-0DL'JN8%F&''LKG^JDV?;[H]FV;151:C;$%.7K+JU30W
M6KRE<EIC0_B*4D5U=46&<A <_3:#<3-".H4C8%ZC CIG;\NMJO*AE:K-31"&
M:S>.<M194H.:T/UVQ+X,6IEH;%G)L2<-J\"5HQ]A^SAJCU2-?UL.2HK1C*+J
M:_=Y9BS"A.U!%VV7V<R-W@UW9.Z,^U6];HMOG:5KPW 6M?/L6G;FA__=_,S[
M#AOM@X+'=6D(#QQP'1%MOTVE*.UX^6A<?]#57I6;4953(5.7P<<LOX,O<'DE
MD4@^!(*^BCF@,IZA5>66A1016T3-'R-?[305^&HL)2FY8GK1P?KPE"JU9$T9
M>]M0_>]A=8@:J"?.LU!BG]MTBZQM?,B--)GKH,L/RG)>ZG6> A:W;@J+N_K7
MY9V4!P)CT!"#8=UL 0,(">?HR_W<^RT)B&*'$Z%;:A0<+$_EI+\=0N=?+TZC
M3T6I77[64;OO\=B@HR3U>J]B0K]&G# RXWAUPD-(AO2\Z(B3'R((@7LC(:6A
M4$581:YCXE84,XG_NG]5M,X25,-MUC@M!=\>Q&N1P3_%0L$07=1 %#NTBT@1
MPAPC%I='>XP(=8P_OH]!L+","XG!\1@59"!)7RPH_E"/GFMP;BM*@AO[A)!-
M7@MLEF]A*D1WF<AK))C(G]6M3/CV;3QA;GS>'_62/"LAU]K'A^ABV":T[J_3
MK\L>S3-GDBAPPJR1E9WL_W'S4)R *9S%_4K[:7.1) 6)#T>44D(-YU_1@_+Q
MX%5]57"@;Y"Y'Q2B.X5>J,HX0<4'W(I]%WB<"-!"F7?U'1<B?0OEA,,B&T8<
M!_F00E3=0EC&+O L,/6)MALK V);ZRBB/%G0U@"P?5*EF_L&[@BM'SG<S5QN
M4V^6;C75B!\8;'*M^!C@1?#:2_;W;O?6*ZGI<&)N4&IQM905Y^32JDQ*$G*&
MN=BO4BEX_Y>I*Q]Q$?I;.O1/HL4;8:(8*R'\&S#_2IIIU<"6U#XC9<WD[/NW
M).#,4SQE1XLZXQW7%[MV2U]]=["[-S!LW7ZUF[6, T0GE!CA]93]'$66(&+H
M'P9SH,KV "E?%:\76?0< ?_9-$;7NFP)XNV</[UD[V%C^)L?J?R9COR"(1WI
M,Y_XXZL<GCJV-'3B]3]HF@+CGF*%,,ZL>6@M3;@J@"'L=S*-":N7*9U^=E?A
M\^1,'%(N7?2E1&0 V:3Z^B7*P[9@2[HH>+R=J<U E#;GN^M+ "I5]+MJC#CQ
M@2&S^)_W"=N!]E QB\02'])'R?E83&48*7A#/ %>\@(.AR,=_8E5[,7B%:DG
M@G.=F)S5DO:9=DA5<2WE6S<&2L]CLO..4%(*9W5"^QP7;WH!ZVM!!LDI 9?7
M\74PP +?[U_'<TBI.4C5<W\HV96BK\HRRE7[FJO[MAC80 ==Q<-\WK+%ZEJ_
M?1WM\_)DOO$XZ8\*]ION]+4ED2WG77N<]H,F0.4G6=E:Z+XJ";I)_/8[LP;
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M[8CN [I<MN7GW $I+=*'5XBQY/"AN;+I(>,2 D1OF=XS4=SYGX/LC," B8[
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M@XZ\5KWN^'@/I^IBN_YYB;?W_%=.H9ZWZ1VR*PYO##B%_5-KEABJ+WI@1A0
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M!@\((B^&4FU$)'3?'L?Z'!%K!#WO.4U4S/[T+\MDJAOR(R-QZACCEBP('U>
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M#&.0H("Y-SM]*;)%!141!7,LK>&)'Z3GS(AJ5N'XILF5&S&)8[&((.(:"$Y
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MK"I?I\&DUZ[S%:;VO>O!+BR"3;R\]V8,6[.4;B#3>?92C>P&7KLP(^W *;=
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M\2\[?JYX:M/X8IA0'=?NHC\SSO;HJWC--83&JFN4;N6$^1X4GE.Q?)&D]1%
MG$Y)V>8$J[MB5.#_\%/?TAX'-NTKU_^K+JZW6+467?V%;!W(0FBM3E5VK=P
MUDNVG>;_@E$58.IYG7F-;<78R_UWL+K;9!O9_C '"8,O^RTTL. 9SXDQ0=^_
M[)MP0U7CLWO"2C_Q,'=*Z/_#>>MA3,K9=N3#GSWM3 2@16I&<]= C[)T@;M!
MAY&T2*:VRN-P@R$#N3V:]-^;=FNFKI/U@](]GW]9<9_Z)2).<__8<Q'$<&4-
MA"A)T]M!ZX/-2]GICVR?;'HKH1(\D_<*U\7<(;R=E)KNV0+9[G()JT5L+]NR
M9/I;]S?J8\/:^T_:;&K3G?/>ODAB6.0=KGM"K.@O0 <EH0Q^5+-9G?'JZZNC
M=JQ*,M= &?"@L_W88T2?+'7^IN=!N=/IAMS6C#>3(8^.PUR_,AD7;KVK?!?]
MWCW)V'['3_;KRLIU=!P\?'_[KR.">X-K %=Z\RS',GA6G/PW>/;V7CU[>H.Z
M=J_V;76%WI*\B$-FD,(;%X6_\8C?2\:ZI\Z43AB7[7X1IS)F34X8NOBC%I!Z
MT>SYKB!$Y+<4JEPKV_+T?QLHUCN?+=(!?7Q?I"/[\2/FY\+A\),-I U\TDRU
MT%QT]G@'A_;(=7MM#>'WC"L]!BS@_))W[(O4-"=>;[I%H<X:*-"J]NC]S,?'
M&Q_[SU))/3F3*Q%Q!OVK.!U^#_7J"$M%BBF/6LA.N]YA;N43XNIV!>Q'/46H
M05IJCJX'-CBD[9HT:6@0MJ)W77*^;C$R%P0LM+)X-JP$DW4=4J9)V@BL#C@W
M&WWQ.8%!NSRW.B*E F>5XG;YM4+8/X<1):WJY*MSR](%#-ZA1NC('UQ>05)J
MP>H8EB 8&.&Q/=):J3)FGCF,,\X>?:J6-92N*]D_)W"'=-'D>YBCM>CXT:9L
M=]/IMB,]4!2^I)Z0?,*;V$<M2?"<WW8XZL^&DQP"H$V?6:1NL5!H&X'L=-XB
M"N6?D=&]O>3Y2+<_FHTB0B+]?[FQ]V8J9VN&2U^.NHUJ1@=,YIT+7'WO=MM)
MW]$&.%6/:D'5(>#_K=3X;W=?1II(35=X%-^8*-V-$0/8W[O\V=YL,(/*9J:,
M.&89#B#70#+:;)&#Q7H^]\DNU):254O2?1$T[("\KR%8<:CS0&30;7L D4+@
MI'#IYR4+%R_WN'J3VB6$[FI1]]^P4V'.!(,4M92IW<10R@PH0J;/%MZ4?G3]
MB:WY;$&13YJ=TR0C[)5.6NK4_#P&163?("=]>%-785A/#!V C5'9CX8J?%FC
M>=)-?T(<L0;ZC380:2V.@[A1!T8$GMV<4F?);JS!%W^\PI!W:8M:5BE__97H
MI;EH]9_O6^X^G<N72S!$[)H^-$LZ93.LG1[\\-,:Z$;_^,;!OMGE:=+K_V%5
MA)\X^'U2>B)W'U]N_"B/3^=NY">P:0VT;>>UYBO0418Z72*C]"=?6MV-3+1*
M<@-D!=0W)\'ONOUM4&>OUMS;7T%.=;0DC<$$#5(H5X;WF(L8O\JCSP3QBEJH
M9,\HCKYL5;.<JLS<8_RV6P'5289UI3T5,GLIFI@DR!%]XQECBCKO$&86]=S0
M(2!K:%,WRV:F=@V4M+!4(3CRBU^@2Q#:HXJY--C-A9]8@8K?4H<KJ3P[VN -
MGW1(,RDAO>J!1&TJW&L4L.%=/"Q1!C8,?#LX0.Z\Y*U<CJ&V,.X\))(2S&"<
MU[WC'8PZ</O'5GM?^F !*D40NAS*#2NN86_<Z%[1S9T5X]N]*M[^O1C'?TT0
M,0>93H\("#-M5E?M#X#*(5?-OYE$))9XI3\>2RZ:#.J?49<9,K9_FRXSJ/IN
M'SJ"P_3*C[OO->!"#<&[L8!3&I)MED(]JSQ,4)NZ<3?5AQ3I</"0.V\-U)9"
M[1,A99/.)9IX(Y06IS,0JO4+6W(' T9T"/M<SD8[&[".!SZ=W&LXKEY*86U#
M^=M.EE"\*]Q.-=@B _22N@91:E6.XCM=8B=<&X'G5R!2Z!'$J01%2HXS,<F"
M<\##H.]-6FDM\NE20FD:V[[+.;=;<A03V'D4Q=V/FCZ8.T+=@5GWE6O_<FX+
M)!NZ!4-K!._$GLK#M+VWT.&QXD3[2P9U9R,YI"W(&L]H[*GB@>H5O44B^GQ-
M?8^AJN>X1TM>[Y=*"T>B8GI-7\!LO2-4;UPS]U"MM;-$KIX <Z7-]ZGI[M[R
MW^(@QMDM_)1V^KF(/7:CZ=YPMYA#N?;SUIKQUS7B#1P\ W][_;)<1>0I+L4/
M4\ \VX2OPU,AZA7\?-8(NCG.XM1[P%MHH970G'E=_Y;378]B3-F@73G@QZX>
M2<6T#&65C\C ;P_)#[>\@MNBM$J-'$/TUD YLR)*Z,'6Y&1KG:J5 '09@F?L
M#?X8R?T![1TE VN@O9L*V80!1(.%G#C%3/5W-.H6WR"'QB&T"#L.J]A@"N!!
MS2&65>%UAEI]SYV9LCH-C@Q*0LA #Q:NPV@)UE[PX'N..+:L@1)<]2C\-5 K
M+9II#I2/P"V_AU)W8\_P7:LX0QZ/$J@S?-?IH*HRQL"Y=7D5CPO#6[NWC%15
M5$7LR3W7^7E5E]Q3U(=F7<\IKT).!9Q)CR Y(SB5,8)N2,JRKU!7^0\[YW_=
M4#"L5*C]HU;Y&@B%_IIPM:).G$[UDI(_.7\OW[@A^OV,J^J: *+HPX(!7;<(
M:\ W"VD++YG5P[9W+1EVW>HG]H\%WS%4M8G>OF2',B7I""KZI]_4D\4!!^WL
M'7RD:,BQ #VU"NZ=FY$RS\WW] P(,K@A</FTKS>*J(?3D]#L"\]9>3QB31.V
MF2'>1 [L<%BX2N$MQ[]*S%&6>058CEW0/2@I6 -YR &'$F:<A;[>74S<#Q>^
M]GV<AD].I[Y^G7S-(Z8:D)S;>,O;/0S!IL7\W"7R]-Q@<6EB]4$7S":%.(Y$
M3O^1>[R_L!!%X08.^D[SX:$OD@L.(>M"!3-Y ].^M'9R0L6A_+\DX_T$%$K!
M..U'AR-G?,-YJKN:*ZLA78O8QM7A&:EYMK%^JM"*.?9Z.@WL'HY0QFH;'^]$
MR3N)+O:0:U61"G['71B8-FM>?K:?@8-153MDY3;+B3D95)7NF^<94#"E$M;7
M$I]=P()U>(>ZA7KK- 1X!B--K,PK^LC\=MF6NJXV@Q/G^1^B)IMM??* H JJ
MP>*BR:'Z?;"!(;U!%Y9Y&()E'_-AXE]DX@\BOIZ5R"P(\9(&BD(W3AE -TN4
M@ $>^MSA'9&\D9%X0C$F%;+->^!ZVB4>--8?%72:'Q2Y^#WNC'>-UF=B,<;Q
MPF_N/:)3<IF_)_=Z?&2FS5+P!'0??-?)PT7FIA:%DX!%T2S]NGB/A(;@!>%G
M^)S3>9,$\OA,.Q_"=LT^$2O5D JBP_1%_9@LY;@.-^'Y<2LZG@WB'WQ^2UG6
M,#^+HD.-!%<+O>_(?5L##4Q+9%370!LZQ06X)A2/*J "-B@2:R:>U0B6KPB6
MR &4T/)W%$*!%W@W%ZL17,)L*1T8X4WT'_!R"WVME=Z'G>HSU"7A:&$H9%#]
MXI10(_7:J&P??4&7@@Q@O;$I7'7>P!LZ*]M)[KHQ>*-EGV!YYX7RTV8*AY(.
M9Z<>;S]JGZN3F[OG^Y,B'45#\W_AS1$-B4EKH&$B]>WF&;/T$@*_1Q#)>X0S
MZVZ6,OJM9AM/ H_YUTM2ST<?)9F!V9&4=[Q/9<<ORD^WIEFH=']M.)+Q_6X9
M-04R*"/9,014<QK> )X"#4 A5W2X*T\>-B"R [X*<(9 >-?)W]-6@YK$\M\!
MA2:5)YIM9;IN-X"4@FI[VD_?Y T8\:OUW-%\2>%$U10W;_&QL;EK8H]KR1JH
M(\PB--!V2']T1/!4_'8-Y*//6&YNDFK.JC:$] GW5'AY>),GS! <F8P$N0DM
MT7L^@&A4NDUKQ"E4HDT"C7 J709%]@N?)9=71CU7RDI158&S:Z BU(J_2<ZS
MZTDVW6N@$FK85[L+_RJD>3UK#>2Y!F+D"A+$*5A[BH'XA<0(:P6<XJS[2/<#
M5)M74Q-O%A]I[2I6/_"EV_$+UM8]NUW)XN<>0U.MIU8_/_P4;PR=G!:8215_
MA04$4".3MN,8U$UUAOR.7R,_5-4!&;S"H[A]V,M.#S:-V/>9:1_$J0+Y*]3_
MC[WWCFIZV_;%HUM%1$6I DI40%2:(D4!B8J(B!A!Z4)4I,80D18A)%M1JH"
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M9 !73M /%+_<#P7M,C)]9W\I_L0 0;E*H(WC&CD1.M+L2+?F@E)NMA0MG1B
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M*-."^QRMCG:PREO$A91E>:9=TT/]J,N^S07.)9@^]/U+LH_=#Z)0E&ZB>B!
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MT:H'-!0-:^WS@?W8!E"LXA[.\H2&5FO6[MICX]]#L^WZ-%6>5D+V0D^?S,
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MS)@P\U)KI2L\X 9\0B3IJ<:&>=$W$@GB"#_L,_[\8!Y\5=C8A#92=/>EXT;
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M!^#T>3%FMUW?ED7YVG%DP;<#==TVPWI@B8<_?>,>%W5!TLX][#>Y(_<AQ_B
MMZ_9 2$AS"RJ?Z+].]F"K^A.!?DWS]:1PD-:&=>]_4]DF]B'ZSH5<><AD;[&
MEVYM/VJLM] O+/NT:BD(E7#*'JS.4P<-$\?&+":'I-Y&"O[6"NKWR/T1+-#C
MP0.O *\'4CWE0]65YQY!'VT/O:&E.169_Z9W;W&BJ8X/1J+$P.!-MJC WA2Y
M;\IY9Z8?P+=UH6M8%&F<H1N(J.RIF<L<3K@78= 4:_AKQL//4J(T>9/=0X?4
MAN\-:2KC:@90Y^?VJ!O*%?F%Z Y<F5'G++*=[N>^:/V_(7G_)_E/(<WNW#+>
M-D?D%^"N5;RPV5XK6L\A_4B<<-#F_FRF5!BN16<M];&:>X4CCFC[]<ZDN8_F
M8JJ"T^ZMU?,#RSLQ>2-\0)NV-H[G4D'W*?-9N >#?J_&5=6E]2_TT_2B:<19
MHGTX;<SSU:[GGNX6SV^,[K2PM]BVM6  *V]AT5PUY%LZUW/ZVD#%+=R;0=_-
MJ++%,A\ZV2UT=GAVEV7YPD_)=A<+H\T2]5VF.7939S8#-X\(S/]\F9&C+R6<
M#U# RADKMG\S=<_FG$__^+8/=Y[3F9)YS&^IW-?%:RE4Q%):7LGF9O<C;GKP
MMSB+U>BWB55+TS 9OS7_L8^;!TR4F7I/QLF[KC&!T7XQ\L)M&YJE8]X--47W
M4X;M[-[;ZG>KOY()E/WY9OB)96?G;BEL@Y71ZT-9GU'T^$U7"+C:(BKK'&-^
MC6C?"A1UE<B>7O+!UC%%Y@_GF1PC4$71F=;](D=:;]_I+[O!F]$5+IU*:-%;
M8($SLYYOWHM*LNM;="= S!>O9#WG X!1GN670_^E7*8Y\E3%_>S-]@WMISB5
M@M$YUR-,$8ZC?W(A\;%RYG?GQ'ZCV+=.)*?.2F<7LK.E/#:C[)J+8(TXT!'4
M)7QEQ'P]%3_2V&(%C7$!T[3PV\79A(Z+L=TZT9??>@:II8H[N>RROBM\0.W0
M1CE-KP 1C?S@5=1A4= XP@,Q%[_V"],1:(L"[$Q)PW+0>M:-JPY_G_*P9?W'
MS'IS=K:1,:.T35&XK.*2-U@,.SFXZGDG(1QQDJH7S>AX<$#QX6*[OH'&<(_2
MLX3J].R$,[$XX%-LF53>["+A S)<$.HK-[ 6UH2.OQ<:_.+K(D@Z%N*HY"/;
M_$HA&S49N5[^;6>R?AF"'7Y;^1AJ=Z_GD=%%O5+]3R>:LQ4)HFV+.V<H^S@B
M5-&M,UN 53@E*EVIC;4@T;W,!U3=R\$F+MAV2QC/]S6-+GQRM?Q^-R#@X>H(
M ;C.6@*C5I>FUYTX#;]M1G$7JL6,IR JQ^M)^_YVKZM/$6/.H1_A[H5]I#2B
M@<F%W%_@';C=OQH3=^E6*Y[EYBQS'3-U!%NX JGB2N,)=]3&9M:UFV#<$_]K
MXL^^A[N5Q1[N'@\U$ M!]1(VJKAI/&54*Y$MP^CMTKY/<$PIHJ9;:2(#P8A>
MFO7>Y@C:0??U5 +=H#DC,$"\?EEVC+9+.6)YGY]T% OUC0^P%E%K(O@V^'LT
M]#FD_2X!FT$-#2Q$F*Q]K:H&/^"G;A4C8MZZ=& !JEV&.1P<W&B8'FAJ]D#@
M&1)-'^PML;GAT)><,"TZ)W!5"K$_+J?#1J0%R=ZN*$I'YGYL/8YM08M9!U9Z
MF$#;,\6&/$[U\@&[FPM.GVYT?&:/$IV5V>>ZU*^*;4B$D-2TM$TDRFD+:&1S
MX2F[H'OSA%Z.(.,V;HUV"Y/<4D7MW3\WMI]0C9%@W[%M^K+*W<>2-[TT5+V>
M)MRH7K?/YL8K-[%SGI/19G"/L&_AGF,RB?J\)#Y X).*3+GYB -VR_-IH/;>
MO:1WF2<9\ZK=X7 R\8"118YRHDZ2)V$^4NN(B'*#"B>WE9YYT)?$-3]:@2$Q
MF_#:0^NRUX*6FLMUYPIYI1@KI7DA=:6S__V]*/\D_VD$N!,U7H"JZF. GFLV
MZ\&]WUM0XR,#4&[,R_>U%U;P\LJG+A-\GMC>B>C0.V$9))0J#)$V^+2F+0=V
MS..Y#C,#K#YV+YB?MDM:)G#X +FP$ ]&*8O,S>'MGQ[FR7Y!@'=BJ=V[VV5]
M8FA< TVDR*F?=C^7DUOSU$T/OA$N+;QCD 2JN7Z13K]M,SL1KQ<_"6W5+&_V
M6N7AL.O.R_A88'5 I_;S*E)6Y-B)QB&=.34$'=C&.N$THR!?^6M<KN=*AMXQ
MS06MY(#CX%G%>_B+WQ(E&VZ\*H"'Z907X"MHT%K,CQMYH\>RS_VOTV]'1X6H
M,C;:09"T4;FGEAT(NNGO=>CJEP;*O]4WX9L:7IC]:#X]^V.PFU!>D4IT2=67
M72L/-N5X[XF@>3H50^\5*Z\H98+;:TZ(BGE[OP")AL^/:G2U;DB]$]=/DBP
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MAQR7#R#<!"8V-G:G;W:7;JY/-C0UUZ<M+<P&>!VM;ZA/+LP,S&CV2/-RR0^
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M)# 9&#B.$2.;3KE>EJS.8L1YSQV21AZ.LW7!Y4=WV>V.UVDP.K%-,R3B1O5
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M>DNH(74GN.:>?F6?;ZTQ]CEG# <_?!DA[_/<Y;KN2A,P</;ZI?"&WH$81PN
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MNBS-)I.VQ5>AWO9.8?J^0I]0;==H2I5E$-U+C@M]$,A)US%+ZF*]3\6V# M
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MY320GBZ)8P&<\Y[BUOL5?LGJ[#6W^S6 BV #M09%Y ^"C@O[Z*#-(&H:7:<
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M54'$6K,D#TTEU6_U'(SX%:AS_NBUST6FY2UB U=C)QDK..HP"P"YKV8-[MB
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M,X2B<U #>FR_\8!&I]D=6.[LB/]R8;Z#WNX&E[S1CH" L_P71WGJU+2#@78
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M) T;SF>E_H'[K[IA+V^<F#BN'L]:F K0B1M1+,J+LXETD/==,6Y2 &VM82>
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MA>(BIC:16A^KF32/$9#3*YH7[K%,"-)F#&K.'_[:GC*1(LN;\+I Y,)<#0G
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M.@'=(O=J#;C4)6 TPF;O#_5-2PMQK90-KFDO>OX9L3<!8_MVN +TZ:"'M'+
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MOT#O0PI_I%GF:\Y$_K!']C^UC+6O?:%X'$!U;YA;Z&$@:3$_QPDE1!9?LGK
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M6C(M&%(J12.3 2TN_[LAW7D$%^6P'5YE&AE=O\?G>!<>&KP5*,A[LL3":;Q
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MOJZL+LC"HEOE0]S<V.+83[YS*ZNG$LS/%<V%IUS.2#"_;.,@$J>H-;^#I5:
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MR_!/*L0U=IO00?MZM@%>\H\ZDX 7RJCNV[SV1VBJ\[]SCC.D#HR[8; CBN)
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M.LU4\F..AG3VWI?Z#O?CG+P_-:W)U*$H;%(4\D=]*:[4,G/GPJ2%/)L-[W<
M77D7YRN:GHV ;&Q*:!PKSFH29$6KG_9I:;$^B)NH'JO$<"XI\IU)9O_RRA)B
M*2KL'\XI=&9@F'<5:2=BVU H^W7^D;YF,[IL Y),M?=A:4J!M/0Q^1A\KA4.
M'J"(O7?P8TI]2ZE.49/]*O&X-D%#ETP>95]=-<N.G<0ZF,UZ/YPI*7;/RAS
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M+>.H1< X;$C B559-,$).LB8<;N3+>B@MDKM\@T*>"II114E1-Q#![$!1J(
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M((24J*\[5Q JUK=\O/X#D&,U+YC^2-35W<\&9/1&R_9;A>(<P=E0&"!]Z1V
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M<EE(&DH->8EL2>*:T"W:X6HP/@"SY>V)_6H1;UIB7U++[<ICE.EB<MRSW6K
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MJ;!?_'&3HD%)N:#1+*YM30U*MN<:A--#LB)Q1#,(>0-,_ @N&:-Q&PL#XWD
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MX[R"I "Q*;3*CN'\XE$%WQ2+%YE1& -FO**-%]IR>)[X-1N5S'4B2ZN67*O
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MX6.@S/?@T3B8SZQ.,V%T,")497[T*%[>$Q9_X(9T:?D+6HQ)N>Y]D>Z;1;
MW?9P?IAA=CBRZ8U"52D.^RY!+]:6YEK8V'G38![8BY)RP>Q'29$5"5HO5^.(
MR]B]@[%Y5]DVXQY[)6GZ&SK<ORG! !FD+!^PO;!7E7-?Z\2$+KAW^6F!,TKR
MRSJ:Q\DG:EY0I2:S?T'0:%VCWB=K7J5S9/!VTV$A^[[5]%=W3NP7Q?+]VC<:
MX+5*+Z-QWEDOK5Q9@-<;+V0V_K'JQ-=!+J;K0(\"_;@\YK.NG/X%@O;;59&5
M_UU%M@[13/^(#P$V5+^KR++\H!,H:]]T 7?S41V.:-*QK0P78(#Z/XSC:/J+
ML.T/W]S$39G9\&UJWM.=4!JSWG[%:W$ _=G ^D*.>??&[QJRV^&;)61V5\H%
M*KB/*K_WB'SXNA=PA,R_<R'L"R*HZ;CW7/Y#W7N%^/P4FS-K[JOWG//AH\?%
MNL</]"WTG,PI6-AQ7%WS@7G9^7C8^<.5,Z:2&_KBO>.Y2\SY\69=U:K\:Y?'
M-3RTSV@\:AI74*O\^1@?G]L=OBT&B'H4O\G\T@/U2,[(H]C1$ U.DJZUK.#4
MLL0 + V1J>)$5<\MUB<<^ZDJSEG)2/>2R'[I(<.6J7-S+H$&-LI;?IDX['RC
MSJ!AWYCO+.:?:\&O6?<=1_\GYY>TE]\A?0 *FFUBF?AGJ]/_P+2H-ICVBOXC
M9E"=8(U49X">Y2%4X<'*-@#%CL).YV'^S'WCNP=*Z!WT_B^%,[1R'\SFY-2V
M-3)^K.*HMU&$2]?R[AIP.C _#JSQ,K-!2QI=6)0!,M_# +UBXH F([V252HP
M+K!(98"XR*?^?I9P*@R0$^9Q)7YQC:1M1O;(=0$//;2VFALL""6(=7_MFL"7
M!%P9-N!;-^.QL4VZ'T22]VS+CELEB=:\K=!?%H\P:=>]W0%S!A8N_FQINT7E
MXDK-?FI=/[B9.^$*7":I!'N)!Y5.+%D;]ZTG]4>*E?9X5KV#/R@0B(KA:SA7
M(7Q R/@*'8LZA+S1I:6$E"<"#0$GFJ(0Z"MA, IOP,R5OJ7P05BB=K0A9I%V
M@ST7,7HADS B4F$R]?E),4:/YCE'AVIRIY^L&ARD+N/R47IO.O_RS'E_:$=@
M/M#Y2&4)$A&38$XGV]-=XI]IZ@UJ1I%8QXH@U?P:JNHYF5RJ0J E']W^;B-2
MF&1*/YA!E&PJM+%%"!K93;A5R,V$EB1,XY$JW>=:8,E[+"I@(9.?-=Z5)#M>
M><(=_4+_P!5W5XA\<FE9E5M9%P-T3BFQV!;]IES>MLQ\K+([9]N$A-\4)T\0
MY:3S82:=$R3TDR6?%OGG&N#-Y$N?Z_I/Y TN)XEQNU0*OEE<6W:3G>J<C*U^
MV5L =F.&B[3]<L&];NM W@8914.XC.D'Z7H-N>AZI6N=AAR%9Q%389?/=%8J
M!.G=R'M>U9U(S\8Y8,.-2=AQZ&,-+U\-#]C:'+. 9NO^&$N2"U2<2_RU2_?I
M TG3LSIYV@<(ZC97A@^_RIM_4 -@/W8E^< R"C;*;XUAVSP#V+^1OO^K$G?0
MYQ#B+4QHWA:4LY:K?_BMOD@E^3'A-/<'O>C[%5^JY:+WN;:)<3<2G%/.'T96
MM1E<>A3I<F;5UHH!@BHX$''&O2QM!"TTJ8^)&$__QHGFG!6,#ZO6_HT,U2F'
MY=LU^'U.^&W.K/58R4X0UG]?X,LSO(I'Q=L;G)^9:4P*2_]OKL8F&\ZMT2#:
M^K*C5?G5B4 ?>OG!@E->^]_'K[B7X$'(Q 3Y%JF-X//XANB^.#0A:7L=\;%)
M Y+_ *^A^?P<9[EN3]ZM!.MXL[I3V_QS-:Y3V\KXZ<N;-BLT5'!8IU7"O]BG
MG;@B2(,[L7PSA&Q'\%WF'[J":3B+@-M&]8<CUJ%\HK,">'/U:Y/[7\E/]M*O
M6[=W=]9IC3Q/R<&>8K$%.FE&G19"?Q]"RM)[H$4=SQ@@YS$NIS+!ON(W"'@#
MZJBK%?00;!!A6 634OZ069"U/S_M"K'Y3?](Q,GW2Y$+QC5E<2-B9;7Z@_.#
M"VN&XW#JT2J"1##EPES<&+]GNPIE OM,A9Q1.J*RK-Y^M,EC8$1DMG+OV2N%
M+D<T&Y>':AXUF[Q]#!3E864O?ZH,PFAL';=4=O5#+C) X]&3WIB4W,IN>.V8
MK'P.)4WGXL7_:B#]^04ESH2#EL!7EUWV/ /T'+(^^1K_U>8?=]G_H(UC7_^)
M>?'9^!\:5;OE<?<^4&]M2L>-F;;_J73T)^JY0VJQ\B$Z$AA/@Q9WDAU(REJG
M$=Z?&L<[PE3C57UR]EJ[KD-/_()7:TQR_:B_L<Z%'>1W4!A1*><PR>/G+GP'
M\9\BSU[=L$W$_%IBEBD6MW5TL(.S-Z_;>GBH_<3FUA%]UNJB7)&.S(VF5I+1
MT3<MO-FM'UL+(JKVTH0HADAW.+JRN9Y+8&S_28DN+>Y9U!%2PNKSZVT$5X%&
ME%+*],Y0-/IP;B:S2\B[;!$Y2J##?L+-IL?D4W'JP(ONS@(&:(86T-S><UUT
MCFM@#_T:?#R+AK:"TI\J Z9\N\.*;U>=O+]?K +2N%*@_C$1N_F4G#QQ^M01
M9[L&#]C@"1CFC"97PQPX1&D(8>SY-MA$\"Y=7J55I^U.#7+-NG%$\FOY^ED_
ME>I^<SSP%H/&3VPMJ1*7";[5R:J-\>:V>WN**'O#":\X4Z+S&@+[4\2->'S&
M7K2Q+]8O>IUDQG?CH&$O"@"& 0.4'$DN>;SC$#FF<:=JV\\\<%T8VJ 6\X0W
M7%BP;M*D<M#B<<WK,J]KN/.VG(!(B@1I?P9AC ?QM-'J4].D.4FN_ WYZ<U?
MHZ]6!A4&:+WVE9(Q1&X)\'!O3*>R^ZPR0) O;U@;SZ$Z3O=1$:S=[]ICF&-(
M3QRI=PJ7E$Z5_R*G?."KT]ZW7#SD6#<E&\'CJAA98<\5LKZ7D._951VOS#I2
M)FFZD;:?9?_QD:6BB&NCXO)__$X/^^HQR4:-Q89!-DV0K*T)N2Q;KUWQL<B'
MV#>X>_+;:IBGP.99%_!.).RF)B:-&L0R981DS4OO>?CO^;TB<:=G(B82>/3M
M]2(MTB]T5C\X;A^I/W"E4BVY("+601(-;80/C6U*=R*E,UP@)U#<<]?GK(SR
M6N312(&L"X7.@Y[F"B^U3A-I)0A#H=,ST:=+(T1&E4M*(DVR!_1@SIQ?8=>]
MG9%EU-#HRB'B0M;<#OA%B5G3*6@%0+P"X>L B),$]).O+UK 04AH.FRSM5GB
M6+5U>OM]DL3MHL89Q#6#.,V0)Y997CX^,;MCJT_OD%"\%\V5?)MF\UV23<N
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MGB(12C]TBZ()U'%/)D$C; 4+[8D=#89E9:0;%R+O=5$?16FL^$A^Y#FM8>K
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MZ_TK@C=I6GUSLCP/UOSB$KQDDN<+&FBDVY=%[N<>C_V./66+![CC/*2TI8E
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M0+Y+P!<>=K,B?O:;H&O6TEDLY"6ZM5^8L!SDYTO8OQ_CO25NNF5)Y\I,[-(
M5'.6-?=W$V1?JJB*F#\PDL0C_U%:78U\4LVA?3>:T1<?5&.@T=>VL><3:9 ^
M]YE/A41W3]_K>FP3=,S9H;JEQZ"J64$?<BLE>1XUM@G:<R,]YR7 2OZ);@\
MH[1!*K -S\@*:RZ4B$S+>KL^&"0K.V+ESKF7UC[Z7W*]!/1P2><G(X3RLQK
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MLIR)\0-_QL^C:!J0CY!PE7ZJ9L8KGSW-J0YDL:=97^N'NB5$=YJ2!C _;6#
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MK6\.OHO9#:[ -\D-[%@H$[^/V$D_YWA;<YC!O602?^LY>! =ZF6KY^L5M_/
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MD0R)EOD75%R,=2"[WWA '@9OQ\A]5;V\1M<_8:CR9MVH.Y<GCKMT!O]0C%,
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MG0]WX*X3F3M6R.Q46LE]SJI4[H2G^RM<S8'G#]="X$F1ES)"Q7M4#Z:Y O9
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MRUY:86?'_;N=L@U8J">1J*AP=H*RL,042M<_A5>9_5/]MX;^!5!+ P04
M"  D0ZA8SJ8H^VOF  #%% D %0   '9R=',M,C R-# S,S%?;&%B+GAM;.2]
M>W/C.)(O^O]^"MS9B+W=$<8T'^!K]G'"78\Y=:*ZRK?*TW,V.FXH\'1Q1R8]
M).4N[Z>_ $E)E"R1  32GG-GMZM<,HG,_$&92 #Y^+?_\?U^#1YY5>=E\>]_
M\/_H_0'P@I8L+^[^_0]_N7T/TS_\C__XIW_ZM_\+PO_]\Y>/X&U)-_>\:,";
MBN.&,_![WGP#S3<._EI6?\L?,;A9XT:4U3V$_]&^]J9\>*KRNV\-"+P ;1_;
M_K;Z4Y3X+$J\!(8!"R%B7@")\'U(,T:CD&$4Q=G5W9]$3*(H21.8R/]!%%,$
M,0I2R#U$8QHBSV=^.^@Z+_[V)_4'P34'4KRB;O_Y[W_XUC0/?_KII]]___V/
MWTFU_F-9W?T4>%[XT_;I/_2/?W_V_.]A^[2?9=E/[6]WC];YJ0?EL/Y/__N7
MCU_I-WZ/85[4#2ZH(E#G?ZK;#S^6%#<MZI-\@;-/J'_![6-0?03] (;^'[_7
M[ __\4\ ='!4Y9I_X0*HO__RY<-9DME/ZHF?"GZGYO:&5WG)OC:X:CYBPM>2
M^W:TYNF!__L?ZOS^8<VWGWVKN#@][+JJ#D957&:*2S]67/[S.6(_7<"^(WZ;
MY[PZ8*X5]Y,K'L<P_>2,W5MI(?C\# _(7,QR]X5Z5["EOKL[4A>S/C_'KKX6
M98/7"WPM]F0&+*_5!Q_E3ST9-="(,6WI]*9[P"K_WO""\<Y:'@P-<O;O?Y _
MK38UO,/X8?6%/^ GM?C5G\5GN>15;SEI5B@A//,B!G$6I1!1$4,2$@Q)'*#0
M2^12%O'5$/85+^!?OFZY:$EIT/F#CI237Z.*U^6FHMU*)VFK5;YCYS]N>IJ@
M+  IJZK\7?H -2!/X,V'FW_[:<^L+5#KF87?3K&1U'MRH!2@)0@4Q;,"E_1@
MZ+5:Q<OJ6*"2Z@FT5XU:2M1*(W!-6I'Z :1H0?@37S?U]A.H/FGU8YS&3\]F
MZKK:<H\K.@%F_\1/M)2.RT,##W 557EO(&93&DQR!ZPD_P=05HQ7TBT](<KN
M2U=7S>I-6=3E.F?J6_^N:/(FY_7U][Q>I=(KS"@)(4ZE7XD\ZD-,,8&))Y"'
M>"*B+%LUNU7G[+=SC(C)E[,YLXZ.?$.'9,&6+OA-4?Y_]=1R%*%QK70EMYE2
M6HFLK9@Z,HWII7Q_H)/R7WM]'!UZ$774$6ZKC5K/FBGC5L&_-B7]V_7#0\5I
MWNYROJ@=8/WU^LO77_@]X96.TFD/-K,&MO3!D '0<0!^D#S4/YHMCM/0Z"V4
M3E$QT\\I0,!O'0<.E-586D<KZC2]15=7;?&/5UK]%^T476XQ/Q2TO.<?R[J^
M;IHJ)YL&DS6_+3])T<JBD6+*]^\^%%+S>-VL$A32E+($AE[J0Y3Z<G$6J73Y
M?0^G(?<R'$9F_K(Q#[/[TH=D0=[3K<TLA3FV 0]X',<>Y&E (4+R)\S2%*99
MY'L)(VGL)ZMG>^U7 ?"Y$X97B+*>?9X'-"M[+5D!'2_@!\7-CV#(#VA*< 3E
MEB5W]ML:#4?VW)S^HO;=&IYC>V\_D)G]YY2M;O#3K_4-K]1IOSK=?IO7=%W6
MFXI_S O^H>'W4]L+S5'FTPQ)'#S68$ >[.F#WQ0'H&7!@2MC*.R)+W[-Z1_O
MRL>?Y$C]=YZR_5===_Q%OMB&PFZ_QJ:OF1\5?)'3SWM'FS(O\T5&8!)Y&"(:
M^Q CE,$@#.+V] XA3_=T8##N[-L1Z<C534[Q&OS"L0*FO9'[[6UYC_/"X%!@
MB,7T.8"EA*9;"TOAC+;_)T2Y8,<_'&VQ3?X)$8;[^E._MO/PE=)]%F\JSO+F
M/:;Y.F^>?L'?\_O-_<_;8^(W^$'^IGE:>6D2Q#[C$),PA8B(%!+EBO($I8)%
M/ @B8;+U-R$^L]KU9/=GXX#VA,W\32,\]5S-N5 R4]UVL2P%Z/@ 6T:NP!:Y
M'2_@S11RQOZE#02.7$LCTHMZE3:@'#N45F/861KIN%;2Y/.WO/O[0_'Y@5=R
M/6@IY U>7Y.ZJ3!M5DD81H*&"$8B\2"*? $SGL00B=B+!4-QD!C9&7W2<Y_V
M?U.&NY:;65!N.0"XKGE3 UPPL,XQ47.0\_I/9G;' %T]JS,/9F8V9\L#^&'+
MQ8\*NATCH.<$_+;EQ>&9I#D CBR. >%%[8TY(,?6QF($\WWK7PI6K9_NOG*Z
MJ90U^UMS4^64O_E6W-W(;[^&V9@>968S(8ES25U]P[<,R&6V^AMO0,L%Z.R(
MGH70P&1Z&^\.#C,+H(G$E=KC4[F3<+./UY/6:@L_,?1BNW<]$8<;=\TW[)R#
M+YQQ?J].LDZ?8[W[^T;25$_=/ZA[CE_Q>L-7)/;C2'@IQ-27?D(6X2YJ5$0T
M08BB)(OIZN$H]% C1L6"%Q,5..9(6QM^QNOV$ LW@/"[O"B47DB?O!O0-(K'
M!G'&0QS$,8$L(0E$TE&#.$PXC ,OE7M 3+($]XAO ^9>"]ZG8P7UT.;2-UL4
M9ST?;7;DS(SUGIUS-PY7H&/I"NR9 BU7+B.R+@#%6<26#0\+1W1= -/SB*]+
M!K-;,M[CO&K'&1PD_C5OOOVE*$G-JT?%S8?B8=/47[C"1.ZKNBMRM8!5DKF?
M<9W7UVKS]16O>;UBB"4QEPM)G!(?(A][D-" PR!$W,-^%'II8'&]ZIK/96Y?
M6U)FEL[YA.@9P1?!U\H^*DX[:W=U</K=)MD,V04=O^"0864T>Y9!R_,5:+F^
M N.396Q!YT+4D7%USMZB=G<N<(]-\FQT+$,&O^&*RR$Y>U/>/_"B;HE=5Y7:
MOK6QPC\_[9_IH]6O?\<5:_^XE52O"W8C]>D3ON?==='*BTDH/!+ *(H01%&:
MPBQ(4DB")(@C%"9A$AB%(L[ Y,Q'!2UAH"@;WA#..C%ZEONEX3:SWB9(FP=
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M)RGS0Z*5E&Y)?^[X"%4H1>U(\ET@FUV+35-8]4S@C&"9F;LM(T!I2UN]J W
M&H1![$O\[OEQ9]4L@7!DP4RI+VJM+*$YMDRVP[SXZ5I7'")E&0]0$D$:>!0B
M&E*8(AQ#Y,<\Q)0''K%(M'?-IHF"OHJ:H^[GR<<^0YX'(RZD.^Y%'!*/"A@%
M*0Y9C/TP2$USY5]^EEZH4JGSV5G\@'/F^BPSG6BZ+H Z%Z"O[[CR!<JFS@7N
MC >2+FK<?"J+7<.*;H_Q[KNZE>0K%OLIB40(HR212Z4((IB2V(-IF(HP%FG&
M(J:3##9)R<AW-\\$NU6O@++=B.?]UIMWE.7NN^"&69SG =.SBDY@,#-O0Y*[
MTX>>ZOEB*N:](J<D<]43\BR=97L_3HG[K,?CY MV*ORFO+_/NSVIBD1N Y[N
MN+0<<O_HT3BA(1<PR%*IQ%F&829]7$@SG'I>1@EGH<FV?(36S%OP >4VZNN
M-OCA4]EPX"/#VD!CT.FILR- S!1Z% MW"JTAFR.5'J.TJ%)KB'RLUCJOF-\.
M?BCJ7#[9)Q3<E.M<#:AVWQ\-FK1JC#+?M[0GOLV, 5OR[5>V/4=@TO^I9VC7
M:B"VU36;SOB+7;L9"#N\AC-YS>)R>[/FOD<B_[J2).Z+AIF$+9Y^>^XK;I7_
MIJA"_Z".V6U_ <PU=]TCXFM<=%\LN>%=]Z303F,2Q\6SN_(^/>1RM]ZC(AU<
M?(\_:5ED)Z_QW5VE+G_E)O&S^,(?>;$9=/(.>!)D##,8$^&K:CL1)#$-(8U)
M'(N 8<1]HVH[$P1GUM)#\NI$K&= ;QFQPU#/%72)C)D67PB*>=$>34E=5>^9
M(K=L&1]-X9_5\]%][[)0LI+7<B_T124T55P=(3WRZFF?:&T1838^XH*!9TQR
M HJR 57'"]@R8Q=^-H&4QF(]"TB&"_@P6$WA([D 7X[P<5R[RT[VBP/:)LB\
M2)R;GNCGPM\TW[8MD7-</D.=D9PJ0,<C[O,DR2!-,P11D,0P\^1,(!\%.$A#
MD7%L5B9'D_+,MJ.OPM!&R& ZGOEW(81Z'L(LP)C9BVWYFUDJ4!C+YZP(CB[=
MA0OA&,+QO!B.Z0!VIN+CB6;Q>^\WBU#D^51 DA%/&H400YS1#*9A0N3_I4E&
MC<S#*+6934+K#DO_^%EU!>O-PSAV>G;!&2)FMN B,(R-@Y:0C@S".*U%C8"6
MV,>*K_>2G;)W5T^W^/NI=2SF?H:"E,(D$1PBCV6J JA4?<21B(6?^(%1W8@Q
M8C.K>G_1*6F;EJ\:14A/HUW);7KBOA5Y_L*].A(ZTN914HLJLX[0Q[JL]8ZE
MB[\A\O'NG%85).LK'"$41+['?1CPF*GBO0$D$<4P9DF""1(\RLS*7IXD,[/Z
M#HD"\V+;9Z#1]-,O%MA,;Y_).D.UIW&97#GBIXDLZW6/"OK,Q1Y_VDXO?\55
MWL5Q]5VRB^; *^1"A%&2I#!!J530C'*81D1 01D-PXPA/Z8F"CI!;V9-W5+?
MEU;NZ%_@5$\!J*?&#F$QT^?+$#%6;4TY'>GX%+5%E5U3]&.MUWW-.J92LM](
M.=9MJ%='8U=!&:$TXUBNQUZ0$HA"N3QG$>?0PWX293AC:<A,M'^<W,S*?TA\
M_X6W+4(]@9V>XKM#Q$SO+P##)MI20T9W(9=CQ):.N]00_$3PI<Y;=@K_2UZ4
M5=L#K!NV+?*[2J/,2R*,8<J3!*+43R F"84Q2E&<Q%Z:9JF)GI^D\E+JW1(W
MU.W3,.FI],7".]+D";F-U7A4+D?:>YK&HDH[*N:QKHX_;*>B/V]JN;K7]37]
M^R:O<W49M'<GO9!Y4>JU=X\4HA@QN6'&"93K<1IG)$OE(FVBJ6/$9E;8+6DP
MH'V!(SX*FY[FN@+#3('M<3!681T!'6GR**E%%5I'Z&.]UGKGU;;J_BO/[[[)
MOZ\?>87O^/-NXU_D8O&^K-2HJRP301;*9=^33H JAR"] ((2R+THB>5'64@B
MHR.XUR7?S$9LRPKH>0$M,__RSW[L_6M;@TGQU/W3H(#H*\7R];2-GNL;8'@8
M^A+-I4]_X\#NR[:MSSI'UZ#7.;'_.-VJC:3[/ZVGM<W4OD#G:RLV+ZP9TG5A
MN2[8QQP3=86>\[I/NF:?]_G4\@')9G607MWM3,,T#+R49Q")4/V!."0LBB )
MB!=%<4)I%)LLXLXXFWGY'99#V%<V4%E;0W;LS@#<S8[>LODBF)LM>([@MB\G
MX0H:UW4D+N;K90I(N(+S;.4(9P0L2\-U*T!;1KU/=FWD3VTZ(>XV=1U;3^_S
M A?TL**9\(7G99S"K.W$R7T&TYABR%%" A$&$?;IMM#FK4&]N$N8TM+MPSJ;
MM^9F=>NDE@+0'8_JQSV3AL7D+IH(/?LY/ZYVA>9Z++L^"CLP#S@#.]:NP(ZY
M><K.N0#)51&ZBWA9MB2="]B>%:AS,NA%EK'^+-[* 1DO6*VJ Y1%&\B]BK*$
MHY0*B%4Q'819 C'V!*0AP@B'F'O$L)?#.$$+LV9FT3I:H%;$ -MR !YP;EBA
M; (X(U-U"1B7V**V/NCG-I:H>@([%E0+JA:EE@OG-F="6K=&Y1RQE[ :$X*?
M,0M3;UEV\,.5JIY8W_"JW2B_S=<;J4PKG/@>C834<"ZDP@>^@)GZ(TXB+Z4!
M91$+C+KPG:8S\W9P2[6O6*U*$':';__RSVG@!__:<P%^R O Y#8>5W7[3*V>
M,2S(<PY)/0O@ !\SU=]!<[/%Y KT1!WVF!N7RE6?N#-4ENWU-B[JLWYM$X];
MWB7US; _BP_[:L_=F4/@T33%?@0IR:1"IURHT*T0REU,(E 2Q#XW:K9[GM3,
M.CUL^#T@;7>F,P*8YMV&$Q@,KQDL$3 _WY\4SM51^WE"RYYZ3PK\[ !Z^@TS
M57ZLFOI,D.=-E=]+!^UG7G"1TUS^^$:M6?(1O,[_6WK )2X^DW7>E6GHTP9H
M$!'IKF=RY18$(DXRF/DI@A[QDXAQSGT_T]%[QWS-;"3>?/RLF3GE&N]QL_&"
M*)K9F'-QX%>@YQ,,&%4;A2&K0/$*]LQ.YX3,.B6LI.T=3_O9:YR: P9?ZQ1I
MKQXS =DM-6IPM7X@+PS]=@UQ36Z1!6<FC+:KTUS#F]?WN>%E6\587<]>WS>Z
M17R.7IMYM;AY]QETM98/HS;NRTVAF;QW2M;QI>!",0T/>JPD-"JK<T86J]HY
MQV,M5B#GC!##*CCG'C'7C;Z Y755_?STH6#=MD-304Z].[.6;(NA#J(KZBL5
MSB3IJX.I#5[KZ\I)V:<5YE*QS;1&0V)WFZXI\:P4Z>2 BVG3F#A#E1I][L)0
MFJXA0=?RM/<'?9)B''L^]'W!U-DFAY@A!"/L17)_)-(H-:H*,T)K9I5L2771
MI.=;#1OCHW?RX4AJ,XT<!IQT=*^VK99G2#S7$-%UX,@)2B\3"G)>Y+/!'2.O
MV"GQ;=6&ACRU%QW]G8<Z+*U7(6*)2$(!,R^)57P;@5F4$)@D*!"91W$0&?7L
M.TMI]C6UH]M=1%YU%P]U>Q_1_6AX"7$>L1AG<:B"5VB4J?9A(H,8)0*&Q.,H
MQA'Q0]^\?9@3W&;J W8%F@-TYT U];"7I$$$O2P,Y5)"!4P]A.5Z0I(D89$7
MLM"TV9=#3)UU[5H"2[UEQPDZIFY@+_K73DD[JE?=K9G#6)Q)T1PM-N?I++K4
M3(I[O-!,OW!!$^ZS+6YV"?PXPKZ79!%,?'4ESJ368Y(RB!,>1812EB5&;J,>
MV9D7H"ZY1+NSTB7XZ>FW>U3,E+T#9+3OU"RY-&9RNVQ</4UT^=[4VD"<;#^M
M_[:9P6 \W^Y5OS[=DW*]4IZF'Q,?!J'T/A'CJK:HGTH_-$E1XB>"Q%K)DL]&
M7N@LIR.FI^[/I1_7Z(MDLCNHF1!'6RG/LCYR""/?Z51._K#7M.<C+:),9P78
MZLOY!RZ+'[TMVQ3IBG<)5K_PYEO)!E?CJY#C+)#>,?0]+%=1HDH(A6D,/9PD
M7I)$*0YCNTC2*=):7[]+8DIOY.??<-W&9? NC_.^96+0>]TNN'025;VUU2E2
MEP6<-B7H>=BFO'9<# -:W$><Z@KN./9TDNR+1*'J@G$N'E7[??.;$;F W_#R
M$R^O'^_:>Q;:;/!Z_72#<V9PBS@QS,QKK*0.U;W;)_G?-C?[\/:M9P<H?HQO
M&Z<PFKY,<0B/F15PBXS1#8NFS%:7+5-C+W;OHBGD\ I&]Q7;PMU;J]"YX[LB
M9@7;QK2O>!!E29R%D%'E& B"81:C&*8T8TG"!/43H[HC&C1G-@"[N!R5$+O-
M,>D;.9N6]9[&+PTX$EX2P3B+L72L4@YQBE.(*$<X) D+)'Y2V4CY0@@.:9MC
M.!=L>IZ38RC,S.6>>'\4<04.OEI;#EQ62-<6UUFA]&F*"]=+UX;@>=ET_5<O
MM:?U[O9M7Z-]Q0(>(S\64.ZN&$0I(Q"'+(4QST(>\8 )SZCZPSBYV:WH](;
M!B13Q;]4=%N=KZ^&97SVM.?0]C$9G2OZ26(OI.-C@I]7[]&W+ LP\]YHJ(0U
MHU+*PQ?GWMGP9G<HWB;6&19*/I!13P^MQ3/<F6A+9E[U^)0$KHH<'XR];$WC
M4V(]*V%\\B'+ML&<-%]599"^>$@;LN31.$:<1S 5::)"NBC$//-A2.(D8UZ4
MA;'1BG>*R,Q*U3;/R&T7NY.HZ*G6I;*::5@KYI[<#%%;8_*X:NM[BL2RK7Q'
MA'S6OG?L66?9:5_X0UFI&[?NGW*5+->/70VV;:[!>OM&W1WIK'! @RP),4RQ
MK^J,!P*F:1A#$6.<X"06%/%5HZ*MQ]76+5M&BKYC3O^RJHW#WU/?;>8NSUBS
MF8-Q(_%RR)J9E?/)4#LVMYU,!HQ>G9R&*Z.S6,?3<7&RVLS3XCI7;8;I<9&I
M=@&*%HEJ-M1>.D_M H0TTM0N&?W"C(']7JX>-+Y)XL!''(:Q%T.$@@SBP"/0
MQP)[OL<B:A9O/$9L9C_SY&%";=WU9A0V/0?4%1AF*X8]#O9Y!","NDXD.$7J
M93()1H0^FTHP]H[Y=?*;;RI]B]UP7OVY*C</[XM]4U3-J^21(6;6UYXR4*1!
M2_L*O"_+IB@;S>N0*0C&M=2A]&8*.B:XX\ZPFC):W0J/C;O8C;"&<,/;8)W'
M+=2P_,K7G#:<]25?/^%[[837DR_/K7KE_0,NGL"6,NA) T7;0/=.RJVA=9>*
M;*AO5M*:Z=B81';:=7+$Y?1J3* #C1I]T,YC'=10OBY8FQ7QK5S+]^LN(FOG
MAF51ZB,A0NCAF$ 4)1ABU2D*9TS0#(<>RXR:1.D2GED]!VRT]^ =<3/W51M#
M/5=V#F3,M/@T*+.XM:;".G)QM<DNZNZ:@G'L^AJ_;UDA4 TL-]=]J#)[NU$%
MUF_:)+_6\UYE'(<TQ!%D/I'&@D8>Q)$T&QY!B:]BLQ+/K 7[%,69K41+'U1[
M!@!K.=AE-CY:]&&:1%'/7#C%QLQ.=+ ,:(...+CI81EO3V5>2U!75%<E!2?I
M+5M94%?\9P4&M5^\P""<7O($3V,:I1Q2A$*(5&PAH9&0?X1QFH0$B\C<$KR$
MH]"O@;AIJIQLFO8@NBG!KWG5;.I!Q@&XP553R/%5@!W]XY\LC,(ESL-+N L=
MG2MP?82-1$(!,DO7L*4<A=?B&I@[ _,M_[MRI<<%B%6/%=I&*+:%B-L://LC
M(H\%W)?;!!B&*J0X\N4.PJ?21_!X%DM+@!&VK!YLQ,?<KL*@L*[:#6^Z6R[U
MSY:M/MJVJQG^O("V;>EALZG0M"7S VSH;PRP/55[_#G 764MX/2@SQ$\SLL>
MFW'Q0C61K: Z7S#9;KB%F^RV?_PJ_8.=T^6OTE3PD 8I%)$JI4Z"!!+AAS @
M/(J3,*6(&UT&NF1N9@O9$^OW3@LUKSTU!YI6\(60-32-E[>-;?\"V]FY&9^=
MY?J\CL#XTDU:3['VC]%A=0149^U1QVB87_R\^\[IILD?^1O<\+NR>KK^GFL%
MMY]]>>X-XY8FV!+5W N>EW;ZNN=B00UW?L]DE+L]2='1=>JH-%97/:='7.RJ
M9U2@X57/^(,6\;:?WO^O_1E%>Q_;QW<''/L!HAXDOI"[,DQ2Z8@0!OW4C[,(
M)WZ4,NW>#N>HS*QJDNSP!*8E;!!X>1:;<7US)K&9SIT2UJ8YPEFI#:)'74AO
M%PQJ-.5FP9Q30HW&9IY]>;E0RRG^#R(G)Q^V3["1V[#NW&F?-_"%=PT"_HSS
MHDW<XIRQT,,8>HG'(8H"!#,_PI!QC$2:(<I\:IISHT%W9GNT)0=^6$MBO/X1
MW$G"-9#N>--7F:IWO)GGZ.@ J[>WF0$N,V/69O(,KICW/*BH[AY%Q8;S5#I#
MT1TF_>A073P/R "*4ZE!)J]?&%K=M?\^T?"[[?#]EZ(D-:\>NVCPATTC?RU1
MR-=YN[[LCT!1DI$@00PR3]H;Q% &29AQF'*<\304.!-VT=AN^%OPE/J0 _5)
M)T)W@EW4Y3IGJI 9^/J@_B6%.KCNJDJVH?+I]V6U*Z-^D'D^%+DON [^HLX?
MFA*\Y9+Y^[S@@_QTR]AQ1]\+/</Y@K-M9F"'Q>[[:=TRJY:C';OMV?G)R3K^
M?LQYI#X3K*[CXAUQ]S*A]&ZA/1M][YC,PD?VW6+VH:B;:M,U3E8U86^_X>+S
M@QJB_E2V)HZS+^5Z+4V?>FGE^R),0R^&E&/IS:99 E-$,/21GR4I$U&&M?HD
MO@S[<V_2-VI?(1>5KM?(1.'SUS"=,]\/S#Y)B]\@]$[\0"30E<)NOJE&@9U4
M5V GE_QQ^Z7H"^&#WY2LH!?6Y67MB\S22U]0V#'_CW&%<='$.+ODN(P+BX/<
M=ORN$(K<= F^*]01!D)$"4V@)P($D0ACB(-00)((PD./1U0OYG:4RLQK1&<M
MNC)][;& HFQPIGD6'(V37!<BFUG<@[X)U[VT-D>Y9\4V.,IU(;[=4:XE#&:'
MNE/BC1[JGGUYN4/=*?X/#G4G'W;7#\_?M@C'V$\H0]#CW(=(>KLP35$"8YJQ
M.//#U$-&Q9-&:,UL@P;]\/S+^^'Y1F64'$EM?T1PV _/7Z@?GC]+@:4Q2B_>
M#\\?+[>D\XIY#(5%RNQRB;)F^;!F6;"+Y+ZZ3W5UE>#Z(FFM$\FLEZ>PJE&D
M0WU7%ER='CWR2C5^-?ERGW[[57W/SP@X_96_7#;#5:2C![8$KX8-CMVIQ+A8
M5MIQ9LC%%&5<I*'.3#QIY]7]N2S9[_EZO4J2V(^"-(2^W"Q"%(L,9FHK28,H
MR@2+$[F[-''AM@//K$];,F:^VDYJ/<?,1A8S_9D4P]C3.N;9D5NU&W91'^I8
MF&.'Z=GO;3,9<=.>]W3G.NHP2"I<T=1M_&7F>02A0"4O!12B(. PRR(, X[#
MA,8IRH+0+)EQA-K,:M.?U>YI3D5N6N"E>8#N"@4SA3,&P"))44,P9WF*8[06
M3E74$/MYMJ+.2[8MP'%1"ZDBJB@"KQYSFA=WG\7[O,!%5P-P=WI[*RG4IW_U
MMKS'>;$*4!JR$ N((RX-04(]F)'4AX'/4I8Q%HO4J(.K2^9F-AD[P@<W/+]U
MM T-A],YT;,S+X6TH1]M![)%HVCW:#CK+>V0M87;4;L']7D'ZQEHF.^\KQG+
MU3$_7B,O>-S76C2NBC@YT,Q6;4\?2 9^>/Q1IS^*!1S36W:G2)A9G3$09JB3
MJ"VIU89^>O3%]O;:@@ZW^?HO+1P5U45K?!9=K,;U(\[7*H#K?5G]6;[;K%(4
M)#RD*?23,(0H0Q1FJ:KXDF6A[W$?A>DR\4\3C,YL4?I0EE( 6M[?EP6HVSI)
M>,L&$&4%\KK>2*O,P0^Y?*!]P[ %SFS3J+EM>P638V;D'$0X/8M7NCZ8U%:
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ML_N\R%6WR3:FM6"MF>F:478Y2_S]ODJ9:@=-P\"'@J ,(B]+U2XZA7$6!UG
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M%O!4L]$S3UK<4[RI.,N;Z[N*MTYO?U(1<R'25-HX&A$AM2V6^S:""$RXX*G
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M2&0:QZ#I?^:D/9\TCB>-.!W$TM>@F0/RHQ>8XS$8OO*'9@1UG#B%G8.*/\W
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M.XYF0FD-=8P@S0E\ LF8&L<-VX-R8/;M0B]6LTD,I+UJ1,G8^I-/*C$0]MS
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M$AS+,HWC/$XCF3I&9IVH3N4 <O3N@[HE;D>P-F/4]P #]9)O&' .*T3%9A[
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M%A!5S\ZY/RX5\2TCZ)F^F _8@FEQW&5ZTPW,$?:GD:(=#ZAC BDN]$@?I/A
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MIPNKA3IO[_"[Z8XCF,$#E&SF ORH#N84M-8T$^BAK[6_;;6VXP7=7M8:V%7
M%>#(>0 (3^I.X HY=C 6*UQ7YKV4'ZM%M1:_Z+.).L^H7ZY*>;8VBOQQLU8'
MFMLG#2;VK^9\WH&S'VV9/ ^2J R9<DIAB$G!(UQ&>8&IKODF22"3%#0XP25S
M$YY%/JS6U5,3">ASA3JVVM/*5H9M.NBW#6-"-/" &ET#VN;L\BL:EK2\TK<!
M5J7T/DO+)VX8/?T"-ZAE]OPWFZ)HW*4F'5>0.V'M5<K)72IUJ+;<*8TKT>'>
MS>EJ=2^;L/3M]VHURWD@:91)S#*N#HJE!L&-\PR+B!2,!$E,"*CL?)"2[X2:
M)J?-N,V!_*%)VN+&G2C)T.6Y$!V8+P-);8\H-R21:W"Y$SJO@S,W).X@Y-S@
M"W 0AP]UTWJB$^[?1/W28A@:(CJ<>]>SW2F2RX58;E;SE[9.\[B^<\N,.?[#
M60V,FZ +X6&69RRW.YS'2T):X4F<77 R<(DQ<?I($Z//6093J-YX[V5W9UHN
M5K,D#HHB93DN4UY@$A0A5ONAP#2.HS@,J$PS4$_J*0G/QGA??Z&+[=E4)RVV
MTV&!(9!3U1B&.JX2&!C2:&CIO6]/3=F:CQ/XL%BN A6G!*8-2 P*>!)X&'[2
MS@S?B^=:L+:L3/UY+IK2Y07OGXAG0<'35*CS:1Z4"29AQ'%!*,$BHW'.J9!!
M"H(*-R'JNYJ@QP+JQB[>Z!D,VVLGU=>#QHB739,#[?$&,V<C%9L9N&O%P4R^
M3_T&[>@W2KHU40_8\B'R.O(%1B0G]0X0)1S["]"[5D6DB]5R7NDF,MZF5S]\
M[V8;G,V^5F+U^]T']0OS^W+=&VZP^]G]AP[YDX51$F01PVF:$TR*,L-%7J0X
MR(@HHC0E1<H!1:=^N/1>I+IGNZN;4*YJ.Z;DX*>]K.-#O>0;9IIG]?L5Q[W:
M#_-M@)?^,Y]EQS,:J'A1K*$WBO&?&F_9\G[VD7OUB 6<KK=/"*K'??U/:5N_
M^^J?%%KZZU?5%TJ%/1&?LK38K_Z.2I$]$X-'N9J0R>/3E_^S_//7Q7/U;K'B
MZN^[')-AO&M\%<^[8T,</59/2D4W2+& ?OWT<-=LBQJ@3QAV)QAHXW+LRYTB
M8%O111TXOI&;RVH5#+NP]&1A,3,1^P$RPS>NS![=ZTP67:CS_/QAN:J:LWRY
M6M>4K6<QR4DIRE(?F-4=G=,,TU#&F'.9!QJ^LRA@@&X&1'TG[7>S>MKT<,L$
MVG*!_MCR89MH&M,G,.?D2$LP\W>@(/N<E('$KM-38R1?)U-EH(3!I)7)NW8.
M8QMV?K=\*G732W?GUQ&M6_;/367UJPY;U-\O_98/U&.D#4$U$;L>+UY^_^W4
MX,@2@,0GM0D[Q1Q;A^4J5\SQ^+J<JS=6+1;'C%*6E6D98"8ITW$G@?,\#3 )
MLR(/TUAFD8 4[IZ2 &V:MG!XHL7JH4<C;'^OZO5F=1 MHO5ZH7AK)M3\Q6)Z
MQZ'Z3'?-:Y0"3!1W W^/I_DJP9VT"UV6R>40CD,"TP_=."O@V2$;YY^T"3'/
MERM];^8?-PN^ZJ)2(J2A*$*"12R5F<HTP1JE$^=)F:1AQ)7VC$I9!REX+Y?2
M)+&&CY>:*"32=TX?)H'6*Z4$!DD;:LV@OX:>54SSG*20>.25$EO&$L&2 T-_
M(U*-A^W.O3AAR&V$[\-PV=B#=AO]T33N3V+=(@K/ I)$!6,YIIQSC?J;X9)+
M@:.PS'B6RSB.L]DW49=+TWOS$"G(+UZ?H'E!ACK\5AV4]AP.6#ZH(AH6E,>\
MP F7F7*U<8 I5?\HTK1(XIC1.(T@@047"K+PN.VY:'&LI),CTN)@^KJN"&C'
MKSO2IMD!R86.8/YZ1Q%M#TSZ]ZFEZNZ0=$DN1T>E03*3'I@N"7M\;+KX_+3S
MG0X1J9H;V&]BO9Z++5XZ*X*LB+%(-30)$0+3(BIP2-(@HF44!CFH)L@/FYZ=
MRN<M),$9%)*M@UDN^N#D-]H%33,HZ,('-/-$K_]98'[,_:B@AO<;U./^]:<%
MF6GWE<<%76#RWV)>D)FB70T,,J1F<8G^N_(_[*OZAZC?T>=*'85^I0O:HM-V
M%ZLRS/(D)Q++B";*H8<Y+DA2XJ@,B&1)D AJA#IA2,^S9^XQ +AQ&JC)X*;M
M5GB8_^O11AUQM*=N<PLWT G@3NY6-W8W]'$=.;JFFPLZ>FDW6&:Z*[RY3 <7
M>L!K%JZM#]]SN^"_*?]:,?%1B%W$2%U<\TS=7=-"XY<&/,)%6::8LIB%/!1!
MP6-CQW:)FF>WUB??'#I7+0-("E.@#3.E&;@YEZJ .;D#+2C2J*.--'$;'W?Y
M=\C<P[E4BYU_NU(],#]G*NZHE[NXR'0^SE2> P]G_-*UPQXOCAI8#<T::-LX
M11J1**(QCHLXPR2C A=2AICE05P&&9-I+.W&/E[)F>]2HA[01#OBI!P=A;+:
MST(I3V>A7.PI]?P5S:[NK_)M8([\]+.,3ZA9C8ZH<=?JZTV%SD='7LO7*PV1
M=*3.X7&2K@C8.>S/0N\';*VHT]57M2/H?^FP[C<Z;X)OE(NDR%B,4R923.(L
MP93G.KT2J&MX$-!$@$:C7"+H.YW=(,+-!?^B)V;4.N;)Q;,N:FLF[MX]P#SE
M1?5%05F2(DUQ6I91"Z^7\S#&ZJ"?\C )A8@26-K.I0*MTG=3J]!L#W&I%MC6
ML*?<(N?IRT[SAQYU=X[>5$Y'_OLBN4G=LJGPQ][6^#T[)SHV!OCCLA;5E\6[
M35V+!7MY5&Y]I1$GF^-W\[=YZ_#Y_VS:S,LGL;Z7C_3[3(1)4O(T5\XB23!)
M"PW2&><X#$F2)W$4%@4(<<D/FYX==L<88AUG:+UG!M$=-TVV2ON?-?VN__6?
M<=H8XG^^B9.?D%S6#7S^6EF%0$_+Q?KK"HF%AF+Y57WMKR@.;Y"^[#7O:".X
M08JG9Z'1$<7<$)+&\Z]#4L0\+Z($%UG","E)CLM<")P6,HBE^L7(,@G;2E[_
M%\)J S+\E0 60GCZ:F:[U^M_"=B>UX[3/&"X*\%HT>Y_ND';K[3E&_48;\RL
MQSJZ[1GRI]:0%?_N=DV_^G6TUWIB<M(=VJ^BC_=US]1LT?)W+"CUO%.;3;78
M5(LO>R2<MT)M2!VKBIY8??BN7%@[]Z5^:>:E?3HH[MHVUL["(I%AD:M+1, D
M)J$(,<UHC"/"61+&@L8:A-&\Z-\CKZ!S ;Q[X,#;H);+K0MJ^(2B]_O[:&9;
MP _R*6#[P.%7T.X [3GOXVV5IQ](>?K#"L8MNRYG#WC7J;/Q!?XXG7@"@G>5
MGPY1\$_R-><4=PF11-"$ZQB<#*F^#>:8BB#"G.8YEW&1% 6HNMDA;[ZO@.Z'
MWMID15Q^3+,MX94^$6P+F/[KO-(T8A_I$9><_1M.(1Y-D?@@85&UHS:&?V[H
MO)*5X)_%NFJ+)!^4#6SY:NHN(A:615"DF!*N3N9)++!RR!$N"0EHJ/QVD9C/
M'C:CZ=GM]IE ]8X+]*R>:D$G(74\AFHTJ.9QKQR8PSO0RYX!I#G8>D"+RAY#
M!0'J>]PKRJ[*QXG"8+4^,-%'*WX,EYJN[@<FVT'U#_!5=VT\#\MYQ5[:?^[A
MJM*B" M! DQ3HB/:.K8MX@A'.2UTBXZ,LO#:SIRSE"<[L/8[.X 1"7,U @^3
M+I5C>U3LZ^4&M0R@/[I_>X'F!HOOL2?E/-U7;S,958=)Y\CX E=ZD[8-Y1?Q
M3<RC;B^,)4^+. AQQA*""<F:*8:1QE;(@E(26H2@VI016IX]1D/JO_XC3(._
M1I9NXHQ^@([A.JGM;XTMW1O44$:1P[, 0$37YGZ&TNL8^+#(@R8]\@K,B+FH
M9AV.Z).HOZ@KV\_U\L_UUVZ,_8RSJ(P*%N(\UE" 89SCG)-,S]%(DD2D::*'
MCUXVX MT/!OOAPZ&MR.-6MJH(VYFSI<T-6[*#N6'F;&EZ,8&;"C8"(:G6J&U
M6_6'O;E>6G<24S44;FNFIH_;9BT/Q\U]$NL=]N_/RR7_LYK/9TE6I$D4,!P4
M28Y)S$-<!F&"PS*C+!-YSBBH(LF$J&?CO3L:I&'3]VZD.RY(H?2D?%V4"^7K
MRDSI+@\P#Z-,2EE&+.:S9U%72_[;FM;KU]'@,0/FEWRQ1N5R^7_1MW93+X7Z
M#5UHG["4J%W5@U)#H0YY!4EQ1$N.21"HNV214*ST' 1A%.>Q8)U2/RSX:ZIT
M2]Y:H1J!RZ<J3;/4;I4#33>?#%O5:GJS1\#?\C",*6211#87V5DVV(#DQ&E=
M<R6<YF<![UK7W-3J'BK>B_;?=XM3:+_/R_G\X[+6G1,SDL:E8++$F62INCG2
M$A=J3\,R*1.6Q:DL):B[#$C?^Y[6<H'>;/GY"54+U&?I?W?H2>@/S1;J^ )F
M1*%:-W4QWG0)]3;.U6A3P6*C#'=5*2#J4U>:V*CF3/6(U3+P41:?Z)/@'[X+
MMM%5Y?=25DQ1^+@ 3[.XN)#OS*"FCW8,H"T'NNAWN5XLU\- ;!9*&?<:SO4!
M3 9>5(6'P1;&\EK-MKB\^F3C+8P%[4^X,'\)9L*K>CUKL9B[&_<6CB@C6933
M" =4<-T7F6,-P(VS,.9E29*X, MB#:SOV98OH$L;:6#<0AW(!;/)EM@V".4P
MG'Q!DK%-5[W:VW#5W_8V-[3J)%9V0:2M75UZS-GT!UV\\V6AH0GON*)6R6;H
M5'MO:&#U:\%OU55:_>=JW@R94C_;*(/?7S)6LR0H:5PH8TP+EF"2I007+"_T
M2,90!C*4:0K**WOBT[-EOQ>R6E1K@>?*#?*3B;$K1#L^88=^7Q_-['+P WP*
MF#,Z-P2DP6[L>$9]IK?5,%NVFSZI'N.HX_Q&S]#1G_:7YM/V!/$Z/L2EIOW-
M&7'"Y6L/)'&I:H/))4[)P7.$[[NZLH_5BM'Y0Q/B_*C^VVHF11Y%819ASK-8
MSS8I<9XD B=")IF@95I((_#>42J^'7%'%[6$44L9-:3-LX/#.KJ<&W0B.<SO
M60D-R@M>%,HJ*SB\ZF0YP8N"]3."EQ^&!RH>OCTW9=/@P,3)B]XO+R_HVTK_
M;LEE_4259M%[I8?Y4E<DW:"&%_-0Q*G8ET,/5TD,O=:<"-MV2K@MF!N5RBJ@
M<+K:9 &$04'Z 8/AA^RN-;=J ^75O D__*9[%9H-LTUY"-[VJ#T];]HJZGOY
M@=8Z3[I2'[;%>7HYO\#M]VHU"Y*XB$L28Y;P4,/B9;C(\@27>9GF!>,1E07D
M:N.15\^VWR>,]I31'YHV,)'A\XN9W6M^D.\ \TB6GP!\%9E .8ZN(SXYG?1*
M,H'*CZ\E4Y"T1#6]!-$WA-#W23'ZK)]MTTAWB]6Z;DYKJY_5NVO!9W$8YA$O
M<IRFA;K?2"[5_8:F6$2QR%E,4@)+1/MCU;<[UTRLT)>6&'I3+=!*,PJ=#N7Q
M6YEY\A_C"\ <N0FBZ2B@:8/E@%OVMRGQG@ WJ!/!(>"I=S6[0D#UQ^BTD*C>
M%7Z"D>J?(OQN_%ASQ<'=@C]6Z[DPO1@?ON79E38TS*^]1Q)=OO/:"P/S2H\U
M;6KZ>E]<-XOPZEO%-W2.QN4$77C/BV1UVSU::K*K[GD1^O?<@2=<GHEF@3K"
M1"4I,(N+%!.:2ESR0&#):,X%BT54&(V['2?CV8": J .3IWUR+HXB5QUBICF
M!+#;V?MVI_%Q&E#;[YH;AY,6QR7UN@G_"!LH;/.[TFC54D_+MKZM*]U(XDC(
M/"EPGI?J_L%*CDM)I*Z&S:.,!"0W&SDS2,&SJ;;TVII,F'F>ZL+,,J^2$&:4
M?>$\=$4.2N+(Z$[7G]3>!L4[-K7A!VW@8C9ZA:5\MYS/J?J%;N=L_K*DB_MR
M7GUI\<C>J?\OYQ6G^EH9D5+P@G(<AYQADH<$YV&8JG^45*1Y&@:D-$>.@9+W
M;)\M/[IQA?6(HG>_W(/ 8\!*';=E_ZJ"&?I>2X?,(,T-ZK&#^OQX52 $9\:G
M(BTA9]PJ% @^8ZN/<1P:\*H30M+82GR(3F.]"OP:O[]&-DD:PVO\X5N>7>>>
MV'^;7^:/Y+I\F;<7">;B>O=V5^FA8?:M+NY'2TUV<3\O0O_B/O $O,[J7;5^
MN:T%?;?D8I;&69G)+, BHU)=U4N&BS*-<1@D09)%912F1F-TCQ?V?>+7L65-
M"VEBYO53![*/V\4U$@%/^&;"@.JBSG%N50IUL-!DU4_GV.\7/)W]N2TLR2WG
MZNNL'I:K-9W_?]5S\\N1%#1,.4UP3LH"$\X37,22X#C/@I@6DA<\@*&2G"/C
MV4PZ9(Z.LL;8TK21(@ZTFQ%%7;8B-^+#;,I6<@M0DC'!KL D.;OLQ) D8Z*=
M(I*,/FT7JSK.[^^K\N(@I7FH=ZHH5AL7+P6F41G@0A1QDL=$QBDH9C5(R;>)
M=G2W\/F*?IMAA06RAA5E%M!R(C[01+>2[T1VW"5I+)NC4-<PG4E#7A?%/0Y]
M77[!HD>R7O(-6]_7W7#AYB+"F,P+PBG.U!\P"6B$*144TYB%*8VB6)1&>^H0
M <^FVI%L^G&V,ZHAA8:#>ADW41?2PBS30E!8^^2(--?T3YY;=KH&RA&A#CHH
MQYZSB#4_BOI)AT>Z_$4>AP7E/,-%'C -AJ1'M48Y#K-"TH(1INS,.)!\N+;O
MB@5%#,T5-4!(\TAX@X"OO4@P&VJD:0*-%C#@1V(!PK#VXMG%6 %BPN*GYP49
M#8X>O3)=Y/,\KP=AS8%'KH3#[;7BV4Y&V)T3BZ D(M5C"\J(8Q*5$2[S7.W5
M!8MDK#;N(#.:7>"32=\E'[WY[OV&VR:#T$M<_?:L_U8W3;??1#LW#G5^?:7Q
M?SH4V[CW\[-#3U;H;[K68KU$[X7B]ZE:"+0'Q;7$ ';Y2V%V>7CM3PWSS'W4
MX?Y7=C*PQC-NN0<%N\8\=LGBZX E>U#R(,JR#UK7ME[_0]"Z;2IF+"8T304.
M,MV8$*;J6!EQ@64:I*Q4/^6%,33S  W/+OVX UG3O:[I>J^=RY%/!S+#?)N%
MN%>T6Y\(Y*#9>K_F*[5:GP@UW&A]^JAE&>T)UMS=HH/&?%C63;W[>EU7Y6;=
M=*@N!T:,EHG,LD@G*GB082(*CDM*4ES$&0L+$::,A9"YL&[8 ADX? 3LHWX%
MB88]8&FN&ZTSDH4\#953C(4Z/,<BP#E+$RS#/"J*,LKR((!#.D^O>VO0Y[=T
MWO2AT_7U>,^.ODDD9!S0.,0)H003'?\H(B&PR&*6R#B.>19#$:%?ZXN ,:-[
MW^,*N&A'7\+L C&];H&IBH8GW7>RA9CNV$)]OO0]SOLT8[>J<E59[X:I:2OQ
MG2KRI'+?[>H6<>'?:5VU5X9VK39'^UD\:_*++^U?[Q;?EO-O;1^=6 A9L8K.
MMV^L?MN4[7CDM>#O1;F^?5IN%LJ[ELI]:OB)G)<))BPMU#E#>5<2R$P=,W@6
MI>8A9F]L^HX5]8@B#?$**67V]VT,(N _A,9A_G?+\LZ?HI9+C:'7L=W]%]1C
M_ ;M6=^]N;I!!Y].LW^#6@%^B"\("/;_$%_2+F_PVE\4EHSPKNC1O(8_ZM.E
M2+QK\"#;XI\:O"+BUVI1/6V>MGC12<P(41=&'DB&2<)R3,NBP(3FG"9Y4"29
M4;_/R<J>M[V.EGG!PZ'8X]O35<+ =I2.C&-<Z+/,7U'1<+C>9*4,9\7HUS"<
M?\#BD&HR%>9S;WB(L@I:R)+B*!&I.GK*3!U"98S+F">2%F62YT8!:1OBOLL?
M=" +< *!JL[@9.A1(3#K!(QXLII=8Z5 P,',HR+MCEL>% H[05EJ9/1<!%US
MNM..I;0'9QC;->Q2$'\7U9>OZJAS^TW4](MHN_#N95,/NKK?K%>*&4WYMERM
M:\K4-24O"\X2@?,X4L>6- AQD=,$1SR4&5,GF"PR L:Q9<#W];ZA:]AS9ZU$
ML^BH3]7 _/*6$]2Q@O8MMBTWJ,?.#7JO<?C4TW]L.7-8$F&K%$<13S#Y26.;
MMLHYCF):KV/GA![JY;.HUR\/ZI=N?;O@.G#ZK#<[Y?MF)$MRSF.)I<A#3(JR
MP&60ACC.!*/J?T(2$.CM&#'/SN7CIEY4ZP:=6FRI-L76<SU[3$>-4?7T7"_;
MRZG-,-I139IY'5?Z@7F8+=4;U-!MM+*CW!Q:W+D0$PD=N8M14I.Z!A.AC]V
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M68DI9V44LI3(PK)"%,*&D7U=4QVZ(]5-L44K.E?V]>99/?^5K@0X[&VC:\,
MN2_]75/SN=(1\HZ??3BF6J ^2XT#VS/EONK31B6.*SY!++Q*M:>-DH8J/:W6
MLO->G\6:5@O!/]!:#S?>QC1S%@J9Y1'.8AYB$@8"%T63:Z4987%!29E"#DGG
MR7@^#&V)HBU5].:6L<W39MX-T]/!K#70!0THS,S)7*\&F!LYU8"[H6!F,CGR
M P-$)K7T<4&/;?G"TW;6NO<'^@[UX;NN]1;J!K6KE LY*4O!A0Y04%UM+3$-
M-+H-S_3H&IJF):AXZ1)!SQ:\V_*V:>6. Z#-7E2;F?6Z5 ;,C@?UT$)Z^BA
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M4MZM5AO!WV_TL,<V3-(>K\['968T*CA/PP('L4X<*A>"=>Y0'7Q8P1EC44J
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M@?+-9+7*\(\L.UF&_[)H_0R_P=/VDT]^%>NO2PZVQH'7/9OBP1R4EC1@<-"
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MV ^ O-[J/2Y3G+CVPQJ"XSH0^X\Z)(WO(@_=N!WQB?XT)F>6LS!3-$P0B[%
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M-6WTUD+HHYBLS6?.J77_?6E_[)__]6_=3_0?IISGO_[M_P!02P,$%     @
M)$.H6"2]T=5_D0  0N<& !4   !V<G1S+3(P,C0P,S,Q7W!R92YX;6SDO=F2
MFT>2+GA_GD*CN1TOQ;ZT=?<QBA3KT$82.22K^O3<P#PV$E-)@ 4@*;*??CR
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MO_WZ+G[,GQ"FL^4*9[$NL)S^RW+]E[_.(Z[64G^2KA\>_(WZ'5S^&M2_ BY
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M7*]F%R5-;VHC;E+@:K68AO-5-;/OYS7]0*P306<W'J\M)U%Q)8HMD)W"FHM
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M"\P[3[0+\NA:=XW9F;AQ:]';F:%!E-$!RM[7BM_SQ;?UN;PYHB_%18%D-J:
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MF%B,%L*FF'=R\Y[H*+4747^&SE+[(.]F9ZGAM-=5F++UG>CTYFS/VGI4\<+
ML.S)*;497 RR?NM$D+SP.-QMWY/DC1M8C ?1H379%4A;5#0)'S%:7Z V@Z-X
MSSD(RD;@T@5I7 FF>?GMZ<O6!NOKTA/03XV&#K;"'9:/KG.25EC!R24W6:]?
MJ"EPW+*:!BG2%&Z#'ZS M0T+XW:;&7\[C(F(/L.UR_8++_(*IV=']82X_(B&
M32&V4G7BKA"VQ*1U5) E.0'*Y0C>6P'<EJRUTKK]!4@'72$F4LK@%<HZ@T2
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MG?T^,\!$WS+I<\PHC/2M7_CO2^.XIFM A#U\[S^ \CHX7;=PM4Z8!N$P!N:
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M= B^.<.K%CUEVJ427*A%3X&<GF"R (>ZYJZXUKSU?=_^5([<M7Y4.+90W/X
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M1O&7?SF/\?K>/N (+ 4D-0&&/%7(&L>1X<PH24&&#\L@1D'B/:+J8K*(ZGO
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MCMK\FE0@;KU%UJ\"%NL)M38/ 2B%H9KFY@1E/53W$9*KK/#?)[/)Y=7EAO#
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M:1IL@RD>(9].==UF*VV$U6?6_5-&^X/.(#_L9)K%_[:;_P/^V^4%9W!PV&A
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MP<N@-XM#E-< $@ND'2,VG#*L$#/"(AXI0R!=C8022AGOHZ3AW/:US/N?)]"
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M2[F0W@)KM:'&N]EB F+],K>K9JIW1AW>I_S$[AI[/E.DU49?-@KTW7CTJ4<
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M.]_*L7+><DS$Z6/4&UHVUGSH:F4VM-TO-_9:[/.#-;]^==[MG%VXRE$5 E-
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MZK[XR>OQZC=>UA^'_R3P?U!+ P04    "  D0ZA8[_3(KEL%  !6'   %@
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M2P$"% ,4    "  D0ZA8#%T]Y/XA 0!ZY1, $0              @ $
M=G)T<RTR,#(T,#,S,2YH=&U02P$"% ,4    "  D0ZA8(#Q@9^ /   $K@
M$0              @ $M(@$ =G)T<RTR,#(T,#,S,2YX<V102P$"% ,4
M"  D0ZA8;?U6+1PA  #80P$ %0              @ $\,@$ =G)T<RTR,#(T
M,#,S,5]C86PN>&UL4$L! A0#%     @ )$.H6!N0:Y?X8@  \W($ !4
M         ( !BU,! '9R=',M,C R-# S,S%?9&5F+GAM;%!+ 0(4 Q0    (
M "1#J%B!6<3 0ST$  =K!0 4              "  ;:V 0!V<G1S+3(P,C0P
M,S,Q7V<Q+FIP9U!+ 0(4 Q0    ( "1#J%C.IBC[:^8  ,44"0 5
M      "  2OT!0!V<G1S+3(P,C0P,S,Q7VQA8BYX;6Q02P$"% ,4    "  D
M0ZA8)+W1U7^1  !"YP8 %0              @ ')V@8 =G)T<RTR,#(T,#,S
M,5]P<F4N>&UL4$L! A0#%     @ )$.H6'RO9Z6.!P  C2   !8
M     ( !>VP' '9R=',P,S,Q,C R-&5X+3,Q,2YH=&U02P$"% ,4    "  D
M0ZA8S?ZF]:,'   K(   %@              @ $]= < =G)T<S S,S$R,#(T
M97@M,S$R+FAT;5!+ 0(4 Q0    ( "1#J%CO],BN6P4  %8<   6
M      "  11\!P!V<G1S,#,S,3(P,C1E>"TS,C$N:'1M4$L%!@     *  H
*F (  *.!!P    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>vrts-20240331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:vrts="http://www.virtus.com/20240331"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="vrts-20240331.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
        </entity>
        <period>
            <instant>2024-05-01</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vrts:InvestmentManagementFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vrts:InvestmentManagementFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vrts:DistributionAndServiceFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vrts:DistributionAndServiceFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vrts:AdministrationAndShareholderServiceFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vrts:AdministrationAndShareholderServiceFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vrts:OtherIncomeAndfeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vrts:OtherIncomeAndfeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:ConsolidatedEntityExcludingVariableInterestEntitiesVIEandVotingInterestEntitiesVOEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vrts:OpenEndFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vrts:OpenEndFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vrts:ClosedEndFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vrts:ClosedEndFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vrts:RetailSeparateAccountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vrts:RetailSeparateAccountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vrts:InstitutionalAccountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vrts:InstitutionalAccountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vrts:AlphaSimplexGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vrts:AlphaSimplexGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">vrts:SponsoredFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">vrts:SponsoredFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">vrts:SponsoredFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">vrts:SponsoredFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">vrts:SponsoredFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">vrts:NonqualifiedRetirementPlanAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">vrts:NonqualifiedRetirementPlanAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">vrts:NonqualifiedRetirementPlanAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">vrts:NonqualifiedRetirementPlanAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vrts:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vrts:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vrts:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vrts:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">vrts:SponsoredFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">vrts:SponsoredFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">vrts:SponsoredFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">vrts:NonqualifiedRetirementPlanAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">vrts:NonqualifiedRetirementPlanAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">vrts:NonqualifiedRetirementPlanAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">vrts:NonqualifiedRetirementPlanAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vrts:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vrts:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vrts:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vrts:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vrts:WestchesterCapitalManagementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vrts:WestchesterCapitalManagementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vrts:WestchesterCapitalManagementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vrts:WestchesterCapitalManagementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputComparabilityAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vrts:NFJInvestmentGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vrts:NFJInvestmentGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vrts:NFJInvestmentGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vrts:NFJInvestmentGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputComparabilityAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vrts:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vrts:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vrts:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vrts:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
        </entity>
        <period>
            <startDate>2024-02-21</startDate>
            <endDate>2024-02-21</endDate>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">vrts:RestrictedStockUnitsRSUsPerformanceBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">vrts:RestrictedStockUnitsRSUsPerformanceBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">vrts:PerformanceStockUnitsIncentiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">vrts:RestrictedStockUnitsandPerformanceSharesUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">vrts:RestrictedStockUnitsandPerformanceSharesUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">vrts:TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vrts:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-28</instant>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">vrts:TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vrts:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-28</startDate>
            <endDate>2021-09-28</endDate>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vrts:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-28</instant>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vrts:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-28</startDate>
            <endDate>2021-09-28</endDate>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">vrts:TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">vrts:TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">vrts:TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vrts:CreditFacility2017Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VotingInterestEntityVOEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryGlobalAndPrivateFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VotingInterestEntityVOEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryGlobalAndPrivateFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vrts:SubordinatedNotesNewfleetCLO20161Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vrts:SeniorSecuredFloatingRateNotesNewfleetCLO20161Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vrts:SubordinatedNotesNewfleetCLO20161Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SubordinatedDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryCollateralizedLoanObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">vrts:VariableInterestEntityPrimaryBeneficiaryandVotingInterestEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883237</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="collateralized_loan_obligation">
        <measure>vrts:collateralized_loan_obligation</measure>
    </unit>
    <dei:AmendmentFlag contextRef="c-1" id="f-25">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-26">2024</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-27">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-28">0000883237</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-29">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-135" id="f-529">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <dei:DocumentType contextRef="c-1" id="f-1">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="c-1" id="f-2">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2024-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-4">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-10994</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-6">VIRTUS INVESTMENT PARTNERS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-7">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-8">26-3962811</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-9">One Financial Plaza</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-10">Hartford</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-11">CT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-12">06103</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-13">800</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-14">248-7971</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-15">Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-16">VRTS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-17">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-18">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-19">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-20">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-21">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-22">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="c-1" id="f-23">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-2" decimals="INF" id="f-24" unitRef="shares">7127881</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-3" id="f-30" unitRef="usd">123880000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-31" unitRef="usd">239602000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:Investments contextRef="c-3" decimals="-3" id="f-32" unitRef="usd">127448000</us-gaap:Investments>
    <us-gaap:Investments contextRef="c-4" decimals="-3" id="f-33" unitRef="usd">132696000</us-gaap:Investments>
    <us-gaap:AccountsReceivableNet contextRef="c-5" decimals="-3" id="f-34" unitRef="usd">116387000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet contextRef="c-6" decimals="-3" id="f-35" unitRef="usd">109076000</us-gaap:AccountsReceivableNet>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-7" decimals="-3" id="f-36" unitRef="usd">123030000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-8" decimals="-3" id="f-37" unitRef="usd">100732000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalents contextRef="c-7" decimals="-3" id="f-38" unitRef="usd">767000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents contextRef="c-8" decimals="-3" id="f-39" unitRef="usd">680000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:Investments contextRef="c-7" decimals="-3" id="f-40" unitRef="usd">2081225000</us-gaap:Investments>
    <us-gaap:Investments contextRef="c-8" decimals="-3" id="f-41" unitRef="usd">2082713000</us-gaap:Investments>
    <us-gaap:OtherAssets contextRef="c-7" decimals="-3" id="f-42" unitRef="usd">31848000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets contextRef="c-8" decimals="-3" id="f-43" unitRef="usd">43235000</us-gaap:OtherAssets>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-5" decimals="-3" id="f-44" unitRef="usd">26088000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-6" decimals="-3" id="f-45" unitRef="usd">26216000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-5" decimals="-3" id="f-46" unitRef="usd">416784000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-6" decimals="-3" id="f-47" unitRef="usd">432119000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill contextRef="c-5" decimals="-3" id="f-48" unitRef="usd">397098000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-6" decimals="-3" id="f-49" unitRef="usd">397098000</us-gaap:Goodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-5" decimals="-3" id="f-50" unitRef="usd">23974000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-6" decimals="-3" id="f-51" unitRef="usd">25024000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssets contextRef="c-3" decimals="-3" id="f-52" unitRef="usd">79596000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets contextRef="c-4" decimals="-3" id="f-53" unitRef="usd">89438000</us-gaap:OtherAssets>
    <us-gaap:Assets contextRef="c-5" decimals="-3" id="f-54" unitRef="usd">3548125000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-6" decimals="-3" id="f-55" unitRef="usd">3678629000</us-gaap:Assets>
    <us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent contextRef="c-5" decimals="-3" id="f-56" unitRef="usd">95591000</us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent contextRef="c-6" decimals="-3" id="f-57" unitRef="usd">200837000</us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent contextRef="c-5" decimals="-3" id="f-58" unitRef="usd">44282000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent contextRef="c-6" decimals="-3" id="f-59" unitRef="usd">38756000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:DividendsPayableCurrentAndNoncurrent contextRef="c-5" decimals="-3" id="f-60" unitRef="usd">16553000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:DividendsPayableCurrentAndNoncurrent contextRef="c-6" decimals="-3" id="f-61" unitRef="usd">17291000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-5" decimals="-3" id="f-62" unitRef="usd">66704000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-6" decimals="-3" id="f-63" unitRef="usd">90938000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:LongTermDebt contextRef="c-5" decimals="-3" id="f-64" unitRef="usd">253008000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-6" decimals="-3" id="f-65" unitRef="usd">253412000</us-gaap:LongTermDebt>
    <us-gaap:OtherLiabilities contextRef="c-5" decimals="-3" id="f-66" unitRef="usd">67460000</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities contextRef="c-6" decimals="-3" id="f-67" unitRef="usd">91471000</us-gaap:OtherLiabilities>
    <us-gaap:SeniorNotes contextRef="c-7" decimals="-3" id="f-68" unitRef="usd">1922051000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes contextRef="c-8" decimals="-3" id="f-69" unitRef="usd">1922243000</us-gaap:SeniorNotes>
    <vrts:SecuritiesPurchasedPayableAndOtherLiabilities contextRef="c-7" decimals="-3" id="f-70" unitRef="usd">91288000</vrts:SecuritiesPurchasedPayableAndOtherLiabilities>
    <vrts:SecuritiesPurchasedPayableAndOtherLiabilities contextRef="c-8" decimals="-3" id="f-71" unitRef="usd">90523000</vrts:SecuritiesPurchasedPayableAndOtherLiabilities>
    <us-gaap:Liabilities contextRef="c-5" decimals="-3" id="f-72" unitRef="usd">2556937000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-6" decimals="-3" id="f-73" unitRef="usd">2705471000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-5" id="f-74" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-6" id="f-75" unitRef="usd" xsi:nil="true"/>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-5" decimals="-3" id="f-76" unitRef="usd">115185000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-6" decimals="-3" id="f-77" unitRef="usd">104869000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-5"
      decimals="INF"
      id="f-78"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-6"
      decimals="INF"
      id="f-79"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-5" decimals="INF" id="f-80" unitRef="shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-6" decimals="INF" id="f-81" unitRef="shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c-5" decimals="INF" id="f-82" unitRef="shares">12224489</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-5" decimals="INF" id="f-83" unitRef="shares">7127881</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-6" decimals="INF" id="f-84" unitRef="shares">12163228</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-6" decimals="INF" id="f-85" unitRef="shares">7087728</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c-5" decimals="-3" id="f-86" unitRef="usd">122000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-6" decimals="-3" id="f-87" unitRef="usd">122000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-5" decimals="-3" id="f-88" unitRef="usd">1298157000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-6" decimals="-3" id="f-89" unitRef="usd">1300999000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-5" decimals="-3" id="f-90" unitRef="usd">223023000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-6" decimals="-3" id="f-91" unitRef="usd">207356000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-5" decimals="-3" id="f-92" unitRef="usd">-187000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-6" decimals="-3" id="f-93" unitRef="usd">-87000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockCommonShares contextRef="c-5" decimals="INF" id="f-94" unitRef="shares">5096608</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares contextRef="c-6" decimals="INF" id="f-95" unitRef="shares">5075500</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue contextRef="c-5" decimals="-3" id="f-96" unitRef="usd">649463000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockCommonValue contextRef="c-6" decimals="-3" id="f-97" unitRef="usd">644464000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:StockholdersEquity contextRef="c-5" decimals="-3" id="f-98" unitRef="usd">871652000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-6" decimals="-3" id="f-99" unitRef="usd">863926000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest contextRef="c-7" decimals="-3" id="f-100" unitRef="usd">4351000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest contextRef="c-8" decimals="-3" id="f-101" unitRef="usd">4363000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-5" decimals="-3" id="f-102" unitRef="usd">876003000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-6" decimals="-3" id="f-103" unitRef="usd">868289000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-5" decimals="-3" id="f-104" unitRef="usd">3548125000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-6" decimals="-3" id="f-105" unitRef="usd">3678629000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-9" decimals="-3" id="f-106" unitRef="usd">188360000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-10" decimals="-3" id="f-107" unitRef="usd">164478000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-11" decimals="-3" id="f-108" unitRef="usd">14030000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-12" decimals="-3" id="f-109" unitRef="usd">14153000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-13" decimals="-3" id="f-110" unitRef="usd">18678000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-14" decimals="-3" id="f-111" unitRef="usd">18359000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-15" decimals="-3" id="f-112" unitRef="usd">974000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-16" decimals="-3" id="f-113" unitRef="usd">884000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-114" unitRef="usd">222042000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-17" decimals="-3" id="f-115" unitRef="usd">197874000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:LaborAndRelatedExpense contextRef="c-1" decimals="-3" id="f-116" unitRef="usd">115163000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense contextRef="c-17" decimals="-3" id="f-117" unitRef="usd">98614000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:ExpenseRelatedToDistributionOrServicingAndUnderwritingFees contextRef="c-1" decimals="-3" id="f-118" unitRef="usd">24348000</us-gaap:ExpenseRelatedToDistributionOrServicingAndUnderwritingFees>
    <us-gaap:ExpenseRelatedToDistributionOrServicingAndUnderwritingFees contextRef="c-17" decimals="-3" id="f-119" unitRef="usd">23715000</us-gaap:ExpenseRelatedToDistributionOrServicingAndUnderwritingFees>
    <us-gaap:OtherCostAndExpenseOperating contextRef="c-18" decimals="-3" id="f-120" unitRef="usd">31375000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OtherCostAndExpenseOperating contextRef="c-19" decimals="-3" id="f-121" unitRef="usd">30730000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OtherCostAndExpenseOperating contextRef="c-20" decimals="-3" id="f-122" unitRef="usd">690000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OtherCostAndExpenseOperating contextRef="c-21" decimals="-3" id="f-123" unitRef="usd">700000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:RestructuringCharges contextRef="c-1" decimals="-3" id="f-124" unitRef="usd">797000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-17" decimals="-3" id="f-125" unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:Depreciation contextRef="c-1" decimals="-3" id="f-126" unitRef="usd">2028000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-17" decimals="-3" id="f-127" unitRef="usd">1145000</us-gaap:Depreciation>
    <vrts:AmortizationOfIntangibleAssetsAndContingentAmortization contextRef="c-1" decimals="-3" id="f-128" unitRef="usd">15335000</vrts:AmortizationOfIntangibleAssetsAndContingentAmortization>
    <vrts:AmortizationOfIntangibleAssetsAndContingentAmortization contextRef="c-17" decimals="-3" id="f-129" unitRef="usd">14391000</vrts:AmortizationOfIntangibleAssetsAndContingentAmortization>
    <us-gaap:OperatingExpenses contextRef="c-1" decimals="-3" id="f-130" unitRef="usd">189736000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-17" decimals="-3" id="f-131" unitRef="usd">169295000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-3" id="f-132" unitRef="usd">32306000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-17" decimals="-3" id="f-133" unitRef="usd">28579000</us-gaap:OperatingIncomeLoss>
    <us-gaap:GainLossOnInvestments contextRef="c-18" decimals="-3" id="f-134" unitRef="usd">3416000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments contextRef="c-19" decimals="-3" id="f-135" unitRef="usd">2670000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments contextRef="c-20" decimals="-3" id="f-136" unitRef="usd">1535000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments contextRef="c-21" decimals="-3" id="f-137" unitRef="usd">2596000</us-gaap:GainLossOnInvestments>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-138" unitRef="usd">550000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-17" decimals="-3" id="f-139" unitRef="usd">-343000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-140" unitRef="usd">5501000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-17" decimals="-3" id="f-141" unitRef="usd">4923000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:InterestExpense contextRef="c-18" decimals="-3" id="f-142" unitRef="usd">5681000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-19" decimals="-3" id="f-143" unitRef="usd">5005000</us-gaap:InterestExpense>
    <us-gaap:InvestmentIncomeInterestAndDividend contextRef="c-18" decimals="-3" id="f-144" unitRef="usd">3469000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend contextRef="c-19" decimals="-3" id="f-145" unitRef="usd">3238000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend contextRef="c-20" decimals="-3" id="f-146" unitRef="usd">51115000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend contextRef="c-21" decimals="-3" id="f-147" unitRef="usd">46814000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InterestExpense contextRef="c-20" decimals="-3" id="f-148" unitRef="usd">40012000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-21" decimals="-3" id="f-149" unitRef="usd">35203000</us-gaap:InterestExpense>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c-1" decimals="-3" id="f-150" unitRef="usd">8891000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c-17" decimals="-3" id="f-151" unitRef="usd">9844000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-152" unitRef="usd">46698000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-17" decimals="-3" id="f-153" unitRef="usd">43346000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-154" unitRef="usd">8831000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-17" decimals="-3" id="f-155" unitRef="usd">8703000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-3" id="f-156" unitRef="usd">37867000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-17" decimals="-3" id="f-157" unitRef="usd">34643000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-158" unitRef="usd">8009000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-17" decimals="-3" id="f-159" unitRef="usd">-3981000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-1" decimals="-3" id="f-160" unitRef="usd">29858000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-17" decimals="-3" id="f-161" unitRef="usd">38624000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-162"
      unitRef="usdPerShare">4.19</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-17"
      decimals="2"
      id="f-163"
      unitRef="usdPerShare">5.33</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-164"
      unitRef="usdPerShare">4.10</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-17"
      decimals="2"
      id="f-165"
      unitRef="usdPerShare">5.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-3" id="f-166" unitRef="shares">7119000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-17" decimals="-3" id="f-167" unitRef="shares">7245000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-3" id="f-168" unitRef="shares">7287000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-17" decimals="-3" id="f-169" unitRef="shares">7410000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-3" id="f-170" unitRef="usd">37867000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-17" decimals="-3" id="f-171" unitRef="usd">34643000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax contextRef="c-1" decimals="-3" id="f-172" unitRef="usd">-36000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax contextRef="c-17" decimals="-3" id="f-173" unitRef="usd">35000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-1" decimals="-3" id="f-174" unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-17" decimals="-3" id="f-175" unitRef="usd">99000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-1" decimals="-3" id="f-176" unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-17" decimals="-3" id="f-177" unitRef="usd">99000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-178" unitRef="usd">37767000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="c-17" decimals="-3" id="f-179" unitRef="usd">34742000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-180" unitRef="usd">8009000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="c-17" decimals="-3" id="f-181" unitRef="usd">-3981000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-3" id="f-182" unitRef="usd">29758000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-17" decimals="-3" id="f-183" unitRef="usd">38723000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-3" id="f-184" unitRef="usd">37867000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-17" decimals="-3" id="f-185" unitRef="usd">34643000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-1" decimals="-3" id="f-186" unitRef="usd">18164000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-17" decimals="-3" id="f-187" unitRef="usd">16410000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-3" id="f-188" unitRef="usd">6831000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-17" decimals="-3" id="f-189" unitRef="usd">5749000</us-gaap:ShareBasedCompensation>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-1" decimals="-3" id="f-190" unitRef="usd">498000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-17" decimals="-3" id="f-191" unitRef="usd">-554000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:DebtAndEquitySecuritiesGainLoss contextRef="c-18" decimals="-3" id="f-192" unitRef="usd">3393000</us-gaap:DebtAndEquitySecuritiesGainLoss>
    <us-gaap:DebtAndEquitySecuritiesGainLoss contextRef="c-19" decimals="-3" id="f-193" unitRef="usd">2670000</us-gaap:DebtAndEquitySecuritiesGainLoss>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-194" unitRef="usd">1086000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-17" decimals="-3" id="f-195" unitRef="usd">1441000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ProceedsFromPaymentsForTradingSecurities contextRef="c-1" decimals="-3" id="f-196" unitRef="usd">5987000</us-gaap:ProceedsFromPaymentsForTradingSecurities>
    <us-gaap:ProceedsFromPaymentsForTradingSecurities contextRef="c-17" decimals="-3" id="f-197" unitRef="usd">5217000</us-gaap:ProceedsFromPaymentsForTradingSecurities>
    <us-gaap:IncreaseDecreaseInOperatingAssets contextRef="c-1" decimals="-3" id="f-198" unitRef="usd">341000</us-gaap:IncreaseDecreaseInOperatingAssets>
    <us-gaap:IncreaseDecreaseInOperatingAssets contextRef="c-17" decimals="-3" id="f-199" unitRef="usd">-8725000</us-gaap:IncreaseDecreaseInOperatingAssets>
    <us-gaap:IncreaseDecreaseInOperatingLiabilities contextRef="c-1" decimals="-3" id="f-200" unitRef="usd">-120631000</us-gaap:IncreaseDecreaseInOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOperatingLiabilities contextRef="c-17" decimals="-3" id="f-201" unitRef="usd">-115514000</us-gaap:IncreaseDecreaseInOperatingLiabilities>
    <us-gaap:DebtAndEquitySecuritiesGainLoss contextRef="c-20" decimals="-3" id="f-202" unitRef="usd">3732000</us-gaap:DebtAndEquitySecuritiesGainLoss>
    <us-gaap:DebtAndEquitySecuritiesGainLoss contextRef="c-21" decimals="-3" id="f-203" unitRef="usd">3844000</us-gaap:DebtAndEquitySecuritiesGainLoss>
    <us-gaap:PaymentsForPurchaseOfSecuritiesOperatingActivities contextRef="c-20" decimals="-3" id="f-204" unitRef="usd">304516000</us-gaap:PaymentsForPurchaseOfSecuritiesOperatingActivities>
    <us-gaap:PaymentsForPurchaseOfSecuritiesOperatingActivities contextRef="c-21" decimals="-3" id="f-205" unitRef="usd">320808000</us-gaap:PaymentsForPurchaseOfSecuritiesOperatingActivities>
    <us-gaap:ProceedsFromSaleOfSecuritiesOperatingActivities contextRef="c-20" decimals="-3" id="f-206" unitRef="usd">323720000</us-gaap:ProceedsFromSaleOfSecuritiesOperatingActivities>
    <us-gaap:ProceedsFromSaleOfSecuritiesOperatingActivities contextRef="c-21" decimals="-3" id="f-207" unitRef="usd">323380000</us-gaap:ProceedsFromSaleOfSecuritiesOperatingActivities>
    <vrts:ProceedsFromPaymentsForOtherInvestmentsOperatingActivities contextRef="c-20" decimals="-3" id="f-208" unitRef="usd">206000</vrts:ProceedsFromPaymentsForOtherInvestmentsOperatingActivities>
    <vrts:ProceedsFromPaymentsForOtherInvestmentsOperatingActivities contextRef="c-21" decimals="-3" id="f-209" unitRef="usd">-218000</vrts:ProceedsFromPaymentsForOtherInvestmentsOperatingActivities>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c-20" decimals="-3" id="f-210" unitRef="usd">-4722000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c-21" decimals="-3" id="f-211" unitRef="usd">-3976000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-3" id="f-212" unitRef="usd">-34528000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-17" decimals="-3" id="f-213" unitRef="usd">-42959000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="-3" id="f-214" unitRef="usd">1923000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-17" decimals="-3" id="f-215" unitRef="usd">1448000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <vrts:IncreaseDecreaseInCashAndCashEquivalentsOfSubsidiariesDueToConsolidation contextRef="c-20" decimals="-3" id="f-216" unitRef="usd">-537000</vrts:IncreaseDecreaseInCashAndCashEquivalentsOfSubsidiariesDueToConsolidation>
    <vrts:IncreaseDecreaseInCashAndCashEquivalentsOfSubsidiariesDueToConsolidation contextRef="c-21" decimals="-3" id="f-217" unitRef="usd">-52000</vrts:IncreaseDecreaseInCashAndCashEquivalentsOfSubsidiariesDueToConsolidation>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments contextRef="c-1" decimals="-3" id="f-218" unitRef="usd">0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments contextRef="c-17" decimals="-3" id="f-219" unitRef="usd">11645000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-3" id="f-220" unitRef="usd">-2460000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-17" decimals="-3" id="f-221" unitRef="usd">-13145000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfLinesOfCredit contextRef="c-1" decimals="-3" id="f-222" unitRef="usd">688000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit contextRef="c-17" decimals="-3" id="f-223" unitRef="usd">688000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:PaymentsOfDividendsCommonStock contextRef="c-1" decimals="-3" id="f-224" unitRef="usd">14929000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock contextRef="c-17" decimals="-3" id="f-225" unitRef="usd">14083000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-1" decimals="-3" id="f-226" unitRef="usd">5000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-17" decimals="-3" id="f-227" unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities contextRef="c-1" decimals="-3" id="f-228" unitRef="usd">24234000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities contextRef="c-17" decimals="-3" id="f-229" unitRef="usd">27179000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-1" decimals="-3" id="f-230" unitRef="usd">9854000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-17" decimals="-3" id="f-231" unitRef="usd">12209000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <vrts:DisposalOfPaymentsForAffiliateEquity contextRef="c-1" decimals="-3" id="f-232" unitRef="usd">419000</vrts:DisposalOfPaymentsForAffiliateEquity>
    <vrts:DisposalOfPaymentsForAffiliateEquity contextRef="c-17" decimals="-3" id="f-233" unitRef="usd">0</vrts:DisposalOfPaymentsForAffiliateEquity>
    <us-gaap:ProceedsFromPaymentsToMinorityShareholders contextRef="c-1" decimals="-3" id="f-234" unitRef="usd">16772000</us-gaap:ProceedsFromPaymentsToMinorityShareholders>
    <us-gaap:ProceedsFromPaymentsToMinorityShareholders contextRef="c-17" decimals="-3" id="f-235" unitRef="usd">294000</us-gaap:ProceedsFromPaymentsToMinorityShareholders>
    <us-gaap:RepaymentsOfOtherDebt contextRef="c-20" decimals="-3" id="f-236" unitRef="usd">17794000</us-gaap:RepaymentsOfOtherDebt>
    <us-gaap:RepaymentsOfOtherDebt contextRef="c-21" decimals="-3" id="f-237" unitRef="usd">61213000</us-gaap:RepaymentsOfOtherDebt>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-3" id="f-238" unitRef="usd">-56146000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-17" decimals="-3" id="f-239" unitRef="usd">-115078000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-1" decimals="-3" id="f-240" unitRef="usd">-203000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-17" decimals="-3" id="f-241" unitRef="usd">180000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-3" id="f-242" unitRef="usd">-93337000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-17" decimals="-3" id="f-243" unitRef="usd">-171002000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-6" decimals="-3" id="f-244" unitRef="usd">341014000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-22" decimals="-3" id="f-245" unitRef="usd">589179000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="-3" id="f-246" unitRef="usd">247677000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-23" decimals="-3" id="f-247" unitRef="usd">418177000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:MinorityInterestChangeInRedemptionValue contextRef="c-1" decimals="-3" id="f-248" unitRef="usd">-13624000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue contextRef="c-17" decimals="-3" id="f-249" unitRef="usd">-3447000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <vrts:CommonStockDividendsAccruedButNotYetPaid contextRef="c-1" decimals="-3" id="f-250" unitRef="usd">13467000</vrts:CommonStockDividendsAccruedButNotYetPaid>
    <vrts:CommonStockDividendsAccruedButNotYetPaid contextRef="c-17" decimals="-3" id="f-251" unitRef="usd">11850000</vrts:CommonStockDividendsAccruedButNotYetPaid>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-3" id="f-252" unitRef="usd">123880000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-253" unitRef="usd">239602000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-7" decimals="-3" id="f-254" unitRef="usd">123030000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-8" decimals="-3" id="f-255" unitRef="usd">100732000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalents contextRef="c-7" decimals="-3" id="f-256" unitRef="usd">767000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents contextRef="c-8" decimals="-3" id="f-257" unitRef="usd">680000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="-3" id="f-258" unitRef="usd">247677000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-6" decimals="-3" id="f-259" unitRef="usd">341014000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CommonStockSharesIssued
      contextRef="c-24"
      decimals="INF"
      id="f-260"
      unitRef="shares">7181554</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-24" decimals="-3" id="f-261" unitRef="usd">120000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-25" decimals="-3" id="f-262" unitRef="usd">1286244000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-26" decimals="-3" id="f-263" unitRef="usd">130261000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-27" decimals="-3" id="f-264" unitRef="usd">-358000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-28"
      decimals="INF"
      id="f-265"
      unitRef="shares">4851693</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-28" decimals="-3" id="f-266" unitRef="usd">-599248000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-29" decimals="-3" id="f-267" unitRef="usd">817019000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-30" decimals="-3" id="f-268" unitRef="usd">5917000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-22" decimals="-3" id="f-269" unitRef="usd">822936000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-22" decimals="-3" id="f-270" unitRef="usd">113718000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest contextRef="c-31" decimals="-3" id="f-271" unitRef="usd">38624000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest contextRef="c-32" decimals="-3" id="f-272" unitRef="usd">38624000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest contextRef="c-33" decimals="-3" id="f-273" unitRef="usd">765000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest contextRef="c-17" decimals="-3" id="f-274" unitRef="usd">39389000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome contextRef="c-17" decimals="-3" id="f-275" unitRef="usd">-4746000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-34" decimals="-3" id="f-276" unitRef="usd">99000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-32" decimals="-3" id="f-277" unitRef="usd">99000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-17" decimals="-3" id="f-278" unitRef="usd">99000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease contextRef="c-35" decimals="-3" id="f-279" unitRef="usd">0</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease contextRef="c-32" decimals="-3" id="f-280" unitRef="usd">0</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease contextRef="c-33" decimals="-3" id="f-281" unitRef="usd">-300000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease contextRef="c-17" decimals="-3" id="f-282" unitRef="usd">-300000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <vrts:NoncontrollingInterestSubscriptionsRedemptions contextRef="c-17" decimals="-3" id="f-283" unitRef="usd">-2342000</vrts:NoncontrollingInterestSubscriptionsRedemptions>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-17"
      decimals="INF"
      id="f-284"
      unitRef="usdPerShare">1.65</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash contextRef="c-31" decimals="-3" id="f-285" unitRef="usd">13093000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-32" decimals="-3" id="f-286" unitRef="usd">13093000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-17" decimals="-3" id="f-287" unitRef="usd">13093000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c-36"
      decimals="INF"
      id="f-288"
      unitRef="shares">106840</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-36" decimals="-3" id="f-289" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-35" decimals="-3" id="f-290" unitRef="usd">-1000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-32" decimals="-3" id="f-291" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-17" decimals="-3" id="f-292" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-35" decimals="-3" id="f-293" unitRef="usd">12209000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-32" decimals="-3" id="f-294" unitRef="usd">12209000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-17" decimals="-3" id="f-295" unitRef="usd">12209000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-35" decimals="-3" id="f-296" unitRef="usd">7475000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-32" decimals="-3" id="f-297" unitRef="usd">7475000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-17" decimals="-3" id="f-298" unitRef="usd">7475000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:CommonStockSharesIssued
      contextRef="c-37"
      decimals="INF"
      id="f-299"
      unitRef="shares">7288394</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-37" decimals="-3" id="f-300" unitRef="usd">121000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-38" decimals="-3" id="f-301" unitRef="usd">1281509000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-39" decimals="-3" id="f-302" unitRef="usd">155792000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-40" decimals="-3" id="f-303" unitRef="usd">-259000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-41"
      decimals="INF"
      id="f-304"
      unitRef="shares">4851693</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-41" decimals="-3" id="f-305" unitRef="usd">-599248000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-42" decimals="-3" id="f-306" unitRef="usd">837915000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-43" decimals="-3" id="f-307" unitRef="usd">6382000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-23" decimals="-3" id="f-308" unitRef="usd">844297000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-23" decimals="-3" id="f-309" unitRef="usd">106630000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockSharesIssued
      contextRef="c-44"
      decimals="INF"
      id="f-310"
      unitRef="shares">7087728</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-44" decimals="-3" id="f-311" unitRef="usd">122000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-45" decimals="-3" id="f-312" unitRef="usd">1300999000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-46" decimals="-3" id="f-313" unitRef="usd">207356000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-47" decimals="-3" id="f-314" unitRef="usd">-87000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-48"
      decimals="INF"
      id="f-315"
      unitRef="shares">5075500</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-48" decimals="-3" id="f-316" unitRef="usd">-644464000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-49" decimals="-3" id="f-317" unitRef="usd">863926000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-50" decimals="-3" id="f-318" unitRef="usd">4363000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-6" decimals="-3" id="f-319" unitRef="usd">868289000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-6" decimals="-3" id="f-320" unitRef="usd">104869000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest contextRef="c-51" decimals="-3" id="f-321" unitRef="usd">29858000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest contextRef="c-52" decimals="-3" id="f-322" unitRef="usd">29858000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest contextRef="c-53" decimals="-3" id="f-323" unitRef="usd">391000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-324" unitRef="usd">30249000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome contextRef="c-1" decimals="-3" id="f-325" unitRef="usd">7618000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-54" decimals="-3" id="f-326" unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-52" decimals="-3" id="f-327" unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-1" decimals="-3" id="f-328" unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease contextRef="c-55" decimals="-3" id="f-329" unitRef="usd">0</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease contextRef="c-52" decimals="-3" id="f-330" unitRef="usd">0</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease contextRef="c-53" decimals="-3" id="f-331" unitRef="usd">-403000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease contextRef="c-1" decimals="-3" id="f-332" unitRef="usd">-403000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <vrts:NoncontrollingInterestSubscriptionsRedemptions contextRef="c-1" decimals="-3" id="f-333" unitRef="usd">2698000</vrts:NoncontrollingInterestSubscriptionsRedemptions>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-1"
      decimals="INF"
      id="f-334"
      unitRef="usdPerShare">1.90</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash contextRef="c-51" decimals="-3" id="f-335" unitRef="usd">14191000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-52" decimals="-3" id="f-336" unitRef="usd">14191000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-1" decimals="-3" id="f-337" unitRef="usd">14191000</us-gaap:DividendsCommonStockCash>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-56"
      decimals="INF"
      id="f-338"
      unitRef="shares">21108</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-57"
      decimals="INF"
      id="f-339"
      unitRef="shares">21108</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-57" decimals="-3" id="f-340" unitRef="usd">4999000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-52" decimals="-3" id="f-341" unitRef="usd">4999000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-1" decimals="-3" id="f-342" unitRef="usd">4999000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c-56"
      decimals="INF"
      id="f-343"
      unitRef="shares">61261</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-52" decimals="-3" id="f-344" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-1" decimals="-3" id="f-345" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-55" decimals="-3" id="f-346" unitRef="usd">9852000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-52" decimals="-3" id="f-347" unitRef="usd">9852000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-1" decimals="-3" id="f-348" unitRef="usd">9852000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-55" decimals="-3" id="f-349" unitRef="usd">7010000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-52" decimals="-3" id="f-350" unitRef="usd">7010000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-1" decimals="-3" id="f-351" unitRef="usd">7010000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:CommonStockSharesIssued
      contextRef="c-58"
      decimals="INF"
      id="f-352"
      unitRef="shares">7127881</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-58" decimals="-3" id="f-353" unitRef="usd">122000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-59" decimals="-3" id="f-354" unitRef="usd">1298157000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-60" decimals="-3" id="f-355" unitRef="usd">223023000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-61" decimals="-3" id="f-356" unitRef="usd">-187000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-62"
      decimals="INF"
      id="f-357"
      unitRef="shares">5096608</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-62" decimals="-3" id="f-358" unitRef="usd">-649463000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-63" decimals="-3" id="f-359" unitRef="usd">871652000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-64" decimals="-3" id="f-360" unitRef="usd">4351000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-5" decimals="-3" id="f-361" unitRef="usd">876003000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-5" decimals="-3" id="f-362" unitRef="usd">115185000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:NatureOfOperations contextRef="c-1" id="f-363">Organization and Business&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Virtus Investment Partners, Inc. (the "Company," "we," "us," "our" or "Virtus"), a Delaware corporation, operates in the investment management industry through its subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company provides investment management and related services to institutions and individuals.  The Company's investment strategies are offered to institutional clients through institutional separate and commingled accounts, including structured products.  The Company&#x2019;s retail investment management services are provided to individuals through products consisting of: mutual funds registered pursuant to the Investment Company Act of 1940, as amended ("U.S. retail funds"); Undertaking for Collective Investment in Transferable Securities and Qualifying Investor Funds (collectively, "global funds") and collectively with U.S. retail funds, variable insurance funds, and exchange-traded funds ("ETFs"), (the "open-end funds"); closed-end funds (collectively, with open-end funds, the "funds"); and retail separate accounts that include intermediary-sold and private client accounts.  The Company also provides subadvisory services to other investment advisers.&lt;/span&gt;&lt;/div&gt;</us-gaap:NatureOfOperations>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-364">Basis of Presentation and Significant Accounting Policies&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") for interim financial information.  Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements.  In the opinion of management, these financial statements contain all adjustments, consisting only of normal recurring adjustments, necessary for a fair statement of the Company&#x2019;s financial condition and results of operations.  Operating results for the three months ended March&#160;31, 2024 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2023 (the "2023 Annual Report on Form 10-K") filed with the Securities and Exchange Commission (the "SEC").  The Company&#x2019;s significant accounting policies, which have been consistently applied, are summarized in its 2023 Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;New Accounting Standards Not Yet Implemented&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2023, the Financial Accounting Standards Board (the "FASB") issued Accounting Standards Update ("ASU") 2023-07, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Reporting (Topic 280)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.  This standard updates reportable segment disclosure requirements, clarifies circumstances in which an entity can disclose multiple segment measures of profit or loss and provides new segment disclosure requirements for entities with a single reportable segment.  This standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024.  Early adoption is permitted, with the amendments to be applied retrospectively to all prior periods presented in the financial statements.  The Company is in the process of evaluating the impact of adopting this standard and, at this time, does not anticipate it will have a material impact on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued ASU 2023-09, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740).&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  This standard updates income tax disclosure requirements by requiring disaggregated information about a reporting entity's effective tax rate reconciliation as well as information on income taxes paid.  This standard is effective for fiscal years beginning after December 15, 2024.  Early adoption is permitted.  The Company is in the process of evaluating the impact of adopting this standard and, at this time, does not anticipate it will have a material impact on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2024, the FASB issued ASU 2024-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation - Stock Compensation (Topic 718), Scope Application of Profits Interest and Similar Awards.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This standard provides clarity regarding whether profits interest and similar awards are within the scope of Topic 718 of the Accounting Standards Codification.  This standard is effective for fiscal years beginning after December 15, 2024.  Early adoption is permitted.  The Company is in the process of evaluating the impact of adopting this standard and, at this time, does not anticipate it will have a material impact on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c-1" id="f-365">&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") for interim financial information.  Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements.  In the opinion of management, these financial statements contain all adjustments, consisting only of normal recurring adjustments, necessary for a fair statement of the Company&#x2019;s financial condition and results of operations.  Operating results for the three months ended March&#160;31, 2024 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2023 (the "2023 Annual Report on Form 10-K") filed with the Securities and Exchange Commission (the "SEC").  The Company&#x2019;s significant accounting policies, which have been consistently applied, are summarized in its 2023 Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-366">&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;New Accounting Standards Not Yet Implemented&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2023, the Financial Accounting Standards Board (the "FASB") issued Accounting Standards Update ("ASU") 2023-07, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Reporting (Topic 280)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.  This standard updates reportable segment disclosure requirements, clarifies circumstances in which an entity can disclose multiple segment measures of profit or loss and provides new segment disclosure requirements for entities with a single reportable segment.  This standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024.  Early adoption is permitted, with the amendments to be applied retrospectively to all prior periods presented in the financial statements.  The Company is in the process of evaluating the impact of adopting this standard and, at this time, does not anticipate it will have a material impact on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued ASU 2023-09, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740).&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  This standard updates income tax disclosure requirements by requiring disaggregated information about a reporting entity's effective tax rate reconciliation as well as information on income taxes paid.  This standard is effective for fiscal years beginning after December 15, 2024.  Early adoption is permitted.  The Company is in the process of evaluating the impact of adopting this standard and, at this time, does not anticipate it will have a material impact on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2024, the FASB issued ASU 2024-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation - Stock Compensation (Topic 718), Scope Application of Profits Interest and Similar Awards.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This standard provides clarity regarding whether profits interest and similar awards are within the scope of Topic 718 of the Accounting Standards Codification.  This standard is effective for fiscal years beginning after December 15, 2024.  Early adoption is permitted.  The Company is in the process of evaluating the impact of adopting this standard and, at this time, does not anticipate it will have a material impact on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="c-1" id="f-367">Revenues&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's revenues are recognized when a performance obligation is satisfied, which occurs when control of the services is transferred to customers.  Investment management fees, distribution and service fees, and administration and shareholder service fees are generally calculated as a percentage of average net assets of the investment portfolios managed.  The net asset values from which these fees are calculated are variable in nature and subject to factors outside of the Company's control, such as additional investments, withdrawals and market performance.  Because of this, these fees are considered constrained until the end of the contractual measurement period (monthly or quarterly), which is when asset values are generally determinable.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investment Management Fees by Source&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes investment management fees by source:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.215%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.215%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.852%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.218%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Investment management fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Open-end funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Closed-end funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retail separate accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Institutional accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total investment management fees&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;188,360&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;164,478&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="c-1" id="f-368">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's revenues are recognized when a performance obligation is satisfied, which occurs when control of the services is transferred to customers.  Investment management fees, distribution and service fees, and administration and shareholder service fees are generally calculated as a percentage of average net assets of the investment portfolios managed.  The net asset values from which these fees are calculated are variable in nature and subject to factors outside of the Company's control, such as additional investments, withdrawals and market performance.  Because of this, these fees are considered constrained until the end of the contractual measurement period (monthly or quarterly), which is when asset values are generally determinable.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="c-1" id="f-369">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes investment management fees by source:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.215%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.215%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.852%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.218%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Investment management fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Open-end funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Closed-end funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retail separate accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Institutional accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total investment management fees&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;188,360&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;164,478&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-65" decimals="-3" id="f-370" unitRef="usd">78680000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-66" decimals="-3" id="f-371" unitRef="usd">71266000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-67" decimals="-3" id="f-372" unitRef="usd">14394000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-68" decimals="-3" id="f-373" unitRef="usd">14678000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-69" decimals="-3" id="f-374" unitRef="usd">48981000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-70" decimals="-3" id="f-375" unitRef="usd">40079000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-71" decimals="-3" id="f-376" unitRef="usd">46305000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-72" decimals="-3" id="f-377" unitRef="usd">38455000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-9" decimals="-3" id="f-378" unitRef="usd">188360000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-10" decimals="-3" id="f-379" unitRef="usd">164478000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="c-1" id="f-380">Acquisitions&lt;div style="margin-bottom:3pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;AlphaSimplex Group, LLC&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 1, 2023, the Company completed the acquisition of AlphaSimplex Group, LLC ("AlphaSimplex"), which was accounted for in accordance with Accounting Standards Codification ("ASC") 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;("ASC 805"). &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price paid of $113.4&#160;million was allocated to the assets acquired and liabilities assumed based upon their estimated fair values at the date of the acquisition.  Goodwill of $48.3&#160;million and intangible assets of $55.4&#160;million were recorded for the acquisition.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="c-73" decimals="-5" id="f-381" unitRef="usd">113400000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:Goodwill contextRef="c-74" decimals="-5" id="f-382" unitRef="usd">48300000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-74" decimals="-5" id="f-383" unitRef="usd">55400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="c-1" id="f-384">Intangible Assets, Net&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Below is a summary of intangible assets, net:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.473%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:30.272%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.971%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.616%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.971%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.616%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.971%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.616%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.971%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.616%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.980%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Definite-Lived&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Indefinite-Lived&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Book Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net Book Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net Book Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net Book Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;806,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(416,834)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,335)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,335)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,335)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances at March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;806,655&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(432,169)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;374,486&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;42,298&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;416,784&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Definite-lived intangible asset amortization for the remainder of fiscal year 2024 and succeeding fiscal years is estimated as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.912%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:53.112%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.631%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.857%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;374,486&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock contextRef="c-1" id="f-385">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Below is a summary of intangible assets, net:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.473%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:30.272%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.971%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.616%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.971%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.616%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.971%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.616%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.971%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.616%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.980%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Definite-Lived&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Indefinite-Lived&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Book Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net Book Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net Book Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net Book Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;806,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(416,834)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,335)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,335)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,335)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances at March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;806,655&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(432,169)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;374,486&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;42,298&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;416,784&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-6" decimals="-3" id="f-386" unitRef="usd">806655000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-6" decimals="-3" id="f-387" unitRef="usd">416834000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-6" decimals="-3" id="f-388" unitRef="usd">389821000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-6" decimals="-3" id="f-389" unitRef="usd">42298000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-6" decimals="-3" id="f-390" unitRef="usd">432119000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-1" decimals="-3" id="f-391" unitRef="usd">15335000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-1" decimals="-3" id="f-392" unitRef="usd">15335000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-1" decimals="-3" id="f-393" unitRef="usd">15335000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-5" decimals="-3" id="f-394" unitRef="usd">806655000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-5" decimals="-3" id="f-395" unitRef="usd">432169000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-5" decimals="-3" id="f-396" unitRef="usd">374486000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-5" decimals="-3" id="f-397" unitRef="usd">42298000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-5" decimals="-3" id="f-398" unitRef="usd">416784000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="c-1" id="f-399">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Definite-lived intangible asset amortization for the remainder of fiscal year 2024 and succeeding fiscal years is estimated as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.912%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:53.112%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.631%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.857%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;374,486&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear contextRef="c-5" decimals="-3" id="f-400" unitRef="usd">40964000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="c-5" decimals="-3" id="f-401" unitRef="usd">51532000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="c-5" decimals="-3" id="f-402" unitRef="usd">50552000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="c-5" decimals="-3" id="f-403" unitRef="usd">47450000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="c-5" decimals="-3" id="f-404" unitRef="usd">41787000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <vrts:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour contextRef="c-5" decimals="-3" id="f-405" unitRef="usd">142201000</vrts:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-5" decimals="-3" id="f-406" unitRef="usd">374486000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:InvestmentTextBlock contextRef="c-1" id="f-407">Investments&lt;div style="margin-bottom:5pt;margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investments consist primarily of investments in the Company's sponsored products.  The Company's investments, excluding the assets of consolidated investment products ("CIP") discussed in Note 16, at March&#160;31, 2024 and December&#160;31, 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.602%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.616%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.599%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.684%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment securities - fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonqualified retirement plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;127,448&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;132,696&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:63pt;padding-right:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;The Company's equity method investments are valued on a three-month lag based upon the availability of financial information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:11.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investment Securities - fair value&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investment securities - fair value consist of investments in the Company's sponsored funds and separately managed accounts.  The composition of the Company&#x2019;s investment securities - fair value was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.304%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:39.794%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.303%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.627%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.972%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.627%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.972%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.627%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.978%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Investment Securities - fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sponsored funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total investment securities - fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;85,942&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;90,497&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;97,147&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;97,304&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2024 and 2023, the Company recognized net realized losses of $0.4&#160;million and net realized gains $1.3&#160;million, respectively, related to its investment securities - fair value.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentTextBlock>
    <us-gaap:InvestmentTableTextBlock contextRef="c-1" id="f-408">The Company's investments, excluding the assets of consolidated investment products ("CIP") discussed in Note 16, at March&#160;31, 2024 and December&#160;31, 2023 were as follows:&lt;div style="margin-bottom:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.602%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.616%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.599%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.684%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment securities - fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonqualified retirement plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;127,448&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;132,696&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:63pt;padding-right:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;The Company's equity method investments are valued on a three-month lag based upon the availability of financial information.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentTableTextBlock>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-75" decimals="-3" id="f-409" unitRef="usd">90497000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-76" decimals="-3" id="f-410" unitRef="usd">97304000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquityMethodInvestments contextRef="c-75" decimals="-3" id="f-411" unitRef="usd">23208000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments contextRef="c-76" decimals="-3" id="f-412" unitRef="usd">22710000</us-gaap:EquityMethodInvestments>
    <vrts:InvestmentsInNonqualifiedRetirementPlanAssets contextRef="c-75" decimals="-3" id="f-413" unitRef="usd">13743000</vrts:InvestmentsInNonqualifiedRetirementPlanAssets>
    <vrts:InvestmentsInNonqualifiedRetirementPlanAssets contextRef="c-76" decimals="-3" id="f-414" unitRef="usd">12682000</vrts:InvestmentsInNonqualifiedRetirementPlanAssets>
    <us-gaap:Investments contextRef="c-75" decimals="-3" id="f-415" unitRef="usd">127448000</us-gaap:Investments>
    <us-gaap:Investments contextRef="c-76" decimals="-3" id="f-416" unitRef="usd">132696000</us-gaap:Investments>
    <us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock contextRef="c-1" id="f-417">The composition of the Company&#x2019;s investment securities - fair value was as follows:&lt;div style="margin-bottom:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.304%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:39.794%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.303%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.627%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.972%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.627%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.972%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.627%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.978%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Investment Securities - fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sponsored funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total investment securities - fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;85,942&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;90,497&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;97,147&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;97,304&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock>
    <us-gaap:EquitySecuritiesFvNiCost contextRef="c-77" decimals="-3" id="f-418" unitRef="usd">69067000</us-gaap:EquitySecuritiesFvNiCost>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-77" decimals="-3" id="f-419" unitRef="usd">69514000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNiCost contextRef="c-78" decimals="-3" id="f-420" unitRef="usd">80794000</us-gaap:EquitySecuritiesFvNiCost>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-78" decimals="-3" id="f-421" unitRef="usd">77433000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNiCost contextRef="c-79" decimals="-3" id="f-422" unitRef="usd">16875000</us-gaap:EquitySecuritiesFvNiCost>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-79" decimals="-3" id="f-423" unitRef="usd">20983000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNiCost contextRef="c-80" decimals="-3" id="f-424" unitRef="usd">16353000</us-gaap:EquitySecuritiesFvNiCost>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-80" decimals="-3" id="f-425" unitRef="usd">19871000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNiCost contextRef="c-5" decimals="-3" id="f-426" unitRef="usd">85942000</us-gaap:EquitySecuritiesFvNiCost>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-5" decimals="-3" id="f-427" unitRef="usd">90497000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNiCost contextRef="c-6" decimals="-3" id="f-428" unitRef="usd">97147000</us-gaap:EquitySecuritiesFvNiCost>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-6" decimals="-3" id="f-429" unitRef="usd">97304000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:DebtAndEquitySecuritiesRealizedGainLoss contextRef="c-1" decimals="-5" id="f-430" unitRef="usd">-400000</us-gaap:DebtAndEquitySecuritiesRealizedGainLoss>
    <us-gaap:DebtAndEquitySecuritiesRealizedGainLoss contextRef="c-17" decimals="-5" id="f-431" unitRef="usd">1300000</us-gaap:DebtAndEquitySecuritiesRealizedGainLoss>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c-1" id="f-432">Fair Value Measurements&lt;div style="margin-bottom:5pt;margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s assets and liabilities measured at fair value on a recurring basis, excluding the assets and liabilities of CIP discussed in Note 16, as of March&#160;31, 2024 and December&#160;31, 2023 by fair value hierarchy level were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;March&#160;31, 2024 &#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.683%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.765%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Investment securities - fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sponsored funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonqualified retirement plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;196,698&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;196,698&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41,708&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41,708&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December&#160;31, 2023 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.752%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.641%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Investment securities - fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sponsored funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonqualified retirement plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;307,226&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;307,226&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;56,200&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;56,200&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a discussion of the valuation methodologies used for the Company&#x2019;s assets measured at fair value:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash equivalents &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;represent investments in money market funds.  Cash investments in money market funds are valued using published net asset values and are classified as Level 1.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sponsored funds &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;represent investments in open-end funds, closed-end funds and ETFs for which the Company acts as the investment manager.  The fair value of open-end funds is determined based on their published net asset values and are categorized as Level 1.  The fair value of closed-end funds and ETFs is determined based on the official closing price on the exchange on which they are traded and are categorized as Level 1.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; represent securities traded on active markets, are valued at the official closing price (typically the last sale or bid) on the exchange on which the securities are primarily traded and are categorized as Level 1.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Nonqualified retirement plan assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;represent mutual funds within the Company's nonqualified retirement plan whose fair value is determined based on their published net asset value and are categorized as Level 1.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingent consideration &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;represents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;liabilities associated with the Company's Westchester Capital Management ("WCM") and NFJ Investment Group ("NFJ")  transactions .  The continent consideration related to the WCM transaction as of March&#160;31, 2024 was $11.1&#160;million and represents the fair value of future potential earn-out payments based on pre-established performance metrics related to revenue growth rates.  The estimated fair value of the WCM liability is measured using an options pricing model valuation technique utilizing unobservable market data inputs prepared with the assistance of an independent valuation firm.  The most significant unobservable inputs used relate to the aforementioned revenue growth rates, discount rate (range of 6%-7%) and the market price of risk adjustment (9%).  The NFJ contingent consideration liability as of March&#160;31, 2024 was $30.6&#160;million and represents the fair value of the projected future revenue participation payments.  The NFJ revenue participation payments consist of variable payments based on a percentage of the investment management fees earned on certain NFJ managed assets.  The estimated fair value of the NFJ liability is measured using an options pricing model valuation technique utilizing unobservable market data inputs prepared with the assistance of an independent valuation firm.  The most significant unobservable inputs used relate to the revenue growth rates, discount rates (range of 6% - 7%) and the market price of risk adjustment (7%).  These liabilities are categorized as Level 3. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a reconciliation of beginning and ending balances of the Company's contingent consideration liabilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.801%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:75.337%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.031%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.098%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reduction for payments made&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,492)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,390)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contingent consideration, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41,708&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;61,710&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash, accounts receivable, accounts payable and accrued liabilities equal or approximate fair value based on the short-term nature of these instruments.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="c-1" id="f-433">&lt;div style="margin-bottom:5pt;margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s assets and liabilities measured at fair value on a recurring basis, excluding the assets and liabilities of CIP discussed in Note 16, as of March&#160;31, 2024 and December&#160;31, 2023 by fair value hierarchy level were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;March&#160;31, 2024 &#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.683%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.765%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Investment securities - fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sponsored funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonqualified retirement plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;196,698&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;196,698&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41,708&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41,708&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December&#160;31, 2023 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.752%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.641%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Investment securities - fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sponsored funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonqualified retirement plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;307,226&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;307,226&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;56,200&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;56,200&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The assets and liabilities of CIP measured at fair value on a recurring basis as of March&#160;31, 2024 and December&#160;31, 2023 by fair value hierarchy level were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;As of March&#160;31, 2024 &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.812%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.556%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.479%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.596%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.798%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.596%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.479%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.596%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.800%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,003,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,051,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;149,383&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,003,963&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;47,793&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,201,139&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,922,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,922,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;485&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,922,051&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,922,536&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;As of December&#160;31, 2023 &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.812%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.556%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.479%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.596%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.798%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.596%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.479%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.596%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.800%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,012,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,049,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;130,984&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,012,768&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;37,062&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,180,814&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,922,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,922,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;518&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,922,243&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,922,761&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-81" decimals="-3" id="f-434" unitRef="usd">92458000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-82" decimals="-3" id="f-435" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-83" decimals="-3" id="f-436" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-5" decimals="-3" id="f-437" unitRef="usd">92458000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-84" decimals="-3" id="f-438" unitRef="usd">69514000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-85" decimals="-3" id="f-439" unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-86" decimals="-3" id="f-440" unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-77" decimals="-3" id="f-441" unitRef="usd">69514000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-87" decimals="-3" id="f-442" unitRef="usd">20983000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-88" decimals="-3" id="f-443" unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-89" decimals="-3" id="f-444" unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-79" decimals="-3" id="f-445" unitRef="usd">20983000</us-gaap:EquitySecuritiesFvNi>
    <vrts:InvestmentsInNonqualifiedRetirementPlanAssets contextRef="c-90" decimals="-3" id="f-446" unitRef="usd">13743000</vrts:InvestmentsInNonqualifiedRetirementPlanAssets>
    <vrts:InvestmentsInNonqualifiedRetirementPlanAssets contextRef="c-91" decimals="-3" id="f-447" unitRef="usd">0</vrts:InvestmentsInNonqualifiedRetirementPlanAssets>
    <vrts:InvestmentsInNonqualifiedRetirementPlanAssets contextRef="c-92" decimals="-3" id="f-448" unitRef="usd">0</vrts:InvestmentsInNonqualifiedRetirementPlanAssets>
    <vrts:InvestmentsInNonqualifiedRetirementPlanAssets contextRef="c-93" decimals="-3" id="f-449" unitRef="usd">13743000</vrts:InvestmentsInNonqualifiedRetirementPlanAssets>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-81" decimals="-3" id="f-450" unitRef="usd">196698000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-82" decimals="-3" id="f-451" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-83" decimals="-3" id="f-452" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-5" decimals="-3" id="f-453" unitRef="usd">196698000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-94" decimals="-3" id="f-454" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-95" decimals="-3" id="f-455" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-96" decimals="-3" id="f-456" unitRef="usd">41708000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-97" decimals="-3" id="f-457" unitRef="usd">41708000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-81" decimals="-3" id="f-458" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-82" decimals="-3" id="f-459" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-83" decimals="-3" id="f-460" unitRef="usd">41708000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-5" decimals="-3" id="f-461" unitRef="usd">41708000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-98" decimals="-3" id="f-462" unitRef="usd">197240000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-99" decimals="-3" id="f-463" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-100" decimals="-3" id="f-464" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-6" decimals="-3" id="f-465" unitRef="usd">197240000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-101" decimals="-3" id="f-466" unitRef="usd">77433000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-102" decimals="-3" id="f-467" unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-103" decimals="-3" id="f-468" unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-78" decimals="-3" id="f-469" unitRef="usd">77433000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-104" decimals="-3" id="f-470" unitRef="usd">19871000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-105" decimals="-3" id="f-471" unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-106" decimals="-3" id="f-472" unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-80" decimals="-3" id="f-473" unitRef="usd">19871000</us-gaap:EquitySecuritiesFvNi>
    <vrts:InvestmentsInNonqualifiedRetirementPlanAssets contextRef="c-107" decimals="-3" id="f-474" unitRef="usd">12682000</vrts:InvestmentsInNonqualifiedRetirementPlanAssets>
    <vrts:InvestmentsInNonqualifiedRetirementPlanAssets contextRef="c-108" decimals="-3" id="f-475" unitRef="usd">0</vrts:InvestmentsInNonqualifiedRetirementPlanAssets>
    <vrts:InvestmentsInNonqualifiedRetirementPlanAssets contextRef="c-109" decimals="-3" id="f-476" unitRef="usd">0</vrts:InvestmentsInNonqualifiedRetirementPlanAssets>
    <vrts:InvestmentsInNonqualifiedRetirementPlanAssets contextRef="c-110" decimals="-3" id="f-477" unitRef="usd">12682000</vrts:InvestmentsInNonqualifiedRetirementPlanAssets>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-98" decimals="-3" id="f-478" unitRef="usd">307226000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-99" decimals="-3" id="f-479" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-100" decimals="-3" id="f-480" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-6" decimals="-3" id="f-481" unitRef="usd">307226000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-111" decimals="-3" id="f-482" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-112" decimals="-3" id="f-483" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-113" decimals="-3" id="f-484" unitRef="usd">56200000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-114" decimals="-3" id="f-485" unitRef="usd">56200000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-98" decimals="-3" id="f-486" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-99" decimals="-3" id="f-487" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-100" decimals="-3" id="f-488" unitRef="usd">56200000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-6" decimals="-3" id="f-489" unitRef="usd">56200000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="c-1" id="f-490">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a discussion of the valuation methodologies used for the Company&#x2019;s assets measured at fair value:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash equivalents &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;represent investments in money market funds.  Cash investments in money market funds are valued using published net asset values and are classified as Level 1.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sponsored funds &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;represent investments in open-end funds, closed-end funds and ETFs for which the Company acts as the investment manager.  The fair value of open-end funds is determined based on their published net asset values and are categorized as Level 1.  The fair value of closed-end funds and ETFs is determined based on the official closing price on the exchange on which they are traded and are categorized as Level 1.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; represent securities traded on active markets, are valued at the official closing price (typically the last sale or bid) on the exchange on which the securities are primarily traded and are categorized as Level 1.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Nonqualified retirement plan assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;represent mutual funds within the Company's nonqualified retirement plan whose fair value is determined based on their published net asset value and are categorized as Level 1.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingent consideration &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;represents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;liabilities associated with the Company's Westchester Capital Management ("WCM") and NFJ Investment Group ("NFJ")  transactions .  The continent consideration related to the WCM transaction as of March&#160;31, 2024 was $11.1&#160;million and represents the fair value of future potential earn-out payments based on pre-established performance metrics related to revenue growth rates.  The estimated fair value of the WCM liability is measured using an options pricing model valuation technique utilizing unobservable market data inputs prepared with the assistance of an independent valuation firm.  The most significant unobservable inputs used relate to the aforementioned revenue growth rates, discount rate (range of 6%-7%) and the market price of risk adjustment (9%).  The NFJ contingent consideration liability as of March&#160;31, 2024 was $30.6&#160;million and represents the fair value of the projected future revenue participation payments.  The NFJ revenue participation payments consist of variable payments based on a percentage of the investment management fees earned on certain NFJ managed assets.  The estimated fair value of the NFJ liability is measured using an options pricing model valuation technique utilizing unobservable market data inputs prepared with the assistance of an independent valuation firm.  The most significant unobservable inputs used relate to the revenue growth rates, discount rates (range of 6% - 7%) and the market price of risk adjustment (7%).  These liabilities are categorized as Level 3. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a discussion of the valuation methodologies used for the assets and liabilities of the Company&#x2019;s CIP measured at fair value:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1 assets represent cash investments in money market funds and debt and equity investments that are valued using published net asset values or the official closing price on the exchange on which the securities are traded.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2 assets represent most debt securities (including bank loans) and certain equity securities (including non-U.S. securities), for which closing prices are not readily available or are deemed to not reflect readily available market prices, and are valued using an independent pricing service.  Debt investments, other than bank loans, are valued based on quotations received from independent pricing services or from dealers who make markets in such securities.  Bank loan investments, which are included as debt investments, are generally priced at the average mid-point of bid and ask quotations obtained from a third-party pricing service.  Fair value may also be based upon valuations obtained from independent third-party brokers or dealers utilizing matrix pricing models that consider information regarding securities with similar characteristics.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3 assets include debt and equity securities that are not widely traded, are illiquid or are priced by dealers based on pricing models used by market makers in the security.  These securities are valued using unadjusted prices from an independent pricing service.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1 liabilities consist of short sales transactions in which a security is sold that is not owned or is owned but there is no intention to deliver, in anticipation that the price of the security will decline.  Short sales are recorded on the Condensed Consolidated Balance Sheets within other liabilities of CIP and are classified as Level 1 based on the underlying equity security.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2 liabilities consist of notes payable issued by CLOs and are measured using the measurement alternative in ASU 2014-13.  Accordingly, the fair value of CLO liabilities was measured as the fair value of CLO assets less the sum of (i) the fair value of the beneficial interests held by the Company, and (ii) the carrying value of any beneficial interests that represent compensation for services.  The fair value of the beneficial interests held by the Company is based on third-party pricing information without adjustment.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-115" decimals="-5" id="f-491" unitRef="usd">11100000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput contextRef="c-116" decimals="2" id="f-492" unitRef="number">0.06</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput contextRef="c-117" decimals="2" id="f-493" unitRef="number">0.07</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput contextRef="c-118" decimals="2" id="f-494" unitRef="number">0.09</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-119" decimals="-5" id="f-495" unitRef="usd">30600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput contextRef="c-120" decimals="2" id="f-496" unitRef="number">0.06</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput contextRef="c-121" decimals="2" id="f-497" unitRef="number">0.07</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput contextRef="c-122" decimals="2" id="f-498" unitRef="number">0.07</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="c-1" id="f-499">&lt;div style="margin-bottom:5pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a reconciliation of beginning and ending balances of the Company's contingent consideration liabilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.801%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:75.337%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.031%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.098%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reduction for payments made&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,492)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,390)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contingent consideration, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41,708&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;61,710&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-113" decimals="-3" id="f-500" unitRef="usd">56200000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-123" decimals="-3" id="f-501" unitRef="usd">78100000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <vrts:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReductionOfLiability contextRef="c-124" decimals="-3" id="f-502" unitRef="usd">14492000</vrts:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReductionOfLiability>
    <vrts:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReductionOfLiability contextRef="c-125" decimals="-3" id="f-503" unitRef="usd">16390000</vrts:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReductionOfLiability>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-96" decimals="-3" id="f-504" unitRef="usd">41708000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-126" decimals="-3" id="f-505" unitRef="usd">61710000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c-1" id="f-506">Equity Transactions &lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Dividends Declared&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 21, 2024, the Company declared a quarterly cash dividend of $1.90 per common share to be paid on May 15, 2024 to shareholders of record at the close of business on April 30, 2024. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Common Stock Repurchases&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2024, the Company repurchased 21,108 common shares at a weighted average price of $236.84 per share for a total cost, including fees and expenses, of $5.0 million under its share repurchase program.  As of March&#160;31, 2024, 583,437 shares remained available for repurchase.  Under the terms of the program, the Company may repurchase shares of its common stock from time to time at its discretion through open market repurchases, privately negotiated transactions and/or other mechanisms, depending on price and prevailing market and business conditions.  The program, which has no specified term, may be suspended or terminated at any time.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-127"
      decimals="INF"
      id="f-507"
      unitRef="usdPerShare">1.90</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:StockRepurchasedDuringPeriodShares contextRef="c-1" decimals="INF" id="f-508" unitRef="shares">21108</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="c-1"
      decimals="2"
      id="f-509"
      unitRef="usdPerShare">236.84</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="c-1" decimals="-5" id="f-510" unitRef="usd">5000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased contextRef="c-5" decimals="INF" id="f-511" unitRef="shares">583437</us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:ComprehensiveIncomeNoteTextBlock contextRef="c-1" id="f-512">Accumulated Other Comprehensive Income (Loss)&lt;div style="margin-bottom:5pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in accumulated other comprehensive income (loss) were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.842%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.994%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.641%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.978%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.845%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive income (loss) (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(187)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(259)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;padding-right:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) &#160;&#160;&#160;&#160;Consists of foreign currency translation adjustments, net of tax of $36 and $(35) for the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; months ended March&#160;31, 2024 and 2023, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock contextRef="c-1" id="f-513">&lt;div style="margin-bottom:5pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in accumulated other comprehensive income (loss) were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.842%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.994%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.641%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.978%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.845%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive income (loss) (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(187)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(259)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;padding-right:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) &#160;&#160;&#160;&#160;Consists of foreign currency translation adjustments, net of tax of $36 and $(35) for the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; months ended March&#160;31, 2024 and 2023, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-128" decimals="-3" id="f-514" unitRef="usd">-87000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-129" decimals="-3" id="f-515" unitRef="usd">-358000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-130" decimals="-3" id="f-516" unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-131" decimals="-3" id="f-517" unitRef="usd">99000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-132" decimals="-3" id="f-518" unitRef="usd">-187000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-133" decimals="-3" id="f-519" unitRef="usd">-259000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax contextRef="c-130" decimals="-3" id="f-520" unitRef="usd">36000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax contextRef="c-131" decimals="-3" id="f-521" unitRef="usd">-35000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c-1" id="f-522">Stock-Based Compensation&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity-based awards, including restricted stock units ("RSUs"), performance stock units ("PSUs"), stock options and unrestricted shares of common stock, may be granted to officers, employees and directors of the Company pursuant to the Company's Omnibus Incentive and Equity Plan (the "Omnibus Plan").  At March&#160;31, 2024, 375,169 shares of common stock remained available for issuance of the 3,370,000 shares that are authorized for issuance under the Omnibus Plan. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense is summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:58.771%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.337%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.059%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.043%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.061%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each RSU entitles the holder to one share of common stock when the restriction expires.  RSUs may be time-vested or performance-contingent PSUs that convert into RSUs after performance measurement is complete and generally vest in &lt;span style="-sec-ix-hidden:f-529"&gt;one&lt;/span&gt; to three years.  Shares that are issued upon vesting are newly issued shares from the Omnibus Plan and are not issued from treasury stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSU activity, inclusive of PSUs, for the three months ended March&#160;31, 2024 is summarized as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:76.169%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.017%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.861%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.759%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.863%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&#160;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Grant&#160;Date&lt;br/&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,333)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(103,849)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding at March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;341,193&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;205.10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2024 and 2023, a total of 42,588 and 70,716 RSUs, respectively, were withheld by the Company as a result of net share settlements to settle minimum employee tax withholding obligations and for which the Company paid $9.9 million and $12.2 million respectively, in minimum employee tax withholding obligations.  These net share settlements had the effect of share repurchases by the Company as they reduced the number of shares that would have otherwise been issued as a result of the vesting.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2024 and 2023, the Company granted 26,733 and 44,291 PSUs, respectively, that contain performance-based metrics in addition to a service condition.  Compensation expense for PSUs is generally recognized over a three-year service period based upon the value determined using a combination of (i) the intrinsic value method for awards that contain a performance metric that represents a "performance condition" in accordance with ASC 718, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock Compensation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;("ASC 718") and (ii) the Monte Carlo simulation valuation model for awards that contain a "market condition" performance metric under ASC 718.  Compensation expense for PSU awards that contain a market condition is fixed at the date of grant and will not be adjusted in future periods based upon the achievement of the market condition.  Compensation expense for PSU awards with a performance condition is recorded each period based upon a probability assessment of the expected outcome of the performance metric with a final adjustment upon measurement at the end of the performance period.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2024, unamortized stock-based compensation expense for unvested RSUs and PSUs was $45.5 million with a weighted-average remaining contractual life of 1.6 years.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="c-5" decimals="INF" id="f-523" unitRef="shares">375169</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="c-5" decimals="INF" id="f-524" unitRef="shares">3370000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <vrts:StockBasedCompensationExpenseTableTextBlock contextRef="c-1" id="f-525">&lt;div style="margin-bottom:5pt;margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense is summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:58.771%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.337%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.059%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.043%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.061%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</vrts:StockBasedCompensationExpenseTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-3" id="f-526" unitRef="usd">6831000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-17" decimals="-3" id="f-527" unitRef="usd">5749000</us-gaap:AllocatedShareBasedCompensationExpense>
    <vrts:ConversionOfStockConversionRatio
      contextRef="c-134"
      decimals="INF"
      id="f-528"
      unitRef="number">1</vrts:ConversionOfStockConversionRatio>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-136" id="f-530">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock contextRef="c-1" id="f-531">&lt;div style="margin-bottom:5pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSU activity, inclusive of PSUs, for the three months ended March&#160;31, 2024 is summarized as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:76.169%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.017%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.861%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.759%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.863%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&#160;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Grant&#160;Date&lt;br/&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,333)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(103,849)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding at March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;341,193&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;205.10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-137"
      decimals="INF"
      id="f-532"
      unitRef="shares">344717</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-137"
      decimals="2"
      id="f-533"
      unitRef="usdPerShare">204.48</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-138"
      decimals="INF"
      id="f-534"
      unitRef="shares">108658</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-138"
      decimals="2"
      id="f-535"
      unitRef="usdPerShare">235.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-138"
      decimals="INF"
      id="f-536"
      unitRef="shares">8333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-138"
      decimals="2"
      id="f-537"
      unitRef="usdPerShare">261.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-138"
      decimals="INF"
      id="f-538"
      unitRef="shares">103849</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-138"
      decimals="2"
      id="f-539"
      unitRef="usdPerShare">229.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-139"
      decimals="INF"
      id="f-540"
      unitRef="shares">341193</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-139"
      decimals="2"
      id="f-541"
      unitRef="usdPerShare">205.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="c-138"
      decimals="INF"
      id="f-542"
      unitRef="shares">42588</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="c-140"
      decimals="INF"
      id="f-543"
      unitRef="shares">70716</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <vrts:PaymentOfWithholdingTaxesRelatedToRestrictedStock contextRef="c-138" decimals="-5" id="f-544" unitRef="usd">9900000</vrts:PaymentOfWithholdingTaxesRelatedToRestrictedStock>
    <vrts:PaymentOfWithholdingTaxesRelatedToRestrictedStock contextRef="c-140" decimals="-5" id="f-545" unitRef="usd">12200000</vrts:PaymentOfWithholdingTaxesRelatedToRestrictedStock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="c-141"
      decimals="INF"
      id="f-546"
      unitRef="shares">26733</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="c-142"
      decimals="INF"
      id="f-547"
      unitRef="shares">44291</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-143" id="f-548">P3Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="c-144" decimals="-5" id="f-549" unitRef="usd">45500000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c-145" id="f-550">P1Y7M6D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-551">Earnings (Loss) Per Share&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings (loss) per share ("EPS") is calculated in accordance with ASC 260, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Earnings per Share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.  Basic EPS is computed by dividing net income (loss) attributable to Virtus Investment Partners, Inc. by the weighted-average number of common shares outstanding for the period, excluding dilution for potential common stock issuances.  Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock, including shares issuable upon the vesting of RSUs and stock option exercises using the treasury stock method, as determined under the if-converted method.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The computation of basic and diluted EPS is as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.748%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:77.168%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.683%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.325%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,009)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Income (Loss) Attributable to Virtus Investment Partners, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic: Weighted-average number of shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plus: Incremental shares from assumed conversion of dilutive instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted: Weighted-average number of shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (Loss) per Share&#x2014;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.19&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.33&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (Loss) per Share&#x2014;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.21&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table details the securities that have been excluded from the above computation of weighted-average number of shares for diluted EPS, because the effect would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.871%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:76.935%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.435%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.692%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.438%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total anti-dilutive securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;40&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-552">&lt;div style="margin-bottom:5pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The computation of basic and diluted EPS is as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.748%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:77.168%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.683%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.325%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,009)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Income (Loss) Attributable to Virtus Investment Partners, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic: Weighted-average number of shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plus: Incremental shares from assumed conversion of dilutive instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted: Weighted-average number of shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (Loss) per Share&#x2014;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.19&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.33&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (Loss) per Share&#x2014;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.21&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-3" id="f-553" unitRef="usd">37867000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-17" decimals="-3" id="f-554" unitRef="usd">34643000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-555" unitRef="usd">8009000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-17" decimals="-3" id="f-556" unitRef="usd">-3981000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-1" decimals="-3" id="f-557" unitRef="usd">29858000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-17" decimals="-3" id="f-558" unitRef="usd">38624000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-3" id="f-559" unitRef="shares">7119000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-17" decimals="-3" id="f-560" unitRef="shares">7245000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-1" decimals="-3" id="f-561" unitRef="shares">168000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-17" decimals="-3" id="f-562" unitRef="shares">165000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-3" id="f-563" unitRef="shares">7287000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-17" decimals="-3" id="f-564" unitRef="shares">7410000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-565"
      unitRef="usdPerShare">4.19</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-17"
      decimals="2"
      id="f-566"
      unitRef="usdPerShare">5.33</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-567"
      unitRef="usdPerShare">4.10</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-17"
      decimals="2"
      id="f-568"
      unitRef="usdPerShare">5.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="c-1" id="f-569">&lt;div style="margin-bottom:5pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table details the securities that have been excluded from the above computation of weighted-average number of shares for diluted EPS, because the effect would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.871%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:76.935%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.435%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.692%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.438%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total anti-dilutive securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;40&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-146"
      decimals="-3"
      id="f-570"
      unitRef="shares">1000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-147"
      decimals="-3"
      id="f-571"
      unitRef="shares">40000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-1" decimals="-3" id="f-572" unitRef="shares">1000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-17" decimals="-3" id="f-573" unitRef="shares">40000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-574">Income Taxes&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In calculating the provision for income taxes, the Company uses an estimate of the annual effective tax rate based upon the facts and circumstances at each interim period.  On a quarterly basis, the estimated annual effective tax rate is adjusted, as appropriate, based upon changes in facts and circumstances, if any, compared to those forecasted at the beginning of the fiscal year and at each interim period thereafter.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes reflected U.S. federal, state and local taxes at an estimated effective tax rate of 18.9% and 20.1% for the three months ended March&#160;31, 2024 and 2023, respectively.  The lower estimated effective tax rate for the three months ended March 31, 2024 was primarily due to excess tax benefits associated with stock-based compensation and the change in valuation allowances in the current year related to the tax effects of unrealized gains on certain Company investments.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-1" decimals="3" id="f-575" unitRef="number">0.189</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-17" decimals="3" id="f-576" unitRef="number">0.201</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:DebtDisclosureTextBlock contextRef="c-1" id="f-577">Debt&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Credit Agreement &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's credit agreement, as amended (the "Credit Agreement"), comprises (i) a $275.0 million term loan with a seven-year term (the "Term Loan") expiring in September 2028, and (ii) a $175.0 million revolving credit facility with a five-year term expiring in September 2026.  The Company repaid $0.7&#160;million outstanding under the Term Loan during the three months ended March&#160;31, 2024 and had $258.1 million outstanding under the Term Loan at March&#160;31, 2024.  In accordance with ASC 835, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest&lt;/span&gt;, the amounts outstanding under the Company's Term Loan are presented on the Condensed Consolidated Balance Sheet net of related debt issuance costs, which were $5.1 million as of March&#160;31, 2024.</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-148" decimals="INF" id="f-578" unitRef="usd">275000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm contextRef="c-149" id="f-579">P7Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-150" decimals="INF" id="f-580" unitRef="usd">175000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm contextRef="c-151" id="f-581">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:RepaymentsOfDebt contextRef="c-152" decimals="-5" id="f-582" unitRef="usd">700000</us-gaap:RepaymentsOfDebt>
    <us-gaap:LineOfCredit contextRef="c-153" decimals="-5" id="f-583" unitRef="usd">258100000</us-gaap:LineOfCredit>
    <us-gaap:DeferredFinanceCostsGross contextRef="c-154" decimals="-5" id="f-584" unitRef="usd">5100000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-585">Commitments and Contingencies&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Legal Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is involved from time to time in litigation and arbitration, as well as examinations, inquiries and investigations by various regulatory bodies, involving its compliance with, among other things, securities laws, client investment guidelines, laws governing the activities of broker-dealers and other laws and regulations affecting its products and other activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records a liability when it is both probable that a liability has been incurred and the amount of the liability can be reasonably estimated.  Significant judgment is required in both the determination of probability and the determination as to whether a loss is reasonably estimable.  Based on information currently available, available insurance coverage, indemnities and established reserves, the Company believes that the outcomes of its legal and regulatory proceedings are not likely, either individually or in the aggregate, to have a material adverse effect on the Company's results of operations, cash flows or its consolidated financial condition.  However, in the event of unexpected subsequent developments, and given the inherent unpredictability of these legal and regulatory matters, the Company can provide no assurance that its assessment of any legal matter will reflect the ultimate outcome, and an adverse outcome in certain matters could have a material adverse effect on the Company's results of operations or cash flows in particular quarterly or annual periods.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:MinorityInterestDisclosureTextBlock contextRef="c-1" id="f-586">Redeemable Noncontrolling Interests&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Redeemable noncontrolling interests represent third-party investments in the Company's CIP and minority interests held in a consolidated affiliate.  Minority interests held in the affiliate are subject to holder put rights and Company call rights at established multiples of earnings before interest, taxes, depreciation and amortization and, as such, are considered redeemable at other than fair value.  The rights are exercisable at pre-established intervals or upon certain conditions, such as retirement.  The put and call rights are not legally detachable or separately exercisable and are deemed to be embedded in the related noncontrolling interests.  The Company, in purchasing affiliate equity, has the option to settle in cash or shares of the Company's common stock and is entitled to the cash flow associated with any purchased equity.  These minority interests in the affiliate are recorded at estimated redemption value within redeemable noncontrolling interests on the Company's Condensed Consolidated Balance Sheets, and any changes in the estimated redemption value are recorded on the Condensed Consolidated Statements of Operations within noncontrolling interests.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Redeemable noncontrolling interests for the three months ended March&#160;31, 2024 included the following amounts:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.906%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.881%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.562%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.143%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.562%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.143%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.562%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.147%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;CIP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Affiliate Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in redemption value (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net income (loss) attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Affiliate equity sales (purchases)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(419)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(419)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net subscriptions (redemptions) and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances at March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;35,189&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;79,996&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;115,185&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) &#160;&#160;&#160;&#160;Relates to noncontrolling interests redeemable at other than fair value.&lt;/span&gt;&lt;/div&gt;</us-gaap:MinorityInterestDisclosureTextBlock>
    <vrts:NoncontrollingInterestPolicyTextBlock contextRef="c-1" id="f-587">Redeemable noncontrolling interests represent third-party investments in the Company's CIP and minority interests held in a consolidated affiliate.  Minority interests held in the affiliate are subject to holder put rights and Company call rights at established multiples of earnings before interest, taxes, depreciation and amortization and, as such, are considered redeemable at other than fair value.  The rights are exercisable at pre-established intervals or upon certain conditions, such as retirement.  The put and call rights are not legally detachable or separately exercisable and are deemed to be embedded in the related noncontrolling interests.  The Company, in purchasing affiliate equity, has the option to settle in cash or shares of the Company's common stock and is entitled to the cash flow associated with any purchased equity.  These minority interests in the affiliate are recorded at estimated redemption value within redeemable noncontrolling interests on the Company's Condensed Consolidated Balance Sheets, and any changes in the estimated redemption value are recorded on the Condensed Consolidated Statements of Operations within noncontrolling interests.</vrts:NoncontrollingInterestPolicyTextBlock>
    <us-gaap:RedeemableNoncontrollingInterestTableTextBlock contextRef="c-1" id="f-588">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Redeemable noncontrolling interests for the three months ended March&#160;31, 2024 included the following amounts:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.906%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.881%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.562%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.143%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.562%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.143%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.562%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.147%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;CIP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Affiliate Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in redemption value (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net income (loss) attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Affiliate equity sales (purchases)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(419)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(419)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net subscriptions (redemptions) and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances at March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;35,189&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;79,996&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;115,185&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) &#160;&#160;&#160;&#160;Relates to noncontrolling interests redeemable at other than fair value.&lt;/span&gt;&lt;/div&gt;</us-gaap:RedeemableNoncontrollingInterestTableTextBlock>
    <us-gaap:RedeemableNoncontrollingInterestEquityRedemptionValue contextRef="c-8" decimals="-3" id="f-589" unitRef="usd">30643000</us-gaap:RedeemableNoncontrollingInterestEquityRedemptionValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityRedemptionValue contextRef="c-155" decimals="-3" id="f-590" unitRef="usd">74226000</us-gaap:RedeemableNoncontrollingInterestEquityRedemptionValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityRedemptionValue contextRef="c-6" decimals="-3" id="f-591" unitRef="usd">104869000</us-gaap:RedeemableNoncontrollingInterestEquityRedemptionValue>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest contextRef="c-20" decimals="-3" id="f-592" unitRef="usd">1429000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest contextRef="c-156" decimals="-3" id="f-593" unitRef="usd">1829000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-594" unitRef="usd">3258000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:MinorityInterestChangeInRedemptionValue contextRef="c-157" decimals="-3" id="f-595" unitRef="usd">0</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue contextRef="c-158" decimals="-3" id="f-596" unitRef="usd">4360000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue contextRef="c-159" decimals="-3" id="f-597" unitRef="usd">4360000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:TemporaryEquityNetIncome contextRef="c-20" decimals="-3" id="f-598" unitRef="usd">1429000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:TemporaryEquityNetIncome contextRef="c-156" decimals="-3" id="f-599" unitRef="usd">6189000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:TemporaryEquityNetIncome contextRef="c-1" decimals="-3" id="f-600" unitRef="usd">7618000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates contextRef="c-20" decimals="-3" id="f-601" unitRef="usd">0</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
    <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates contextRef="c-156" decimals="-3" id="f-602" unitRef="usd">419000</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
    <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates contextRef="c-1" decimals="-3" id="f-603" unitRef="usd">419000</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
    <vrts:NoncontrollingInterestSubscriptionsRedemptionsAndOther contextRef="c-20" decimals="-3" id="f-604" unitRef="usd">-3117000</vrts:NoncontrollingInterestSubscriptionsRedemptionsAndOther>
    <vrts:NoncontrollingInterestSubscriptionsRedemptionsAndOther contextRef="c-156" decimals="-3" id="f-605" unitRef="usd">0</vrts:NoncontrollingInterestSubscriptionsRedemptionsAndOther>
    <vrts:NoncontrollingInterestSubscriptionsRedemptionsAndOther contextRef="c-1" decimals="-3" id="f-606" unitRef="usd">-3117000</vrts:NoncontrollingInterestSubscriptionsRedemptionsAndOther>
    <us-gaap:RedeemableNoncontrollingInterestEquityRedemptionValue contextRef="c-7" decimals="-3" id="f-607" unitRef="usd">35189000</us-gaap:RedeemableNoncontrollingInterestEquityRedemptionValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityRedemptionValue contextRef="c-160" decimals="-3" id="f-608" unitRef="usd">79996000</us-gaap:RedeemableNoncontrollingInterestEquityRedemptionValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityRedemptionValue contextRef="c-5" decimals="-3" id="f-609" unitRef="usd">115185000</us-gaap:RedeemableNoncontrollingInterestEquityRedemptionValue>
    <srt:CondensedFinancialStatementsTextBlock contextRef="c-1" id="f-610">Consolidation&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements include the accounts of the Company, its subsidiaries and investment products that are consolidated.  A voting interest entity ("VOE") is consolidated when the Company is considered to have a controlling financial interest, which is typically present when the Company owns a majority of the voting interest in an entity or otherwise has the power to govern the financial and operating policies of the entity.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates any variable interest entity ("VIE") in which the Company has a variable interest for consolidation.  A VIE is an entity in which either (i) the equity investment at risk is not sufficient to permit the entity to finance its own activities without additional financial support, or (ii) where as a group, the holders of the equity investment at risk do not possess any one of the following: (a) the power through voting or similar rights to direct the activities that most significantly impact the entity's economic performance, (b) the obligation to absorb expected losses or the right to receive expected residual returns of the entity, or (c) proportionate voting and economic interests and where substantially all of the entity's activities either involve or are conducted on behalf of an investor with disproportionately fewer voting rights.  If an entity has any of these characteristics, it is considered a VIE and is required to be consolidated by its primary beneficiary.  The primary beneficiary is the entity that has both the power to direct the activities that most significantly impact the VIE's economic performance and has the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of its business, the Company sponsors various investment products, some of which are consolidated by the Company.  CIP includes both VOEs, made up primarily of U.S. retail funds and ETFs in which the Company holds a controlling financial interest, and VIEs, which consist of collateralized loan obligations ("CLO") and certain global and private funds ("GF") of which the Company is considered the primary beneficiary.  The consolidation and deconsolidation of these investment products have no impact on the Company's net income (loss).  The Company's risk with respect to these investment products is limited to its beneficial interests in these products.  The Company has no right to the benefits from, and does not bear the risks associated with, these investment products beyond the Company's investments in, and fees generated from, these products.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the balances of CIP that, after intercompany eliminations, were reflected on the Condensed Consolidated Balance Sheets as of March&#160;31, 2024 and December&#160;31, 2023:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.321%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:30.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.102%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.873%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.096%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.873%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.096%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.873%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.102%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.026%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.096%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.026%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.103%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;VOEs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;VIEs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;VOEs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;VIEs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;CLOs &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;GFs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;CLOs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;GFs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,962,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,972,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,922,051)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,922,243)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Securities purchased payable and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88,270)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,999)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(740)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(89,167)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(616)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,311)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,351)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,878)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,316)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,327)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net interests in CIP&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;29,148&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;98,003&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;56,840&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;24,326&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;96,655&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;58,607&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Consolidated CLOs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of the Company's CIP that are VIEs are CLOs.  The financial information of certain CLOs is included on the Company's condensed consolidated financial statements on a one-month lag based upon the availability of their financial information.  A majority-owned consolidated private fund, whose primary purpose is to invest in CLOs for which the Company serves as the collateral manager, is also included.  At March&#160;31, 2024, the Company consolidated seven CLOs.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments of CLOs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The CLOs held investments of $2.0 billion at March&#160;31, 2024, consisting of bank loan investments that comprise the majority of the CLOs' portfolio asset collateral and are senior secured corporate loans across a variety of industries.  These bank loan investments mature at various dates between 2024 and 2032 and generally pay interest at SOFR plus a spread.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Notes Payable of CLOs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The CLOs held notes payable with a total value, at par, of $2.1 billion at March&#160;31, 2024, consisting of senior secured floating rate notes payable with a par value of $1.9 billion and subordinated notes with a par value of $215.1 million.  These note obligations bear interest at variable rates based on SOFR plus a pre-defined spread. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's beneficial interests and maximum exposure to loss related to these consolidated CLOs is limited to (i) ownership in the subordinated notes and (ii) accrued management fees.  The secured notes of the consolidated CLOs have contractual recourse only to the related assets of the CLO and are classified as financial liabilities.  Although these beneficial interests are eliminated upon consolidation, the application of the measurement alternative prescribed by ASU 2014-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Consolidation (Topic 810)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; ("ASU 2014-13"), results in the net assets of the consolidated CLOs shown above to be equivalent to the beneficial interests retained by the Company at March&#160;31, 2024, as shown in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.818%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:27.747%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subordinated notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued investment management fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Beneficial Interests&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;98,003&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents income and expenses of the consolidated CLOs included on the Company&#x2019;s Condensed Consolidated Statements of Operations for the period indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.719%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.897%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.903%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Realized and unrealized gain (loss), net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(391)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Income (Loss) Attributable to CLOs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,380&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents the Company&#x2019;s own economic interests in the consolidated CLOs, which are eliminated upon consolidation:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.719%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.897%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.903%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributions received and unrealized gains (losses) on the subordinated notes held by the Company&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment management fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Economic Interests&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,380&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:11.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Measurements of CIP&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The assets and liabilities of CIP measured at fair value on a recurring basis as of March&#160;31, 2024 and December&#160;31, 2023 by fair value hierarchy level were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;As of March&#160;31, 2024 &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.812%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.556%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.479%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.596%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.798%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.596%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.479%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.596%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.800%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,003,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,051,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;149,383&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,003,963&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;47,793&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,201,139&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,922,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,922,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;485&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,922,051&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,922,536&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;As of December&#160;31, 2023 &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.812%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.556%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.479%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.596%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.798%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.596%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.479%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.596%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.800%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,012,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,049,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;130,984&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,012,768&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;37,062&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,180,814&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,922,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,922,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;518&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,922,243&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,922,761&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a discussion of the valuation methodologies used for the assets and liabilities of the Company&#x2019;s CIP measured at fair value:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1 assets represent cash investments in money market funds and debt and equity investments that are valued using published net asset values or the official closing price on the exchange on which the securities are traded.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2 assets represent most debt securities (including bank loans) and certain equity securities (including non-U.S. securities), for which closing prices are not readily available or are deemed to not reflect readily available market prices, and are valued using an independent pricing service.  Debt investments, other than bank loans, are valued based on quotations received from independent pricing services or from dealers who make markets in such securities.  Bank loan investments, which are included as debt investments, are generally priced at the average mid-point of bid and ask quotations obtained from a third-party pricing service.  Fair value may also be based upon valuations obtained from independent third-party brokers or dealers utilizing matrix pricing models that consider information regarding securities with similar characteristics.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3 assets include debt and equity securities that are not widely traded, are illiquid or are priced by dealers based on pricing models used by market makers in the security.  These securities are valued using unadjusted prices from an independent pricing service.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1 liabilities consist of short sales transactions in which a security is sold that is not owned or is owned but there is no intention to deliver, in anticipation that the price of the security will decline.  Short sales are recorded on the Condensed Consolidated Balance Sheets within other liabilities of CIP and are classified as Level 1 based on the underlying equity security.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2 liabilities consist of notes payable issued by CLOs and are measured using the measurement alternative in ASU 2014-13.  Accordingly, the fair value of CLO liabilities was measured as the fair value of CLO assets less the sum of (i) the fair value of the beneficial interests held by the Company, and (ii) the carrying value of any beneficial interests that represent compensation for services.  The fair value of the beneficial interests held by the Company is based on third-party pricing information without adjustment.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The securities purchased payable at March&#160;31, 2024 and December&#160;31, 2023 approximated fair value due to the short-term nature of the instruments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a reconciliation of assets of CIP for Level 3 investments for which significant unobservable inputs were used to determine fair value:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.912%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.890%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.341%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.926%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.343%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Realized and unrealized gains (losses), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(324)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,625)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,195)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers to Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,468)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,747)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers from Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at end of period (1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;47,793&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,658&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:108pt;padding-right:90pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8pt"&gt;The investments that are categorized as Level 3 were valued utilizing third-party pricing information without adjustment.  Transfers in and/or out of levels are reflected when significant inputs, including market inputs or performance attributes, used for the fair value measurement become observable/unobservable at period end.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:11.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Nonconsolidated VIEs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company serves as the collateral manager for other CLOs that are not consolidated.  The assets and liabilities of these CLOs reside in bankruptcy remote, special purpose entities in which the Company has no ownership of, nor holds any notes issued by, the CLOs, and provides neither recourse nor guarantees.  The Company has determined that the investment management fees it receives for serving as collateral manager for these CLOs did not represent a variable interest as (i) the fees the Company earns are compensation for services provided and are commensurate with the level of effort required to provide the investment management services, (ii) the Company does not hold other interests in the CLOs that individually, or in the aggregate, would absorb more than an insignificant amount of the CLOs' expected losses or receive more than an insignificant amount of the CLOs' expected residual return, and (iii) the investment management arrangement only includes terms, conditions and amounts that are customarily present in arrangements for similar services negotiated at arm's length. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;The Company has interests in certain other VIEs that the Company does not consolidate as it is not the primary beneficiary since its interest in these entities does not provide the Company with the power to direct the activities that most significantly impact the entities' economic performance.  At March&#160;31, 2024, the carrying value and maximum risk of loss related to the Company's interest in these VIEs was $29.1 million.</srt:CondensedFinancialStatementsTextBlock>
    <srt:ScheduleOfCondensedBalanceSheetTableTextBlock contextRef="c-1" id="f-611">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the balances of CIP that, after intercompany eliminations, were reflected on the Condensed Consolidated Balance Sheets as of March&#160;31, 2024 and December&#160;31, 2023:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.321%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:30.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.102%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.873%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.096%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.873%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.096%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.873%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.102%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.026%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.096%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.026%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.103%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;VOEs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;VIEs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;VOEs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;VIEs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;CLOs &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;GFs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;CLOs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;GFs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,962,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,972,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,922,051)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,922,243)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Securities purchased payable and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88,270)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,999)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(740)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(89,167)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(616)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,311)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,351)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,878)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,316)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,327)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net interests in CIP&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;29,148&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;98,003&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;56,840&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;24,326&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;96,655&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;58,607&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</srt:ScheduleOfCondensedBalanceSheetTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-161" decimals="-3" id="f-612" unitRef="usd">1271000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-162" decimals="-3" id="f-613" unitRef="usd">119914000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-163" decimals="-3" id="f-614" unitRef="usd">2612000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-164" decimals="-3" id="f-615" unitRef="usd">1223000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-165" decimals="-3" id="f-616" unitRef="usd">98101000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-166" decimals="-3" id="f-617" unitRef="usd">2088000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:Investments contextRef="c-161" decimals="-3" id="f-618" unitRef="usd">40591000</us-gaap:Investments>
    <us-gaap:Investments contextRef="c-162" decimals="-3" id="f-619" unitRef="usd">1962697000</us-gaap:Investments>
    <us-gaap:Investments contextRef="c-163" decimals="-3" id="f-620" unitRef="usd">77937000</us-gaap:Investments>
    <us-gaap:Investments contextRef="c-164" decimals="-3" id="f-621" unitRef="usd">30985000</us-gaap:Investments>
    <us-gaap:Investments contextRef="c-165" decimals="-3" id="f-622" unitRef="usd">1972342000</us-gaap:Investments>
    <us-gaap:Investments contextRef="c-166" decimals="-3" id="f-623" unitRef="usd">79386000</us-gaap:Investments>
    <us-gaap:OtherAssets contextRef="c-161" decimals="-3" id="f-624" unitRef="usd">616000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets contextRef="c-162" decimals="-3" id="f-625" unitRef="usd">30064000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets contextRef="c-163" decimals="-3" id="f-626" unitRef="usd">1168000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets contextRef="c-164" decimals="-3" id="f-627" unitRef="usd">174000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets contextRef="c-165" decimals="-3" id="f-628" unitRef="usd">41985000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets contextRef="c-166" decimals="-3" id="f-629" unitRef="usd">1076000</us-gaap:OtherAssets>
    <us-gaap:NotesPayable contextRef="c-161" decimals="-3" id="f-630" unitRef="usd">0</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="c-162" decimals="-3" id="f-631" unitRef="usd">1922051000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="c-163" decimals="-3" id="f-632" unitRef="usd">0</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="c-164" decimals="-3" id="f-633" unitRef="usd">0</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="c-165" decimals="-3" id="f-634" unitRef="usd">1922243000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="c-166" decimals="-3" id="f-635" unitRef="usd">0</us-gaap:NotesPayable>
    <vrts:SecuritiesPurchasedPayable contextRef="c-161" decimals="-3" id="f-636" unitRef="usd">1019000</vrts:SecuritiesPurchasedPayable>
    <vrts:SecuritiesPurchasedPayable contextRef="c-162" decimals="-3" id="f-637" unitRef="usd">88270000</vrts:SecuritiesPurchasedPayable>
    <vrts:SecuritiesPurchasedPayable contextRef="c-163" decimals="-3" id="f-638" unitRef="usd">1999000</vrts:SecuritiesPurchasedPayable>
    <vrts:SecuritiesPurchasedPayable contextRef="c-164" decimals="-3" id="f-639" unitRef="usd">740000</vrts:SecuritiesPurchasedPayable>
    <vrts:SecuritiesPurchasedPayable contextRef="c-165" decimals="-3" id="f-640" unitRef="usd">89167000</vrts:SecuritiesPurchasedPayable>
    <vrts:SecuritiesPurchasedPayable contextRef="c-166" decimals="-3" id="f-641" unitRef="usd">616000</vrts:SecuritiesPurchasedPayable>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-161" decimals="-3" id="f-642" unitRef="usd">12311000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-162" decimals="-3" id="f-643" unitRef="usd">4351000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-163" decimals="-3" id="f-644" unitRef="usd">22878000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-164" decimals="-3" id="f-645" unitRef="usd">7316000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-165" decimals="-3" id="f-646" unitRef="usd">4363000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-166" decimals="-3" id="f-647" unitRef="usd">23327000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <vrts:NetInterestInInvestmentProducts contextRef="c-161" decimals="-3" id="f-648" unitRef="usd">29148000</vrts:NetInterestInInvestmentProducts>
    <vrts:NetInterestInInvestmentProducts contextRef="c-162" decimals="-3" id="f-649" unitRef="usd">98003000</vrts:NetInterestInInvestmentProducts>
    <vrts:NetInterestInInvestmentProducts contextRef="c-163" decimals="-3" id="f-650" unitRef="usd">56840000</vrts:NetInterestInInvestmentProducts>
    <vrts:NetInterestInInvestmentProducts contextRef="c-164" decimals="-3" id="f-651" unitRef="usd">24326000</vrts:NetInterestInInvestmentProducts>
    <vrts:NetInterestInInvestmentProducts contextRef="c-165" decimals="-3" id="f-652" unitRef="usd">96655000</vrts:NetInterestInInvestmentProducts>
    <vrts:NetInterestInInvestmentProducts contextRef="c-166" decimals="-3" id="f-653" unitRef="usd">58607000</vrts:NetInterestInInvestmentProducts>
    <vrts:NumberofCollateralizedLoanObligationsConsolidated
      contextRef="c-162"
      decimals="INF"
      id="f-654"
      unitRef="collateralized_loan_obligation">7</vrts:NumberofCollateralizedLoanObligationsConsolidated>
    <us-gaap:Investments contextRef="c-162" decimals="-8" id="f-655" unitRef="usd">2000000000</us-gaap:Investments>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-167" decimals="-8" id="f-656" unitRef="usd">2100000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-168" decimals="-8" id="f-657" unitRef="usd">1900000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-169" decimals="-5" id="f-658" unitRef="usd">215100000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ScheduleOfVariableInterestEntitiesTextBlock contextRef="c-1" id="f-659">Although these beneficial interests are eliminated upon consolidation, the application of the measurement alternative prescribed by ASU 2014-13, &lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Consolidation (Topic 810)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; ("ASU 2014-13"), results in the net assets of the consolidated CLOs shown above to be equivalent to the beneficial interests retained by the Company at March&#160;31, 2024, as shown in the table below:&lt;/span&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.818%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:27.747%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subordinated notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued investment management fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Beneficial Interests&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;98,003&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents income and expenses of the consolidated CLOs included on the Company&#x2019;s Condensed Consolidated Statements of Operations for the period indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.719%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.897%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.903%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Realized and unrealized gain (loss), net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(391)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Income (Loss) Attributable to CLOs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,380&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents the Company&#x2019;s own economic interests in the consolidated CLOs, which are eliminated upon consolidation:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.719%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.897%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.903%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributions received and unrealized gains (losses) on the subordinated notes held by the Company&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment management fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Economic Interests&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,380&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfVariableInterestEntitiesTextBlock>
    <vrts:VariableInterestEntityReportingEntityInvolvementBeneficialInterestsSubordinatedDebtAmount contextRef="c-162" decimals="-3" id="f-660" unitRef="usd">96416000</vrts:VariableInterestEntityReportingEntityInvolvementBeneficialInterestsSubordinatedDebtAmount>
    <vrts:VariableInterestEntityReportingEntityInvolvementBeneficialInterestsDeferredRevenueAmount contextRef="c-162" decimals="-3" id="f-661" unitRef="usd">1587000</vrts:VariableInterestEntityReportingEntityInvolvementBeneficialInterestsDeferredRevenueAmount>
    <vrts:VariableInterestEntityReportingEntityInvolvementBeneficialInterestsAmount contextRef="c-162" decimals="-3" id="f-662" unitRef="usd">98003000</vrts:VariableInterestEntityReportingEntityInvolvementBeneficialInterestsAmount>
    <us-gaap:GainLossOnInvestments contextRef="c-170" decimals="-3" id="f-663" unitRef="usd">1000</us-gaap:GainLossOnInvestments>
    <us-gaap:InvestmentIncomeInterestAndDividend contextRef="c-170" decimals="-3" id="f-664" unitRef="usd">49280000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:Revenues contextRef="c-170" decimals="-3" id="f-665" unitRef="usd">49281000</us-gaap:Revenues>
    <us-gaap:OtherCostAndExpenseOperating contextRef="c-170" decimals="-3" id="f-666" unitRef="usd">499000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:InterestExpense contextRef="c-170" decimals="-3" id="f-667" unitRef="usd">40011000</us-gaap:InterestExpense>
    <vrts:OperatingandNonoperatingExpense contextRef="c-170" decimals="-3" id="f-668" unitRef="usd">40510000</vrts:OperatingandNonoperatingExpense>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-170" decimals="-3" id="f-669" unitRef="usd">391000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-170" decimals="-3" id="f-670" unitRef="usd">8380000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <vrts:VariableInterestEntityMeasureofActivityDistributionsReceivedandUnrealizedGainsLossesOnInvestment contextRef="c-170" decimals="-3" id="f-671" unitRef="usd">6083000</vrts:VariableInterestEntityMeasureofActivityDistributionsReceivedandUnrealizedGainsLossesOnInvestment>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues contextRef="c-170" decimals="-3" id="f-672" unitRef="usd">2297000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax contextRef="c-170" decimals="-3" id="f-673" unitRef="usd">8380000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-171" decimals="-3" id="f-674" unitRef="usd">119914000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-172" decimals="-3" id="f-675" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-173" decimals="-3" id="f-676" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-174" decimals="-3" id="f-677" unitRef="usd">119914000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-175" decimals="-3" id="f-678" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-176" decimals="-3" id="f-679" unitRef="usd">2003579000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-177" decimals="-3" id="f-680" unitRef="usd">47551000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-178" decimals="-3" id="f-681" unitRef="usd">2051130000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-179" decimals="-3" id="f-682" unitRef="usd">29469000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-180" decimals="-3" id="f-683" unitRef="usd">384000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-181" decimals="-3" id="f-684" unitRef="usd">242000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-182" decimals="-3" id="f-685" unitRef="usd">30095000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-171" decimals="-3" id="f-686" unitRef="usd">149383000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-172" decimals="-3" id="f-687" unitRef="usd">2003963000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-173" decimals="-3" id="f-688" unitRef="usd">47793000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-174" decimals="-3" id="f-689" unitRef="usd">2201139000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:NotesPayableFairValueDisclosure contextRef="c-171" decimals="-3" id="f-690" unitRef="usd">0</us-gaap:NotesPayableFairValueDisclosure>
    <us-gaap:NotesPayableFairValueDisclosure contextRef="c-172" decimals="-3" id="f-691" unitRef="usd">1922051000</us-gaap:NotesPayableFairValueDisclosure>
    <us-gaap:NotesPayableFairValueDisclosure contextRef="c-173" decimals="-3" id="f-692" unitRef="usd">0</us-gaap:NotesPayableFairValueDisclosure>
    <us-gaap:NotesPayableFairValueDisclosure contextRef="c-174" decimals="-3" id="f-693" unitRef="usd">1922051000</us-gaap:NotesPayableFairValueDisclosure>
    <us-gaap:FinancialInstrumentsSoldNotYetPurchasedAtFairValue contextRef="c-171" decimals="-3" id="f-694" unitRef="usd">485000</us-gaap:FinancialInstrumentsSoldNotYetPurchasedAtFairValue>
    <us-gaap:FinancialInstrumentsSoldNotYetPurchasedAtFairValue contextRef="c-172" decimals="-3" id="f-695" unitRef="usd">0</us-gaap:FinancialInstrumentsSoldNotYetPurchasedAtFairValue>
    <us-gaap:FinancialInstrumentsSoldNotYetPurchasedAtFairValue contextRef="c-173" decimals="-3" id="f-696" unitRef="usd">0</us-gaap:FinancialInstrumentsSoldNotYetPurchasedAtFairValue>
    <us-gaap:FinancialInstrumentsSoldNotYetPurchasedAtFairValue contextRef="c-174" decimals="-3" id="f-697" unitRef="usd">485000</us-gaap:FinancialInstrumentsSoldNotYetPurchasedAtFairValue>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-171" decimals="-3" id="f-698" unitRef="usd">485000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-172" decimals="-3" id="f-699" unitRef="usd">1922051000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-173" decimals="-3" id="f-700" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-174" decimals="-3" id="f-701" unitRef="usd">1922536000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-183" decimals="-3" id="f-702" unitRef="usd">98101000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-184" decimals="-3" id="f-703" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-185" decimals="-3" id="f-704" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-186" decimals="-3" id="f-705" unitRef="usd">98101000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-187" decimals="-3" id="f-706" unitRef="usd">241000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-188" decimals="-3" id="f-707" unitRef="usd">2012760000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-189" decimals="-3" id="f-708" unitRef="usd">36616000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-190" decimals="-3" id="f-709" unitRef="usd">2049617000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-191" decimals="-3" id="f-710" unitRef="usd">32642000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-192" decimals="-3" id="f-711" unitRef="usd">8000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-193" decimals="-3" id="f-712" unitRef="usd">446000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-194" decimals="-3" id="f-713" unitRef="usd">33096000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-183" decimals="-3" id="f-714" unitRef="usd">130984000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-184" decimals="-3" id="f-715" unitRef="usd">2012768000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-185" decimals="-3" id="f-716" unitRef="usd">37062000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-186" decimals="-3" id="f-717" unitRef="usd">2180814000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:NotesPayableFairValueDisclosure contextRef="c-183" decimals="-3" id="f-718" unitRef="usd">0</us-gaap:NotesPayableFairValueDisclosure>
    <us-gaap:NotesPayableFairValueDisclosure contextRef="c-184" decimals="-3" id="f-719" unitRef="usd">1922243000</us-gaap:NotesPayableFairValueDisclosure>
    <us-gaap:NotesPayableFairValueDisclosure contextRef="c-185" decimals="-3" id="f-720" unitRef="usd">0</us-gaap:NotesPayableFairValueDisclosure>
    <us-gaap:NotesPayableFairValueDisclosure contextRef="c-186" decimals="-3" id="f-721" unitRef="usd">1922243000</us-gaap:NotesPayableFairValueDisclosure>
    <us-gaap:FinancialInstrumentsSoldNotYetPurchasedAtFairValue contextRef="c-183" decimals="-3" id="f-722" unitRef="usd">518000</us-gaap:FinancialInstrumentsSoldNotYetPurchasedAtFairValue>
    <us-gaap:FinancialInstrumentsSoldNotYetPurchasedAtFairValue contextRef="c-184" decimals="-3" id="f-723" unitRef="usd">0</us-gaap:FinancialInstrumentsSoldNotYetPurchasedAtFairValue>
    <us-gaap:FinancialInstrumentsSoldNotYetPurchasedAtFairValue contextRef="c-185" decimals="-3" id="f-724" unitRef="usd">0</us-gaap:FinancialInstrumentsSoldNotYetPurchasedAtFairValue>
    <us-gaap:FinancialInstrumentsSoldNotYetPurchasedAtFairValue contextRef="c-186" decimals="-3" id="f-725" unitRef="usd">518000</us-gaap:FinancialInstrumentsSoldNotYetPurchasedAtFairValue>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-183" decimals="-3" id="f-726" unitRef="usd">518000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-184" decimals="-3" id="f-727" unitRef="usd">1922243000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-185" decimals="-3" id="f-728" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-186" decimals="-3" id="f-729" unitRef="usd">1922761000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="c-1" id="f-730">&lt;div style="margin-bottom:5pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a reconciliation of assets of CIP for Level 3 investments for which significant unobservable inputs were used to determine fair value:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.912%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.890%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.341%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.926%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.343%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Realized and unrealized gains (losses), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(324)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,625)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,195)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers to Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,468)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,747)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers from Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at end of period (1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;47,793&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,658&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:108pt;padding-right:90pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8pt"&gt;The investments that are categorized as Level 3 were valued utilizing third-party pricing information without adjustment.  Transfers in and/or out of levels are reflected when significant inputs, including market inputs or performance attributes, used for the fair value measurement become observable/unobservable at period end.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue contextRef="c-195" decimals="-3" id="f-731" unitRef="usd">37062000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue contextRef="c-196" decimals="-3" id="f-732" unitRef="usd">43581000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements contextRef="c-197" decimals="-3" id="f-733" unitRef="usd">-324000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements contextRef="c-198" decimals="-3" id="f-734" unitRef="usd">111000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases contextRef="c-197" decimals="-3" id="f-735" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases contextRef="c-198" decimals="-3" id="f-736" unitRef="usd">4000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales contextRef="c-197" decimals="-3" id="f-737" unitRef="usd">14625000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales contextRef="c-198" decimals="-3" id="f-738" unitRef="usd">7195000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 contextRef="c-197" decimals="-3" id="f-739" unitRef="usd">13468000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 contextRef="c-198" decimals="-3" id="f-740" unitRef="usd">35747000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 contextRef="c-197" decimals="-3" id="f-741" unitRef="usd">39148000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 contextRef="c-198" decimals="-3" id="f-742" unitRef="usd">9904000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue contextRef="c-199" decimals="-3" id="f-743" unitRef="usd">47793000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue contextRef="c-200" decimals="-3" id="f-744" unitRef="usd">10658000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:ConsolidationVariableInterestEntityPolicy contextRef="c-1" id="f-745">&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Nonconsolidated VIEs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company serves as the collateral manager for other CLOs that are not consolidated.  The assets and liabilities of these CLOs reside in bankruptcy remote, special purpose entities in which the Company has no ownership of, nor holds any notes issued by, the CLOs, and provides neither recourse nor guarantees.  The Company has determined that the investment management fees it receives for serving as collateral manager for these CLOs did not represent a variable interest as (i) the fees the Company earns are compensation for services provided and are commensurate with the level of effort required to provide the investment management services, (ii) the Company does not hold other interests in the CLOs that individually, or in the aggregate, would absorb more than an insignificant amount of the CLOs' expected losses or receive more than an insignificant amount of the CLOs' expected residual return, and (iii) the investment management arrangement only includes terms, conditions and amounts that are customarily present in arrangements for similar services negotiated at arm's length. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;The Company has interests in certain other VIEs that the Company does not consolidate as it is not the primary beneficiary since its interest in these entities does not provide the Company with the power to direct the activities that most significantly impact the entities' economic performance.</us-gaap:ConsolidationVariableInterestEntityPolicy>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount contextRef="c-201" decimals="-5" id="f-746" unitRef="usd">29100000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-1" id="f-747">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-1" id="f-748">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-1" id="f-749">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-1" id="f-750">false</ecd:Rule10b51ArrTrmntdFlag>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
